data_2ky4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ky4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.729 0.299 . . . . 75.22 110.63 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.74 110.83 21.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.269 0.557 . . . . 75.32 111.355 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.43 167.15 26.99 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.314 1.046 . . . . 64.13 109.088 169.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -85.72 117.06 24.37 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.778 0.431 . . . . 73.51 110.255 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 10' ' ' ILE . 61.7 t -89.08 136.99 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.194 -1.039 . . . . 74.25 108.194 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.11 82.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.313 0.578 . . . . 72.41 110.805 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.09 -18.75 0.4 Allowed Glycine 0 CA--C 1.536 1.367 0 CA-C-N 115.474 -0.785 . . . . 45.42 113.533 -172.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.496 HG13 ' HB ' ' A' ' 7' ' ' VAL . 55.8 mt -73.69 88.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.016 0.908 . . . . 72.11 110.982 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -94.63 2.57 55.61 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.555 0.742 . . . . 74.31 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -79.88 121.02 24.9 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.284 0.634 . . . . 72.32 111.083 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -68.98 -26.76 65.19 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.703 0.401 . . . . 73.45 111.492 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.04 -48.81 64.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.285 0.634 . . . . 64.1 111.074 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.75 84.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.973 0.509 . . . . 74.54 111.596 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.527 HG13 ' HA2' ' A' ' 49' ' ' GLY . 29.3 mm -55.96 -49.6 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.601 0.76 . . . . 74.23 111.367 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -67.73 -27.85 67.14 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.269 0.47 . . . . 73.25 112.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.4 m -69.96 -40.09 75.61 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.197 0.522 . . . . 74.23 111.259 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.71 -39.4 84.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.49 1.116 . . . . 74.24 110.418 172.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 16' ' ' ILE . 92.6 mt -70.23 -40.62 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.529 1.132 . . . . 72.31 111.911 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.1 m -64.74 -38.71 91.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.158 0.583 . . . . 71.3 111.155 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.6 96.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.496 -0.775 . . . . 61.4 111.405 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.67 -30.76 70.94 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.539 0.736 . . . . 70.03 112.177 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.62 -48.76 75.99 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.813 0.445 . . . . 73.01 111.182 170.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -70.76 -15.12 62.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.064 0.546 . . . . 74.31 111.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -85.32 -53.62 5.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.183 0.593 . . . . 74.42 111.27 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.808 HD11 HG23 ' A' ' 59' ' ' ILE . 65.0 mt -82.35 -66.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.078 0.551 . . . . 65.32 111.353 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 22.7 m-85 -66.39 -14.56 62.3 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.955 0.902 . . . . 73.31 111.813 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 70.68 -50.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.025 1.73 . . . . 73.14 112.717 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -61.28 143.46 55.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.204 1.002 . . . . 74.13 113.273 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.55 114.32 9.5 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.614 -1.176 . . . . 73.23 108.779 162.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.4 mt -90.85 129.14 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.584 -0.524 . . . . 72.14 109.584 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.27 125.47 81.69 Favored Pre-proline 0 CA--C 1.557 1.214 0 O-C-N 123.951 0.782 . . . . 74.11 111.029 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.27 -32.21 32.15 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.751 2.968 . . . . 75.21 115.34 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -71.04 -29.55 65.49 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.191 0.441 . . . . 71.35 112.191 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.86 -44.83 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 122.749 0.42 . . . . 71.53 109.908 170.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.5 72.57 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.846 0.858 . . . . 73.12 112.619 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -79.87 -18.76 49.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.354 0.501 . . . . 74.22 112.354 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -80.47 -31.04 37.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 70.22 111.653 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.28 -55.44 3.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.045 0.538 . . . . 74.54 112.242 -174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -117.55 19.69 13.83 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.72 1.378 . . . . 71.23 114.72 -169.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.7 p -66.23 -30.2 70.6 Favored 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 120.554 1.525 . . . . 73.24 112.171 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.91 41.63 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.732 -0.667 . . . . 74.21 112.364 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -81.1 -31.51 34.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.81 1.244 . . . . 75.13 111.467 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -37.37 81.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.165 1.386 . . . . 75.25 111.765 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.6 p -59.01 -38.66 79.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.312 0.645 . . . . 72.04 112.024 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -63.17 -38.29 90.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.065 0.546 . . . . 75.24 111.897 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.473 HD11 HG23 ' A' ' 55' ' ' VAL . 42.4 tp -72.96 -42.94 62.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.702 0.287 . . . . 73.15 111.267 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.527 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -69.64 -35.43 74.3 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.357 -0.383 . . . . 70.33 113.904 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -92.58 -19.18 22.19 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.293 0.637 . . . . 73.13 111.314 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.06 19.33 26.63 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 115.783 1.073 . . . . 72.21 115.783 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.14 -29.55 67.62 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 118.226 1.013 . . . . 65.24 112.212 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.432 HD11 ' HD1' ' A' ' 58' ' ' PHE . 27.1 pt -120.68 169.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.322 0.649 . . . . 72.33 111.034 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 29.8 p -91.94 172.32 8.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.828 -0.624 . . . . 75.04 110.389 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.473 HG23 HD11 ' A' ' 48' ' ' LEU . 58.6 t -71.56 -39.56 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 116.399 -0.364 . . . . 73.53 110.573 175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HE2' HG11 ' A' ' 120' ' ' VAL . 54.7 tttm -53.95 -50.49 66.37 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.36 0.664 . . . . 75.23 112.522 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -34.22 76.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.216 0.606 . . . . 65.33 111.979 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.432 ' HD1' HD11 ' A' ' 53' ' ' ILE . 63.7 t80 -63.42 -50.61 69.14 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.141 0.576 . . . . 64.43 111.024 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.808 HG23 HD11 ' A' ' 27' ' ' ILE . 49.2 mt -70.11 -39.49 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.861 1.264 . . . . 64.43 112.57 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.79 -38.77 86.43 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.366 0.666 . . . . 74.33 110.085 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.58 -32.99 85.0 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 116.137 -0.483 . . . . 64.52 114.212 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.493 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 84.2 mt -66.61 -37.92 85.89 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.185 0.517 . . . . 73.4 110.875 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.8 -23.93 67.77 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-N 115.34 -0.845 . . . . 74.13 114.116 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -82.34 -18.74 41.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.616 0.766 . . . . 75.05 112.061 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 t -60.35 119.7 8.47 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.306 0.854 . . . . 75.1 113.306 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.76 -16.41 57.67 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 123.597 0.759 . . . . 74.3 112.038 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.98 -49.51 75.8 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.025 0.53 . . . . 74.32 111.094 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.76 -47.57 84.2 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.217 0.607 . . . . 62.34 111.32 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.498 ' HG ' HG12 ' A' ' 112' ' ' ILE . 2.1 mm? -71.94 -29.45 64.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.052 0.76 . . . . 62.1 113.052 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.31 -37.41 83.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.219 0.533 . . . . 75.54 110.704 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -50.09 10.86 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.216 0.821 . . . . 63.44 113.216 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.94 34.13 5.32 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.838 1.051 . . . . 75.12 113.838 -167.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -154.48 -58.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.647 0.61 . . . . 74.1 112.647 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.4 p -65.32 -35.61 12.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 113.853 1.057 . . . . 70.33 113.853 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -92.05 -4.51 3.8 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 121.875 1.717 . . . . 74.54 113.657 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -101.88 146.72 32.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 C-N-CA 123.827 0.851 . . . . 75.41 112.157 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.06 147.5 73.64 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.273 1.982 . . . . 75.01 111.537 168.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -55.88 -39.7 71.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.473 0.709 . . . . 74.13 112.677 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.441 ' HA ' HD13 ' A' ' 82' ' ' ILE . 40.8 m -61.05 -38.9 87.82 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.98 0.912 . . . . 72.13 113.316 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -69.64 -32.3 70.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.191 -0.318 . . . . 74.4 111.725 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.5 -32.45 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.307 0.643 . . . . 75.34 110.033 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.511 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 93.6 mt -64.15 -53.5 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.488 0.715 . . . . 75.05 112.422 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -68.73 -42.5 77.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.165 0.432 . . . . 75.41 112.165 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.76 -32.93 70.24 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.313 0.645 . . . . 75.43 111.922 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.0 -47.03 57.03 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 112.172 -0.371 . . . . 75.34 112.172 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.548 HG23 HD13 ' A' ' 90' ' ' LEU . 86.7 m -67.28 -36.75 82.21 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.245 1.018 . . . . 72.24 111.136 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -55.97 -41.93 75.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.703 0.801 . . . . 75.43 112.186 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 49.1 m170 -78.58 -29.52 46.22 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 113.021 0.749 . . . . 74.51 113.021 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -100.54 -63.62 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.227 0.825 . . . . 75.04 113.227 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.548 HD13 HG23 ' A' ' 86' ' ' THR . 77.0 mt -77.08 -25.75 52.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 74.43 112.354 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.94 12.75 81.14 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 123.143 0.277 . . . . 70.25 113.208 -170.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -112.61 159.51 18.79 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.044 0.937 . . . . 74.31 110.423 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.67 154.9 62.12 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.245 0.618 . . . . 75.23 109.861 164.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.7 144.92 97.48 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.067 1.845 . . . . 72.42 112.226 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.5 mp -71.79 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.156 0.582 . . . . 75.33 110.868 -168.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -126.09 173.55 9.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.758 0.823 . . . . 64.32 109.46 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 60.8 tp60 -62.42 -31.66 72.39 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 122.798 0.439 . . . . 73.33 111.072 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.44 -35.75 73.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.674 0.79 . . . . 45.22 111.331 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -60.97 -44.94 96.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 74.41 110.235 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.9 mt -58.35 -44.28 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 114.866 -1.061 . . . . 73.14 110.998 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.1 mtt-85 -62.72 -33.64 75.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.87 0.468 . . . . 74.41 111.688 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' HZ2' ' HB3' ' A' ' 102' ' ' LYS . 7.7 ttpm? -70.6 -53.02 17.59 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.136 0.273 . . . . 75.0 111.483 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -59.78 -36.92 77.7 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.826 0.45 . . . . 74.44 111.803 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.25 -40.68 94.31 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.993 0.917 . . . . 72.44 110.757 176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -69.53 -43.88 72.11 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.575 0.75 . . . . 74.2 111.599 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 98.0 mt -61.99 -47.43 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.281 1.032 . . . . 74.33 110.771 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.5 tp -61.04 -40.4 93.47 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.982 -1.008 . . . . 71.51 112.087 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.52 -44.71 77.72 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.991 0.517 . . . . 70.05 112.115 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.9 p -84.86 -65.65 0.99 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.421 0.688 . . . . 75.42 111.588 -174.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.93 -57.07 4.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.96 0.504 . . . . 73.44 111.207 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.27 -174.7 20.52 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 121.301 0.389 . . . . 73.52 113.704 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.498 HG12 ' HG ' ' A' ' 69' ' ' LEU . 10.8 tp -69.97 -31.54 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 113.124 0.787 . . . . 75.4 113.124 -170.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -65.74 -34.45 78.2 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.425 0.29 . . . . 72.4 111.452 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.08 -31.26 58.67 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.036 0.534 . . . . 73.14 111.492 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.511 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 56.6 t80 -64.55 -55.45 20.42 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.626 0.771 . . . . 72.22 111.444 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.85 -44.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 122.88 0.472 . . . . 72.0 110.716 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.21 -34.08 71.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.824 0.449 . . . . 72.23 111.583 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.63 80.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.057 0.543 . . . . 70.02 111.858 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.86 -36.34 78.01 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.385 0.674 . . . . 73.52 111.863 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.509 HG11 ' HE2' ' A' ' 56' ' ' LYS . 98.6 t -80.52 -32.48 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.972 0.909 . . . . 73.02 111.655 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.86 4.53 52.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.22 0.608 . . . . 74.31 112.047 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.7 t -62.83 129.47 40.61 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.372 -0.603 . . . . 60.13 109.372 164.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -53.9 -35.18 61.36 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.434 0.694 . . . . 74.11 112.659 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.26 -41.79 85.05 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 123.512 0.507 . . . . 71.14 111.642 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -63.52 -56.41 16.22 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.454 0.302 . . . . 71.23 110.921 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -66.14 -36.46 83.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.143 0.794 . . . . 75.04 113.143 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HG3' HG22 ' A' ' 128' ' ' VAL . 12.9 pt-20 -71.76 -32.88 68.15 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.023 0.749 . . . . 71.15 113.023 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 127' ' ' GLU . 93.6 t -100.56 -64.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 118.34 0.518 . . . . 74.33 111.696 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -99.45 67.1 1.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.736 0.815 . . . . 72.11 109.887 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.03 -156.06 0.49 Allowed Glycine 0 N--CA 1.483 1.796 0 N-CA-C 115.169 0.828 . . . . 63.14 115.169 -174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -79.21 21.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.576 0.954 . . . . 74.12 113.576 -176.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.18 -36.62 0.9 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.832 1.253 . . . . 74.11 110.809 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.3 m -91.97 137.31 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.813 0.672 . . . . 71.33 112.813 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.8 t -80.34 132.26 59.68 Favored Pre-proline 0 CA--C 1.561 1.376 0 C-N-CA 123.946 0.898 . . . . 75.43 110.355 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.576 ' HD2' HD12 ' A' ' 59' ' ' ILE . 55.6 Cg_endo -66.72 84.66 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.889 2.393 . . . . 73.11 113.82 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.6 p90 . . . . . 0 N--CA 1.478 0.97 0 CA-C-N 115.808 -0.633 . . . . 74.41 110.721 172.841 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.508 -0.553 . . . . 64.24 109.508 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.01 87.15 1.84 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 116.047 -0.524 . . . . 75.04 110.502 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -120.91 148.04 44.61 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.606 0.762 . . . . 74.34 110.044 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -95.87 91.87 6.24 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.332 0.586 . . . . 74.42 111.075 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.18 112.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-N 115.0 -1.0 . . . . 75.3 109.961 164.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.5 90.1 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.118 0.967 . . . . 63.15 113.111 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -46.08 -29.33 3.38 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 115.689 1.035 . . . . 70.1 115.689 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.07 130.57 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 109.363 -0.606 . . . . 53.03 109.363 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB3' ' HZ3' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -116.74 -27.49 6.63 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.882 0.473 . . . . 73.23 111.088 -176.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -32.75 114.7 0.17 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.593 1.557 . . . . 63.21 113.57 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HE3' ' HA3' ' A' ' 49' ' ' GLY . 14.4 mmmm -67.95 -12.1 60.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.915 0.486 . . . . 73.35 112.169 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.03 76.7 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.772 0.829 . . . . 73.51 110.895 171.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.54 62.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.191 0.596 . . . . 72.43 110.963 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.439 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.9 mp -60.09 -45.51 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.36 0.664 . . . . 72.34 110.714 169.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.16 -50.49 73.84 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.359 0.663 . . . . 72.51 112.168 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -62.39 -34.45 76.76 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.115 0.566 . . . . 74.34 111.286 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.419 ' HG ' HG21 ' A' ' 134' ' ' VAL . 9.9 tp -62.39 -45.68 92.06 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.644 0.778 . . . . 64.44 111.022 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 16' ' ' ILE . 67.4 mt -72.04 -34.1 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.265 1.026 . . . . 74.2 111.519 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -68.26 -42.72 79.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.207 0.603 . . . . 75.13 110.294 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.42 90.96 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.657 0.783 . . . . 73.11 111.238 172.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.99 97.93 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.47 0.708 . . . . 71.02 111.845 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -65.93 -49.38 68.16 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.119 0.568 . . . . 75.22 111.929 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -69.83 -15.51 63.11 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.756 0.65 . . . . 75.41 112.756 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -94.54 -47.31 6.6 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 122.971 0.508 . . . . 75.01 111.54 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 83.0 mt -83.14 -58.57 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.061 0.544 . . . . 74.33 111.934 -174.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.498 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 8.7 m-85 -73.31 -16.06 61.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.816 0.446 . . . . 74.24 110.654 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 66.49 17.44 10.65 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.196 1.398 . . . . 75.41 111.968 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -153.4 143.77 22.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 74.5 110.158 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.56 141.11 48.43 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 120.913 0.387 . . . . 62.11 110.098 165.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.4 mt -106.17 141.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 108.712 -0.847 . . . . 73.24 108.712 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.37 117.08 10.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.877 0.871 . . . . 64.11 111.28 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.32 -38.22 86.1 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.375 2.716 . . . . 73.32 113.505 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -63.56 -26.93 68.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.843 0.857 . . . . 74.41 112.744 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -83.31 -47.16 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 123.06 0.544 . . . . 72.24 110.564 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.7 68.86 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.312 1.045 . . . . 51.34 113.365 -173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -75.51 -25.85 57.62 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.165 0.432 . . . . 70.21 112.165 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -81.46 -44.17 17.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.861 0.465 . . . . 74.32 111.599 173.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -58.48 -54.01 51.89 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.614 0.721 . . . . 74.15 111.175 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -99.7 45.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.872 -1.058 . . . . 74.11 110.175 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 p -61.55 -49.62 75.93 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.273 0.629 . . . . 64.15 112.286 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 -45.91 9.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.612 -0.722 . . . . 61.24 112.638 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -66.04 -37.81 86.81 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.513 1.301 . . . . 74.22 114.513 -170.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -65.04 -46.8 79.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.18 -0.674 . . . . 73.14 109.18 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 m -59.21 -35.67 74.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.7 0.8 . . . . 60.24 111.943 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -59.29 -42.09 90.5 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.818 0.847 . . . . 75.15 112.388 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD11 HG22 ' A' ' 55' ' ' VAL . 42.2 tp -74.04 -45.51 49.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.809 0.444 . . . . 74.14 111.342 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' ' HE3' ' A' ' 13' ' ' LYS . . . -64.03 -31.95 82.54 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.874 0.749 . . . . 54.12 114.376 -174.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.93 -18.87 29.78 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.306 0.643 . . . . 72.5 111.275 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.75 31.73 35.3 Favored Glycine 0 C--N 1.355 1.609 0 CA-C-N 117.731 0.241 . . . . 72.41 113.538 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -88.39 -18.96 27.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.334 0.654 . . . . 73.31 111.884 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.8 pt -122.53 163.94 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.94 0.896 . . . . 74.34 110.327 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p -77.18 152.16 34.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.954 -0.387 . . . . 74.33 109.954 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 48' ' ' LEU . 40.1 t -64.01 -32.22 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.17 0.588 . . . . 72.13 110.081 175.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 1.5 tmtp? -54.08 -48.24 70.86 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.248 1.019 . . . . 73.2 111.457 171.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.92 -37.85 72.92 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.068 -0.515 . . . . 70.43 110.941 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.78 -51.84 66.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.389 0.675 . . . . 72.55 111.257 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.437 HG22 HD13 ' A' ' 27' ' ' ILE . 26.5 mm -56.03 -38.58 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.848 1.259 . . . . 74.23 111.512 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -67.52 -39.49 85.1 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.064 -0.516 . . . . 74.24 110.949 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.72 -23.07 75.64 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 113.844 0.298 . . . . 71.45 113.844 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 79.0 mt -67.63 -23.11 65.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.528 0.731 . . . . 75.12 110.975 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -87.73 -14.07 63.82 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.453 -1.249 . . . . 73.22 113.032 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -92.81 -3.68 54.28 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.85 0.86 . . . . 71.13 111.012 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -73.32 112.59 9.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.349 0.659 . . . . 72.42 110.778 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.97 -18.1 63.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.731 0.412 . . . . 72.34 111.741 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.42 -51.73 68.23 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.943 0.497 . . . . 72.33 110.47 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -59.64 -45.63 91.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.972 0.909 . . . . 75.31 112.015 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 63' ' ' GLY . 2.5 mm? -71.21 -29.17 64.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 112.365 0.506 . . . . 74.32 112.365 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.96 -38.95 92.66 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 121.879 -0.513 . . . . 74.13 110.565 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.95 -54.62 7.53 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 113.21 0.818 . . . . 74.52 113.21 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -117.07 36.89 4.03 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 114.06 1.133 . . . . 72.24 114.06 -168.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -159.29 -42.92 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.831 0.453 . . . . 73.31 111.507 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -65.96 -45.62 63.89 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 112.641 0.608 . . . . 73.2 112.641 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.55 12.23 1.37 Allowed 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.556 2.171 . . . . 72.21 113.689 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.475 ' HD2' ' HG2' ' A' ' 80' ' ' LYS . 80.9 m-85 -122.62 140.78 33.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 123.27 0.628 . . . . 73.43 111.965 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.45 159.55 46.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.946 2.43 . . . . 72.35 112.574 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -49.77 -52.5 31.44 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.922 0.889 . . . . 71.11 113.045 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.579 ' HA ' HD13 ' A' ' 82' ' ' ILE . 62.7 m -53.86 -43.01 69.18 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.942 1.09 . . . . 74.41 113.942 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.475 ' HG2' ' HD2' ' A' ' 76' ' ' TYR . 58.8 tptt -65.08 -36.75 85.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.378 0.51 . . . . 64.21 112.378 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.24 -26.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.779 0.431 . . . . 75.21 110.203 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.579 HD13 ' HA ' ' A' ' 79' ' ' THR . 95.4 mt -68.44 -52.84 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.604 0.761 . . . . 74.43 111.974 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 84' ' ' LEU . 5.1 pt-20 -64.64 -43.56 93.26 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.697 0.226 . . . . 72.33 110.96 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.413 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 22.7 mt -60.2 -41.1 92.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.391 0.677 . . . . 73.22 111.289 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.26 -51.09 55.73 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.74 -0.209 . . . . 74.04 112.713 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.531 HG23 HD12 ' A' ' 90' ' ' LEU . 37.5 m -67.53 -38.02 83.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.633 0.773 . . . . 73.04 111.162 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -53.93 -36.32 62.65 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.69 1.196 . . . . 74.41 112.784 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 53.2 m170 -89.47 -43.03 11.13 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.452 0.701 . . . . 75.44 112.771 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -92.23 -46.68 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.009 0.524 . . . . 74.34 112.014 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.531 HD12 HG23 ' A' ' 86' ' ' THR . 48.6 mt -97.73 -7.02 31.67 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.986 0.514 . . . . 74.2 111.717 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 27.21 72.41 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 115.162 0.825 . . . . 51.44 115.162 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -154.46 177.79 10.79 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 117.501 0.651 . . . . 75.33 112.285 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.72 150.76 54.17 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.674 0.79 . . . . 63.54 111.942 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.76 136.07 47.72 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.487 2.125 . . . . 74.42 110.922 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.16 -66.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.317 0.647 . . . . 73.43 111.451 -166.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 99' ' ' GLU . 8.9 m-20 -93.07 165.03 13.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.295 0.638 . . . . 75.04 111.922 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 50.3 tp60 -67.27 -33.9 76.28 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 109.457 -0.571 . . . . 71.11 109.457 163.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.71 73.37 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.452 0.701 . . . . 75.21 111.518 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.48 ' H ' ' HB2' ' A' ' 96' ' ' ASP . 12.2 tp10 -61.87 -42.02 98.55 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.851 0.861 . . . . 73.52 110.347 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.491 HG21 HG23 ' A' ' 79' ' ' THR . 72.1 mt -63.94 -46.13 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 114.914 -1.039 . . . . 73.43 110.905 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 28.5 mmm180 -63.04 -32.2 73.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.275 0.63 . . . . 72.34 111.72 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -66.71 -51.11 59.73 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.551 0.34 . . . . 74.34 111.124 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -65.02 -29.26 70.15 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.425 0.29 . . . . 73.15 111.722 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -68.66 -41.68 78.96 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.216 1.006 . . . . 74.14 110.467 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -72.08 -39.51 68.91 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.395 -0.821 . . . . 75.24 111.146 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 92.3 mt -67.12 -44.42 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.332 0.653 . . . . 74.52 110.975 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.25 -38.81 92.62 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.541 0.736 . . . . 72.3 110.819 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.59 -54.6 9.94 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 112.403 0.52 . . . . 70.13 112.403 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.8 p -83.38 -20.15 34.76 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.401 0.889 . . . . 71.11 113.401 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -114.98 -64.78 1.27 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 122.975 0.51 . . . . 70.45 111.088 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.96 -177.99 28.65 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 120.991 -0.623 . . . . 74.11 114.115 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.0 tp -72.9 -31.35 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.577 0.751 . . . . 73.24 111.441 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -64.66 -30.99 72.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.035 0.534 . . . . 73.03 111.435 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.51 67.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.737 0.815 . . . . 71.12 110.678 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 82' ' ' ILE . 54.4 t80 -60.79 -50.29 74.04 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.391 1.076 . . . . 71.23 112.392 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.95 -45.3 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.979 0.512 . . . . 64.32 111.216 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.06 -34.36 77.84 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.838 -0.619 . . . . 73.24 111.011 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.2 87.7 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.375 0.67 . . . . 63.52 112.139 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.9 mt -76.22 -51.39 12.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.264 0.625 . . . . 71.35 112.295 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.76 -20.52 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 121.125 0.488 . . . . 74.44 111.941 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -97.78 21.48 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.386 0.674 . . . . 75.31 111.963 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.0 m -83.06 153.93 24.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.951 -0.468 . . . . 73.15 111.846 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.52 -44.47 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.436 1.094 . . . . 74.51 111.632 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.422 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 30.9 tp10 -54.08 -52.86 59.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.459 -0.791 . . . . 73.04 111.902 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -64.86 -39.88 94.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 120.523 0.201 . . . . 71.51 110.582 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -60.9 -63.38 1.32 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.482 0.713 . . . . 72.15 111.742 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -76.33 -36.87 58.05 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 113.037 0.754 . . . . 73.14 113.037 -170.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.76 -27.93 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.008 0.523 . . . . 72.34 112.251 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -118.9 -78.49 0.59 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.936 -0.478 . . . . 62.02 110.498 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.1 170.46 15.83 Favored Glycine 0 N--CA 1.474 1.191 0 N-CA-C 112.399 -0.28 . . . . 74.24 112.399 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -73.22 -11.71 60.61 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.736 0.643 . . . . 74.51 112.736 -178.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.02 -10.75 19.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.034 0.934 . . . . 75.25 112.392 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.8 m -116.22 140.24 49.52 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.266 0.839 . . . . 64.45 113.266 -168.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.432 HG23 HD13 ' A' ' 59' ' ' ILE . 58.6 t -83.56 150.63 60.27 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 125.966 1.706 . . . . 71.45 110.623 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.3 90.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.729 2.286 . . . . 74.3 112.6 161.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.3 p90 . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 123.694 0.798 . . . . 75.03 111.984 -175.316 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 107.783 -1.192 . . . . 74.3 107.783 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -74.9 106.34 6.37 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.128 0.571 . . . . 72.22 110.826 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.59 154.54 42.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.487 0.715 . . . . 74.21 110.223 175.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -70.96 147.2 48.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.142 0.973 . . . . 71.31 111.929 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.9 t -120.47 119.14 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.559 -1.645 . . . . 74.22 106.559 163.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.95 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.677 0.791 . . . . 74.13 112.177 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.57 -24.15 2.78 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.401 -0.818 . . . . 74.32 112.266 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.13 59.03 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 123.344 1.545 . . . . 73.01 109.845 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -80.28 8.47 7.38 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.189 -1.823 . . . . 72.44 113.28 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.91 133.08 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.029 0.532 . . . . 72.41 110.059 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 45.5 mtpt -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.154 0.798 . . . . 75.4 113.154 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.72 -53.02 62.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.053 0.541 . . . . 73.21 111.168 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.68 54.65 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.774 -0.648 . . . . 73.44 112.16 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 39.1 mm -57.91 -40.37 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 122.959 0.504 . . . . 74.44 111.643 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.6 ' HZ1' ' HB3' ' A' ' 17' ' ' LYS . 2.6 ttpm? -56.7 -48.81 76.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.735 0.814 . . . . 73.34 112.01 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 m -68.65 -33.03 73.3 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.164 0.586 . . . . 73.44 111.618 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.63 -43.85 97.77 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.812 0.845 . . . . 73.12 110.213 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -68.7 -33.72 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.372 1.069 . . . . 74.34 111.618 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 71.6 m -67.77 -41.58 83.04 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.253 0.621 . . . . 74.33 110.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.4 85.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.262 0.625 . . . . 73.54 111.478 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.52 -30.36 70.59 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.893 0.877 . . . . 73.43 112.272 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.5 ' HH ' ' HB2' ' A' ' 37' ' ' ALA . 22.5 m-85 -76.31 -37.69 57.07 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.401 0.519 . . . . 75.43 112.401 173.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' SER . 89.0 mtt180 -65.95 -26.49 67.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.523 0.729 . . . . 72.4 112.627 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.534 HE22 ' HG2' ' A' ' 135' ' ' PRO . 14.4 pt20 -85.59 -36.39 20.43 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 122.696 0.398 . . . . 75.13 111.895 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.517 HG12 ' HG3' ' A' ' 26' ' ' GLN . 46.2 mm -87.75 -63.27 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.359 0.664 . . . . 73.34 110.786 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.21 -4.75 54.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.817 0.847 . . . . 75.11 111.545 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 68.92 10.09 7.74 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.411 1.485 . . . . 74.05 112.909 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.56 144.83 25.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.42 0.628 . . . . 72.13 111.624 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -68.16 134.27 50.25 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.054 -0.976 . . . . 54.12 110.405 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.31 140.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 122.955 0.502 . . . . 75.31 110.185 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.93 129.26 91.13 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-N 115.063 -0.971 . . . . 71.35 110.839 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -54.95 -38.72 92.93 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.841 3.027 . . . . 61.01 115.181 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -64.73 -27.54 68.98 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.235 0.457 . . . . 71.55 112.235 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -79.82 -49.13 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.509 0.724 . . . . 72.23 110.037 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.5 ' HB2' ' HH ' ' A' ' 24' ' ' TYR . . . -58.46 -34.72 71.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.552 1.141 . . . . 63.44 113.232 -175.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.08 -26.17 56.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.926 0.49 . . . . 73.21 111.642 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -75.63 -33.52 60.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.474 0.31 . . . . 74.43 110.622 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -74.11 -53.65 9.47 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 116.016 -0.538 . . . . 73.31 111.06 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.537 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 78.9 m-85 -116.65 55.7 0.81 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.791 0.836 . . . . 73.34 111.847 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 98.7 p -62.67 -48.33 79.78 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.721 -0.612 . . . . 73.55 112.579 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.9 -40.73 13.76 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.837 -0.62 . . . . 61.42 112.418 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 21.6 t-105 -62.06 -42.0 98.74 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.324 1.05 . . . . 73.01 112.036 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.12 -46.52 88.11 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.27 1.028 . . . . 75.45 111.534 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.8 t -61.01 -41.93 97.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.488 -0.778 . . . . 62.14 111.601 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 53' ' ' ILE . 59.6 mtpt -65.29 -32.6 74.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 73.31 111.835 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.69 -45.05 60.79 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.725 0.298 . . . . 74.5 111.061 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.07 76.59 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.711 -0.677 . . . . 74.53 113.942 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -91.47 -20.06 22.16 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.808 0.843 . . . . 71.35 111.871 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.61 25.17 33.57 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 114.172 0.429 . . . . 74.04 114.172 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -69.58 -44.06 71.56 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.315 0.646 . . . . 73.24 110.179 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.419 HG22 ' HE2' ' A' ' 47' ' ' LYS . 32.6 pt -110.62 157.44 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.021 0.929 . . . . 75.14 110.081 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.9 t -90.15 167.25 12.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.566 0.346 . . . . 73.03 110.33 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 59' ' ' ILE . 66.2 t -61.79 -44.21 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 122.977 0.511 . . . . 73.21 111.134 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 64.1 tttm -55.39 -42.12 73.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.223 1.009 . . . . 73.32 112.815 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -69.42 -36.21 76.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.758 -0.655 . . . . 74.41 111.082 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.0 -47.08 86.38 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.733 0.813 . . . . 72.41 110.726 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 55' ' ' VAL . 47.7 mm -56.87 -45.55 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 124.431 1.093 . . . . 75.33 111.129 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.74 -44.24 93.88 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.402 -0.817 . . . . 72.55 110.871 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.02 -26.98 69.68 Favored Glycine 0 CA--C 1.543 1.782 0 N-CA-C 114.768 0.667 . . . . 72.31 114.768 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.02 -25.89 63.8 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.006 0.522 . . . . 74.52 110.933 172.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.33 -25.47 74.33 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.503 -0.771 . . . . 72.43 113.64 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.02 -7.45 59.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.637 0.775 . . . . 74.04 111.905 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.409 ' O ' HD21 ' A' ' 69' ' ' LEU . 57.3 p -74.41 134.55 42.39 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -56.69 -28.74 61.41 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.696 0.799 . . . . 72.54 112.29 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.6 tp -65.82 -46.71 77.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.93 0.492 . . . . 65.13 111.253 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.6 -35.51 79.11 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.191 0.52 . . . . 71.12 111.069 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 HG23 ' A' ' 112' ' ' ILE . 4.3 mm? -60.81 -48.35 82.18 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.8 0.84 . . . . 71.35 112.106 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -75.86 -30.59 58.95 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.489 0.551 . . . . 72.43 112.489 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.32 -47.04 45.82 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.897 0.703 . . . . 73.24 112.897 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.48 -55.33 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.794 1.035 . . . . 75.52 113.794 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.462 ' HE1' HD23 ' A' ' 107' ' ' LEU . 83.3 t80 -62.89 -33.41 75.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.057 0.762 . . . . 75.04 113.057 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.498 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 33.4 m -79.14 -55.1 0.95 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 118.549 -0.739 . . . . 63.51 112.721 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 11.9 Cg_exo -74.37 -5.06 16.38 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.657 2.238 . . . . 63.04 114.541 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -124.87 146.18 52.36 Favored Pre-proline 0 N--CA 1.494 1.726 0 C-N-CA 122.98 0.512 . . . . 74.42 111.884 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' O ' HG21 ' A' ' 81' ' ' VAL . 72.5 Cg_endo -72.44 168.5 24.13 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.822 2.348 . . . . 73.13 112.816 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -48.93 -54.77 14.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.402 1.081 . . . . 71.5 112.432 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.508 ' HA ' HD13 ' A' ' 82' ' ' ILE . 37.1 m -54.82 -40.05 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.935 0.894 . . . . 72.42 113.281 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -69.2 -32.0 70.98 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.088 0.403 . . . . 74.02 112.088 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 77' ' ' PRO . 59.0 t -69.39 -26.18 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.029 0.532 . . . . 74.32 109.997 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 79' ' ' THR . 61.0 mt -74.36 -52.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.724 0.809 . . . . 74.41 111.003 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -56.25 24.07 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.941 0.897 . . . . 72.4 112.261 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.96 -40.2 94.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.281 0.632 . . . . 74.24 111.323 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.68 -51.45 55.86 Favored Glycine 0 N--CA 1.474 1.219 0 O-C-N 123.481 0.488 . . . . 72.41 112.93 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.441 HG22 ' HG3' ' A' ' 94' ' ' PRO . 40.1 p -61.43 -36.46 80.41 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.522 0.729 . . . . 72.44 112.514 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 87' ' ' LYS . 8.9 mtmp? -73.0 -16.46 61.51 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.94 0.719 . . . . 73.34 112.94 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -86.27 -40.64 15.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.869 0.468 . . . . 74.32 111.319 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.411 ' HD1' HG21 ' A' ' 59' ' ' ILE . 88.4 m-85 -91.05 -64.74 1.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.343 0.592 . . . . 74.04 110.7 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.46 -10.01 59.2 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.008 0.923 . . . . 70.23 112.397 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.86 21.37 67.45 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 114.209 0.443 . . . . 72.31 114.209 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -149.47 169.92 19.78 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.875 0.87 . . . . 74.45 111.051 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.6 150.69 39.22 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.427 0.691 . . . . 71.12 110.264 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HG3' HG22 ' A' ' 86' ' ' THR . 32.9 Cg_exo -58.55 159.87 18.84 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.931 2.421 . . . . 65.0 112.712 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.43 -62.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.978 0.511 . . . . 70.13 111.542 -169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -133.85 163.21 30.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.636 0.775 . . . . 64.43 110.148 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -59.13 -33.12 70.5 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.848 0.859 . . . . 73.54 112.615 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.12 77.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.514 0.326 . . . . 65.34 111.803 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.9 -36.71 70.09 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.032 0.533 . . . . 73.43 111.111 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.22 -43.61 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.876 0.47 . . . . 71.4 110.077 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 mtm105 -66.27 -30.22 70.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.331 0.652 . . . . 73.22 111.804 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -62.56 -52.47 63.29 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.987 0.515 . . . . 75.13 111.094 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.09 -37.41 84.95 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.898 0.479 . . . . 74.14 111.514 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.37 -39.55 94.84 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.405 1.082 . . . . 70.43 110.863 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.427 HE21 HG23 ' A' ' 109' ' ' THR . 24.1 tp60 -67.74 -44.62 77.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.475 0.71 . . . . 73.41 111.104 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.89 -43.29 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.016 0.926 . . . . 74.44 111.61 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.462 HD23 ' HE1' ' A' ' 73' ' ' TYR . 6.8 tt -65.1 -41.07 95.28 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.224 0.61 . . . . 75.11 110.966 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.01 -38.54 86.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.738 0.415 . . . . 74.25 112.032 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.427 HG23 HE21 ' A' ' 105' ' ' GLN . 40.9 p -81.6 -69.59 0.6 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.775 0.83 . . . . 75.15 112.125 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.96 -35.3 24.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.98 0.912 . . . . 75.52 111.891 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.08 -172.41 14.88 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 121.119 0.288 . . . . 53.44 113.518 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 69' ' ' LEU . 7.4 tp -68.97 -38.21 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.558 0.743 . . . . 74.23 112.249 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -63.52 -42.89 98.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.322 0.649 . . . . 71.05 111.434 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.4 -32.67 66.57 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.713 -0.676 . . . . 73.15 110.636 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.448 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 32.8 t80 -61.78 -51.92 66.33 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 124.122 0.969 . . . . 75.11 112.269 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.9 mm -55.97 -51.77 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.85 0.86 . . . . 74.13 110.442 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -52.14 -49.05 64.5 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 115.23 -0.896 . . . . 75.43 111.86 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.77 67.88 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 73.04 112.787 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.48 -53.3 36.73 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.093 0.473 . . . . 73.42 110.585 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.476 HG11 ' NZ ' ' A' ' 56' ' ' LYS . 39.2 t -69.12 -18.54 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.792 0.837 . . . . 73.44 112.612 -171.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.16 13.65 2.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 73.31 112.766 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.7 p -77.34 136.56 38.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.326 0.651 . . . . 73.25 110.774 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.6 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 46.4 tt0 -68.71 -39.77 80.29 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.713 0.635 . . . . 72.51 112.713 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -53.89 -30.85 47.73 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.516 0.561 . . . . 74.1 112.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.28 -56.46 21.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.138 0.575 . . . . 74.4 110.527 172.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.6 ' ND2' ' HA ' ' A' ' 123' ' ' GLN . 10.4 p30 -73.87 -20.86 60.29 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 111.976 0.361 . . . . 73.33 111.976 -173.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 27.6 mm-40 -67.49 -59.15 3.61 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.149 0.499 . . . . 64.52 111.164 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -71.96 -61.0 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.598 -0.728 . . . . 73.22 111.574 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -84.43 -62.6 1.51 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.083 0.553 . . . . 73.12 110.46 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.26 173.47 27.39 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.615 -0.72 . . . . 63.34 112.657 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.31 -34.19 48.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.884 0.473 . . . . 75.33 111.606 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.25 -8.31 59.08 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.042 0.937 . . . . 61.05 112.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -113.05 143.95 43.45 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.384 0.674 . . . . 74.33 111.344 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.05 130.01 85.53 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.924 0.89 . . . . 74.32 109.248 170.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.534 ' HG2' HE22 ' A' ' 26' ' ' GLN . 89.9 Cg_exo -46.97 85.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.953 3.102 . . . . 74.24 115.71 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.1 p90 . . . . . 0 CA--C 1.552 1.02 0 CA-C-O 121.63 0.729 . . . . 73.41 109.036 172.356 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 136' ' ' TYR . 6.3 p . . . . . 0 CA--C 1.556 1.196 0 CA-C-O 121.803 0.811 . . . . 75.42 109.145 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -107.72 105.52 15.4 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.437 0.695 . . . . 73.31 112.011 -168.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -94.7 111.12 22.9 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.136 0.575 . . . . 73.21 111.417 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -62.23 131.18 48.55 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.226 0.536 . . . . 74.42 110.915 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.57 ' HB ' HG13 ' A' ' 10' ' ' ILE . 47.4 t -98.87 131.63 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.148 -0.686 . . . . 73.42 109.148 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.03 -36.16 2.4 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.717 1.006 . . . . 74.34 113.717 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.467 ' H ' HG11 ' A' ' 7' ' ' VAL . . . -70.96 -24.52 77.03 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.605 1.002 . . . . 74.51 115.605 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.57 HG13 ' HB ' ' A' ' 7' ' ' VAL . 71.9 mt -71.24 89.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 118.191 0.996 . . . . 75.23 110.71 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.48 6.64 0.58 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.654 1.353 . . . . 73.44 114.654 173.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.09 98.28 9.79 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.698 -0.626 . . . . 62.33 111.155 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -59.12 -24.93 63.42 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.802 0.841 . . . . 75.33 110.973 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -48.51 68.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.862 0.865 . . . . 74.45 111.082 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.26 67.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 75.21 112.414 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mm -61.01 -48.9 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.714 0.405 . . . . 73.53 109.916 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -61.37 -35.76 78.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.351 0.5 . . . . 74.45 112.351 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.5 m -65.65 -41.34 92.68 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.876 0.47 . . . . 75.43 111.23 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.56 -46.07 87.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.384 1.074 . . . . 70.42 111.116 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.494 HD13 ' HG2' ' A' ' 45' ' ' GLU . 91.6 mt -61.79 -43.29 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.908 1.283 . . . . 74.1 111.601 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.7 m -63.84 -45.12 90.95 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.633 -0.712 . . . . 71.32 110.297 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.4 71.24 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.808 0.843 . . . . 74.34 112.498 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.83 -43.55 81.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.309 0.644 . . . . 61.3 112.552 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.421 ' HE1' HD21 ' A' ' 62' ' ' LEU . 21.5 m-85 -60.94 -28.42 68.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.101 0.778 . . . . 72.03 113.101 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.81 -13.99 60.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.609 0.764 . . . . 75.21 112.007 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -118.32 -52.05 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.17 0.433 . . . . 72.35 112.17 169.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.46 HD11 ' O ' ' A' ' 88' ' ' HIS . 41.7 mm -55.8 -38.14 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 123.81 0.844 . . . . 75.42 112.197 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -114.72 2.83 14.55 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.643 0.777 . . . . 73.22 110.799 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 35.28 35.72 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 116.053 1.871 . . . . 74.12 116.053 -168.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.509 HH12 ' HG3' ' A' ' 71' ' ' GLU . 3.9 ptp85 -135.55 155.54 50.32 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.586 0.708 . . . . 74.24 111.635 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.97 96.26 8.79 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.909 -1.041 . . . . 72.15 109.541 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.74 134.32 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.038 -0.727 . . . . 74.12 109.038 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.35 126.78 87.16 Favored Pre-proline 0 CA--C 1.551 0.999 0 O-C-N 123.993 0.808 . . . . 72.4 110.238 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.49 -25.21 75.73 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.826 2.351 . . . . 70.52 112.857 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -79.2 -26.78 42.56 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.31 0.644 . . . . 52.33 112.21 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.7 mt -80.07 -39.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.053 0.541 . . . . 72.02 110.207 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.51 85.62 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.944 0.898 . . . . 60.03 111.709 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -72.93 -20.4 61.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.685 0.624 . . . . 72.13 112.685 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -75.87 -41.53 51.94 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.004 0.43 . . . . 62.01 110.639 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -76.57 -39.85 51.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.697 -0.683 . . . . 75.42 111.906 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 96.4 m-85 -116.66 26.62 9.72 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.675 0.991 . . . . 61.54 113.675 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -49.21 -49.83 41.16 Favored 'General case' 0 N--CA 1.515 2.78 0 N-CA-C 114.502 1.297 . . . . 70.14 114.502 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -75.1 -34.53 51.89 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.392 -0.367 . . . . 64.1 112.766 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -63.4 -31.64 72.85 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.201 1.001 . . . . 73.23 111.328 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HG2' HD13 ' A' ' 20' ' ' ILE . 47.7 mt-10 -70.45 -41.75 72.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.167 0.987 . . . . 71.32 110.67 172.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.9 t -61.84 -39.24 91.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 64.3 111.017 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.5 mmmm -60.16 -38.0 81.82 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.747 0.419 . . . . 74.54 110.726 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 55' ' ' VAL . 22.7 tp -73.25 -49.05 29.9 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.522 0.729 . . . . 75.31 111.942 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.37 73.59 Favored Glycine 0 N--CA 1.484 1.841 0 C-N-CA 123.315 0.483 . . . . 64.01 114.199 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -85.74 -19.11 31.28 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.444 0.697 . . . . 75.52 110.02 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.02 24.65 47.87 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.714 -1.13 . . . . 65.22 112.739 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -66.23 -40.04 89.97 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.003 0.921 . . . . 63.12 110.29 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 58' ' ' PHE . 22.2 pt -116.1 143.83 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.91 0.884 . . . . 74.44 110.123 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.448 HG21 ' H ' ' A' ' 57' ' ' GLU . 8.7 t -71.73 162.83 28.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.413 0.285 . . . . 73.42 111.24 163.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 59' ' ' ILE . 22.2 t -65.16 -34.54 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.231 0.212 . . . . 73.22 110.985 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.709 ' HZ1' ' HA ' ' A' ' 126' ' ' ASN . 26.8 tttp -50.43 -51.04 50.22 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.695 0.798 . . . . 74.04 113.059 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.448 ' H ' HG21 ' A' ' 54' ' ' THR . 29.1 tt0 -69.61 -31.2 69.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.474 0.71 . . . . 70.24 110.945 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HD2' HD11 ' A' ' 53' ' ' ILE . 36.9 t80 -57.85 -46.94 84.04 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.192 0.597 . . . . 72.12 110.93 170.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 55' ' ' VAL . 51.5 mm -60.69 -40.21 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.039 0.936 . . . . 72.33 111.308 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -54.34 -50.74 66.72 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 115.58 -0.737 . . . . 75.01 111.74 172.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.72 -28.62 57.14 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 115.063 0.785 . . . . 75.34 115.063 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.421 HD21 ' HE1' ' A' ' 24' ' ' TYR . 43.9 mt -71.65 -37.7 70.79 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.018 0.527 . . . . 70.32 110.988 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.91 -26.17 73.19 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 116.413 -0.358 . . . . 53.34 113.454 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.64 -3.17 55.83 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.896 0.879 . . . . 72.5 112.052 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -81.79 130.11 34.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.012 0.525 . . . . 70.14 111.798 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.37 -17.28 28.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.152 0.981 . . . . 75.14 112.371 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.69 -57.09 14.15 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.804 0.442 . . . . 74.14 111.198 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -58.73 -37.04 75.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.97 0.729 . . . . 74.01 112.97 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.612 HD12 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -61.89 -49.68 75.23 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.34 0.496 . . . . 74.14 112.34 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.94 -31.22 71.65 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 113.043 0.757 . . . . 74.43 113.043 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' HH12 ' A' ' 30' ' ' ARG . 19.7 mm-40 -87.93 -60.77 1.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.724 1.009 . . . . 75.22 113.724 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -111.77 60.16 0.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.746 0.703 . . . . 73.41 112.429 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 81' ' ' VAL . 58.6 t80 -165.57 -58.7 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.236 0.614 . . . . 74.3 110.293 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 m -63.75 -49.18 77.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 113.021 0.749 . . . . 74.14 113.021 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -86.98 13.34 2.73 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.016 1.811 . . . . 71.22 113.505 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -124.09 150.02 62.01 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.642 0.777 . . . . 70.31 111.455 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.82 165.78 31.8 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.412 2.074 . . . . 74.21 112.406 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.1 -34.76 78.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 73.33 112.517 -170.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.471 ' HA ' HD13 ' A' ' 82' ' ' ILE . 78.4 m -70.39 -38.37 74.66 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.536 0.734 . . . . 75.42 112.353 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.3 -34.42 76.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.147 -0.346 . . . . 74.31 111.601 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 73' ' ' TYR . 87.1 t -56.56 -34.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.595 0.758 . . . . 64.33 110.848 171.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 79' ' ' THR . 77.0 mt -74.04 -48.7 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.546 0.739 . . . . 74.23 111.917 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -58.06 6.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.215 0.45 . . . . 75.15 112.215 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.3 mt -61.85 -25.21 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.35 0.66 . . . . 73.23 111.047 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.7 -40.8 98.92 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 114.695 -1.138 . . . . 62.11 112.147 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -79.1 -44.52 21.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.256 0.623 . . . . 74.1 111.978 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 87' ' ' LYS . 7.0 mtpm? -61.77 -49.55 75.93 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.327 0.862 . . . . 73.14 113.327 -176.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' O ' HD11 ' A' ' 27' ' ' ILE . 11.8 m170 -61.59 -31.02 71.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.525 0.73 . . . . 72.03 112.534 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.593 ' HB3' HD12 ' A' ' 90' ' ' LEU . 1.1 t80 -98.96 -67.04 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.252 0.621 . . . . 75.03 112.088 -167.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.593 HD12 ' HB3' ' A' ' 89' ' ' PHE . 6.5 mp -77.32 -5.42 49.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.459 0.911 . . . . 74.33 113.459 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.57 33.04 75.69 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.054 0.252 . . . . 62.14 113.081 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.648 HH22 HG21 ' A' ' 128' ' ' VAL . 19.2 ptp180 -160.02 157.25 28.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.955 0.902 . . . . 73.43 111.297 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.82 153.09 95.81 Favored Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 109.944 -0.391 . . . . 72.55 109.944 168.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.15 167.14 4.84 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.451 2.101 . . . . 74.44 113.063 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 99' ' ' GLU . 2.6 mp -80.59 -53.34 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.108 0.563 . . . . 72.34 110.402 -169.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.47 165.14 10.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 74.01 109.187 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 58.2 tp60 -61.94 -30.25 70.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.854 0.462 . . . . 74.04 111.697 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.05 -45.47 88.67 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.058 0.543 . . . . 72.21 111.763 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.471 ' HG2' HD12 ' A' ' 95' ' ' ILE . 7.9 tp10 -62.55 -38.23 89.24 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.176 0.591 . . . . 75.42 111.303 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.449 HG21 HG23 ' A' ' 79' ' ' THR . 72.4 mt -60.58 -42.53 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.761 0.824 . . . . 71.32 111.209 173.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.6 mtt180 -58.13 -37.0 73.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.64 0.607 . . . . 71.22 112.64 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -62.08 -53.74 51.15 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 120.879 0.371 . . . . 75.13 110.59 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -62.38 -36.22 81.6 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.567 -0.742 . . . . 75.04 112.412 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.56 -38.95 91.04 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.529 0.732 . . . . 74.23 111.387 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -62.58 -38.5 90.38 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.582 -0.735 . . . . 75.13 110.506 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 81.9 mt -64.47 -48.64 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 123.589 0.756 . . . . 72.44 111.291 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.25 -37.09 66.77 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.137 0.575 . . . . 75.02 112.099 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.58 -48.53 32.08 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.191 0.596 . . . . 74.44 111.881 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -77.05 -71.91 0.38 Allowed 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.618 -0.719 . . . . 73.12 112.413 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -89.89 -53.49 4.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 70.12 112.003 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 -157.97 23.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.346 0.499 . . . . 65.3 114.346 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.612 HG12 HD12 ' A' ' 69' ' ' LEU . 8.8 tp -76.98 -37.58 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.507 0.723 . . . . 73.1 112.457 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.11 -31.22 71.96 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 75.4 111.521 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.76 57.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.99 -1.004 . . . . 74.11 110.671 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -67.19 -45.69 76.16 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 74.14 111.048 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.482 ' O ' HG21 ' A' ' 120' ' ' VAL . 47.9 mm -63.97 -55.53 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.901 0.48 . . . . 65.44 110.171 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.58 -38.57 55.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.115 0.566 . . . . 73.33 112.237 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.86 88.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.552 0.341 . . . . 62.2 111.813 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.63 -39.29 77.23 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.274 0.63 . . . . 75.54 111.862 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 116' ' ' ILE . 18.1 t -67.41 -41.89 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.482 0.658 . . . . 70.34 110.605 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.477 ' N ' HD21 ' A' ' 121' ' ' ASN . 0.7 OUTLIER -87.2 -10.0 53.72 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.907 0.883 . . . . 73.32 111.444 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.9 t -57.6 146.47 30.27 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.273 0.629 . . . . 75.41 111.448 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.7 pt20 -69.46 -38.01 77.57 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.926 0.49 . . . . 73.34 110.405 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -61.39 -38.71 88.02 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.101 0.961 . . . . 62.34 111.777 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.504 ' HB2' ' HG ' ' A' ' 90' ' ' LEU . 59.5 t80 -77.2 -41.89 39.64 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.581 0.753 . . . . 75.54 111.447 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.709 ' HA ' ' HZ1' ' A' ' 56' ' ' LYS . 63.9 t30 -67.44 -51.59 49.84 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.183 0.808 . . . . 71.15 113.183 -165.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 12.6 pt-20 -91.16 -26.14 19.23 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.409 0.522 . . . . 72.0 112.409 -171.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.648 HG21 HH22 ' A' ' 92' ' ' ARG . 79.2 t -78.76 -50.72 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 122.871 0.469 . . . . 74.3 110.732 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.498 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 1.5 t80 -81.03 -45.79 16.02 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.594 0.758 . . . . 74.52 111.972 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.76 -144.02 17.04 Favored Glycine 0 N--CA 1.482 1.752 0 CA-C-O 119.749 -0.473 . . . . 71.31 112.807 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 56' ' ' LYS . 4.7 mp0 -126.13 -58.13 1.38 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 117.831 0.815 . . . . 72.15 112.5 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.71 11.8 0.96 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.878 1.807 . . . . 63.23 115.878 -162.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.0 t -134.94 174.29 10.76 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.956 0.724 . . . . 75.42 112.956 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -84.71 136.34 39.39 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 123.896 0.879 . . . . 74.43 110.287 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -58.54 134.1 58.81 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.966 2.444 . . . . 74.32 112.214 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.515 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 17.9 p90 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 123.947 0.899 . . . . 74.42 112.247 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.695 -0.483 . . . . 72.55 109.695 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.99 93.22 1.35 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.432 0.634 . . . . 73.55 109.624 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -126.58 151.05 48.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.389 1.075 . . . . 71.43 109.002 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -84.87 122.17 28.79 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.094 -0.379 . . . . 73.22 110.373 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -83.37 122.32 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.222 0.609 . . . . 64.21 109.439 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.06 94.35 0.23 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.41 0.684 . . . . 65.31 112.069 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.73 11.41 16.98 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.636 0.615 . . . . 62.03 114.636 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.25 97.98 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.801 0 CA-C-N 117.632 0.716 . . . . 75.52 110.64 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -64.18 -32.22 73.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.835 -1.165 . . . . 73.44 113.154 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -42.68 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.772 0.829 . . . . 64.11 112.336 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -71.67 -9.03 57.65 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 114.865 -1.061 . . . . 73.11 111.359 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.35 -41.71 93.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.375 0.67 . . . . 72.24 109.991 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.1 75.47 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.822 0.849 . . . . 74.12 111.838 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.92 -44.99 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.923 0.489 . . . . 73.31 111.354 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -73.76 -35.67 65.03 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.557 0.743 . . . . 75.44 112.899 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 t -66.71 -29.97 70.09 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 120.711 0.291 . . . . 74.14 111.413 172.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.597 HD22 HD22 ' A' ' 48' ' ' LEU . 8.3 tt -68.27 -45.3 73.51 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.072 0.949 . . . . 75.52 109.661 173.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.11 -44.9 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 124.504 1.122 . . . . 73.13 111.71 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -69.17 -36.85 77.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.374 0.67 . . . . 73.11 111.722 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.06 80.09 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.628 0.771 . . . . 62.44 111.105 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.15 -42.81 65.52 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.098 0.959 . . . . 71.5 111.911 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.84 -49.86 48.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.019 0.527 . . . . 72.02 111.895 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -64.0 -14.88 57.47 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.829 1.048 . . . . 70.34 113.829 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -95.23 -61.66 1.44 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.327 0.512 . . . . 73.5 110.398 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.3 -42.82 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 123.587 0.755 . . . . 73.42 111.837 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.32 -12.16 33.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.497 0.319 . . . . 71.32 111.709 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.35 32.72 22.41 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.042 1.497 . . . . 75.43 115.042 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 166.63 29.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.092 0.775 . . . . 73.24 113.092 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.43 101.29 8.09 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 114.208 -1.36 . . . . 70.13 110.6 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -80.69 118.84 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.352 -0.61 . . . . 73.12 109.352 167.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.14 93.63 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.336 0.655 . . . . 71.51 111.45 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.13 -37.41 79.6 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.235 2.623 . . . . 74.4 114.3 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -71.5 -26.85 62.86 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.483 0.549 . . . . 74.41 112.483 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.45 -38.22 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.158 0.504 . . . . 75.44 110.199 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.16 -32.98 74.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.154 0.982 . . . . 73.11 112.797 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -76.13 -16.82 59.81 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.681 0.392 . . . . 64.24 111.728 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -80.54 -47.39 14.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.028 0.531 . . . . 75.42 110.983 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.86 -45.58 23.85 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.621 0.768 . . . . 75.13 111.695 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 75.8 m-85 -116.64 52.71 0.92 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.764 0.825 . . . . 74.43 111.657 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.74 -55.4 13.25 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.123 0.487 . . . . 64.35 112.189 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.86 -30.31 63.79 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.706 -0.679 . . . . 62.25 113.008 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 6.7 t-105 -67.5 -38.24 84.02 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.718 0.807 . . . . 64.23 112.041 -174.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -57.62 -49.84 75.11 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.253 1.021 . . . . 75.54 110.177 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -53.47 -49.78 66.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.212 1.005 . . . . 74.45 111.881 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.99 -33.88 76.35 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.721 0.637 . . . . 75.33 112.721 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.597 HD22 HD22 ' A' ' 19' ' ' LEU . 37.9 tp -71.8 -43.25 65.99 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 120.731 0.3 . . . . 75.02 110.93 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.85 -19.72 77.07 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.597 0.599 . . . . 72.5 114.597 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -94.9 -12.21 27.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.128 0.571 . . . . 74.54 112.098 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.0 71.37 Favored Glycine 0 C--N 1.35 1.308 0 C-N-CA 121.859 -0.21 . . . . 74.04 113.615 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.73 -32.42 65.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.644 0.777 . . . . 73.31 111.394 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -129.35 156.58 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.427 0.691 . . . . 63.43 109.517 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 p -85.4 178.8 7.32 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.818 0.342 . . . . 75.31 110.611 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 59' ' ' ILE . 74.4 t -64.34 -38.28 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 116.492 -0.322 . . . . 71.24 110.527 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.631 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 13.9 tttm -60.02 -44.21 94.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.894 0.478 . . . . 73.31 111.731 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -68.01 -24.73 65.15 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.344 0.658 . . . . 74.12 111.456 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -77.44 -48.11 18.0 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.283 -1.006 . . . . 75.14 108.283 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 55' ' ' VAL . 46.7 mm -60.67 -33.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 125.062 1.345 . . . . 75.52 111.244 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.26 -51.52 69.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.283 0.633 . . . . 71.35 111.214 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.34 -29.47 66.18 Favored Glycine 0 C--N 1.357 1.729 0 N-CA-C 114.883 0.713 . . . . 74.23 114.883 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.27 -28.57 68.14 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.969 0.385 . . . . 74.33 110.989 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.73 -31.57 44.15 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.116 -0.493 . . . . 74.2 113.461 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.8 -4.44 57.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.56 0.744 . . . . 74.25 112.643 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 p -77.77 141.38 39.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.042 0.383 . . . . 61.41 111.407 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -56.93 -31.29 64.8 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.714 0.805 . . . . 71.11 111.677 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.3 tp -62.0 -46.68 88.13 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.562 0.745 . . . . 74.45 111.315 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -63.21 -36.45 83.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.924 0.393 . . . . 75.2 111.333 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.465 HD11 HG23 ' A' ' 112' ' ' ILE . 4.5 mm? -68.18 -45.23 74.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.722 0.809 . . . . 60.03 112.815 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -73.17 -30.46 63.58 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.002 -0.436 . . . . 73.34 112.126 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -82.12 -53.49 6.05 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.796 1.036 . . . . 73.1 113.796 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -118.25 42.13 2.77 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.399 0.888 . . . . 73.25 113.399 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.541 ' HA ' HG23 ' A' ' 81' ' ' VAL . 65.7 t80 -155.9 -53.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.027 0.442 . . . . 73.24 111.256 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 m -68.59 -48.1 33.33 Favored Pre-proline 0 CA--C 1.573 1.854 0 N-CA-C 113.33 0.863 . . . . 74.34 113.33 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.73 3.93 7.46 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.92 1.746 . . . . 74.53 113.961 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.27 150.77 70.92 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.697 0.799 . . . . 73.53 111.654 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.24 171.01 15.8 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.351 2.034 . . . . 73.23 111.906 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.59 -49.55 74.57 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.329 0.651 . . . . 75.03 111.542 -176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 100' ' ' ILE . 30.4 m -58.67 -21.99 55.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.934 1.293 . . . . 75.01 114.389 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.86 -35.53 13.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.989 -0.745 . . . . 64.23 108.989 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 73' ' ' TYR . 60.2 t -56.81 -31.88 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.538 -0.755 . . . . 73.14 110.244 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 79' ' ' THR . 92.1 mt -68.09 -53.28 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.36 -0.836 . . . . 74.32 112.119 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.24 -50.13 56.02 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.402 1.001 . . . . 74.31 112.392 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.21 -31.04 69.78 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.098 0.559 . . . . 75.41 112.053 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.81 -45.74 50.19 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.558 -0.292 . . . . 62.31 112.902 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.616 HG23 HD12 ' A' ' 90' ' ' LEU . 88.0 m -64.19 -43.81 93.94 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.499 0.72 . . . . 63.01 111.911 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -60.98 -28.29 68.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.659 0.985 . . . . 74.1 113.659 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -73.41 -34.65 65.6 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.581 0.586 . . . . 75.31 112.581 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -104.76 -65.02 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.67 0.388 . . . . 75.15 111.581 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.616 HD12 HG23 ' A' ' 86' ' ' THR . 90.5 mt -75.47 -12.03 60.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.127 0.571 . . . . 74.44 112.466 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.45 24.95 75.41 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.651 0.62 . . . . 63.22 114.651 175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -159.27 -176.19 5.67 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 117.618 0.709 . . . . 74.41 111.794 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.02 30.58 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.693 0.797 . . . . 74.04 110.603 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.89 155.31 18.55 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.43 2.753 . . . . 74.4 113.636 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 49.5 mt -65.1 -52.61 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.694 0.798 . . . . 65.13 112.568 -169.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -148.59 171.58 15.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.47 0.708 . . . . 65.31 109.297 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -60.79 -28.98 69.16 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.031 0.532 . . . . 74.31 111.524 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.44 85.94 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.712 0.805 . . . . 73.14 111.215 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 15.4 tp10 -58.85 -43.61 90.79 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.288 1.035 . . . . 73.31 111.631 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.587 HG22 HG23 ' A' ' 79' ' ' THR . 73.2 mt -62.67 -50.56 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.873 0.869 . . . . 74.21 111.251 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -64.59 -29.59 70.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.324 0.65 . . . . 74.34 111.655 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -62.09 -49.92 74.03 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.711 0.804 . . . . 73.13 110.409 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -63.25 -40.72 98.23 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.902 0.481 . . . . 72.23 111.714 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.9 -34.97 77.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.406 0.683 . . . . 62.23 110.972 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -64.28 -36.43 84.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.763 0.825 . . . . 62.31 111.325 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.96 -42.89 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.601 0.761 . . . . 73.23 110.989 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -36.17 82.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.192 0.597 . . . . 75.21 111.669 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.46 -44.85 73.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.216 0.606 . . . . 75.52 111.495 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.2 p -77.71 -69.59 0.53 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.119 0.785 . . . . 74.15 113.119 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -93.3 -46.95 7.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.964 -0.46 . . . . 73.22 111.724 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.8 -159.68 15.39 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 121.002 0.223 . . . . 62.42 113.581 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.465 HG23 HD11 ' A' ' 69' ' ' LEU . 8.5 tp -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 123.908 0.883 . . . . 74.03 113.114 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -57.36 -42.35 81.85 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.316 0.646 . . . . 73.4 111.709 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.96 -28.24 43.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.269 -0.878 . . . . 75.45 110.899 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.63 -48.66 71.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.049 0.939 . . . . 73.52 110.931 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.67 -54.63 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 74.11 110.323 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -45.41 -42.08 9.91 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.13 0.972 . . . . 73.24 113.052 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.68 94.31 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.767 0.427 . . . . 75.24 111.882 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.7 -41.7 78.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.521 0.728 . . . . 72.3 112.131 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.28 -47.54 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 122.806 0.442 . . . . 71.33 111.689 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -81.46 2.27 29.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.46 0.541 . . . . 74.0 112.46 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 t -61.2 132.5 53.86 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.953 0.501 . . . . 52.34 109.986 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.03 -36.0 74.24 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.265 0.353 . . . . 72.43 111.139 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.9 -45.41 82.61 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.965 0.906 . . . . 73.22 111.786 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.458 ' HB2' HD22 ' A' ' 90' ' ' LEU . 87.8 t80 -58.23 -54.71 43.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.883 -0.414 . . . . 74.43 109.883 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -60.5 -28.3 68.26 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.611 0.764 . . . . 71.35 112.745 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.21 -40.1 14.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.448 0.699 . . . . 75.51 112.332 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 91.5 t -89.44 -61.52 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 122.932 0.493 . . . . 75.54 110.505 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -102.76 70.19 1.1 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.697 . . . . 70.51 109.395 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.06 178.65 0.79 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.623 -0.717 . . . . 64.03 114.537 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.631 ' HG2' ' HD3' ' A' ' 56' ' ' LYS . 27.9 mt-10 -63.91 -14.3 52.43 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.288 0.847 . . . . 74.45 113.288 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.22 -33.0 12.18 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.175 0.59 . . . . 73.15 111.884 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.5 m -86.0 136.59 33.19 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.125 0.57 . . . . 71.34 112.421 -173.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.77 135.73 31.78 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.398 1.079 . . . . 75.43 109.954 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.63 136.06 63.57 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.478 2.119 . . . . 72.12 112.796 167.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.5 p90 . . . . . 0 N--CA 1.483 1.188 0 C-N-CA 123.11 0.564 . . . . 75.5 111.195 177.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 t . . . . . 0 CA--C 1.55 0.949 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.62 123.73 17.28 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.307 1.043 . . . . 74.21 111.783 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.14 162.15 38.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.252 0.621 . . . . 75.21 111.035 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -74.86 89.24 2.33 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.693 -0.685 . . . . 74.45 110.787 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -70.93 112.45 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-N 115.878 -0.601 . . . . 63.14 111.008 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.78 43.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.001 1.32 . . . . 74.01 113.583 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.26 -42.09 55.41 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.688 0.635 . . . . 72.12 114.688 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.5 mm -71.58 -54.54 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.565 0.746 . . . . 74.24 110.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 46.37 17.21 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 126.123 1.769 . . . . 73.41 115.146 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.43 138.31 31.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.921 0.888 . . . . 74.11 110.824 -169.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.49 -29.07 65.51 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.174 0.805 . . . . 74.32 113.174 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.12 -30.5 49.41 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.698 0.399 . . . . 71.4 110.696 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.79 -38.68 64.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.26 0.624 . . . . 75.42 109.959 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.553 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.5 mp -63.95 -34.97 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 115.256 -0.884 . . . . 74.55 110.027 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 34' ' ' PRO . 24.4 ttmm -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.918 0.71 . . . . 74.22 112.918 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -69.7 -34.01 73.32 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 122.018 -0.426 . . . . 64.0 110.41 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.04 -34.35 77.83 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.854 1.262 . . . . 64.55 110.355 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 16' ' ' ILE . 51.5 mm -62.59 -53.17 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.05 0.94 . . . . 73.42 109.514 174.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -65.76 -29.05 69.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.202 1.001 . . . . 74.23 112.867 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -41.41 59.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.528 0.731 . . . . 72.31 110.543 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.02 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.941 0.897 . . . . 73.42 111.927 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.949 0.499 . . . . 75.23 112.209 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtp85 -67.57 -14.36 62.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.111 0.564 . . . . 75.03 112.028 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.735 ' HG2' ' HB2' ' A' ' 135' ' ' PRO . 23.9 tp60 -95.9 -50.33 4.93 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.928 0.491 . . . . 74.12 111.147 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -78.46 -59.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.257 0.623 . . . . 75.22 111.005 -175.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -81.51 -7.05 59.53 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.723 0.409 . . . . 72.02 111.634 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 65.97 -54.48 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.502 1.921 . . . . 71.52 114.479 -174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -65.64 139.12 58.38 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.53 0.732 . . . . 75.3 112.282 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -65.59 128.66 36.85 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.229 -0.896 . . . . 71.21 109.649 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -105.47 142.51 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.193 0.597 . . . . 73.21 109.973 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' A' ' 36' ' ' ILE . . . -62.66 124.34 82.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.955 0.902 . . . . 74.0 111.402 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 51.0 Cg_exo -56.01 -32.31 85.62 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 123.513 2.809 . . . . 75.43 115.575 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -72.78 -35.73 67.48 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.37 0.268 . . . . 72.3 111.206 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.461 ' HA ' HD22 ' A' ' 39' ' ' ASN . 71.3 mt -66.25 -41.57 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.919 0.888 . . . . 73.43 110.423 172.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.68 64.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.031 0.932 . . . . 72.12 111.691 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -75.9 -61.38 1.95 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.526 -0.761 . . . . 73.22 110.914 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.461 HD22 ' HA ' ' A' ' 36' ' ' ILE . 9.3 p30 -63.21 -25.69 68.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.235 0.828 . . . . 71.2 113.235 -174.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.26 -54.49 5.91 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.86 0.464 . . . . 75.42 110.773 172.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 85.1 m-85 -113.92 60.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.678 0.791 . . . . 75.21 111.557 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -73.27 -50.94 19.53 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.928 -0.483 . . . . 71.25 111.988 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.68 -31.34 58.6 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.287 -0.415 . . . . 60.43 112.377 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.416 ' HZ3' ' HZ2' ' A' ' 47' ' ' LYS . 8.7 t-105 -69.93 -37.47 75.9 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.194 0.997 . . . . 75.0 111.157 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.9 -41.9 81.99 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.013 0.925 . . . . 72.22 111.542 169.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -53.62 -54.46 37.35 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.57 1.148 . . . . 65.24 113.193 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.642 ' HD3' HG22 ' A' ' 53' ' ' ILE . 15.1 ptpt -61.18 -35.08 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.269 0.84 . . . . 73.24 113.269 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.1 tp -71.15 -34.22 70.8 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.308 0.243 . . . . 62.43 110.707 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 16' ' ' ILE . . . -67.08 -33.52 83.72 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.76 -0.2 . . . . 72.25 112.861 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -73.63 -10.38 59.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.01 0.924 . . . . 75.23 112.144 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.99 32.5 82.36 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 115.364 0.906 . . . . 53.03 115.364 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.4 -60.2 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.902 0.858 . . . . 73.22 110.201 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.642 HG22 ' HD3' ' A' ' 47' ' ' LYS . 21.9 pt -73.13 176.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.797 -1.547 . . . . 74.35 112.181 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 57' ' ' GLU . 1.8 t -99.51 153.37 19.08 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.078 -0.712 . . . . 65.32 109.078 170.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 59' ' ' ILE . 91.2 t -64.06 -31.13 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 110.119 -0.326 . . . . 75.44 110.119 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -44.83 -50.93 9.99 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.735 1.013 . . . . 74.0 113.735 166.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 54' ' ' THR . 31.6 tt0 -58.52 -42.51 87.9 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.651 0.38 . . . . 75.24 110.822 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HZ ' HG23 ' A' ' 20' ' ' ILE . 86.7 t80 -63.75 -43.34 96.72 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.01 0.924 . . . . 73.41 110.881 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 55' ' ' VAL . 33.7 mm -68.11 -46.47 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.751 1.22 . . . . 74.44 111.911 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.72 -39.08 64.94 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.894 0.478 . . . . 73.2 111.471 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.09 -25.42 72.16 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 116.142 -0.481 . . . . 75.11 114.165 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.7 mt -75.68 -38.1 58.99 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.426 0.69 . . . . 73.2 111.134 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.44 -18.08 79.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 121.554 -0.355 . . . . 73.1 113.657 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -84.59 -28.15 26.75 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.528 0.731 . . . . 75.33 111.566 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.3 p -71.99 129.4 38.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.673 -0.491 . . . . 63.44 109.673 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -58.71 -15.87 13.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.138 1.162 . . . . 72.54 114.138 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.69 -42.62 93.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.885 0.874 . . . . 73.22 112.072 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -65.51 -43.21 90.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.542 0.687 . . . . 62.54 111.031 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.96 -28.75 63.64 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.012 -0.994 . . . . 74.51 111.327 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -60.37 -45.87 91.98 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.959 1.304 . . . . 73.14 111.072 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.81 -42.05 61.48 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.015 -0.993 . . . . 73.41 111.832 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -114.31 -67.56 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.922 1.082 . . . . 75.54 113.922 -167.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -61.19 -30.02 70.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.338 1.236 . . . . 75.33 114.338 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.527 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 45.8 m -78.65 -54.74 1.09 Allowed Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.729 -0.653 . . . . 75.31 112.054 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 14.8 Cg_exo -71.8 -16.86 29.57 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 121.989 1.792 . . . . 71.0 114.274 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 56.3 m-85 -115.24 147.71 39.13 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 123.088 0.555 . . . . 75.02 112.357 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.407 ' O ' HG22 ' A' ' 81' ' ' VAL . 91.7 Cg_endo -75.54 169.93 21.32 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.367 . . . . 75.42 112.549 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.407 ' O ' HG13 ' A' ' 82' ' ' ILE . 3.1 m-20 -49.95 -49.56 49.77 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.25 1.02 . . . . 74.42 113.002 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.579 ' HA ' HD12 ' A' ' 82' ' ' ILE . 26.3 m -59.69 -35.53 74.67 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.6 0.76 . . . . 73.4 112.981 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 22.4 tptm -72.72 -36.18 67.74 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.904 0.383 . . . . 74.31 110.859 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 77' ' ' PRO . 41.7 t -68.84 -28.53 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.242 0.617 . . . . 75.21 110.569 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 79' ' ' THR . 96.9 mt -66.77 -52.11 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 73.33 111.26 174.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -71.99 -37.57 69.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 111.832 0.308 . . . . 73.4 111.832 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.97 -31.26 61.41 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.299 0.639 . . . . 71.34 111.508 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.9 52.05 Favored Glycine 0 N--CA 1.476 1.312 0 N-CA-C 112.039 -0.424 . . . . 74.44 112.039 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.657 HG22 HD12 ' A' ' 90' ' ' LEU . 53.6 m -66.48 -35.78 81.11 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.098 0.959 . . . . 74.33 110.747 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.93 -42.44 90.08 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 64.31 112.627 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.8 m170 -82.84 -36.0 25.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.961 0.504 . . . . 75.54 112.353 -175.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -94.29 -68.87 0.78 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 119.179 -0.439 . . . . 74.33 111.274 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 86' ' ' THR . 79.2 mt -66.9 -18.24 65.28 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.945 0.72 . . . . 73.01 112.945 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.23 21.3 78.16 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.321 0.388 . . . . 71.33 113.422 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 86' ' ' THR . 9.7 ptt180 -143.09 172.79 12.23 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.166 0.587 . . . . 75.5 110.951 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.06 151.28 54.21 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 123.246 0.618 . . . . 72.14 111.07 165.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.05 140.45 65.69 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.232 1.955 . . . . 63.24 111.486 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.65 -42.83 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.426 0.528 . . . . 75.11 112.426 -164.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -155.65 160.88 40.77 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.161 -0.681 . . . . 60.14 109.161 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -54.91 -36.08 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.447 0.699 . . . . 73.22 112.654 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.37 74.23 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.294 0.638 . . . . 61.12 112.323 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.42 -39.88 67.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.615 0.766 . . . . 72.01 111.624 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.57 -53.27 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.335 0.654 . . . . 74.53 111.713 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -55.81 -32.72 63.79 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.782 0.833 . . . . 74.25 111.867 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.4 tmmm? -61.01 -52.13 66.29 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.503 0.721 . . . . 74.03 110.856 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -64.99 -35.77 82.25 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.849 0.46 . . . . 75.42 112.021 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -67.87 -36.85 80.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.064 0.946 . . . . 74.54 111.398 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -67.78 -30.74 70.26 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.575 -0.739 . . . . 75.24 110.632 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 102' ' ' LYS . 74.3 mt -65.77 -40.75 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 122.952 0.501 . . . . 73.04 110.426 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.75 -37.97 76.62 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.241 0.617 . . . . 75.24 112.044 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.4 71.47 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.404 0.682 . . . . 62.1 112.115 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 p -75.79 -52.16 11.02 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.965 0.906 . . . . 72.13 111.642 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.09 -73.03 0.69 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.936 0.894 . . . . 73.41 111.356 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.02 -174.21 22.55 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.297 0.499 . . . . 74.34 113.543 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.8 mm -52.73 -36.64 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.966 1.306 . . . . 72.13 113.706 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -61.17 -51.35 69.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.884 0.373 . . . . 74.21 111.139 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.9 -37.45 87.69 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.524 -0.762 . . . . 73.45 112.539 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.39 -55.95 17.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.31 1.044 . . . . 72.11 112.624 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -57.51 -44.55 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.673 0.789 . . . . 74.12 110.693 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.58 -39.19 76.22 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.322 0.649 . . . . 75.02 112.263 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.96 98.49 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.245 0.618 . . . . 64.14 111.472 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.0 mt -62.83 -55.04 29.84 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.836 0.854 . . . . 72.11 111.399 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.435 HG11 ' HG3' ' A' ' 56' ' ' LYS . 74.9 t -67.23 -32.6 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 123.186 0.595 . . . . 75.04 112.438 -173.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.93 22.11 15.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.63 -0.669 . . . . 74.22 111.824 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -71.5 142.03 50.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.258 0.623 . . . . 72.41 110.453 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.65 -37.39 79.62 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.724 0.41 . . . . 72.33 111.563 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.58 -32.5 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 120.776 0.322 . . . . 74.24 110.887 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -75.49 -54.13 7.53 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.455 0.702 . . . . 74.23 111.712 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -69.86 -23.35 63.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.905 0.705 . . . . 74.42 112.905 -169.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.46 -39.1 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.042 0.537 . . . . 75.23 111.984 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.29 -58.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.089 0.947 . . . . 75.44 110.394 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.527 ' HE2' ' HB2' ' A' ' 56' ' ' LYS . 45.5 t80 -59.88 -46.64 88.68 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.037 1.735 . . . . 74.2 112.786 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.94 -129.18 9.2 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-O 119.534 -0.592 . . . . 74.35 112.183 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -135.06 -64.58 0.65 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.504 0.652 . . . . 73.34 111.271 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.43 1.14 34.45 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.844 0.858 . . . . 73.44 112.693 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.9 m -92.35 151.65 20.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.843 0.857 . . . . 72.54 111.528 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.7 137.67 85.65 Favored Pre-proline 0 N--CA 1.488 1.452 0 C-N-CA 124.468 1.107 . . . . 75.04 110.284 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.735 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 2.8 Cg_exo -67.82 135.57 35.86 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.158 1.905 . . . . 75.51 111.798 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.3 p90 . . . . . 0 CA--C 1.55 0.968 0 C-N-CA 123.493 0.717 . . . . 75.24 110.299 -178.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.985 0.421 . . . . 64.14 110.68 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -92.23 87.22 6.0 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.63 0.729 . . . . 73.1 109.748 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.53 155.43 17.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.546 0.738 . . . . 73.13 110.881 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -92.77 113.8 26.18 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.22 -1.03 . . . . 70.53 108.22 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.56 124.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.912 -0.773 . . . . 75.31 108.912 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.87 99.86 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.707 0.803 . . . . 54.45 111.945 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.29 -31.49 2.34 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.067 -0.515 . . . . 73.31 113.929 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.3 mt -67.68 102.16 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-O 121.709 0.766 . . . . 70.14 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -113.62 24.93 11.69 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.709 -1.132 . . . . 73.34 110.176 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.42 109.31 21.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.697 0.799 . . . . 71.2 108.984 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -61.51 -23.34 65.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.64 0.607 . . . . 74.43 112.64 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.27 -38.84 68.72 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.267 0.627 . . . . 74.53 111.074 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.01 52.14 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.357 0.663 . . . . 74.53 111.289 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 mm -72.52 -42.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.08 0.552 . . . . 74.14 110.07 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.38 -31.75 73.02 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.866 0.867 . . . . 74.45 112.527 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -77.14 -31.0 55.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 120.902 0.382 . . . . 72.23 111.446 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.07 -43.55 98.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.741 0.816 . . . . 74.44 109.654 170.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.3 -38.04 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.481 1.112 . . . . 71.12 111.48 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.8 t -65.74 -38.37 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.519 0.728 . . . . 74.42 111.771 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.41 -37.6 63.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.146 0.578 . . . . 72.33 110.885 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.9 77.14 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.777 0.831 . . . . 74.23 111.601 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -59.07 -49.91 76.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.984 0.514 . . . . 74.32 110.923 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.78 -26.5 68.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.88 0.696 . . . . 74.0 112.88 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.29 -46.89 72.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.853 0.461 . . . . 74.52 111.367 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.701 HD11 HG23 ' A' ' 59' ' ' ILE . 2.4 mp -89.12 -67.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.079 0.552 . . . . 73.22 109.954 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -83.77 82.35 8.36 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.879 0.872 . . . . 75.15 109.122 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.32 69.17 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.609 1.195 . . . . 73.34 114.113 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 176.23 145.73 0.09 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.256 1.822 . . . . 65.43 108.911 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -71.03 119.64 15.44 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-O 121.006 0.432 . . . . 75.44 110.6 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 mm -84.1 125.24 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.473 -0.936 . . . . 75.4 108.473 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -59.24 122.47 63.77 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.603 -0.713 . . . . 74.24 111.173 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.95 -38.47 86.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.611 2.874 . . . . 71.51 114.275 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 33' ' ' ALA . 44.1 p90 -68.71 -25.38 64.74 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.205 0.602 . . . . 73.11 112.198 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.485 ' HA ' HD22 ' A' ' 39' ' ' ASN . 62.1 mt -83.32 -44.49 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.429 0.692 . . . . 71.15 111.004 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -33.84 72.6 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.478 1.111 . . . . 62.54 112.208 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -36.52 72.94 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.519 -0.764 . . . . 74.1 112.312 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.485 HD22 ' HA ' ' A' ' 36' ' ' ILE . 10.3 p30 -83.34 -41.57 18.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.344 0.498 . . . . 70.44 112.344 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.39 -54.08 28.46 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.714 . . . . 72.33 112.269 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -98.31 33.0 2.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.92 0.888 . . . . 72.34 111.006 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.8 t -62.38 -50.43 71.58 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.191 0.997 . . . . 75.31 113.081 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.16 36.72 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.788 -0.642 . . . . 72.44 112.096 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -70.54 -29.94 66.54 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.497 0.719 . . . . 74.43 111.957 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -38.57 75.49 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.691 0.796 . . . . 71.23 110.834 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.0 t -52.37 -38.16 58.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.153 0.981 . . . . 73.43 113.365 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.33 -40.07 62.43 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 111.969 0.359 . . . . 74.35 111.969 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.32 -30.69 67.72 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 118.212 0.46 . . . . 74.04 112.178 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.36 -31.7 68.54 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.893 0.163 . . . . 72.41 112.711 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 56.1 m-20 -88.19 -18.44 28.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.534 0.734 . . . . 74.52 111.609 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.17 71.86 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.143 0.417 . . . . 72.12 114.143 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.5 mm-40 -61.07 -32.6 72.25 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.822 0.849 . . . . 71.22 111.677 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -113.41 158.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.574 0.749 . . . . 71.55 110.055 171.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.4 p -84.75 169.18 14.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.255 0.622 . . . . 63.13 110.99 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.8 t -63.79 -47.69 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.479 -0.563 . . . . 75.4 109.479 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -43.57 -51.84 6.62 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.61 1.337 . . . . 71.35 114.61 169.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -57.75 -39.49 77.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.094 0.558 . . . . 72.04 111.301 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 45.3 t80 -71.83 -38.72 70.13 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.482 0.713 . . . . 75.54 110.792 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.701 HG23 HD11 ' A' ' 27' ' ' ILE . 30.6 mm -63.47 -50.35 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.983 1.313 . . . . 75.52 110.937 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.441 ' HB2' HG12 ' A' ' 120' ' ' VAL . 25.8 tt0 -57.34 -38.85 74.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.085 -0.961 . . . . 74.12 111.425 172.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.73 85.22 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.821 -0.627 . . . . 73.42 113.941 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 84.1 mt -69.78 -39.89 76.37 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.245 0.618 . . . . 75.23 111.326 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.75 81.95 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.529 0.572 . . . . 72.11 114.529 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -72.77 -21.69 60.96 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.518 0.727 . . . . 72.15 111.73 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -63.22 128.68 36.94 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.095 0.558 . . . . 65.14 111.919 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.14 -19.2 52.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.24 113.09 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.78 -44.01 97.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.33 0.652 . . . . 64.13 110.723 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -67.54 -31.13 71.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.832 0.453 . . . . 75.34 111.475 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 4.3 mm? -71.89 -34.46 69.16 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.276 0.63 . . . . 72.43 112.318 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HA ' ' HG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -81.06 -29.7 34.95 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.543 -0.723 . . . . 74.44 111.693 176.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.85 -56.63 4.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.664 0.616 . . . . 74.32 112.664 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -128.05 60.01 1.47 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.539 0.735 . . . . 75.43 112.306 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.589 ' HD1' HG12 ' A' ' 81' ' ' VAL . 76.9 t80 -162.66 -60.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.911 -0.586 . . . . 74.02 110.725 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.43 ' HG1' ' HA ' ' A' ' 70' ' ' LYS . 64.6 p -64.33 -41.26 58.76 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 114.405 1.261 . . . . 72.41 114.405 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.32 -7.58 8.9 Favored 'Trans proline' 0 C--N 1.389 2.704 0 CA-C-N 121.84 1.693 . . . . 74.1 114.039 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -109.37 149.98 40.5 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 123.805 0.842 . . . . 72.55 111.819 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.89 152.94 76.65 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.095 1.863 . . . . 64.54 111.323 168.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -50.56 -47.79 57.72 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.804 0.842 . . . . 73.02 112.708 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.519 ' HA ' HD13 ' A' ' 82' ' ' ILE . 17.8 m -55.61 -33.59 64.12 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.656 0.783 . . . . 64.2 112.354 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -76.23 -36.0 58.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.001 0.521 . . . . 74.34 111.636 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.589 HG12 ' HD1' ' A' ' 73' ' ' TYR . 59.7 t -63.09 -34.8 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.445 0.641 . . . . 74.24 110.476 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 79' ' ' THR . 95.5 mt -63.21 -51.28 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.814 -1.084 . . . . 65.4 111.92 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.4 -31.06 60.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.821 0.448 . . . . 72.4 111.442 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -76.93 -28.51 55.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.418 0.687 . . . . 75.31 111.222 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.26 -54.52 8.87 Favored Glycine 0 C--N 1.344 1.022 0 C-N-CA 122.101 -0.095 . . . . 72.54 112.935 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 t -60.59 -33.34 72.58 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.42 0.896 . . . . 72.2 113.42 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.23 -14.74 62.34 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.543 0.571 . . . . 74.55 112.543 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -89.41 -50.25 6.22 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.774 0.657 . . . . 71.32 112.774 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -85.67 -40.04 16.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.864 0.466 . . . . 74.44 111.82 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 124' ' ' GLU . 77.6 mt -95.84 -49.02 5.5 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 122.439 0.296 . . . . 74.0 110.994 175.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.29 40.39 87.45 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 122.192 -0.317 . . . . 71.44 113.707 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.685 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 2.6 ptm180 -131.2 7.97 4.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.157 0.799 . . . . 74.31 113.157 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 60.12 158.56 0.11 Allowed Pre-proline 0 N--CA 1.504 2.256 0 N-CA-C 113.87 1.063 . . . . 53.44 113.87 -163.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.02 152.96 61.21 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.318 2.012 . . . . 72.12 113.705 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -74.44 -72.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 C-N-CA 123.193 0.597 . . . . 74.31 111.08 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -123.86 171.36 9.73 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.816 0.846 . . . . 54.12 109.854 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -69.5 -29.79 67.5 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.776 -0.578 . . . . 72.13 110.172 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.52 -30.94 68.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.088 0.555 . . . . 53.23 111.96 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -71.89 -39.62 69.45 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.209 0.604 . . . . 64.34 111.21 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.98 -52.15 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.217 0.607 . . . . 75.14 110.567 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -54.74 -39.91 68.76 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.11 0.964 . . . . 73.13 111.91 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 106' ' ' ILE . 34.6 ttpt -57.15 -45.55 83.5 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.527 0.731 . . . . 65.43 111.15 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.513 ' HD1' HD12 ' A' ' 106' ' ' ILE . 17.8 m-85 -68.25 -35.39 77.83 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.755 0.422 . . . . 75.1 111.921 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -67.46 -32.71 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.892 0.477 . . . . 74.13 110.988 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -64.45 -40.75 96.33 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.865 0.866 . . . . 74.31 110.429 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.516 HG22 HE21 ' A' ' 110' ' ' GLN . 80.1 mt -62.48 -46.16 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 124.267 1.027 . . . . 74.23 111.52 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.3 -42.72 99.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.207 0.603 . . . . 74.23 111.69 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.2 -44.6 75.47 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.743 0.646 . . . . 74.3 112.743 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.4 p -72.41 -51.77 18.91 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.021 0.749 . . . . 73.44 113.021 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.516 HE21 HG22 ' A' ' 106' ' ' ILE . 2.3 pm0 -124.26 -46.75 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 112.906 0.706 . . . . 74.22 112.906 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.1 -153.45 20.74 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 115.414 0.925 . . . . 70.44 115.414 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.1 tp -70.81 -35.57 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.107 0.963 . . . . 71.1 112.775 -169.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -61.2 -44.27 97.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.427 0.528 . . . . 74.23 112.427 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -29.44 66.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.029 0.531 . . . . 62.31 112.294 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -65.12 -48.07 74.88 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.269 0.628 . . . . 74.22 110.707 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 112' ' ' ILE . 46.7 mm -64.22 -45.6 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.568 0.747 . . . . 74.53 110.026 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -58.87 -36.36 74.49 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.103 0.961 . . . . 70.4 111.671 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.18 -28.72 68.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.4 0.68 . . . . 72.04 112.142 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.0 -43.56 13.05 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.838 0.855 . . . . 73.22 112.326 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 60' ' ' GLU . 61.8 t -78.15 -37.54 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.416 0.686 . . . . 74.33 111.504 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -87.53 4.37 43.8 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.918 0.487 . . . . 74.53 112.039 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.1 t -67.62 137.58 55.74 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.921 0.488 . . . . 74.42 110.489 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . 13.7 pt20 -54.74 -29.21 53.07 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.786 1.032 . . . . 75.1 113.786 -175.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.685 ' HG2' ' HD2' ' A' ' 92' ' ' ARG . 34.3 tp10 -50.85 -47.53 60.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.121 0.968 . . . . 64.33 112.225 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.9 -44.58 20.14 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.624 0.769 . . . . 75.34 111.092 168.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 123' ' ' GLN . 6.8 t30 -72.46 -67.7 0.53 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.707 1.002 . . . . 73.53 113.707 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 8.3 pt-20 -56.81 -37.21 70.86 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.296 0.85 . . . . 75.23 113.296 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.67 -61.62 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 112.502 0.556 . . . . 75.4 112.502 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.3 -53.59 2.63 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.05 0.54 . . . . 71.05 111.479 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.65 -126.91 8.78 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.878 -0.601 . . . . 54.22 113.095 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -106.42 -20.46 13.37 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.781 0.832 . . . . 74.25 111.377 -169.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.21 11.84 38.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.143 1.534 . . . . 74.42 115.143 -156.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 t -153.91 164.23 38.74 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 119.43 1.014 . . . . 73.34 112.333 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.86 135.37 92.14 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 123.871 0.868 . . . . 74.13 110.498 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.85 76.74 1.97 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.207 2.605 . . . . 74.43 113.198 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.0 p90 . . . . . 0 N--CA 1.485 1.321 0 C-N-CA 123.32 0.648 . . . . 75.41 110.701 176.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.803 -0.814 . . . . 73.54 108.803 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -88.01 101.15 13.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.296 0.638 . . . . 75.24 111.123 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HZ2' HG21 ' A' ' 7' ' ' VAL . 2.7 pptp? -132.06 163.2 28.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.014 0.526 . . . . 72.24 111.176 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.613 HH22 ' HG ' ' A' ' 48' ' ' LEU . 19.7 tpp85 -79.47 98.25 6.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.262 -0.881 . . . . 71.45 109.736 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 HG21 ' HZ2' ' A' ' 5' ' ' LYS . 15.2 t -75.73 130.71 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.338 -0.986 . . . . 73.53 108.338 177.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.66 75.8 0.59 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.861 0.839 . . . . 72.44 111.928 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.75 -37.98 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.517 -1.22 . . . . 64.2 112.356 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.43 80.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.439 0 CA-C-O 122.529 1.156 . . . . 75.25 110.819 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -89.44 10.03 24.17 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.583 -1.644 . . . . 65.11 113.599 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 16' ' ' ILE . 5.6 m-20 -70.69 126.15 28.8 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.007 0.523 . . . . 75.03 111.198 -172.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -60.45 -29.47 69.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.926 0.491 . . . . 73.53 112.035 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 -50.58 62.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.025 0.93 . . . . 75.14 110.937 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.4 94.51 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.603 0.761 . . . . 71.35 112.496 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.559 HG22 ' HA2' ' A' ' 49' ' ' GLY . 46.1 mm -63.2 -49.06 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.06 0.544 . . . . 64.2 111.556 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.25 -25.14 61.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.313 0.486 . . . . 74.12 112.313 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.8 m -65.73 -38.63 89.68 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.792 0.437 . . . . 74.33 111.226 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.33 -40.36 93.59 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.012 0.925 . . . . 73.0 109.983 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.27 -43.92 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.653 1.181 . . . . 71.35 111.544 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -70.47 -35.54 73.36 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.311 0.644 . . . . 74.11 111.438 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.18 90.14 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.666 0.786 . . . . 54.33 112.022 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.78 99.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.512 0.725 . . . . 65.43 111.126 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.474 ' HE2' ' HB2' ' A' ' 37' ' ' ALA . 13.3 m-30 -70.92 -41.02 71.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.567 -0.742 . . . . 75.44 111.556 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -60.88 -35.78 77.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.256 1.022 . . . . 75.31 112.367 179.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.0 -62.92 1.54 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.876 0.471 . . . . 71.35 110.122 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.75 -54.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.78 0.832 . . . . 73.02 112.674 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -78.98 -8.33 58.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.121 0.568 . . . . 75.35 112.029 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 53.85 45.77 27.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.521 1.153 . . . . 74.02 112.577 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 8.0 ptp180 -153.85 -179.0 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.348 -0.842 . . . . 72.43 111.264 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -125.78 107.95 11.02 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.848 -1.167 . . . . 70.53 107.848 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.408 HD12 ' CD2' ' A' ' 24' ' ' TYR . 20.0 mt -90.98 139.84 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.769 0.428 . . . . 73.34 110.849 -174.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.67 94.6 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.791 -0.623 . . . . 74.01 109.941 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.58 -44.13 41.7 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.656 2.904 . . . . 75.02 113.957 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.01 -44.58 79.95 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.173 -0.921 . . . . 73.41 112.523 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -57.91 -43.78 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 122.956 0.502 . . . . 75.41 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.474 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . . . -58.72 -48.19 81.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.287 1.035 . . . . 71.42 111.795 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.95 -12.13 59.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.619 0.6 . . . . 72.23 112.619 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -80.3 -47.26 14.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.677 -0.64 . . . . 73.31 111.729 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.52 -42.48 67.9 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 120.949 0.404 . . . . 74.1 111.047 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 60.7 m-85 -105.66 55.07 0.69 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.785 0.834 . . . . 64.45 110.939 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.6 m -64.34 -50.2 68.68 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 122.891 0.476 . . . . 70.25 111.636 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -70.64 -39.01 67.66 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.85 -0.614 . . . . 74.53 113.389 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -70.32 -42.16 72.3 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.135 0.974 . . . . 72.51 112.889 -169.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.04 -39.72 93.3 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.883 0.473 . . . . 73.41 110.584 174.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 m -62.77 -47.56 82.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.856 0.863 . . . . 73.11 111.885 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.4 mmmm -59.12 -44.87 92.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.069 0.547 . . . . 74.13 111.983 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.613 ' HG ' HH22 ' A' ' 6' ' ' ARG . 16.3 tp -74.0 -33.28 63.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 116.317 -0.402 . . . . 74.22 111.32 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.559 ' HA2' HG22 ' A' ' 16' ' ' ILE . . . -66.0 -26.72 72.4 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 123.035 0.35 . . . . 73.21 113.883 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -92.28 -17.51 24.67 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.548 0.739 . . . . 71.5 110.985 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.79 28.51 60.82 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.887 -0.597 . . . . 72.44 113.973 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.41 -25.27 54.33 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.697 0.799 . . . . 74.14 112.647 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.17 171.0 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.727 0.811 . . . . 74.33 109.151 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 p -89.69 170.27 10.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.7 -0.852 . . . . 72.34 108.7 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -59.56 -33.53 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 119.721 -0.18 . . . . 73.21 110.562 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 131' ' ' GLU . 78.7 tttt -44.82 -56.81 4.19 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.0 1.32 . . . . 72.32 113.556 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.98 -40.58 78.74 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.288 0.635 . . . . 62.31 111.354 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 85.3 t80 -53.49 -51.9 61.26 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.908 0.755 . . . . 74.02 110.808 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 55' ' ' VAL . 37.8 mm -57.88 -43.5 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.643 1.177 . . . . 72.32 111.758 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HB2' HG12 ' A' ' 120' ' ' VAL . 32.2 tt0 -58.97 -47.95 83.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 122.783 0.433 . . . . 65.23 111.81 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.17 -18.83 65.43 Favored Glycine 0 CA--C 1.541 1.698 0 N-CA-C 114.867 0.707 . . . . 73.01 114.867 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 54.2 mt -70.73 -30.67 67.26 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 117.566 0.683 . . . . 74.35 111.105 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.61 -10.67 79.94 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 115.315 -0.857 . . . . 72.33 114.129 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -95.54 -7.75 37.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.658 0.783 . . . . 75.24 111.014 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.426 ' O ' HD21 ' A' ' 69' ' ' LEU . 57.7 p -84.13 137.35 33.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.986 0.514 . . . . 75.23 111.273 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 6.0 t30 -62.38 -23.58 66.89 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.01 0.524 . . . . 72.11 111.576 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.5 tp -67.56 -38.01 83.5 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.605 0.762 . . . . 75.22 111.611 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -74.27 -45.6 46.72 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 120.811 0.339 . . . . 74.42 110.716 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.462 HD13 HG12 ' A' ' 112' ' ' ILE . 4.0 mm? -55.96 -44.17 78.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.587 1.155 . . . . 72.32 112.887 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.82 -29.71 70.23 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.873 0.694 . . . . 74.42 112.873 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HG3' HH21 ' A' ' 30' ' ' ARG . 6.3 mm-40 -93.37 -36.64 12.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.314 1.227 . . . . 74.22 114.314 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.407 ' HD1' HD12 ' A' ' 84' ' ' LEU . 80.1 m-85 -128.86 32.42 4.78 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.658 0.614 . . . . 75.44 112.658 -171.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.541 ' HD1' HG11 ' A' ' 81' ' ' VAL . 78.1 t80 -150.16 -54.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.95 0.5 . . . . 74.55 110.974 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -68.16 -43.7 35.6 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.582 0.956 . . . . 75.43 113.582 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.1 7.63 4.97 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.127 1.885 . . . . 74.1 113.422 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 58.3 m-85 -130.07 141.6 42.44 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.579 0.751 . . . . 75.24 111.395 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.65 167.55 16.97 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.29 1.993 . . . . 72.33 111.766 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.52 -40.72 72.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.289 0.636 . . . . 73.11 112.356 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.574 ' HA ' HD13 ' A' ' 82' ' ' ILE . 99.2 m -66.36 -42.38 88.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.073 0.949 . . . . 75.31 113.457 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 48.8 tptt -63.66 -32.95 74.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.258 0.466 . . . . 75.23 112.258 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.541 HG11 ' HD1' ' A' ' 73' ' ' TYR . 45.8 t -63.18 -30.56 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.188 0.595 . . . . 73.23 110.642 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 79' ' ' THR . 95.6 mt -69.92 -51.17 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.947 0.899 . . . . 73.02 112.251 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.64 -45.44 65.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.115 0.416 . . . . 75.1 111.697 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.505 HD21 ' HD3' ' A' ' 87' ' ' LYS . 74.8 mt -61.85 -29.04 69.91 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.361 0.665 . . . . 74.24 112.196 171.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.1 -41.67 46.7 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 115.705 -0.68 . . . . 75.12 111.903 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.426 HG23 HD13 ' A' ' 90' ' ' LEU . 78.3 m -68.9 -46.1 69.22 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.308 0.643 . . . . 65.13 112.016 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HD3' HD21 ' A' ' 84' ' ' LEU . 14.6 ptmt -70.5 -24.42 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.59 0.959 . . . . 73.34 113.59 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -85.02 -33.61 22.49 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 113.695 0.998 . . . . 62.01 113.695 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -104.18 -41.97 5.65 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.844 1.053 . . . . 73.54 113.844 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.426 HD13 HG23 ' A' ' 86' ' ' THR . 69.0 mt -94.71 -14.7 24.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.127 0.417 . . . . 74.13 112.127 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.87 14.97 2.05 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.608 0.603 . . . . 73.12 114.608 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -98.23 -84.78 0.38 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.321 0.648 . . . . 74.11 112.476 -161.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 175.98 137.11 0.19 Allowed Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 74.34 108.938 -168.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.39 122.89 10.18 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.459 1.44 . . . . 75.12 109.531 165.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.29 -63.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 122.086 -0.383 . . . . 74.44 111.504 -168.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -158.14 166.5 32.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.473 -0.936 . . . . 75.01 108.473 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -66.29 -27.76 68.18 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.232 0.469 . . . . 73.2 111.396 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.2 72.44 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.945 0.498 . . . . 71.21 111.458 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.87 -45.73 84.8 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.25 0.62 . . . . 75.24 110.667 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.511 HG21 HG23 ' A' ' 79' ' ' THR . 85.0 mt -59.33 -36.76 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.685 -0.689 . . . . 74.22 110.573 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -68.81 -31.96 71.33 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.676 0.39 . . . . 73.31 111.608 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.53 -50.1 41.16 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.528 0.331 . . . . 73.5 111.44 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -62.58 -38.44 90.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.081 0.4 . . . . 72.43 112.081 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.59 -36.16 77.85 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.935 0.894 . . . . 73.33 111.255 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -69.36 -44.02 72.43 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.67 0.788 . . . . 72.54 110.907 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -42.78 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.551 0.741 . . . . 75.45 110.831 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.422 HD13 ' HE1' ' A' ' 73' ' ' TYR . 31.5 tp -65.51 -33.29 75.58 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.364 1.065 . . . . 72.1 112.438 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.41 -46.35 17.72 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.019 0.528 . . . . 63.13 112.322 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.8 p -70.45 -45.16 66.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.99 0.916 . . . . 74.24 111.843 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -110.6 -68.79 0.9 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.228 0.611 . . . . 71.15 111.914 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.89 -170.33 28.57 Favored Glycine 0 C--N 1.356 1.688 0 C-N-CA 121.691 -0.29 . . . . 73.12 113.792 -175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.462 HG12 HD13 ' A' ' 69' ' ' LEU . 8.6 tp -65.82 -39.2 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.925 0.89 . . . . 75.23 112.637 -173.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -65.69 -33.57 76.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.946 0.498 . . . . 75.52 111.861 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.87 -34.63 51.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.606 0.762 . . . . 54.25 110.425 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.78 -51.98 65.0 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.273 1.029 . . . . 62.43 111.174 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.88 -51.88 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.937 0.895 . . . . 73.41 110.867 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -48.29 -47.78 36.25 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.675 0.79 . . . . 64.14 112.288 171.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -33.54 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.569 0.747 . . . . 75.22 112.337 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.59 -57.99 4.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.955 0.502 . . . . 74.03 110.895 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 60' ' ' GLU . 94.3 t -63.77 -35.85 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 113.847 1.054 . . . . 74.01 113.847 -166.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.62 36.27 2.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 75.24 112.101 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.4 p -84.02 171.26 13.11 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.163 0.506 . . . . 74.11 110.789 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -69.56 -31.53 69.77 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.01 0.91 . . . . 72.05 110.339 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -69.81 -36.2 75.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.425 1.49 . . . . 75.04 111.596 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -76.22 -37.66 57.45 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.994 0.518 . . . . 70.41 110.958 173.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.15 -61.09 2.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.811 0.844 . . . . 74.42 112.577 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.56 -38.71 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.722 0.296 . . . . 72.23 111.72 -168.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.03 -44.36 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.639 0.775 . . . . 64.15 111.657 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -101.68 -45.64 5.19 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.042 0.537 . . . . 74.34 112.174 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.19 20.04 63.52 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-O 119.715 -0.492 . . . . 71.22 113.906 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 8.5 pt-20 57.08 -1.81 0.05 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.903 2.186 . . . . 73.0 116.903 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -93.04 -17.5 23.78 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.315 0.646 . . . . 73.24 111.433 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 t -108.99 162.42 14.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.439 0.696 . . . . 75.5 112.339 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.21 136.96 89.09 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.706 -1.133 . . . . 65.41 108.401 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.78 88.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.548 2.165 . . . . 74.55 112.179 173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 p90 . . . . . 0 CA--C 1.543 0.705 0 CA-C-N 115.395 -0.82 . . . . 75.45 108.896 174.121 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.107 -0.701 . . . . 75.14 109.107 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -83.29 124.21 30.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.332 0.587 . . . . 72.02 111.168 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.21 173.77 16.36 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.847 1.259 . . . . 74.32 109.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.614 ' NH2' ' HA2' ' A' ' 51' ' ' GLY . 81.4 mtp180 -102.5 116.21 32.16 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.57 0.7 . . . . 75.3 111.315 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.4 2.62 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.977 0 C-N-CA 125.345 1.458 . . . . 65.53 111.004 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 78.58 -67.47 0.17 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.406 1.882 . . . . 61.41 110.369 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 49.28 4.12 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.036 0.374 . . . . 64.43 114.036 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 6' ' ' ARG . 66.6 mt -72.99 -53.4 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.256 0.622 . . . . 75.24 110.11 172.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 65.7 -65.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.348 1.459 . . . . 73.25 112.094 -171.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 16' ' ' ILE . 32.1 t70 -44.68 133.96 5.71 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.966 1.706 . . . . 73.22 115.588 -173.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.28 -25.38 39.47 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 112.93 -1.941 . . . . 75.11 112.545 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -70.84 -51.46 26.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 73.42 111.444 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.24 -50.64 58.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.73 1.011 . . . . 74.14 113.73 167.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 12' ' ' ASP . 43.8 mm -56.84 -43.05 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.852 0.686 . . . . 70.43 112.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 2.7 pptp? -67.14 -30.47 70.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 112.512 0.56 . . . . 74.11 112.512 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 m -70.57 -49.4 48.31 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.14 0.495 . . . . 74.44 111.022 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -44.54 -46.49 9.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.821 -1.081 . . . . 74.51 111.805 165.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.9 -36.19 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.341 1.056 . . . . 75.42 112.353 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -61.71 -49.01 78.17 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.261 0.624 . . . . 61.45 111.668 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.34 88.96 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.138 0.575 . . . . 74.23 111.827 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.67 -31.17 15.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.684 -1.144 . . . . 74.23 112.596 171.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.88 -48.15 17.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.888 0.475 . . . . 72.14 111.766 168.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -55.8 -28.36 55.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.355 1.613 . . . . 75.04 115.355 -167.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -86.68 -41.64 14.03 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.097 0.408 . . . . 64.12 111.274 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.579 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -75.8 -57.25 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.537 0.735 . . . . 62.42 111.221 -173.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HB3' HH11 ' A' ' 30' ' ' ARG . 93.2 m-85 -78.91 -6.38 56.03 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.095 0.558 . . . . 75.12 111.94 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 54.87 37.67 29.02 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 125.425 1.49 . . . . 72.42 112.927 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.425 HH11 ' HB3' ' A' ' 28' ' ' PHE . 10.0 ptp85 -155.0 151.73 28.83 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.275 0.559 . . . . 74.21 112.247 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.04 100.94 2.1 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.149 -0.932 . . . . 64.22 109.427 165.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.3 mt -81.11 126.53 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 110.044 -0.354 . . . . 75.11 110.044 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.38 132.45 94.17 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.814 0.846 . . . . 65.05 111.035 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.81 -33.03 98.27 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.999 2.466 . . . . 75.23 113.368 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -69.17 -21.71 63.97 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.956 0.724 . . . . 73.12 112.956 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -81.99 -48.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.152 0.581 . . . . 74.04 109.884 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 -32.02 71.99 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.073 0.949 . . . . 55.03 113.182 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -76.6 -19.19 58.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.849 0.46 . . . . 73.22 111.747 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -80.15 -47.1 15.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.223 0.609 . . . . 63.34 111.251 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -85.5 -59.82 2.21 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.889 0.376 . . . . 72.14 111.725 -171.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -93.15 41.55 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.565 0.746 . . . . 74.54 112.535 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.9 t -66.68 -50.8 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.523 0.729 . . . . 70.15 112.058 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.2 -28.6 57.94 Favored Glycine 0 N--CA 1.477 1.374 0 CA-C-N 115.777 -0.647 . . . . 33.12 113.051 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -65.3 -25.12 67.49 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.237 1.015 . . . . 75.53 112.259 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.66 -45.27 75.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.65 0.78 . . . . 73.2 110.824 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -57.45 -30.92 65.41 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.02 0.928 . . . . 71.4 112.575 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -73.58 -35.74 65.47 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.473 0.309 . . . . 75.22 111.687 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.2 tp -73.38 -60.94 2.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.282 0.845 . . . . 74.3 113.282 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.59 -36.67 76.71 Favored Glycine 0 C--N 1.358 1.772 0 CA-C-N 118.622 0.646 . . . . 73.32 114.377 -171.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -59.98 -16.59 31.68 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.89 0.876 . . . . 74.33 113.347 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.614 ' HA2' ' NH2' ' A' ' 6' ' ' ARG . . . 103.04 5.17 47.37 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 114.635 0.614 . . . . 72.44 114.635 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.2 -63.99 1.03 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.187 0.493 . . . . 75.04 111.991 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -85.06 -142.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-N 116.025 -0.534 . . . . 73.31 111.259 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.439 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 3.3 t -170.43 152.16 3.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 73.13 108.916 -165.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.05 -31.49 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 112.603 0.594 . . . . 65.2 112.603 -171.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -76.38 -44.0 38.26 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.097 -0.377 . . . . 73.21 111.183 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.84 -22.18 66.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.49 0.716 . . . . 75.42 111.435 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -74.29 -46.21 42.64 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.427 -1.323 . . . . 73.11 107.427 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 27' ' ' ILE . 54.0 mt -70.92 -30.78 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 113.46 -1.7 . . . . 74.21 113.318 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -63.93 -46.81 83.11 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 122.819 0.448 . . . . 73.31 110.536 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.87 -35.54 47.93 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 114.617 0.607 . . . . 72.34 114.617 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -69.11 -26.18 64.78 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.165 0.586 . . . . 75.14 111.526 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.07 -23.94 58.41 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 116.078 -0.51 . . . . 64.43 113.09 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.454 ' HE1' ' HB ' ' A' ' 116' ' ' ILE . 3.6 m-30 -86.0 5.7 32.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.787 0.835 . . . . 74.53 110.955 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.1 t -85.46 129.84 34.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.484 0.713 . . . . 74.5 110.41 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 23.5 p-10 -62.77 -16.13 56.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.995 0.739 . . . . 72.32 112.995 -175.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 43.1 tp -61.5 -59.7 4.84 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.013 0.525 . . . . 74.43 110.681 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.8 -36.94 65.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.949 0.722 . . . . 75.14 112.949 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 66' ' ' ASN . 4.2 mm? -63.95 -30.51 71.58 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.349 0.87 . . . . 71.13 113.349 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -92.02 -40.59 11.01 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.718 -0.614 . . . . 70.04 112.189 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.486 ' HG3' ' H ' ' A' ' 72' ' ' PHE . 10.3 pt-20 -78.04 -54.69 5.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.097 1.147 . . . . 74.24 114.097 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.486 ' H ' ' HG3' ' A' ' 71' ' ' GLU . 83.5 m-85 -83.89 -59.06 2.53 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.115 0.871 . . . . 74.22 113.076 171.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.51 ' HE1' HD21 ' A' ' 107' ' ' LEU . 61.6 t80 -55.67 -46.63 77.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.213 1.19 . . . . 72.34 114.213 -166.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.8 m -71.03 -55.96 6.05 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.445 0.906 . . . . 73.52 113.445 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.02 -28.32 19.39 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.931 1.754 . . . . 71.0 112.999 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.418 ' HD1' ' HG2' ' A' ' 80' ' ' LYS . 91.0 m-85 -94.06 140.96 23.06 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 122.822 0.449 . . . . 75.45 110.77 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.4 Cg_exo -54.29 146.11 52.24 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.088 2.525 . . . . 62.12 113.515 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.425 ' ND2' ' HA ' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -30.48 -46.69 0.08 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 123.62 0.768 . . . . 55.02 112.934 156.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.458 ' HA ' HD13 ' A' ' 82' ' ' ILE . 21.4 m -70.59 -23.84 62.65 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.334 0.654 . . . . 73.22 112.601 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HG2' ' HD1' ' A' ' 76' ' ' TYR . 53.5 tptt -91.14 -28.32 17.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.19 0.519 . . . . 74.2 110.382 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 77' ' ' PRO . 84.7 t -62.86 -27.51 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.791 0.836 . . . . 71.43 110.038 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 79' ' ' THR . 81.5 mt -65.88 -47.52 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.098 0.959 . . . . 62.14 112.626 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.587 ' HG3' ' H ' ' A' ' 84' ' ' LEU . 7.2 pt-20 -78.51 -57.8 3.58 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.908 0.322 . . . . 73.23 110.818 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.587 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 97.0 mt -43.85 -31.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.774 1.398 . . . . 74.42 114.774 161.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.33 -49.72 8.07 Favored Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.855 -0.498 . . . . 73.1 111.855 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.656 HG23 HD11 ' A' ' 90' ' ' LEU . 88.3 m -59.88 -31.55 69.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.673 1.189 . . . . 75.44 112.277 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -75.84 -57.16 4.04 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.598 -0.689 . . . . 75.01 111.486 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.7 m170 -50.9 -30.58 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.979 1.474 . . . . 74.41 114.979 172.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -101.52 -68.62 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.233 0.827 . . . . 72.35 113.233 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.656 HD11 HG23 ' A' ' 86' ' ' THR . 66.0 mt -71.42 -28.36 63.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.853 0.686 . . . . 73.33 112.853 -173.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.99 33.63 20.44 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 122.94 0.15 . . . . 65.21 112.788 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.82 -177.05 6.13 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.172 0.989 . . . . 73.44 110.782 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.19 165.42 13.9 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.532 0.733 . . . . 75.14 109.74 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.75 173.73 4.38 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.272 1.982 . . . . 73.12 111.973 169.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.423 ' HB ' ' H ' ' A' ' 96' ' ' ASP . 20.3 mt -119.04 -86.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 121.127 0.489 . . . . 74.25 109.992 -167.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.423 ' H ' ' HB ' ' A' ' 95' ' ' ILE . 26.9 t70 -88.63 172.41 9.31 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.961 -1.125 . . . . 73.44 107.961 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 2.8 tp-100 -74.9 -10.1 59.17 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 121.441 1.928 . . . . 74.14 109.59 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.75 84.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.851 0.86 . . . . 73.35 110.563 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.8 -54.11 46.4 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.903 0.881 . . . . 72.14 110.289 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.434 ' HA ' HG21 ' A' ' 82' ' ' ILE . 75.6 mt -64.71 -36.17 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-N 114.818 -1.083 . . . . 74.42 112.275 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.528 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 70.3 mtp180 -74.54 -38.84 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.851 0.46 . . . . 74.15 109.913 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.35 -56.44 18.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.233 -0.894 . . . . 73.21 110.921 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -61.49 -52.74 63.24 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.387 0.514 . . . . 74.35 112.387 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.425 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 14.2 t-20 -43.73 -48.23 7.97 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 115.394 -0.821 . . . . 60.21 112.676 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -73.3 -41.03 64.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.856 0.462 . . . . 74.13 111.705 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.9 mt -59.83 -55.18 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 124.081 0.952 . . . . 75.21 111.637 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.51 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.3 tt -50.98 -53.14 35.78 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.038 0.935 . . . . 65.24 112.204 170.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.35 78.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.44 0.533 . . . . 75.1 112.44 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.0 p -68.31 -53.03 27.03 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.109 0.781 . . . . 73.31 113.109 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -101.53 -62.32 1.27 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.654 0.782 . . . . 74.0 112.262 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -172.8 31.8 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.97 0.348 . . . . 73.33 113.97 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.411 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.2 tp -68.74 -33.71 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.903 0.881 . . . . 73.05 112.209 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -65.07 -55.86 16.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.701 0.4 . . . . 73.53 110.69 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -50.1 -30.93 12.05 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 114.713 -1.131 . . . . 74.25 113.451 168.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -75.67 -42.9 49.92 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.272 0.629 . . . . 74.32 112.201 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.454 ' HB ' ' HE1' ' A' ' 64' ' ' TYR . 46.3 mm -72.52 -52.3 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.01 0.524 . . . . 73.22 109.718 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -43.63 -38.24 2.96 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.7 1.2 . . . . 72.41 113.112 166.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.85 76.61 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.021 0.528 . . . . 73.54 112.404 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 78.1 mt -83.99 -59.9 2.27 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.603 0.761 . . . . 74.34 110.841 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 t -44.95 -50.89 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.584 1.554 . . . . 74.34 113.216 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -100.3 17.47 21.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.402 0.519 . . . . 62.54 112.402 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.9 p -74.03 164.15 26.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.951 -0.759 . . . . 74.01 108.951 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.41 -22.51 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.965 -0.46 . . . . 71.43 111.669 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.46 -53.31 44.57 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.335 0.494 . . . . 73.51 112.335 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -61.6 -40.46 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.153 -0.684 . . . . 73.32 109.153 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -57.93 -42.7 85.38 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.164 0.986 . . . . 71.2 112.69 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.99 -47.38 11.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.773 -0.579 . . . . 71.24 112.013 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.4 -41.38 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.925 0.49 . . . . 72.54 111.987 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 36.9 m-85 -116.01 -68.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.822 0.449 . . . . 73.14 110.669 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.51 -127.56 9.13 Favored Glycine 0 C--N 1.347 1.139 0 C-N-CA 123.227 0.442 . . . . 73.44 112.403 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -88.86 -73.12 0.51 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.41 0.684 . . . . 73.23 111.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 36.0 m-20 -102.35 66.6 0.99 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.548 0.69 . . . . 72.43 112.835 -171.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.9 m -148.32 124.43 10.76 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.043 -0.981 . . . . 75.54 109.495 173.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.68 138.23 83.08 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.251 0.62 . . . . 74.13 109.936 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.436 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 52.4 Cg_exo -53.6 89.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 123.152 2.568 . . . . 74.44 113.319 173.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.4 p90 . . . . . 0 CA--C 1.543 0.711 0 CA-C-N 115.17 -0.923 . . . . 71.42 111.456 176.711 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 CA--C 1.56 1.355 0 N-CA-C 109.393 -0.595 . . . . 71.2 109.393 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.67 -0.3 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 126.211 1.805 . . . . 70.04 113.196 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 18.7 ptmt -47.32 113.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.284 1.433 . . . . 74.25 114.061 -171.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.502 ' NH1' HD21 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -51.28 94.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.337 1.606 . . . . 75.32 115.337 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.679 HG11 ' H ' ' A' ' 8' ' ' ALA . 2.9 t -45.89 178.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.223 0 C-N-CA 126.046 1.738 . . . . 72.23 112.514 162.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.679 ' H ' HG11 ' A' ' 7' ' ' VAL . . . -73.96 132.32 42.31 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 107.598 -1.26 . . . . 73.53 107.598 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -13.5 74.6 0.0 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 117.85 1.9 . . . . 64.45 117.85 -158.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -67.38 134.28 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.236 0.614 . . . . 75.22 110.679 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -83.33 -13.41 55.1 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.537 0.735 . . . . 72.12 112.523 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.92 112.47 18.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.924 0.489 . . . . 72.44 110.759 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.39 -10.88 37.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.438 0.695 . . . . 74.51 112.026 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.11 -51.44 13.45 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.439 0.638 . . . . 71.21 109.634 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.5 71.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.683 -1.144 . . . . 72.52 112.378 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 41.1 mm -78.25 -48.79 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.467 0.707 . . . . 74.35 110.783 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -67.4 -44.81 77.94 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.653 0.781 . . . . 63.45 113.008 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.3 m -63.37 -37.84 88.82 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.335 0.654 . . . . 70.31 111.889 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.502 HD21 ' NH1' ' A' ' 6' ' ' ARG . 11.4 tp -53.0 -51.56 61.24 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.747 -1.115 . . . . 74.24 110.103 169.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.85 -37.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.955 1.302 . . . . 75.14 113.121 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.1 p -69.19 -53.06 21.95 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.587 0.355 . . . . 71.55 111.149 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.86 -26.46 65.85 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 113.33 0.863 . . . . 71.42 113.33 171.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.57 -33.88 74.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 123.473 0.483 . . . . 75.03 110.758 172.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -78.78 -49.21 13.39 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.691 . . . . 62.51 111.834 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.9 mtp85 -50.0 -26.07 3.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.842 1.793 . . . . 75.01 115.842 -168.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 -58.53 2.54 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 118.34 0.518 . . . . 51.34 110.239 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.47 -55.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.555 0.742 . . . . 72.52 110.5 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.89 -27.02 67.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.422 0.689 . . . . 74.22 112.594 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 67.63 32.44 5.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.615 1.198 . . . . 73.5 109.588 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.449 ' NH2' ' HG3' ' A' ' 71' ' ' GLU . 18.9 ptp180 -168.23 150.73 5.41 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.945 -1.48 . . . . 75.13 110.36 -173.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.22 108.89 5.61 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.822 -0.627 . . . . 74.2 110.286 165.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.05 133.03 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.946 -0.761 . . . . 75.23 108.946 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.25 138.1 95.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.837 -0.601 . . . . 71.45 110.6 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.61 -43.09 23.33 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.839 3.026 . . . . 75.21 114.992 -170.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -70.11 -32.9 71.16 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 112.764 0.653 . . . . 74.1 112.764 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -72.85 -42.31 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.269 0.628 . . . . 63.04 110.953 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.48 -36.35 83.48 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.247 0.619 . . . . 75.42 112.164 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 42' ' ' SER . 3.7 pt20 -79.4 -36.26 39.39 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.909 -0.587 . . . . 74.22 112.077 -176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -81.66 -43.87 17.95 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.223 0.823 . . . . 73.02 113.223 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.59 -60.33 2.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.757 0.423 . . . . 74.31 111.787 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -89.67 38.04 0.9 Allowed 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.651 0.982 . . . . 74.54 113.651 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 38' ' ' GLN . 90.7 p -72.08 -49.83 33.27 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.69 0.396 . . . . 71.21 111.326 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 47' ' ' LYS . . . -69.5 -27.4 73.53 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 123.259 0.457 . . . . 62.22 113.112 174.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -81.63 -39.38 24.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.221 1.009 . . . . 74.43 110.63 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.58 -29.29 67.8 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.337 0.655 . . . . 61.35 111.668 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -65.83 -36.54 83.76 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.665 0.786 . . . . 60.14 111.87 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 43' ' ' GLY . 26.9 mtpp -67.74 -37.85 82.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.912 0.885 . . . . 75.43 111.076 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.0 -37.56 75.73 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.95 0.9 . . . . 70.41 110.862 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.67 -28.68 68.77 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-N 115.988 -0.551 . . . . 74.33 113.753 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -87.84 4.47 44.42 Favored 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 124.173 0.989 . . . . 71.23 111.043 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 50.09 33.6 22.46 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 115.422 0.929 . . . . 61.24 115.422 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -71.29 -80.03 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.077 -0.712 . . . . 74.33 109.077 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -63.04 -164.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 113.962 1.097 . . . . 75.52 113.962 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.2 p -127.58 172.57 10.62 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.211 -1.403 . . . . 62.03 107.211 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.11 -32.39 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 O-C-N 121.833 -0.542 . . . . 75.31 110.039 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -64.72 -38.96 92.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.744 0.818 . . . . 74.44 111.584 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.28 -26.06 42.39 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.679 0.792 . . . . 75.24 109.654 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -62.2 -49.08 77.21 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.235 1.014 . . . . 73.33 110.306 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.91 -28.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 125.202 1.401 . . . . 75.01 112.656 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.8 -42.02 96.78 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.472 0.709 . . . . 71.43 109.764 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.26 -23.61 58.57 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 114.501 0.56 . . . . 63.33 114.501 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.2 mt -68.91 -40.75 78.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.189 0.518 . . . . 73.41 110.147 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.33 -24.6 63.74 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-N 114.846 -1.07 . . . . 62.35 114.027 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -84.84 -12.68 53.02 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.691 0.796 . . . . 75.31 112.487 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -74.98 121.9 22.67 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.946 0.498 . . . . 72.22 111.19 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.23 -15.63 26.37 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.167 0.987 . . . . 64.12 113.503 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.5 tp -59.65 -61.35 2.69 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.209 0.458 . . . . 61.53 112.048 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -51.63 -38.78 56.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 112.771 0.656 . . . . 73.41 112.771 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 3.0 mm? -69.6 -26.59 64.52 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.245 0.831 . . . . 74.2 113.245 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.33 -49.28 72.34 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.756 -1.215 . . . . 73.41 108.994 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HG3' ' NH2' ' A' ' 30' ' ' ARG . 3.2 mm-40 -64.66 -56.89 10.9 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 114.333 -1.303 . . . . 65.42 112.73 172.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.06 69.34 0.72 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.68 0.993 . . . . 72.31 113.68 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 42.4 t80 -170.68 -56.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.013 1.325 . . . . 62.22 108.663 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.2 p -69.97 -39.7 11.46 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.469 1.285 . . . . 63.42 114.469 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.51 -42.61 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.928 0 CA-C-N 122.147 1.802 . . . . 75.24 112.632 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.46 147.67 82.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.546 1.138 . . . . 74.44 112.057 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.21 148.12 84.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.21 1.94 . . . . 75.51 111.55 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -52.38 -49.74 63.82 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.146 0.978 . . . . 71.21 112.807 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 82' ' ' ILE . 59.7 m -51.71 -44.01 63.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.597 0.962 . . . . 74.41 113.597 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -65.04 -37.13 86.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.984 0.514 . . . . 74.05 111.837 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.29 -24.53 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 122.887 0.475 . . . . 74.21 111.286 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 79' ' ' THR . 90.6 mt -72.03 -54.31 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.208 0.603 . . . . 71.01 111.682 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.66 -23.54 67.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.241 0.544 . . . . 71.03 111.768 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tt -79.85 -45.75 18.11 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.777 1.231 . . . . 74.45 108.684 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.84 -54.26 29.38 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.001 -0.999 . . . . 61.4 114.358 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.542 ' HA ' HD13 ' A' ' 119' ' ' LEU . 34.6 p -54.64 -39.52 68.06 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.201 0.6 . . . . 72.14 112.145 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.05 -37.84 61.93 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 113.449 0.907 . . . . 71.21 113.449 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -88.05 13.68 10.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.617 0.969 . . . . 73.03 113.617 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.74 -69.75 0.51 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.577 0.751 . . . . 70.13 109.677 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.78 -19.91 63.01 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.472 1.109 . . . . 74.53 112.781 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.34 87.49 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 114.351 0.501 . . . . 74.32 114.351 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.42 174.92 14.68 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 123.299 0.64 . . . . 73.44 110.721 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.45 160.76 78.89 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 124.001 0.92 . . . . 64.44 111.321 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -55.44 -174.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.038 2.492 . . . . 65.41 114.486 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.405 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 68.5 mt -97.43 -24.34 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 75.21 110.333 -164.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 179.23 -174.86 0.22 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.222 1.409 . . . . 74.15 109.316 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -76.94 -35.06 57.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.665 0.386 . . . . 72.34 111.929 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.45 -35.03 75.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.85 0.46 . . . . 74.44 111.421 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 19.8 tp10 -57.58 -47.48 82.0 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.726 0.81 . . . . 75.02 110.558 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.11 -46.87 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 124.094 0.957 . . . . 73.24 112.022 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -67.57 -30.58 70.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.392 0.886 . . . . 73.31 113.392 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -53.75 -47.45 70.66 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.467 0.707 . . . . 74.43 110.865 166.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -78.23 -22.17 48.84 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.701 -1.136 . . . . 74.12 111.056 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -74.68 -41.96 59.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.651 1.181 . . . . 72.11 110.72 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -72.11 -49.85 32.86 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.77 0.828 . . . . 73.45 111.267 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 87.6 mt -56.86 -37.22 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 124.466 1.106 . . . . 74.53 111.679 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.06 -49.68 34.53 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.698 0.799 . . . . 74.15 110.953 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.37 95.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.722 0.809 . . . . 70.1 112.634 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.8 p -75.59 -65.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 74.34 112.459 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -87.6 -37.31 16.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.795 0.838 . . . . 75.42 112.953 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 173.51 13.2 Favored Glycine 0 C--N 1.346 1.132 0 C-N-CA 122.002 -0.142 . . . . 62.53 112.98 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 116' ' ' ILE . 9.9 tp -61.29 -30.66 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 123.158 0.583 . . . . 73.21 110.417 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -56.58 -40.48 75.3 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.533 1.133 . . . . 74.53 112.749 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.5 55.7 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.041 0.537 . . . . 75.22 111.386 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 57.9 t80 -65.12 -50.8 64.66 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.75 0.82 . . . . 74.4 110.324 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 112' ' ' ILE . 49.2 mm -59.78 -44.3 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.16 0.984 . . . . 73.4 110.943 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -56.89 -39.73 74.94 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.977 0.911 . . . . 65.33 111.889 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.2 77.72 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.324 0.65 . . . . 74.54 112.26 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 86' ' ' THR . 13.6 mt -79.76 -39.17 31.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.166 0.587 . . . . 74.52 110.937 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.45 -34.2 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.491 0.716 . . . . 63.2 111.176 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -99.7 22.89 10.31 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.368 0.667 . . . . 74.12 112.385 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.4 t -83.03 132.56 35.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.157 0.583 . . . . 65.31 110.773 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -44.34 -37.55 3.39 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.315 1.228 . . . . 73.12 114.315 170.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.33 -41.1 92.83 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-N 118.31 0.505 . . . . 72.41 111.322 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -73.79 -53.88 9.29 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.877 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -69.7 -27.59 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.045 0.757 . . . . 74.31 113.045 -172.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.51 -47.19 34.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.831 0.453 . . . . 74.43 112.169 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.9 -51.78 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.341 0.591 . . . . 75.34 111.273 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -77.1 -67.54 0.7 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.075 0.95 . . . . 75.03 111.12 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.61 -148.12 16.5 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.658 0.623 . . . . 74.41 114.658 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -114.89 -23.73 8.98 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.849 0.859 . . . . 72.15 111.841 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.76 -32.55 12.66 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.314 1.046 . . . . 74.35 113.65 -158.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' LYS . 9.9 t -98.66 165.98 11.54 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.304 0.853 . . . . 70.33 113.304 -165.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.456 HG22 HD11 ' A' ' 19' ' ' LEU . 6.6 t -83.51 142.27 42.92 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 124.164 0.986 . . . . 74.03 108.766 165.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.98 83.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.901 2.4 . . . . 74.44 113.32 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.3 p90 . . . . . 0 C--O 1.246 0.903 0 CA-C-N 114.08 -1.418 . . . . 74.51 108.711 170.258 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 CA--C 1.553 1.068 0 CA-C-O 121.468 0.651 . . . . 73.51 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -80.44 104.98 11.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.368 0.604 . . . . 73.14 110.123 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HB3' HG21 ' A' ' 133' ' ' THR . 19.6 ptmt -149.16 168.56 22.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.997 0.919 . . . . 74.44 110.144 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 ttp85 -119.4 106.64 12.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.729 -0.471 . . . . 73.23 109.729 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.585 HG11 ' H ' ' A' ' 8' ' ' ALA . 3.3 t -79.0 -149.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.959 0 C-N-CA 124.083 0.953 . . . . 75.31 109.13 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.585 ' H ' HG11 ' A' ' 7' ' ' VAL . . . -85.43 -81.28 0.2 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 119.945 1.248 . . . . 71.42 109.767 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -32.29 -30.22 0.01 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.001 2.76 . . . . 73.15 120.001 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.532 HD11 ' H ' ' A' ' 7' ' ' VAL . 50.8 mt -64.99 105.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 119.855 1.828 . . . . 75.05 110.558 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -155.47 24.62 0.4 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.527 1.131 . . . . 74.34 108.756 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.51 ' O ' HG12 ' A' ' 16' ' ' ILE . 3.8 m-20 -100.01 142.72 31.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.141 1.376 . . . . 73.22 108.891 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HZ3' ' HG2' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -67.0 -39.23 87.06 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 120.945 1.702 . . . . 75.23 112.631 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.54 66.49 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 122.367 1.08 . . . . 74.24 112.231 171.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 10' ' ' ILE . . . -76.62 -38.92 53.91 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 112.978 -1.919 . . . . 70.54 111.071 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.617 HG13 ' HA2' ' A' ' 49' ' ' GLY . 51.0 mm -81.21 -39.62 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 N-CA-C 114.029 1.122 . . . . 71.24 114.029 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.605 ' HZ1' ' HB3' ' A' ' 38' ' ' GLN . 28.1 mtpp -74.59 -50.86 16.29 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.109 -0.994 . . . . 75.23 111.347 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 m -49.12 -21.57 0.77 Allowed 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.124 -1.398 . . . . 63.14 113.168 164.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 16' ' ' ILE . 7.8 tt -81.43 -42.98 19.55 Favored 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 123.588 0.755 . . . . 74.31 110.659 169.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 16' ' ' ILE . 85.5 mt -75.18 -48.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 N-CA-C 116.494 2.035 . . . . 73.54 116.494 -171.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.471 ' HA ' ' CD2' ' A' ' 24' ' ' TYR . 44.0 m -66.67 -39.24 88.09 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.702 1.239 . . . . 74.02 109.882 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.94 -28.23 22.58 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 111.58 -2.554 . . . . 71.11 111.708 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.39 24.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.719 0.808 . . . . 73.42 111.763 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' A' ' 21' ' ' SER . 21.6 m-85 -68.98 -52.48 28.44 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 120.98 0.419 . . . . 74.2 110.914 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -46.98 -16.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.539 1.311 . . . . 75.05 114.539 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.474 HE22 ' HA ' ' A' ' 88' ' ' HIS . 13.0 tm0? -87.48 -61.16 1.78 Allowed 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.144 0.577 . . . . 72.11 109.627 166.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 59' ' ' ILE . 61.7 mt -78.15 -65.46 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 124.509 1.123 . . . . 73.2 113.119 -170.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.507 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 66.4 m-85 -74.87 -9.64 58.73 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.032 0.933 . . . . 75.03 112.476 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 76.33 -56.02 0.58 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.988 1.715 . . . . 70.44 112.914 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -84.07 156.33 22.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.95 0.9 . . . . 72.31 112.927 -165.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -62.84 120.01 10.48 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.569 -1.196 . . . . 75.25 109.717 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.4 mt -109.65 120.24 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.454 -1.684 . . . . 72.04 106.454 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 134.06 72.29 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 123.929 0.768 . . . . 61.32 112.06 -172.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.33 -31.02 36.02 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.811 3.007 . . . . 71.11 115.164 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -75.89 -39.05 57.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.722 0.409 . . . . 73.43 111.989 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -47.77 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 122.735 0.414 . . . . 75.22 110.205 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.06 79.19 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.111 0.964 . . . . 70.55 112.561 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.605 ' HB3' ' HZ1' ' A' ' 17' ' ' LYS . 1.8 pt20 -75.42 -25.03 57.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.252 0.464 . . . . 74.42 112.252 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.29 -47.56 15.65 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 117.987 0.358 . . . . 75.54 111.622 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -66.07 -51.21 60.18 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.469 0.708 . . . . 74.12 111.168 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.22 48.23 0.85 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.054 -0.976 . . . . 74.43 110.373 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -64.97 -51.88 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.246 0.462 . . . . 65.51 112.246 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -31.29 58.5 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.045 -0.525 . . . . 71.25 113.287 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -72.22 -50.96 23.36 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.254 0.622 . . . . 73.33 111.494 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.556 ' HG2' ' HZ3' ' A' ' 13' ' ' LYS . 35.7 tt0 -50.36 -37.91 39.61 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.503 0.927 . . . . 74.3 113.503 165.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.6 m -65.82 -35.6 81.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.484 0.314 . . . . 74.13 111.495 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -65.08 -42.38 94.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.218 0.451 . . . . 74.3 112.218 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.77 -50.7 33.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 120.755 0.312 . . . . 73.34 111.056 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.617 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -50.58 -51.36 33.03 Favored Glycine 0 CA--C 1.545 1.909 0 N-CA-C 116.285 1.274 . . . . 65.44 116.285 174.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 2.2 m-20 -73.11 0.19 12.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.925 1.083 . . . . 73.31 113.925 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.33 26.29 67.74 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.745 0.658 . . . . 54.23 114.745 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.0 mm-40 -67.61 -29.94 69.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.941 0.896 . . . . 75.42 111.164 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.421 HD11 ' HD1' ' A' ' 58' ' ' PHE . 21.1 pt -132.77 156.67 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.518 1.127 . . . . 72.42 108.93 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 57' ' ' GLU . 10.2 t -82.04 166.86 19.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.028 -0.42 . . . . 73.43 110.738 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -61.79 -38.31 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.717 0.407 . . . . 73.33 111.172 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 57' ' ' GLU . 1.1 tmtp? -56.79 -58.79 6.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.604 1.162 . . . . 72.51 112.137 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 21.8 tt0 -50.1 -34.57 22.35 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 114.375 -1.284 . . . . 72.13 111.983 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.421 ' HD1' HD11 ' A' ' 53' ' ' ILE . 59.8 t80 -71.48 -38.03 71.26 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 123.399 0.68 . . . . 75.42 112.211 173.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 27' ' ' ILE . 22.4 mm -73.36 -50.24 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 124.731 1.213 . . . . 75.11 111.696 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' HB2' HG13 ' A' ' 120' ' ' VAL . 31.9 tt0 -51.02 -41.43 59.8 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.487 1.115 . . . . 73.02 110.878 163.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.21 -38.9 62.64 Favored Glycine 0 CA--C 1.55 2.219 0 CA-C-N 112.438 -2.164 . . . . 74.12 112.98 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.507 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 80.9 mt -77.15 -36.02 55.59 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.068 0.947 . . . . 73.41 112.328 176.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.68 -21.85 61.12 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 114.31 0.484 . . . . 64.52 114.31 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -77.44 -34.18 54.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.502 0.721 . . . . 71.24 111.831 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 t -48.04 140.55 6.9 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.473 1.286 . . . . 73.34 114.473 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -62.02 -30.09 70.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.696 1.199 . . . . 63.22 113.423 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 tp -69.43 -24.27 63.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.399 0.619 . . . . 73.32 111.593 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.92 -34.87 57.67 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.13 -0.941 . . . . 73.11 108.752 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 -51.31 20.05 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.882 -1.053 . . . . 71.14 113.697 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 12.7 ptpt -64.15 -55.66 20.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.995 2.18 . . . . 72.34 115.234 172.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -51.51 -22.69 3.35 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.629 1.714 . . . . 73.4 115.629 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -137.44 -19.62 1.22 Allowed 'General case' 0 N--CA 1.514 2.768 0 N-CA-C 116.939 2.2 . . . . 73.03 116.939 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.433 ' HA ' HG21 ' A' ' 81' ' ' VAL . 85.8 t80 -110.83 -37.49 5.4 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.512 1.051 . . . . 73.33 112.773 -176.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.9 m -71.52 -46.74 13.17 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 114.332 1.234 . . . . 73.34 114.332 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.4 Cg_endo -84.08 -15.02 6.97 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.784 2.323 . . . . 75.45 112.408 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.6 140.21 21.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.66 0.784 . . . . 74.24 110.91 -172.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.01 151.93 82.65 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.148 1.899 . . . . 73.03 111.447 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -45.74 -28.42 1.03 Allowed 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.859 1.264 . . . . 73.12 112.605 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 m -61.61 -52.67 63.43 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.502 -1.681 . . . . 71.12 109.87 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD2' ' HB3' ' A' ' 83' ' ' GLU . 55.2 tptt -73.83 -26.87 60.82 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.182 0.993 . . . . 75.11 113.232 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.496 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 62.8 t -66.13 -25.16 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 122.955 0.502 . . . . 74.41 111.271 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 94' ' ' PRO . 46.3 mt -80.41 -28.53 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.164 0.985 . . . . 63.11 112.466 169.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.42 ' HB3' ' HD2' ' A' ' 80' ' ' LYS . 6.0 tm-20 -76.85 -51.92 10.42 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.453 0.701 . . . . 75.31 109.43 -172.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 87' ' ' LYS . 93.9 mt -75.53 -15.09 60.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.561 1.144 . . . . 74.32 109.829 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . -82.05 -49.8 5.15 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.02 -0.991 . . . . 72.2 114.026 -158.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -73.3 -19.21 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.973 1.387 . . . . 60.45 110.577 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 91.8 mttt -62.18 -33.31 74.3 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.015 -0.993 . . . . 75.11 111.371 -167.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.474 ' HA ' HE22 ' A' ' 26' ' ' GLN . 66.5 m-70 -87.88 13.11 11.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.854 0.862 . . . . 65.42 113.031 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -138.74 -58.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.531 -1.285 . . . . 75.02 107.531 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.477 HD11 ' HE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -127.04 91.1 3.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.143 0.977 . . . . 74.11 108.978 164.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 87' ' ' LYS . . . -65.69 87.26 0.1 OUTLIER Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.656 -0.702 . . . . 75.51 113.015 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.482 HH21 ' HB3' ' A' ' 124' ' ' GLU . 4.4 ptp180 -143.31 24.46 1.77 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.925 0.49 . . . . 64.31 111.766 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.21 174.58 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.307 0.855 . . . . 72.31 113.307 -158.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HB3' HG23 ' A' ' 82' ' ' ILE . 61.5 Cg_endo -72.25 137.24 28.21 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.694 1.596 . . . . 62.22 110.518 161.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.92 -61.39 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.428 1.091 . . . . 74.53 112.134 -170.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -147.76 157.84 43.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.718 0.407 . . . . 75.12 111.005 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -63.25 -10.35 15.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.425 0.898 . . . . 72.11 113.425 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.96 -42.05 12.73 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.264 1.031 . . . . 74.2 108.389 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 102' ' ' LYS . 4.0 tm-20 -64.25 -32.47 74.07 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 113.759 -1.564 . . . . 74.55 111.62 170.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.88 -54.49 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 123.284 0.634 . . . . 64.31 110.024 173.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -46.55 -34.74 5.14 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 114.23 1.196 . . . . 71.2 114.23 167.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 31.6 ttpt -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.969 0.508 . . . . 74.43 112.035 175.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.15 -46.53 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.596 0.358 . . . . 74.44 110.607 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -44.86 -42.6 8.11 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.153 0.981 . . . . 74.42 112.962 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -64.88 -29.63 70.59 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.142 0.428 . . . . 72.14 111.777 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.9 mt -79.67 -57.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.086 -1.079 . . . . 70.14 108.086 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.6 tp -45.99 -35.0 4.38 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.422 1.638 . . . . 70.34 115.422 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.32 -21.57 53.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.032 0.752 . . . . 72.42 113.032 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.7 p -113.2 -14.46 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.093 0.557 . . . . 71.41 112.08 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -138.97 -51.8 0.55 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.692 0.797 . . . . 74.12 111.156 -170.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.86 169.85 13.68 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 114.258 0.463 . . . . 60.14 114.258 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.0 tp -37.74 -34.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.247 1.573 . . . . 75.0 115.247 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -53.39 -53.91 44.42 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.397 0.679 . . . . 74.41 111.508 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.34 37.65 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.543 -1.208 . . . . 74.21 112.033 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -50.64 -70.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.51 1.3 . . . . 75.34 114.51 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.44 -37.07 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 114.034 1.124 . . . . 72.54 114.034 170.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -67.14 -38.14 85.03 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.772 0.715 . . . . 74.4 111.218 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.19 -52.05 57.25 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 123.082 0.553 . . . . 75.44 111.806 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.2 mt -49.66 -54.55 17.92 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.445 0.906 . . . . 63.33 113.445 171.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 60' ' ' GLU . 89.9 t -69.11 -26.34 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 123.84 0.856 . . . . 73.44 112.694 -172.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -100.6 13.55 34.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.146 0.795 . . . . 73.24 113.146 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.3 m -66.92 151.01 48.4 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 122.863 0.465 . . . . 70.52 110.371 167.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 126' ' ' ASN . 29.9 tt0 -72.0 -25.24 61.76 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.0 0.818 . . . . 73.41 110.524 -174.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.482 ' HB3' HH21 ' A' ' 92' ' ' ARG . 41.4 mt-10 -62.15 -36.11 80.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.877 0.871 . . . . 71.4 111.329 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -67.69 -40.3 84.38 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 109.995 -0.372 . . . . 75.52 109.995 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.512 HD22 ' HG3' ' A' ' 123' ' ' GLN . 1.5 p30 -68.6 -38.4 80.58 Favored 'General case' 0 C--N 1.366 1.311 0 CA-C-O 118.673 -0.679 . . . . 74.11 112.025 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -60.87 -56.88 15.92 Favored 'General case' 0 C--N 1.367 1.337 0 N-CA-C 115.257 1.576 . . . . 75.21 115.257 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.98 -35.84 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.348 0.594 . . . . 74.43 111.397 -162.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -111.94 -45.35 3.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.517 -0.765 . . . . 75.5 110.688 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.62 -87.36 0.93 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.403 -1.479 . . . . 73.02 109.403 -162.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.25 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.134 0.973 . . . . 75.42 111.175 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -81.8 36.71 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.67 0.788 . . . . 70.02 112.385 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 5' ' ' LYS . 45.5 m -147.52 145.4 29.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.026 0.93 . . . . 75.22 110.051 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.05 132.83 82.2 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 108.65 -0.87 . . . . 74.42 108.65 172.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.0 81.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.598 2.199 . . . . 75.13 113.447 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.9 p90 . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 123.006 0.522 . . . . 74.41 111.18 178.91 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.184 0.516 . . . . 70.12 112.307 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -71.4 132.75 45.26 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.994 0.518 . . . . 75.31 110.101 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -152.6 159.84 43.22 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.502 . . . . 74.44 112.017 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.7 100.03 12.03 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.548 -0.908 . . . . 75.23 108.548 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 ' HB ' HG13 ' A' ' 10' ' ' ILE . 98.0 t -78.38 141.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.614 -0.514 . . . . 72.51 109.614 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.99 93.07 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.359 0.664 . . . . 64.01 111.845 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.15 2.01 6.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 119.457 -0.635 . . . . 72.33 114.462 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.4 HG13 ' HB ' ' A' ' 7' ' ' VAL . 35.2 mt -79.88 82.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.673 1.236 . . . . 75.51 109.951 172.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -107.03 13.22 27.76 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.02 -0.991 . . . . 72.33 110.077 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.85 116.5 22.78 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.547 1.139 . . . . 73.14 109.076 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.34 -24.11 63.86 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.925 1.083 . . . . 75.12 113.925 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.95 -31.18 70.73 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.077 0.465 . . . . 73.44 111.06 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -50.21 13.94 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.645 -0.707 . . . . 72.3 110.698 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.2 mm -55.65 -45.45 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.406 1.082 . . . . 72.21 113.191 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.486 ' HB3' ' HZ2' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -61.55 -39.54 91.44 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 111.988 0.366 . . . . 74.41 111.988 -177.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 m -62.74 -41.13 99.05 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.394 0.677 . . . . 75.53 112.053 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 48' ' ' LEU . 20.6 tp -61.78 -44.7 96.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.368 0.667 . . . . 74.4 111.086 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.16 -41.32 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.666 1.186 . . . . 73.11 111.147 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.6 m -62.94 -53.02 60.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.387 0.675 . . . . 71.5 111.287 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.62 82.16 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.714 0.806 . . . . 73.43 112.539 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.86 -42.93 72.64 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.123 0.569 . . . . 50.55 111.357 173.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.34 -43.72 85.33 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.278 0.631 . . . . 64.12 111.979 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -68.21 -13.2 62.06 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.334 0.654 . . . . 70.41 112.308 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -89.77 -63.13 1.33 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.771 0.428 . . . . 75.44 111.386 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -65.12 -57.78 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 122.662 0.385 . . . . 73.32 110.727 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -83.04 -13.05 56.58 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.291 0.636 . . . . 75.42 112.252 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 65.58 -53.44 0.36 Allowed 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.367 1.467 . . . . 74.32 114.108 -168.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -57.57 128.76 38.66 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.203 1.001 . . . . 71.32 113.022 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.0 120.31 13.42 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.117 -0.947 . . . . 75.14 109.515 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.79 126.7 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.378 -0.601 . . . . 74.44 109.378 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.34 135.23 96.15 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 123.649 0.593 . . . . 62.45 109.991 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 -35.1 86.82 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.409 2.739 . . . . 74.14 114.14 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -69.73 -38.8 77.01 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.484 0.314 . . . . 75.11 111.437 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 71.4 mt -63.05 -41.73 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.547 0.739 . . . . 73.23 110.269 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -53.22 59.77 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.084 -0.962 . . . . 55.12 111.855 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 38' ' ' GLN . 2.5 pt20 -79.6 -11.44 59.87 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.954 1.464 . . . . 72.44 114.954 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' A' ' 36' ' ' ILE . 8.4 p30 -81.66 -45.21 16.09 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.875 1.216 . . . . 74.44 110.797 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.77 -46.27 14.46 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.804 0.841 . . . . 74.14 111.609 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -105.8 44.3 1.05 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 124.657 1.183 . . . . 64.44 109.755 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -51.67 66.88 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.818 0.673 . . . . 72.41 112.818 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.05 -30.88 64.82 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.625 -0.716 . . . . 61.01 112.569 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.4 ' CZ2' ' HA3' ' A' ' 61' ' ' GLY . 13.8 t-105 -72.58 -42.05 65.02 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.305 1.042 . . . . 75.33 111.701 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.85 -50.44 73.43 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.443 1.097 . . . . 75.05 110.777 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.1 t -59.61 -43.79 93.63 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.014 -0.994 . . . . 62.03 111.786 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HG2' HG12 ' A' ' 53' ' ' ILE . 25.2 ttmm -58.83 -46.5 87.54 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.755 1.222 . . . . 75.14 112.553 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD23 HD21 ' A' ' 19' ' ' LEU . 48.4 tp -64.56 -44.71 89.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.778 0.431 . . . . 75.32 111.278 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.73 -39.97 98.16 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 116.36 -0.382 . . . . 62.32 113.863 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -79.96 6.49 11.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.109 0.964 . . . . 73.22 112.915 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.35 32.55 68.32 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 114.595 0.598 . . . . 75.24 114.595 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.14 -26.53 42.8 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.155 0.582 . . . . 74.42 109.531 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.416 HG12 ' HG2' ' A' ' 47' ' ' LYS . 40.5 pt -134.76 170.14 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 124.282 1.033 . . . . 74.22 110.764 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.6 p -95.58 -176.57 3.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.388 0.675 . . . . 71.1 109.637 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 59' ' ' ILE . 80.0 t -65.89 -45.81 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 119.27 -0.395 . . . . 74.24 110.927 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 51.0 tttm -47.43 -52.65 16.27 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.807 1.04 . . . . 73.34 113.807 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.72 -37.17 85.47 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.672 0.389 . . . . 61.43 111.707 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 50.7 t80 -61.22 -43.27 99.15 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.66 0.784 . . . . 71.42 111.124 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 55' ' ' VAL . 34.9 mm -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.829 1.252 . . . . 73.41 111.247 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -52.18 -45.48 65.14 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.597 0.759 . . . . 73.32 112.061 172.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' HA3' ' CZ2' ' A' ' 44' ' ' TRP . . . -62.84 -36.79 93.87 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.266 -0.425 . . . . 75.21 113.324 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 46.2 mt -64.69 -44.11 91.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.378 0.671 . . . . 73.54 111.551 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.39 -34.74 86.43 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 115.447 0.939 . . . . 74.34 115.447 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -74.71 -23.13 58.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.29 0.545 . . . . 75.54 112.011 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -55.85 134.44 51.88 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.502 0.926 . . . . 72.52 113.502 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -60.65 -26.2 66.88 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.269 1.028 . . . . 74.34 112.092 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.18 -39.53 93.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.964 0.506 . . . . 72.14 111.1 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -69.33 -39.25 78.28 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.19 0.519 . . . . 74.34 110.56 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 4.6 mm? -64.74 -31.19 72.3 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.655 -0.702 . . . . 74.14 112.132 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -75.23 -46.34 34.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.865 0.466 . . . . 75.51 111.287 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -82.68 -46.31 13.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.804 0.668 . . . . 74.42 112.804 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.56 48.64 1.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 112.772 0.656 . . . . 72.54 112.772 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 74.6 t80 -159.68 -48.37 0.05 Allowed 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 116.082 -0.508 . . . . 75.13 110.88 171.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 m -66.02 -47.28 63.36 Favored Pre-proline 0 CA--C 1.573 1.848 0 N-CA-C 112.815 0.672 . . . . 71.44 112.815 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -90.08 11.07 2.87 Favored 'Trans proline' 0 C--N 1.395 2.993 0 C-N-CA 122.638 2.225 . . . . 75.02 113.202 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.0 141.26 38.97 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 122.988 0.515 . . . . 72.33 111.861 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.29 158.24 58.32 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.501 2.134 . . . . 75.43 111.384 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -51.54 -41.99 61.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.573 0.582 . . . . 74.52 112.573 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.9 m -54.14 -42.85 70.0 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.514 0.726 . . . . 75.12 111.536 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -74.92 -33.17 61.94 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.061 0.545 . . . . 75.31 112.019 178.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.09 -31.96 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.231 0.539 . . . . 75.52 110.921 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.58 -49.73 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.795 0.838 . . . . 72.13 111.008 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 80' ' ' LYS . 13.4 pt-20 -71.18 -35.47 71.6 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 111.588 0.218 . . . . 73.03 111.588 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.94 -44.53 26.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.314 0.645 . . . . 75.45 110.99 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.38 -49.86 58.82 Favored Glycine 0 N--CA 1.475 1.265 0 O-C-N 123.292 0.37 . . . . 75.43 113.639 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.575 HG21 HD13 ' A' ' 90' ' ' LEU . 86.7 m -55.73 -40.39 72.41 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 123.033 0.533 . . . . 73.25 110.632 171.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -71.33 -21.77 62.0 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 123.075 0.55 . . . . 74.31 111.434 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 67.2 m170 -87.29 -8.57 56.59 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.03 0.932 . . . . 72.23 112.363 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.8 -61.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.389 1.076 . . . . 74.45 108.88 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -110.08 84.74 1.98 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.359 -1.348 . . . . 74.31 107.359 176.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.53 78.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 114.896 0.718 . . . . 51.51 114.896 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.593 HH12 HD13 ' A' ' 95' ' ' ILE . 27.8 mtm105 -137.94 151.43 47.96 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.375 1.07 . . . . 74.4 111.089 -174.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 132.02 85.85 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-N 115.471 -0.786 . . . . 64.33 110.748 168.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.27 135.91 46.28 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.31 2.673 . . . . 70.02 113.824 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.593 HD13 HH12 ' A' ' 92' ' ' ARG . 49.6 mm -82.69 -69.12 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.495 0.718 . . . . 75.55 112.76 -170.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -147.81 156.58 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.583 0.753 . . . . 72.12 109.073 -165.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -58.44 -40.31 82.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.954 0.724 . . . . 75.22 112.954 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.63 71.78 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.248 0.462 . . . . 74.14 112.248 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -65.7 -40.32 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.613 0.765 . . . . 75.33 110.919 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.03 -50.44 64.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.533 0.733 . . . . 73.21 110.968 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.2 mmm180 -52.05 -40.85 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.537 1.135 . . . . 73.42 112.386 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.42 ' O ' HG13 ' A' ' 106' ' ' ILE . 35.7 ttpt -56.39 -52.68 63.73 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.76 0.824 . . . . 74.24 111.194 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -72.24 -36.79 69.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.795 0.438 . . . . 74.45 112.167 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.47 -40.83 96.43 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.956 0.902 . . . . 74.24 111.296 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.415 HE21 HG23 ' A' ' 109' ' ' THR . 24.3 tp60 -67.6 -28.93 68.17 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.466 -0.788 . . . . 70.33 111.015 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 102' ' ' LYS . 82.2 mt -63.19 -39.14 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 122.991 0.516 . . . . 64.54 110.526 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.96 -39.92 96.11 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.836 0.454 . . . . 72.43 111.602 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.21 -37.32 53.63 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.716 0.635 . . . . 54.23 112.716 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.415 HG23 HE21 ' A' ' 105' ' ' GLN . 67.0 p -80.93 -60.15 2.41 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.193 0.597 . . . . 73.13 112.493 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -103.04 -36.23 8.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.0 0.92 . . . . 73.14 112.801 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.4 -162.01 12.51 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 122.847 0.261 . . . . 71.21 113.315 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.5 tp -79.69 -29.14 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.111 0.564 . . . . 75.44 111.476 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -49.42 77.82 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.384 0.673 . . . . 74.4 110.381 -175.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -33.3 73.88 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.128 -0.942 . . . . 74.3 112.738 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.21 -52.29 66.3 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.234 0.613 . . . . 73.52 111.328 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.83 -45.68 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.666 0.786 . . . . 74.14 110.718 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -57.94 -35.68 71.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.166 0.986 . . . . 72.12 111.387 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -67.55 -48.37 67.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.128 0.571 . . . . 73.12 111.387 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.487 ' HB3' HD12 ' A' ' 90' ' ' LEU . 82.0 mt -58.31 -44.74 88.73 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.617 0.767 . . . . 71.54 112.554 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.8 t -68.17 -52.19 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.079 0.952 . . . . 73.53 111.954 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.81 24.06 4.4 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.291 0.636 . . . . 62.1 112.155 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 19.6 t -79.53 155.4 28.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.577 0.751 . . . . 72.11 112.275 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.98 -52.58 64.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.691 0.796 . . . . 65.51 110.952 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.94 -30.84 66.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.852 0.861 . . . . 73.14 112.595 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -71.45 -54.26 11.23 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.218 0.207 . . . . 75.45 111.098 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -69.48 -34.3 74.13 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.961 0.726 . . . . 75.22 112.961 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.57 -42.58 58.51 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 111.682 0.252 . . . . 74.3 111.682 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.81 -54.79 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.289 0.636 . . . . 75.22 111.857 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.436 ' HE2' ' H ' ' A' ' 136' ' ' TYR . 52.9 m-85 -88.41 -49.29 7.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.164 0.986 . . . . 74.32 110.832 -176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 93.25 -118.91 5.77 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.218 -0.447 . . . . 71.42 112.546 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -141.31 -23.18 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.858 0.863 . . . . 74.22 111.615 176.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -84.13 -23.54 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.558 0.577 . . . . 62.0 112.558 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.2 m -93.74 138.09 32.31 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.277 0.473 . . . . 72.52 112.277 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.18 136.34 75.92 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.851 0.86 . . . . 73.1 109.678 168.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -34.77 111.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.586 3.524 . . . . 63.41 115.5 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.436 ' H ' ' HE2' ' A' ' 129' ' ' PHE . 52.9 p90 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 123.395 0.678 . . . . 75.02 110.88 175.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.922 0.391 . . . . 73.43 110.893 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 70.15 29.14 3.83 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.193 1.397 . . . . 70.15 112.845 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HZ3' HG21 ' A' ' 7' ' ' VAL . 17.2 pttp -92.25 145.89 24.14 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.855 -0.528 . . . . 71.32 109.597 170.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -78.26 101.23 7.03 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.564 -0.532 . . . . 75.51 109.564 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.428 HG21 ' HZ3' ' A' ' 5' ' ' LYS . 49.5 t -68.02 113.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.29 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.144 0.978 . . . . 75.13 112.608 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.58 -18.02 4.4 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 115.436 -0.802 . . . . 74.33 114.267 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.43 104.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 117.903 0.852 . . . . 74.52 111.162 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -86.54 -38.22 17.41 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 75.01 111.406 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.01 102.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.78 1.232 . . . . 71.33 113.894 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.618 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 68.5 mttt -67.77 -9.19 41.9 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.542 -0.754 . . . . 75.42 112.54 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.04 -39.6 79.1 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.561 0.744 . . . . 75.52 110.91 163.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.64 43.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.745 0.818 . . . . 74.3 110.991 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 1.7 mp -58.0 -39.81 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.079 0.951 . . . . 75.32 110.827 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -64.71 -49.88 69.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.999 0.52 . . . . 71.35 111.467 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -54.39 -42.36 70.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.166 0.802 . . . . 75.2 113.166 172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 48' ' ' LEU . 9.6 tt -58.27 -48.41 80.53 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.171 0.988 . . . . 74.35 110.893 173.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.69 -43.24 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.386 1.074 . . . . 75.11 111.379 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.3 m -63.75 -48.68 76.04 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.347 0.659 . . . . 74.54 111.012 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.82 57.77 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.327 0.862 . . . . 74.2 113.327 170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.15 72.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.259 0.837 . . . . 55.31 113.259 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -72.96 -48.1 39.63 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.588 0.755 . . . . 75.25 111.227 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.4 ttm180 -51.02 -36.88 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.223 1.009 . . . . 65.11 113.668 172.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.21 -63.68 1.27 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.8 0.44 . . . . 70.14 110.576 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 59' ' ' ILE . 61.2 mt -65.32 -48.4 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.913 0.885 . . . . 75.21 112.452 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -84.35 9.63 12.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.258 0.623 . . . . 72.41 111.628 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 49.95 19.87 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 125.922 1.689 . . . . 72.31 115.183 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -164.12 143.51 7.75 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.416 0.626 . . . . 65.54 111.604 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.2 111.21 2.86 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.008 -0.996 . . . . 55.22 111.042 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.2 mt -78.89 134.89 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 116.105 -0.498 . . . . 72.24 109.968 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 123.8 52.98 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 124.254 0.971 . . . . 72.41 110.649 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -54.15 -37.84 87.47 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.526 2.817 . . . . 71.21 114.069 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -67.85 -24.91 65.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.663 0.785 . . . . 73.33 113.07 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.36 -44.45 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.213 0.605 . . . . 75.11 110.681 171.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.18 80.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.064 0.945 . . . . 65.45 112.195 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -72.55 -25.26 61.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.982 0.513 . . . . 65.42 111.833 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.31 -47.23 18.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.667 0.787 . . . . 70.01 110.977 -170.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.2 -32.89 59.22 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.633 -0.712 . . . . 72.41 110.764 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.37 43.08 1.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.902 0.881 . . . . 73.42 111.07 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -68.61 -43.91 75.39 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.163 0.585 . . . . 75.14 112.433 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.89 -26.89 61.52 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.844 -0.502 . . . . 42.32 111.844 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -82.21 -30.85 30.62 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.088 0.955 . . . . 75.11 110.483 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -68.79 -41.58 78.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.95 0.9 . . . . 73.41 108.862 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 t -57.09 -35.65 69.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.62 0.768 . . . . 71.4 111.92 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -42.6 99.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.9 0.48 . . . . 75.54 111.279 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD23 HD21 ' A' ' 19' ' ' LEU . 49.2 tp -73.24 -36.07 66.36 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.736 0.815 . . . . 60.32 111.503 177.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.7 -48.42 12.78 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 123.313 0.482 . . . . 72.32 113.153 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -78.26 3.15 16.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.744 0.646 . . . . 74.04 112.744 172.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.4 34.09 67.58 Favored Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.727 0.651 . . . . 74.22 114.727 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -68.46 -28.34 66.96 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.509 0.724 . . . . 73.44 111.58 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 pt -130.03 170.42 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.365 1.066 . . . . 73.44 110.362 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p -90.8 164.35 14.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.206 0.602 . . . . 74.22 110.258 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.73 -41.23 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.612 0.365 . . . . 74.11 110.46 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 87.0 tttt -41.78 -55.59 2.97 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.253 1.205 . . . . 75.12 114.253 162.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -66.07 -26.79 67.66 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.921 -0.581 . . . . 74.02 111.777 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -72.99 -38.36 66.68 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.166 0.986 . . . . 74.31 110.801 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.432 HG13 HD11 ' A' ' 27' ' ' ILE . 1.2 mp -73.41 -45.17 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.972 1.309 . . . . 73.21 111.829 -174.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.522 ' HB2' HG12 ' A' ' 120' ' ' VAL . 32.6 tt0 -50.28 -35.92 29.24 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.69 0.626 . . . . 74.21 112.69 165.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.45 -26.95 74.05 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-N 115.93 -0.577 . . . . 73.55 112.439 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -74.04 -48.34 30.64 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.999 0.92 . . . . 64.13 111.2 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.69 -31.65 45.82 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 116.308 1.283 . . . . 41.41 116.308 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -72.44 -17.86 61.75 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 117.472 0.636 . . . . 73.35 112.119 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -75.4 131.87 40.5 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.395 0.678 . . . . 62.03 111.368 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -61.03 -18.95 60.54 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.73 0.812 . . . . 75.11 112.808 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 32.3 tp -61.71 -41.14 97.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.608 0.763 . . . . 74.33 111.189 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.07 -37.16 86.63 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.042 0.448 . . . . 71.33 111.308 172.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.483 HD11 HG23 ' A' ' 112' ' ' ILE . 4.2 mm? -70.99 -30.11 66.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.883 0.873 . . . . 75.35 112.722 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HA ' ' HG1' ' A' ' 74' ' ' THR . 17.9 ptpt -77.58 -25.02 49.65 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 122.133 -0.354 . . . . 72.15 110.59 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 22.4 mm-40 -75.49 -56.27 4.87 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.561 172.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -130.08 70.35 1.44 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.775 0.657 . . . . 63.55 112.775 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -176.04 -61.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.493 0.717 . . . . 75.22 110.53 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.451 ' HG1' ' HA ' ' A' ' 70' ' ' LYS . 70.9 p -65.16 -38.46 28.29 Favored Pre-proline 0 CA--C 1.573 1.849 0 N-CA-C 113.961 1.097 . . . . 64.12 113.961 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -94.73 17.41 0.89 Allowed 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 121.987 1.791 . . . . 72.25 113.674 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -137.46 153.42 74.46 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 123.857 0.863 . . . . 75.45 111.372 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.94 153.56 63.43 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.226 1.951 . . . . 64.45 111.551 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -46.81 -54.32 10.1 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.329 1.233 . . . . 72.35 114.329 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -49.2 -32.68 10.86 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 113.956 1.095 . . . . 75.54 113.956 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -74.89 -27.63 60.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.882 0.473 . . . . 73.43 111.196 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.75 -30.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.761 0.824 . . . . 73.44 111.755 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 100' ' ' ILE . 2.0 mp -67.44 -43.78 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.004 0.521 . . . . 75.14 110.884 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.42 -26.04 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.095 -0.502 . . . . 74.44 111.846 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.6 mt -85.38 -31.17 23.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.635 0.774 . . . . 71.53 111.771 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.99 -54.75 12.61 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 116.218 -0.447 . . . . 64.11 112.435 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 90' ' ' LEU . 47.8 m -57.64 -30.63 65.55 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.308 1.043 . . . . 71.32 111.464 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.41 -38.4 77.91 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.854 0.862 . . . . 72.44 111.819 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -94.27 -1.48 53.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.147 1.166 . . . . 75.53 114.147 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -123.36 -57.92 1.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.061 0.391 . . . . 72.34 111.69 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 86' ' ' THR . 60.8 mt -84.12 -12.72 54.56 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.302 0.241 . . . . 73.41 111.389 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.56 11.16 56.26 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 116.2 -0.455 . . . . 75.52 113.551 -173.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -104.92 135.17 46.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.977 0.911 . . . . 65.32 111.547 -167.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.92 158.4 70.5 Favored Pre-proline 0 CA--C 1.565 1.531 0 CA-C-N 115.383 -0.826 . . . . 53.21 111.386 169.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.87 161.59 0.48 Allowed 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.043 2.495 . . . . 71.25 113.961 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.16 -75.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.771 -0.825 . . . . 73.23 108.771 -160.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -141.04 153.24 45.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.257 1.423 . . . . 73.02 107.437 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -63.26 -14.44 49.41 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.905 1.229 . . . . 61.42 113.618 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.37 -31.27 21.58 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.21 -1.033 . . . . 63.23 108.21 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.52 -39.53 77.48 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.289 1.436 . . . . 71.22 111.114 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 82' ' ' ILE . 87.8 mt -64.02 -52.8 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.244 0.618 . . . . 74.23 110.264 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -55.26 -31.22 61.37 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.213 1.005 . . . . 75.31 113.514 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.27 -49.35 74.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.548 0.339 . . . . 74.52 110.818 173.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -68.27 -39.66 82.12 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.971 0.509 . . . . 73.52 111.29 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -58.76 -42.77 89.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.39 1.076 . . . . 74.42 112.463 172.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -62.39 -27.39 69.05 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.25 0.62 . . . . 74.02 111.958 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.04 -60.33 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 108.798 -0.816 . . . . 74.21 108.798 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 115' ' ' PHE . 22.8 tp -41.96 -31.97 0.39 Allowed 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 115.658 1.725 . . . . 72.22 115.658 160.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.19 -41.47 25.19 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 119.176 0.898 . . . . 73.42 112.317 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.2 p -97.79 -22.97 16.1 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.024 0.75 . . . . 54.23 113.024 -172.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -126.36 -38.07 2.15 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.426 0.69 . . . . 75.34 112.113 -171.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.61 174.33 14.0 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 113.986 0.354 . . . . 62.05 113.986 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.483 HG23 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -67.66 -29.6 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.051 0.94 . . . . 73.01 110.62 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.441 ' HG3' ' H ' ' A' ' 114' ' ' ALA . 10.0 ptt180 -54.67 -53.0 60.57 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.629 0.772 . . . . 74.51 111.371 171.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' H ' ' HG3' ' A' ' 113' ' ' ARG . . . -64.24 -29.03 70.15 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.973 0.909 . . . . 64.23 113.153 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.403 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 55.3 t80 -67.76 -49.51 62.08 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.407 0.683 . . . . 72.54 111.106 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -59.37 -46.34 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.586 0.754 . . . . 72.4 110.414 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.67 -40.45 75.55 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.715 0.806 . . . . 54.43 112.345 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.64 93.22 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.262 0.625 . . . . 72.2 112.119 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.462 ' O ' HD22 ' A' ' 90' ' ' LEU . 83.6 mt -72.6 -55.74 6.42 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.303 0.641 . . . . 75.04 111.816 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 60' ' ' GLU . 88.7 t -61.66 -42.6 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.57 0.748 . . . . 74.12 112.412 -173.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -82.75 -0.47 47.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.294 0.85 . . . . 74.31 113.294 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -66.95 158.02 31.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.015 0.526 . . . . 73.02 111.913 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -65.12 -25.99 68.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.823 0.849 . . . . 74.45 110.628 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.486 ' HB2' HD21 ' A' ' 90' ' ' LEU . 42.6 mm-40 -62.89 -48.35 79.38 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.201 1.0 . . . . 71.23 111.671 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -68.46 -46.33 70.06 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.437 0.637 . . . . 73.44 110.013 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.74 -52.03 64.83 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.468 -1.242 . . . . 74.05 112.32 -165.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.49 -42.65 19.96 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.467 0.914 . . . . 71.23 113.467 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.07 -49.16 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.252 0.621 . . . . 73.2 112.5 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -96.15 -53.98 3.46 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 120.991 0.424 . . . . 74.53 111.195 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.7 144.3 13.51 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.853 -0.612 . . . . 35.24 111.581 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 16.3 pt-20 -74.84 -19.5 60.15 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.768 0.655 . . . . 75.22 112.768 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.01 -6.91 59.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.698 0.799 . . . . 74.51 111.84 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 m -116.2 149.74 38.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.433 0.693 . . . . 72.5 112.244 -167.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 141.51 97.42 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.728 0.811 . . . . 74.55 109.563 166.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.402 ' HD3' HG12 ' A' ' 59' ' ' ILE . 38.8 Cg_endo -65.3 77.36 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.587 2.192 . . . . 63.03 112.726 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.9 p90 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 108.654 -0.869 . . . . 74.43 108.654 176.92 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.565 1.531 0 CA-C-O 120.94 0.4 . . . . 73.44 111.435 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 63.8 86.13 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.038 1.335 . . . . 72.24 112.059 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -127.48 170.75 12.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.664 1.186 . . . . 74.32 110.803 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -116.27 94.29 4.58 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.877 -0.602 . . . . 74.22 110.121 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.64 141.85 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.927 -0.768 . . . . 75.5 108.927 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.54 -20.65 0.46 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.86 1.8 . . . . 75.41 115.86 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.32 -103.7 0.86 Allowed Glycine 0 C--N 1.368 2.34 0 CA-C-N 120.155 1.343 . . . . 75.02 110.519 166.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm 41.29 49.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 125.431 1.492 . . . . 71.12 111.945 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -64.63 13.38 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 114.918 1.451 . . . . 72.52 114.918 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.98 113.08 17.88 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.867 0.841 . . . . 74.34 110.551 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -28.15 64.51 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.714 -1.585 . . . . 74.35 109.368 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.26 71.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.519 1.127 . . . . 54.03 111.08 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.09 67.86 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.072 0.767 . . . . 72.1 113.072 171.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 20' ' ' ILE . 45.7 mm -54.09 -54.45 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 112.794 0.664 . . . . 71.2 112.794 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HA ' HD12 ' A' ' 20' ' ' ILE . 15.5 ptpt -66.04 -30.89 71.5 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.934 0.716 . . . . 72.31 112.934 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -70.33 -48.79 54.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.23 0.612 . . . . 73.21 111.431 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.77 -43.21 8.39 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.187 0.995 . . . . 63.34 112.446 167.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 16' ' ' ILE . 66.4 mt -66.13 -35.83 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.496 0.718 . . . . 74.15 111.454 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -67.05 -41.7 86.06 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.182 0.593 . . . . 73.3 112.089 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.33 91.7 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.059 0.544 . . . . 73.42 111.983 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.48 9.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.368 -1.287 . . . . 63.32 112.166 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.446 ' HH ' ' HB1' ' A' ' 37' ' ' ALA . 26.3 m-85 -78.13 -47.06 19.03 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.92 0.488 . . . . 73.1 112.067 167.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -68.25 -15.71 63.68 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.176 0.99 . . . . 72.32 112.391 -171.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -95.57 -35.55 11.6 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.655 -0.653 . . . . 71.43 111.592 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 50.2 mm -87.67 -66.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.147 0.579 . . . . 75.51 111.014 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.48 -17.89 64.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.284 0.634 . . . . 72.44 111.274 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 25' ' ' ARG . 23.2 tt0 62.65 31.33 16.8 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.535 1.534 . . . . 74.13 112.276 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -152.37 156.55 39.78 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.807 -0.633 . . . . 71.24 111.776 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.93 108.44 8.81 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.81 -1.086 . . . . 65.21 109.166 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.51 135.24 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 109.352 -0.61 . . . . 73.51 109.352 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.15 118.04 21.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.73 0.812 . . . . 75.32 111.075 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -47.74 -39.92 31.11 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.847 3.031 . . . . 74.03 114.56 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -67.99 -39.37 83.29 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 112.904 0.705 . . . . 75.42 112.904 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -67.07 -44.27 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.326 0.584 . . . . 72.03 110.542 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB1' ' HH ' ' A' ' 24' ' ' TYR . . . -62.44 -36.58 82.85 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.27 1.028 . . . . 72.14 112.698 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.0 -23.82 35.78 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 116.317 -0.402 . . . . 72.13 110.765 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -75.48 -35.38 60.86 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.103 0.561 . . . . 73.22 111.483 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.6 -61.96 1.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.645 0.736 . . . . 75.54 110.996 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.8 43.79 1.07 Allowed 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 115.348 -0.842 . . . . 74.43 112.814 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.15 -51.88 33.71 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.074 -0.391 . . . . 62.41 112.014 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.96 -34.54 33.52 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.136 -0.484 . . . . 62.21 111.959 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -66.88 -39.85 87.63 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.89 0.876 . . . . 75.13 112.822 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.08 -28.7 63.48 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.164 0.586 . . . . 75.02 110.583 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -53.63 -31.41 47.2 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.451 0.7 . . . . 74.14 112.026 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.94 -44.35 66.29 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.984 0.514 . . . . 73.31 111.125 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.5 tp -65.54 -57.76 7.42 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 112.738 0.644 . . . . 74.23 112.738 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.92 -49.34 35.84 Favored Glycine 0 C--N 1.362 2.0 0 N-CA-C 115.246 0.858 . . . . 71.05 115.246 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -67.79 20.07 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 115.207 1.558 . . . . 74.21 115.207 171.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.4 19.75 0.1 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 118.633 2.213 . . . . 43.54 118.633 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -62.2 -54.72 36.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 118.476 1.138 . . . . 75.13 111.079 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 pt -108.15 140.17 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.137 -1.392 . . . . 74.52 110.467 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.0 p -69.15 169.96 11.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.792 0.437 . . . . 73.45 111.604 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.69 -24.35 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.51 0 CA-C-N 116.006 -0.543 . . . . 74.15 111.323 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -68.4 -53.13 25.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.603 1.161 . . . . 70.33 110.965 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.8 -21.81 65.21 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.83 0.852 . . . . 72.1 111.57 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.19 -43.81 40.78 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.238 -1.023 . . . . 75.23 108.238 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.3 mt -66.18 -28.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 113.696 -1.593 . . . . 73.32 112.098 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -58.21 -50.9 71.93 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.832 -0.433 . . . . 65.14 109.832 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.37 65.05 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 114.743 0.657 . . . . 74.01 114.743 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -73.44 -33.3 64.84 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.136 0.575 . . . . 73.32 111.014 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.66 -12.11 78.4 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 115.669 -0.696 . . . . 63.34 112.405 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.402 ' HH ' ' HB2' ' A' ' 117' ' ' ASN . 4.2 m-30 -97.7 11.74 36.08 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.575 1.15 . . . . 72.4 111.199 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.1 p -99.48 126.97 45.51 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.34 -0.615 . . . . 62.21 109.34 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -57.94 -15.6 9.36 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.458 0.703 . . . . 73.12 112.777 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.08 -59.35 3.87 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.038 0.935 . . . . 73.5 111.726 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -49.38 -48.85 46.58 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.292 1.219 . . . . 75.34 114.292 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.548 HD11 HG22 ' A' ' 112' ' ' ILE . 3.2 mm? -62.32 -21.28 65.15 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.072 0.767 . . . . 72.12 113.072 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -76.14 -42.19 47.56 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.522 -0.918 . . . . 74.3 108.522 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.2 -64.11 1.21 Allowed 'General case' 0 C--N 1.371 1.519 0 CA-C-N 118.984 0.811 . . . . 75.0 111.846 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CD1' HD12 ' A' ' 84' ' ' LEU . 23.1 m-85 -100.76 61.59 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.276 1.213 . . . . 74.21 114.276 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.512 ' HD1' HG21 ' A' ' 81' ' ' VAL . 31.2 t80 -171.73 -57.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 122.979 0.511 . . . . 75.44 112.099 168.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.6 m -59.14 -44.13 98.13 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 113.053 0.76 . . . . 63.53 113.053 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -96.5 16.83 0.72 Allowed 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.442 2.095 . . . . 73.3 113.945 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.55 144.02 51.22 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 112.588 0.588 . . . . 72.24 112.588 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.88 145.27 31.75 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.199 1.932 . . . . 75.25 112.637 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -21.92 -60.58 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.848 1.795 . . . . 63.52 115.848 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.424 ' HA ' HD11 ' A' ' 82' ' ' ILE . 18.5 m -66.03 -20.27 66.13 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.347 0.976 . . . . 74.11 113.099 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.57 -33.1 16.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.759 -1.2 . . . . 75.21 107.759 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.512 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.4 t -69.53 -29.06 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.578 -1.192 . . . . 70.43 110.106 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 79' ' ' THR . 90.0 mt -65.56 -43.08 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.262 0.625 . . . . 75.34 110.182 170.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.79 -65.14 0.77 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 117.575 0.171 . . . . 75.32 111.005 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.453 HD12 ' CD1' ' A' ' 72' ' ' PHE . 96.6 mt -49.06 -30.94 6.96 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.529 1.678 . . . . 72.23 115.529 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.33 -56.67 3.35 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 118.247 0.476 . . . . 73.05 112.77 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.466 HG23 HD12 ' A' ' 90' ' ' LEU . 86.6 m -60.17 -39.24 85.76 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.045 0.938 . . . . 73.32 112.734 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -71.82 -6.17 39.65 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.283 1.033 . . . . 75.41 113.49 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 55.9 m170 -100.69 -32.78 10.56 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.21 -1.033 . . . . 75.34 108.21 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -96.72 -66.72 0.89 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.944 1.298 . . . . 74.11 110.358 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.466 HD12 HG23 ' A' ' 86' ' ' THR . 52.6 mt -73.74 -13.78 61.02 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.538 0.335 . . . . 75.34 111.71 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.53 -19.29 4.01 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 115.874 1.11 . . . . 53.25 115.874 168.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.21 -174.25 2.51 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 117.593 0.697 . . . . 74.54 110.21 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.15 152.87 44.5 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 121.722 -0.611 . . . . 74.32 110.151 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.01 153.52 8.72 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 C-N-CA 122.966 2.444 . . . . 74.53 114.901 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.4 mt -78.62 -64.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.314 0.487 . . . . 74.21 112.314 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -114.46 -146.96 0.41 Allowed 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 104.598 -2.371 . . . . 75.11 104.598 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -97.5 -18.17 19.17 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-N 123.644 2.929 . . . . 74.24 108.655 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.565 0.746 . . . . 65.34 111.663 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.67 -42.3 70.92 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.802 0.441 . . . . 74.13 111.021 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.3 mt -59.87 -38.97 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.515 0.726 . . . . 74.5 110.494 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -72.87 -30.31 63.87 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.914 -1.039 . . . . 71.35 110.827 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -67.69 -51.39 50.08 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.8 0.84 . . . . 73.45 110.262 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -65.64 -42.52 91.37 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.115 0.566 . . . . 75.33 112.17 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -45.3 -44.58 11.62 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.054 0.942 . . . . 75.23 112.84 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -70.95 -44.42 66.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.183 0.593 . . . . 73.41 111.601 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 73.6 mt -53.04 -53.62 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.774 0.83 . . . . 74.5 111.122 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.535 HD21 HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -52.82 -42.36 65.06 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.122 1.369 . . . . 72.12 113.057 172.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.08 -55.07 13.84 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.028 0.531 . . . . 71.31 112.065 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.2 p -62.93 -62.7 1.54 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.685 0.794 . . . . 73.44 113.125 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -98.96 -52.36 3.58 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.841 0.856 . . . . 71.12 112.595 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.51 -148.4 17.17 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 116.555 -0.293 . . . . 62.52 113.261 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 69' ' ' LEU . 10.1 mm -79.3 -35.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.246 1.018 . . . . 71.12 112.037 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -59.39 -65.96 0.59 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.769 0.319 . . . . 71.15 110.38 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -49.29 -20.91 0.71 Allowed 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.361 1.986 . . . . 73.43 116.361 165.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -73.64 -62.75 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.309 1.413 . . . . 63.23 110.078 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 120' ' ' VAL . 50.3 mm -47.1 -59.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.07 0.948 . . . . 75.13 112.93 170.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.402 ' HB2' ' HH ' ' A' ' 64' ' ' TYR . 59.4 t30 -40.68 -46.28 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.52 0.933 . . . . 72.25 113.52 169.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -63.74 -23.08 67.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.864 0.691 . . . . 75.5 112.864 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.36 -34.23 18.88 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.208 1.003 . . . . 73.1 111.205 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 116' ' ' ILE . 93.1 t -69.51 -60.44 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.349 1.06 . . . . 75.43 111.229 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -76.88 -5.4 48.29 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.219 0.608 . . . . 73.2 112.394 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 32.5 t -53.48 143.48 19.4 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.564 0.746 . . . . 75.52 111.25 173.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.81 -29.19 65.3 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.438 -0.578 . . . . 73.13 109.438 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -66.55 -48.82 68.48 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.089 0.956 . . . . 74.5 111.67 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.4 ' HB2' HD22 ' A' ' 90' ' ' LEU . 90.0 t80 -60.5 -48.26 82.54 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 120.838 0.351 . . . . 73.54 110.719 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.0 -27.28 68.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 115.301 -0.863 . . . . 74.25 112.197 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -91.55 -54.41 3.91 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.974 0.51 . . . . 60.12 112.355 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.19 -52.46 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.355 0.662 . . . . 75.21 111.924 -174.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.07 -41.6 9.46 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.167 0.587 . . . . 63.25 111.241 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.53 166.69 26.44 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.993 -0.549 . . . . 72.21 113.423 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.79 -33.11 60.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.418 0.687 . . . . 74.13 112.097 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -129.01 60.45 1.55 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.319 1.057 . . . . 72.24 110.458 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.3 m -153.74 145.71 23.6 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 114.128 -1.396 . . . . 73.45 108.868 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 82.9 t -68.07 134.28 91.68 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 123.567 0.747 . . . . 74.44 110.477 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.34 85.51 0.27 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.936 2.424 . . . . 62.41 111.542 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.0 p90 . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 124.595 1.158 . . . . 63.13 112.997 -175.84 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 112.189 0.44 . . . . 72.43 112.189 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -70.89 94.94 1.1 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.191 0.596 . . . . 72.1 110.109 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.6 109.34 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.06 0.544 . . . . 75.22 110.63 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.74 110.83 21.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.269 0.557 . . . . 75.32 111.355 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.43 167.15 26.99 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.314 1.046 . . . . 64.13 109.088 169.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -85.72 117.06 24.37 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.778 0.431 . . . . 73.51 110.255 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 10' ' ' ILE . 61.7 t -89.08 136.99 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.194 -1.039 . . . . 74.25 108.194 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.11 82.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.313 0.578 . . . . 72.41 110.805 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.09 -18.75 0.4 Allowed Glycine 0 CA--C 1.536 1.367 0 CA-C-N 115.474 -0.785 . . . . 45.42 113.533 -172.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.496 HG13 ' HB ' ' A' ' 7' ' ' VAL . 55.8 mt -73.69 88.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.016 0.908 . . . . 72.11 110.982 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -94.63 2.57 55.61 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.555 0.742 . . . . 74.31 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -79.88 121.02 24.9 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.284 0.634 . . . . 72.32 111.083 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -68.98 -26.76 65.19 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.703 0.401 . . . . 73.45 111.492 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.04 -48.81 64.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.285 0.634 . . . . 64.1 111.074 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.75 84.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.973 0.509 . . . . 74.54 111.596 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.527 HG13 ' HA2' ' A' ' 49' ' ' GLY . 29.3 mm -55.96 -49.6 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.601 0.76 . . . . 74.23 111.367 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -67.73 -27.85 67.14 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.269 0.47 . . . . 73.25 112.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.4 m -69.96 -40.09 75.61 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.197 0.522 . . . . 74.23 111.259 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.71 -39.4 84.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.49 1.116 . . . . 74.24 110.418 172.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 16' ' ' ILE . 92.6 mt -70.23 -40.62 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.529 1.132 . . . . 72.31 111.911 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.1 m -64.74 -38.71 91.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.158 0.583 . . . . 71.3 111.155 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.6 96.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.496 -0.775 . . . . 61.4 111.405 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.67 -30.76 70.94 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.539 0.736 . . . . 70.03 112.177 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.62 -48.76 75.99 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.813 0.445 . . . . 73.01 111.182 170.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -70.76 -15.12 62.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.064 0.546 . . . . 74.31 111.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -85.32 -53.62 5.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.183 0.593 . . . . 74.42 111.27 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.808 HD11 HG23 ' A' ' 59' ' ' ILE . 65.0 mt -82.35 -66.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.078 0.551 . . . . 65.32 111.353 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 22.7 m-85 -66.39 -14.56 62.3 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.955 0.902 . . . . 73.31 111.813 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 70.68 -50.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.025 1.73 . . . . 73.14 112.717 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -61.28 143.46 55.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.204 1.002 . . . . 74.13 113.273 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.55 114.32 9.5 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.614 -1.176 . . . . 73.23 108.779 162.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.4 mt -90.85 129.14 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.584 -0.524 . . . . 72.14 109.584 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.27 125.47 81.69 Favored Pre-proline 0 CA--C 1.557 1.214 0 O-C-N 123.951 0.782 . . . . 74.11 111.029 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.27 -32.21 32.15 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.751 2.968 . . . . 75.21 115.34 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -71.04 -29.55 65.49 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.191 0.441 . . . . 71.35 112.191 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.86 -44.83 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 122.749 0.42 . . . . 71.53 109.908 170.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.5 72.57 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.846 0.858 . . . . 73.12 112.619 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -79.87 -18.76 49.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.354 0.501 . . . . 74.22 112.354 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -80.47 -31.04 37.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 70.22 111.653 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.28 -55.44 3.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.045 0.538 . . . . 74.54 112.242 -174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -117.55 19.69 13.83 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.72 1.378 . . . . 71.23 114.72 -169.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.7 p -66.23 -30.2 70.6 Favored 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 120.554 1.525 . . . . 73.24 112.171 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.91 41.63 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.732 -0.667 . . . . 74.21 112.364 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -81.1 -31.51 34.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.81 1.244 . . . . 75.13 111.467 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -37.37 81.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.165 1.386 . . . . 75.25 111.765 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.6 p -59.01 -38.66 79.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.312 0.645 . . . . 72.04 112.024 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -63.17 -38.29 90.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.065 0.546 . . . . 75.24 111.897 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.473 HD11 HG23 ' A' ' 55' ' ' VAL . 42.4 tp -72.96 -42.94 62.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.702 0.287 . . . . 73.15 111.267 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.527 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -69.64 -35.43 74.3 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.357 -0.383 . . . . 70.33 113.904 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -92.58 -19.18 22.19 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.293 0.637 . . . . 73.13 111.314 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.06 19.33 26.63 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 115.783 1.073 . . . . 72.21 115.783 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.14 -29.55 67.62 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 118.226 1.013 . . . . 65.24 112.212 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.432 HD11 ' HD1' ' A' ' 58' ' ' PHE . 27.1 pt -120.68 169.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.322 0.649 . . . . 72.33 111.034 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 29.8 p -91.94 172.32 8.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.828 -0.624 . . . . 75.04 110.389 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.473 HG23 HD11 ' A' ' 48' ' ' LEU . 58.6 t -71.56 -39.56 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 116.399 -0.364 . . . . 73.53 110.573 175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HE2' HG11 ' A' ' 120' ' ' VAL . 54.7 tttm -53.95 -50.49 66.37 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.36 0.664 . . . . 75.23 112.522 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -34.22 76.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.216 0.606 . . . . 65.33 111.979 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.432 ' HD1' HD11 ' A' ' 53' ' ' ILE . 63.7 t80 -63.42 -50.61 69.14 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.141 0.576 . . . . 64.43 111.024 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.808 HG23 HD11 ' A' ' 27' ' ' ILE . 49.2 mt -70.11 -39.49 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.861 1.264 . . . . 64.43 112.57 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.79 -38.77 86.43 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.366 0.666 . . . . 74.33 110.085 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.58 -32.99 85.0 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 116.137 -0.483 . . . . 64.52 114.212 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.493 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 84.2 mt -66.61 -37.92 85.89 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.185 0.517 . . . . 73.4 110.875 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.8 -23.93 67.77 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-N 115.34 -0.845 . . . . 74.13 114.116 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -82.34 -18.74 41.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.616 0.766 . . . . 75.05 112.061 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 t -60.35 119.7 8.47 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.306 0.854 . . . . 75.1 113.306 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.76 -16.41 57.67 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 123.597 0.759 . . . . 74.3 112.038 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.98 -49.51 75.8 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.025 0.53 . . . . 74.32 111.094 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.76 -47.57 84.2 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.217 0.607 . . . . 62.34 111.32 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.498 ' HG ' HG12 ' A' ' 112' ' ' ILE . 2.1 mm? -71.94 -29.45 64.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.052 0.76 . . . . 62.1 113.052 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.31 -37.41 83.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.219 0.533 . . . . 75.54 110.704 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -50.09 10.86 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.216 0.821 . . . . 63.44 113.216 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.94 34.13 5.32 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.838 1.051 . . . . 75.12 113.838 -167.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -154.48 -58.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.647 0.61 . . . . 74.1 112.647 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.4 p -65.32 -35.61 12.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 113.853 1.057 . . . . 70.33 113.853 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -92.05 -4.51 3.8 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 121.875 1.717 . . . . 74.54 113.657 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -101.88 146.72 32.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 C-N-CA 123.827 0.851 . . . . 75.41 112.157 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.06 147.5 73.64 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.273 1.982 . . . . 75.01 111.537 168.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -55.88 -39.7 71.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.473 0.709 . . . . 74.13 112.677 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.441 ' HA ' HD13 ' A' ' 82' ' ' ILE . 40.8 m -61.05 -38.9 87.82 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.98 0.912 . . . . 72.13 113.316 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -69.64 -32.3 70.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.191 -0.318 . . . . 74.4 111.725 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.5 -32.45 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.307 0.643 . . . . 75.34 110.033 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.511 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 93.6 mt -64.15 -53.5 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.488 0.715 . . . . 75.05 112.422 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -68.73 -42.5 77.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.165 0.432 . . . . 75.41 112.165 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.76 -32.93 70.24 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.313 0.645 . . . . 75.43 111.922 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.0 -47.03 57.03 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 112.172 -0.371 . . . . 75.34 112.172 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.548 HG23 HD13 ' A' ' 90' ' ' LEU . 86.7 m -67.28 -36.75 82.21 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.245 1.018 . . . . 72.24 111.136 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -55.97 -41.93 75.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.703 0.801 . . . . 75.43 112.186 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 49.1 m170 -78.58 -29.52 46.22 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 113.021 0.749 . . . . 74.51 113.021 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -100.54 -63.62 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.227 0.825 . . . . 75.04 113.227 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.548 HD13 HG23 ' A' ' 86' ' ' THR . 77.0 mt -77.08 -25.75 52.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 74.43 112.354 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.94 12.75 81.14 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 123.143 0.277 . . . . 70.25 113.208 -170.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -112.61 159.51 18.79 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.044 0.937 . . . . 74.31 110.423 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.67 154.9 62.12 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.245 0.618 . . . . 75.23 109.861 164.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.7 144.92 97.48 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.067 1.845 . . . . 72.42 112.226 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.5 mp -71.79 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.156 0.582 . . . . 75.33 110.868 -168.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -126.09 173.55 9.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.758 0.823 . . . . 64.32 109.46 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 60.8 tp60 -62.42 -31.66 72.39 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 122.798 0.439 . . . . 73.33 111.072 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.44 -35.75 73.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.674 0.79 . . . . 45.22 111.331 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -60.97 -44.94 96.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 74.41 110.235 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.9 mt -58.35 -44.28 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 114.866 -1.061 . . . . 73.14 110.998 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.1 mtt-85 -62.72 -33.64 75.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.87 0.468 . . . . 74.41 111.688 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' HB3' ' HZ2' ' A' ' 102' ' ' LYS . 7.7 ttpm? -70.6 -53.02 17.59 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.136 0.273 . . . . 75.0 111.483 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -59.78 -36.92 77.7 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.826 0.45 . . . . 74.44 111.803 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.25 -40.68 94.31 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.993 0.917 . . . . 72.44 110.757 176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -69.53 -43.88 72.11 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.575 0.75 . . . . 74.2 111.599 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 98.0 mt -61.99 -47.43 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.281 1.032 . . . . 74.33 110.771 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.5 tp -61.04 -40.4 93.47 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.982 -1.008 . . . . 71.51 112.087 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.52 -44.71 77.72 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.991 0.517 . . . . 70.05 112.115 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.9 p -84.86 -65.65 0.99 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.421 0.688 . . . . 75.42 111.588 -174.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.93 -57.07 4.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.96 0.504 . . . . 73.44 111.207 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.27 -174.7 20.52 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 121.301 0.389 . . . . 73.52 113.704 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.498 HG12 ' HG ' ' A' ' 69' ' ' LEU . 10.8 tp -69.97 -31.54 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 113.124 0.787 . . . . 75.4 113.124 -170.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -65.74 -34.45 78.2 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.425 0.29 . . . . 72.4 111.452 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.08 -31.26 58.67 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.036 0.534 . . . . 73.14 111.492 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.511 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 56.6 t80 -64.55 -55.45 20.42 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.626 0.771 . . . . 72.22 111.444 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.85 -44.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 122.88 0.472 . . . . 72.0 110.716 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.21 -34.08 71.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.824 0.449 . . . . 72.23 111.583 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.63 80.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.057 0.543 . . . . 70.02 111.858 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.86 -36.34 78.01 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.385 0.674 . . . . 73.52 111.863 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.509 HG11 ' HE2' ' A' ' 56' ' ' LYS . 98.6 t -80.52 -32.48 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.972 0.909 . . . . 73.02 111.655 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.86 4.53 52.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.22 0.608 . . . . 74.31 112.047 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.7 t -62.83 129.47 40.61 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.372 -0.603 . . . . 60.13 109.372 164.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -53.9 -35.18 61.36 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.434 0.694 . . . . 74.11 112.659 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.26 -41.79 85.05 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 123.512 0.507 . . . . 71.14 111.642 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -63.52 -56.41 16.22 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.454 0.302 . . . . 71.23 110.921 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -66.14 -36.46 83.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.143 0.794 . . . . 75.04 113.143 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HG3' HG22 ' A' ' 128' ' ' VAL . 12.9 pt-20 -71.76 -32.88 68.15 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.023 0.749 . . . . 71.15 113.023 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 127' ' ' GLU . 93.6 t -100.56 -64.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 118.34 0.518 . . . . 74.33 111.696 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -99.45 67.1 1.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.736 0.815 . . . . 72.11 109.887 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.03 -156.06 0.49 Allowed Glycine 0 N--CA 1.483 1.796 0 N-CA-C 115.169 0.828 . . . . 63.14 115.169 -174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -79.21 21.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.576 0.954 . . . . 74.12 113.576 -176.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.18 -36.62 0.9 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.832 1.253 . . . . 74.11 110.809 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.3 m -91.97 137.31 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.813 0.672 . . . . 71.33 112.813 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.8 t -80.34 132.26 59.68 Favored Pre-proline 0 CA--C 1.561 1.376 0 C-N-CA 123.946 0.898 . . . . 75.43 110.355 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.576 ' HD2' HD12 ' A' ' 59' ' ' ILE . 55.6 Cg_endo -66.72 84.66 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.889 2.393 . . . . 73.11 113.82 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -79.97 152.09 29.7 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.808 -0.633 . . . . 74.41 110.721 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.462 ' H ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -58.86 125.32 23.06 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.641 0.377 . . . . 75.32 110.326 175.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -84.04 40.69 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.739 1.015 . . . . 74.35 113.739 -165.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 66.07 160.09 0.13 Allowed Pre-proline 0 CA--C 1.568 1.643 0 C-N-CA 124.481 1.112 . . . . 75.24 112.123 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.96 -4.12 12.84 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.099 1.866 . . . . 73.32 113.881 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.0 p -65.14 -81.62 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.867 0.867 . . . . 72.44 112.531 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.8 mt 69.33 -32.93 0.24 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 115.831 1.789 . . . . 74.04 115.831 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.72 105.45 3.19 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.847 0.832 . . . . 75.22 112.633 -169.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -137.05 162.98 31.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.981 0.912 . . . . 74.0 111.031 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 74.85 -25.13 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.172 1.545 . . . . 74.42 115.172 165.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -64.6 96.51 0.17 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 118.461 0.573 . . . . 74.43 112.494 -170.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -95.64 -179.11 4.62 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.737 0.815 . . . . 74.21 111.843 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -66.85 129.66 40.59 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.563 0.745 . . . . 74.14 110.636 170.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 N--CA 1.478 0.955 0 C-N-CA 123.223 0.609 . . . . 75.14 110.73 177.78 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.703 -0.48 . . . . 75.31 109.703 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -100.75 135.06 42.79 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.782 0.433 . . . . 75.33 110.164 171.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.3 t -96.19 101.73 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.24 0.616 . . . . 64.24 109.508 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.01 87.15 1.84 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 116.047 -0.524 . . . . 75.04 110.502 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -120.91 148.04 44.61 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.606 0.762 . . . . 74.34 110.044 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -95.87 91.87 6.24 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.332 0.586 . . . . 74.42 111.075 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.18 112.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-N 115.0 -1.0 . . . . 75.3 109.961 164.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.5 90.1 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.118 0.967 . . . . 63.15 113.111 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -46.08 -29.33 3.38 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 115.689 1.035 . . . . 70.1 115.689 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.07 130.57 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 109.363 -0.606 . . . . 53.03 109.363 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB3' ' HZ3' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -116.74 -27.49 6.63 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.882 0.473 . . . . 73.23 111.088 -176.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -32.75 114.7 0.17 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.593 1.557 . . . . 63.21 113.57 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HE3' ' HA3' ' A' ' 49' ' ' GLY . 14.4 mmmm -67.95 -12.1 60.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.915 0.486 . . . . 73.35 112.169 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.03 76.7 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.772 0.829 . . . . 73.51 110.895 171.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.54 62.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.191 0.596 . . . . 72.43 110.963 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.439 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.9 mp -60.09 -45.51 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.36 0.664 . . . . 72.34 110.714 169.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.16 -50.49 73.84 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.359 0.663 . . . . 72.51 112.168 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -62.39 -34.45 76.76 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.115 0.566 . . . . 74.34 111.286 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.419 ' HG ' HG21 ' A' ' 134' ' ' VAL . 9.9 tp -62.39 -45.68 92.06 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.644 0.778 . . . . 64.44 111.022 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 16' ' ' ILE . 67.4 mt -72.04 -34.1 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.265 1.026 . . . . 74.2 111.519 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -68.26 -42.72 79.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.207 0.603 . . . . 75.13 110.294 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.42 90.96 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.657 0.783 . . . . 73.11 111.238 172.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.99 97.93 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.47 0.708 . . . . 71.02 111.845 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -65.93 -49.38 68.16 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.119 0.568 . . . . 75.22 111.929 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -69.83 -15.51 63.11 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.756 0.65 . . . . 75.41 112.756 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -94.54 -47.31 6.6 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 122.971 0.508 . . . . 75.01 111.54 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 83.0 mt -83.14 -58.57 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.061 0.544 . . . . 74.33 111.934 -174.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.498 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 8.7 m-85 -73.31 -16.06 61.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.816 0.446 . . . . 74.24 110.654 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 66.49 17.44 10.65 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.196 1.398 . . . . 75.41 111.968 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -153.4 143.77 22.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 74.5 110.158 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.56 141.11 48.43 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 120.913 0.387 . . . . 62.11 110.098 165.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.4 mt -106.17 141.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 108.712 -0.847 . . . . 73.24 108.712 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.37 117.08 10.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.877 0.871 . . . . 64.11 111.28 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.32 -38.22 86.1 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.375 2.716 . . . . 73.32 113.505 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -63.56 -26.93 68.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.843 0.857 . . . . 74.41 112.744 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -83.31 -47.16 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 123.06 0.544 . . . . 72.24 110.564 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.7 68.86 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.312 1.045 . . . . 51.34 113.365 -173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -75.51 -25.85 57.62 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.165 0.432 . . . . 70.21 112.165 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -81.46 -44.17 17.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.861 0.465 . . . . 74.32 111.599 173.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -58.48 -54.01 51.89 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.614 0.721 . . . . 74.15 111.175 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -99.7 45.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.872 -1.058 . . . . 74.11 110.175 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 p -61.55 -49.62 75.93 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.273 0.629 . . . . 64.15 112.286 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 -45.91 9.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.612 -0.722 . . . . 61.24 112.638 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -66.04 -37.81 86.81 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.513 1.301 . . . . 74.22 114.513 -170.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -65.04 -46.8 79.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.18 -0.674 . . . . 73.14 109.18 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 m -59.21 -35.67 74.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.7 0.8 . . . . 60.24 111.943 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -59.29 -42.09 90.5 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.818 0.847 . . . . 75.15 112.388 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD11 HG22 ' A' ' 55' ' ' VAL . 42.2 tp -74.04 -45.51 49.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.809 0.444 . . . . 74.14 111.342 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' ' HE3' ' A' ' 13' ' ' LYS . . . -64.03 -31.95 82.54 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.874 0.749 . . . . 54.12 114.376 -174.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.93 -18.87 29.78 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.306 0.643 . . . . 72.5 111.275 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.75 31.73 35.3 Favored Glycine 0 C--N 1.355 1.609 0 CA-C-N 117.731 0.241 . . . . 72.41 113.538 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -88.39 -18.96 27.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.334 0.654 . . . . 73.31 111.884 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.8 pt -122.53 163.94 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.94 0.896 . . . . 74.34 110.327 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p -77.18 152.16 34.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.954 -0.387 . . . . 74.33 109.954 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 48' ' ' LEU . 40.1 t -64.01 -32.22 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.17 0.588 . . . . 72.13 110.081 175.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 1.5 tmtp? -54.08 -48.24 70.86 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.248 1.019 . . . . 73.2 111.457 171.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.92 -37.85 72.92 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.068 -0.515 . . . . 70.43 110.941 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.78 -51.84 66.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.389 0.675 . . . . 72.55 111.257 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.437 HG22 HD13 ' A' ' 27' ' ' ILE . 26.5 mm -56.03 -38.58 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.848 1.259 . . . . 74.23 111.512 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -67.52 -39.49 85.1 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.064 -0.516 . . . . 74.24 110.949 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.72 -23.07 75.64 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 113.844 0.298 . . . . 71.45 113.844 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 79.0 mt -67.63 -23.11 65.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.528 0.731 . . . . 75.12 110.975 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -87.73 -14.07 63.82 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.453 -1.249 . . . . 73.22 113.032 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -92.81 -3.68 54.28 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.85 0.86 . . . . 71.13 111.012 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -73.32 112.59 9.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.349 0.659 . . . . 72.42 110.778 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.97 -18.1 63.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.731 0.412 . . . . 72.34 111.741 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.42 -51.73 68.23 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.943 0.497 . . . . 72.33 110.47 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -59.64 -45.63 91.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.972 0.909 . . . . 75.31 112.015 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 63' ' ' GLY . 2.5 mm? -71.21 -29.17 64.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 112.365 0.506 . . . . 74.32 112.365 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.96 -38.95 92.66 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 121.879 -0.513 . . . . 74.13 110.565 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.95 -54.62 7.53 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 113.21 0.818 . . . . 74.52 113.21 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -117.07 36.89 4.03 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 114.06 1.133 . . . . 72.24 114.06 -168.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -159.29 -42.92 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.831 0.453 . . . . 73.31 111.507 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -65.96 -45.62 63.89 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 112.641 0.608 . . . . 73.2 112.641 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.55 12.23 1.37 Allowed 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.556 2.171 . . . . 72.21 113.689 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.475 ' HD2' ' HG2' ' A' ' 80' ' ' LYS . 80.9 m-85 -122.62 140.78 33.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 123.27 0.628 . . . . 73.43 111.965 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.45 159.55 46.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.946 2.43 . . . . 72.35 112.574 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -49.77 -52.5 31.44 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.922 0.889 . . . . 71.11 113.045 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.579 ' HA ' HD13 ' A' ' 82' ' ' ILE . 62.7 m -53.86 -43.01 69.18 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.942 1.09 . . . . 74.41 113.942 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.475 ' HG2' ' HD2' ' A' ' 76' ' ' TYR . 58.8 tptt -65.08 -36.75 85.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.378 0.51 . . . . 64.21 112.378 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.24 -26.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.779 0.431 . . . . 75.21 110.203 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.579 HD13 ' HA ' ' A' ' 79' ' ' THR . 95.4 mt -68.44 -52.84 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.604 0.761 . . . . 74.43 111.974 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 84' ' ' LEU . 5.1 pt-20 -64.64 -43.56 93.26 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.697 0.226 . . . . 72.33 110.96 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.413 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 22.7 mt -60.2 -41.1 92.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.391 0.677 . . . . 73.22 111.289 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.26 -51.09 55.73 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.74 -0.209 . . . . 74.04 112.713 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.531 HG23 HD12 ' A' ' 90' ' ' LEU . 37.5 m -67.53 -38.02 83.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.633 0.773 . . . . 73.04 111.162 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -53.93 -36.32 62.65 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.69 1.196 . . . . 74.41 112.784 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 53.2 m170 -89.47 -43.03 11.13 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.452 0.701 . . . . 75.44 112.771 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -92.23 -46.68 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.009 0.524 . . . . 74.34 112.014 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.531 HD12 HG23 ' A' ' 86' ' ' THR . 48.6 mt -97.73 -7.02 31.67 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.986 0.514 . . . . 74.2 111.717 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 27.21 72.41 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 115.162 0.825 . . . . 51.44 115.162 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -154.46 177.79 10.79 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 117.501 0.651 . . . . 75.33 112.285 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.72 150.76 54.17 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.674 0.79 . . . . 63.54 111.942 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.76 136.07 47.72 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.487 2.125 . . . . 74.42 110.922 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.16 -66.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.317 0.647 . . . . 73.43 111.451 -166.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 99' ' ' GLU . 8.9 m-20 -93.07 165.03 13.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.295 0.638 . . . . 75.04 111.922 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 50.3 tp60 -67.27 -33.9 76.28 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 109.457 -0.571 . . . . 71.11 109.457 163.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.71 73.37 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.452 0.701 . . . . 75.21 111.518 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.48 ' H ' ' HB2' ' A' ' 96' ' ' ASP . 12.2 tp10 -61.87 -42.02 98.55 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.851 0.861 . . . . 73.52 110.347 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.491 HG21 HG23 ' A' ' 79' ' ' THR . 72.1 mt -63.94 -46.13 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 114.914 -1.039 . . . . 73.43 110.905 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 28.5 mmm180 -63.04 -32.2 73.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.275 0.63 . . . . 72.34 111.72 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -66.71 -51.11 59.73 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.551 0.34 . . . . 74.34 111.124 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -65.02 -29.26 70.15 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.425 0.29 . . . . 73.15 111.722 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -68.66 -41.68 78.96 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.216 1.006 . . . . 74.14 110.467 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -72.08 -39.51 68.91 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.395 -0.821 . . . . 75.24 111.146 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 92.3 mt -67.12 -44.42 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.332 0.653 . . . . 74.52 110.975 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.25 -38.81 92.62 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.541 0.736 . . . . 72.3 110.819 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.59 -54.6 9.94 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 112.403 0.52 . . . . 70.13 112.403 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.8 p -83.38 -20.15 34.76 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.401 0.889 . . . . 71.11 113.401 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -114.98 -64.78 1.27 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 122.975 0.51 . . . . 70.45 111.088 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.96 -177.99 28.65 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 120.991 -0.623 . . . . 74.11 114.115 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.0 tp -72.9 -31.35 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.577 0.751 . . . . 73.24 111.441 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -64.66 -30.99 72.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.035 0.534 . . . . 73.03 111.435 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.51 67.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.737 0.815 . . . . 71.12 110.678 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 82' ' ' ILE . 54.4 t80 -60.79 -50.29 74.04 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.391 1.076 . . . . 71.23 112.392 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.95 -45.3 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.979 0.512 . . . . 64.32 111.216 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.06 -34.36 77.84 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.838 -0.619 . . . . 73.24 111.011 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.2 87.7 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.375 0.67 . . . . 63.52 112.139 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.9 mt -76.22 -51.39 12.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.264 0.625 . . . . 71.35 112.295 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.76 -20.52 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 121.125 0.488 . . . . 74.44 111.941 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -97.78 21.48 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.386 0.674 . . . . 75.31 111.963 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.0 m -83.06 153.93 24.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.951 -0.468 . . . . 73.15 111.846 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.52 -44.47 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.436 1.094 . . . . 74.51 111.632 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.422 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 30.9 tp10 -54.08 -52.86 59.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.459 -0.791 . . . . 73.04 111.902 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -64.86 -39.88 94.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 120.523 0.201 . . . . 71.51 110.582 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -60.9 -63.38 1.32 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.482 0.713 . . . . 72.15 111.742 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -76.33 -36.87 58.05 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 113.037 0.754 . . . . 73.14 113.037 -170.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.76 -27.93 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.008 0.523 . . . . 72.34 112.251 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -118.9 -78.49 0.59 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.936 -0.478 . . . . 62.02 110.498 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.1 170.46 15.83 Favored Glycine 0 N--CA 1.474 1.191 0 N-CA-C 112.399 -0.28 . . . . 74.24 112.399 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -73.22 -11.71 60.61 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.736 0.643 . . . . 74.51 112.736 -178.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.02 -10.75 19.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.034 0.934 . . . . 75.25 112.392 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.8 m -116.22 140.24 49.52 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.266 0.839 . . . . 64.45 113.266 -168.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.432 HG23 HD13 ' A' ' 59' ' ' ILE . 58.6 t -83.56 150.63 60.27 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 125.966 1.706 . . . . 71.45 110.623 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.3 90.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.729 2.286 . . . . 74.3 112.6 161.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -91.65 176.69 6.45 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.694 0.798 . . . . 75.03 111.984 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -72.75 97.05 2.13 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.77 -0.65 . . . . 74.03 110.918 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -84.82 118.39 24.45 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.552 -0.536 . . . . 73.32 109.552 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 73.12 146.15 0.11 Allowed Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 125.274 1.43 . . . . 73.41 112.054 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.85 -12.72 33.28 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.81 2.34 . . . . 74.31 112.486 171.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -103.45 179.39 4.28 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.353 1.061 . . . . 75.23 110.375 172.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.1 mt 67.65 27.55 7.65 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 124.534 1.134 . . . . 74.24 112.405 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -144.36 121.04 11.16 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.475 -0.784 . . . . 64.31 109.084 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -61.19 90.83 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.488 0.715 . . . . 61.25 111.25 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -75.78 142.42 42.33 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.509 -0.768 . . . . 75.11 112.199 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -97.33 67.37 2.12 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.972 0.909 . . . . 75.33 110.707 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 49.98 68.1 0.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.909 1.284 . . . . 71.45 111.674 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 70.46 -59.85 0.51 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.329 1.452 . . . . 75.32 112.123 -172.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.994 0.902 . . . . 64.35 110.781 177.173 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 111.157 0.058 . . . . 63.21 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.13 -176.83 3.88 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.094 0.958 . . . . 74.12 110.77 173.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t -91.23 108.6 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 107.783 -1.192 . . . . 74.3 107.783 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -74.9 106.34 6.37 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.128 0.571 . . . . 72.22 110.826 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.59 154.54 42.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.487 0.715 . . . . 74.21 110.223 175.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -70.96 147.2 48.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.142 0.973 . . . . 71.31 111.929 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.9 t -120.47 119.14 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.559 -1.645 . . . . 74.22 106.559 163.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.95 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.677 0.791 . . . . 74.13 112.177 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.57 -24.15 2.78 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.401 -0.818 . . . . 74.32 112.266 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.13 59.03 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 123.344 1.545 . . . . 73.01 109.845 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -80.28 8.47 7.38 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.189 -1.823 . . . . 72.44 113.28 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.91 133.08 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.029 0.532 . . . . 72.41 110.059 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 45.5 mtpt -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.154 0.798 . . . . 75.4 113.154 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.72 -53.02 62.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.053 0.541 . . . . 73.21 111.168 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.68 54.65 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.774 -0.648 . . . . 73.44 112.16 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 39.1 mm -57.91 -40.37 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 122.959 0.504 . . . . 74.44 111.643 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.6 ' HZ1' ' HB3' ' A' ' 17' ' ' LYS . 2.6 ttpm? -56.7 -48.81 76.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.735 0.814 . . . . 73.34 112.01 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 m -68.65 -33.03 73.3 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.164 0.586 . . . . 73.44 111.618 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.63 -43.85 97.77 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.812 0.845 . . . . 73.12 110.213 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -68.7 -33.72 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.372 1.069 . . . . 74.34 111.618 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 71.6 m -67.77 -41.58 83.04 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.253 0.621 . . . . 74.33 110.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.4 85.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.262 0.625 . . . . 73.54 111.478 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.52 -30.36 70.59 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.893 0.877 . . . . 73.43 112.272 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.5 ' HH ' ' HB2' ' A' ' 37' ' ' ALA . 22.5 m-85 -76.31 -37.69 57.07 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.401 0.519 . . . . 75.43 112.401 173.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' SER . 89.0 mtt180 -65.95 -26.49 67.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.523 0.729 . . . . 72.4 112.627 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.534 HE22 ' HG2' ' A' ' 135' ' ' PRO . 14.4 pt20 -85.59 -36.39 20.43 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 122.696 0.398 . . . . 75.13 111.895 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.517 HG12 ' HG3' ' A' ' 26' ' ' GLN . 46.2 mm -87.75 -63.27 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.359 0.664 . . . . 73.34 110.786 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.21 -4.75 54.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.817 0.847 . . . . 75.11 111.545 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 68.92 10.09 7.74 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.411 1.485 . . . . 74.05 112.909 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.56 144.83 25.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.42 0.628 . . . . 72.13 111.624 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -68.16 134.27 50.25 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.054 -0.976 . . . . 54.12 110.405 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.31 140.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 122.955 0.502 . . . . 75.31 110.185 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.93 129.26 91.13 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-N 115.063 -0.971 . . . . 71.35 110.839 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -54.95 -38.72 92.93 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.841 3.027 . . . . 61.01 115.181 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -64.73 -27.54 68.98 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.235 0.457 . . . . 71.55 112.235 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -79.82 -49.13 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.509 0.724 . . . . 72.23 110.037 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' HB2' ' HH ' ' A' ' 24' ' ' TYR . . . -58.46 -34.72 71.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.552 1.141 . . . . 63.44 113.232 -175.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.08 -26.17 56.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.926 0.49 . . . . 73.21 111.642 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -75.63 -33.52 60.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.474 0.31 . . . . 74.43 110.622 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -74.11 -53.65 9.47 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 116.016 -0.538 . . . . 73.31 111.06 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.537 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 78.9 m-85 -116.65 55.7 0.81 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.791 0.836 . . . . 73.34 111.847 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 98.7 p -62.67 -48.33 79.78 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.721 -0.612 . . . . 73.55 112.579 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.9 -40.73 13.76 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.837 -0.62 . . . . 61.42 112.418 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 21.6 t-105 -62.06 -42.0 98.74 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.324 1.05 . . . . 73.01 112.036 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.12 -46.52 88.11 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.27 1.028 . . . . 75.45 111.534 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.8 t -61.01 -41.93 97.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.488 -0.778 . . . . 62.14 111.601 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 53' ' ' ILE . 59.6 mtpt -65.29 -32.6 74.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 73.31 111.835 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.69 -45.05 60.79 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.725 0.298 . . . . 74.5 111.061 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.07 76.59 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.711 -0.677 . . . . 74.53 113.942 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -91.47 -20.06 22.16 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.808 0.843 . . . . 71.35 111.871 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.61 25.17 33.57 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 114.172 0.429 . . . . 74.04 114.172 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -69.58 -44.06 71.56 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.315 0.646 . . . . 73.24 110.179 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.419 HG22 ' HE2' ' A' ' 47' ' ' LYS . 32.6 pt -110.62 157.44 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.021 0.929 . . . . 75.14 110.081 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.9 t -90.15 167.25 12.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.566 0.346 . . . . 73.03 110.33 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 59' ' ' ILE . 66.2 t -61.79 -44.21 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 122.977 0.511 . . . . 73.21 111.134 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 64.1 tttm -55.39 -42.12 73.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.223 1.009 . . . . 73.32 112.815 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -69.42 -36.21 76.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.758 -0.655 . . . . 74.41 111.082 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.0 -47.08 86.38 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.733 0.813 . . . . 72.41 110.726 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 55' ' ' VAL . 47.7 mm -56.87 -45.55 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 124.431 1.093 . . . . 75.33 111.129 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.74 -44.24 93.88 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.402 -0.817 . . . . 72.55 110.871 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.02 -26.98 69.68 Favored Glycine 0 CA--C 1.543 1.782 0 N-CA-C 114.768 0.667 . . . . 72.31 114.768 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.02 -25.89 63.8 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.006 0.522 . . . . 74.52 110.933 172.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.33 -25.47 74.33 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.503 -0.771 . . . . 72.43 113.64 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.02 -7.45 59.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.637 0.775 . . . . 74.04 111.905 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.409 ' O ' HD21 ' A' ' 69' ' ' LEU . 57.3 p -74.41 134.55 42.39 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -56.69 -28.74 61.41 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.696 0.799 . . . . 72.54 112.29 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.6 tp -65.82 -46.71 77.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.93 0.492 . . . . 65.13 111.253 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.6 -35.51 79.11 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.191 0.52 . . . . 71.12 111.069 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 HG23 ' A' ' 112' ' ' ILE . 4.3 mm? -60.81 -48.35 82.18 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.8 0.84 . . . . 71.35 112.106 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -75.86 -30.59 58.95 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.489 0.551 . . . . 72.43 112.489 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.32 -47.04 45.82 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.897 0.703 . . . . 73.24 112.897 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.48 -55.33 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.794 1.035 . . . . 75.52 113.794 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.462 ' HE1' HD23 ' A' ' 107' ' ' LEU . 83.3 t80 -62.89 -33.41 75.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.057 0.762 . . . . 75.04 113.057 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.498 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 33.4 m -79.14 -55.1 0.95 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 118.549 -0.739 . . . . 63.51 112.721 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 11.9 Cg_exo -74.37 -5.06 16.38 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.657 2.238 . . . . 63.04 114.541 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -124.87 146.18 52.36 Favored Pre-proline 0 N--CA 1.494 1.726 0 C-N-CA 122.98 0.512 . . . . 74.42 111.884 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' O ' HG21 ' A' ' 81' ' ' VAL . 72.5 Cg_endo -72.44 168.5 24.13 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.822 2.348 . . . . 73.13 112.816 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -48.93 -54.77 14.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.402 1.081 . . . . 71.5 112.432 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.508 ' HA ' HD13 ' A' ' 82' ' ' ILE . 37.1 m -54.82 -40.05 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.935 0.894 . . . . 72.42 113.281 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -69.2 -32.0 70.98 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.088 0.403 . . . . 74.02 112.088 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 77' ' ' PRO . 59.0 t -69.39 -26.18 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.029 0.532 . . . . 74.32 109.997 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 79' ' ' THR . 61.0 mt -74.36 -52.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.724 0.809 . . . . 74.41 111.003 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -56.25 24.07 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.941 0.897 . . . . 72.4 112.261 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.96 -40.2 94.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.281 0.632 . . . . 74.24 111.323 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.68 -51.45 55.86 Favored Glycine 0 N--CA 1.474 1.219 0 O-C-N 123.481 0.488 . . . . 72.41 112.93 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.441 HG22 ' HG3' ' A' ' 94' ' ' PRO . 40.1 p -61.43 -36.46 80.41 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.522 0.729 . . . . 72.44 112.514 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 87' ' ' LYS . 8.9 mtmp? -73.0 -16.46 61.51 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.94 0.719 . . . . 73.34 112.94 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -86.27 -40.64 15.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.869 0.468 . . . . 74.32 111.319 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.411 ' HD1' HG21 ' A' ' 59' ' ' ILE . 88.4 m-85 -91.05 -64.74 1.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.343 0.592 . . . . 74.04 110.7 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.46 -10.01 59.2 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.008 0.923 . . . . 70.23 112.397 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.86 21.37 67.45 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 114.209 0.443 . . . . 72.31 114.209 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -149.47 169.92 19.78 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.875 0.87 . . . . 74.45 111.051 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.6 150.69 39.22 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.427 0.691 . . . . 71.12 110.264 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HG3' HG22 ' A' ' 86' ' ' THR . 32.9 Cg_exo -58.55 159.87 18.84 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.931 2.421 . . . . 65.0 112.712 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.43 -62.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.978 0.511 . . . . 70.13 111.542 -169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -133.85 163.21 30.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.636 0.775 . . . . 64.43 110.148 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -59.13 -33.12 70.5 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.848 0.859 . . . . 73.54 112.615 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.12 77.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.514 0.326 . . . . 65.34 111.803 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.9 -36.71 70.09 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.032 0.533 . . . . 73.43 111.111 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.22 -43.61 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.876 0.47 . . . . 71.4 110.077 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 mtm105 -66.27 -30.22 70.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.331 0.652 . . . . 73.22 111.804 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -62.56 -52.47 63.29 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.987 0.515 . . . . 75.13 111.094 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.09 -37.41 84.95 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.898 0.479 . . . . 74.14 111.514 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.37 -39.55 94.84 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.405 1.082 . . . . 70.43 110.863 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.427 HE21 HG23 ' A' ' 109' ' ' THR . 24.1 tp60 -67.74 -44.62 77.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.475 0.71 . . . . 73.41 111.104 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.89 -43.29 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.016 0.926 . . . . 74.44 111.61 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.462 HD23 ' HE1' ' A' ' 73' ' ' TYR . 6.8 tt -65.1 -41.07 95.28 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.224 0.61 . . . . 75.11 110.966 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.01 -38.54 86.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.738 0.415 . . . . 74.25 112.032 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.427 HG23 HE21 ' A' ' 105' ' ' GLN . 40.9 p -81.6 -69.59 0.6 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.775 0.83 . . . . 75.15 112.125 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.96 -35.3 24.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.98 0.912 . . . . 75.52 111.891 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.08 -172.41 14.88 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 121.119 0.288 . . . . 53.44 113.518 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 69' ' ' LEU . 7.4 tp -68.97 -38.21 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.558 0.743 . . . . 74.23 112.249 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -63.52 -42.89 98.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.322 0.649 . . . . 71.05 111.434 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.4 -32.67 66.57 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.713 -0.676 . . . . 73.15 110.636 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.448 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 32.8 t80 -61.78 -51.92 66.33 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 124.122 0.969 . . . . 75.11 112.269 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.9 mm -55.97 -51.77 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.85 0.86 . . . . 74.13 110.442 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -52.14 -49.05 64.5 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 115.23 -0.896 . . . . 75.43 111.86 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.77 67.88 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 73.04 112.787 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.48 -53.3 36.73 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.093 0.473 . . . . 73.42 110.585 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.476 HG11 ' NZ ' ' A' ' 56' ' ' LYS . 39.2 t -69.12 -18.54 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.792 0.837 . . . . 73.44 112.612 -171.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.16 13.65 2.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 73.31 112.766 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.7 p -77.34 136.56 38.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.326 0.651 . . . . 73.25 110.774 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.6 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 46.4 tt0 -68.71 -39.77 80.29 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.713 0.635 . . . . 72.51 112.713 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -53.89 -30.85 47.73 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.516 0.561 . . . . 74.1 112.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.28 -56.46 21.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.138 0.575 . . . . 74.4 110.527 172.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.6 ' ND2' ' HA ' ' A' ' 123' ' ' GLN . 10.4 p30 -73.87 -20.86 60.29 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 111.976 0.361 . . . . 73.33 111.976 -173.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 27.6 mm-40 -67.49 -59.15 3.61 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.149 0.499 . . . . 64.52 111.164 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -71.96 -61.0 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.598 -0.728 . . . . 73.22 111.574 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -84.43 -62.6 1.51 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.083 0.553 . . . . 73.12 110.46 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.26 173.47 27.39 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.615 -0.72 . . . . 63.34 112.657 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.31 -34.19 48.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.884 0.473 . . . . 75.33 111.606 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.25 -8.31 59.08 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.042 0.937 . . . . 61.05 112.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -113.05 143.95 43.45 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.384 0.674 . . . . 74.33 111.344 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.05 130.01 85.53 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.924 0.89 . . . . 74.32 109.248 170.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.534 ' HG2' HE22 ' A' ' 26' ' ' GLN . 89.9 Cg_exo -46.97 85.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.953 3.102 . . . . 74.24 115.71 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -79.33 85.52 5.15 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.63 0.729 . . . . 73.41 109.036 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -56.65 104.72 0.16 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.478 -0.783 . . . . 75.33 110.502 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -69.49 83.43 0.41 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.908 0.861 . . . . 75.0 111.422 -169.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -142.29 112.68 6.12 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.545 1.138 . . . . 71.02 109.645 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.77 15.57 1.07 Allowed 'Trans proline' 0 CA--C 1.562 1.904 0 C-N-CA 123.012 2.475 . . . . 64.05 113.825 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.0 t -127.96 -24.49 3.19 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.681 0.793 . . . . 75.21 112.681 -171.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.21 22.66 6.51 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.247 0.832 . . . . 72.11 113.247 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -31.33 68.27 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 122.936 0.494 . . . . 72.53 112.077 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -84.16 -16.81 42.16 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.409 0.684 . . . . 71.23 111.249 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 25.4 t60 70.3 7.65 6.31 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.425 1.09 . . . . 74.12 112.487 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 63.63 -73.54 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.181 1.392 . . . . 70.21 111.681 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -76.31 154.37 35.12 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.664 0.786 . . . . 75.54 110.687 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -64.13 -29.46 70.59 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.449 0.7 . . . . 72.21 111.4 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.8 p80 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.845 0.831 . . . . 71.43 110.631 171.918 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.911 0.386 . . . . 74.51 111.883 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -116.34 14.89 15.81 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 123.621 0.768 . . . . 74.4 110.759 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 136' ' ' TYR . 6.3 p -129.7 103.66 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 124.326 1.05 . . . . 75.42 109.145 -174.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -107.72 105.52 15.4 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.437 0.695 . . . . 73.31 112.011 -168.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -94.7 111.12 22.9 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.136 0.575 . . . . 73.21 111.417 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -62.23 131.18 48.55 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.226 0.536 . . . . 74.42 110.915 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.57 ' HB ' HG13 ' A' ' 10' ' ' ILE . 47.4 t -98.87 131.63 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.148 -0.686 . . . . 73.42 109.148 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.03 -36.16 2.4 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.717 1.006 . . . . 74.34 113.717 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.467 ' H ' HG11 ' A' ' 7' ' ' VAL . . . -70.96 -24.52 77.03 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.605 1.002 . . . . 74.51 115.605 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.57 HG13 ' HB ' ' A' ' 7' ' ' VAL . 71.9 mt -71.24 89.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 118.191 0.996 . . . . 75.23 110.71 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.48 6.64 0.58 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.654 1.353 . . . . 73.44 114.654 173.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.09 98.28 9.79 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.698 -0.626 . . . . 62.33 111.155 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -59.12 -24.93 63.42 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.802 0.841 . . . . 75.33 110.973 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -48.51 68.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.862 0.865 . . . . 74.45 111.082 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.26 67.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 75.21 112.414 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mm -61.01 -48.9 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.714 0.405 . . . . 73.53 109.916 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -61.37 -35.76 78.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.351 0.5 . . . . 74.45 112.351 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.5 m -65.65 -41.34 92.68 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.876 0.47 . . . . 75.43 111.23 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.56 -46.07 87.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.384 1.074 . . . . 70.42 111.116 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.494 HD13 ' HG2' ' A' ' 45' ' ' GLU . 91.6 mt -61.79 -43.29 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.908 1.283 . . . . 74.1 111.601 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.7 m -63.84 -45.12 90.95 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.633 -0.712 . . . . 71.32 110.297 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.4 71.24 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.808 0.843 . . . . 74.34 112.498 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.83 -43.55 81.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.309 0.644 . . . . 61.3 112.552 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' HE1' HD21 ' A' ' 62' ' ' LEU . 21.5 m-85 -60.94 -28.42 68.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.101 0.778 . . . . 72.03 113.101 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.81 -13.99 60.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.609 0.764 . . . . 75.21 112.007 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -118.32 -52.05 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.17 0.433 . . . . 72.35 112.17 169.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.46 HD11 ' O ' ' A' ' 88' ' ' HIS . 41.7 mm -55.8 -38.14 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 123.81 0.844 . . . . 75.42 112.197 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -114.72 2.83 14.55 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.643 0.777 . . . . 73.22 110.799 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 35.28 35.72 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 116.053 1.871 . . . . 74.12 116.053 -168.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.509 HH12 ' HG3' ' A' ' 71' ' ' GLU . 3.9 ptp85 -135.55 155.54 50.32 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.586 0.708 . . . . 74.24 111.635 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.97 96.26 8.79 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.909 -1.041 . . . . 72.15 109.541 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.74 134.32 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.038 -0.727 . . . . 74.12 109.038 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.35 126.78 87.16 Favored Pre-proline 0 CA--C 1.551 0.999 0 O-C-N 123.993 0.808 . . . . 72.4 110.238 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.49 -25.21 75.73 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.826 2.351 . . . . 70.52 112.857 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -79.2 -26.78 42.56 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.31 0.644 . . . . 52.33 112.21 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.7 mt -80.07 -39.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.053 0.541 . . . . 72.02 110.207 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.51 85.62 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.944 0.898 . . . . 60.03 111.709 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -72.93 -20.4 61.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.685 0.624 . . . . 72.13 112.685 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -75.87 -41.53 51.94 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.004 0.43 . . . . 62.01 110.639 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -76.57 -39.85 51.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.697 -0.683 . . . . 75.42 111.906 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 96.4 m-85 -116.66 26.62 9.72 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.675 0.991 . . . . 61.54 113.675 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -49.21 -49.83 41.16 Favored 'General case' 0 N--CA 1.515 2.78 0 N-CA-C 114.502 1.297 . . . . 70.14 114.502 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -75.1 -34.53 51.89 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.392 -0.367 . . . . 64.1 112.766 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -63.4 -31.64 72.85 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.201 1.001 . . . . 73.23 111.328 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HG2' HD13 ' A' ' 20' ' ' ILE . 47.7 mt-10 -70.45 -41.75 72.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.167 0.987 . . . . 71.32 110.67 172.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.9 t -61.84 -39.24 91.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 64.3 111.017 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.5 mmmm -60.16 -38.0 81.82 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.747 0.419 . . . . 74.54 110.726 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 55' ' ' VAL . 22.7 tp -73.25 -49.05 29.9 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.522 0.729 . . . . 75.31 111.942 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.37 73.59 Favored Glycine 0 N--CA 1.484 1.841 0 C-N-CA 123.315 0.483 . . . . 64.01 114.199 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -85.74 -19.11 31.28 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.444 0.697 . . . . 75.52 110.02 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.02 24.65 47.87 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.714 -1.13 . . . . 65.22 112.739 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -66.23 -40.04 89.97 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.003 0.921 . . . . 63.12 110.29 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 58' ' ' PHE . 22.2 pt -116.1 143.83 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.91 0.884 . . . . 74.44 110.123 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.448 HG21 ' H ' ' A' ' 57' ' ' GLU . 8.7 t -71.73 162.83 28.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.413 0.285 . . . . 73.42 111.24 163.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 59' ' ' ILE . 22.2 t -65.16 -34.54 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.231 0.212 . . . . 73.22 110.985 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.709 ' HZ1' ' HA ' ' A' ' 126' ' ' ASN . 26.8 tttp -50.43 -51.04 50.22 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.695 0.798 . . . . 74.04 113.059 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' H ' HG21 ' A' ' 54' ' ' THR . 29.1 tt0 -69.61 -31.2 69.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.474 0.71 . . . . 70.24 110.945 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HD2' HD11 ' A' ' 53' ' ' ILE . 36.9 t80 -57.85 -46.94 84.04 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.192 0.597 . . . . 72.12 110.93 170.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 55' ' ' VAL . 51.5 mm -60.69 -40.21 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.039 0.936 . . . . 72.33 111.308 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -54.34 -50.74 66.72 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 115.58 -0.737 . . . . 75.01 111.74 172.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.72 -28.62 57.14 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 115.063 0.785 . . . . 75.34 115.063 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.421 HD21 ' HE1' ' A' ' 24' ' ' TYR . 43.9 mt -71.65 -37.7 70.79 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.018 0.527 . . . . 70.32 110.988 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.91 -26.17 73.19 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 116.413 -0.358 . . . . 53.34 113.454 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.64 -3.17 55.83 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.896 0.879 . . . . 72.5 112.052 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -81.79 130.11 34.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.012 0.525 . . . . 70.14 111.798 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.37 -17.28 28.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.152 0.981 . . . . 75.14 112.371 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.69 -57.09 14.15 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.804 0.442 . . . . 74.14 111.198 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -58.73 -37.04 75.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.97 0.729 . . . . 74.01 112.97 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.612 HD12 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -61.89 -49.68 75.23 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.34 0.496 . . . . 74.14 112.34 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.94 -31.22 71.65 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 113.043 0.757 . . . . 74.43 113.043 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' HH12 ' A' ' 30' ' ' ARG . 19.7 mm-40 -87.93 -60.77 1.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.724 1.009 . . . . 75.22 113.724 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -111.77 60.16 0.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.746 0.703 . . . . 73.41 112.429 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 81' ' ' VAL . 58.6 t80 -165.57 -58.7 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.236 0.614 . . . . 74.3 110.293 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 m -63.75 -49.18 77.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 113.021 0.749 . . . . 74.14 113.021 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -86.98 13.34 2.73 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.016 1.811 . . . . 71.22 113.505 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -124.09 150.02 62.01 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.642 0.777 . . . . 70.31 111.455 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.82 165.78 31.8 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.412 2.074 . . . . 74.21 112.406 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.1 -34.76 78.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 73.33 112.517 -170.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.471 ' HA ' HD13 ' A' ' 82' ' ' ILE . 78.4 m -70.39 -38.37 74.66 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.536 0.734 . . . . 75.42 112.353 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.3 -34.42 76.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.147 -0.346 . . . . 74.31 111.601 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 73' ' ' TYR . 87.1 t -56.56 -34.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.595 0.758 . . . . 64.33 110.848 171.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 79' ' ' THR . 77.0 mt -74.04 -48.7 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.546 0.739 . . . . 74.23 111.917 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -58.06 6.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.215 0.45 . . . . 75.15 112.215 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.3 mt -61.85 -25.21 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.35 0.66 . . . . 73.23 111.047 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.7 -40.8 98.92 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 114.695 -1.138 . . . . 62.11 112.147 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -79.1 -44.52 21.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.256 0.623 . . . . 74.1 111.978 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 87' ' ' LYS . 7.0 mtpm? -61.77 -49.55 75.93 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.327 0.862 . . . . 73.14 113.327 -176.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' O ' HD11 ' A' ' 27' ' ' ILE . 11.8 m170 -61.59 -31.02 71.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.525 0.73 . . . . 72.03 112.534 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.593 ' HB3' HD12 ' A' ' 90' ' ' LEU . 1.1 t80 -98.96 -67.04 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.252 0.621 . . . . 75.03 112.088 -167.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.593 HD12 ' HB3' ' A' ' 89' ' ' PHE . 6.5 mp -77.32 -5.42 49.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.459 0.911 . . . . 74.33 113.459 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.57 33.04 75.69 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.054 0.252 . . . . 62.14 113.081 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.648 HH22 HG21 ' A' ' 128' ' ' VAL . 19.2 ptp180 -160.02 157.25 28.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.955 0.902 . . . . 73.43 111.297 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.82 153.09 95.81 Favored Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 109.944 -0.391 . . . . 72.55 109.944 168.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.15 167.14 4.84 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.451 2.101 . . . . 74.44 113.063 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 99' ' ' GLU . 2.6 mp -80.59 -53.34 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.108 0.563 . . . . 72.34 110.402 -169.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.47 165.14 10.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 74.01 109.187 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 58.2 tp60 -61.94 -30.25 70.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.854 0.462 . . . . 74.04 111.697 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.05 -45.47 88.67 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.058 0.543 . . . . 72.21 111.763 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.471 ' HG2' HD12 ' A' ' 95' ' ' ILE . 7.9 tp10 -62.55 -38.23 89.24 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.176 0.591 . . . . 75.42 111.303 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.449 HG21 HG23 ' A' ' 79' ' ' THR . 72.4 mt -60.58 -42.53 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.761 0.824 . . . . 71.32 111.209 173.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.6 mtt180 -58.13 -37.0 73.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.64 0.607 . . . . 71.22 112.64 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -62.08 -53.74 51.15 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 120.879 0.371 . . . . 75.13 110.59 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -62.38 -36.22 81.6 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.567 -0.742 . . . . 75.04 112.412 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.56 -38.95 91.04 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.529 0.732 . . . . 74.23 111.387 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -62.58 -38.5 90.38 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.582 -0.735 . . . . 75.13 110.506 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 81.9 mt -64.47 -48.64 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 123.589 0.756 . . . . 72.44 111.291 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.25 -37.09 66.77 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.137 0.575 . . . . 75.02 112.099 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.58 -48.53 32.08 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.191 0.596 . . . . 74.44 111.881 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -77.05 -71.91 0.38 Allowed 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.618 -0.719 . . . . 73.12 112.413 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -89.89 -53.49 4.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 70.12 112.003 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 -157.97 23.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.346 0.499 . . . . 65.3 114.346 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.612 HG12 HD12 ' A' ' 69' ' ' LEU . 8.8 tp -76.98 -37.58 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.507 0.723 . . . . 73.1 112.457 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.11 -31.22 71.96 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 75.4 111.521 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.76 57.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.99 -1.004 . . . . 74.11 110.671 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -67.19 -45.69 76.16 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 74.14 111.048 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.482 ' O ' HG21 ' A' ' 120' ' ' VAL . 47.9 mm -63.97 -55.53 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.901 0.48 . . . . 65.44 110.171 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.58 -38.57 55.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.115 0.566 . . . . 73.33 112.237 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.86 88.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.552 0.341 . . . . 62.2 111.813 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.63 -39.29 77.23 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.274 0.63 . . . . 75.54 111.862 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 116' ' ' ILE . 18.1 t -67.41 -41.89 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.482 0.658 . . . . 70.34 110.605 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.477 ' N ' HD21 ' A' ' 121' ' ' ASN . 0.7 OUTLIER -87.2 -10.0 53.72 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.907 0.883 . . . . 73.32 111.444 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.9 t -57.6 146.47 30.27 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.273 0.629 . . . . 75.41 111.448 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.7 pt20 -69.46 -38.01 77.57 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.926 0.49 . . . . 73.34 110.405 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -61.39 -38.71 88.02 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.101 0.961 . . . . 62.34 111.777 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.504 ' HB2' ' HG ' ' A' ' 90' ' ' LEU . 59.5 t80 -77.2 -41.89 39.64 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.581 0.753 . . . . 75.54 111.447 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.709 ' HA ' ' HZ1' ' A' ' 56' ' ' LYS . 63.9 t30 -67.44 -51.59 49.84 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.183 0.808 . . . . 71.15 113.183 -165.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 12.6 pt-20 -91.16 -26.14 19.23 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.409 0.522 . . . . 72.0 112.409 -171.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.648 HG21 HH22 ' A' ' 92' ' ' ARG . 79.2 t -78.76 -50.72 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 122.871 0.469 . . . . 74.3 110.732 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.498 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 1.5 t80 -81.03 -45.79 16.02 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.594 0.758 . . . . 74.52 111.972 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.76 -144.02 17.04 Favored Glycine 0 N--CA 1.482 1.752 0 CA-C-O 119.749 -0.473 . . . . 71.31 112.807 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 56' ' ' LYS . 4.7 mp0 -126.13 -58.13 1.38 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 117.831 0.815 . . . . 72.15 112.5 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.71 11.8 0.96 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.878 1.807 . . . . 63.23 115.878 -162.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.0 t -134.94 174.29 10.76 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.956 0.724 . . . . 75.42 112.956 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -84.71 136.34 39.39 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 123.896 0.879 . . . . 74.43 110.287 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -58.54 134.1 58.81 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.966 2.444 . . . . 74.32 112.214 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.515 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 17.9 p90 -108.82 150.34 27.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.947 0.899 . . . . 74.42 112.247 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -83.49 98.92 9.8 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.022 -0.99 . . . . 74.1 109.703 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -81.98 63.55 6.26 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.209 0.604 . . . . 72.42 111.497 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -138.98 139.06 22.33 Favored Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 123.041 0.537 . . . . 75.24 111.178 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.33 -47.6 9.52 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 123.0 2.466 . . . . 64.13 112.526 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.0 t -89.05 130.33 35.53 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.066 0.46 . . . . 55.1 110.135 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.86 145.32 51.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.903 0.881 . . . . 71.34 110.303 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -69.14 88.29 0.42 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.356 0.662 . . . . 71.33 111.42 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -83.51 77.77 9.77 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.576 0.703 . . . . 74.33 109.361 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -107.35 -178.16 3.56 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.416 -0.811 . . . . 71.21 111.273 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -76.49 171.95 13.77 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 115.568 -0.742 . . . . 75.4 111.485 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -150.6 90.24 1.62 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.596 0.758 . . . . 74.21 111.009 -174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -73.09 126.78 30.79 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.901 -0.59 . . . . 74.11 110.179 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.1 t60 . . . . . 0 N--CA 1.484 1.275 0 C-N-CA 123.695 0.798 . . . . 71.24 111.874 -178.731 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.6 ttm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 110.162 -0.31 . . . . 74.01 110.162 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.55 140.86 15.44 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.402 0.681 . . . . 74.52 110.669 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.36 121.0 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.695 -0.483 . . . . 72.55 109.695 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.99 93.22 1.35 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.432 0.634 . . . . 73.55 109.624 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -126.58 151.05 48.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.389 1.075 . . . . 71.43 109.002 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -84.87 122.17 28.79 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.094 -0.379 . . . . 73.22 110.373 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -83.37 122.32 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.222 0.609 . . . . 64.21 109.439 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.06 94.35 0.23 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.41 0.684 . . . . 65.31 112.069 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.73 11.41 16.98 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.636 0.615 . . . . 62.03 114.636 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.25 97.98 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.801 0 CA-C-N 117.632 0.716 . . . . 75.52 110.64 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -64.18 -32.22 73.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.835 -1.165 . . . . 73.44 113.154 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -42.68 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.772 0.829 . . . . 64.11 112.336 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -71.67 -9.03 57.65 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 114.865 -1.061 . . . . 73.11 111.359 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.35 -41.71 93.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.375 0.67 . . . . 72.24 109.991 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.1 75.47 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.822 0.849 . . . . 74.12 111.838 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.92 -44.99 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.923 0.489 . . . . 73.31 111.354 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -73.76 -35.67 65.03 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.557 0.743 . . . . 75.44 112.899 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 t -66.71 -29.97 70.09 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 120.711 0.291 . . . . 74.14 111.413 172.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.597 HD22 HD22 ' A' ' 48' ' ' LEU . 8.3 tt -68.27 -45.3 73.51 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.072 0.949 . . . . 75.52 109.661 173.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.11 -44.9 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 124.504 1.122 . . . . 73.13 111.71 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -69.17 -36.85 77.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.374 0.67 . . . . 73.11 111.722 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.06 80.09 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.628 0.771 . . . . 62.44 111.105 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.15 -42.81 65.52 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.098 0.959 . . . . 71.5 111.911 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.84 -49.86 48.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.019 0.527 . . . . 72.02 111.895 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -64.0 -14.88 57.47 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.829 1.048 . . . . 70.34 113.829 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -95.23 -61.66 1.44 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.327 0.512 . . . . 73.5 110.398 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.3 -42.82 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 123.587 0.755 . . . . 73.42 111.837 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.32 -12.16 33.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.497 0.319 . . . . 71.32 111.709 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.35 32.72 22.41 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.042 1.497 . . . . 75.43 115.042 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 166.63 29.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.092 0.775 . . . . 73.24 113.092 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.43 101.29 8.09 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 114.208 -1.36 . . . . 70.13 110.6 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -80.69 118.84 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.352 -0.61 . . . . 73.12 109.352 167.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.14 93.63 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.336 0.655 . . . . 71.51 111.45 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.13 -37.41 79.6 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.235 2.623 . . . . 74.4 114.3 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -71.5 -26.85 62.86 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.483 0.549 . . . . 74.41 112.483 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.45 -38.22 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.158 0.504 . . . . 75.44 110.199 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.16 -32.98 74.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.154 0.982 . . . . 73.11 112.797 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -76.13 -16.82 59.81 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.681 0.392 . . . . 64.24 111.728 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -80.54 -47.39 14.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.028 0.531 . . . . 75.42 110.983 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.86 -45.58 23.85 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.621 0.768 . . . . 75.13 111.695 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 75.8 m-85 -116.64 52.71 0.92 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.764 0.825 . . . . 74.43 111.657 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.74 -55.4 13.25 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.123 0.487 . . . . 64.35 112.189 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.86 -30.31 63.79 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.706 -0.679 . . . . 62.25 113.008 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 6.7 t-105 -67.5 -38.24 84.02 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.718 0.807 . . . . 64.23 112.041 -174.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -57.62 -49.84 75.11 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.253 1.021 . . . . 75.54 110.177 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -53.47 -49.78 66.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.212 1.005 . . . . 74.45 111.881 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.99 -33.88 76.35 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.721 0.637 . . . . 75.33 112.721 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.597 HD22 HD22 ' A' ' 19' ' ' LEU . 37.9 tp -71.8 -43.25 65.99 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 120.731 0.3 . . . . 75.02 110.93 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.85 -19.72 77.07 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.597 0.599 . . . . 72.5 114.597 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -94.9 -12.21 27.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.128 0.571 . . . . 74.54 112.098 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.0 71.37 Favored Glycine 0 C--N 1.35 1.308 0 C-N-CA 121.859 -0.21 . . . . 74.04 113.615 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.73 -32.42 65.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.644 0.777 . . . . 73.31 111.394 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -129.35 156.58 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.427 0.691 . . . . 63.43 109.517 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 p -85.4 178.8 7.32 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.818 0.342 . . . . 75.31 110.611 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 59' ' ' ILE . 74.4 t -64.34 -38.28 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 116.492 -0.322 . . . . 71.24 110.527 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.631 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 13.9 tttm -60.02 -44.21 94.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.894 0.478 . . . . 73.31 111.731 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -68.01 -24.73 65.15 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.344 0.658 . . . . 74.12 111.456 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -77.44 -48.11 18.0 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.283 -1.006 . . . . 75.14 108.283 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 55' ' ' VAL . 46.7 mm -60.67 -33.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 125.062 1.345 . . . . 75.52 111.244 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.26 -51.52 69.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.283 0.633 . . . . 71.35 111.214 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.34 -29.47 66.18 Favored Glycine 0 C--N 1.357 1.729 0 N-CA-C 114.883 0.713 . . . . 74.23 114.883 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.27 -28.57 68.14 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.969 0.385 . . . . 74.33 110.989 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.73 -31.57 44.15 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.116 -0.493 . . . . 74.2 113.461 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.8 -4.44 57.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.56 0.744 . . . . 74.25 112.643 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 p -77.77 141.38 39.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.042 0.383 . . . . 61.41 111.407 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -56.93 -31.29 64.8 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.714 0.805 . . . . 71.11 111.677 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.3 tp -62.0 -46.68 88.13 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.562 0.745 . . . . 74.45 111.315 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -63.21 -36.45 83.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.924 0.393 . . . . 75.2 111.333 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.465 HD11 HG23 ' A' ' 112' ' ' ILE . 4.5 mm? -68.18 -45.23 74.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.722 0.809 . . . . 60.03 112.815 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -73.17 -30.46 63.58 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.002 -0.436 . . . . 73.34 112.126 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -82.12 -53.49 6.05 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.796 1.036 . . . . 73.1 113.796 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -118.25 42.13 2.77 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.399 0.888 . . . . 73.25 113.399 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.541 ' HA ' HG23 ' A' ' 81' ' ' VAL . 65.7 t80 -155.9 -53.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.027 0.442 . . . . 73.24 111.256 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 m -68.59 -48.1 33.33 Favored Pre-proline 0 CA--C 1.573 1.854 0 N-CA-C 113.33 0.863 . . . . 74.34 113.33 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.73 3.93 7.46 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.92 1.746 . . . . 74.53 113.961 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.27 150.77 70.92 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.697 0.799 . . . . 73.53 111.654 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.24 171.01 15.8 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.351 2.034 . . . . 73.23 111.906 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.59 -49.55 74.57 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.329 0.651 . . . . 75.03 111.542 -176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 100' ' ' ILE . 30.4 m -58.67 -21.99 55.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.934 1.293 . . . . 75.01 114.389 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.86 -35.53 13.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.989 -0.745 . . . . 64.23 108.989 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 73' ' ' TYR . 60.2 t -56.81 -31.88 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.538 -0.755 . . . . 73.14 110.244 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 79' ' ' THR . 92.1 mt -68.09 -53.28 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.36 -0.836 . . . . 74.32 112.119 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.24 -50.13 56.02 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.402 1.001 . . . . 74.31 112.392 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.21 -31.04 69.78 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.098 0.559 . . . . 75.41 112.053 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.81 -45.74 50.19 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.558 -0.292 . . . . 62.31 112.902 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.616 HG23 HD12 ' A' ' 90' ' ' LEU . 88.0 m -64.19 -43.81 93.94 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.499 0.72 . . . . 63.01 111.911 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -60.98 -28.29 68.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.659 0.985 . . . . 74.1 113.659 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -73.41 -34.65 65.6 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.581 0.586 . . . . 75.31 112.581 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -104.76 -65.02 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.67 0.388 . . . . 75.15 111.581 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.616 HD12 HG23 ' A' ' 86' ' ' THR . 90.5 mt -75.47 -12.03 60.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.127 0.571 . . . . 74.44 112.466 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.45 24.95 75.41 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.651 0.62 . . . . 63.22 114.651 175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -159.27 -176.19 5.67 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 117.618 0.709 . . . . 74.41 111.794 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.02 30.58 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.693 0.797 . . . . 74.04 110.603 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.89 155.31 18.55 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.43 2.753 . . . . 74.4 113.636 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 49.5 mt -65.1 -52.61 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.694 0.798 . . . . 65.13 112.568 -169.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -148.59 171.58 15.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.47 0.708 . . . . 65.31 109.297 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -60.79 -28.98 69.16 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.031 0.532 . . . . 74.31 111.524 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.44 85.94 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.712 0.805 . . . . 73.14 111.215 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 15.4 tp10 -58.85 -43.61 90.79 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.288 1.035 . . . . 73.31 111.631 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.587 HG22 HG23 ' A' ' 79' ' ' THR . 73.2 mt -62.67 -50.56 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.873 0.869 . . . . 74.21 111.251 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -64.59 -29.59 70.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.324 0.65 . . . . 74.34 111.655 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -62.09 -49.92 74.03 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.711 0.804 . . . . 73.13 110.409 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -63.25 -40.72 98.23 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.902 0.481 . . . . 72.23 111.714 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.9 -34.97 77.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.406 0.683 . . . . 62.23 110.972 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -64.28 -36.43 84.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.763 0.825 . . . . 62.31 111.325 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.96 -42.89 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.601 0.761 . . . . 73.23 110.989 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -36.17 82.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.192 0.597 . . . . 75.21 111.669 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.46 -44.85 73.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.216 0.606 . . . . 75.52 111.495 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.2 p -77.71 -69.59 0.53 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.119 0.785 . . . . 74.15 113.119 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -93.3 -46.95 7.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.964 -0.46 . . . . 73.22 111.724 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.8 -159.68 15.39 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 121.002 0.223 . . . . 62.42 113.581 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.465 HG23 HD11 ' A' ' 69' ' ' LEU . 8.5 tp -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 123.908 0.883 . . . . 74.03 113.114 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -57.36 -42.35 81.85 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.316 0.646 . . . . 73.4 111.709 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.96 -28.24 43.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.269 -0.878 . . . . 75.45 110.899 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.63 -48.66 71.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.049 0.939 . . . . 73.52 110.931 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.67 -54.63 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 74.11 110.323 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -45.41 -42.08 9.91 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.13 0.972 . . . . 73.24 113.052 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.68 94.31 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.767 0.427 . . . . 75.24 111.882 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.7 -41.7 78.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.521 0.728 . . . . 72.3 112.131 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.28 -47.54 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 122.806 0.442 . . . . 71.33 111.689 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -81.46 2.27 29.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.46 0.541 . . . . 74.0 112.46 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 t -61.2 132.5 53.86 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.953 0.501 . . . . 52.34 109.986 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.03 -36.0 74.24 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.265 0.353 . . . . 72.43 111.139 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.9 -45.41 82.61 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.965 0.906 . . . . 73.22 111.786 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.458 ' HB2' HD22 ' A' ' 90' ' ' LEU . 87.8 t80 -58.23 -54.71 43.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.883 -0.414 . . . . 74.43 109.883 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -60.5 -28.3 68.26 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.611 0.764 . . . . 71.35 112.745 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.21 -40.1 14.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.448 0.699 . . . . 75.51 112.332 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 91.5 t -89.44 -61.52 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 122.932 0.493 . . . . 75.54 110.505 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -102.76 70.19 1.1 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.697 . . . . 70.51 109.395 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.06 178.65 0.79 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.623 -0.717 . . . . 64.03 114.537 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.631 ' HG2' ' HD3' ' A' ' 56' ' ' LYS . 27.9 mt-10 -63.91 -14.3 52.43 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.288 0.847 . . . . 74.45 113.288 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.22 -33.0 12.18 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.175 0.59 . . . . 73.15 111.884 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.5 m -86.0 136.59 33.19 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.125 0.57 . . . . 71.34 112.421 -173.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.77 135.73 31.78 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.398 1.079 . . . . 75.43 109.954 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.63 136.06 63.57 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.478 2.119 . . . . 72.12 112.796 167.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -143.65 178.74 7.59 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.11 0.564 . . . . 75.5 111.195 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -70.29 91.15 0.72 Allowed 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 121.296 0.569 . . . . 72.03 110.7 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -92.46 -34.9 13.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.343 0.657 . . . . 72.24 111.759 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -106.0 144.24 28.53 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.333 0.653 . . . . 75.14 111.709 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.46 -10.21 25.12 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.058 2.506 . . . . 73.41 113.652 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -77.2 -31.22 55.14 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.934 0.494 . . . . 64.03 111.876 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.3 pp -105.23 42.74 1.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.126 0.965 . . . . 74.32 109.652 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -31.82 18.14 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 115.756 1.762 . . . . 64.11 115.756 -171.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 56.09 32.82 20.79 Favored 'General case' 0 CA--C 1.579 2.085 0 C-N-CA 124.353 1.061 . . . . 75.54 112.135 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -68.73 -33.19 73.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.47 -0.769 . . . . 74.2 111.238 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -70.14 131.82 44.87 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.322 0.649 . . . . 75.45 111.474 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -167.8 19.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.694 0.798 . . . . 75.31 112.202 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -65.73 88.13 0.1 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.439 0.696 . . . . 75.44 112.084 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 N--CA 1.481 1.102 0 C-N-CA 124.383 1.073 . . . . 73.14 109.749 178.469 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.721 0.296 . . . . 73.44 111.495 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -118.31 114.38 22.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.034 0.934 . . . . 70.5 109.485 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 t -109.68 98.81 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.62 123.73 17.28 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.307 1.043 . . . . 74.21 111.783 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.14 162.15 38.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.252 0.621 . . . . 75.21 111.035 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -74.86 89.24 2.33 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.693 -0.685 . . . . 74.45 110.787 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -70.93 112.45 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-N 115.878 -0.601 . . . . 63.14 111.008 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.78 43.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.001 1.32 . . . . 74.01 113.583 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.26 -42.09 55.41 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.688 0.635 . . . . 72.12 114.688 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.5 mm -71.58 -54.54 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.565 0.746 . . . . 74.24 110.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 46.37 17.21 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 126.123 1.769 . . . . 73.41 115.146 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.43 138.31 31.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.921 0.888 . . . . 74.11 110.824 -169.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.49 -29.07 65.51 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.174 0.805 . . . . 74.32 113.174 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.12 -30.5 49.41 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.698 0.399 . . . . 71.4 110.696 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.79 -38.68 64.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.26 0.624 . . . . 75.42 109.959 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.553 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.5 mp -63.95 -34.97 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 115.256 -0.884 . . . . 74.55 110.027 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 34' ' ' PRO . 24.4 ttmm -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.918 0.71 . . . . 74.22 112.918 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -69.7 -34.01 73.32 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 122.018 -0.426 . . . . 64.0 110.41 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.04 -34.35 77.83 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.854 1.262 . . . . 64.55 110.355 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 16' ' ' ILE . 51.5 mm -62.59 -53.17 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.05 0.94 . . . . 73.42 109.514 174.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -65.76 -29.05 69.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.202 1.001 . . . . 74.23 112.867 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -41.41 59.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.528 0.731 . . . . 72.31 110.543 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.02 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.941 0.897 . . . . 73.42 111.927 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.949 0.499 . . . . 75.23 112.209 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtp85 -67.57 -14.36 62.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.111 0.564 . . . . 75.03 112.028 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.735 ' HG2' ' HB2' ' A' ' 135' ' ' PRO . 23.9 tp60 -95.9 -50.33 4.93 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.928 0.491 . . . . 74.12 111.147 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -78.46 -59.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.257 0.623 . . . . 75.22 111.005 -175.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -81.51 -7.05 59.53 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.723 0.409 . . . . 72.02 111.634 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 65.97 -54.48 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.502 1.921 . . . . 71.52 114.479 -174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -65.64 139.12 58.38 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.53 0.732 . . . . 75.3 112.282 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -65.59 128.66 36.85 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.229 -0.896 . . . . 71.21 109.649 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -105.47 142.51 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.193 0.597 . . . . 73.21 109.973 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' A' ' 36' ' ' ILE . . . -62.66 124.34 82.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.955 0.902 . . . . 74.0 111.402 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 51.0 Cg_exo -56.01 -32.31 85.62 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 123.513 2.809 . . . . 75.43 115.575 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -72.78 -35.73 67.48 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.37 0.268 . . . . 72.3 111.206 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.461 ' HA ' HD22 ' A' ' 39' ' ' ASN . 71.3 mt -66.25 -41.57 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.919 0.888 . . . . 73.43 110.423 172.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.68 64.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.031 0.932 . . . . 72.12 111.691 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -75.9 -61.38 1.95 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.526 -0.761 . . . . 73.22 110.914 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.461 HD22 ' HA ' ' A' ' 36' ' ' ILE . 9.3 p30 -63.21 -25.69 68.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.235 0.828 . . . . 71.2 113.235 -174.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.26 -54.49 5.91 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.86 0.464 . . . . 75.42 110.773 172.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 85.1 m-85 -113.92 60.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.678 0.791 . . . . 75.21 111.557 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -73.27 -50.94 19.53 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.928 -0.483 . . . . 71.25 111.988 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.68 -31.34 58.6 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.287 -0.415 . . . . 60.43 112.377 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.416 ' HZ3' ' HZ2' ' A' ' 47' ' ' LYS . 8.7 t-105 -69.93 -37.47 75.9 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.194 0.997 . . . . 75.0 111.157 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.9 -41.9 81.99 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.013 0.925 . . . . 72.22 111.542 169.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -53.62 -54.46 37.35 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.57 1.148 . . . . 65.24 113.193 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.642 ' HD3' HG22 ' A' ' 53' ' ' ILE . 15.1 ptpt -61.18 -35.08 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.269 0.84 . . . . 73.24 113.269 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.1 tp -71.15 -34.22 70.8 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.308 0.243 . . . . 62.43 110.707 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 16' ' ' ILE . . . -67.08 -33.52 83.72 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.76 -0.2 . . . . 72.25 112.861 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -73.63 -10.38 59.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.01 0.924 . . . . 75.23 112.144 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.99 32.5 82.36 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 115.364 0.906 . . . . 53.03 115.364 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.4 -60.2 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.902 0.858 . . . . 73.22 110.201 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.642 HG22 ' HD3' ' A' ' 47' ' ' LYS . 21.9 pt -73.13 176.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.797 -1.547 . . . . 74.35 112.181 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 57' ' ' GLU . 1.8 t -99.51 153.37 19.08 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.078 -0.712 . . . . 65.32 109.078 170.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 59' ' ' ILE . 91.2 t -64.06 -31.13 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 110.119 -0.326 . . . . 75.44 110.119 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -44.83 -50.93 9.99 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.735 1.013 . . . . 74.0 113.735 166.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 54' ' ' THR . 31.6 tt0 -58.52 -42.51 87.9 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.651 0.38 . . . . 75.24 110.822 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.487 ' HZ ' HG23 ' A' ' 20' ' ' ILE . 86.7 t80 -63.75 -43.34 96.72 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.01 0.924 . . . . 73.41 110.881 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 55' ' ' VAL . 33.7 mm -68.11 -46.47 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.751 1.22 . . . . 74.44 111.911 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.72 -39.08 64.94 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.894 0.478 . . . . 73.2 111.471 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.09 -25.42 72.16 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 116.142 -0.481 . . . . 75.11 114.165 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.7 mt -75.68 -38.1 58.99 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.426 0.69 . . . . 73.2 111.134 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.44 -18.08 79.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 121.554 -0.355 . . . . 73.1 113.657 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -84.59 -28.15 26.75 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.528 0.731 . . . . 75.33 111.566 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.3 p -71.99 129.4 38.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.673 -0.491 . . . . 63.44 109.673 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -58.71 -15.87 13.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.138 1.162 . . . . 72.54 114.138 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.69 -42.62 93.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.885 0.874 . . . . 73.22 112.072 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -65.51 -43.21 90.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.542 0.687 . . . . 62.54 111.031 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.96 -28.75 63.64 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.012 -0.994 . . . . 74.51 111.327 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -60.37 -45.87 91.98 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.959 1.304 . . . . 73.14 111.072 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.81 -42.05 61.48 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.015 -0.993 . . . . 73.41 111.832 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -114.31 -67.56 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.922 1.082 . . . . 75.54 113.922 -167.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -61.19 -30.02 70.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.338 1.236 . . . . 75.33 114.338 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.527 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 45.8 m -78.65 -54.74 1.09 Allowed Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.729 -0.653 . . . . 75.31 112.054 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 14.8 Cg_exo -71.8 -16.86 29.57 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 121.989 1.792 . . . . 71.0 114.274 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 56.3 m-85 -115.24 147.71 39.13 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 123.088 0.555 . . . . 75.02 112.357 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.407 ' O ' HG22 ' A' ' 81' ' ' VAL . 91.7 Cg_endo -75.54 169.93 21.32 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.367 . . . . 75.42 112.549 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.407 ' O ' HG13 ' A' ' 82' ' ' ILE . 3.1 m-20 -49.95 -49.56 49.77 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.25 1.02 . . . . 74.42 113.002 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.579 ' HA ' HD12 ' A' ' 82' ' ' ILE . 26.3 m -59.69 -35.53 74.67 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.6 0.76 . . . . 73.4 112.981 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 22.4 tptm -72.72 -36.18 67.74 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.904 0.383 . . . . 74.31 110.859 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 77' ' ' PRO . 41.7 t -68.84 -28.53 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.242 0.617 . . . . 75.21 110.569 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 79' ' ' THR . 96.9 mt -66.77 -52.11 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 73.33 111.26 174.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -71.99 -37.57 69.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 111.832 0.308 . . . . 73.4 111.832 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.97 -31.26 61.41 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.299 0.639 . . . . 71.34 111.508 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.9 52.05 Favored Glycine 0 N--CA 1.476 1.312 0 N-CA-C 112.039 -0.424 . . . . 74.44 112.039 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.657 HG22 HD12 ' A' ' 90' ' ' LEU . 53.6 m -66.48 -35.78 81.11 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.098 0.959 . . . . 74.33 110.747 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.93 -42.44 90.08 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 64.31 112.627 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.8 m170 -82.84 -36.0 25.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.961 0.504 . . . . 75.54 112.353 -175.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -94.29 -68.87 0.78 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 119.179 -0.439 . . . . 74.33 111.274 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 86' ' ' THR . 79.2 mt -66.9 -18.24 65.28 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.945 0.72 . . . . 73.01 112.945 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.23 21.3 78.16 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.321 0.388 . . . . 71.33 113.422 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 86' ' ' THR . 9.7 ptt180 -143.09 172.79 12.23 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.166 0.587 . . . . 75.5 110.951 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.06 151.28 54.21 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 123.246 0.618 . . . . 72.14 111.07 165.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.05 140.45 65.69 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.232 1.955 . . . . 63.24 111.486 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.65 -42.83 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.426 0.528 . . . . 75.11 112.426 -164.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -155.65 160.88 40.77 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.161 -0.681 . . . . 60.14 109.161 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -54.91 -36.08 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.447 0.699 . . . . 73.22 112.654 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.37 74.23 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.294 0.638 . . . . 61.12 112.323 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.42 -39.88 67.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.615 0.766 . . . . 72.01 111.624 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.57 -53.27 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.335 0.654 . . . . 74.53 111.713 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -55.81 -32.72 63.79 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.782 0.833 . . . . 74.25 111.867 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.4 tmmm? -61.01 -52.13 66.29 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.503 0.721 . . . . 74.03 110.856 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -64.99 -35.77 82.25 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.849 0.46 . . . . 75.42 112.021 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -67.87 -36.85 80.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.064 0.946 . . . . 74.54 111.398 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -67.78 -30.74 70.26 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.575 -0.739 . . . . 75.24 110.632 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 102' ' ' LYS . 74.3 mt -65.77 -40.75 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 122.952 0.501 . . . . 73.04 110.426 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.75 -37.97 76.62 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.241 0.617 . . . . 75.24 112.044 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.4 71.47 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.404 0.682 . . . . 62.1 112.115 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 p -75.79 -52.16 11.02 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.965 0.906 . . . . 72.13 111.642 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.09 -73.03 0.69 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.936 0.894 . . . . 73.41 111.356 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.02 -174.21 22.55 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.297 0.499 . . . . 74.34 113.543 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.8 mm -52.73 -36.64 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.966 1.306 . . . . 72.13 113.706 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -61.17 -51.35 69.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.884 0.373 . . . . 74.21 111.139 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.9 -37.45 87.69 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.524 -0.762 . . . . 73.45 112.539 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.39 -55.95 17.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.31 1.044 . . . . 72.11 112.624 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -57.51 -44.55 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.673 0.789 . . . . 74.12 110.693 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.58 -39.19 76.22 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.322 0.649 . . . . 75.02 112.263 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.96 98.49 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.245 0.618 . . . . 64.14 111.472 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.0 mt -62.83 -55.04 29.84 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.836 0.854 . . . . 72.11 111.399 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.435 HG11 ' HG3' ' A' ' 56' ' ' LYS . 74.9 t -67.23 -32.6 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 123.186 0.595 . . . . 75.04 112.438 -173.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.93 22.11 15.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.63 -0.669 . . . . 74.22 111.824 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -71.5 142.03 50.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.258 0.623 . . . . 72.41 110.453 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.65 -37.39 79.62 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.724 0.41 . . . . 72.33 111.563 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.58 -32.5 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 120.776 0.322 . . . . 74.24 110.887 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -75.49 -54.13 7.53 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.455 0.702 . . . . 74.23 111.712 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -69.86 -23.35 63.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.905 0.705 . . . . 74.42 112.905 -169.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.46 -39.1 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.042 0.537 . . . . 75.23 111.984 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.29 -58.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.089 0.947 . . . . 75.44 110.394 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.527 ' HE2' ' HB2' ' A' ' 56' ' ' LYS . 45.5 t80 -59.88 -46.64 88.68 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.037 1.735 . . . . 74.2 112.786 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.94 -129.18 9.2 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-O 119.534 -0.592 . . . . 74.35 112.183 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -135.06 -64.58 0.65 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.504 0.652 . . . . 73.34 111.271 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.43 1.14 34.45 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.844 0.858 . . . . 73.44 112.693 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.9 m -92.35 151.65 20.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.843 0.857 . . . . 72.54 111.528 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.7 137.67 85.65 Favored Pre-proline 0 N--CA 1.488 1.452 0 C-N-CA 124.468 1.107 . . . . 75.04 110.284 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.735 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 2.8 Cg_exo -67.82 135.57 35.86 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.158 1.905 . . . . 75.51 111.798 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -136.21 141.35 43.99 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.493 0.717 . . . . 75.24 110.299 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.421 ' H ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -86.47 18.54 3.22 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.437 0.695 . . . . 71.52 112.523 -176.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 65.72 -104.89 0.1 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 125.031 1.332 . . . . 75.13 112.514 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.523 ' H ' ' HD3' ' A' ' 140' ' ' PRO . 38.8 p90 -160.38 27.1 0.03 OUTLIER Pre-proline 0 CA--C 1.59 2.496 0 N-CA-C 116.208 1.929 . . . . 73.42 116.208 -171.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.523 ' HD3' ' H ' ' A' ' 139' ' ' PHE . 15.9 Cg_exo -66.79 -11.89 33.8 Favored 'Trans proline' 0 C--N 1.401 3.298 0 CA-C-N 123.4 2.25 . . . . 74.41 112.878 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 t -61.7 -44.16 97.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.404 1.082 . . . . 74.45 111.466 169.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.6 mt 61.77 6.44 1.62 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.149 1.38 . . . . 72.42 113.88 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -85.89 89.15 7.69 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.562 0.696 . . . . 74.51 109.324 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -83.74 98.11 9.5 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.49 -0.777 . . . . 74.13 111.968 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.5 126.01 34.65 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.747 -0.661 . . . . 74.2 109.532 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -68.52 -6.5 25.62 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.862 1.06 . . . . 74.41 113.862 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -132.39 128.19 37.04 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.886 0.874 . . . . 63.3 110.502 167.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -155.23 81.73 1.06 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.702 0.801 . . . . 74.44 109.505 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 N--CA 1.49 1.555 0 C-N-CA 124.064 0.946 . . . . 75.01 112.417 -170.905 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.607 0.241 . . . . 65.25 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -138.28 130.4 28.61 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.871 0.868 . . . . 75.45 109.852 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 p -108.99 125.24 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.67 0.788 . . . . 64.14 110.68 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -92.23 87.22 6.0 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.63 0.729 . . . . 73.1 109.748 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.53 155.43 17.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.546 0.738 . . . . 73.13 110.881 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -92.77 113.8 26.18 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.22 -1.03 . . . . 70.53 108.22 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.56 124.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.912 -0.773 . . . . 75.31 108.912 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.87 99.86 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.707 0.803 . . . . 54.45 111.945 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.29 -31.49 2.34 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.067 -0.515 . . . . 73.31 113.929 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.3 mt -67.68 102.16 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-O 121.709 0.766 . . . . 70.14 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -113.62 24.93 11.69 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.709 -1.132 . . . . 73.34 110.176 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.42 109.31 21.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.697 0.799 . . . . 71.2 108.984 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -61.51 -23.34 65.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.64 0.607 . . . . 74.43 112.64 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.27 -38.84 68.72 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.267 0.627 . . . . 74.53 111.074 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.01 52.14 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.357 0.663 . . . . 74.53 111.289 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 mm -72.52 -42.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.08 0.552 . . . . 74.14 110.07 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.38 -31.75 73.02 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.866 0.867 . . . . 74.45 112.527 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -77.14 -31.0 55.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 120.902 0.382 . . . . 72.23 111.446 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.07 -43.55 98.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.741 0.816 . . . . 74.44 109.654 170.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.3 -38.04 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.481 1.112 . . . . 71.12 111.48 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.8 t -65.74 -38.37 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.519 0.728 . . . . 74.42 111.771 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.41 -37.6 63.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.146 0.578 . . . . 72.33 110.885 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.9 77.14 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.777 0.831 . . . . 74.23 111.601 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -59.07 -49.91 76.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.984 0.514 . . . . 74.32 110.923 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.78 -26.5 68.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.88 0.696 . . . . 74.0 112.88 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.29 -46.89 72.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.853 0.461 . . . . 74.52 111.367 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.701 HD11 HG23 ' A' ' 59' ' ' ILE . 2.4 mp -89.12 -67.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.079 0.552 . . . . 73.22 109.954 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -83.77 82.35 8.36 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.879 0.872 . . . . 75.15 109.122 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.32 69.17 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.609 1.195 . . . . 73.34 114.113 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 176.23 145.73 0.09 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.256 1.822 . . . . 65.43 108.911 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -71.03 119.64 15.44 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-O 121.006 0.432 . . . . 75.44 110.6 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 mm -84.1 125.24 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.473 -0.936 . . . . 75.4 108.473 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -59.24 122.47 63.77 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.603 -0.713 . . . . 74.24 111.173 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.95 -38.47 86.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.611 2.874 . . . . 71.51 114.275 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 33' ' ' ALA . 44.1 p90 -68.71 -25.38 64.74 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.205 0.602 . . . . 73.11 112.198 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.485 ' HA ' HD22 ' A' ' 39' ' ' ASN . 62.1 mt -83.32 -44.49 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.429 0.692 . . . . 71.15 111.004 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -33.84 72.6 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.478 1.111 . . . . 62.54 112.208 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -36.52 72.94 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.519 -0.764 . . . . 74.1 112.312 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.485 HD22 ' HA ' ' A' ' 36' ' ' ILE . 10.3 p30 -83.34 -41.57 18.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.344 0.498 . . . . 70.44 112.344 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.39 -54.08 28.46 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.714 . . . . 72.33 112.269 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -98.31 33.0 2.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.92 0.888 . . . . 72.34 111.006 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.8 t -62.38 -50.43 71.58 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.191 0.997 . . . . 75.31 113.081 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.16 36.72 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.788 -0.642 . . . . 72.44 112.096 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -70.54 -29.94 66.54 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.497 0.719 . . . . 74.43 111.957 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -38.57 75.49 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.691 0.796 . . . . 71.23 110.834 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.0 t -52.37 -38.16 58.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.153 0.981 . . . . 73.43 113.365 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.33 -40.07 62.43 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 111.969 0.359 . . . . 74.35 111.969 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.32 -30.69 67.72 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 118.212 0.46 . . . . 74.04 112.178 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.36 -31.7 68.54 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.893 0.163 . . . . 72.41 112.711 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 56.1 m-20 -88.19 -18.44 28.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.534 0.734 . . . . 74.52 111.609 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.17 71.86 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.143 0.417 . . . . 72.12 114.143 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.5 mm-40 -61.07 -32.6 72.25 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.822 0.849 . . . . 71.22 111.677 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -113.41 158.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.574 0.749 . . . . 71.55 110.055 171.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.4 p -84.75 169.18 14.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.255 0.622 . . . . 63.13 110.99 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.8 t -63.79 -47.69 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.479 -0.563 . . . . 75.4 109.479 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -43.57 -51.84 6.62 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.61 1.337 . . . . 71.35 114.61 169.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -57.75 -39.49 77.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.094 0.558 . . . . 72.04 111.301 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 45.3 t80 -71.83 -38.72 70.13 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.482 0.713 . . . . 75.54 110.792 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.701 HG23 HD11 ' A' ' 27' ' ' ILE . 30.6 mm -63.47 -50.35 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.983 1.313 . . . . 75.52 110.937 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.441 ' HB2' HG12 ' A' ' 120' ' ' VAL . 25.8 tt0 -57.34 -38.85 74.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.085 -0.961 . . . . 74.12 111.425 172.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.73 85.22 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.821 -0.627 . . . . 73.42 113.941 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 84.1 mt -69.78 -39.89 76.37 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.245 0.618 . . . . 75.23 111.326 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.75 81.95 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.529 0.572 . . . . 72.11 114.529 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -72.77 -21.69 60.96 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.518 0.727 . . . . 72.15 111.73 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -63.22 128.68 36.94 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.095 0.558 . . . . 65.14 111.919 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.14 -19.2 52.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.24 113.09 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.78 -44.01 97.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.33 0.652 . . . . 64.13 110.723 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -67.54 -31.13 71.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.832 0.453 . . . . 75.34 111.475 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 4.3 mm? -71.89 -34.46 69.16 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.276 0.63 . . . . 72.43 112.318 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HA ' ' HG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -81.06 -29.7 34.95 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.543 -0.723 . . . . 74.44 111.693 176.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.85 -56.63 4.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.664 0.616 . . . . 74.32 112.664 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -128.05 60.01 1.47 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.539 0.735 . . . . 75.43 112.306 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.589 ' HD1' HG12 ' A' ' 81' ' ' VAL . 76.9 t80 -162.66 -60.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.911 -0.586 . . . . 74.02 110.725 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.43 ' HG1' ' HA ' ' A' ' 70' ' ' LYS . 64.6 p -64.33 -41.26 58.76 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 114.405 1.261 . . . . 72.41 114.405 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.32 -7.58 8.9 Favored 'Trans proline' 0 C--N 1.389 2.704 0 CA-C-N 121.84 1.693 . . . . 74.1 114.039 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -109.37 149.98 40.5 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 123.805 0.842 . . . . 72.55 111.819 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.89 152.94 76.65 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.095 1.863 . . . . 64.54 111.323 168.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -50.56 -47.79 57.72 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.804 0.842 . . . . 73.02 112.708 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.519 ' HA ' HD13 ' A' ' 82' ' ' ILE . 17.8 m -55.61 -33.59 64.12 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.656 0.783 . . . . 64.2 112.354 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -76.23 -36.0 58.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.001 0.521 . . . . 74.34 111.636 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.589 HG12 ' HD1' ' A' ' 73' ' ' TYR . 59.7 t -63.09 -34.8 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.445 0.641 . . . . 74.24 110.476 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 79' ' ' THR . 95.5 mt -63.21 -51.28 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.814 -1.084 . . . . 65.4 111.92 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.4 -31.06 60.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.821 0.448 . . . . 72.4 111.442 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -76.93 -28.51 55.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.418 0.687 . . . . 75.31 111.222 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.26 -54.52 8.87 Favored Glycine 0 C--N 1.344 1.022 0 C-N-CA 122.101 -0.095 . . . . 72.54 112.935 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 t -60.59 -33.34 72.58 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.42 0.896 . . . . 72.2 113.42 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.23 -14.74 62.34 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.543 0.571 . . . . 74.55 112.543 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -89.41 -50.25 6.22 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.774 0.657 . . . . 71.32 112.774 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -85.67 -40.04 16.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.864 0.466 . . . . 74.44 111.82 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 124' ' ' GLU . 77.6 mt -95.84 -49.02 5.5 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 122.439 0.296 . . . . 74.0 110.994 175.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.29 40.39 87.45 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 122.192 -0.317 . . . . 71.44 113.707 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.685 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 2.6 ptm180 -131.2 7.97 4.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.157 0.799 . . . . 74.31 113.157 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 60.12 158.56 0.11 Allowed Pre-proline 0 N--CA 1.504 2.256 0 N-CA-C 113.87 1.063 . . . . 53.44 113.87 -163.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.02 152.96 61.21 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.318 2.012 . . . . 72.12 113.705 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -74.44 -72.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 C-N-CA 123.193 0.597 . . . . 74.31 111.08 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -123.86 171.36 9.73 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.816 0.846 . . . . 54.12 109.854 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -69.5 -29.79 67.5 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.776 -0.578 . . . . 72.13 110.172 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.52 -30.94 68.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.088 0.555 . . . . 53.23 111.96 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -71.89 -39.62 69.45 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.209 0.604 . . . . 64.34 111.21 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.98 -52.15 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.217 0.607 . . . . 75.14 110.567 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -54.74 -39.91 68.76 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.11 0.964 . . . . 73.13 111.91 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 106' ' ' ILE . 34.6 ttpt -57.15 -45.55 83.5 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.527 0.731 . . . . 65.43 111.15 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.513 ' HD1' HD12 ' A' ' 106' ' ' ILE . 17.8 m-85 -68.25 -35.39 77.83 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.755 0.422 . . . . 75.1 111.921 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -67.46 -32.71 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.892 0.477 . . . . 74.13 110.988 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -64.45 -40.75 96.33 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.865 0.866 . . . . 74.31 110.429 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.516 HG22 HE21 ' A' ' 110' ' ' GLN . 80.1 mt -62.48 -46.16 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 124.267 1.027 . . . . 74.23 111.52 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.3 -42.72 99.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.207 0.603 . . . . 74.23 111.69 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.2 -44.6 75.47 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.743 0.646 . . . . 74.3 112.743 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.4 p -72.41 -51.77 18.91 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.021 0.749 . . . . 73.44 113.021 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.516 HE21 HG22 ' A' ' 106' ' ' ILE . 2.3 pm0 -124.26 -46.75 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 112.906 0.706 . . . . 74.22 112.906 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.1 -153.45 20.74 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 115.414 0.925 . . . . 70.44 115.414 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.1 tp -70.81 -35.57 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.107 0.963 . . . . 71.1 112.775 -169.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -61.2 -44.27 97.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.427 0.528 . . . . 74.23 112.427 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -29.44 66.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.029 0.531 . . . . 62.31 112.294 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -65.12 -48.07 74.88 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.269 0.628 . . . . 74.22 110.707 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 112' ' ' ILE . 46.7 mm -64.22 -45.6 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.568 0.747 . . . . 74.53 110.026 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -58.87 -36.36 74.49 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.103 0.961 . . . . 70.4 111.671 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.18 -28.72 68.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.4 0.68 . . . . 72.04 112.142 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.0 -43.56 13.05 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.838 0.855 . . . . 73.22 112.326 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 60' ' ' GLU . 61.8 t -78.15 -37.54 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.416 0.686 . . . . 74.33 111.504 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -87.53 4.37 43.8 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.918 0.487 . . . . 74.53 112.039 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.1 t -67.62 137.58 55.74 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.921 0.488 . . . . 74.42 110.489 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . 13.7 pt20 -54.74 -29.21 53.07 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.786 1.032 . . . . 75.1 113.786 -175.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.685 ' HG2' ' HD2' ' A' ' 92' ' ' ARG . 34.3 tp10 -50.85 -47.53 60.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.121 0.968 . . . . 64.33 112.225 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.9 -44.58 20.14 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.624 0.769 . . . . 75.34 111.092 168.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 123' ' ' GLN . 6.8 t30 -72.46 -67.7 0.53 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.707 1.002 . . . . 73.53 113.707 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 8.3 pt-20 -56.81 -37.21 70.86 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.296 0.85 . . . . 75.23 113.296 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.67 -61.62 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 112.502 0.556 . . . . 75.4 112.502 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.3 -53.59 2.63 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.05 0.54 . . . . 71.05 111.479 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.65 -126.91 8.78 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.878 -0.601 . . . . 54.22 113.095 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -106.42 -20.46 13.37 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.781 0.832 . . . . 74.25 111.377 -169.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.21 11.84 38.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.143 1.534 . . . . 74.42 115.143 -156.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 t -153.91 164.23 38.74 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 119.43 1.014 . . . . 73.34 112.333 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.86 135.37 92.14 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 123.871 0.868 . . . . 74.13 110.498 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.85 76.74 1.97 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.207 2.605 . . . . 74.43 113.198 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -86.17 171.23 11.46 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.32 0.648 . . . . 75.41 110.701 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -62.82 133.07 54.17 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.108 0.48 . . . . 74.21 111.832 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.527 ' HB3' HD22 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -84.94 130.34 34.65 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.034 0.445 . . . . 74.41 110.552 176.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -66.74 158.98 77.72 Favored Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 125.129 1.372 . . . . 72.13 111.695 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -52.13 -39.16 71.45 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 123.529 2.819 . . . . 62.45 113.377 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.7 t -107.24 148.54 28.8 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.48 0.712 . . . . 52.2 110.164 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 138' ' ' ARG . 94.7 mt -118.66 109.17 15.81 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.471 0.708 . . . . 70.22 110.377 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -85.26 69.21 10.72 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.823 0.821 . . . . 73.23 109.586 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -148.88 88.04 1.58 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.881 -1.155 . . . . 72.42 107.881 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -54.14 107.32 0.26 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.34 1.056 . . . . 74.41 113.784 -169.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -75.37 150.14 38.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.775 0.83 . . . . 74.32 110.889 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -65.67 140.37 58.48 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 112.596 0.591 . . . . 74.31 112.596 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -94.32 -11.14 30.65 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.99 0.916 . . . . 75.14 111.622 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 17.9 p80 . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 123.87 0.868 . . . . 73.15 110.628 174.568 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 110.309 -0.256 . . . . 74.31 110.309 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -128.41 127.93 43.51 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 121.562 0.696 . . . . 75.43 111.868 -171.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.2 t -114.69 118.71 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.712 1.205 . . . . 73.54 108.803 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -88.01 101.15 13.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.296 0.638 . . . . 75.24 111.123 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HZ2' HG21 ' A' ' 7' ' ' VAL . 2.7 pptp? -132.06 163.2 28.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.014 0.526 . . . . 72.24 111.176 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.613 HH22 ' HG ' ' A' ' 48' ' ' LEU . 19.7 tpp85 -79.47 98.25 6.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.262 -0.881 . . . . 71.45 109.736 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 HG21 ' HZ2' ' A' ' 5' ' ' LYS . 15.2 t -75.73 130.71 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.338 -0.986 . . . . 73.53 108.338 177.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.66 75.8 0.59 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.861 0.839 . . . . 72.44 111.928 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.75 -37.98 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.517 -1.22 . . . . 64.2 112.356 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.43 80.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.439 0 CA-C-O 122.529 1.156 . . . . 75.25 110.819 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -89.44 10.03 24.17 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.583 -1.644 . . . . 65.11 113.599 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 16' ' ' ILE . 5.6 m-20 -70.69 126.15 28.8 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.007 0.523 . . . . 75.03 111.198 -172.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -60.45 -29.47 69.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.926 0.491 . . . . 73.53 112.035 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 -50.58 62.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.025 0.93 . . . . 75.14 110.937 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.4 94.51 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.603 0.761 . . . . 71.35 112.496 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.559 HG22 ' HA2' ' A' ' 49' ' ' GLY . 46.1 mm -63.2 -49.06 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.06 0.544 . . . . 64.2 111.556 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.25 -25.14 61.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.313 0.486 . . . . 74.12 112.313 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.8 m -65.73 -38.63 89.68 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.792 0.437 . . . . 74.33 111.226 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.33 -40.36 93.59 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.012 0.925 . . . . 73.0 109.983 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.27 -43.92 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.653 1.181 . . . . 71.35 111.544 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -70.47 -35.54 73.36 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.311 0.644 . . . . 74.11 111.438 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.18 90.14 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.666 0.786 . . . . 54.33 112.022 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.78 99.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.512 0.725 . . . . 65.43 111.126 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.474 ' HE2' ' HB2' ' A' ' 37' ' ' ALA . 13.3 m-30 -70.92 -41.02 71.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.567 -0.742 . . . . 75.44 111.556 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -60.88 -35.78 77.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.256 1.022 . . . . 75.31 112.367 179.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.0 -62.92 1.54 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.876 0.471 . . . . 71.35 110.122 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.75 -54.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.78 0.832 . . . . 73.02 112.674 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -78.98 -8.33 58.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.121 0.568 . . . . 75.35 112.029 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 146' ' ' HIS . 8.8 tp10 53.85 45.77 27.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.521 1.153 . . . . 74.02 112.577 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 8.0 ptp180 -153.85 -179.0 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.348 -0.842 . . . . 72.43 111.264 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -125.78 107.95 11.02 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.848 -1.167 . . . . 70.53 107.848 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.408 HD12 ' CD2' ' A' ' 24' ' ' TYR . 20.0 mt -90.98 139.84 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.769 0.428 . . . . 73.34 110.849 -174.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.67 94.6 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.791 -0.623 . . . . 74.01 109.941 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.58 -44.13 41.7 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.656 2.904 . . . . 75.02 113.957 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.01 -44.58 79.95 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.173 -0.921 . . . . 73.41 112.523 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -57.91 -43.78 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 122.956 0.502 . . . . 75.41 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.474 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . . . -58.72 -48.19 81.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.287 1.035 . . . . 71.42 111.795 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.95 -12.13 59.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.619 0.6 . . . . 72.23 112.619 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -80.3 -47.26 14.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.677 -0.64 . . . . 73.31 111.729 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.52 -42.48 67.9 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 120.949 0.404 . . . . 74.1 111.047 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 60.7 m-85 -105.66 55.07 0.69 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.785 0.834 . . . . 64.45 110.939 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.6 m -64.34 -50.2 68.68 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 122.891 0.476 . . . . 70.25 111.636 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -70.64 -39.01 67.66 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.85 -0.614 . . . . 74.53 113.389 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -70.32 -42.16 72.3 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.135 0.974 . . . . 72.51 112.889 -169.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.04 -39.72 93.3 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.883 0.473 . . . . 73.41 110.584 174.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 m -62.77 -47.56 82.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.856 0.863 . . . . 73.11 111.885 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.4 mmmm -59.12 -44.87 92.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.069 0.547 . . . . 74.13 111.983 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.613 ' HG ' HH22 ' A' ' 6' ' ' ARG . 16.3 tp -74.0 -33.28 63.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 116.317 -0.402 . . . . 74.22 111.32 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.559 ' HA2' HG22 ' A' ' 16' ' ' ILE . . . -66.0 -26.72 72.4 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 123.035 0.35 . . . . 73.21 113.883 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -92.28 -17.51 24.67 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.548 0.739 . . . . 71.5 110.985 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.79 28.51 60.82 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.887 -0.597 . . . . 72.44 113.973 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.41 -25.27 54.33 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.697 0.799 . . . . 74.14 112.647 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.17 171.0 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.727 0.811 . . . . 74.33 109.151 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 p -89.69 170.27 10.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.7 -0.852 . . . . 72.34 108.7 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -59.56 -33.53 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 119.721 -0.18 . . . . 73.21 110.562 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 131' ' ' GLU . 78.7 tttt -44.82 -56.81 4.19 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.0 1.32 . . . . 72.32 113.556 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.98 -40.58 78.74 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.288 0.635 . . . . 62.31 111.354 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 85.3 t80 -53.49 -51.9 61.26 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.908 0.755 . . . . 74.02 110.808 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 55' ' ' VAL . 37.8 mm -57.88 -43.5 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.643 1.177 . . . . 72.32 111.758 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HB2' HG12 ' A' ' 120' ' ' VAL . 32.2 tt0 -58.97 -47.95 83.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 122.783 0.433 . . . . 65.23 111.81 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.17 -18.83 65.43 Favored Glycine 0 CA--C 1.541 1.698 0 N-CA-C 114.867 0.707 . . . . 73.01 114.867 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 54.2 mt -70.73 -30.67 67.26 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 117.566 0.683 . . . . 74.35 111.105 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.61 -10.67 79.94 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 115.315 -0.857 . . . . 72.33 114.129 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -95.54 -7.75 37.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.658 0.783 . . . . 75.24 111.014 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.426 ' O ' HD21 ' A' ' 69' ' ' LEU . 57.7 p -84.13 137.35 33.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.986 0.514 . . . . 75.23 111.273 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 6.0 t30 -62.38 -23.58 66.89 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.01 0.524 . . . . 72.11 111.576 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.5 tp -67.56 -38.01 83.5 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.605 0.762 . . . . 75.22 111.611 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -74.27 -45.6 46.72 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 120.811 0.339 . . . . 74.42 110.716 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.462 HD13 HG12 ' A' ' 112' ' ' ILE . 4.0 mm? -55.96 -44.17 78.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.587 1.155 . . . . 72.32 112.887 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.82 -29.71 70.23 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.873 0.694 . . . . 74.42 112.873 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HG3' HH21 ' A' ' 30' ' ' ARG . 6.3 mm-40 -93.37 -36.64 12.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.314 1.227 . . . . 74.22 114.314 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.407 ' HD1' HD12 ' A' ' 84' ' ' LEU . 80.1 m-85 -128.86 32.42 4.78 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.658 0.614 . . . . 75.44 112.658 -171.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.541 ' HD1' HG11 ' A' ' 81' ' ' VAL . 78.1 t80 -150.16 -54.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.95 0.5 . . . . 74.55 110.974 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -68.16 -43.7 35.6 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.582 0.956 . . . . 75.43 113.582 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.1 7.63 4.97 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.127 1.885 . . . . 74.1 113.422 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 58.3 m-85 -130.07 141.6 42.44 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.579 0.751 . . . . 75.24 111.395 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.65 167.55 16.97 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.29 1.993 . . . . 72.33 111.766 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.52 -40.72 72.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.289 0.636 . . . . 73.11 112.356 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.574 ' HA ' HD13 ' A' ' 82' ' ' ILE . 99.2 m -66.36 -42.38 88.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.073 0.949 . . . . 75.31 113.457 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 48.8 tptt -63.66 -32.95 74.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.258 0.466 . . . . 75.23 112.258 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.541 HG11 ' HD1' ' A' ' 73' ' ' TYR . 45.8 t -63.18 -30.56 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.188 0.595 . . . . 73.23 110.642 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 79' ' ' THR . 95.6 mt -69.92 -51.17 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.947 0.899 . . . . 73.02 112.251 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.64 -45.44 65.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.115 0.416 . . . . 75.1 111.697 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.505 HD21 ' HD3' ' A' ' 87' ' ' LYS . 74.8 mt -61.85 -29.04 69.91 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.361 0.665 . . . . 74.24 112.196 171.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.1 -41.67 46.7 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 115.705 -0.68 . . . . 75.12 111.903 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.426 HG23 HD13 ' A' ' 90' ' ' LEU . 78.3 m -68.9 -46.1 69.22 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.308 0.643 . . . . 65.13 112.016 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HD3' HD21 ' A' ' 84' ' ' LEU . 14.6 ptmt -70.5 -24.42 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.59 0.959 . . . . 73.34 113.59 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -85.02 -33.61 22.49 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 113.695 0.998 . . . . 62.01 113.695 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -104.18 -41.97 5.65 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.844 1.053 . . . . 73.54 113.844 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.426 HD13 HG23 ' A' ' 86' ' ' THR . 69.0 mt -94.71 -14.7 24.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.127 0.417 . . . . 74.13 112.127 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.87 14.97 2.05 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.608 0.603 . . . . 73.12 114.608 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.626 ' HA ' HH11 ' A' ' 138' ' ' ARG . 24.3 ttt180 -98.23 -84.78 0.38 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.321 0.648 . . . . 74.11 112.476 -161.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 175.98 137.11 0.19 Allowed Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 74.34 108.938 -168.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.39 122.89 10.18 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.459 1.44 . . . . 75.12 109.531 165.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.29 -63.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 122.086 -0.383 . . . . 74.44 111.504 -168.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -158.14 166.5 32.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.473 -0.936 . . . . 75.01 108.473 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -66.29 -27.76 68.18 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.232 0.469 . . . . 73.2 111.396 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.2 72.44 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.945 0.498 . . . . 71.21 111.458 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.87 -45.73 84.8 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.25 0.62 . . . . 75.24 110.667 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.511 HG21 HG23 ' A' ' 79' ' ' THR . 85.0 mt -59.33 -36.76 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.685 -0.689 . . . . 74.22 110.573 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -68.81 -31.96 71.33 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.676 0.39 . . . . 73.31 111.608 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.53 -50.1 41.16 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.528 0.331 . . . . 73.5 111.44 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -62.58 -38.44 90.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.081 0.4 . . . . 72.43 112.081 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.59 -36.16 77.85 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.935 0.894 . . . . 73.33 111.255 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -69.36 -44.02 72.43 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.67 0.788 . . . . 72.54 110.907 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -42.78 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.551 0.741 . . . . 75.45 110.831 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.422 HD13 ' HE1' ' A' ' 73' ' ' TYR . 31.5 tp -65.51 -33.29 75.58 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.364 1.065 . . . . 72.1 112.438 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.41 -46.35 17.72 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.019 0.528 . . . . 63.13 112.322 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.8 p -70.45 -45.16 66.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.99 0.916 . . . . 74.24 111.843 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -110.6 -68.79 0.9 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.228 0.611 . . . . 71.15 111.914 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.89 -170.33 28.57 Favored Glycine 0 C--N 1.356 1.688 0 C-N-CA 121.691 -0.29 . . . . 73.12 113.792 -175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.462 HG12 HD13 ' A' ' 69' ' ' LEU . 8.6 tp -65.82 -39.2 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.925 0.89 . . . . 75.23 112.637 -173.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -65.69 -33.57 76.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.946 0.498 . . . . 75.52 111.861 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.87 -34.63 51.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.606 0.762 . . . . 54.25 110.425 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.78 -51.98 65.0 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.273 1.029 . . . . 62.43 111.174 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.88 -51.88 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.937 0.895 . . . . 73.41 110.867 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -48.29 -47.78 36.25 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.675 0.79 . . . . 64.14 112.288 171.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -33.54 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.569 0.747 . . . . 75.22 112.337 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.59 -57.99 4.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.955 0.502 . . . . 74.03 110.895 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 60' ' ' GLU . 94.3 t -63.77 -35.85 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 113.847 1.054 . . . . 74.01 113.847 -166.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.62 36.27 2.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 75.24 112.101 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.4 p -84.02 171.26 13.11 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.163 0.506 . . . . 74.11 110.789 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -69.56 -31.53 69.77 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.01 0.91 . . . . 72.05 110.339 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -69.81 -36.2 75.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.425 1.49 . . . . 75.04 111.596 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -76.22 -37.66 57.45 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.994 0.518 . . . . 70.41 110.958 173.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.15 -61.09 2.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.811 0.844 . . . . 74.42 112.577 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.56 -38.71 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.722 0.296 . . . . 72.23 111.72 -168.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.03 -44.36 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.639 0.775 . . . . 64.15 111.657 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -101.68 -45.64 5.19 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.042 0.537 . . . . 74.34 112.174 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.19 20.04 63.52 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-O 119.715 -0.492 . . . . 71.22 113.906 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 8.5 pt-20 57.08 -1.81 0.05 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.903 2.186 . . . . 73.0 116.903 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -93.04 -17.5 23.78 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.315 0.646 . . . . 73.24 111.433 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 t -108.99 162.42 14.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.439 0.696 . . . . 75.5 112.339 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.21 136.96 89.09 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.706 -1.133 . . . . 65.41 108.401 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.78 88.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.548 2.165 . . . . 74.55 112.179 173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -70.24 107.88 3.92 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.395 -0.82 . . . . 75.45 108.896 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -45.44 112.62 0.47 Allowed 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.062 -0.972 . . . . 74.43 111.718 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.626 HH11 ' HA ' ' A' ' 92' ' ' ARG . 34.1 mtp-105 -84.17 13.53 5.11 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.957 0.903 . . . . 74.44 112.062 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -90.94 115.67 64.79 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 124.342 1.057 . . . . 72.45 110.743 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.63 -32.97 78.99 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.999 2.466 . . . . 73.3 112.743 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.5 t -78.95 170.53 16.55 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.922 0.889 . . . . 75.42 111.614 175.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 80.7 mt 68.44 20.76 8.44 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 124.796 1.239 . . . . 75.2 112.341 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.35 -26.33 66.52 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.908 1.283 . . . . 72.41 112.181 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -51.67 -26.4 9.08 Favored 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 125.031 1.332 . . . . 73.22 114.555 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.7 p80 46.19 117.42 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.002 0 C-N-CA 126.591 1.956 . . . . 74.42 115.235 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.494 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 49.6 m-70 -75.28 132.31 40.94 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.914 1.079 . . . . 73.34 113.914 -167.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -101.42 162.9 12.56 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.782 1.233 . . . . 74.5 109.625 164.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -149.33 127.01 11.69 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.137 0.575 . . . . 74.42 110.355 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.4 t60 . . . . . 0 N--CA 1.481 1.093 0 C-N-CA 123.695 0.798 . . . . 73.02 109.984 178.155 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 112.088 0.403 . . . . 74.32 112.088 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -114.77 161.69 17.84 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.33 0.652 . . . . 75.41 112.212 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.1 t -126.71 124.91 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.175 0.99 . . . . 75.14 109.107 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -83.29 124.21 30.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.332 0.587 . . . . 72.02 111.168 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.21 173.77 16.36 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.847 1.259 . . . . 74.32 109.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.614 ' NH2' ' HA2' ' A' ' 51' ' ' GLY . 81.4 mtp180 -102.5 116.21 32.16 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.57 0.7 . . . . 75.3 111.315 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.4 2.62 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.977 0 C-N-CA 125.345 1.458 . . . . 65.53 111.004 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 78.58 -67.47 0.17 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.406 1.882 . . . . 61.41 110.369 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 49.28 4.12 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.036 0.374 . . . . 64.43 114.036 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 6' ' ' ARG . 66.6 mt -72.99 -53.4 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.256 0.622 . . . . 75.24 110.11 172.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 65.7 -65.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.348 1.459 . . . . 73.25 112.094 -171.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 16' ' ' ILE . 32.1 t70 -44.68 133.96 5.71 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.966 1.706 . . . . 73.22 115.588 -173.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.28 -25.38 39.47 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 112.93 -1.941 . . . . 75.11 112.545 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -70.84 -51.46 26.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 73.42 111.444 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.24 -50.64 58.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.73 1.011 . . . . 74.14 113.73 167.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 12' ' ' ASP . 43.8 mm -56.84 -43.05 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.852 0.686 . . . . 70.43 112.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 2.7 pptp? -67.14 -30.47 70.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 112.512 0.56 . . . . 74.11 112.512 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 m -70.57 -49.4 48.31 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.14 0.495 . . . . 74.44 111.022 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -44.54 -46.49 9.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.821 -1.081 . . . . 74.51 111.805 165.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.9 -36.19 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.341 1.056 . . . . 75.42 112.353 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -61.71 -49.01 78.17 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.261 0.624 . . . . 61.45 111.668 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.34 88.96 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.138 0.575 . . . . 74.23 111.827 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.67 -31.17 15.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.684 -1.144 . . . . 74.23 112.596 171.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.88 -48.15 17.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.888 0.475 . . . . 72.14 111.766 168.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -55.8 -28.36 55.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.355 1.613 . . . . 75.04 115.355 -167.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -86.68 -41.64 14.03 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.097 0.408 . . . . 64.12 111.274 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.579 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -75.8 -57.25 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.537 0.735 . . . . 62.42 111.221 -173.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HB3' HH11 ' A' ' 30' ' ' ARG . 93.2 m-85 -78.91 -6.38 56.03 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.095 0.558 . . . . 75.12 111.94 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 54.87 37.67 29.02 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 125.425 1.49 . . . . 72.42 112.927 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.425 HH11 ' HB3' ' A' ' 28' ' ' PHE . 10.0 ptp85 -155.0 151.73 28.83 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.275 0.559 . . . . 74.21 112.247 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.04 100.94 2.1 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.149 -0.932 . . . . 64.22 109.427 165.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.3 mt -81.11 126.53 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 110.044 -0.354 . . . . 75.11 110.044 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.38 132.45 94.17 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.814 0.846 . . . . 65.05 111.035 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.81 -33.03 98.27 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.999 2.466 . . . . 75.23 113.368 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -69.17 -21.71 63.97 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.956 0.724 . . . . 73.12 112.956 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -81.99 -48.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.152 0.581 . . . . 74.04 109.884 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 -32.02 71.99 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.073 0.949 . . . . 55.03 113.182 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -76.6 -19.19 58.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.849 0.46 . . . . 73.22 111.747 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -80.15 -47.1 15.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.223 0.609 . . . . 63.34 111.251 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -85.5 -59.82 2.21 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.889 0.376 . . . . 72.14 111.725 -171.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -93.15 41.55 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.565 0.746 . . . . 74.54 112.535 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.9 t -66.68 -50.8 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.523 0.729 . . . . 70.15 112.058 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.2 -28.6 57.94 Favored Glycine 0 N--CA 1.477 1.374 0 CA-C-N 115.777 -0.647 . . . . 33.12 113.051 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -65.3 -25.12 67.49 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.237 1.015 . . . . 75.53 112.259 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.66 -45.27 75.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.65 0.78 . . . . 73.2 110.824 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -57.45 -30.92 65.41 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.02 0.928 . . . . 71.4 112.575 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -73.58 -35.74 65.47 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.473 0.309 . . . . 75.22 111.687 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.2 tp -73.38 -60.94 2.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.282 0.845 . . . . 74.3 113.282 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.59 -36.67 76.71 Favored Glycine 0 C--N 1.358 1.772 0 CA-C-N 118.622 0.646 . . . . 73.32 114.377 -171.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -59.98 -16.59 31.68 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.89 0.876 . . . . 74.33 113.347 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.614 ' HA2' ' NH2' ' A' ' 6' ' ' ARG . . . 103.04 5.17 47.37 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 114.635 0.614 . . . . 72.44 114.635 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.2 -63.99 1.03 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.187 0.493 . . . . 75.04 111.991 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -85.06 -142.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-N 116.025 -0.534 . . . . 73.31 111.259 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.439 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 3.3 t -170.43 152.16 3.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 73.13 108.916 -165.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.05 -31.49 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 112.603 0.594 . . . . 65.2 112.603 -171.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -76.38 -44.0 38.26 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.097 -0.377 . . . . 73.21 111.183 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.84 -22.18 66.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.49 0.716 . . . . 75.42 111.435 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -74.29 -46.21 42.64 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.427 -1.323 . . . . 73.11 107.427 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 27' ' ' ILE . 54.0 mt -70.92 -30.78 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 113.46 -1.7 . . . . 74.21 113.318 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -63.93 -46.81 83.11 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 122.819 0.448 . . . . 73.31 110.536 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.87 -35.54 47.93 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 114.617 0.607 . . . . 72.34 114.617 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -69.11 -26.18 64.78 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.165 0.586 . . . . 75.14 111.526 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.07 -23.94 58.41 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 116.078 -0.51 . . . . 64.43 113.09 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.454 ' HE1' ' HB ' ' A' ' 116' ' ' ILE . 3.6 m-30 -86.0 5.7 32.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.787 0.835 . . . . 74.53 110.955 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.1 t -85.46 129.84 34.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.484 0.713 . . . . 74.5 110.41 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 23.5 p-10 -62.77 -16.13 56.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.995 0.739 . . . . 72.32 112.995 -175.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 43.1 tp -61.5 -59.7 4.84 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.013 0.525 . . . . 74.43 110.681 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.8 -36.94 65.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.949 0.722 . . . . 75.14 112.949 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 66' ' ' ASN . 4.2 mm? -63.95 -30.51 71.58 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.349 0.87 . . . . 71.13 113.349 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -92.02 -40.59 11.01 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.718 -0.614 . . . . 70.04 112.189 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' HG3' ' H ' ' A' ' 72' ' ' PHE . 10.3 pt-20 -78.04 -54.69 5.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.097 1.147 . . . . 74.24 114.097 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.486 ' H ' ' HG3' ' A' ' 71' ' ' GLU . 83.5 m-85 -83.89 -59.06 2.53 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.115 0.871 . . . . 74.22 113.076 171.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.51 ' HE1' HD21 ' A' ' 107' ' ' LEU . 61.6 t80 -55.67 -46.63 77.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.213 1.19 . . . . 72.34 114.213 -166.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.8 m -71.03 -55.96 6.05 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.445 0.906 . . . . 73.52 113.445 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.02 -28.32 19.39 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.931 1.754 . . . . 71.0 112.999 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.418 ' HD1' ' HG2' ' A' ' 80' ' ' LYS . 91.0 m-85 -94.06 140.96 23.06 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 122.822 0.449 . . . . 75.45 110.77 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.4 Cg_exo -54.29 146.11 52.24 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.088 2.525 . . . . 62.12 113.515 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.425 ' ND2' ' HA ' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -30.48 -46.69 0.08 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 123.62 0.768 . . . . 55.02 112.934 156.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.458 ' HA ' HD13 ' A' ' 82' ' ' ILE . 21.4 m -70.59 -23.84 62.65 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.334 0.654 . . . . 73.22 112.601 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HG2' ' HD1' ' A' ' 76' ' ' TYR . 53.5 tptt -91.14 -28.32 17.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.19 0.519 . . . . 74.2 110.382 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 77' ' ' PRO . 84.7 t -62.86 -27.51 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.791 0.836 . . . . 71.43 110.038 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 79' ' ' THR . 81.5 mt -65.88 -47.52 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.098 0.959 . . . . 62.14 112.626 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.587 ' HG3' ' H ' ' A' ' 84' ' ' LEU . 7.2 pt-20 -78.51 -57.8 3.58 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.908 0.322 . . . . 73.23 110.818 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.587 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 97.0 mt -43.85 -31.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.774 1.398 . . . . 74.42 114.774 161.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.33 -49.72 8.07 Favored Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.855 -0.498 . . . . 73.1 111.855 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.656 HG23 HD11 ' A' ' 90' ' ' LEU . 88.3 m -59.88 -31.55 69.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.673 1.189 . . . . 75.44 112.277 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -75.84 -57.16 4.04 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.598 -0.689 . . . . 75.01 111.486 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.7 m170 -50.9 -30.58 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.979 1.474 . . . . 74.41 114.979 172.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -101.52 -68.62 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.233 0.827 . . . . 72.35 113.233 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.656 HD11 HG23 ' A' ' 86' ' ' THR . 66.0 mt -71.42 -28.36 63.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.853 0.686 . . . . 73.33 112.853 -173.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.99 33.63 20.44 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 122.94 0.15 . . . . 65.21 112.788 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.82 -177.05 6.13 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.172 0.989 . . . . 73.44 110.782 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.19 165.42 13.9 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.532 0.733 . . . . 75.14 109.74 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.75 173.73 4.38 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.272 1.982 . . . . 73.12 111.973 169.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.423 ' HB ' ' H ' ' A' ' 96' ' ' ASP . 20.3 mt -119.04 -86.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 121.127 0.489 . . . . 74.25 109.992 -167.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.423 ' H ' ' HB ' ' A' ' 95' ' ' ILE . 26.9 t70 -88.63 172.41 9.31 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.961 -1.125 . . . . 73.44 107.961 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 2.8 tp-100 -74.9 -10.1 59.17 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 121.441 1.928 . . . . 74.14 109.59 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.75 84.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.851 0.86 . . . . 73.35 110.563 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.8 -54.11 46.4 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.903 0.881 . . . . 72.14 110.289 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.434 ' HA ' HG21 ' A' ' 82' ' ' ILE . 75.6 mt -64.71 -36.17 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-N 114.818 -1.083 . . . . 74.42 112.275 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.528 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 70.3 mtp180 -74.54 -38.84 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.851 0.46 . . . . 74.15 109.913 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.35 -56.44 18.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.233 -0.894 . . . . 73.21 110.921 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -61.49 -52.74 63.24 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.387 0.514 . . . . 74.35 112.387 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.425 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 14.2 t-20 -43.73 -48.23 7.97 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 115.394 -0.821 . . . . 60.21 112.676 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -73.3 -41.03 64.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.856 0.462 . . . . 74.13 111.705 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.9 mt -59.83 -55.18 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 124.081 0.952 . . . . 75.21 111.637 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.51 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.3 tt -50.98 -53.14 35.78 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.038 0.935 . . . . 65.24 112.204 170.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.35 78.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.44 0.533 . . . . 75.1 112.44 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.0 p -68.31 -53.03 27.03 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.109 0.781 . . . . 73.31 113.109 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -101.53 -62.32 1.27 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.654 0.782 . . . . 74.0 112.262 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -172.8 31.8 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.97 0.348 . . . . 73.33 113.97 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.411 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.2 tp -68.74 -33.71 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.903 0.881 . . . . 73.05 112.209 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -65.07 -55.86 16.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.701 0.4 . . . . 73.53 110.69 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -50.1 -30.93 12.05 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 114.713 -1.131 . . . . 74.25 113.451 168.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -75.67 -42.9 49.92 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.272 0.629 . . . . 74.32 112.201 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.454 ' HB ' ' HE1' ' A' ' 64' ' ' TYR . 46.3 mm -72.52 -52.3 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.01 0.524 . . . . 73.22 109.718 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -43.63 -38.24 2.96 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.7 1.2 . . . . 72.41 113.112 166.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.85 76.61 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.021 0.528 . . . . 73.54 112.404 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 78.1 mt -83.99 -59.9 2.27 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.603 0.761 . . . . 74.34 110.841 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 t -44.95 -50.89 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.584 1.554 . . . . 74.34 113.216 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -100.3 17.47 21.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.402 0.519 . . . . 62.54 112.402 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.9 p -74.03 164.15 26.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.951 -0.759 . . . . 74.01 108.951 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.41 -22.51 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.965 -0.46 . . . . 71.43 111.669 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.46 -53.31 44.57 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.335 0.494 . . . . 73.51 112.335 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -61.6 -40.46 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.153 -0.684 . . . . 73.32 109.153 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -57.93 -42.7 85.38 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.164 0.986 . . . . 71.2 112.69 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.99 -47.38 11.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.773 -0.579 . . . . 71.24 112.013 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.4 -41.38 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.925 0.49 . . . . 72.54 111.987 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 36.9 m-85 -116.01 -68.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.822 0.449 . . . . 73.14 110.669 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.51 -127.56 9.13 Favored Glycine 0 C--N 1.347 1.139 0 C-N-CA 123.227 0.442 . . . . 73.44 112.403 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -88.86 -73.12 0.51 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.41 0.684 . . . . 73.23 111.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 36.0 m-20 -102.35 66.6 0.99 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.548 0.69 . . . . 72.43 112.835 -171.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.9 m -148.32 124.43 10.76 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.043 -0.981 . . . . 75.54 109.495 173.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.68 138.23 83.08 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.251 0.62 . . . . 74.13 109.936 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.436 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 52.4 Cg_exo -53.6 89.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 123.152 2.568 . . . . 74.44 113.319 173.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -73.19 169.26 17.43 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.17 -0.923 . . . . 71.42 111.456 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -59.87 93.29 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.211 -0.904 . . . . 74.43 112.047 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -77.75 -26.73 50.11 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.351 0.596 . . . . 73.43 109.961 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -95.61 149.49 36.16 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.235 1.014 . . . . 74.21 109.593 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.75 2.55 4.57 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.749 2.299 . . . . 72.31 113.949 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.0 p 53.86 57.98 5.51 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.449 1.5 . . . . 73.45 111.699 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.11 81.04 6.45 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.229 -0.896 . . . . 71.43 111.706 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -130.55 103.15 6.47 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.398 1.079 . . . . 65.44 108.765 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -72.52 -22.0 61.1 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.215 0.606 . . . . 75.23 112.174 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -61.08 112.83 2.25 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.999 0.519 . . . . 75.52 110.888 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -69.12 95.31 0.73 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 109.479 -0.563 . . . . 75.04 109.479 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -107.71 171.74 7.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.471 0.708 . . . . 75.53 111.27 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.98 165.79 19.35 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.026 0.931 . . . . 63.02 110.385 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 112.364 0.505 . . . . 74.52 112.364 -169.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.57 -0.159 . . . . 74.51 110.57 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -136.15 170.74 15.52 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.702 0.801 . . . . 75.33 110.804 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 t -78.92 -32.92 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.355 0 CA-C-N 115.574 -0.739 . . . . 71.2 109.393 165.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.67 -0.3 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 126.211 1.805 . . . . 70.04 113.196 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 18.7 ptmt -47.32 113.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.284 1.433 . . . . 74.25 114.061 -171.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.502 ' NH1' HD21 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -51.28 94.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.337 1.606 . . . . 75.32 115.337 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.679 HG11 ' H ' ' A' ' 8' ' ' ALA . 2.9 t -45.89 178.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.223 0 C-N-CA 126.046 1.738 . . . . 72.23 112.514 162.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.679 ' H ' HG11 ' A' ' 7' ' ' VAL . . . -73.96 132.32 42.31 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 107.598 -1.26 . . . . 73.53 107.598 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -13.5 74.6 0.0 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 117.85 1.9 . . . . 64.45 117.85 -158.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -67.38 134.28 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.236 0.614 . . . . 75.22 110.679 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -83.33 -13.41 55.1 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.537 0.735 . . . . 72.12 112.523 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.92 112.47 18.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.924 0.489 . . . . 72.44 110.759 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.39 -10.88 37.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.438 0.695 . . . . 74.51 112.026 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.11 -51.44 13.45 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.439 0.638 . . . . 71.21 109.634 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.5 71.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.683 -1.144 . . . . 72.52 112.378 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 41.1 mm -78.25 -48.79 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.467 0.707 . . . . 74.35 110.783 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -67.4 -44.81 77.94 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.653 0.781 . . . . 63.45 113.008 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.3 m -63.37 -37.84 88.82 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.335 0.654 . . . . 70.31 111.889 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.502 HD21 ' NH1' ' A' ' 6' ' ' ARG . 11.4 tp -53.0 -51.56 61.24 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.747 -1.115 . . . . 74.24 110.103 169.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.85 -37.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.955 1.302 . . . . 75.14 113.121 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.1 p -69.19 -53.06 21.95 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.587 0.355 . . . . 71.55 111.149 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.86 -26.46 65.85 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 113.33 0.863 . . . . 71.42 113.33 171.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.57 -33.88 74.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 123.473 0.483 . . . . 75.03 110.758 172.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -78.78 -49.21 13.39 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.691 . . . . 62.51 111.834 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.9 mtp85 -50.0 -26.07 3.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.842 1.793 . . . . 75.01 115.842 -168.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 -58.53 2.54 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 118.34 0.518 . . . . 51.34 110.239 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.47 -55.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.555 0.742 . . . . 72.52 110.5 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.89 -27.02 67.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.422 0.689 . . . . 74.22 112.594 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 67.63 32.44 5.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.615 1.198 . . . . 73.5 109.588 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.449 ' NH2' ' HG3' ' A' ' 71' ' ' GLU . 18.9 ptp180 -168.23 150.73 5.41 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.945 -1.48 . . . . 75.13 110.36 -173.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.22 108.89 5.61 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.822 -0.627 . . . . 74.2 110.286 165.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.05 133.03 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.946 -0.761 . . . . 75.23 108.946 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.25 138.1 95.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.837 -0.601 . . . . 71.45 110.6 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.61 -43.09 23.33 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.839 3.026 . . . . 75.21 114.992 -170.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -70.11 -32.9 71.16 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 112.764 0.653 . . . . 74.1 112.764 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -72.85 -42.31 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.269 0.628 . . . . 63.04 110.953 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.48 -36.35 83.48 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.247 0.619 . . . . 75.42 112.164 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 42' ' ' SER . 3.7 pt20 -79.4 -36.26 39.39 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.909 -0.587 . . . . 74.22 112.077 -176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -81.66 -43.87 17.95 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.223 0.823 . . . . 73.02 113.223 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.59 -60.33 2.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.757 0.423 . . . . 74.31 111.787 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -89.67 38.04 0.9 Allowed 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.651 0.982 . . . . 74.54 113.651 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 38' ' ' GLN . 90.7 p -72.08 -49.83 33.27 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.69 0.396 . . . . 71.21 111.326 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 47' ' ' LYS . . . -69.5 -27.4 73.53 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 123.259 0.457 . . . . 62.22 113.112 174.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -81.63 -39.38 24.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.221 1.009 . . . . 74.43 110.63 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.58 -29.29 67.8 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.337 0.655 . . . . 61.35 111.668 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -65.83 -36.54 83.76 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.665 0.786 . . . . 60.14 111.87 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 43' ' ' GLY . 26.9 mtpp -67.74 -37.85 82.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.912 0.885 . . . . 75.43 111.076 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.0 -37.56 75.73 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.95 0.9 . . . . 70.41 110.862 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.67 -28.68 68.77 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-N 115.988 -0.551 . . . . 74.33 113.753 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -87.84 4.47 44.42 Favored 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 124.173 0.989 . . . . 71.23 111.043 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 50.09 33.6 22.46 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 115.422 0.929 . . . . 61.24 115.422 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -71.29 -80.03 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.077 -0.712 . . . . 74.33 109.077 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -63.04 -164.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 113.962 1.097 . . . . 75.52 113.962 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.2 p -127.58 172.57 10.62 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.211 -1.403 . . . . 62.03 107.211 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.11 -32.39 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 O-C-N 121.833 -0.542 . . . . 75.31 110.039 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -64.72 -38.96 92.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.744 0.818 . . . . 74.44 111.584 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.28 -26.06 42.39 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.679 0.792 . . . . 75.24 109.654 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -62.2 -49.08 77.21 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.235 1.014 . . . . 73.33 110.306 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.91 -28.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 125.202 1.401 . . . . 75.01 112.656 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.8 -42.02 96.78 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.472 0.709 . . . . 71.43 109.764 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.26 -23.61 58.57 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 114.501 0.56 . . . . 63.33 114.501 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.2 mt -68.91 -40.75 78.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.189 0.518 . . . . 73.41 110.147 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.33 -24.6 63.74 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-N 114.846 -1.07 . . . . 62.35 114.027 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -84.84 -12.68 53.02 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.691 0.796 . . . . 75.31 112.487 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -74.98 121.9 22.67 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.946 0.498 . . . . 72.22 111.19 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.23 -15.63 26.37 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.167 0.987 . . . . 64.12 113.503 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.5 tp -59.65 -61.35 2.69 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.209 0.458 . . . . 61.53 112.048 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -51.63 -38.78 56.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 112.771 0.656 . . . . 73.41 112.771 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 3.0 mm? -69.6 -26.59 64.52 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.245 0.831 . . . . 74.2 113.245 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.33 -49.28 72.34 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.756 -1.215 . . . . 73.41 108.994 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HG3' ' NH2' ' A' ' 30' ' ' ARG . 3.2 mm-40 -64.66 -56.89 10.9 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 114.333 -1.303 . . . . 65.42 112.73 172.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.06 69.34 0.72 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.68 0.993 . . . . 72.31 113.68 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 42.4 t80 -170.68 -56.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.013 1.325 . . . . 62.22 108.663 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.2 p -69.97 -39.7 11.46 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.469 1.285 . . . . 63.42 114.469 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.51 -42.61 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.928 0 CA-C-N 122.147 1.802 . . . . 75.24 112.632 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.46 147.67 82.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.546 1.138 . . . . 74.44 112.057 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.21 148.12 84.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.21 1.94 . . . . 75.51 111.55 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -52.38 -49.74 63.82 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.146 0.978 . . . . 71.21 112.807 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 82' ' ' ILE . 59.7 m -51.71 -44.01 63.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.597 0.962 . . . . 74.41 113.597 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -65.04 -37.13 86.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.984 0.514 . . . . 74.05 111.837 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.29 -24.53 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 122.887 0.475 . . . . 74.21 111.286 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 79' ' ' THR . 90.6 mt -72.03 -54.31 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.208 0.603 . . . . 71.01 111.682 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.66 -23.54 67.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.241 0.544 . . . . 71.03 111.768 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tt -79.85 -45.75 18.11 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.777 1.231 . . . . 74.45 108.684 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.84 -54.26 29.38 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.001 -0.999 . . . . 61.4 114.358 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.542 ' HA ' HD13 ' A' ' 119' ' ' LEU . 34.6 p -54.64 -39.52 68.06 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.201 0.6 . . . . 72.14 112.145 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.05 -37.84 61.93 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 113.449 0.907 . . . . 71.21 113.449 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -88.05 13.68 10.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.617 0.969 . . . . 73.03 113.617 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.74 -69.75 0.51 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.577 0.751 . . . . 70.13 109.677 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.78 -19.91 63.01 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.472 1.109 . . . . 74.53 112.781 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.34 87.49 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 114.351 0.501 . . . . 74.32 114.351 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.42 174.92 14.68 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 123.299 0.64 . . . . 73.44 110.721 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.45 160.76 78.89 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 124.001 0.92 . . . . 64.44 111.321 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -55.44 -174.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.038 2.492 . . . . 65.41 114.486 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.405 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 68.5 mt -97.43 -24.34 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 75.21 110.333 -164.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 179.23 -174.86 0.22 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.222 1.409 . . . . 74.15 109.316 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -76.94 -35.06 57.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.665 0.386 . . . . 72.34 111.929 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.45 -35.03 75.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.85 0.46 . . . . 74.44 111.421 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 19.8 tp10 -57.58 -47.48 82.0 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.726 0.81 . . . . 75.02 110.558 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.11 -46.87 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 124.094 0.957 . . . . 73.24 112.022 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -67.57 -30.58 70.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.392 0.886 . . . . 73.31 113.392 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -53.75 -47.45 70.66 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.467 0.707 . . . . 74.43 110.865 166.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -78.23 -22.17 48.84 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.701 -1.136 . . . . 74.12 111.056 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -74.68 -41.96 59.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.651 1.181 . . . . 72.11 110.72 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -72.11 -49.85 32.86 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.77 0.828 . . . . 73.45 111.267 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 87.6 mt -56.86 -37.22 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 124.466 1.106 . . . . 74.53 111.679 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.06 -49.68 34.53 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.698 0.799 . . . . 74.15 110.953 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.37 95.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.722 0.809 . . . . 70.1 112.634 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.8 p -75.59 -65.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 74.34 112.459 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -87.6 -37.31 16.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.795 0.838 . . . . 75.42 112.953 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 173.51 13.2 Favored Glycine 0 C--N 1.346 1.132 0 C-N-CA 122.002 -0.142 . . . . 62.53 112.98 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 116' ' ' ILE . 9.9 tp -61.29 -30.66 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 123.158 0.583 . . . . 73.21 110.417 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -56.58 -40.48 75.3 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.533 1.133 . . . . 74.53 112.749 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.5 55.7 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.041 0.537 . . . . 75.22 111.386 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 57.9 t80 -65.12 -50.8 64.66 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.75 0.82 . . . . 74.4 110.324 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 112' ' ' ILE . 49.2 mm -59.78 -44.3 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.16 0.984 . . . . 73.4 110.943 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -56.89 -39.73 74.94 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.977 0.911 . . . . 65.33 111.889 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.2 77.72 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.324 0.65 . . . . 74.54 112.26 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 86' ' ' THR . 13.6 mt -79.76 -39.17 31.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.166 0.587 . . . . 74.52 110.937 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.45 -34.2 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.491 0.716 . . . . 63.2 111.176 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -99.7 22.89 10.31 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.368 0.667 . . . . 74.12 112.385 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.4 t -83.03 132.56 35.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.157 0.583 . . . . 65.31 110.773 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -44.34 -37.55 3.39 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.315 1.228 . . . . 73.12 114.315 170.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.33 -41.1 92.83 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-N 118.31 0.505 . . . . 72.41 111.322 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -73.79 -53.88 9.29 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.877 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -69.7 -27.59 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.045 0.757 . . . . 74.31 113.045 -172.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.51 -47.19 34.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.831 0.453 . . . . 74.43 112.169 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.9 -51.78 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.341 0.591 . . . . 75.34 111.273 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -77.1 -67.54 0.7 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.075 0.95 . . . . 75.03 111.12 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.61 -148.12 16.5 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.658 0.623 . . . . 74.41 114.658 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -114.89 -23.73 8.98 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.849 0.859 . . . . 72.15 111.841 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.76 -32.55 12.66 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.314 1.046 . . . . 74.35 113.65 -158.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' LYS . 9.9 t -98.66 165.98 11.54 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.304 0.853 . . . . 70.33 113.304 -165.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.456 HG22 HD11 ' A' ' 19' ' ' LEU . 6.6 t -83.51 142.27 42.92 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 124.164 0.986 . . . . 74.03 108.766 165.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.98 83.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.901 2.4 . . . . 74.44 113.32 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -68.55 136.06 52.51 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 114.08 -1.418 . . . . 74.51 108.711 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -71.64 120.19 16.87 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 108.392 -0.966 . . . . 73.44 108.392 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -52.59 -29.0 23.51 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 124.878 1.271 . . . . 75.33 112.61 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -119.91 143.84 36.1 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.784 1.234 . . . . 73.44 108.534 167.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 146' ' ' HIS . 73.0 Cg_endo -79.44 38.21 0.72 Allowed 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 122.491 2.128 . . . . 72.21 113.598 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m 63.12 10.15 4.35 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 125.43 1.492 . . . . 64.11 112.319 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp 56.19 26.05 9.88 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 124.308 1.043 . . . . 72.25 111.857 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.71 -76.07 0.28 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.403 1.081 . . . . 73.21 110.336 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -145.84 165.57 28.48 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.019 1.328 . . . . 74.14 108.64 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 77.7 t60 60.2 57.7 2.87 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 121.778 0.799 . . . . 64.44 111.435 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.539 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 1.6 p-80 -67.36 107.03 2.27 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.886 -0.597 . . . . 74.31 109.774 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.98 86.19 0.71 Allowed 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 122.367 1.08 . . . . 75.3 112.575 -170.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -78.66 94.71 5.1 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.417 -1.265 . . . . 71.33 109.564 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 t60 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.172 0.511 . . . . 73.24 110.303 -174.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 120.593 0.235 . . . . 64.54 110.526 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -72.11 93.46 1.42 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.387 0.613 . . . . 74.04 110.21 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -91.34 114.14 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.593 0.757 . . . . 73.51 110.886 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -80.44 104.98 11.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.368 0.604 . . . . 73.14 110.123 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HB3' HG21 ' A' ' 133' ' ' THR . 19.6 ptmt -149.16 168.56 22.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.997 0.919 . . . . 74.44 110.144 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 ttp85 -119.4 106.64 12.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.729 -0.471 . . . . 73.23 109.729 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.585 HG11 ' H ' ' A' ' 8' ' ' ALA . 3.3 t -79.0 -149.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.959 0 C-N-CA 124.083 0.953 . . . . 75.31 109.13 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.585 ' H ' HG11 ' A' ' 7' ' ' VAL . . . -85.43 -81.28 0.2 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 119.945 1.248 . . . . 71.42 109.767 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -32.29 -30.22 0.01 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.001 2.76 . . . . 73.15 120.001 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.532 HD11 ' H ' ' A' ' 7' ' ' VAL . 50.8 mt -64.99 105.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 119.855 1.828 . . . . 75.05 110.558 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -155.47 24.62 0.4 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.527 1.131 . . . . 74.34 108.756 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.51 ' O ' HG12 ' A' ' 16' ' ' ILE . 3.8 m-20 -100.01 142.72 31.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.141 1.376 . . . . 73.22 108.891 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HZ3' ' HG2' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -67.0 -39.23 87.06 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 120.945 1.702 . . . . 75.23 112.631 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.54 66.49 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 122.367 1.08 . . . . 74.24 112.231 171.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 10' ' ' ILE . . . -76.62 -38.92 53.91 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 112.978 -1.919 . . . . 70.54 111.071 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.617 HG13 ' HA2' ' A' ' 49' ' ' GLY . 51.0 mm -81.21 -39.62 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 N-CA-C 114.029 1.122 . . . . 71.24 114.029 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.605 ' HZ1' ' HB3' ' A' ' 38' ' ' GLN . 28.1 mtpp -74.59 -50.86 16.29 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.109 -0.994 . . . . 75.23 111.347 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 m -49.12 -21.57 0.77 Allowed 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.124 -1.398 . . . . 63.14 113.168 164.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 16' ' ' ILE . 7.8 tt -81.43 -42.98 19.55 Favored 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 123.588 0.755 . . . . 74.31 110.659 169.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 16' ' ' ILE . 85.5 mt -75.18 -48.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 N-CA-C 116.494 2.035 . . . . 73.54 116.494 -171.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.471 ' HA ' ' CD2' ' A' ' 24' ' ' TYR . 44.0 m -66.67 -39.24 88.09 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.702 1.239 . . . . 74.02 109.882 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.94 -28.23 22.58 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 111.58 -2.554 . . . . 71.11 111.708 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.39 24.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.719 0.808 . . . . 73.42 111.763 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' A' ' 21' ' ' SER . 21.6 m-85 -68.98 -52.48 28.44 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 120.98 0.419 . . . . 74.2 110.914 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -46.98 -16.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.539 1.311 . . . . 75.05 114.539 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.474 HE22 ' HA ' ' A' ' 88' ' ' HIS . 13.0 tm0? -87.48 -61.16 1.78 Allowed 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.144 0.577 . . . . 72.11 109.627 166.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 59' ' ' ILE . 61.7 mt -78.15 -65.46 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 124.509 1.123 . . . . 73.2 113.119 -170.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.507 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 66.4 m-85 -74.87 -9.64 58.73 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.032 0.933 . . . . 75.03 112.476 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 76.33 -56.02 0.58 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.988 1.715 . . . . 70.44 112.914 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -84.07 156.33 22.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.95 0.9 . . . . 72.31 112.927 -165.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -62.84 120.01 10.48 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.569 -1.196 . . . . 75.25 109.717 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.4 mt -109.65 120.24 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.454 -1.684 . . . . 72.04 106.454 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 134.06 72.29 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 123.929 0.768 . . . . 61.32 112.06 -172.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.33 -31.02 36.02 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.811 3.007 . . . . 71.11 115.164 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -75.89 -39.05 57.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.722 0.409 . . . . 73.43 111.989 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -47.77 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 122.735 0.414 . . . . 75.22 110.205 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.06 79.19 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.111 0.964 . . . . 70.55 112.561 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.605 ' HB3' ' HZ1' ' A' ' 17' ' ' LYS . 1.8 pt20 -75.42 -25.03 57.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.252 0.464 . . . . 74.42 112.252 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.29 -47.56 15.65 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 117.987 0.358 . . . . 75.54 111.622 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -66.07 -51.21 60.18 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.469 0.708 . . . . 74.12 111.168 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.22 48.23 0.85 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.054 -0.976 . . . . 74.43 110.373 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -64.97 -51.88 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.246 0.462 . . . . 65.51 112.246 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -31.29 58.5 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.045 -0.525 . . . . 71.25 113.287 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -72.22 -50.96 23.36 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.254 0.622 . . . . 73.33 111.494 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.556 ' HG2' ' HZ3' ' A' ' 13' ' ' LYS . 35.7 tt0 -50.36 -37.91 39.61 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.503 0.927 . . . . 74.3 113.503 165.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.6 m -65.82 -35.6 81.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.484 0.314 . . . . 74.13 111.495 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -65.08 -42.38 94.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.218 0.451 . . . . 74.3 112.218 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.77 -50.7 33.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 120.755 0.312 . . . . 73.34 111.056 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.617 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -50.58 -51.36 33.03 Favored Glycine 0 CA--C 1.545 1.909 0 N-CA-C 116.285 1.274 . . . . 65.44 116.285 174.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 2.2 m-20 -73.11 0.19 12.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.925 1.083 . . . . 73.31 113.925 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.33 26.29 67.74 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.745 0.658 . . . . 54.23 114.745 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.0 mm-40 -67.61 -29.94 69.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.941 0.896 . . . . 75.42 111.164 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.421 HD11 ' HD1' ' A' ' 58' ' ' PHE . 21.1 pt -132.77 156.67 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.518 1.127 . . . . 72.42 108.93 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 57' ' ' GLU . 10.2 t -82.04 166.86 19.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.028 -0.42 . . . . 73.43 110.738 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -61.79 -38.31 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.717 0.407 . . . . 73.33 111.172 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 57' ' ' GLU . 1.1 tmtp? -56.79 -58.79 6.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.604 1.162 . . . . 72.51 112.137 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 21.8 tt0 -50.1 -34.57 22.35 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 114.375 -1.284 . . . . 72.13 111.983 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.421 ' HD1' HD11 ' A' ' 53' ' ' ILE . 59.8 t80 -71.48 -38.03 71.26 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 123.399 0.68 . . . . 75.42 112.211 173.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 27' ' ' ILE . 22.4 mm -73.36 -50.24 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 124.731 1.213 . . . . 75.11 111.696 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' HB2' HG13 ' A' ' 120' ' ' VAL . 31.9 tt0 -51.02 -41.43 59.8 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.487 1.115 . . . . 73.02 110.878 163.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.21 -38.9 62.64 Favored Glycine 0 CA--C 1.55 2.219 0 CA-C-N 112.438 -2.164 . . . . 74.12 112.98 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 80.9 mt -77.15 -36.02 55.59 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.068 0.947 . . . . 73.41 112.328 176.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.68 -21.85 61.12 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 114.31 0.484 . . . . 64.52 114.31 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -77.44 -34.18 54.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.502 0.721 . . . . 71.24 111.831 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 t -48.04 140.55 6.9 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.473 1.286 . . . . 73.34 114.473 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -62.02 -30.09 70.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.696 1.199 . . . . 63.22 113.423 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 tp -69.43 -24.27 63.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.399 0.619 . . . . 73.32 111.593 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.92 -34.87 57.67 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.13 -0.941 . . . . 73.11 108.752 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 -51.31 20.05 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.882 -1.053 . . . . 71.14 113.697 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 12.7 ptpt -64.15 -55.66 20.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.995 2.18 . . . . 72.34 115.234 172.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -51.51 -22.69 3.35 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.629 1.714 . . . . 73.4 115.629 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -137.44 -19.62 1.22 Allowed 'General case' 0 N--CA 1.514 2.768 0 N-CA-C 116.939 2.2 . . . . 73.03 116.939 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.433 ' HA ' HG21 ' A' ' 81' ' ' VAL . 85.8 t80 -110.83 -37.49 5.4 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.512 1.051 . . . . 73.33 112.773 -176.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.9 m -71.52 -46.74 13.17 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 114.332 1.234 . . . . 73.34 114.332 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.4 Cg_endo -84.08 -15.02 6.97 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.784 2.323 . . . . 75.45 112.408 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.6 140.21 21.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.66 0.784 . . . . 74.24 110.91 -172.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.01 151.93 82.65 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.148 1.899 . . . . 73.03 111.447 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -45.74 -28.42 1.03 Allowed 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.859 1.264 . . . . 73.12 112.605 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 m -61.61 -52.67 63.43 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.502 -1.681 . . . . 71.12 109.87 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD2' ' HB3' ' A' ' 83' ' ' GLU . 55.2 tptt -73.83 -26.87 60.82 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.182 0.993 . . . . 75.11 113.232 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.496 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 62.8 t -66.13 -25.16 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 122.955 0.502 . . . . 74.41 111.271 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 94' ' ' PRO . 46.3 mt -80.41 -28.53 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.164 0.985 . . . . 63.11 112.466 169.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' HB3' ' HD2' ' A' ' 80' ' ' LYS . 6.0 tm-20 -76.85 -51.92 10.42 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.453 0.701 . . . . 75.31 109.43 -172.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 87' ' ' LYS . 93.9 mt -75.53 -15.09 60.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.561 1.144 . . . . 74.32 109.829 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . -82.05 -49.8 5.15 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.02 -0.991 . . . . 72.2 114.026 -158.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -73.3 -19.21 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.973 1.387 . . . . 60.45 110.577 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 91.8 mttt -62.18 -33.31 74.3 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.015 -0.993 . . . . 75.11 111.371 -167.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.474 ' HA ' HE22 ' A' ' 26' ' ' GLN . 66.5 m-70 -87.88 13.11 11.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.854 0.862 . . . . 65.42 113.031 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -138.74 -58.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.531 -1.285 . . . . 75.02 107.531 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.542 ' HA ' HH12 ' A' ' 138' ' ' ARG . 0.2 OUTLIER -127.04 91.1 3.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.143 0.977 . . . . 74.11 108.978 164.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 87' ' ' LYS . . . -65.69 87.26 0.1 OUTLIER Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.656 -0.702 . . . . 75.51 113.015 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.482 HH21 ' HB3' ' A' ' 124' ' ' GLU . 4.4 ptp180 -143.31 24.46 1.77 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.925 0.49 . . . . 64.31 111.766 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.21 174.58 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.307 0.855 . . . . 72.31 113.307 -158.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HB3' HG23 ' A' ' 82' ' ' ILE . 61.5 Cg_endo -72.25 137.24 28.21 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.694 1.596 . . . . 62.22 110.518 161.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.92 -61.39 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.428 1.091 . . . . 74.53 112.134 -170.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -147.76 157.84 43.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.718 0.407 . . . . 75.12 111.005 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -63.25 -10.35 15.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.425 0.898 . . . . 72.11 113.425 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.96 -42.05 12.73 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.264 1.031 . . . . 74.2 108.389 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 102' ' ' LYS . 4.0 tm-20 -64.25 -32.47 74.07 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 113.759 -1.564 . . . . 74.55 111.62 170.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.88 -54.49 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 123.284 0.634 . . . . 64.31 110.024 173.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -46.55 -34.74 5.14 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 114.23 1.196 . . . . 71.2 114.23 167.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 31.6 ttpt -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.969 0.508 . . . . 74.43 112.035 175.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.15 -46.53 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.596 0.358 . . . . 74.44 110.607 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -44.86 -42.6 8.11 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.153 0.981 . . . . 74.42 112.962 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -64.88 -29.63 70.59 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.142 0.428 . . . . 72.14 111.777 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.9 mt -79.67 -57.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.086 -1.079 . . . . 70.14 108.086 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.6 tp -45.99 -35.0 4.38 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.422 1.638 . . . . 70.34 115.422 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.32 -21.57 53.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.032 0.752 . . . . 72.42 113.032 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.7 p -113.2 -14.46 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.093 0.557 . . . . 71.41 112.08 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -138.97 -51.8 0.55 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.692 0.797 . . . . 74.12 111.156 -170.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.86 169.85 13.68 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 114.258 0.463 . . . . 60.14 114.258 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.0 tp -37.74 -34.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.247 1.573 . . . . 75.0 115.247 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -53.39 -53.91 44.42 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.397 0.679 . . . . 74.41 111.508 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.34 37.65 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.543 -1.208 . . . . 74.21 112.033 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -50.64 -70.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.51 1.3 . . . . 75.34 114.51 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.44 -37.07 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 114.034 1.124 . . . . 72.54 114.034 170.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -67.14 -38.14 85.03 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.772 0.715 . . . . 74.4 111.218 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.19 -52.05 57.25 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 123.082 0.553 . . . . 75.44 111.806 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.2 mt -49.66 -54.55 17.92 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.445 0.906 . . . . 63.33 113.445 171.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 60' ' ' GLU . 89.9 t -69.11 -26.34 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 123.84 0.856 . . . . 73.44 112.694 -172.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -100.6 13.55 34.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.146 0.795 . . . . 73.24 113.146 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.3 m -66.92 151.01 48.4 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 122.863 0.465 . . . . 70.52 110.371 167.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 126' ' ' ASN . 29.9 tt0 -72.0 -25.24 61.76 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.0 0.818 . . . . 73.41 110.524 -174.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.482 ' HB3' HH21 ' A' ' 92' ' ' ARG . 41.4 mt-10 -62.15 -36.11 80.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.877 0.871 . . . . 71.4 111.329 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -67.69 -40.3 84.38 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 109.995 -0.372 . . . . 75.52 109.995 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.512 HD22 ' HG3' ' A' ' 123' ' ' GLN . 1.5 p30 -68.6 -38.4 80.58 Favored 'General case' 0 C--N 1.366 1.311 0 CA-C-O 118.673 -0.679 . . . . 74.11 112.025 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -60.87 -56.88 15.92 Favored 'General case' 0 C--N 1.367 1.337 0 N-CA-C 115.257 1.576 . . . . 75.21 115.257 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.98 -35.84 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.348 0.594 . . . . 74.43 111.397 -162.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -111.94 -45.35 3.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.517 -0.765 . . . . 75.5 110.688 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.62 -87.36 0.93 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.403 -1.479 . . . . 73.02 109.403 -162.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.25 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.134 0.973 . . . . 75.42 111.175 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -81.8 36.71 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.67 0.788 . . . . 70.02 112.385 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 5' ' ' LYS . 45.5 m -147.52 145.4 29.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.026 0.93 . . . . 75.22 110.051 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.05 132.83 82.2 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 108.65 -0.87 . . . . 74.42 108.65 172.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.0 81.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.598 2.199 . . . . 75.13 113.447 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -59.81 145.85 43.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.006 0.522 . . . . 74.41 111.18 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.455 ' NH1' ' HA ' ' A' ' 141' ' ' THR . 10.6 ttp180 -70.49 118.06 12.81 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.398 0.679 . . . . 75.54 110.848 -173.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.542 HH12 ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -65.31 -18.15 65.08 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.652 1.181 . . . . 74.25 113.315 -173.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -122.79 140.16 32.64 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.412 0.685 . . . . 74.23 111.288 -175.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.17 -31.14 27.69 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.587 2.858 . . . . 75.33 113.974 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.455 ' HA ' ' NH1' ' A' ' 137' ' ' ARG . 8.8 t -145.48 141.25 28.16 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.259 0.552 . . . . 73.42 111.966 172.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.5 mt -129.49 140.63 51.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.307 1.043 . . . . 74.11 108.859 171.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -69.38 95.26 0.78 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.119 0.568 . . . . 72.53 111.735 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -153.4 127.75 9.21 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.349 -0.841 . . . . 71.34 109.912 171.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -70.16 172.75 7.56 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.312 0.645 . . . . 75.21 111.146 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -100.91 151.5 21.67 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.265 0.626 . . . . 74.21 110.762 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -86.15 -26.44 25.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.778 0.831 . . . . 74.04 111.695 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 67.07 -68.16 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.076 1.35 . . . . 72.51 111.305 -172.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 N--CA 1.48 1.06 0 C-N-CA 124.187 0.995 . . . . 71.4 111.383 176.755 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 110.546 -0.168 . . . . 71.12 110.546 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -160.64 -40.71 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.535 0.334 . . . . 75.32 111.316 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t 48.82 86.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 124.642 1.177 . . . . 70.12 112.307 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -71.4 132.75 45.26 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.994 0.518 . . . . 75.31 110.101 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -152.6 159.84 43.22 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.502 . . . . 74.44 112.017 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.7 100.03 12.03 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.548 -0.908 . . . . 75.23 108.548 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 ' HB ' HG13 ' A' ' 10' ' ' ILE . 98.0 t -78.38 141.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.614 -0.514 . . . . 72.51 109.614 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.99 93.07 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.359 0.664 . . . . 64.01 111.845 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.15 2.01 6.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 119.457 -0.635 . . . . 72.33 114.462 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.4 HG13 ' HB ' ' A' ' 7' ' ' VAL . 35.2 mt -79.88 82.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.673 1.236 . . . . 75.51 109.951 172.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -107.03 13.22 27.76 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.02 -0.991 . . . . 72.33 110.077 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.85 116.5 22.78 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.547 1.139 . . . . 73.14 109.076 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.34 -24.11 63.86 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.925 1.083 . . . . 75.12 113.925 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.95 -31.18 70.73 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.077 0.465 . . . . 73.44 111.06 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -50.21 13.94 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.645 -0.707 . . . . 72.3 110.698 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.2 mm -55.65 -45.45 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.406 1.082 . . . . 72.21 113.191 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.486 ' HB3' ' HZ2' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -61.55 -39.54 91.44 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 111.988 0.366 . . . . 74.41 111.988 -177.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 m -62.74 -41.13 99.05 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.394 0.677 . . . . 75.53 112.053 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 48' ' ' LEU . 20.6 tp -61.78 -44.7 96.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.368 0.667 . . . . 74.4 111.086 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.16 -41.32 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.666 1.186 . . . . 73.11 111.147 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.6 m -62.94 -53.02 60.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.387 0.675 . . . . 71.5 111.287 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.62 82.16 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.714 0.806 . . . . 73.43 112.539 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.86 -42.93 72.64 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.123 0.569 . . . . 50.55 111.357 173.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.34 -43.72 85.33 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.278 0.631 . . . . 64.12 111.979 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -68.21 -13.2 62.06 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.334 0.654 . . . . 70.41 112.308 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -89.77 -63.13 1.33 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.771 0.428 . . . . 75.44 111.386 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -65.12 -57.78 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 122.662 0.385 . . . . 73.32 110.727 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -83.04 -13.05 56.58 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.291 0.636 . . . . 75.42 112.252 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 65.58 -53.44 0.36 Allowed 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.367 1.467 . . . . 74.32 114.108 -168.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -57.57 128.76 38.66 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.203 1.001 . . . . 71.32 113.022 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.0 120.31 13.42 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.117 -0.947 . . . . 75.14 109.515 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.79 126.7 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.378 -0.601 . . . . 74.44 109.378 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.34 135.23 96.15 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 123.649 0.593 . . . . 62.45 109.991 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 -35.1 86.82 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.409 2.739 . . . . 74.14 114.14 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -69.73 -38.8 77.01 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.484 0.314 . . . . 75.11 111.437 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 71.4 mt -63.05 -41.73 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.547 0.739 . . . . 73.23 110.269 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -53.22 59.77 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.084 -0.962 . . . . 55.12 111.855 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 38' ' ' GLN . 2.5 pt20 -79.6 -11.44 59.87 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.954 1.464 . . . . 72.44 114.954 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' A' ' 36' ' ' ILE . 8.4 p30 -81.66 -45.21 16.09 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.875 1.216 . . . . 74.44 110.797 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.77 -46.27 14.46 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.804 0.841 . . . . 74.14 111.609 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -105.8 44.3 1.05 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 124.657 1.183 . . . . 64.44 109.755 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -51.67 66.88 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.818 0.673 . . . . 72.41 112.818 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.05 -30.88 64.82 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.625 -0.716 . . . . 61.01 112.569 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.4 ' CZ2' ' HA3' ' A' ' 61' ' ' GLY . 13.8 t-105 -72.58 -42.05 65.02 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.305 1.042 . . . . 75.33 111.701 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.85 -50.44 73.43 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.443 1.097 . . . . 75.05 110.777 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.1 t -59.61 -43.79 93.63 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.014 -0.994 . . . . 62.03 111.786 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HG2' HG12 ' A' ' 53' ' ' ILE . 25.2 ttmm -58.83 -46.5 87.54 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.755 1.222 . . . . 75.14 112.553 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD23 HD21 ' A' ' 19' ' ' LEU . 48.4 tp -64.56 -44.71 89.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.778 0.431 . . . . 75.32 111.278 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.73 -39.97 98.16 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 116.36 -0.382 . . . . 62.32 113.863 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -79.96 6.49 11.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.109 0.964 . . . . 73.22 112.915 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.35 32.55 68.32 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 114.595 0.598 . . . . 75.24 114.595 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.14 -26.53 42.8 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.155 0.582 . . . . 74.42 109.531 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.416 HG12 ' HG2' ' A' ' 47' ' ' LYS . 40.5 pt -134.76 170.14 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 124.282 1.033 . . . . 74.22 110.764 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.6 p -95.58 -176.57 3.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.388 0.675 . . . . 71.1 109.637 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 59' ' ' ILE . 80.0 t -65.89 -45.81 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 119.27 -0.395 . . . . 74.24 110.927 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 51.0 tttm -47.43 -52.65 16.27 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.807 1.04 . . . . 73.34 113.807 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.72 -37.17 85.47 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.672 0.389 . . . . 61.43 111.707 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 50.7 t80 -61.22 -43.27 99.15 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.66 0.784 . . . . 71.42 111.124 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 55' ' ' VAL . 34.9 mm -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.829 1.252 . . . . 73.41 111.247 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -52.18 -45.48 65.14 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.597 0.759 . . . . 73.32 112.061 172.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' HA3' ' CZ2' ' A' ' 44' ' ' TRP . . . -62.84 -36.79 93.87 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.266 -0.425 . . . . 75.21 113.324 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 46.2 mt -64.69 -44.11 91.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.378 0.671 . . . . 73.54 111.551 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.39 -34.74 86.43 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 115.447 0.939 . . . . 74.34 115.447 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -74.71 -23.13 58.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.29 0.545 . . . . 75.54 112.011 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -55.85 134.44 51.88 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.502 0.926 . . . . 72.52 113.502 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -60.65 -26.2 66.88 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.269 1.028 . . . . 74.34 112.092 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.18 -39.53 93.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.964 0.506 . . . . 72.14 111.1 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -69.33 -39.25 78.28 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.19 0.519 . . . . 74.34 110.56 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 4.6 mm? -64.74 -31.19 72.3 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.655 -0.702 . . . . 74.14 112.132 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -75.23 -46.34 34.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.865 0.466 . . . . 75.51 111.287 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -82.68 -46.31 13.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.804 0.668 . . . . 74.42 112.804 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.56 48.64 1.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 112.772 0.656 . . . . 72.54 112.772 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 74.6 t80 -159.68 -48.37 0.05 Allowed 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 116.082 -0.508 . . . . 75.13 110.88 171.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 m -66.02 -47.28 63.36 Favored Pre-proline 0 CA--C 1.573 1.848 0 N-CA-C 112.815 0.672 . . . . 71.44 112.815 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -90.08 11.07 2.87 Favored 'Trans proline' 0 C--N 1.395 2.993 0 C-N-CA 122.638 2.225 . . . . 75.02 113.202 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.0 141.26 38.97 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 122.988 0.515 . . . . 72.33 111.861 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.29 158.24 58.32 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.501 2.134 . . . . 75.43 111.384 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -51.54 -41.99 61.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.573 0.582 . . . . 74.52 112.573 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.9 m -54.14 -42.85 70.0 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.514 0.726 . . . . 75.12 111.536 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -74.92 -33.17 61.94 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.061 0.545 . . . . 75.31 112.019 178.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.09 -31.96 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.231 0.539 . . . . 75.52 110.921 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.58 -49.73 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.795 0.838 . . . . 72.13 111.008 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 80' ' ' LYS . 13.4 pt-20 -71.18 -35.47 71.6 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 111.588 0.218 . . . . 73.03 111.588 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.94 -44.53 26.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.314 0.645 . . . . 75.45 110.99 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.38 -49.86 58.82 Favored Glycine 0 N--CA 1.475 1.265 0 O-C-N 123.292 0.37 . . . . 75.43 113.639 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.575 HG21 HD13 ' A' ' 90' ' ' LEU . 86.7 m -55.73 -40.39 72.41 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 123.033 0.533 . . . . 73.25 110.632 171.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -71.33 -21.77 62.0 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 123.075 0.55 . . . . 74.31 111.434 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 67.2 m170 -87.29 -8.57 56.59 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.03 0.932 . . . . 72.23 112.363 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.8 -61.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.389 1.076 . . . . 74.45 108.88 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -110.08 84.74 1.98 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.359 -1.348 . . . . 74.31 107.359 176.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.53 78.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 114.896 0.718 . . . . 51.51 114.896 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.593 HH12 HD13 ' A' ' 95' ' ' ILE . 27.8 mtm105 -137.94 151.43 47.96 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.375 1.07 . . . . 74.4 111.089 -174.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 132.02 85.85 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-N 115.471 -0.786 . . . . 64.33 110.748 168.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.27 135.91 46.28 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.31 2.673 . . . . 70.02 113.824 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.593 HD13 HH12 ' A' ' 92' ' ' ARG . 49.6 mm -82.69 -69.12 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.495 0.718 . . . . 75.55 112.76 -170.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -147.81 156.58 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.583 0.753 . . . . 72.12 109.073 -165.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -58.44 -40.31 82.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.954 0.724 . . . . 75.22 112.954 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.63 71.78 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.248 0.462 . . . . 74.14 112.248 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -65.7 -40.32 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.613 0.765 . . . . 75.33 110.919 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.03 -50.44 64.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.533 0.733 . . . . 73.21 110.968 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.2 mmm180 -52.05 -40.85 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.537 1.135 . . . . 73.42 112.386 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.42 ' O ' HG13 ' A' ' 106' ' ' ILE . 35.7 ttpt -56.39 -52.68 63.73 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.76 0.824 . . . . 74.24 111.194 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -72.24 -36.79 69.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.795 0.438 . . . . 74.45 112.167 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.47 -40.83 96.43 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.956 0.902 . . . . 74.24 111.296 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.415 HE21 HG23 ' A' ' 109' ' ' THR . 24.3 tp60 -67.6 -28.93 68.17 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.466 -0.788 . . . . 70.33 111.015 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 102' ' ' LYS . 82.2 mt -63.19 -39.14 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 122.991 0.516 . . . . 64.54 110.526 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.96 -39.92 96.11 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.836 0.454 . . . . 72.43 111.602 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.21 -37.32 53.63 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.716 0.635 . . . . 54.23 112.716 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.415 HG23 HE21 ' A' ' 105' ' ' GLN . 67.0 p -80.93 -60.15 2.41 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.193 0.597 . . . . 73.13 112.493 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -103.04 -36.23 8.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.0 0.92 . . . . 73.14 112.801 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.4 -162.01 12.51 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 122.847 0.261 . . . . 71.21 113.315 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.5 tp -79.69 -29.14 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.111 0.564 . . . . 75.44 111.476 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -49.42 77.82 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.384 0.673 . . . . 74.4 110.381 -175.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -33.3 73.88 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.128 -0.942 . . . . 74.3 112.738 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.21 -52.29 66.3 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.234 0.613 . . . . 73.52 111.328 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.83 -45.68 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.666 0.786 . . . . 74.14 110.718 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -57.94 -35.68 71.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.166 0.986 . . . . 72.12 111.387 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -67.55 -48.37 67.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.128 0.571 . . . . 73.12 111.387 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.487 ' HB3' HD12 ' A' ' 90' ' ' LEU . 82.0 mt -58.31 -44.74 88.73 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.617 0.767 . . . . 71.54 112.554 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.8 t -68.17 -52.19 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.079 0.952 . . . . 73.53 111.954 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.81 24.06 4.4 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.291 0.636 . . . . 62.1 112.155 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 19.6 t -79.53 155.4 28.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.577 0.751 . . . . 72.11 112.275 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.98 -52.58 64.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.691 0.796 . . . . 65.51 110.952 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.94 -30.84 66.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.852 0.861 . . . . 73.14 112.595 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -71.45 -54.26 11.23 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.218 0.207 . . . . 75.45 111.098 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -69.48 -34.3 74.13 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.961 0.726 . . . . 75.22 112.961 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.57 -42.58 58.51 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 111.682 0.252 . . . . 74.3 111.682 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.81 -54.79 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.289 0.636 . . . . 75.22 111.857 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.436 ' HE2' ' H ' ' A' ' 136' ' ' TYR . 52.9 m-85 -88.41 -49.29 7.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.164 0.986 . . . . 74.32 110.832 -176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 93.25 -118.91 5.77 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.218 -0.447 . . . . 71.42 112.546 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -141.31 -23.18 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.858 0.863 . . . . 74.22 111.615 176.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -84.13 -23.54 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.558 0.577 . . . . 62.0 112.558 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.2 m -93.74 138.09 32.31 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.277 0.473 . . . . 72.52 112.277 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.18 136.34 75.92 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.851 0.86 . . . . 73.1 109.678 168.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -34.77 111.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.586 3.524 . . . . 63.41 115.5 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.436 ' H ' ' HE2' ' A' ' 129' ' ' PHE . 52.9 p90 -120.23 147.06 45.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.395 0.678 . . . . 75.02 110.88 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.452 ' H ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -75.08 124.34 26.83 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.978 -0.555 . . . . 74.32 109.516 167.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -86.44 52.74 2.58 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.455 1.121 . . . . 73.14 109.861 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -144.61 140.83 16.94 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.231 1.012 . . . . 73.32 109.864 -173.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.83 18.73 1.23 Allowed 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.814 2.343 . . . . 75.25 113.995 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.0 p 55.97 24.31 7.55 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 125.466 1.506 . . . . 74.54 113.49 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.1 mt 56.54 48.84 15.86 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.97 0.908 . . . . 74.32 111.237 -173.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 56.85 15.47 2.27 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 126.099 1.76 . . . . 74.43 113.717 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -61.02 -42.97 99.48 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.95 0.5 . . . . 71.32 111.77 -172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -137.15 103.57 5.16 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.676 0.75 . . . . 75.53 110.892 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -116.91 111.74 20.06 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.275 1.03 . . . . 74.1 109.125 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 74.75 -39.73 0.42 Allowed 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.58 1.552 . . . . 74.12 112.28 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -63.53 103.62 0.55 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.207 1.003 . . . . 65.11 110.097 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 121.235 0.54 . . . . 74.42 111.532 -175.842 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.723 0.296 . . . . 71.02 110.388 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -92.19 57.19 3.0 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.305 1.05 . . . . 73.45 110.391 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.93 -21.91 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-N 114.66 -1.155 . . . . 73.43 110.893 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 70.15 29.14 3.83 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.193 1.397 . . . . 70.15 112.845 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HZ3' HG21 ' A' ' 7' ' ' VAL . 17.2 pttp -92.25 145.89 24.14 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.855 -0.528 . . . . 71.32 109.597 170.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -78.26 101.23 7.03 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.564 -0.532 . . . . 75.51 109.564 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.428 HG21 ' HZ3' ' A' ' 5' ' ' LYS . 49.5 t -68.02 113.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.29 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.144 0.978 . . . . 75.13 112.608 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.58 -18.02 4.4 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 115.436 -0.802 . . . . 74.33 114.267 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.43 104.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 117.903 0.852 . . . . 74.52 111.162 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -86.54 -38.22 17.41 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 75.01 111.406 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.01 102.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.78 1.232 . . . . 71.33 113.894 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.618 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 68.5 mttt -67.77 -9.19 41.9 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.542 -0.754 . . . . 75.42 112.54 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.04 -39.6 79.1 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.561 0.744 . . . . 75.52 110.91 163.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.64 43.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.745 0.818 . . . . 74.3 110.991 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 1.7 mp -58.0 -39.81 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.079 0.951 . . . . 75.32 110.827 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -64.71 -49.88 69.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.999 0.52 . . . . 71.35 111.467 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -54.39 -42.36 70.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.166 0.802 . . . . 75.2 113.166 172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 48' ' ' LEU . 9.6 tt -58.27 -48.41 80.53 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.171 0.988 . . . . 74.35 110.893 173.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.69 -43.24 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.386 1.074 . . . . 75.11 111.379 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.3 m -63.75 -48.68 76.04 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.347 0.659 . . . . 74.54 111.012 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.82 57.77 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.327 0.862 . . . . 74.2 113.327 170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.15 72.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.259 0.837 . . . . 55.31 113.259 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -72.96 -48.1 39.63 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.588 0.755 . . . . 75.25 111.227 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.4 ttm180 -51.02 -36.88 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.223 1.009 . . . . 65.11 113.668 172.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.21 -63.68 1.27 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.8 0.44 . . . . 70.14 110.576 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 59' ' ' ILE . 61.2 mt -65.32 -48.4 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.913 0.885 . . . . 75.21 112.452 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -84.35 9.63 12.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.258 0.623 . . . . 72.41 111.628 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 49.95 19.87 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 125.922 1.689 . . . . 72.31 115.183 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -164.12 143.51 7.75 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.416 0.626 . . . . 65.54 111.604 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.2 111.21 2.86 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.008 -0.996 . . . . 55.22 111.042 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.2 mt -78.89 134.89 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 116.105 -0.498 . . . . 72.24 109.968 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 123.8 52.98 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 124.254 0.971 . . . . 72.41 110.649 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -54.15 -37.84 87.47 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.526 2.817 . . . . 71.21 114.069 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -67.85 -24.91 65.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.663 0.785 . . . . 73.33 113.07 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.36 -44.45 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.213 0.605 . . . . 75.11 110.681 171.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.18 80.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.064 0.945 . . . . 65.45 112.195 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -72.55 -25.26 61.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.982 0.513 . . . . 65.42 111.833 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.31 -47.23 18.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.667 0.787 . . . . 70.01 110.977 -170.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.2 -32.89 59.22 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.633 -0.712 . . . . 72.41 110.764 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.37 43.08 1.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.902 0.881 . . . . 73.42 111.07 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -68.61 -43.91 75.39 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.163 0.585 . . . . 75.14 112.433 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.89 -26.89 61.52 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.844 -0.502 . . . . 42.32 111.844 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -82.21 -30.85 30.62 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.088 0.955 . . . . 75.11 110.483 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -68.79 -41.58 78.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.95 0.9 . . . . 73.41 108.862 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 t -57.09 -35.65 69.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.62 0.768 . . . . 71.4 111.92 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -42.6 99.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.9 0.48 . . . . 75.54 111.279 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD23 HD21 ' A' ' 19' ' ' LEU . 49.2 tp -73.24 -36.07 66.36 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.736 0.815 . . . . 60.32 111.503 177.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.7 -48.42 12.78 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 123.313 0.482 . . . . 72.32 113.153 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -78.26 3.15 16.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.744 0.646 . . . . 74.04 112.744 172.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.4 34.09 67.58 Favored Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.727 0.651 . . . . 74.22 114.727 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -68.46 -28.34 66.96 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.509 0.724 . . . . 73.44 111.58 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 pt -130.03 170.42 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.365 1.066 . . . . 73.44 110.362 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p -90.8 164.35 14.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.206 0.602 . . . . 74.22 110.258 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.73 -41.23 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.612 0.365 . . . . 74.11 110.46 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 87.0 tttt -41.78 -55.59 2.97 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.253 1.205 . . . . 75.12 114.253 162.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -66.07 -26.79 67.66 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.921 -0.581 . . . . 74.02 111.777 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -72.99 -38.36 66.68 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.166 0.986 . . . . 74.31 110.801 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.432 HG13 HD11 ' A' ' 27' ' ' ILE . 1.2 mp -73.41 -45.17 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.972 1.309 . . . . 73.21 111.829 -174.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.522 ' HB2' HG12 ' A' ' 120' ' ' VAL . 32.6 tt0 -50.28 -35.92 29.24 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.69 0.626 . . . . 74.21 112.69 165.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.45 -26.95 74.05 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-N 115.93 -0.577 . . . . 73.55 112.439 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -74.04 -48.34 30.64 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.999 0.92 . . . . 64.13 111.2 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.69 -31.65 45.82 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 116.308 1.283 . . . . 41.41 116.308 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -72.44 -17.86 61.75 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 117.472 0.636 . . . . 73.35 112.119 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -75.4 131.87 40.5 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.395 0.678 . . . . 62.03 111.368 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -61.03 -18.95 60.54 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.73 0.812 . . . . 75.11 112.808 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 32.3 tp -61.71 -41.14 97.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.608 0.763 . . . . 74.33 111.189 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.07 -37.16 86.63 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.042 0.448 . . . . 71.33 111.308 172.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.483 HD11 HG23 ' A' ' 112' ' ' ILE . 4.2 mm? -70.99 -30.11 66.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.883 0.873 . . . . 75.35 112.722 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HA ' ' HG1' ' A' ' 74' ' ' THR . 17.9 ptpt -77.58 -25.02 49.65 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 122.133 -0.354 . . . . 72.15 110.59 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 22.4 mm-40 -75.49 -56.27 4.87 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.561 172.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -130.08 70.35 1.44 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.775 0.657 . . . . 63.55 112.775 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -176.04 -61.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.493 0.717 . . . . 75.22 110.53 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.451 ' HG1' ' HA ' ' A' ' 70' ' ' LYS . 70.9 p -65.16 -38.46 28.29 Favored Pre-proline 0 CA--C 1.573 1.849 0 N-CA-C 113.961 1.097 . . . . 64.12 113.961 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -94.73 17.41 0.89 Allowed 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 121.987 1.791 . . . . 72.25 113.674 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -137.46 153.42 74.46 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 123.857 0.863 . . . . 75.45 111.372 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.94 153.56 63.43 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.226 1.951 . . . . 64.45 111.551 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -46.81 -54.32 10.1 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.329 1.233 . . . . 72.35 114.329 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -49.2 -32.68 10.86 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 113.956 1.095 . . . . 75.54 113.956 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -74.89 -27.63 60.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.882 0.473 . . . . 73.43 111.196 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.75 -30.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.761 0.824 . . . . 73.44 111.755 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 100' ' ' ILE . 2.0 mp -67.44 -43.78 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.004 0.521 . . . . 75.14 110.884 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.42 -26.04 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.095 -0.502 . . . . 74.44 111.846 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.6 mt -85.38 -31.17 23.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.635 0.774 . . . . 71.53 111.771 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.99 -54.75 12.61 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 116.218 -0.447 . . . . 64.11 112.435 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 90' ' ' LEU . 47.8 m -57.64 -30.63 65.55 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.308 1.043 . . . . 71.32 111.464 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.41 -38.4 77.91 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.854 0.862 . . . . 72.44 111.819 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -94.27 -1.48 53.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.147 1.166 . . . . 75.53 114.147 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -123.36 -57.92 1.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.061 0.391 . . . . 72.34 111.69 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 86' ' ' THR . 60.8 mt -84.12 -12.72 54.56 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.302 0.241 . . . . 73.41 111.389 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.56 11.16 56.26 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 116.2 -0.455 . . . . 75.52 113.551 -173.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -104.92 135.17 46.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.977 0.911 . . . . 65.32 111.547 -167.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.92 158.4 70.5 Favored Pre-proline 0 CA--C 1.565 1.531 0 CA-C-N 115.383 -0.826 . . . . 53.21 111.386 169.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.87 161.59 0.48 Allowed 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.043 2.495 . . . . 71.25 113.961 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.16 -75.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.771 -0.825 . . . . 73.23 108.771 -160.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -141.04 153.24 45.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.257 1.423 . . . . 73.02 107.437 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -63.26 -14.44 49.41 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.905 1.229 . . . . 61.42 113.618 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.37 -31.27 21.58 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.21 -1.033 . . . . 63.23 108.21 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.52 -39.53 77.48 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.289 1.436 . . . . 71.22 111.114 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 82' ' ' ILE . 87.8 mt -64.02 -52.8 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.244 0.618 . . . . 74.23 110.264 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -55.26 -31.22 61.37 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.213 1.005 . . . . 75.31 113.514 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.27 -49.35 74.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.548 0.339 . . . . 74.52 110.818 173.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -68.27 -39.66 82.12 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.971 0.509 . . . . 73.52 111.29 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -58.76 -42.77 89.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.39 1.076 . . . . 74.42 112.463 172.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -62.39 -27.39 69.05 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.25 0.62 . . . . 74.02 111.958 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.04 -60.33 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 108.798 -0.816 . . . . 74.21 108.798 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 115' ' ' PHE . 22.8 tp -41.96 -31.97 0.39 Allowed 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 115.658 1.725 . . . . 72.22 115.658 160.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.19 -41.47 25.19 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 119.176 0.898 . . . . 73.42 112.317 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.2 p -97.79 -22.97 16.1 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.024 0.75 . . . . 54.23 113.024 -172.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -126.36 -38.07 2.15 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.426 0.69 . . . . 75.34 112.113 -171.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.61 174.33 14.0 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 113.986 0.354 . . . . 62.05 113.986 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.483 HG23 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -67.66 -29.6 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.051 0.94 . . . . 73.01 110.62 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.441 ' HG3' ' H ' ' A' ' 114' ' ' ALA . 10.0 ptt180 -54.67 -53.0 60.57 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.629 0.772 . . . . 74.51 111.371 171.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' H ' ' HG3' ' A' ' 113' ' ' ARG . . . -64.24 -29.03 70.15 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.973 0.909 . . . . 64.23 113.153 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.403 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 55.3 t80 -67.76 -49.51 62.08 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.407 0.683 . . . . 72.54 111.106 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -59.37 -46.34 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.586 0.754 . . . . 72.4 110.414 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.67 -40.45 75.55 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.715 0.806 . . . . 54.43 112.345 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.64 93.22 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.262 0.625 . . . . 72.2 112.119 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.462 ' O ' HD22 ' A' ' 90' ' ' LEU . 83.6 mt -72.6 -55.74 6.42 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.303 0.641 . . . . 75.04 111.816 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 60' ' ' GLU . 88.7 t -61.66 -42.6 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.57 0.748 . . . . 74.12 112.412 -173.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -82.75 -0.47 47.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.294 0.85 . . . . 74.31 113.294 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -66.95 158.02 31.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.015 0.526 . . . . 73.02 111.913 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -65.12 -25.99 68.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.823 0.849 . . . . 74.45 110.628 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.486 ' HB2' HD21 ' A' ' 90' ' ' LEU . 42.6 mm-40 -62.89 -48.35 79.38 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.201 1.0 . . . . 71.23 111.671 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -68.46 -46.33 70.06 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.437 0.637 . . . . 73.44 110.013 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.74 -52.03 64.83 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.468 -1.242 . . . . 74.05 112.32 -165.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.49 -42.65 19.96 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.467 0.914 . . . . 71.23 113.467 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.07 -49.16 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.252 0.621 . . . . 73.2 112.5 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -96.15 -53.98 3.46 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 120.991 0.424 . . . . 74.53 111.195 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.7 144.3 13.51 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.853 -0.612 . . . . 35.24 111.581 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 16.3 pt-20 -74.84 -19.5 60.15 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.768 0.655 . . . . 75.22 112.768 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.01 -6.91 59.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.698 0.799 . . . . 74.51 111.84 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 m -116.2 149.74 38.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.433 0.693 . . . . 72.5 112.244 -167.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 141.51 97.42 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.728 0.811 . . . . 74.55 109.563 166.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.402 ' HD3' HG12 ' A' ' 59' ' ' ILE . 38.8 Cg_endo -65.3 77.36 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.587 2.192 . . . . 63.03 112.726 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -76.64 85.77 3.3 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.654 -0.869 . . . . 74.43 108.654 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -52.87 94.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.535 1.16 . . . . 72.52 111.542 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -83.34 1.34 41.73 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 113.382 -1.735 . . . . 65.01 112.877 -160.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.53 129.96 91.05 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 124.181 0.993 . . . . 74.11 110.713 -177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.89 -5.17 7.06 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.723 2.949 . . . . 73.45 115.488 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -62.28 -23.61 66.81 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.128 0.971 . . . . 74.1 113.032 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.77 -10.86 18.78 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.016 0.747 . . . . 73.12 113.016 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.11 86.77 1.37 Allowed 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.71 0.767 . . . . 75.53 111.193 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -106.79 12.39 29.09 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 124.419 1.088 . . . . 74.51 110.433 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -130.71 177.34 7.47 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.459 1.104 . . . . 73.44 110.965 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -67.61 104.21 1.55 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.385 0.674 . . . . 71.53 111.26 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -150.94 117.01 5.57 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.557 0.743 . . . . 72.23 109.257 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -65.95 99.34 0.48 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.216 0.606 . . . . 64.13 111.691 -173.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.5 t60 . . . . . 0 N--CA 1.486 1.325 0 C-N-CA 123.545 0.738 . . . . 75.33 110.283 -177.829 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 111.771 0.285 . . . . 62.4 111.771 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -74.39 98.62 3.31 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.149 0.5 . . . . 73.54 110.665 -179.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p -112.31 -12.97 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.531 0 C-N-CA 124.201 1.0 . . . . 73.44 111.435 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 63.8 86.13 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.038 1.335 . . . . 72.24 112.059 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -127.48 170.75 12.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.664 1.186 . . . . 74.32 110.803 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -116.27 94.29 4.58 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.877 -0.602 . . . . 74.22 110.121 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.64 141.85 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.927 -0.768 . . . . 75.5 108.927 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.54 -20.65 0.46 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.86 1.8 . . . . 75.41 115.86 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.32 -103.7 0.86 Allowed Glycine 0 C--N 1.368 2.34 0 CA-C-N 120.155 1.343 . . . . 75.02 110.519 166.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm 41.29 49.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 125.431 1.492 . . . . 71.12 111.945 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -64.63 13.38 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 114.918 1.451 . . . . 72.52 114.918 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.98 113.08 17.88 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.867 0.841 . . . . 74.34 110.551 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -28.15 64.51 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.714 -1.585 . . . . 74.35 109.368 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.26 71.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.519 1.127 . . . . 54.03 111.08 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.09 67.86 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.072 0.767 . . . . 72.1 113.072 171.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 20' ' ' ILE . 45.7 mm -54.09 -54.45 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 112.794 0.664 . . . . 71.2 112.794 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HA ' HD12 ' A' ' 20' ' ' ILE . 15.5 ptpt -66.04 -30.89 71.5 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.934 0.716 . . . . 72.31 112.934 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -70.33 -48.79 54.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.23 0.612 . . . . 73.21 111.431 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.77 -43.21 8.39 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.187 0.995 . . . . 63.34 112.446 167.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 16' ' ' ILE . 66.4 mt -66.13 -35.83 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.496 0.718 . . . . 74.15 111.454 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -67.05 -41.7 86.06 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.182 0.593 . . . . 73.3 112.089 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.33 91.7 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.059 0.544 . . . . 73.42 111.983 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.48 9.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.368 -1.287 . . . . 63.32 112.166 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.446 ' HH ' ' HB1' ' A' ' 37' ' ' ALA . 26.3 m-85 -78.13 -47.06 19.03 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.92 0.488 . . . . 73.1 112.067 167.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -68.25 -15.71 63.68 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.176 0.99 . . . . 72.32 112.391 -171.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -95.57 -35.55 11.6 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.655 -0.653 . . . . 71.43 111.592 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 50.2 mm -87.67 -66.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.147 0.579 . . . . 75.51 111.014 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.48 -17.89 64.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.284 0.634 . . . . 72.44 111.274 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 25' ' ' ARG . 23.2 tt0 62.65 31.33 16.8 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.535 1.534 . . . . 74.13 112.276 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -152.37 156.55 39.78 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.807 -0.633 . . . . 71.24 111.776 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.93 108.44 8.81 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.81 -1.086 . . . . 65.21 109.166 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.51 135.24 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 109.352 -0.61 . . . . 73.51 109.352 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.15 118.04 21.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.73 0.812 . . . . 75.32 111.075 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -47.74 -39.92 31.11 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.847 3.031 . . . . 74.03 114.56 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -67.99 -39.37 83.29 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 112.904 0.705 . . . . 75.42 112.904 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -67.07 -44.27 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.326 0.584 . . . . 72.03 110.542 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB1' ' HH ' ' A' ' 24' ' ' TYR . . . -62.44 -36.58 82.85 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.27 1.028 . . . . 72.14 112.698 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.0 -23.82 35.78 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 116.317 -0.402 . . . . 72.13 110.765 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -75.48 -35.38 60.86 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.103 0.561 . . . . 73.22 111.483 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.6 -61.96 1.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.645 0.736 . . . . 75.54 110.996 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.8 43.79 1.07 Allowed 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 115.348 -0.842 . . . . 74.43 112.814 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.15 -51.88 33.71 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.074 -0.391 . . . . 62.41 112.014 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.96 -34.54 33.52 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.136 -0.484 . . . . 62.21 111.959 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -66.88 -39.85 87.63 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.89 0.876 . . . . 75.13 112.822 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.08 -28.7 63.48 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.164 0.586 . . . . 75.02 110.583 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -53.63 -31.41 47.2 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.451 0.7 . . . . 74.14 112.026 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.94 -44.35 66.29 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.984 0.514 . . . . 73.31 111.125 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.5 tp -65.54 -57.76 7.42 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 112.738 0.644 . . . . 74.23 112.738 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.92 -49.34 35.84 Favored Glycine 0 C--N 1.362 2.0 0 N-CA-C 115.246 0.858 . . . . 71.05 115.246 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -67.79 20.07 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 115.207 1.558 . . . . 74.21 115.207 171.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.4 19.75 0.1 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 118.633 2.213 . . . . 43.54 118.633 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -62.2 -54.72 36.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 118.476 1.138 . . . . 75.13 111.079 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 pt -108.15 140.17 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.137 -1.392 . . . . 74.52 110.467 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.0 p -69.15 169.96 11.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.792 0.437 . . . . 73.45 111.604 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.69 -24.35 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.51 0 CA-C-N 116.006 -0.543 . . . . 74.15 111.323 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -68.4 -53.13 25.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.603 1.161 . . . . 70.33 110.965 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.8 -21.81 65.21 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.83 0.852 . . . . 72.1 111.57 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.19 -43.81 40.78 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.238 -1.023 . . . . 75.23 108.238 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.3 mt -66.18 -28.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 113.696 -1.593 . . . . 73.32 112.098 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -58.21 -50.9 71.93 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.832 -0.433 . . . . 65.14 109.832 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.37 65.05 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 114.743 0.657 . . . . 74.01 114.743 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -73.44 -33.3 64.84 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.136 0.575 . . . . 73.32 111.014 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.66 -12.11 78.4 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 115.669 -0.696 . . . . 63.34 112.405 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.402 ' HH ' ' HB2' ' A' ' 117' ' ' ASN . 4.2 m-30 -97.7 11.74 36.08 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.575 1.15 . . . . 72.4 111.199 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.1 p -99.48 126.97 45.51 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.34 -0.615 . . . . 62.21 109.34 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -57.94 -15.6 9.36 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.458 0.703 . . . . 73.12 112.777 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.08 -59.35 3.87 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.038 0.935 . . . . 73.5 111.726 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -49.38 -48.85 46.58 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.292 1.219 . . . . 75.34 114.292 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.548 HD11 HG22 ' A' ' 112' ' ' ILE . 3.2 mm? -62.32 -21.28 65.15 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.072 0.767 . . . . 72.12 113.072 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -76.14 -42.19 47.56 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.522 -0.918 . . . . 74.3 108.522 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.2 -64.11 1.21 Allowed 'General case' 0 C--N 1.371 1.519 0 CA-C-N 118.984 0.811 . . . . 75.0 111.846 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CD1' HD12 ' A' ' 84' ' ' LEU . 23.1 m-85 -100.76 61.59 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.276 1.213 . . . . 74.21 114.276 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.512 ' HD1' HG21 ' A' ' 81' ' ' VAL . 31.2 t80 -171.73 -57.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 122.979 0.511 . . . . 75.44 112.099 168.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.6 m -59.14 -44.13 98.13 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 113.053 0.76 . . . . 63.53 113.053 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -96.5 16.83 0.72 Allowed 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.442 2.095 . . . . 73.3 113.945 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.55 144.02 51.22 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 112.588 0.588 . . . . 72.24 112.588 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.88 145.27 31.75 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.199 1.932 . . . . 75.25 112.637 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -21.92 -60.58 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.848 1.795 . . . . 63.52 115.848 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.424 ' HA ' HD11 ' A' ' 82' ' ' ILE . 18.5 m -66.03 -20.27 66.13 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.347 0.976 . . . . 74.11 113.099 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.57 -33.1 16.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.759 -1.2 . . . . 75.21 107.759 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.512 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.4 t -69.53 -29.06 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.578 -1.192 . . . . 70.43 110.106 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 79' ' ' THR . 90.0 mt -65.56 -43.08 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.262 0.625 . . . . 75.34 110.182 170.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.79 -65.14 0.77 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 117.575 0.171 . . . . 75.32 111.005 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.453 HD12 ' CD1' ' A' ' 72' ' ' PHE . 96.6 mt -49.06 -30.94 6.96 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.529 1.678 . . . . 72.23 115.529 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.33 -56.67 3.35 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 118.247 0.476 . . . . 73.05 112.77 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.466 HG23 HD12 ' A' ' 90' ' ' LEU . 86.6 m -60.17 -39.24 85.76 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.045 0.938 . . . . 73.32 112.734 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -71.82 -6.17 39.65 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.283 1.033 . . . . 75.41 113.49 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 55.9 m170 -100.69 -32.78 10.56 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.21 -1.033 . . . . 75.34 108.21 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -96.72 -66.72 0.89 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.944 1.298 . . . . 74.11 110.358 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.466 HD12 HG23 ' A' ' 86' ' ' THR . 52.6 mt -73.74 -13.78 61.02 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.538 0.335 . . . . 75.34 111.71 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.53 -19.29 4.01 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 115.874 1.11 . . . . 53.25 115.874 168.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.21 -174.25 2.51 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 117.593 0.697 . . . . 74.54 110.21 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.15 152.87 44.5 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 121.722 -0.611 . . . . 74.32 110.151 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.01 153.52 8.72 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 C-N-CA 122.966 2.444 . . . . 74.53 114.901 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.4 mt -78.62 -64.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.314 0.487 . . . . 74.21 112.314 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -114.46 -146.96 0.41 Allowed 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 104.598 -2.371 . . . . 75.11 104.598 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -97.5 -18.17 19.17 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-N 123.644 2.929 . . . . 74.24 108.655 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.565 0.746 . . . . 65.34 111.663 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.67 -42.3 70.92 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.802 0.441 . . . . 74.13 111.021 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.3 mt -59.87 -38.97 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.515 0.726 . . . . 74.5 110.494 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -72.87 -30.31 63.87 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.914 -1.039 . . . . 71.35 110.827 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -67.69 -51.39 50.08 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.8 0.84 . . . . 73.45 110.262 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -65.64 -42.52 91.37 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.115 0.566 . . . . 75.33 112.17 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -45.3 -44.58 11.62 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.054 0.942 . . . . 75.23 112.84 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -70.95 -44.42 66.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.183 0.593 . . . . 73.41 111.601 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 73.6 mt -53.04 -53.62 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.774 0.83 . . . . 74.5 111.122 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.535 HD21 HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -52.82 -42.36 65.06 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.122 1.369 . . . . 72.12 113.057 172.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.08 -55.07 13.84 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.028 0.531 . . . . 71.31 112.065 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.2 p -62.93 -62.7 1.54 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.685 0.794 . . . . 73.44 113.125 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -98.96 -52.36 3.58 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.841 0.856 . . . . 71.12 112.595 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.51 -148.4 17.17 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 116.555 -0.293 . . . . 62.52 113.261 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 69' ' ' LEU . 10.1 mm -79.3 -35.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.246 1.018 . . . . 71.12 112.037 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -59.39 -65.96 0.59 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.769 0.319 . . . . 71.15 110.38 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -49.29 -20.91 0.71 Allowed 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.361 1.986 . . . . 73.43 116.361 165.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -73.64 -62.75 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.309 1.413 . . . . 63.23 110.078 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 120' ' ' VAL . 50.3 mm -47.1 -59.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.07 0.948 . . . . 75.13 112.93 170.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.402 ' HB2' ' HH ' ' A' ' 64' ' ' TYR . 59.4 t30 -40.68 -46.28 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.52 0.933 . . . . 72.25 113.52 169.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -63.74 -23.08 67.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.864 0.691 . . . . 75.5 112.864 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.36 -34.23 18.88 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.208 1.003 . . . . 73.1 111.205 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 116' ' ' ILE . 93.1 t -69.51 -60.44 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.349 1.06 . . . . 75.43 111.229 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -76.88 -5.4 48.29 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.219 0.608 . . . . 73.2 112.394 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 32.5 t -53.48 143.48 19.4 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.564 0.746 . . . . 75.52 111.25 173.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.81 -29.19 65.3 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.438 -0.578 . . . . 73.13 109.438 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -66.55 -48.82 68.48 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.089 0.956 . . . . 74.5 111.67 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.4 ' HB2' HD22 ' A' ' 90' ' ' LEU . 90.0 t80 -60.5 -48.26 82.54 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 120.838 0.351 . . . . 73.54 110.719 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.0 -27.28 68.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 115.301 -0.863 . . . . 74.25 112.197 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -91.55 -54.41 3.91 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.974 0.51 . . . . 60.12 112.355 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.19 -52.46 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.355 0.662 . . . . 75.21 111.924 -174.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.07 -41.6 9.46 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.167 0.587 . . . . 63.25 111.241 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.53 166.69 26.44 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.993 -0.549 . . . . 72.21 113.423 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.79 -33.11 60.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.418 0.687 . . . . 74.13 112.097 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -129.01 60.45 1.55 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.319 1.057 . . . . 72.24 110.458 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.3 m -153.74 145.71 23.6 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 114.128 -1.396 . . . . 73.45 108.868 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 82.9 t -68.07 134.28 91.68 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 123.567 0.747 . . . . 74.44 110.477 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.34 85.51 0.27 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.936 2.424 . . . . 62.41 111.542 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -58.13 161.61 4.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.595 1.158 . . . . 63.13 112.997 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -66.16 128.51 36.37 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.812 -1.086 . . . . 74.21 109.811 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 57.5 mmm-85 -80.4 26.92 0.36 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.767 0.827 . . . . 75.25 112.587 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -132.91 162.64 56.31 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.911 1.284 . . . . 74.31 109.69 -172.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.36 51.02 2.79 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.823 2.348 . . . . 54.15 113.924 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.9 p -116.56 -1.86 12.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.849 0.86 . . . . 74.31 111.834 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.18 -27.61 69.49 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.07 1.137 . . . . 73.4 114.07 -170.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.43 -7.72 27.49 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.158 0.983 . . . . 73.34 112.681 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -35.45 113.62 0.21 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 124.873 1.269 . . . . 74.25 114.263 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -64.62 128.77 37.18 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.935 0.894 . . . . 74.01 110.908 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -123.22 136.42 54.72 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.323 1.049 . . . . 75.2 110.998 -172.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -74.15 167.56 21.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.611 0.764 . . . . 74.33 111.84 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -88.95 133.93 34.14 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.546 -0.752 . . . . 75.33 110.779 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.8 t60 . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.711 0.804 . . . . 73.0 109.786 177.848 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.729 0.299 . . . . 75.22 110.63 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.74 110.83 21.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.269 0.557 . . . . 73.03 111.355 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.43 167.15 26.99 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.314 1.046 . . . . 60.01 109.088 169.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -85.72 117.06 24.37 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.778 0.431 . . . . 64.45 110.255 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 10' ' ' ILE . 61.7 t -89.08 136.99 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.194 -1.039 . . . . 53.33 108.194 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.11 82.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.313 0.578 . . . . 44.31 110.805 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.09 -18.75 0.4 Allowed Glycine 0 CA--C 1.536 1.367 0 CA-C-N 115.474 -0.785 . . . . 45.42 113.533 -172.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 7' ' ' VAL . 55.8 mt -73.69 88.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.016 0.908 . . . . 72.11 110.982 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -94.63 2.57 55.61 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.555 0.742 . . . . 73.24 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -79.88 121.02 24.9 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.284 0.634 . . . . 54.41 111.083 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -68.98 -26.76 65.19 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.703 0.401 . . . . 73.45 111.492 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.04 -48.81 64.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.285 0.634 . . . . 64.1 111.074 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.75 84.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.973 0.509 . . . . 74.54 111.596 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.525 HG13 ' HA2' ' A' ' 49' ' ' GLY . 29.3 mm -55.96 -49.6 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.601 0.76 . . . . 72.21 111.367 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -67.73 -27.85 67.14 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.269 0.47 . . . . 53.14 112.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.4 m -69.96 -40.09 75.61 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.197 0.522 . . . . 74.23 111.259 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.71 -39.4 84.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.49 1.116 . . . . 72.41 110.418 172.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 16' ' ' ILE . 92.6 mt -70.23 -40.62 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.529 1.132 . . . . 72.31 111.911 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.1 m -64.74 -38.71 91.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.158 0.583 . . . . 71.3 111.155 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.6 96.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.496 -0.775 . . . . 61.4 111.405 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.67 -30.76 70.94 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.539 0.736 . . . . 70.03 112.177 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.62 -48.76 75.99 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.813 0.445 . . . . 73.01 111.182 170.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -70.76 -15.12 62.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.064 0.546 . . . . 61.03 111.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -85.32 -53.62 5.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.183 0.593 . . . . 74.42 111.27 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.863 HD11 HG23 ' A' ' 59' ' ' ILE . 65.0 mt -82.35 -66.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.078 0.551 . . . . 53.11 111.353 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.492 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 22.7 m-85 -66.39 -14.56 62.3 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.955 0.902 . . . . 73.1 111.813 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 70.68 -50.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.025 1.73 . . . . 73.14 112.717 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -61.28 143.46 55.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.204 1.002 . . . . 45.22 113.273 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.55 114.32 9.5 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.614 -1.176 . . . . 73.23 108.779 162.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.4 mt -90.85 129.14 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.584 -0.524 . . . . 55.32 109.584 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.27 125.47 81.69 Favored Pre-proline 0 CA--C 1.557 1.214 0 O-C-N 123.951 0.782 . . . . 74.11 111.029 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.27 -32.21 32.15 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.751 2.968 . . . . 75.21 115.34 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -71.04 -29.55 65.49 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.191 0.441 . . . . 71.35 112.191 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.86 -44.83 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 122.749 0.42 . . . . 60.45 109.908 170.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.5 72.57 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.846 0.858 . . . . 61.54 112.619 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -79.87 -18.76 49.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.354 0.501 . . . . 74.22 112.354 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -80.47 -31.04 37.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 70.22 111.653 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.28 -55.44 3.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.045 0.538 . . . . 74.54 112.242 -174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -117.55 19.69 13.83 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.72 1.378 . . . . 71.23 114.72 -169.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.7 p -66.23 -30.2 70.6 Favored 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 120.554 1.525 . . . . 61.22 112.171 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.91 41.63 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.732 -0.667 . . . . 64.24 112.364 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -81.1 -31.51 34.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.81 1.244 . . . . 75.13 111.467 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -37.37 81.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.165 1.386 . . . . 75.25 111.765 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.6 p -59.01 -38.66 79.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.312 0.645 . . . . 72.04 112.024 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -63.17 -38.29 90.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.065 0.546 . . . . 73.15 111.897 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.51 HD11 HG22 ' A' ' 55' ' ' VAL . 42.4 tp -72.96 -42.94 62.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.702 0.287 . . . . 73.11 111.267 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.525 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -69.64 -35.43 74.3 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.357 -0.383 . . . . 70.33 113.904 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -92.58 -19.18 22.19 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.293 0.637 . . . . 73.13 111.314 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.06 19.33 26.63 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 115.783 1.073 . . . . 72.21 115.783 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.14 -29.55 67.62 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 118.226 1.013 . . . . 60.11 112.212 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.425 HD11 ' HD1' ' A' ' 58' ' ' PHE . 27.1 pt -120.68 169.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.322 0.649 . . . . 63.23 111.034 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 29.8 p -91.94 172.32 8.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.828 -0.624 . . . . 75.04 110.389 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 48' ' ' LEU . 58.6 t -71.56 -39.56 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 116.399 -0.364 . . . . 72.43 110.573 175.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HE2' HG12 ' A' ' 120' ' ' VAL . 54.7 tttm -53.95 -50.49 66.37 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.36 0.664 . . . . 74.42 112.522 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -34.22 76.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.216 0.606 . . . . 65.33 111.979 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' HD1' HD11 ' A' ' 53' ' ' ILE . 63.7 t80 -63.42 -50.61 69.14 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.141 0.576 . . . . 52.31 111.024 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.863 HG23 HD11 ' A' ' 27' ' ' ILE . 49.2 mt -70.11 -39.49 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.861 1.264 . . . . 64.1 112.57 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.79 -38.77 86.43 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.366 0.666 . . . . 71.01 110.085 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.58 -32.99 85.0 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 116.137 -0.483 . . . . 54.05 114.212 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.492 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 84.2 mt -66.61 -37.92 85.89 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.185 0.517 . . . . 73.4 110.875 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.8 -23.93 67.77 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-N 115.34 -0.845 . . . . 72.52 114.116 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -82.34 -18.74 41.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.616 0.766 . . . . 75.05 112.061 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 t -60.35 119.7 8.47 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.306 0.854 . . . . 75.1 113.306 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.76 -16.41 57.67 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 123.597 0.759 . . . . 73.54 112.038 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.98 -49.51 75.8 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.025 0.53 . . . . 64.42 111.094 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.76 -47.57 84.2 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.217 0.607 . . . . 54.45 111.32 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HG ' HG12 ' A' ' 112' ' ' ILE . 2.1 mm? -71.94 -29.45 64.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.052 0.76 . . . . 62.1 113.052 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.31 -37.41 83.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.219 0.533 . . . . 75.54 110.704 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -50.09 10.86 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.216 0.821 . . . . 52.45 113.216 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.94 34.13 5.32 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.838 1.051 . . . . 71.23 113.838 -167.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -154.48 -58.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.647 0.61 . . . . 74.1 112.647 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.4 p -65.32 -35.61 12.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 113.853 1.057 . . . . 64.1 113.853 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -92.05 -4.51 3.8 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 121.875 1.717 . . . . 74.54 113.657 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -101.88 146.72 32.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 C-N-CA 123.827 0.851 . . . . 74.45 112.157 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.06 147.5 73.64 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.273 1.982 . . . . 75.01 111.537 168.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -55.88 -39.7 71.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.473 0.709 . . . . 72.2 112.677 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.48 ' HA ' HD12 ' A' ' 82' ' ' ILE . 40.8 m -61.05 -38.9 87.82 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.98 0.912 . . . . 72.13 113.316 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -69.64 -32.3 70.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.191 -0.318 . . . . 73.11 111.725 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.5 -32.45 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.307 0.643 . . . . 70.04 110.033 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.526 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 93.6 mt -64.15 -53.5 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.488 0.715 . . . . 72.12 112.422 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -68.73 -42.5 77.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.165 0.432 . . . . 75.41 112.165 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.76 -32.93 70.24 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.313 0.645 . . . . 73.05 111.922 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.0 -47.03 57.03 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 112.172 -0.371 . . . . 75.34 112.172 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.559 HG23 HD12 ' A' ' 90' ' ' LEU . 86.7 m -67.28 -36.75 82.21 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.245 1.018 . . . . 64.45 111.136 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -55.97 -41.93 75.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.703 0.801 . . . . 73.25 112.186 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 49.1 m170 -78.58 -29.52 46.22 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 113.021 0.749 . . . . 74.51 113.021 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -100.54 -63.62 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.227 0.825 . . . . 75.04 113.227 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.559 HD12 HG23 ' A' ' 86' ' ' THR . 77.0 mt -77.08 -25.75 52.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 74.3 112.354 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.94 12.75 81.14 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 123.143 0.277 . . . . 70.25 113.208 -170.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -112.61 159.51 18.79 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.044 0.937 . . . . 51.0 110.423 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.67 154.9 62.12 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.245 0.618 . . . . 75.23 109.861 164.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.7 144.92 97.48 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.067 1.845 . . . . 71.03 112.226 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.401 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 2.5 mp -71.79 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.156 0.582 . . . . 75.33 110.868 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -126.09 173.55 9.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.758 0.823 . . . . 64.32 109.46 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 60.8 tp60 -62.42 -31.66 72.39 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 122.798 0.439 . . . . 73.33 111.072 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.44 -35.75 73.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.674 0.79 . . . . 45.22 111.331 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 11.0 tp10 -60.97 -44.94 96.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 74.41 110.235 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.9 mt -58.35 -44.28 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 114.866 -1.061 . . . . 54.15 110.998 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.1 mtt-85 -62.72 -33.64 75.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.87 0.468 . . . . 74.41 111.688 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -70.6 -53.02 17.59 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.136 0.273 . . . . 73.2 111.483 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -59.78 -36.92 77.7 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.826 0.45 . . . . 74.44 111.803 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.25 -40.68 94.31 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.993 0.917 . . . . 64.1 110.757 176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.53 -43.88 72.11 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.575 0.75 . . . . 72.43 111.599 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 98.0 mt -61.99 -47.43 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.281 1.032 . . . . 74.33 110.771 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.5 tp -61.04 -40.4 93.47 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.982 -1.008 . . . . 71.51 112.087 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.52 -44.71 77.72 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.991 0.517 . . . . 70.05 112.115 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.9 p -84.86 -65.65 0.99 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.421 0.688 . . . . 75.21 111.588 -174.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.93 -57.07 4.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.96 0.504 . . . . 73.43 111.207 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.27 -174.7 20.52 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 121.301 0.389 . . . . 73.43 113.704 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.494 HG12 ' HG ' ' A' ' 69' ' ' LEU . 10.8 tp -69.97 -31.54 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 113.124 0.787 . . . . 75.22 113.124 -170.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -65.74 -34.45 78.2 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.425 0.29 . . . . 61.21 111.452 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.08 -31.26 58.67 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.036 0.534 . . . . 73.14 111.492 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.526 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 56.6 t80 -64.55 -55.45 20.42 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.626 0.771 . . . . 72.22 111.444 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.414 HD12 ' HD2' ' A' ' 115' ' ' PHE . 1.9 mp -57.85 -44.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 122.88 0.472 . . . . 53.34 110.716 173.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.21 -34.08 71.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.824 0.449 . . . . 72.23 111.583 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.63 80.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.057 0.543 . . . . 55.14 111.858 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.86 -36.34 78.01 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.385 0.674 . . . . 73.52 111.863 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.506 HG12 ' HE2' ' A' ' 56' ' ' LYS . 98.6 t -80.52 -32.48 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.972 0.909 . . . . 52.01 111.655 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.86 4.53 52.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.22 0.608 . . . . 64.11 112.047 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.7 t -62.83 129.47 40.61 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.372 -0.603 . . . . 43.1 109.372 164.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -53.9 -35.18 61.36 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.434 0.694 . . . . 53.53 112.659 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.26 -41.79 85.05 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 123.512 0.507 . . . . 65.33 111.642 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -63.52 -56.41 16.22 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.454 0.302 . . . . 71.23 110.921 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -66.14 -36.46 83.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.143 0.794 . . . . 73.3 113.143 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HG3' HG23 ' A' ' 128' ' ' VAL . 12.9 pt-20 -71.76 -32.88 68.15 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.023 0.749 . . . . 60.21 113.023 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.441 HG23 ' HG3' ' A' ' 127' ' ' GLU . 93.6 t -100.56 -64.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 118.34 0.518 . . . . 74.33 111.696 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -99.45 67.1 1.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.736 0.815 . . . . 64.42 109.887 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.03 -156.06 0.49 Allowed Glycine 0 N--CA 1.483 1.796 0 N-CA-C 115.169 0.828 . . . . 63.14 115.169 -174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -79.21 21.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.576 0.954 . . . . 74.12 113.576 -176.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.18 -36.62 0.9 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.832 1.253 . . . . 61.33 110.809 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.3 m -91.97 137.31 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.813 0.672 . . . . 53.14 112.813 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.8 t -80.34 132.26 59.68 Favored Pre-proline 0 CA--C 1.561 1.376 0 C-N-CA 123.946 0.898 . . . . 55.42 110.355 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HD2' HD13 ' A' ' 59' ' ' ILE . 55.6 Cg_endo -66.72 84.66 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.889 2.393 . . . . 73.11 113.82 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.6 p90 . . . . . 0 N--CA 1.478 0.97 0 CA-C-N 115.808 -0.633 . . . . 74.41 110.721 172.841 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.508 -0.553 . . . . 53.03 109.508 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.01 87.15 1.84 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 116.047 -0.524 . . . . 75.04 110.502 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -120.91 148.04 44.61 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.606 0.762 . . . . 51.11 110.044 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -95.87 91.87 6.24 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.332 0.586 . . . . 72.33 111.075 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.18 112.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-N 115.0 -1.0 . . . . 73.02 109.961 164.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.5 90.1 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.118 0.967 . . . . 63.15 113.111 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -46.08 -29.33 3.38 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 115.689 1.035 . . . . 53.21 115.689 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.07 130.57 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 109.363 -0.606 . . . . 50.34 109.363 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.74 -27.49 6.63 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.882 0.473 . . . . 73.23 111.088 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -32.75 114.7 0.17 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.593 1.557 . . . . 63.21 113.57 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HE3' ' HA3' ' A' ' 49' ' ' GLY . 14.4 mmmm -67.95 -12.1 60.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.915 0.486 . . . . 71.13 112.169 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.03 76.7 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.772 0.829 . . . . 73.51 110.895 171.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.54 62.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.191 0.596 . . . . 72.43 110.963 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.462 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.9 mp -60.09 -45.51 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.36 0.664 . . . . 72.34 110.714 169.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.16 -50.49 73.84 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.359 0.663 . . . . 72.51 112.168 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -62.39 -34.45 76.76 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.115 0.566 . . . . 74.34 111.286 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 48' ' ' LEU . 9.9 tp -62.39 -45.68 92.06 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.644 0.778 . . . . 64.44 111.022 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 16' ' ' ILE . 67.4 mt -72.04 -34.1 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.265 1.026 . . . . 74.2 111.519 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -68.26 -42.72 79.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.207 0.603 . . . . 74.42 110.294 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.42 90.96 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.657 0.783 . . . . 72.11 111.238 172.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.99 97.93 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.47 0.708 . . . . 44.04 111.845 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -65.93 -49.38 68.16 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.119 0.568 . . . . 70.51 111.929 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -69.83 -15.51 63.11 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.756 0.65 . . . . 71.41 112.756 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -94.54 -47.31 6.6 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 122.971 0.508 . . . . 52.41 111.54 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 83.0 mt -83.14 -58.57 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.061 0.544 . . . . 74.1 111.934 -174.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 8.7 m-85 -73.31 -16.06 61.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.816 0.446 . . . . 72.3 110.654 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 66.49 17.44 10.65 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.196 1.398 . . . . 72.23 111.968 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -153.4 143.77 22.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 74.5 110.158 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.56 141.11 48.43 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 120.913 0.387 . . . . 62.11 110.098 165.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.4 mt -106.17 141.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 108.712 -0.847 . . . . 51.33 108.712 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.37 117.08 10.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.877 0.871 . . . . 63.41 111.28 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.32 -38.22 86.1 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.375 2.716 . . . . 73.32 113.505 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -63.56 -26.93 68.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.843 0.857 . . . . 74.41 112.744 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -83.31 -47.16 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 123.06 0.544 . . . . 72.24 110.564 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.7 68.86 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.312 1.045 . . . . 51.34 113.365 -173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -75.51 -25.85 57.62 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.165 0.432 . . . . 70.21 112.165 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -81.46 -44.17 17.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.861 0.465 . . . . 71.15 111.599 173.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -58.48 -54.01 51.89 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.614 0.721 . . . . 72.51 111.175 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -99.7 45.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.872 -1.058 . . . . 72.32 110.175 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 p -61.55 -49.62 75.93 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.273 0.629 . . . . 64.15 112.286 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 -45.91 9.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.612 -0.722 . . . . 61.24 112.638 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -66.04 -37.81 86.81 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.513 1.301 . . . . 71.42 114.513 -170.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -65.04 -46.8 79.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.18 -0.674 . . . . 73.14 109.18 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 m -59.21 -35.67 74.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.7 0.8 . . . . 60.24 111.943 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -59.29 -42.09 90.5 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.818 0.847 . . . . 75.15 112.388 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 55' ' ' VAL . 42.2 tp -74.04 -45.51 49.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.809 0.444 . . . . 74.14 111.342 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' HA3' ' HE3' ' A' ' 13' ' ' LYS . . . -64.03 -31.95 82.54 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.874 0.749 . . . . 11.11 114.376 -174.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.93 -18.87 29.78 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.306 0.643 . . . . 72.5 111.275 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.75 31.73 35.3 Favored Glycine 0 C--N 1.355 1.609 0 CA-C-N 117.731 0.241 . . . . 72.41 113.538 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -88.39 -18.96 27.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.334 0.654 . . . . 73.31 111.884 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.8 pt -122.53 163.94 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.94 0.896 . . . . 74.1 110.327 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p -77.18 152.16 34.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.954 -0.387 . . . . 74.33 109.954 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 48' ' ' LEU . 40.1 t -64.01 -32.22 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.17 0.588 . . . . 71.22 110.081 175.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 1.5 tmtp? -54.08 -48.24 70.86 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.248 1.019 . . . . 73.2 111.457 171.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.92 -37.85 72.92 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.068 -0.515 . . . . 70.43 110.941 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.78 -51.84 66.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.389 0.675 . . . . 52.51 111.257 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 27' ' ' ILE . 26.5 mm -56.03 -38.58 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.848 1.259 . . . . 74.23 111.512 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -67.52 -39.49 85.1 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.064 -0.516 . . . . 74.13 110.949 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.72 -23.07 75.64 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 113.844 0.298 . . . . 71.45 113.844 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.499 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 79.0 mt -67.63 -23.11 65.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.528 0.731 . . . . 72.11 110.975 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.431 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -87.73 -14.07 63.82 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.453 -1.249 . . . . 52.11 113.032 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -92.81 -3.68 54.28 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.85 0.86 . . . . 70.23 111.012 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -73.32 112.59 9.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.349 0.659 . . . . 72.33 110.778 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.97 -18.1 63.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.731 0.412 . . . . 72.34 111.741 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.42 -51.73 68.23 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.943 0.497 . . . . 53.32 110.47 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.416 ' HB2' ' CE2' ' A' ' 28' ' ' PHE . 69.4 t80 -59.64 -45.63 91.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.972 0.909 . . . . 60.13 112.015 175.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 63' ' ' GLY . 2.5 mm? -71.21 -29.17 64.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 112.365 0.506 . . . . 74.32 112.365 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.96 -38.95 92.66 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 121.879 -0.513 . . . . 73.44 110.565 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.95 -54.62 7.53 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 113.21 0.818 . . . . 65.54 113.21 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -117.07 36.89 4.03 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 114.06 1.133 . . . . 71.25 114.06 -168.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.416 ' HD1' HG21 ' A' ' 81' ' ' VAL . 47.5 t80 -159.29 -42.92 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.831 0.453 . . . . 72.21 111.507 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -65.96 -45.62 63.89 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 112.641 0.608 . . . . 73.2 112.641 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.55 12.23 1.37 Allowed 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.556 2.171 . . . . 72.21 113.689 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HD2' ' HG2' ' A' ' 80' ' ' LYS . 80.9 m-85 -122.62 140.78 33.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 123.27 0.628 . . . . 73.43 111.965 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' O ' HG23 ' A' ' 81' ' ' VAL . 93.4 Cg_endo -73.45 159.55 46.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.946 2.43 . . . . 72.35 112.574 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -49.77 -52.5 31.44 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.922 0.889 . . . . 71.11 113.045 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.619 ' HA ' HD12 ' A' ' 82' ' ' ILE . 62.7 m -53.86 -43.01 69.18 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.942 1.09 . . . . 74.21 113.942 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 76' ' ' TYR . 58.8 tptt -65.08 -36.75 85.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.378 0.51 . . . . 55.45 112.378 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.416 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.1 t -68.24 -26.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.779 0.431 . . . . 75.21 110.203 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.4 mt -68.44 -52.84 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.604 0.761 . . . . 74.43 111.974 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 84' ' ' LEU . 5.1 pt-20 -64.64 -43.56 93.26 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.697 0.226 . . . . 65.03 110.96 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 22.7 mt -60.2 -41.1 92.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.391 0.677 . . . . 73.22 111.289 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.26 -51.09 55.73 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.74 -0.209 . . . . 74.04 112.713 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 90' ' ' LEU . 37.5 m -67.53 -38.02 83.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.633 0.773 . . . . 64.0 111.162 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -53.93 -36.32 62.65 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.69 1.196 . . . . 74.41 112.784 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 53.2 m170 -89.47 -43.03 11.13 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.452 0.701 . . . . 73.44 112.771 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -92.23 -46.68 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.009 0.524 . . . . 71.04 112.014 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 86' ' ' THR . 48.6 mt -97.73 -7.02 31.67 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.986 0.514 . . . . 74.2 111.717 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 27.21 72.41 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 115.162 0.825 . . . . 42.44 115.162 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -154.46 177.79 10.79 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 117.501 0.651 . . . . 75.33 112.285 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.72 150.76 54.17 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.674 0.79 . . . . 63.54 111.942 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.76 136.07 47.72 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.487 2.125 . . . . 74.42 110.922 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.16 -66.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.317 0.647 . . . . 71.25 111.451 -166.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HB2' ' H ' ' A' ' 99' ' ' GLU . 8.9 m-20 -93.07 165.03 13.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.295 0.638 . . . . 75.04 111.922 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 7.0 tp-100 -67.27 -33.9 76.28 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 109.457 -0.571 . . . . 71.11 109.457 163.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.71 73.37 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.452 0.701 . . . . 53.44 111.518 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.536 ' H ' ' HB2' ' A' ' 96' ' ' ASP . 12.2 tp10 -61.87 -42.02 98.55 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.851 0.861 . . . . 73.52 110.347 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.499 HG21 HG23 ' A' ' 79' ' ' THR . 72.1 mt -63.94 -46.13 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 114.914 -1.039 . . . . 73.43 110.905 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 28.5 mmm180 -63.04 -32.2 73.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.275 0.63 . . . . 72.34 111.72 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -66.71 -51.11 59.73 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.551 0.34 . . . . 71.31 111.124 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -65.02 -29.26 70.15 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.425 0.29 . . . . 73.15 111.722 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -68.66 -41.68 78.96 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.216 1.006 . . . . 74.14 110.467 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -72.08 -39.51 68.91 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.395 -0.821 . . . . 71.45 111.146 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 92.3 mt -67.12 -44.42 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.332 0.653 . . . . 70.33 110.975 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.25 -38.81 92.62 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.541 0.736 . . . . 53.13 110.819 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.59 -54.6 9.94 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 112.403 0.52 . . . . 70.13 112.403 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.8 p -83.38 -20.15 34.76 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.401 0.889 . . . . 71.11 113.401 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -114.98 -64.78 1.27 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 122.975 0.51 . . . . 70.45 111.088 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.96 -177.99 28.65 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 120.991 -0.623 . . . . 73.32 114.115 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.0 tp -72.9 -31.35 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.577 0.751 . . . . 73.24 111.441 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -64.66 -30.99 72.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.035 0.534 . . . . 73.03 111.435 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.51 67.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.737 0.815 . . . . 71.12 110.678 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 82' ' ' ILE . 54.4 t80 -60.79 -50.29 74.04 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.391 1.076 . . . . 71.23 112.392 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.95 -45.3 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.979 0.512 . . . . 63.45 111.216 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.06 -34.36 77.84 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.838 -0.619 . . . . 41.32 111.011 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.2 87.7 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.375 0.67 . . . . 63.52 112.139 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.9 mt -76.22 -51.39 12.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.264 0.625 . . . . 64.52 112.295 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.76 -20.52 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 121.125 0.488 . . . . 45.02 111.941 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -97.78 21.48 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.386 0.674 . . . . 65.42 111.963 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.0 m -83.06 153.93 24.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.951 -0.468 . . . . 71.44 111.846 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.52 -44.47 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.436 1.094 . . . . 72.31 111.632 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 30.9 tp10 -54.08 -52.86 59.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.459 -0.791 . . . . 73.04 111.902 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -64.86 -39.88 94.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 120.523 0.201 . . . . 71.51 110.582 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -60.9 -63.38 1.32 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.482 0.713 . . . . 72.15 111.742 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -76.33 -36.87 58.05 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 113.037 0.754 . . . . 73.14 113.037 -170.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.76 -27.93 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.008 0.523 . . . . 64.42 112.251 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -118.9 -78.49 0.59 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.936 -0.478 . . . . 62.02 110.498 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.1 170.46 15.83 Favored Glycine 0 N--CA 1.474 1.191 0 N-CA-C 112.399 -0.28 . . . . 74.24 112.399 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.668 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -73.22 -11.71 60.61 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.736 0.643 . . . . 74.51 112.736 -178.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.02 -10.75 19.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.034 0.934 . . . . 75.25 112.392 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.8 m -116.22 140.24 49.52 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.266 0.839 . . . . 64.45 113.266 -168.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 59' ' ' ILE . 58.6 t -83.56 150.63 60.27 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 125.966 1.706 . . . . 71.41 110.623 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.3 90.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.729 2.286 . . . . 74.3 112.6 161.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.3 p90 . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 123.694 0.798 . . . . 75.03 111.984 -175.316 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 107.783 -1.192 . . . . 74.3 107.783 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -74.9 106.34 6.37 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.128 0.571 . . . . 71.41 110.826 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.59 154.54 42.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.487 0.715 . . . . 74.2 110.223 175.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -70.96 147.2 48.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.142 0.973 . . . . 65.13 111.929 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.9 t -120.47 119.14 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.559 -1.645 . . . . 74.22 106.559 163.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.95 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.677 0.791 . . . . 71.04 112.177 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.57 -24.15 2.78 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.401 -0.818 . . . . 65.3 112.266 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.13 59.03 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 123.344 1.545 . . . . 73.01 109.845 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -80.28 8.47 7.38 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.189 -1.823 . . . . 72.44 113.28 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.91 133.08 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.029 0.532 . . . . 72.41 110.059 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 45.5 mtpt -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.154 0.798 . . . . 73.23 113.154 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.72 -53.02 62.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.053 0.541 . . . . 73.21 111.168 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.68 54.65 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.774 -0.648 . . . . 60.15 112.16 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 39.1 mm -57.91 -40.37 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 122.959 0.504 . . . . 74.44 111.643 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 2.6 ttpm? -56.7 -48.81 76.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.735 0.814 . . . . 73.34 112.01 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 m -68.65 -33.03 73.3 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.164 0.586 . . . . 73.44 111.618 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.63 -43.85 97.77 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.812 0.845 . . . . 73.04 110.213 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -68.7 -33.72 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.372 1.069 . . . . 71.21 111.618 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 71.6 m -67.77 -41.58 83.04 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.253 0.621 . . . . 74.33 110.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.4 85.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.262 0.625 . . . . 71.44 111.478 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.52 -30.36 70.59 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.893 0.877 . . . . 65.23 112.272 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -76.31 -37.69 57.07 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.401 0.519 . . . . 75.43 112.401 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 21' ' ' SER . 89.0 mtt180 -65.95 -26.49 67.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.523 0.729 . . . . 72.4 112.627 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.57 HE22 ' HG2' ' A' ' 135' ' ' PRO . 14.4 pt20 -85.59 -36.39 20.43 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 122.696 0.398 . . . . 75.13 111.895 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.514 HG12 ' HG3' ' A' ' 26' ' ' GLN . 46.2 mm -87.75 -63.27 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.359 0.664 . . . . 53.54 110.786 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.21 -4.75 54.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.817 0.847 . . . . 72.14 111.545 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 68.92 10.09 7.74 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.411 1.485 . . . . 74.05 112.909 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.56 144.83 25.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.42 0.628 . . . . 72.13 111.624 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -68.16 134.27 50.25 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.054 -0.976 . . . . 54.12 110.405 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.31 140.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 122.955 0.502 . . . . 75.31 110.185 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.93 129.26 91.13 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-N 115.063 -0.971 . . . . 71.35 110.839 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -54.95 -38.72 92.93 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.841 3.027 . . . . 45.51 115.181 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -64.73 -27.54 68.98 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.235 0.457 . . . . 65.31 112.235 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -79.82 -49.13 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.509 0.724 . . . . 52.44 110.037 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.552 1.141 . . . . 61.44 113.232 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.08 -26.17 56.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.926 0.49 . . . . 73.13 111.642 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -75.63 -33.52 60.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.474 0.31 . . . . 74.43 110.622 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -74.11 -53.65 9.47 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 116.016 -0.538 . . . . 55.03 111.06 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 78.9 m-85 -116.65 55.7 0.81 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.791 0.836 . . . . 73.34 111.847 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 98.7 p -62.67 -48.33 79.78 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.721 -0.612 . . . . 62.44 112.579 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.9 -40.73 13.76 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.837 -0.62 . . . . 61.42 112.418 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 21.6 t-105 -62.06 -42.0 98.74 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.324 1.05 . . . . 73.01 112.036 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.12 -46.52 88.11 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.27 1.028 . . . . 75.03 111.534 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.8 t -61.01 -41.93 97.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.488 -0.778 . . . . 62.14 111.601 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' HG23 ' A' ' 53' ' ' ILE . 59.6 mtpt -65.29 -32.6 74.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 73.13 111.835 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.69 -45.05 60.79 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.725 0.298 . . . . 73.43 111.061 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.07 76.59 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.711 -0.677 . . . . 74.53 113.942 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -91.47 -20.06 22.16 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.808 0.843 . . . . 71.35 111.871 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.61 25.17 33.57 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 114.172 0.429 . . . . 74.04 114.172 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -69.58 -44.06 71.56 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.315 0.646 . . . . 62.32 110.179 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.418 HG23 ' HE2' ' A' ' 47' ' ' LYS . 32.6 pt -110.62 157.44 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.021 0.929 . . . . 72.21 110.081 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 57' ' ' GLU . 11.9 t -90.15 167.25 12.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.566 0.346 . . . . 73.03 110.33 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 59' ' ' ILE . 66.2 t -61.79 -44.21 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 122.977 0.511 . . . . 62.24 111.134 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 64.1 tttm -55.39 -42.12 73.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.223 1.009 . . . . 62.35 112.815 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' H ' HG23 ' A' ' 54' ' ' THR . 26.5 tt0 -69.42 -36.21 76.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.758 -0.655 . . . . 74.41 111.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.0 -47.08 86.38 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.733 0.813 . . . . 72.41 110.726 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 55' ' ' VAL . 47.7 mm -56.87 -45.55 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 124.431 1.093 . . . . 72.22 111.129 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.74 -44.24 93.88 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.402 -0.817 . . . . 72.55 110.871 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.02 -26.98 69.68 Favored Glycine 0 CA--C 1.543 1.782 0 N-CA-C 114.768 0.667 . . . . 72.31 114.768 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.02 -25.89 63.8 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.006 0.522 . . . . 74.52 110.933 172.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.33 -25.47 74.33 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.503 -0.771 . . . . 60.55 113.64 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.02 -7.45 59.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.637 0.775 . . . . 54.54 111.905 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.423 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.3 p -74.41 134.55 42.39 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -56.69 -28.74 61.41 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.696 0.799 . . . . 63.41 112.29 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.6 tp -65.82 -46.71 77.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.93 0.492 . . . . 65.03 111.253 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.6 -35.51 79.11 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.191 0.52 . . . . 43.21 111.069 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.636 HD11 HG12 ' A' ' 112' ' ' ILE . 4.3 mm? -60.81 -48.35 82.18 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.8 0.84 . . . . 71.35 112.106 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -75.86 -30.59 58.95 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.489 0.551 . . . . 43.22 112.489 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.32 -47.04 45.82 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.897 0.703 . . . . 53.24 112.897 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.48 -55.33 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.794 1.035 . . . . 54.3 113.794 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' HE1' HD21 ' A' ' 107' ' ' LEU . 83.3 t80 -62.89 -33.41 75.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.057 0.762 . . . . 73.54 113.057 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.512 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 33.4 m -79.14 -55.1 0.95 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 118.549 -0.739 . . . . 63.51 112.721 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 11.9 Cg_exo -74.37 -5.06 16.38 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.657 2.238 . . . . 44.35 114.541 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -124.87 146.18 52.36 Favored Pre-proline 0 N--CA 1.494 1.726 0 C-N-CA 122.98 0.512 . . . . 74.42 111.884 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 81' ' ' VAL . 72.5 Cg_endo -72.44 168.5 24.13 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.822 2.348 . . . . 71.14 112.816 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -48.93 -54.77 14.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.402 1.081 . . . . 71.5 112.432 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.55 ' HA ' HD12 ' A' ' 82' ' ' ILE . 37.1 m -54.82 -40.05 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.935 0.894 . . . . 72.21 113.281 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -69.2 -32.0 70.98 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.088 0.403 . . . . 71.32 112.088 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 77' ' ' PRO . 59.0 t -69.39 -26.18 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.029 0.532 . . . . 74.32 109.997 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 79' ' ' THR . 61.0 mt -74.36 -52.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.724 0.809 . . . . 74.41 111.003 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -56.25 24.07 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.941 0.897 . . . . 72.4 112.261 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.96 -40.2 94.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.281 0.632 . . . . 74.24 111.323 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.68 -51.45 55.86 Favored Glycine 0 N--CA 1.474 1.219 0 O-C-N 123.481 0.488 . . . . 72.25 112.93 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 94' ' ' PRO . 40.1 p -61.43 -36.46 80.41 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.522 0.729 . . . . 72.3 112.514 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -73.0 -16.46 61.51 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.94 0.719 . . . . 72.53 112.94 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -86.27 -40.64 15.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.869 0.468 . . . . 74.32 111.319 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' HG22 ' A' ' 59' ' ' ILE . 88.4 m-85 -91.05 -64.74 1.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.343 0.592 . . . . 72.43 110.7 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.46 -10.01 59.2 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.008 0.923 . . . . 63.14 112.397 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.86 21.37 67.45 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 114.209 0.443 . . . . 44.53 114.209 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -149.47 169.92 19.78 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.875 0.87 . . . . 74.45 111.051 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.6 150.69 39.22 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.427 0.691 . . . . 71.12 110.264 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HG3' HG21 ' A' ' 86' ' ' THR . 32.9 Cg_exo -58.55 159.87 18.84 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.931 2.421 . . . . 61.11 112.712 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.43 -62.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.978 0.511 . . . . 62.44 111.542 -169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -133.85 163.21 30.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.636 0.775 . . . . 64.43 110.148 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -59.13 -33.12 70.5 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.848 0.859 . . . . 73.54 112.615 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.12 77.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.514 0.326 . . . . 64.24 111.803 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.9 -36.71 70.09 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.032 0.533 . . . . 73.43 111.111 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.22 -43.61 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.876 0.47 . . . . 60.12 110.077 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 mtm105 -66.27 -30.22 70.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.331 0.652 . . . . 71.02 111.804 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -62.56 -52.47 63.29 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.987 0.515 . . . . 75.13 111.094 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.09 -37.41 84.95 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.898 0.479 . . . . 74.14 111.514 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.37 -39.55 94.84 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.405 1.082 . . . . 70.43 110.863 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.74 -44.62 77.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.475 0.71 . . . . 73.41 111.104 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.89 -43.29 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.016 0.926 . . . . 74.44 111.61 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.8 tt -65.1 -41.07 95.28 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.224 0.61 . . . . 73.54 110.966 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.01 -38.54 86.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.738 0.415 . . . . 41.34 112.032 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.9 p -81.6 -69.59 0.6 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.775 0.83 . . . . 63.21 112.125 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -83.96 -35.3 24.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.98 0.912 . . . . 72.54 111.891 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.08 -172.41 14.88 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 121.119 0.288 . . . . 44.43 113.518 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.636 HG12 HD11 ' A' ' 69' ' ' LEU . 7.4 tp -68.97 -38.21 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.558 0.743 . . . . 73.41 112.249 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -63.52 -42.89 98.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.322 0.649 . . . . 63.11 111.434 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.4 -32.67 66.57 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.713 -0.676 . . . . 63.02 110.636 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.451 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 32.8 t80 -61.78 -51.92 66.33 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 124.122 0.969 . . . . 75.11 112.269 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.9 mm -55.97 -51.77 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.85 0.86 . . . . 74.13 110.442 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -52.14 -49.05 64.5 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 115.23 -0.896 . . . . 75.43 111.86 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.77 67.88 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 61.14 112.787 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.48 -53.3 36.73 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.093 0.473 . . . . 53.4 110.585 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.484 HG12 ' NZ ' ' A' ' 56' ' ' LYS . 39.2 t -69.12 -18.54 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.792 0.837 . . . . 73.44 112.612 -171.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.16 13.65 2.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 73.31 112.766 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.7 p -77.34 136.56 38.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.326 0.651 . . . . 73.25 110.774 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.444 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 46.4 tt0 -68.71 -39.77 80.29 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.713 0.635 . . . . 72.51 112.713 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -53.89 -30.85 47.73 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.516 0.561 . . . . 74.1 112.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.28 -56.46 21.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.138 0.575 . . . . 61.44 110.527 172.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 123' ' ' GLN . 1.9 p-10 -73.87 -20.86 60.29 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 111.976 0.361 . . . . 73.33 111.976 -173.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 27.6 mm-40 -67.49 -59.15 3.61 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.149 0.499 . . . . 64.52 111.164 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -71.96 -61.0 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.598 -0.728 . . . . 61.04 111.574 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -84.43 -62.6 1.51 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.083 0.553 . . . . 61.42 110.46 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.26 173.47 27.39 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.615 -0.72 . . . . 54.23 112.657 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.31 -34.19 48.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.884 0.473 . . . . 75.33 111.606 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.25 -8.31 59.08 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.042 0.937 . . . . 61.05 112.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -113.05 143.95 43.45 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.384 0.674 . . . . 73.23 111.344 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.05 130.01 85.53 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.924 0.89 . . . . 74.32 109.248 170.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.57 ' HG2' HE22 ' A' ' 26' ' ' GLN . 89.9 Cg_exo -46.97 85.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.953 3.102 . . . . 65.12 115.71 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.1 p90 . . . . . 0 CA--C 1.552 1.02 0 CA-C-O 121.63 0.729 . . . . 73.41 109.036 172.356 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 136' ' ' TYR . 6.3 p . . . . . 0 CA--C 1.556 1.196 0 CA-C-O 121.803 0.811 . . . . 75.42 109.145 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -107.72 105.52 15.4 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.437 0.695 . . . . 73.31 112.011 -168.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -94.7 111.12 22.9 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.136 0.575 . . . . 71.25 111.417 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.403 ' HD2' ' HG ' ' A' ' 48' ' ' LEU . 6.2 ptm180 -62.23 131.18 48.55 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.226 0.536 . . . . 74.42 110.915 169.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 10' ' ' ILE . 47.4 t -98.87 131.63 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.148 -0.686 . . . . 73.42 109.148 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.03 -36.16 2.4 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.717 1.006 . . . . 72.15 113.717 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -70.96 -24.52 77.03 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.605 1.002 . . . . 64.01 115.605 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 7' ' ' VAL . 71.9 mt -71.24 89.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 118.191 0.996 . . . . 64.12 110.71 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.48 6.64 0.58 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.654 1.353 . . . . 73.14 114.654 173.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.09 98.28 9.79 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.698 -0.626 . . . . 62.33 111.155 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -59.12 -24.93 63.42 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.802 0.841 . . . . 75.33 110.973 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -48.51 68.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.862 0.865 . . . . 71.24 111.082 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.26 67.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 64.5 112.414 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mm -61.01 -48.9 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.714 0.405 . . . . 73.53 109.916 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -61.37 -35.76 78.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.351 0.5 . . . . 74.45 112.351 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.5 m -65.65 -41.34 92.68 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.876 0.47 . . . . 75.43 111.23 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.56 -46.07 87.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.384 1.074 . . . . 62.21 111.116 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.498 HD13 ' HG2' ' A' ' 45' ' ' GLU . 91.6 mt -61.79 -43.29 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.908 1.283 . . . . 61.25 111.601 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.7 m -63.84 -45.12 90.95 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.633 -0.712 . . . . 71.32 110.297 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.4 71.24 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.808 0.843 . . . . 74.34 112.498 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.83 -43.55 81.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.309 0.644 . . . . 61.3 112.552 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HE1' HD22 ' A' ' 62' ' ' LEU . 21.5 m-85 -60.94 -28.42 68.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.101 0.778 . . . . 72.03 113.101 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.81 -13.99 60.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.609 0.764 . . . . 75.13 112.007 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -118.32 -52.05 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.17 0.433 . . . . 64.21 112.17 169.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 88' ' ' HIS . 41.7 mm -55.8 -38.14 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 123.81 0.844 . . . . 75.42 112.197 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -114.72 2.83 14.55 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.643 0.777 . . . . 73.22 110.799 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 35.28 35.72 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 116.053 1.871 . . . . 63.43 116.053 -168.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.515 HH12 ' HG3' ' A' ' 71' ' ' GLU . 3.9 ptp85 -135.55 155.54 50.32 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.586 0.708 . . . . 73.44 111.635 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.97 96.26 8.79 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.909 -1.041 . . . . 54.24 109.541 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.74 134.32 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.038 -0.727 . . . . 74.12 109.038 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.35 126.78 87.16 Favored Pre-proline 0 CA--C 1.551 0.999 0 O-C-N 123.993 0.808 . . . . 72.4 110.238 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.49 -25.21 75.73 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.826 2.351 . . . . 62.12 112.857 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -79.2 -26.78 42.56 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.31 0.644 . . . . 52.14 112.21 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.7 mt -80.07 -39.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.053 0.541 . . . . 61.52 110.207 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.51 85.62 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.944 0.898 . . . . 54.02 111.709 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -72.93 -20.4 61.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.685 0.624 . . . . 72.13 112.685 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -75.87 -41.53 51.94 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.004 0.43 . . . . 60.23 110.639 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -76.57 -39.85 51.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.906 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 96.4 m-85 -116.66 26.62 9.72 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.675 0.991 . . . . 61.54 113.675 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -49.21 -49.83 41.16 Favored 'General case' 0 N--CA 1.515 2.78 0 N-CA-C 114.502 1.297 . . . . 62.52 114.502 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -75.1 -34.53 51.89 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.392 -0.367 . . . . 54.02 112.766 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -63.4 -31.64 72.85 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.201 1.001 . . . . 65.13 111.328 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HG2' HD13 ' A' ' 20' ' ' ILE . 47.7 mt-10 -70.45 -41.75 72.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.167 0.987 . . . . 71.32 110.67 172.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.9 t -61.84 -39.24 91.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 53.23 111.017 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.5 mmmm -60.16 -38.0 81.82 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.747 0.419 . . . . 74.54 110.726 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD11 HG22 ' A' ' 55' ' ' VAL . 22.7 tp -73.25 -49.05 29.9 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.522 0.729 . . . . 75.31 111.942 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.37 73.59 Favored Glycine 0 N--CA 1.484 1.841 0 C-N-CA 123.315 0.483 . . . . 54.13 114.199 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -85.74 -19.11 31.28 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.444 0.697 . . . . 75.52 110.02 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.02 24.65 47.87 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.714 -1.13 . . . . 64.33 112.739 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -66.23 -40.04 89.97 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.003 0.921 . . . . 63.12 110.29 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' HD2' ' A' ' 58' ' ' PHE . 22.2 pt -116.1 143.83 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.91 0.884 . . . . 71.5 110.123 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 57' ' ' GLU . 8.7 t -71.73 162.83 28.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.413 0.285 . . . . 73.42 111.24 163.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 48' ' ' LEU . 22.2 t -65.16 -34.54 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.231 0.212 . . . . 73.22 110.985 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.573 ' HD2' ' HG3' ' A' ' 131' ' ' GLU . 26.8 tttp -50.43 -51.04 50.22 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.695 0.798 . . . . 74.04 113.059 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 54' ' ' THR . 29.1 tt0 -69.61 -31.2 69.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.474 0.71 . . . . 60.12 110.945 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HD2' HD11 ' A' ' 53' ' ' ILE . 36.9 t80 -57.85 -46.94 84.04 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.192 0.597 . . . . 72.12 110.93 170.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 55' ' ' VAL . 51.5 mm -60.69 -40.21 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.039 0.936 . . . . 71.32 111.308 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -54.34 -50.74 66.72 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 115.58 -0.737 . . . . 75.01 111.74 172.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.72 -28.62 57.14 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 115.063 0.785 . . . . 75.34 115.063 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.425 HD22 ' HE1' ' A' ' 24' ' ' TYR . 43.9 mt -71.65 -37.7 70.79 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.018 0.527 . . . . 70.32 110.988 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.91 -26.17 73.19 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 116.413 -0.358 . . . . 53.34 113.454 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.64 -3.17 55.83 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.896 0.879 . . . . 72.5 112.052 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -81.79 130.11 34.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.012 0.525 . . . . 70.14 111.798 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.37 -17.28 28.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.152 0.981 . . . . 75.14 112.371 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.69 -57.09 14.15 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.804 0.442 . . . . 74.14 111.198 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -58.73 -37.04 75.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.97 0.729 . . . . 74.01 112.97 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.681 HD11 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -61.89 -49.68 75.23 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.34 0.496 . . . . 74.12 112.34 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.94 -31.22 71.65 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 113.043 0.757 . . . . 74.43 113.043 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.515 ' HG3' HH12 ' A' ' 30' ' ' ARG . 19.7 mm-40 -87.93 -60.77 1.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.724 1.009 . . . . 64.22 113.724 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -111.77 60.16 0.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.746 0.703 . . . . 73.41 112.429 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 81' ' ' VAL . 58.6 t80 -165.57 -58.7 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.236 0.614 . . . . 72.25 110.293 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 m -63.75 -49.18 77.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 113.021 0.749 . . . . 62.41 113.021 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -86.98 13.34 2.73 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.016 1.811 . . . . 71.22 113.505 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -124.09 150.02 62.01 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.642 0.777 . . . . 61.33 111.455 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.82 165.78 31.8 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.412 2.074 . . . . 63.31 112.406 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.1 -34.76 78.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 73.33 112.517 -170.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.501 ' HA ' HD12 ' A' ' 82' ' ' ILE . 78.4 m -70.39 -38.37 74.66 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.536 0.734 . . . . 74.42 112.353 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.3 -34.42 76.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.147 -0.346 . . . . 63.11 111.601 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 73' ' ' TYR . 87.1 t -56.56 -34.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.595 0.758 . . . . 64.33 110.848 171.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 79' ' ' THR . 77.0 mt -74.04 -48.7 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.546 0.739 . . . . 74.23 111.917 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -58.06 6.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.215 0.45 . . . . 75.15 112.215 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.3 mt -61.85 -25.21 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.35 0.66 . . . . 72.53 111.047 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 89' ' ' PHE . . . -63.7 -40.8 98.92 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 114.695 -1.138 . . . . 60.04 112.147 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -79.1 -44.52 21.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.256 0.623 . . . . 63.4 111.978 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -61.77 -49.55 75.93 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.327 0.862 . . . . 73.14 113.327 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.48 ' O ' HD13 ' A' ' 27' ' ' ILE . 11.8 m170 -61.59 -31.02 71.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.525 0.73 . . . . 72.03 112.534 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.609 ' HB3' HD12 ' A' ' 90' ' ' LEU . 1.1 t80 -98.96 -67.04 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.252 0.621 . . . . 75.03 112.088 -167.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 89' ' ' PHE . 6.5 mp -77.32 -5.42 49.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.459 0.911 . . . . 72.13 113.459 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.57 33.04 75.69 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.054 0.252 . . . . 62.14 113.081 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.672 HH22 HG21 ' A' ' 128' ' ' VAL . 19.2 ptp180 -160.02 157.25 28.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.955 0.902 . . . . 72.34 111.297 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.82 153.09 95.81 Favored Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 109.944 -0.391 . . . . 31.13 109.944 168.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.15 167.14 4.84 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.451 2.101 . . . . 65.42 113.063 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.494 HD13 ' HG2' ' A' ' 99' ' ' GLU . 2.6 mp -80.59 -53.34 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.108 0.563 . . . . 71.5 110.402 -169.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.47 165.14 10.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 74.01 109.187 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 58.2 tp60 -61.94 -30.25 70.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.854 0.462 . . . . 70.2 111.697 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.05 -45.47 88.67 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.058 0.543 . . . . 62.32 111.763 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.494 ' HG2' HD13 ' A' ' 95' ' ' ILE . 7.9 tp10 -62.55 -38.23 89.24 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.176 0.591 . . . . 75.4 111.303 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.455 HG21 HG23 ' A' ' 79' ' ' THR . 72.4 mt -60.58 -42.53 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.761 0.824 . . . . 52.33 111.209 173.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.6 mtt180 -58.13 -37.0 73.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.64 0.607 . . . . 63.43 112.64 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -62.08 -53.74 51.15 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 120.879 0.371 . . . . 62.02 110.59 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -62.38 -36.22 81.6 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.567 -0.742 . . . . 65.44 112.412 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.56 -38.95 91.04 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.529 0.732 . . . . 64.03 111.387 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.58 -38.5 90.38 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.582 -0.735 . . . . 75.13 110.506 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 81.9 mt -64.47 -48.64 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 123.589 0.756 . . . . 70.11 111.291 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.25 -37.09 66.77 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.137 0.575 . . . . 75.02 112.099 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.58 -48.53 32.08 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.191 0.596 . . . . 62.34 111.881 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -77.05 -71.91 0.38 Allowed 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.618 -0.719 . . . . 73.12 112.413 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -89.89 -53.49 4.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 70.12 112.003 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 -157.97 23.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.346 0.499 . . . . 34.43 114.346 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.681 HG12 HD11 ' A' ' 69' ' ' LEU . 8.8 tp -76.98 -37.58 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.507 0.723 . . . . 73.1 112.457 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.11 -31.22 71.96 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 75.4 111.521 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.76 57.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.99 -1.004 . . . . 73.04 110.671 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -67.19 -45.69 76.16 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 64.25 111.048 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 120' ' ' VAL . 47.9 mm -63.97 -55.53 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.901 0.48 . . . . 65.44 110.171 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.58 -38.57 55.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.115 0.566 . . . . 73.33 112.237 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.86 88.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.552 0.341 . . . . 53.21 111.813 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.63 -39.29 77.23 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.274 0.63 . . . . 72.23 111.862 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 116' ' ' ILE . 18.1 t -67.41 -41.89 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.482 0.658 . . . . 70.34 110.605 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.2 -10.0 53.72 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.907 0.883 . . . . 73.32 111.444 -177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.9 t -57.6 146.47 30.27 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.273 0.629 . . . . 75.41 111.448 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.7 pt20 -69.46 -38.01 77.57 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.926 0.49 . . . . 73.34 110.405 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -61.39 -38.71 88.02 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.101 0.961 . . . . 62.34 111.777 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.496 ' HD1' ' HA ' ' A' ' 90' ' ' LEU . 59.5 t80 -77.2 -41.89 39.64 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.581 0.753 . . . . 75.54 111.447 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 63.9 t30 -67.44 -51.59 49.84 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.183 0.808 . . . . 71.15 113.183 -165.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 12.6 pt-20 -91.16 -26.14 19.23 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.409 0.522 . . . . 72.0 112.409 -171.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 HH22 ' A' ' 92' ' ' ARG . 79.2 t -78.76 -50.72 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 122.871 0.469 . . . . 72.55 110.732 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.491 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 1.5 t80 -81.03 -45.79 16.02 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.594 0.758 . . . . 71.22 111.972 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.76 -144.02 17.04 Favored Glycine 0 N--CA 1.482 1.752 0 CA-C-O 119.749 -0.473 . . . . 71.31 112.807 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.573 ' HG3' ' HD2' ' A' ' 56' ' ' LYS . 4.7 mp0 -126.13 -58.13 1.38 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 117.831 0.815 . . . . 72.15 112.5 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.71 11.8 0.96 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.878 1.807 . . . . 63.23 115.878 -162.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.0 t -134.94 174.29 10.76 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.956 0.724 . . . . 64.23 112.956 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -84.71 136.34 39.39 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 123.896 0.879 . . . . 74.1 110.287 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -58.54 134.1 58.81 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.966 2.444 . . . . 74.32 112.214 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.519 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 17.9 p90 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 123.947 0.899 . . . . 74.42 112.247 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.695 -0.483 . . . . 65.21 109.695 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.99 93.22 1.35 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.432 0.634 . . . . 73.55 109.624 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -126.58 151.05 48.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.389 1.075 . . . . 65.51 109.002 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -84.87 122.17 28.79 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.094 -0.379 . . . . 72.43 110.373 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -83.37 122.32 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.222 0.609 . . . . 44.51 109.439 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.06 94.35 0.23 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.41 0.684 . . . . 65.31 112.069 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.73 11.41 16.98 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.636 0.615 . . . . 62.03 114.636 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.25 97.98 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.801 0 CA-C-N 117.632 0.716 . . . . 74.21 110.64 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -64.18 -32.22 73.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.835 -1.165 . . . . 52.34 113.154 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -42.68 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.772 0.829 . . . . 64.11 112.336 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -71.67 -9.03 57.65 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 114.865 -1.061 . . . . 73.11 111.359 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.35 -41.71 93.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.375 0.67 . . . . 72.24 109.991 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.1 75.47 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.822 0.849 . . . . 74.12 111.838 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.92 -44.99 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.923 0.489 . . . . 73.31 111.354 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -73.76 -35.67 65.03 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.557 0.743 . . . . 75.44 112.899 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 t -66.71 -29.97 70.09 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 120.711 0.291 . . . . 74.14 111.413 172.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.613 HD22 HD21 ' A' ' 48' ' ' LEU . 8.3 tt -68.27 -45.3 73.51 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.072 0.949 . . . . 65.24 109.661 173.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.11 -44.9 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 124.504 1.122 . . . . 73.13 111.71 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -69.17 -36.85 77.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.374 0.67 . . . . 73.11 111.722 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.06 80.09 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.628 0.771 . . . . 53.01 111.105 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.15 -42.81 65.52 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.098 0.959 . . . . 71.5 111.911 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.84 -49.86 48.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.019 0.527 . . . . 72.02 111.895 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -64.0 -14.88 57.47 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.829 1.048 . . . . 70.34 113.829 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -95.23 -61.66 1.44 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.327 0.512 . . . . 62.32 110.398 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.3 -42.82 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 123.587 0.755 . . . . 73.42 111.837 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.32 -12.16 33.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.497 0.319 . . . . 71.32 111.709 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.35 32.72 22.41 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.042 1.497 . . . . 72.14 115.042 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 166.63 29.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.092 0.775 . . . . 73.24 113.092 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.43 101.29 8.09 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 114.208 -1.36 . . . . 52.44 110.6 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -80.69 118.84 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.352 -0.61 . . . . 73.12 109.352 167.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.14 93.63 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.336 0.655 . . . . 71.51 111.45 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.13 -37.41 79.6 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.235 2.623 . . . . 64.53 114.3 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -71.5 -26.85 62.86 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.483 0.549 . . . . 74.41 112.483 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.45 -38.22 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.158 0.504 . . . . 75.44 110.199 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.16 -32.98 74.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.154 0.982 . . . . 60.4 112.797 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -76.13 -16.82 59.81 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.681 0.392 . . . . 64.24 111.728 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -80.54 -47.39 14.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.028 0.531 . . . . 75.42 110.983 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.86 -45.58 23.85 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.621 0.768 . . . . 75.13 111.695 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 75.8 m-85 -116.64 52.71 0.92 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.764 0.825 . . . . 74.34 111.657 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.74 -55.4 13.25 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.123 0.487 . . . . 64.35 112.189 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.86 -30.31 63.79 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.706 -0.679 . . . . 62.25 113.008 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 6.7 t-105 -67.5 -38.24 84.02 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.718 0.807 . . . . 64.23 112.041 -174.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -57.62 -49.84 75.11 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.253 1.021 . . . . 73.32 110.177 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -53.47 -49.78 66.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.212 1.005 . . . . 74.45 111.881 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.99 -33.88 76.35 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.721 0.637 . . . . 75.33 112.721 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.613 HD21 HD22 ' A' ' 19' ' ' LEU . 37.9 tp -71.8 -43.25 65.99 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 120.731 0.3 . . . . 72.44 110.93 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.85 -19.72 77.07 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.597 0.599 . . . . 72.5 114.597 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -94.9 -12.21 27.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.128 0.571 . . . . 74.54 112.098 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.0 71.37 Favored Glycine 0 C--N 1.35 1.308 0 C-N-CA 121.859 -0.21 . . . . 70.23 113.615 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.73 -32.42 65.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.644 0.777 . . . . 44.43 111.394 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -129.35 156.58 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.427 0.691 . . . . 63.43 109.517 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 p -85.4 178.8 7.32 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.818 0.342 . . . . 75.31 110.611 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 59' ' ' ILE . 74.4 t -64.34 -38.28 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 116.492 -0.322 . . . . 71.24 110.527 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 13.9 tttm -60.02 -44.21 94.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.894 0.478 . . . . 64.34 111.731 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -68.01 -24.73 65.15 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.344 0.658 . . . . 74.12 111.456 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -77.44 -48.11 18.0 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.283 -1.006 . . . . 75.14 108.283 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 46.7 mm -60.67 -33.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 125.062 1.345 . . . . 71.24 111.244 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.26 -51.52 69.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.283 0.633 . . . . 71.35 111.214 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.34 -29.47 66.18 Favored Glycine 0 C--N 1.357 1.729 0 N-CA-C 114.883 0.713 . . . . 72.31 114.883 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.27 -28.57 68.14 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.969 0.385 . . . . 55.34 110.989 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.73 -31.57 44.15 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.116 -0.493 . . . . 51.01 113.461 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.8 -4.44 57.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.56 0.744 . . . . 70.03 112.643 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 p -77.77 141.38 39.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.042 0.383 . . . . 61.41 111.407 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -56.93 -31.29 64.8 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.714 0.805 . . . . 71.11 111.677 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.3 tp -62.0 -46.68 88.13 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.562 0.745 . . . . 74.45 111.315 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -63.21 -36.45 83.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.924 0.393 . . . . 72.43 111.333 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 112' ' ' ILE . 4.5 mm? -68.18 -45.23 74.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.722 0.809 . . . . 60.03 112.815 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -73.17 -30.46 63.58 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.002 -0.436 . . . . 73.34 112.126 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -82.12 -53.49 6.05 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.796 1.036 . . . . 73.1 113.796 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -118.25 42.13 2.77 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.399 0.888 . . . . 73.25 113.399 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.553 ' HA ' HG22 ' A' ' 81' ' ' VAL . 65.7 t80 -155.9 -53.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.027 0.442 . . . . 62.54 111.256 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 m -68.59 -48.1 33.33 Favored Pre-proline 0 CA--C 1.573 1.854 0 N-CA-C 113.33 0.863 . . . . 72.22 113.33 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.73 3.93 7.46 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.92 1.746 . . . . 74.53 113.961 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.27 150.77 70.92 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.697 0.799 . . . . 73.5 111.654 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.24 171.01 15.8 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.351 2.034 . . . . 73.11 111.906 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.59 -49.55 74.57 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.329 0.651 . . . . 75.03 111.542 -176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 HG21 ' A' ' 100' ' ' ILE . 30.4 m -58.67 -21.99 55.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.934 1.293 . . . . 75.01 114.389 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.86 -35.53 13.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.989 -0.745 . . . . 64.23 108.989 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 73' ' ' TYR . 60.2 t -56.81 -31.88 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.538 -0.755 . . . . 73.14 110.244 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 79' ' ' THR . 92.1 mt -68.09 -53.28 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.36 -0.836 . . . . 74.32 112.119 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.24 -50.13 56.02 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.402 1.001 . . . . 70.02 112.392 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.21 -31.04 69.78 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.098 0.559 . . . . 75.41 112.053 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.81 -45.74 50.19 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.558 -0.292 . . . . 62.31 112.902 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.638 HG23 HD12 ' A' ' 90' ' ' LEU . 88.0 m -64.19 -43.81 93.94 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.499 0.72 . . . . 62.55 111.911 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -60.98 -28.29 68.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.659 0.985 . . . . 74.1 113.659 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -73.41 -34.65 65.6 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.581 0.586 . . . . 63.13 112.581 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -104.76 -65.02 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.67 0.388 . . . . 65.03 111.581 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD12 HG23 ' A' ' 86' ' ' THR . 90.5 mt -75.47 -12.03 60.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.127 0.571 . . . . 74.44 112.466 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.45 24.95 75.41 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.651 0.62 . . . . 63.22 114.651 175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -159.27 -176.19 5.67 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 117.618 0.709 . . . . 52.34 111.794 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.02 30.58 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.693 0.797 . . . . 70.25 110.603 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.89 155.31 18.55 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.43 2.753 . . . . 72.55 113.636 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.481 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 49.5 mt -65.1 -52.61 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.694 0.798 . . . . 63.12 112.568 -169.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -148.59 171.58 15.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.47 0.708 . . . . 65.31 109.297 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -60.79 -28.98 69.16 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.031 0.532 . . . . 72.21 111.524 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.44 85.94 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.712 0.805 . . . . 52.44 111.215 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 15.4 tp10 -58.85 -43.61 90.79 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.288 1.035 . . . . 73.31 111.631 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.587 HG21 HG23 ' A' ' 79' ' ' THR . 73.2 mt -62.67 -50.56 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.873 0.869 . . . . 72.53 111.251 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -64.59 -29.59 70.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.324 0.65 . . . . 74.34 111.655 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -62.09 -49.92 74.03 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.711 0.804 . . . . 72.51 110.409 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -63.25 -40.72 98.23 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.902 0.481 . . . . 72.23 111.714 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.9 -34.97 77.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.406 0.683 . . . . 40.2 110.972 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -64.28 -36.43 84.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.763 0.825 . . . . 51.31 111.325 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.96 -42.89 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.601 0.761 . . . . 70.23 110.989 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -36.17 82.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.192 0.597 . . . . 75.12 111.669 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.46 -44.85 73.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.216 0.606 . . . . 53.3 111.495 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.2 p -77.71 -69.59 0.53 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.119 0.785 . . . . 74.15 113.119 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -93.3 -46.95 7.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.964 -0.46 . . . . 73.22 111.724 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.8 -159.68 15.39 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 121.002 0.223 . . . . 62.25 113.581 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 69' ' ' LEU . 8.5 tp -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 123.908 0.883 . . . . 74.03 113.114 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -57.36 -42.35 81.85 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.316 0.646 . . . . 71.31 111.709 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.96 -28.24 43.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.269 -0.878 . . . . 75.45 110.899 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.63 -48.66 71.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.049 0.939 . . . . 72.42 110.931 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.67 -54.63 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 74.11 110.323 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -45.41 -42.08 9.91 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.13 0.972 . . . . 73.24 113.052 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.68 94.31 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.767 0.427 . . . . 61.23 111.882 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.7 -41.7 78.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.521 0.728 . . . . 61.14 112.131 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.28 -47.54 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 122.806 0.442 . . . . 63.34 111.689 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -81.46 2.27 29.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.46 0.541 . . . . 74.0 112.46 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 t -61.2 132.5 53.86 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.953 0.501 . . . . 52.3 109.986 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.03 -36.0 74.24 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.265 0.353 . . . . 72.43 111.139 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.9 -45.41 82.61 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.965 0.906 . . . . 73.22 111.786 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.468 ' HB2' HD23 ' A' ' 90' ' ' LEU . 87.8 t80 -58.23 -54.71 43.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.883 -0.414 . . . . 72.45 109.883 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -60.5 -28.3 68.26 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.611 0.764 . . . . 70.12 112.745 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.21 -40.1 14.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.448 0.699 . . . . 75.51 112.332 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 91.5 t -89.44 -61.52 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 122.932 0.493 . . . . 63.24 110.505 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -102.76 70.19 1.1 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.697 . . . . 70.51 109.395 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.06 178.65 0.79 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.623 -0.717 . . . . 64.03 114.537 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.644 ' HG2' ' HD3' ' A' ' 56' ' ' LYS . 27.9 mt-10 -63.91 -14.3 52.43 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.288 0.847 . . . . 54.41 113.288 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.22 -33.0 12.18 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.175 0.59 . . . . 73.15 111.884 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.5 m -86.0 136.59 33.19 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.125 0.57 . . . . 63.44 112.421 -173.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.77 135.73 31.78 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.398 1.079 . . . . 60.34 109.954 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.63 136.06 63.57 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.478 2.119 . . . . 72.12 112.796 167.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.5 p90 . . . . . 0 N--CA 1.483 1.188 0 C-N-CA 123.11 0.564 . . . . 71.11 111.195 177.948 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 t . . . . . 0 CA--C 1.55 0.949 0 N-CA-C 108.465 -0.939 . . . . 65.11 108.465 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.62 123.73 17.28 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.307 1.043 . . . . 74.21 111.783 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.14 162.15 38.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.252 0.621 . . . . 72.32 111.035 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -74.86 89.24 2.33 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.693 -0.685 . . . . 74.45 110.787 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -70.93 112.45 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-N 115.878 -0.601 . . . . 62.42 111.008 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.78 43.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.001 1.32 . . . . 72.12 113.583 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.26 -42.09 55.41 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.688 0.635 . . . . 42.31 114.688 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.5 mm -71.58 -54.54 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.565 0.746 . . . . 74.24 110.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 46.37 17.21 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 126.123 1.769 . . . . 64.53 115.146 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.43 138.31 31.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.921 0.888 . . . . 74.11 110.824 -169.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.49 -29.07 65.51 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.174 0.805 . . . . 62.01 113.174 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.12 -30.5 49.41 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.698 0.399 . . . . 64.24 110.696 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.79 -38.68 64.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.26 0.624 . . . . 74.3 109.959 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.573 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.5 mp -63.95 -34.97 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 115.256 -0.884 . . . . 74.55 110.027 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 34' ' ' PRO . 24.4 ttmm -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.918 0.71 . . . . 72.43 112.918 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -69.7 -34.01 73.32 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 122.018 -0.426 . . . . 64.0 110.41 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.04 -34.35 77.83 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.854 1.262 . . . . 45.12 110.355 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 16' ' ' ILE . 51.5 mm -62.59 -53.17 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.05 0.94 . . . . 73.42 109.514 174.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -65.76 -29.05 69.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.202 1.001 . . . . 74.23 112.867 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -41.41 59.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.528 0.731 . . . . 71.25 110.543 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.02 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.941 0.897 . . . . 73.41 111.927 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.949 0.499 . . . . 70.2 112.209 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtp85 -67.57 -14.36 62.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.111 0.564 . . . . 75.03 112.028 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.754 ' HG2' ' HB2' ' A' ' 135' ' ' PRO . 23.9 tp60 -95.9 -50.33 4.93 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.928 0.491 . . . . 74.12 111.147 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -78.46 -59.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.257 0.623 . . . . 74.53 111.005 -175.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -81.51 -7.05 59.53 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.723 0.409 . . . . 65.33 111.634 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 65.97 -54.48 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.502 1.921 . . . . 65.44 114.479 -174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -65.64 139.12 58.38 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.53 0.732 . . . . 74.43 112.282 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -65.59 128.66 36.85 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.229 -0.896 . . . . 63.51 109.649 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -105.47 142.51 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.193 0.597 . . . . 65.34 109.973 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 36' ' ' ILE . . . -62.66 124.34 82.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.955 0.902 . . . . 74.0 111.402 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 51.0 Cg_exo -56.01 -32.31 85.62 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 123.513 2.809 . . . . 75.43 115.575 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -72.78 -35.73 67.48 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.37 0.268 . . . . 64.53 111.206 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 33' ' ' ALA . 71.3 mt -66.25 -41.57 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.919 0.888 . . . . 73.43 110.423 172.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.68 64.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.031 0.932 . . . . 72.12 111.691 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -75.9 -61.38 1.95 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.526 -0.761 . . . . 73.22 110.914 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -63.21 -25.69 68.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.235 0.828 . . . . 63.14 113.235 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.26 -54.49 5.91 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.86 0.464 . . . . 73.32 110.773 172.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 85.1 m-85 -113.92 60.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.678 0.791 . . . . 75.03 111.557 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -73.27 -50.94 19.53 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.928 -0.483 . . . . 71.25 111.988 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.68 -31.34 58.6 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.287 -0.415 . . . . 60.43 112.377 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 8.7 t-105 -69.93 -37.47 75.9 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.194 0.997 . . . . 75.0 111.157 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.9 -41.9 81.99 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.013 0.925 . . . . 72.03 111.542 169.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -53.62 -54.46 37.35 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.57 1.148 . . . . 65.24 113.193 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.691 ' HD3' HG21 ' A' ' 53' ' ' ILE . 15.1 ptpt -61.18 -35.08 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.269 0.84 . . . . 63.54 113.269 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.1 tp -71.15 -34.22 70.8 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.308 0.243 . . . . 62.43 110.707 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.573 ' HA2' HG12 ' A' ' 16' ' ' ILE . . . -67.08 -33.52 83.72 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.76 -0.2 . . . . 72.25 112.861 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -73.63 -10.38 59.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.01 0.924 . . . . 75.23 112.144 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.99 32.5 82.36 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 115.364 0.906 . . . . 51.34 115.364 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.4 -60.2 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.902 0.858 . . . . 73.22 110.201 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.691 HG21 ' HD3' ' A' ' 47' ' ' LYS . 21.9 pt -73.13 176.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.797 -1.547 . . . . 74.35 112.181 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.608 HG23 ' H ' ' A' ' 57' ' ' GLU . 1.8 t -99.51 153.37 19.08 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.078 -0.712 . . . . 62.02 109.078 170.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 59' ' ' ILE . 91.2 t -64.06 -31.13 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 110.119 -0.326 . . . . 75.21 110.119 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -44.83 -50.93 9.99 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.735 1.013 . . . . 63.53 113.735 166.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.608 ' H ' HG23 ' A' ' 54' ' ' THR . 31.6 tt0 -58.52 -42.51 87.9 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.651 0.38 . . . . 75.24 110.822 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' HZ ' HG23 ' A' ' 20' ' ' ILE . 86.7 t80 -63.75 -43.34 96.72 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.01 0.924 . . . . 72.33 110.881 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 55' ' ' VAL . 33.7 mm -68.11 -46.47 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.751 1.22 . . . . 63.24 111.911 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.72 -39.08 64.94 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.894 0.478 . . . . 62.03 111.471 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.09 -25.42 72.16 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 116.142 -0.481 . . . . 75.11 114.165 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.7 mt -75.68 -38.1 58.99 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.426 0.69 . . . . 71.4 111.134 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.44 -18.08 79.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 121.554 -0.355 . . . . 73.1 113.657 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -84.59 -28.15 26.75 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.528 0.731 . . . . 75.33 111.566 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.3 p -71.99 129.4 38.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.673 -0.491 . . . . 63.44 109.673 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -58.71 -15.87 13.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.138 1.162 . . . . 72.54 114.138 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.69 -42.62 93.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.885 0.874 . . . . 64.43 112.072 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -65.51 -43.21 90.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.542 0.687 . . . . 60.4 111.031 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.96 -28.75 63.64 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.012 -0.994 . . . . 74.51 111.327 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -60.37 -45.87 91.98 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.959 1.304 . . . . 73.14 111.072 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.81 -42.05 61.48 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.015 -0.993 . . . . 73.41 111.832 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -114.31 -67.56 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.922 1.082 . . . . 71.21 113.922 -167.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -61.19 -30.02 70.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.338 1.236 . . . . 71.11 114.338 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.557 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 45.8 m -78.65 -54.74 1.09 Allowed Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.729 -0.653 . . . . 75.31 112.054 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 14.8 Cg_exo -71.8 -16.86 29.57 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 121.989 1.792 . . . . 55.21 114.274 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 56.3 m-85 -115.24 147.71 39.13 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 123.088 0.555 . . . . 72.41 112.357 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 81' ' ' VAL . 91.7 Cg_endo -75.54 169.93 21.32 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.367 . . . . 75.42 112.549 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -49.95 -49.56 49.77 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.25 1.02 . . . . 74.42 113.002 -173.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.589 ' HA ' HD12 ' A' ' 82' ' ' ILE . 26.3 m -59.69 -35.53 74.67 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.6 0.76 . . . . 73.4 112.981 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 22.4 tptm -72.72 -36.18 67.74 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.904 0.383 . . . . 71.43 110.859 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.7 t -68.84 -28.53 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.242 0.617 . . . . 75.21 110.569 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 79' ' ' THR . 96.9 mt -66.77 -52.11 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 73.33 111.26 174.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -71.99 -37.57 69.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 111.832 0.308 . . . . 73.4 111.832 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.97 -31.26 61.41 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.299 0.639 . . . . 71.34 111.508 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.9 52.05 Favored Glycine 0 N--CA 1.476 1.312 0 N-CA-C 112.039 -0.424 . . . . 74.44 112.039 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.68 HG23 HD12 ' A' ' 90' ' ' LEU . 53.6 m -66.48 -35.78 81.11 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.098 0.959 . . . . 74.33 110.747 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.93 -42.44 90.08 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 60.24 112.627 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.8 m170 -82.84 -36.0 25.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.961 0.504 . . . . 75.54 112.353 -175.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -94.29 -68.87 0.78 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 119.179 -0.439 . . . . 71.13 111.274 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.68 HD12 HG23 ' A' ' 86' ' ' THR . 79.2 mt -66.9 -18.24 65.28 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.945 0.72 . . . . 73.01 112.945 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.23 21.3 78.16 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.321 0.388 . . . . 71.33 113.422 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 86' ' ' THR . 9.7 ptt180 -143.09 172.79 12.23 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.166 0.587 . . . . 74.0 110.951 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.06 151.28 54.21 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 123.246 0.618 . . . . 72.14 111.07 165.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.05 140.45 65.69 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.232 1.955 . . . . 34.22 111.486 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.65 -42.83 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.426 0.528 . . . . 75.11 112.426 -164.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -155.65 160.88 40.77 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.161 -0.681 . . . . 52.31 109.161 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -54.91 -36.08 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.447 0.699 . . . . 73.22 112.654 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.37 74.23 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.294 0.638 . . . . 60.53 112.323 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.42 -39.88 67.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.615 0.766 . . . . 64.42 111.624 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.57 -53.27 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.335 0.654 . . . . 71.2 111.713 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -55.81 -32.72 63.79 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.782 0.833 . . . . 71.44 111.867 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.4 tmmm? -61.01 -52.13 66.29 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.503 0.721 . . . . 74.03 110.856 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -64.99 -35.77 82.25 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.849 0.46 . . . . 75.2 112.021 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.408 ' HB2' HD11 ' A' ' 82' ' ' ILE . 47.9 t30 -67.87 -36.85 80.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.064 0.946 . . . . 70.41 111.398 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -67.78 -30.74 70.26 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.575 -0.739 . . . . 65.41 110.632 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 102' ' ' LYS . 74.3 mt -65.77 -40.75 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 122.952 0.501 . . . . 73.04 110.426 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.75 -37.97 76.62 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.241 0.617 . . . . 75.24 112.044 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.4 71.47 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.404 0.682 . . . . 62.1 112.115 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 p -75.79 -52.16 11.02 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.965 0.906 . . . . 72.13 111.642 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.09 -73.03 0.69 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.936 0.894 . . . . 73.41 111.356 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.02 -174.21 22.55 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.297 0.499 . . . . 74.34 113.543 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.8 mm -52.73 -36.64 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.966 1.306 . . . . 72.13 113.706 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -61.17 -51.35 69.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.884 0.373 . . . . 74.21 111.139 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.9 -37.45 87.69 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.524 -0.762 . . . . 73.45 112.539 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.39 -55.95 17.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.31 1.044 . . . . 64.53 112.624 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -57.51 -44.55 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.673 0.789 . . . . 63.52 110.693 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -57.58 -39.19 76.22 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.322 0.649 . . . . 74.02 112.263 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.96 98.49 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.245 0.618 . . . . 64.14 111.472 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.0 mt -62.83 -55.04 29.84 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.836 0.854 . . . . 72.11 111.399 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 56' ' ' LYS . 74.9 t -67.23 -32.6 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 123.186 0.595 . . . . 75.04 112.438 -173.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.93 22.11 15.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.63 -0.669 . . . . 74.22 111.824 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -71.5 142.03 50.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.258 0.623 . . . . 72.41 110.453 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.65 -37.39 79.62 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.724 0.41 . . . . 72.33 111.563 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.58 -32.5 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 120.776 0.322 . . . . 74.24 110.887 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -75.49 -54.13 7.53 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.455 0.702 . . . . 73.13 111.712 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -69.86 -23.35 63.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.905 0.705 . . . . 74.42 112.905 -169.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.46 -39.1 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.042 0.537 . . . . 75.23 111.984 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.29 -58.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.089 0.947 . . . . 75.44 110.394 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.527 ' HE2' ' HB2' ' A' ' 56' ' ' LYS . 45.5 t80 -59.88 -46.64 88.68 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.037 1.735 . . . . 74.2 112.786 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.94 -129.18 9.2 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-O 119.534 -0.592 . . . . 41.21 112.183 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -135.06 -64.58 0.65 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.504 0.652 . . . . 65.21 111.271 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.43 1.14 34.45 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.844 0.858 . . . . 73.44 112.693 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.9 m -92.35 151.65 20.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.843 0.857 . . . . 72.5 111.528 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.7 137.67 85.65 Favored Pre-proline 0 N--CA 1.488 1.452 0 C-N-CA 124.468 1.107 . . . . 74.4 110.284 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.754 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 2.8 Cg_exo -67.82 135.57 35.86 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.158 1.905 . . . . 74.32 111.798 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.3 p90 . . . . . 0 CA--C 1.55 0.968 0 C-N-CA 123.493 0.717 . . . . 75.24 110.299 -178.983 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.985 0.421 . . . . 54.2 110.68 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -92.23 87.22 6.0 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.63 0.729 . . . . 71.31 109.748 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.53 155.43 17.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.546 0.738 . . . . 73.13 110.881 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -92.77 113.8 26.18 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.22 -1.03 . . . . 70.53 108.22 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.56 124.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.912 -0.773 . . . . 74.2 108.912 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.87 99.86 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.707 0.803 . . . . 54.45 111.945 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.29 -31.49 2.34 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.067 -0.515 . . . . 73.31 113.929 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.3 mt -67.68 102.16 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-O 121.709 0.766 . . . . 70.14 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -113.62 24.93 11.69 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.709 -1.132 . . . . 73.34 110.176 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.42 109.31 21.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.697 0.799 . . . . 71.2 108.984 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -61.51 -23.34 65.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.64 0.607 . . . . 61.41 112.64 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.27 -38.84 68.72 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.267 0.627 . . . . 74.14 111.074 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.01 52.14 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.357 0.663 . . . . 74.53 111.289 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.41 HG21 ' HA2' ' A' ' 49' ' ' GLY . 49.0 mm -72.52 -42.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.08 0.552 . . . . 74.14 110.07 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.38 -31.75 73.02 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.866 0.867 . . . . 72.04 112.527 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -77.14 -31.0 55.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 120.902 0.382 . . . . 72.23 111.446 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.07 -43.55 98.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.741 0.816 . . . . 74.44 109.654 170.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.3 -38.04 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.481 1.112 . . . . 71.12 111.48 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.8 t -65.74 -38.37 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.519 0.728 . . . . 60.34 111.771 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.41 -37.6 63.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.146 0.578 . . . . 60.53 110.885 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.9 77.14 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.777 0.831 . . . . 74.23 111.601 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -59.07 -49.91 76.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.984 0.514 . . . . 73.04 110.923 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.78 -26.5 68.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.88 0.696 . . . . 74.0 112.88 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -67.29 -46.89 72.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.853 0.461 . . . . 74.52 111.367 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.719 HD11 HG23 ' A' ' 59' ' ' ILE . 2.4 mp -89.12 -67.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.079 0.552 . . . . 65.1 109.954 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -83.77 82.35 8.36 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.879 0.872 . . . . 72.12 109.122 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.32 69.17 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.609 1.195 . . . . 61.41 114.113 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 176.23 145.73 0.09 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.256 1.822 . . . . 61.21 108.911 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -71.03 119.64 15.44 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-O 121.006 0.432 . . . . 75.44 110.6 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 mm -84.1 125.24 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.473 -0.936 . . . . 73.13 108.473 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 35' ' ' TYR . . . -59.24 122.47 63.77 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.603 -0.713 . . . . 52.41 111.173 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.95 -38.47 86.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.611 2.874 . . . . 71.51 114.275 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.408 ' CE1' ' HB1' ' A' ' 33' ' ' ALA . 44.1 p90 -68.71 -25.38 64.74 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.205 0.602 . . . . 72.52 112.198 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.1 mt -83.32 -44.49 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.429 0.692 . . . . 65.13 111.004 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -33.84 72.6 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.478 1.111 . . . . 34.44 112.208 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -70.83 -36.52 72.94 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.519 -0.764 . . . . 74.1 112.312 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -83.34 -41.57 18.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.344 0.498 . . . . 70.44 112.344 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.39 -54.08 28.46 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.714 . . . . 70.45 112.269 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -98.31 33.0 2.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.92 0.888 . . . . 72.34 111.006 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.8 t -62.38 -50.43 71.58 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.191 0.997 . . . . 75.31 113.081 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.16 36.72 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.788 -0.642 . . . . 72.44 112.096 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -70.54 -29.94 66.54 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.497 0.719 . . . . 74.43 111.957 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -38.57 75.49 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.691 0.796 . . . . 70.14 110.834 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.0 t -52.37 -38.16 58.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.153 0.981 . . . . 73.43 113.365 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.33 -40.07 62.43 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 111.969 0.359 . . . . 63.24 111.969 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.32 -30.69 67.72 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 118.212 0.46 . . . . 73.42 112.178 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' HG21 ' A' ' 16' ' ' ILE . . . -70.36 -31.7 68.54 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.893 0.163 . . . . 71.31 112.711 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.548 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 56.1 m-20 -88.19 -18.44 28.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.534 0.734 . . . . 64.23 111.609 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.17 71.86 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.143 0.417 . . . . 72.12 114.143 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.5 mm-40 -61.07 -32.6 72.25 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.822 0.849 . . . . 71.22 111.677 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -113.41 158.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.574 0.749 . . . . 62.3 110.055 171.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.4 p -84.75 169.18 14.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.255 0.622 . . . . 63.13 110.99 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 59' ' ' ILE . 50.8 t -63.79 -47.69 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.479 -0.563 . . . . 75.4 109.479 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -43.57 -51.84 6.62 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.61 1.337 . . . . 53.33 114.61 169.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -57.75 -39.49 77.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.094 0.558 . . . . 72.04 111.301 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.435 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 45.3 t80 -71.83 -38.72 70.13 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.482 0.713 . . . . 75.54 110.792 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.719 HG23 HD11 ' A' ' 27' ' ' ILE . 30.6 mm -63.47 -50.35 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.983 1.313 . . . . 64.5 110.937 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' HG11 ' A' ' 120' ' ' VAL . 25.8 tt0 -57.34 -38.85 74.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.085 -0.961 . . . . 74.12 111.425 172.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.73 85.22 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.821 -0.627 . . . . 63.42 113.941 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 84.1 mt -69.78 -39.89 76.37 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.245 0.618 . . . . 44.14 111.326 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.75 81.95 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.529 0.572 . . . . 72.11 114.529 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -72.77 -21.69 60.96 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.518 0.727 . . . . 71.43 111.73 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -63.22 128.68 36.94 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.095 0.558 . . . . 65.14 111.919 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.14 -19.2 52.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.24 113.09 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.78 -44.01 97.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.33 0.652 . . . . 64.13 110.723 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -67.54 -31.13 71.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.832 0.453 . . . . 75.34 111.475 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 4.3 mm? -71.89 -34.46 69.16 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.276 0.63 . . . . 70.13 112.318 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -29.7 34.95 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.543 -0.723 . . . . 74.44 111.693 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.85 -56.63 4.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.664 0.616 . . . . 72.34 112.664 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -128.05 60.01 1.47 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.539 0.735 . . . . 75.43 112.306 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.607 ' HD1' HG11 ' A' ' 81' ' ' VAL . 76.9 t80 -162.66 -60.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.911 -0.586 . . . . 65.45 110.725 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.6 p -64.33 -41.26 58.76 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 114.405 1.261 . . . . 72.41 114.405 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.32 -7.58 8.9 Favored 'Trans proline' 0 C--N 1.389 2.704 0 CA-C-N 121.84 1.693 . . . . 70.35 114.039 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -109.37 149.98 40.5 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 123.805 0.842 . . . . 72.55 111.819 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.89 152.94 76.65 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.095 1.863 . . . . 62.22 111.323 168.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -50.56 -47.79 57.72 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.804 0.842 . . . . 72.43 112.708 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.529 ' HA ' HD12 ' A' ' 82' ' ' ILE . 17.8 m -55.61 -33.59 64.12 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.656 0.783 . . . . 63.23 112.354 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -76.23 -36.0 58.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.001 0.521 . . . . 72.42 111.636 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.607 HG11 ' HD1' ' A' ' 73' ' ' TYR . 59.7 t -63.09 -34.8 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.445 0.641 . . . . 74.24 110.476 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.5 mt -63.21 -51.28 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.814 -1.084 . . . . 64.44 111.92 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.4 -31.06 60.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.821 0.448 . . . . 72.4 111.442 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -76.93 -28.51 55.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.418 0.687 . . . . 72.25 111.222 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.26 -54.52 8.87 Favored Glycine 0 C--N 1.344 1.022 0 C-N-CA 122.101 -0.095 . . . . 35.04 112.935 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 t -60.59 -33.34 72.58 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.42 0.896 . . . . 72.2 113.42 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.23 -14.74 62.34 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.543 0.571 . . . . 52.31 112.543 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -89.41 -50.25 6.22 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.774 0.657 . . . . 44.3 112.774 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -85.67 -40.04 16.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.864 0.466 . . . . 55.31 111.82 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 124' ' ' GLU . 77.6 mt -95.84 -49.02 5.5 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 122.439 0.296 . . . . 74.0 110.994 175.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.29 40.39 87.45 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 122.192 -0.317 . . . . 71.12 113.707 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.686 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 2.6 ptm180 -131.2 7.97 4.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.157 0.799 . . . . 74.24 113.157 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 60.12 158.56 0.11 Allowed Pre-proline 0 N--CA 1.504 2.256 0 N-CA-C 113.87 1.063 . . . . 52.02 113.87 -163.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.02 152.96 61.21 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.318 2.012 . . . . 61.03 113.705 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -74.44 -72.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 C-N-CA 123.193 0.597 . . . . 74.24 111.08 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -123.86 171.36 9.73 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.816 0.846 . . . . 54.12 109.854 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -69.5 -29.79 67.5 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.776 -0.578 . . . . 61.41 110.172 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.52 -30.94 68.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.088 0.555 . . . . 41.43 111.96 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -71.89 -39.62 69.45 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.209 0.604 . . . . 62.33 111.21 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.41 ' O ' HD13 ' A' ' 82' ' ' ILE . 76.7 mt -63.98 -52.15 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.217 0.607 . . . . 73.11 110.567 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -54.74 -39.91 68.76 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.11 0.964 . . . . 73.13 111.91 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' O ' HG13 ' A' ' 106' ' ' ILE . 34.6 ttpt -57.15 -45.55 83.5 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.527 0.731 . . . . 64.03 111.15 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.511 ' HD1' HD12 ' A' ' 106' ' ' ILE . 17.8 m-85 -68.25 -35.39 77.83 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.755 0.422 . . . . 75.1 111.921 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -67.46 -32.71 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.892 0.477 . . . . 74.13 110.988 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -64.45 -40.75 96.33 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.865 0.866 . . . . 62.05 110.429 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.511 HD12 ' HD1' ' A' ' 103' ' ' TYR . 80.1 mt -62.48 -46.16 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 124.267 1.027 . . . . 71.31 111.52 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.3 -42.72 99.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.207 0.603 . . . . 74.23 111.69 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.2 -44.6 75.47 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.743 0.646 . . . . 74.3 112.743 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.4 p -72.41 -51.77 18.91 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.021 0.749 . . . . 73.4 113.021 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.26 -46.75 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 112.906 0.706 . . . . 74.22 112.906 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.1 -153.45 20.74 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 115.414 0.925 . . . . 70.44 115.414 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.1 tp -70.81 -35.57 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.107 0.963 . . . . 51.42 112.775 -169.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -61.2 -44.27 97.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.427 0.528 . . . . 73.52 112.427 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -29.44 66.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.029 0.531 . . . . 61.13 112.294 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -65.12 -48.07 74.88 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.269 0.628 . . . . 74.22 110.707 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 112' ' ' ILE . 46.7 mm -64.22 -45.6 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.568 0.747 . . . . 63.24 110.026 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -58.87 -36.36 74.49 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.103 0.961 . . . . 70.4 111.671 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.18 -28.72 68.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.4 0.68 . . . . 50.4 112.142 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.0 -43.56 13.05 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.838 0.855 . . . . 42.45 112.326 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 60' ' ' GLU . 61.8 t -78.15 -37.54 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.416 0.686 . . . . 74.33 111.504 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -87.53 4.37 43.8 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.918 0.487 . . . . 73.24 112.039 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.1 t -67.62 137.58 55.74 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.921 0.488 . . . . 74.42 110.489 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.545 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . 13.7 pt20 -54.74 -29.21 53.07 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.786 1.032 . . . . 75.1 113.786 -175.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.686 ' HG2' ' HD2' ' A' ' 92' ' ' ARG . 34.3 tp10 -50.85 -47.53 60.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.121 0.968 . . . . 64.33 112.225 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.9 -44.58 20.14 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.624 0.769 . . . . 73.52 111.092 168.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 123' ' ' GLN . 6.8 t30 -72.46 -67.7 0.53 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.707 1.002 . . . . 72.1 113.707 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 8.3 pt-20 -56.81 -37.21 70.86 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.296 0.85 . . . . 75.23 113.296 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.67 -61.62 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 112.502 0.556 . . . . 70.42 112.502 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.3 -53.59 2.63 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.05 0.54 . . . . 62.24 111.479 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.65 -126.91 8.78 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.878 -0.601 . . . . 51.32 113.095 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -106.42 -20.46 13.37 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.781 0.832 . . . . 74.25 111.377 -169.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.21 11.84 38.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.143 1.534 . . . . 74.42 115.143 -156.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 t -153.91 164.23 38.74 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 119.43 1.014 . . . . 73.34 112.333 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 55.3 t -67.86 135.37 92.14 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 123.871 0.868 . . . . 63.55 110.498 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 134' ' ' VAL . 7.1 Cg_exo -71.85 76.74 1.97 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.207 2.605 . . . . 74.3 113.198 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.0 p90 . . . . . 0 N--CA 1.485 1.321 0 C-N-CA 123.32 0.648 . . . . 75.41 110.701 176.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.803 -0.814 . . . . 54.51 108.803 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -88.01 101.15 13.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.296 0.638 . . . . 73.43 111.123 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -132.06 163.2 28.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.014 0.526 . . . . 71.11 111.176 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.642 HH22 ' HG ' ' A' ' 48' ' ' LEU . 19.7 tpp85 -79.47 98.25 6.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.262 -0.881 . . . . 71.45 109.736 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.73 130.71 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.338 -0.986 . . . . 72.33 108.338 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.66 75.8 0.59 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.861 0.839 . . . . 70.21 111.928 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.75 -37.98 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.517 -1.22 . . . . 64.2 112.356 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.43 80.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.439 0 CA-C-O 122.529 1.156 . . . . 64.43 110.819 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -89.44 10.03 24.17 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.583 -1.644 . . . . 64.11 113.599 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' HG12 ' A' ' 16' ' ' ILE . 5.6 m-20 -70.69 126.15 28.8 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.007 0.523 . . . . 75.03 111.198 -172.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -60.45 -29.47 69.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.926 0.491 . . . . 73.32 112.035 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 -50.58 62.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.025 0.93 . . . . 75.14 110.937 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.4 94.51 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.603 0.761 . . . . 65.24 112.496 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.579 HG21 ' HA2' ' A' ' 49' ' ' GLY . 46.1 mm -63.2 -49.06 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.06 0.544 . . . . 61.12 111.556 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.25 -25.14 61.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.313 0.486 . . . . 65.44 112.313 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.8 m -65.73 -38.63 89.68 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.792 0.437 . . . . 74.33 111.226 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.33 -40.36 93.59 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.012 0.925 . . . . 73.0 109.983 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.27 -43.92 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.653 1.181 . . . . 63.23 111.544 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -70.47 -35.54 73.36 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.311 0.644 . . . . 74.11 111.438 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.18 90.14 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.666 0.786 . . . . 54.33 112.022 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.78 99.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.512 0.725 . . . . 63.32 111.126 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.464 ' HE2' ' HB1' ' A' ' 37' ' ' ALA . 13.3 m-30 -70.92 -41.02 71.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.567 -0.742 . . . . 72.31 111.556 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -60.88 -35.78 77.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.256 1.022 . . . . 54.02 112.367 179.217 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.0 -62.92 1.54 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.876 0.471 . . . . 71.35 110.122 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.75 -54.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.78 0.832 . . . . 73.02 112.674 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -78.98 -8.33 58.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.121 0.568 . . . . 75.35 112.029 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 53.85 45.77 27.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.521 1.153 . . . . 74.02 112.577 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.428 HH21 ' HG3' ' A' ' 71' ' ' GLU . 8.0 ptp180 -153.85 -179.0 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.348 -0.842 . . . . 72.43 111.264 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -125.78 107.95 11.02 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.848 -1.167 . . . . 61.03 107.848 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 24' ' ' TYR . 20.0 mt -90.98 139.84 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.769 0.428 . . . . 73.34 110.849 -174.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.67 94.6 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.791 -0.623 . . . . 64.41 109.941 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.58 -44.13 41.7 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.656 2.904 . . . . 71.44 113.957 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.01 -44.58 79.95 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.173 -0.921 . . . . 73.21 112.523 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -57.91 -43.78 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 122.956 0.502 . . . . 75.41 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB1' ' HE2' ' A' ' 24' ' ' TYR . . . -58.72 -48.19 81.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.287 1.035 . . . . 71.42 111.795 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -80.95 -12.13 59.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.619 0.6 . . . . 72.23 112.619 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -80.3 -47.26 14.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.677 -0.64 . . . . 73.31 111.729 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.52 -42.48 67.9 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 120.949 0.404 . . . . 74.1 111.047 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.508 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 60.7 m-85 -105.66 55.07 0.69 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.785 0.834 . . . . 64.45 110.939 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.6 m -64.34 -50.2 68.68 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 122.891 0.476 . . . . 62.13 111.636 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -70.64 -39.01 67.66 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.85 -0.614 . . . . 74.53 113.389 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -70.32 -42.16 72.3 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.135 0.974 . . . . 72.11 112.889 -169.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.04 -39.72 93.3 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.883 0.473 . . . . 73.41 110.584 174.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 m -62.77 -47.56 82.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.856 0.863 . . . . 63.32 111.885 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.4 mmmm -59.12 -44.87 92.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.069 0.547 . . . . 72.24 111.983 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' HH22 ' A' ' 6' ' ' ARG . 16.3 tp -74.0 -33.28 63.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 116.317 -0.402 . . . . 71.23 111.32 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.579 ' HA2' HG21 ' A' ' 16' ' ' ILE . . . -66.0 -26.72 72.4 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 123.035 0.35 . . . . 73.21 113.883 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -92.28 -17.51 24.67 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.548 0.739 . . . . 54.33 110.985 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.79 28.51 60.82 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.887 -0.597 . . . . 72.44 113.973 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.41 -25.27 54.33 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.697 0.799 . . . . 74.14 112.647 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.17 171.0 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.727 0.811 . . . . 74.33 109.151 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 p -89.69 170.27 10.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.7 -0.852 . . . . 62.41 108.7 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -59.56 -33.53 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 119.721 -0.18 . . . . 52.01 110.562 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 131' ' ' GLU . 78.7 tttt -44.82 -56.81 4.19 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.0 1.32 . . . . 72.22 113.556 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.98 -40.58 78.74 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.288 0.635 . . . . 62.31 111.354 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 85.3 t80 -53.49 -51.9 61.26 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.908 0.755 . . . . 73.43 110.808 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 55' ' ' VAL . 37.8 mm -57.88 -43.5 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.643 1.177 . . . . 70.4 111.758 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' HG11 ' A' ' 120' ' ' VAL . 32.2 tt0 -58.97 -47.95 83.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 122.783 0.433 . . . . 65.23 111.81 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.17 -18.83 65.43 Favored Glycine 0 CA--C 1.541 1.698 0 N-CA-C 114.867 0.707 . . . . 62.1 114.867 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 54.2 mt -70.73 -30.67 67.26 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 117.566 0.683 . . . . 54.33 111.105 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.61 -10.67 79.94 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 115.315 -0.857 . . . . 72.33 114.129 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -95.54 -7.75 37.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.658 0.783 . . . . 75.24 111.014 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.439 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.7 p -84.13 137.35 33.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.986 0.514 . . . . 62.3 111.273 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 6.0 t30 -62.38 -23.58 66.89 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.01 0.524 . . . . 72.11 111.576 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.5 tp -67.56 -38.01 83.5 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.605 0.762 . . . . 75.22 111.611 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -74.27 -45.6 46.72 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 120.811 0.339 . . . . 74.42 110.716 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.527 HD11 HG12 ' A' ' 112' ' ' ILE . 4.0 mm? -55.96 -44.17 78.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.587 1.155 . . . . 64.2 112.887 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.82 -29.71 70.23 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.873 0.694 . . . . 65.13 112.873 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' HG3' HH21 ' A' ' 30' ' ' ARG . 6.3 mm-40 -93.37 -36.64 12.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.314 1.227 . . . . 74.22 114.314 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HD1' HD13 ' A' ' 84' ' ' LEU . 80.1 m-85 -128.86 32.42 4.78 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.658 0.614 . . . . 75.44 112.658 -171.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HD1' HG11 ' A' ' 81' ' ' VAL . 78.1 t80 -150.16 -54.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.95 0.5 . . . . 74.55 110.974 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -68.16 -43.7 35.6 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.582 0.956 . . . . 65.21 113.582 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.1 7.63 4.97 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.127 1.885 . . . . 74.1 113.422 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 58.3 m-85 -130.07 141.6 42.44 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.579 0.751 . . . . 75.24 111.395 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.65 167.55 16.97 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.29 1.993 . . . . 71.12 111.766 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.52 -40.72 72.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.289 0.636 . . . . 62.11 112.356 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.62 ' HA ' HD12 ' A' ' 82' ' ' ILE . 99.2 m -66.36 -42.38 88.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.073 0.949 . . . . 72.45 113.457 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 48.8 tptt -63.66 -32.95 74.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.258 0.466 . . . . 64.3 112.258 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.568 HG11 ' HD1' ' A' ' 73' ' ' TYR . 45.8 t -63.18 -30.56 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.188 0.595 . . . . 73.23 110.642 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.6 mt -69.92 -51.17 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.947 0.899 . . . . 73.02 112.251 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.64 -45.44 65.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.115 0.416 . . . . 72.53 111.697 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.518 HD23 ' HD3' ' A' ' 87' ' ' LYS . 74.8 mt -61.85 -29.04 69.91 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.361 0.665 . . . . 64.5 112.196 171.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.1 -41.67 46.7 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 115.705 -0.68 . . . . 75.12 111.903 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.438 HG23 HD12 ' A' ' 90' ' ' LEU . 78.3 m -68.9 -46.1 69.22 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.308 0.643 . . . . 65.13 112.016 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HD3' HD23 ' A' ' 84' ' ' LEU . 14.6 ptmt -70.5 -24.42 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.59 0.959 . . . . 73.34 113.59 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -85.02 -33.61 22.49 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 113.695 0.998 . . . . 62.01 113.695 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -104.18 -41.97 5.65 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.844 1.053 . . . . 65.11 113.844 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.438 HD12 HG23 ' A' ' 86' ' ' THR . 69.0 mt -94.71 -14.7 24.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.127 0.417 . . . . 71.32 112.127 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.87 14.97 2.05 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.608 0.603 . . . . 62.14 114.608 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -98.23 -84.78 0.38 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.321 0.648 . . . . 60.54 112.476 -161.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 175.98 137.11 0.19 Allowed Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 72.13 108.938 -168.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.39 122.89 10.18 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.459 1.44 . . . . 51.1 109.531 165.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.29 -63.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 122.086 -0.383 . . . . 74.3 111.504 -168.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -158.14 166.5 32.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.473 -0.936 . . . . 74.34 108.473 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -66.29 -27.76 68.18 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.232 0.469 . . . . 73.2 111.396 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.2 72.44 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.945 0.498 . . . . 71.21 111.458 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.87 -45.73 84.8 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.25 0.62 . . . . 74.3 110.667 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.545 HG21 HG23 ' A' ' 79' ' ' THR . 85.0 mt -59.33 -36.76 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.685 -0.689 . . . . 74.22 110.573 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -68.81 -31.96 71.33 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.676 0.39 . . . . 73.31 111.608 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.53 -50.1 41.16 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.528 0.331 . . . . 73.22 111.44 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -62.58 -38.44 90.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.081 0.4 . . . . 72.43 112.081 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.59 -36.16 77.85 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.935 0.894 . . . . 73.33 111.255 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -69.36 -44.02 72.43 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.67 0.788 . . . . 72.54 110.907 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -42.78 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.551 0.741 . . . . 70.35 110.831 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.429 HD11 ' HE1' ' A' ' 73' ' ' TYR . 31.5 tp -65.51 -33.29 75.58 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.364 1.065 . . . . 71.21 112.438 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.41 -46.35 17.72 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.019 0.528 . . . . 63.13 112.322 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.8 p -70.45 -45.16 66.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.99 0.916 . . . . 74.24 111.843 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -110.6 -68.79 0.9 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.228 0.611 . . . . 71.15 111.914 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.89 -170.33 28.57 Favored Glycine 0 C--N 1.356 1.688 0 C-N-CA 121.691 -0.29 . . . . 73.12 113.792 -175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 69' ' ' LEU . 8.6 tp -65.82 -39.2 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.925 0.89 . . . . 71.12 112.637 -173.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -65.69 -33.57 76.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.946 0.498 . . . . 75.52 111.861 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.87 -34.63 51.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.606 0.762 . . . . 54.25 110.425 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.78 -51.98 65.0 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.273 1.029 . . . . 54.5 111.174 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.88 -51.88 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.937 0.895 . . . . 52.42 110.867 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -48.29 -47.78 36.25 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.675 0.79 . . . . 44.23 112.288 171.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -33.54 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.569 0.747 . . . . 72.13 112.337 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.59 -57.99 4.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.955 0.502 . . . . 73.43 110.895 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 60' ' ' GLU . 94.3 t -63.77 -35.85 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 113.847 1.054 . . . . 73.54 113.847 -166.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -108.62 36.27 2.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 75.15 112.101 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.4 p -84.02 171.26 13.11 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.163 0.506 . . . . 63.12 110.789 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -69.56 -31.53 69.77 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.01 0.91 . . . . 70.25 110.339 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -69.81 -36.2 75.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.425 1.49 . . . . 63.52 111.596 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -76.22 -37.66 57.45 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.994 0.518 . . . . 70.41 110.958 173.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.15 -61.09 2.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.811 0.844 . . . . 74.42 112.577 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.56 -38.71 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.722 0.296 . . . . 72.23 111.72 -168.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.03 -44.36 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.639 0.775 . . . . 61.11 111.657 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -101.68 -45.64 5.19 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.042 0.537 . . . . 74.34 112.174 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.19 20.04 63.52 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-O 119.715 -0.492 . . . . 63.54 113.906 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 8.5 pt-20 57.08 -1.81 0.05 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.903 2.186 . . . . 71.35 116.903 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -93.04 -17.5 23.78 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.315 0.646 . . . . 73.24 111.433 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 t -108.99 162.42 14.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.439 0.696 . . . . 75.5 112.339 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.21 136.96 89.09 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.706 -1.133 . . . . 65.41 108.401 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.78 88.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.548 2.165 . . . . 61.31 112.179 173.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 p90 . . . . . 0 CA--C 1.543 0.705 0 CA-C-N 115.395 -0.82 . . . . 72.53 108.896 174.121 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.107 -0.701 . . . . 62.22 109.107 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -83.29 124.21 30.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.332 0.587 . . . . 72.02 111.168 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.21 173.77 16.36 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.847 1.259 . . . . 74.11 109.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.616 ' NH2' ' HA2' ' A' ' 51' ' ' GLY . 81.4 mtp180 -102.5 116.21 32.16 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.57 0.7 . . . . 71.01 111.315 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.4 2.62 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.977 0 C-N-CA 125.345 1.458 . . . . 62.4 111.004 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 78.58 -67.47 0.17 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.406 1.882 . . . . 61.41 110.369 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 49.28 4.12 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.036 0.374 . . . . 64.43 114.036 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 6' ' ' ARG . 66.6 mt -72.99 -53.4 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.256 0.622 . . . . 75.12 110.11 172.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 65.7 -65.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.348 1.459 . . . . 73.25 112.094 -171.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 16' ' ' ILE . 32.1 t70 -44.68 133.96 5.71 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.966 1.706 . . . . 73.22 115.588 -173.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.28 -25.38 39.47 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 112.93 -1.941 . . . . 73.24 112.545 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -70.84 -51.46 26.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 64.03 111.444 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.24 -50.64 58.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.73 1.011 . . . . 74.14 113.73 167.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 12' ' ' ASP . 43.8 mm -56.84 -43.05 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.852 0.686 . . . . 63.22 112.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 2.7 pptp? -67.14 -30.47 70.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 112.512 0.56 . . . . 63.21 112.512 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 m -70.57 -49.4 48.31 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.14 0.495 . . . . 70.42 111.022 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -44.54 -46.49 9.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.821 -1.081 . . . . 73.54 111.805 165.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.9 -36.19 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.341 1.056 . . . . 71.25 112.353 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -61.71 -49.01 78.17 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.261 0.624 . . . . 54.53 111.668 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.34 88.96 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.138 0.575 . . . . 63.14 111.827 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.67 -31.17 15.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.684 -1.144 . . . . 74.23 112.596 171.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.88 -48.15 17.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.888 0.475 . . . . 65.21 111.766 168.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -55.8 -28.36 55.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.355 1.613 . . . . 72.13 115.355 -167.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -86.68 -41.64 14.03 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.097 0.408 . . . . 64.12 111.274 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.588 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -75.8 -57.25 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.537 0.735 . . . . 62.42 111.221 -173.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.446 ' HB3' HH11 ' A' ' 30' ' ' ARG . 93.2 m-85 -78.91 -6.38 56.03 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.095 0.558 . . . . 75.12 111.94 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 54.87 37.67 29.02 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 125.425 1.49 . . . . 65.32 112.927 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.446 HH11 ' HB3' ' A' ' 28' ' ' PHE . 10.0 ptp85 -155.0 151.73 28.83 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.275 0.559 . . . . 55.34 112.247 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.04 100.94 2.1 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.149 -0.932 . . . . 62.22 109.427 165.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.3 mt -81.11 126.53 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 110.044 -0.354 . . . . 72.43 110.044 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.38 132.45 94.17 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.814 0.846 . . . . 45.23 111.035 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.81 -33.03 98.27 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.999 2.466 . . . . 75.23 113.368 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -69.17 -21.71 63.97 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.956 0.724 . . . . 65.41 112.956 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -81.99 -48.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.152 0.581 . . . . 74.04 109.884 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 -32.02 71.99 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.073 0.949 . . . . 55.03 113.182 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -76.6 -19.19 58.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.849 0.46 . . . . 73.22 111.747 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -80.15 -47.1 15.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.223 0.609 . . . . 63.34 111.251 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -85.5 -59.82 2.21 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.889 0.376 . . . . 65.01 111.725 -171.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -93.15 41.55 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.565 0.746 . . . . 74.54 112.535 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.9 t -66.68 -50.8 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.523 0.729 . . . . 70.15 112.058 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.2 -28.6 57.94 Favored Glycine 0 N--CA 1.477 1.374 0 CA-C-N 115.777 -0.647 . . . . 33.12 113.051 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -65.3 -25.12 67.49 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.237 1.015 . . . . 75.53 112.259 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.66 -45.27 75.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.65 0.78 . . . . 73.2 110.824 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -57.45 -30.92 65.41 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.02 0.928 . . . . 33.14 112.575 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -73.58 -35.74 65.47 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.473 0.309 . . . . 55.45 111.687 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.2 tp -73.38 -60.94 2.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.282 0.845 . . . . 74.3 113.282 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.59 -36.67 76.71 Favored Glycine 0 C--N 1.358 1.772 0 CA-C-N 118.622 0.646 . . . . 73.32 114.377 -171.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -59.98 -16.59 31.68 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.89 0.876 . . . . 63.2 113.347 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.616 ' HA2' ' NH2' ' A' ' 6' ' ' ARG . . . 103.04 5.17 47.37 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 114.635 0.614 . . . . 72.44 114.635 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.2 -63.99 1.03 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.187 0.493 . . . . 72.41 111.991 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -85.06 -142.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-N 116.025 -0.534 . . . . 73.31 111.259 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.433 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 3.3 t -170.43 152.16 3.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 73.13 108.916 -165.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.05 -31.49 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 112.603 0.594 . . . . 65.2 112.603 -171.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -76.38 -44.0 38.26 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.097 -0.377 . . . . 73.21 111.183 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.84 -22.18 66.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.49 0.716 . . . . 71.33 111.435 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -74.29 -46.21 42.64 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.427 -1.323 . . . . 73.01 107.427 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 27' ' ' ILE . 54.0 mt -70.92 -30.78 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 113.46 -1.7 . . . . 64.12 113.318 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -63.93 -46.81 83.11 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 122.819 0.448 . . . . 73.31 110.536 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.87 -35.54 47.93 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 114.617 0.607 . . . . 72.34 114.617 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -69.11 -26.18 64.78 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.165 0.586 . . . . 74.51 111.526 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.07 -23.94 58.41 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 116.078 -0.51 . . . . 53.23 113.09 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.447 ' HE1' ' HB ' ' A' ' 116' ' ' ILE . 3.6 m-30 -86.0 5.7 32.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.787 0.835 . . . . 73.02 110.955 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.1 t -85.46 129.84 34.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.484 0.713 . . . . 63.13 110.41 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.661 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 23.5 p-10 -62.77 -16.13 56.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.995 0.739 . . . . 72.32 112.995 -175.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 43.1 tp -61.5 -59.7 4.84 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.013 0.525 . . . . 74.1 110.681 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.8 -36.94 65.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.949 0.722 . . . . 73.53 112.949 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.661 ' HB2' ' HA ' ' A' ' 66' ' ' ASN . 4.2 mm? -63.95 -30.51 71.58 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.349 0.87 . . . . 63.03 113.349 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -92.02 -40.59 11.01 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.718 -0.614 . . . . 63.41 112.189 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 10.3 pt-20 -78.04 -54.69 5.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.097 1.147 . . . . 74.23 114.097 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -83.89 -59.06 2.53 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.115 0.871 . . . . 74.22 113.076 171.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.523 ' HE1' HD21 ' A' ' 107' ' ' LEU . 61.6 t80 -55.67 -46.63 77.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.213 1.19 . . . . 72.34 114.213 -166.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.8 m -71.03 -55.96 6.05 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.445 0.906 . . . . 73.52 113.445 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.02 -28.32 19.39 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.931 1.754 . . . . 64.3 112.999 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.418 ' HD1' ' HG2' ' A' ' 80' ' ' LYS . 91.0 m-85 -94.06 140.96 23.06 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 122.822 0.449 . . . . 72.22 110.77 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.525 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.4 Cg_exo -54.29 146.11 52.24 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.088 2.525 . . . . 31.31 113.515 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -30.48 -46.69 0.08 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 123.62 0.768 . . . . 43.43 112.934 156.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.498 ' HA ' HD12 ' A' ' 82' ' ' ILE . 21.4 m -70.59 -23.84 62.65 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.334 0.654 . . . . 73.22 112.601 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HG2' ' HD1' ' A' ' 76' ' ' TYR . 53.5 tptt -91.14 -28.32 17.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.19 0.519 . . . . 74.2 110.382 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 77' ' ' PRO . 84.7 t -62.86 -27.51 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.791 0.836 . . . . 71.43 110.038 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 79' ' ' THR . 81.5 mt -65.88 -47.52 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.098 0.959 . . . . 54.25 112.626 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HG3' ' H ' ' A' ' 84' ' ' LEU . 7.2 pt-20 -78.51 -57.8 3.58 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.908 0.322 . . . . 73.23 110.818 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.546 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 97.0 mt -43.85 -31.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.774 1.398 . . . . 74.42 114.774 161.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.33 -49.72 8.07 Favored Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.855 -0.498 . . . . 73.1 111.855 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.692 HG23 HD12 ' A' ' 90' ' ' LEU . 88.3 m -59.88 -31.55 69.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.673 1.189 . . . . 65.2 112.277 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -75.84 -57.16 4.04 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.598 -0.689 . . . . 55.1 111.486 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.7 m170 -50.9 -30.58 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.979 1.474 . . . . 74.41 114.979 172.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -101.52 -68.62 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.233 0.827 . . . . 72.35 113.233 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.692 HD12 HG23 ' A' ' 86' ' ' THR . 66.0 mt -71.42 -28.36 63.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.853 0.686 . . . . 73.33 112.853 -173.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.99 33.63 20.44 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 122.94 0.15 . . . . 50.33 112.788 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.82 -177.05 6.13 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.172 0.989 . . . . 73.44 110.782 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.19 165.42 13.9 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.532 0.733 . . . . 75.14 109.74 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.75 173.73 4.38 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.272 1.982 . . . . 61.11 111.973 169.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 mt -119.04 -86.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 121.127 0.489 . . . . 73.34 109.992 -167.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -88.63 172.41 9.31 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.961 -1.125 . . . . 51.44 107.961 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 2.8 tp-100 -74.9 -10.1 59.17 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 121.441 1.928 . . . . 74.14 109.59 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.75 84.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.851 0.86 . . . . 73.35 110.563 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.8 -54.11 46.4 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.903 0.881 . . . . 72.14 110.289 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.419 ' HA ' HG21 ' A' ' 82' ' ' ILE . 75.6 mt -64.71 -36.17 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-N 114.818 -1.083 . . . . 73.14 112.275 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.545 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 70.3 mtp180 -74.54 -38.84 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.851 0.46 . . . . 63.42 109.913 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.35 -56.44 18.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.233 -0.894 . . . . 73.21 110.921 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -61.49 -52.74 63.24 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.387 0.514 . . . . 73.44 112.387 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -43.73 -48.23 7.97 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 115.394 -0.821 . . . . 53.44 112.676 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -73.3 -41.03 64.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.856 0.462 . . . . 71.22 111.705 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.9 mt -59.83 -55.18 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 124.081 0.952 . . . . 75.21 111.637 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.523 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.3 tt -50.98 -53.14 35.78 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.038 0.935 . . . . 50.15 112.204 170.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.35 78.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.44 0.533 . . . . 72.53 112.44 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.0 p -68.31 -53.03 27.03 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.109 0.781 . . . . 71.0 113.109 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -101.53 -62.32 1.27 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.654 0.782 . . . . 74.0 112.262 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -172.8 31.8 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.97 0.348 . . . . 73.33 113.97 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.429 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.2 tp -68.74 -33.71 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.903 0.881 . . . . 72.11 112.209 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -65.07 -55.86 16.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.701 0.4 . . . . 73.53 110.69 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -50.1 -30.93 12.05 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 114.713 -1.131 . . . . 73.32 113.451 168.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -75.67 -42.9 49.92 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.272 0.629 . . . . 74.32 112.201 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.447 ' HB ' ' HE1' ' A' ' 64' ' ' TYR . 46.3 mm -72.52 -52.3 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.01 0.524 . . . . 72.34 109.718 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -43.63 -38.24 2.96 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.7 1.2 . . . . 72.41 113.112 166.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.85 76.61 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.021 0.528 . . . . 63.05 112.404 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.402 ' O ' HD21 ' A' ' 90' ' ' LEU . 78.1 mt -83.99 -59.9 2.27 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.603 0.761 . . . . 74.34 110.841 176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 t -44.95 -50.89 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.584 1.554 . . . . 65.02 113.216 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -100.3 17.47 21.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.402 0.519 . . . . 62.54 112.402 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.9 p -74.03 164.15 26.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.951 -0.759 . . . . 54.31 108.951 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -72.41 -22.51 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.965 -0.46 . . . . 71.43 111.669 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.46 -53.31 44.57 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.335 0.494 . . . . 64.03 112.335 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -61.6 -40.46 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.153 -0.684 . . . . 65.31 109.153 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -57.93 -42.7 85.38 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.164 0.986 . . . . 71.2 112.69 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.99 -47.38 11.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.773 -0.579 . . . . 71.11 112.013 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.4 -41.38 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.925 0.49 . . . . 72.42 111.987 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 36.9 m-85 -116.01 -68.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.822 0.449 . . . . 73.14 110.669 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.51 -127.56 9.13 Favored Glycine 0 C--N 1.347 1.139 0 C-N-CA 123.227 0.442 . . . . 73.44 112.403 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -88.86 -73.12 0.51 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.41 0.684 . . . . 73.1 111.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 36.0 m-20 -102.35 66.6 0.99 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.548 0.69 . . . . 65.24 112.835 -171.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.9 m -148.32 124.43 10.76 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.043 -0.981 . . . . 75.54 109.495 173.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.68 138.23 83.08 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.251 0.62 . . . . 72.42 109.936 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.458 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 52.4 Cg_exo -53.6 89.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 123.152 2.568 . . . . 70.21 113.319 173.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.4 p90 . . . . . 0 CA--C 1.543 0.711 0 CA-C-N 115.17 -0.923 . . . . 62.55 111.456 176.711 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 CA--C 1.56 1.355 0 N-CA-C 109.393 -0.595 . . . . 64.44 109.393 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.67 -0.3 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 126.211 1.805 . . . . 70.04 113.196 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -47.32 113.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.284 1.433 . . . . 74.25 114.061 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.543 ' NH1' HD22 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -51.28 94.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.337 1.606 . . . . 75.32 115.337 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 8' ' ' ALA . 2.9 t -45.89 178.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.223 0 C-N-CA 126.046 1.738 . . . . 63.3 112.514 162.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.592 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -73.96 132.32 42.31 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 107.598 -1.26 . . . . 73.34 107.598 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -13.5 74.6 0.0 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 117.85 1.9 . . . . 64.45 117.85 -158.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -67.38 134.28 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.236 0.614 . . . . 63.54 110.679 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -83.33 -13.41 55.1 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.537 0.735 . . . . 71.43 112.523 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.92 112.47 18.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.924 0.489 . . . . 72.44 110.759 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.39 -10.88 37.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.438 0.695 . . . . 64.41 112.026 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.11 -51.44 13.45 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.439 0.638 . . . . 71.21 109.634 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.5 71.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.683 -1.144 . . . . 62.1 112.378 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 41.1 mm -78.25 -48.79 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.467 0.707 . . . . 74.35 110.783 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -67.4 -44.81 77.94 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.653 0.781 . . . . 51.12 113.008 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.3 m -63.37 -37.84 88.82 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.335 0.654 . . . . 70.31 111.889 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' NH1' ' A' ' 6' ' ' ARG . 11.4 tp -53.0 -51.56 61.24 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.747 -1.115 . . . . 70.44 110.103 169.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.85 -37.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.955 1.302 . . . . 70.34 113.121 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.1 p -69.19 -53.06 21.95 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.587 0.355 . . . . 71.55 111.149 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.417 ' HB1' HG11 ' A' ' 134' ' ' VAL . . . -59.86 -26.46 65.85 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 113.33 0.863 . . . . 71.42 113.33 171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.57 -33.88 74.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 123.473 0.483 . . . . 62.33 110.758 172.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -78.78 -49.21 13.39 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.691 . . . . 42.32 111.834 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.9 mtp85 -50.0 -26.07 3.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.842 1.793 . . . . 74.32 115.842 -168.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 -58.53 2.54 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 118.34 0.518 . . . . 51.15 110.239 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.47 -55.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.555 0.742 . . . . 72.52 110.5 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.89 -27.02 67.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.422 0.689 . . . . 74.22 112.594 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 67.63 32.44 5.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.615 1.198 . . . . 73.5 109.588 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.449 ' NH2' ' HG3' ' A' ' 71' ' ' GLU . 18.9 ptp180 -168.23 150.73 5.41 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.945 -1.48 . . . . 75.13 110.36 -173.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.22 108.89 5.61 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.822 -0.627 . . . . 74.2 110.286 165.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.05 133.03 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.946 -0.761 . . . . 75.23 108.946 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.25 138.1 95.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.837 -0.601 . . . . 63.43 110.6 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.61 -43.09 23.33 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.839 3.026 . . . . 75.21 114.992 -170.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -70.11 -32.9 71.16 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 112.764 0.653 . . . . 74.1 112.764 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -72.85 -42.31 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.269 0.628 . . . . 53.03 110.953 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.48 -36.35 83.48 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.247 0.619 . . . . 75.42 112.164 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 42' ' ' SER . 3.7 pt20 -79.4 -36.26 39.39 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.909 -0.587 . . . . 71.51 112.077 -176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -81.66 -43.87 17.95 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.223 0.823 . . . . 73.02 113.223 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.59 -60.33 2.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.757 0.423 . . . . 70.1 111.787 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -89.67 38.04 0.9 Allowed 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.651 0.982 . . . . 74.54 113.651 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' GLN . 90.7 p -72.08 -49.83 33.27 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.69 0.396 . . . . 71.21 111.326 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 47' ' ' LYS . . . -69.5 -27.4 73.53 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 123.259 0.457 . . . . 43.14 113.112 174.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -81.63 -39.38 24.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.221 1.009 . . . . 74.43 110.63 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.58 -29.29 67.8 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.337 0.655 . . . . 61.35 111.668 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -65.83 -36.54 83.76 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.665 0.786 . . . . 60.14 111.87 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 43' ' ' GLY . 26.9 mtpp -67.74 -37.85 82.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.912 0.885 . . . . 64.02 111.076 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.0 -37.56 75.73 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.95 0.9 . . . . 70.41 110.862 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.67 -28.68 68.77 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-N 115.988 -0.551 . . . . 23.24 113.753 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -87.84 4.47 44.42 Favored 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 124.173 0.989 . . . . 71.23 111.043 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 50.09 33.6 22.46 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 115.422 0.929 . . . . 34.01 115.422 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -71.29 -80.03 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.077 -0.712 . . . . 64.33 109.077 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -63.04 -164.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 113.962 1.097 . . . . 75.52 113.962 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.2 p -127.58 172.57 10.62 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.211 -1.403 . . . . 33.44 107.211 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.11 -32.39 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 O-C-N 121.833 -0.542 . . . . 75.31 110.039 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -64.72 -38.96 92.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.744 0.818 . . . . 74.44 111.584 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.28 -26.06 42.39 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.679 0.792 . . . . 74.03 109.654 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -62.2 -49.08 77.21 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.235 1.014 . . . . 73.33 110.306 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 ' HD3' ' A' ' 135' ' ' PRO . 96.7 mt -59.91 -28.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 125.202 1.401 . . . . 75.01 112.656 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.8 -42.02 96.78 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.472 0.709 . . . . 62.31 109.764 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.26 -23.61 58.57 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 114.501 0.56 . . . . 63.33 114.501 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.2 mt -68.91 -40.75 78.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.189 0.518 . . . . 54.51 110.147 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.33 -24.6 63.74 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-N 114.846 -1.07 . . . . 62.35 114.027 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -84.84 -12.68 53.02 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.691 0.796 . . . . 75.31 112.487 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -74.98 121.9 22.67 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.946 0.498 . . . . 65.33 111.19 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.23 -15.63 26.37 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.167 0.987 . . . . 64.12 113.503 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.5 tp -59.65 -61.35 2.69 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.209 0.458 . . . . 61.53 112.048 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -51.63 -38.78 56.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 112.771 0.656 . . . . 72.4 112.771 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 3.0 mm? -69.6 -26.59 64.52 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.245 0.831 . . . . 70.24 113.245 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.33 -49.28 72.34 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.756 -1.215 . . . . 73.41 108.994 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HG3' ' NH2' ' A' ' 30' ' ' ARG . 3.2 mm-40 -64.66 -56.89 10.9 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 114.333 -1.303 . . . . 51.24 112.73 172.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.06 69.34 0.72 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.68 0.993 . . . . 65.11 113.68 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 42.4 t80 -170.68 -56.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.013 1.325 . . . . 61.42 108.663 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.2 p -69.97 -39.7 11.46 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.469 1.285 . . . . 63.42 114.469 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.51 -42.61 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.928 0 CA-C-N 122.147 1.802 . . . . 74.24 112.632 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.46 147.67 82.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.546 1.138 . . . . 73.24 112.057 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.21 148.12 84.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.21 1.94 . . . . 62.24 111.55 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -52.38 -49.74 63.82 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.146 0.978 . . . . 71.21 112.807 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.464 ' HA ' HD12 ' A' ' 82' ' ' ILE . 59.7 m -51.71 -44.01 63.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.597 0.962 . . . . 74.24 113.597 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -65.04 -37.13 86.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.984 0.514 . . . . 70.22 111.837 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.29 -24.53 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 122.887 0.475 . . . . 63.32 111.286 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 79' ' ' THR . 90.6 mt -72.03 -54.31 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.208 0.603 . . . . 63.23 111.682 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.66 -23.54 67.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.241 0.544 . . . . 71.03 111.768 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tt -79.85 -45.75 18.11 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.777 1.231 . . . . 70.0 108.684 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.84 -54.26 29.38 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.001 -0.999 . . . . 61.4 114.358 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.58 ' HA ' HD13 ' A' ' 119' ' ' LEU . 34.6 p -54.64 -39.52 68.06 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.201 0.6 . . . . 71.12 112.145 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.05 -37.84 61.93 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 113.449 0.907 . . . . 62.35 113.449 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -88.05 13.68 10.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.617 0.969 . . . . 73.03 113.617 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.74 -69.75 0.51 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.577 0.751 . . . . 60.04 109.677 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.4 HD12 ' HB ' ' A' ' 86' ' ' THR . 78.5 mt -61.78 -19.91 63.01 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.472 1.109 . . . . 72.0 112.781 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.34 87.49 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 114.351 0.501 . . . . 52.43 114.351 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.42 174.92 14.68 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 123.299 0.64 . . . . 53.31 110.721 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.45 160.76 78.89 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 124.001 0.92 . . . . 51.24 111.321 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -55.44 -174.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.038 2.492 . . . . 65.41 114.486 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.55 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 68.5 mt -97.43 -24.34 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 75.21 110.333 -164.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 179.23 -174.86 0.22 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.222 1.409 . . . . 73.43 109.316 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -76.94 -35.06 57.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.665 0.386 . . . . 72.34 111.929 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.45 -35.03 75.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.85 0.46 . . . . 51.2 111.421 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.55 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 19.8 tp10 -57.58 -47.48 82.0 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.726 0.81 . . . . 75.02 110.558 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.11 -46.87 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 124.094 0.957 . . . . 64.34 112.022 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -67.57 -30.58 70.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.392 0.886 . . . . 73.31 113.392 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -53.75 -47.45 70.66 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.467 0.707 . . . . 74.4 110.865 166.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -78.23 -22.17 48.84 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.701 -1.136 . . . . 74.12 111.056 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -74.68 -41.96 59.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.651 1.181 . . . . 64.42 110.72 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -72.11 -49.85 32.86 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.77 0.828 . . . . 73.45 111.267 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 87.6 mt -56.86 -37.22 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 124.466 1.106 . . . . 73.44 111.679 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.06 -49.68 34.53 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.698 0.799 . . . . 74.14 110.953 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.37 95.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.722 0.809 . . . . 63.54 112.634 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.8 p -75.59 -65.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 74.34 112.459 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -87.6 -37.31 16.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.795 0.838 . . . . 75.42 112.953 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 173.51 13.2 Favored Glycine 0 C--N 1.346 1.132 0 C-N-CA 122.002 -0.142 . . . . 51.42 112.98 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 116' ' ' ILE . 9.9 tp -61.29 -30.66 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 123.158 0.583 . . . . 73.21 110.417 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -56.58 -40.48 75.3 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.533 1.133 . . . . 74.4 112.749 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.5 55.7 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.041 0.537 . . . . 71.22 111.386 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 57.9 t80 -65.12 -50.8 64.66 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.75 0.82 . . . . 73.22 110.324 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 112' ' ' ILE . 49.2 mm -59.78 -44.3 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.16 0.984 . . . . 65.42 110.943 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -56.89 -39.73 74.94 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.977 0.911 . . . . 65.33 111.889 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.2 77.72 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.324 0.65 . . . . 74.54 112.26 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 86' ' ' THR . 13.6 mt -79.76 -39.17 31.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.166 0.587 . . . . 74.52 110.937 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.45 -34.2 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.491 0.716 . . . . 62.0 111.176 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -99.7 22.89 10.31 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.368 0.667 . . . . 74.12 112.385 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.4 t -83.03 132.56 35.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.157 0.583 . . . . 65.31 110.773 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -44.34 -37.55 3.39 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.315 1.228 . . . . 71.34 114.315 170.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.33 -41.1 92.83 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-N 118.31 0.505 . . . . 72.41 111.322 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -73.79 -53.88 9.29 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.877 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -69.7 -27.59 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.045 0.757 . . . . 64.22 113.045 -172.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.51 -47.19 34.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.831 0.453 . . . . 74.43 112.169 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.9 -51.78 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.341 0.591 . . . . 62.33 111.273 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -77.1 -67.54 0.7 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.075 0.95 . . . . 72.51 111.12 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.61 -148.12 16.5 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.658 0.623 . . . . 23.31 114.658 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -114.89 -23.73 8.98 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.849 0.859 . . . . 70.32 111.841 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.76 -32.55 12.66 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.314 1.046 . . . . 64.32 113.65 -158.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -98.66 165.98 11.54 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.304 0.853 . . . . 70.33 113.304 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.518 HG23 HD12 ' A' ' 19' ' ' LEU . 6.6 t -83.51 142.27 42.92 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 124.164 0.986 . . . . 74.03 108.766 165.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HD3' HD11 ' A' ' 59' ' ' ILE . 34.6 Cg_endo -61.98 83.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.901 2.4 . . . . 54.5 113.32 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.3 p90 . . . . . 0 C--O 1.246 0.903 0 CA-C-N 114.08 -1.418 . . . . 70.23 108.711 170.258 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 CA--C 1.553 1.068 0 CA-C-O 121.468 0.651 . . . . 73.51 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -80.44 104.98 11.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.368 0.604 . . . . 73.14 110.123 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 133' ' ' THR . 19.6 ptmt -149.16 168.56 22.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.997 0.919 . . . . 71.05 110.144 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 ttp85 -119.4 106.64 12.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.729 -0.471 . . . . 70.43 109.729 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 8' ' ' ALA . 3.3 t -79.0 -149.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.959 0 C-N-CA 124.083 0.953 . . . . 61.21 109.13 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.615 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -85.43 -81.28 0.2 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 119.945 1.248 . . . . 55.4 109.767 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -32.29 -30.22 0.01 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.001 2.76 . . . . 62.51 120.001 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 7' ' ' VAL . 50.8 mt -64.99 105.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 119.855 1.828 . . . . 75.05 110.558 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -155.47 24.62 0.4 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.527 1.131 . . . . 73.43 108.756 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' O ' HG12 ' A' ' 16' ' ' ILE . 3.8 m-20 -100.01 142.72 31.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.141 1.376 . . . . 71.44 108.891 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.45 ' NZ ' ' HG2' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -67.0 -39.23 87.06 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 120.945 1.702 . . . . 74.4 112.631 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.54 66.49 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 122.367 1.08 . . . . 74.24 112.231 171.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB1' HG23 ' A' ' 10' ' ' ILE . . . -76.62 -38.92 53.91 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 112.978 -1.919 . . . . 70.54 111.071 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.62 HG13 ' HA2' ' A' ' 49' ' ' GLY . 51.0 mm -81.21 -39.62 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 N-CA-C 114.029 1.122 . . . . 62.22 114.029 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 28.1 mtpp -74.59 -50.86 16.29 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.109 -0.994 . . . . 72.22 111.347 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 m -49.12 -21.57 0.77 Allowed 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.124 -1.398 . . . . 62.32 113.168 164.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 16' ' ' ILE . 7.8 tt -81.43 -42.98 19.55 Favored 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 123.588 0.755 . . . . 74.31 110.659 169.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 16' ' ' ILE . 85.5 mt -75.18 -48.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 N-CA-C 116.494 2.035 . . . . 53.01 116.494 -171.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 24' ' ' TYR . 44.0 m -66.67 -39.24 88.09 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.702 1.239 . . . . 61.14 109.882 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.94 -28.23 22.58 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 111.58 -2.554 . . . . 71.11 111.708 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.39 24.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.719 0.808 . . . . 54.13 111.763 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CD2' ' HA ' ' A' ' 21' ' ' SER . 21.6 m-85 -68.98 -52.48 28.44 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 120.98 0.419 . . . . 74.2 110.914 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -46.98 -16.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.539 1.311 . . . . 75.05 114.539 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.518 HE22 ' HA ' ' A' ' 88' ' ' HIS . 13.0 tm0? -87.48 -61.16 1.78 Allowed 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.144 0.577 . . . . 72.11 109.627 166.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 59' ' ' ILE . 61.7 mt -78.15 -65.46 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 124.509 1.123 . . . . 73.2 113.119 -170.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 66.4 m-85 -74.87 -9.64 58.73 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.032 0.933 . . . . 62.22 112.476 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 76.33 -56.02 0.58 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.988 1.715 . . . . 70.44 112.914 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -84.07 156.33 22.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.95 0.9 . . . . 64.33 112.927 -165.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -62.84 120.01 10.48 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.569 -1.196 . . . . 75.25 109.717 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.4 mt -109.65 120.24 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.454 -1.684 . . . . 70.35 106.454 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 134.06 72.29 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 123.929 0.768 . . . . 61.32 112.06 -172.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.33 -31.02 36.02 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.811 3.007 . . . . 71.11 115.164 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -75.89 -39.05 57.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.722 0.409 . . . . 73.43 111.989 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -47.77 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 122.735 0.414 . . . . 71.2 110.205 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.06 79.19 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.111 0.964 . . . . 51.13 112.561 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -75.42 -25.03 57.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.252 0.464 . . . . 52.03 112.252 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.29 -47.56 15.65 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 117.987 0.358 . . . . 75.54 111.622 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -66.07 -51.21 60.18 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.469 0.708 . . . . 74.12 111.168 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.22 48.23 0.85 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.054 -0.976 . . . . 65.22 110.373 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -64.97 -51.88 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.246 0.462 . . . . 41.31 112.246 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -31.29 58.5 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.045 -0.525 . . . . 52.01 113.287 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -72.22 -50.96 23.36 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.254 0.622 . . . . 73.33 111.494 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HG2' ' NZ ' ' A' ' 13' ' ' LYS . 35.7 tt0 -50.36 -37.91 39.61 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.503 0.927 . . . . 74.3 113.503 165.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.6 m -65.82 -35.6 81.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.484 0.314 . . . . 74.13 111.495 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -65.08 -42.38 94.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.218 0.451 . . . . 74.3 112.218 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.77 -50.7 33.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 120.755 0.312 . . . . 73.34 111.056 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.62 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -50.58 -51.36 33.03 Favored Glycine 0 CA--C 1.545 1.909 0 N-CA-C 116.285 1.274 . . . . 54.31 116.285 174.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 2.2 m-20 -73.11 0.19 12.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.925 1.083 . . . . 73.31 113.925 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.33 26.29 67.74 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.745 0.658 . . . . 54.23 114.745 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.0 mm-40 -67.61 -29.94 69.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.941 0.896 . . . . 75.42 111.164 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.419 HD11 ' HD1' ' A' ' 58' ' ' PHE . 21.1 pt -132.77 156.67 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.518 1.127 . . . . 64.35 108.93 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 57' ' ' GLU . 10.2 t -82.04 166.86 19.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.028 -0.42 . . . . 73.43 110.738 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -61.79 -38.31 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.717 0.407 . . . . 43.4 111.172 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 57' ' ' GLU . 1.1 tmtp? -56.79 -58.79 6.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.604 1.162 . . . . 72.23 112.137 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.565 ' H ' HG23 ' A' ' 54' ' ' THR . 21.8 tt0 -50.1 -34.57 22.35 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 114.375 -1.284 . . . . 54.33 111.983 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.424 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 59.8 t80 -71.48 -38.03 71.26 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 123.399 0.68 . . . . 75.42 112.211 173.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 27' ' ' ILE . 22.4 mm -73.36 -50.24 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 124.731 1.213 . . . . 70.33 111.696 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.526 ' HB2' HG11 ' A' ' 120' ' ' VAL . 31.9 tt0 -51.02 -41.43 59.8 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.487 1.115 . . . . 72.5 110.878 163.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.21 -38.9 62.64 Favored Glycine 0 CA--C 1.55 2.219 0 CA-C-N 112.438 -2.164 . . . . 74.12 112.98 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 80.9 mt -77.15 -36.02 55.59 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.068 0.947 . . . . 54.33 112.328 176.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.68 -21.85 61.12 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 114.31 0.484 . . . . 64.52 114.31 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -77.44 -34.18 54.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.502 0.721 . . . . 71.24 111.831 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 t -48.04 140.55 6.9 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.473 1.286 . . . . 73.34 114.473 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -62.02 -30.09 70.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.696 1.199 . . . . 63.22 113.423 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 tp -69.43 -24.27 63.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.399 0.619 . . . . 73.32 111.593 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.92 -34.87 57.67 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.13 -0.941 . . . . 72.53 108.752 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 -51.31 20.05 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.882 -1.053 . . . . 71.14 113.697 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 12.7 ptpt -64.15 -55.66 20.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.995 2.18 . . . . 64.32 115.234 172.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -51.51 -22.69 3.35 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.629 1.714 . . . . 54.4 115.629 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -137.44 -19.62 1.22 Allowed 'General case' 0 N--CA 1.514 2.768 0 N-CA-C 116.939 2.2 . . . . 73.03 116.939 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.418 ' HA ' HG22 ' A' ' 81' ' ' VAL . 85.8 t80 -110.83 -37.49 5.4 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.512 1.051 . . . . 73.33 112.773 -176.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.9 m -71.52 -46.74 13.17 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 114.332 1.234 . . . . 73.34 114.332 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.4 Cg_endo -84.08 -15.02 6.97 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.784 2.323 . . . . 52.33 112.408 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.6 140.21 21.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.66 0.784 . . . . 71.54 110.91 -172.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.407 ' O ' HG23 ' A' ' 81' ' ' VAL . 46.2 Cg_endo -66.01 151.93 82.65 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.148 1.899 . . . . 73.03 111.447 171.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -45.74 -28.42 1.03 Allowed 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.859 1.264 . . . . 70.54 112.605 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 m -61.61 -52.67 63.43 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.502 -1.681 . . . . 71.12 109.87 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.419 ' HD2' ' HB3' ' A' ' 83' ' ' GLU . 55.2 tptt -73.83 -26.87 60.82 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.182 0.993 . . . . 64.11 113.232 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.515 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 62.8 t -66.13 -25.16 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 122.955 0.502 . . . . 64.32 111.271 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.517 HG22 ' HB3' ' A' ' 94' ' ' PRO . 46.3 mt -80.41 -28.53 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.164 0.985 . . . . 61.44 112.466 169.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 80' ' ' LYS . 6.0 tm-20 -76.85 -51.92 10.42 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.453 0.701 . . . . 75.31 109.43 -172.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 87' ' ' LYS . 93.9 mt -75.53 -15.09 60.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.561 1.144 . . . . 74.32 109.829 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . -82.05 -49.8 5.15 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.02 -0.991 . . . . 65.34 114.026 -158.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -73.3 -19.21 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.973 1.387 . . . . 51.03 110.577 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 91.8 mttt -62.18 -33.31 74.3 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.015 -0.993 . . . . 75.11 111.371 -167.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.518 ' HA ' HE22 ' A' ' 26' ' ' GLN . 66.5 m-70 -87.88 13.11 11.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.854 0.862 . . . . 65.42 113.031 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -138.74 -58.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.531 -1.285 . . . . 75.02 107.531 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.523 HD12 ' HE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -127.04 91.1 3.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.143 0.977 . . . . 73.2 108.978 164.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 87' ' ' LYS . . . -65.69 87.26 0.1 OUTLIER Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.656 -0.702 . . . . 75.43 113.015 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.523 ' HE ' HD12 ' A' ' 90' ' ' LEU . 4.4 ptp180 -143.31 24.46 1.77 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.925 0.49 . . . . 64.31 111.766 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.21 174.58 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.307 0.855 . . . . 72.31 113.307 -158.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 82' ' ' ILE . 61.5 Cg_endo -72.25 137.24 28.21 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.694 1.596 . . . . 62.22 110.518 161.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.92 -61.39 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.428 1.091 . . . . 70.44 112.134 -170.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -147.76 157.84 43.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.718 0.407 . . . . 71.42 111.005 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -63.25 -10.35 15.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.425 0.898 . . . . 64.42 113.425 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.96 -42.05 12.73 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.264 1.031 . . . . 71.34 108.389 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 102' ' ' LYS . 4.0 tm-20 -64.25 -32.47 74.07 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 113.759 -1.564 . . . . 74.55 111.62 170.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.88 -54.49 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 123.284 0.634 . . . . 61.24 110.024 173.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -46.55 -34.74 5.14 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 114.23 1.196 . . . . 54.41 114.23 167.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 31.6 ttpt -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.969 0.508 . . . . 74.43 112.035 175.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.15 -46.53 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.596 0.358 . . . . 74.44 110.607 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -44.86 -42.6 8.11 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.153 0.981 . . . . 74.42 112.962 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -64.88 -29.63 70.59 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.142 0.428 . . . . 72.14 111.777 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.9 mt -79.67 -57.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.086 -1.079 . . . . 70.14 108.086 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.6 tp -45.99 -35.0 4.38 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.422 1.638 . . . . 61.42 115.422 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.32 -21.57 53.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.032 0.752 . . . . 51.33 113.032 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.7 p -113.2 -14.46 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.093 0.557 . . . . 71.41 112.08 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -138.97 -51.8 0.55 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.692 0.797 . . . . 74.12 111.156 -170.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.86 169.85 13.68 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 114.258 0.463 . . . . 52.13 114.258 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' ' 115' ' ' PHE . 8.0 tp -37.74 -34.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.247 1.573 . . . . 72.53 115.247 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -53.39 -53.91 44.42 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.397 0.679 . . . . 74.41 111.508 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.34 37.65 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.543 -1.208 . . . . 63.11 112.033 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.403 ' HD2' HD12 ' A' ' 112' ' ' ILE . 31.0 t80 -50.64 -70.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.51 1.3 . . . . 75.34 114.51 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.44 -37.07 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 114.034 1.124 . . . . 63.02 114.034 170.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -67.14 -38.14 85.03 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.772 0.715 . . . . 74.31 111.218 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.19 -52.05 57.25 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 123.082 0.553 . . . . 75.44 111.806 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.2 mt -49.66 -54.55 17.92 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.445 0.906 . . . . 63.33 113.445 171.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 60' ' ' GLU . 89.9 t -69.11 -26.34 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 123.84 0.856 . . . . 72.32 112.694 -172.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -100.6 13.55 34.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.146 0.795 . . . . 71.41 113.146 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.3 m -66.92 151.01 48.4 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 122.863 0.465 . . . . 70.13 110.371 167.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.529 ' HG3' HD21 ' A' ' 126' ' ' ASN . 29.9 tt0 -72.0 -25.24 61.76 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.0 0.818 . . . . 73.41 110.524 -174.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.506 ' HB3' HH21 ' A' ' 92' ' ' ARG . 41.4 mt-10 -62.15 -36.11 80.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.877 0.871 . . . . 51.25 111.329 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -67.69 -40.3 84.38 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 109.995 -0.372 . . . . 75.52 109.995 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.529 HD21 ' HG3' ' A' ' 123' ' ' GLN . 1.5 p30 -68.6 -38.4 80.58 Favored 'General case' 0 C--N 1.366 1.311 0 CA-C-O 118.673 -0.679 . . . . 73.52 112.025 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -60.87 -56.88 15.92 Favored 'General case' 0 C--N 1.367 1.337 0 N-CA-C 115.257 1.576 . . . . 75.21 115.257 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.98 -35.84 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.348 0.594 . . . . 72.02 111.397 -162.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 44.2 m-85 -111.94 -45.35 3.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.517 -0.765 . . . . 55.53 110.688 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.62 -87.36 0.93 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.403 -1.479 . . . . 41.44 109.403 -162.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.25 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.134 0.973 . . . . 75.42 111.175 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -81.8 36.71 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.67 0.788 . . . . 70.02 112.385 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 5' ' ' LYS . 45.5 m -147.52 145.4 29.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.026 0.93 . . . . 75.22 110.051 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.05 132.83 82.2 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 108.65 -0.87 . . . . 74.42 108.65 172.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 38.1 Cg_endo -62.0 81.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.598 2.199 . . . . 44.44 113.447 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.9 p90 . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 123.006 0.522 . . . . 62.55 111.18 178.91 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.184 0.516 . . . . 52.12 112.307 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -71.4 132.75 45.26 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.994 0.518 . . . . 75.31 110.101 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -152.6 159.84 43.22 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.502 . . . . 63.54 112.017 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.7 100.03 12.03 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.548 -0.908 . . . . 71.32 108.548 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.436 ' H ' HD12 ' A' ' 10' ' ' ILE . 98.0 t -78.38 141.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.614 -0.514 . . . . 72.51 109.614 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.99 93.07 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.359 0.664 . . . . 64.01 111.845 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.15 2.01 6.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 119.457 -0.635 . . . . 72.33 114.462 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 7' ' ' VAL . 35.2 mt -79.88 82.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.673 1.236 . . . . 73.44 109.951 172.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -107.03 13.22 27.76 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.02 -0.991 . . . . 72.33 110.077 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.85 116.5 22.78 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.547 1.139 . . . . 73.14 109.076 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.34 -24.11 63.86 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.925 1.083 . . . . 75.12 113.925 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.95 -31.18 70.73 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.077 0.465 . . . . 63.35 111.06 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -50.21 13.94 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.645 -0.707 . . . . 72.3 110.698 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.2 mm -55.65 -45.45 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.406 1.082 . . . . 61.13 113.191 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.55 -39.54 91.44 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 111.988 0.366 . . . . 74.41 111.988 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 m -62.74 -41.13 99.05 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.394 0.677 . . . . 75.53 112.053 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.491 HD23 HD21 ' A' ' 48' ' ' LEU . 20.6 tp -61.78 -44.7 96.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.368 0.667 . . . . 74.4 111.086 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.16 -41.32 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.666 1.186 . . . . 72.44 111.147 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.6 m -62.94 -53.02 60.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.387 0.675 . . . . 54.25 111.287 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.62 82.16 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.714 0.806 . . . . 72.45 112.539 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.86 -42.93 72.64 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.123 0.569 . . . . 42.21 111.357 173.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.34 -43.72 85.33 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.278 0.631 . . . . 64.03 111.979 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -68.21 -13.2 62.06 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.334 0.654 . . . . 55.44 112.308 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -89.77 -63.13 1.33 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.771 0.428 . . . . 71.14 111.386 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -65.12 -57.78 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 122.662 0.385 . . . . 64.21 110.727 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -83.04 -13.05 56.58 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.291 0.636 . . . . 75.24 112.252 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 65.58 -53.44 0.36 Allowed 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.367 1.467 . . . . 72.44 114.108 -168.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -57.57 128.76 38.66 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.203 1.001 . . . . 71.32 113.022 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.0 120.31 13.42 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.117 -0.947 . . . . 75.14 109.515 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.79 126.7 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.378 -0.601 . . . . 74.44 109.378 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.34 135.23 96.15 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 123.649 0.593 . . . . 62.45 109.991 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 -35.1 86.82 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.409 2.739 . . . . 74.13 114.14 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -69.73 -38.8 77.01 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.484 0.314 . . . . 75.11 111.437 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.423 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 71.4 mt -63.05 -41.73 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.547 0.739 . . . . 71.1 110.269 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -53.22 59.77 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.084 -0.962 . . . . 41.31 111.855 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.6 -11.44 59.87 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.954 1.464 . . . . 70.21 114.954 -172.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 36' ' ' ILE . 8.4 p30 -81.66 -45.21 16.09 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.875 1.216 . . . . 64.42 110.797 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.77 -46.27 14.46 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.804 0.841 . . . . 74.14 111.609 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -105.8 44.3 1.05 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 124.657 1.183 . . . . 64.44 109.755 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -51.67 66.88 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.818 0.673 . . . . 60.42 112.818 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.05 -30.88 64.82 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.625 -0.716 . . . . 61.01 112.569 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.41 ' CZ2' ' HA3' ' A' ' 61' ' ' GLY . 13.8 t-105 -72.58 -42.05 65.02 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.305 1.042 . . . . 75.33 111.701 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.85 -50.44 73.43 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.443 1.097 . . . . 64.02 110.777 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.1 t -59.61 -43.79 93.63 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.014 -0.994 . . . . 62.03 111.786 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HG2' HG12 ' A' ' 53' ' ' ILE . 25.2 ttmm -58.83 -46.5 87.54 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.755 1.222 . . . . 54.44 112.553 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.491 HD21 HD23 ' A' ' 19' ' ' LEU . 48.4 tp -64.56 -44.71 89.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.778 0.431 . . . . 75.32 111.278 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.73 -39.97 98.16 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 116.36 -0.382 . . . . 62.32 113.863 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -79.96 6.49 11.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.109 0.964 . . . . 73.22 112.915 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.35 32.55 68.32 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 114.595 0.598 . . . . 72.23 114.595 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.14 -26.53 42.8 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.155 0.582 . . . . 74.42 109.531 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.409 HG12 ' HG2' ' A' ' 47' ' ' LYS . 40.5 pt -134.76 170.14 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 124.282 1.033 . . . . 74.22 110.764 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.6 p -95.58 -176.57 3.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.388 0.675 . . . . 71.1 109.637 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 59' ' ' ILE . 80.0 t -65.89 -45.81 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 119.27 -0.395 . . . . 73.31 110.927 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 51.0 tttm -47.43 -52.65 16.27 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.807 1.04 . . . . 72.23 113.807 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.72 -37.17 85.47 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.672 0.389 . . . . 61.43 111.707 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.431 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 50.7 t80 -61.22 -43.27 99.15 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.66 0.784 . . . . 71.42 111.124 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 55' ' ' VAL . 34.9 mm -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.829 1.252 . . . . 64.32 111.247 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -52.18 -45.48 65.14 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.597 0.759 . . . . 72.13 112.061 172.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' HA3' ' CZ2' ' A' ' 44' ' ' TRP . . . -62.84 -36.79 93.87 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.266 -0.425 . . . . 75.21 113.324 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 46.2 mt -64.69 -44.11 91.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.378 0.671 . . . . 73.54 111.551 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.39 -34.74 86.43 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 115.447 0.939 . . . . 74.34 115.447 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -74.71 -23.13 58.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.29 0.545 . . . . 75.54 112.011 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -55.85 134.44 51.88 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.502 0.926 . . . . 72.52 113.502 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -60.65 -26.2 66.88 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.269 1.028 . . . . 73.2 112.092 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.18 -39.53 93.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.964 0.506 . . . . 72.14 111.1 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -69.33 -39.25 78.28 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.19 0.519 . . . . 74.34 110.56 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD11 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -64.74 -31.19 72.3 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.655 -0.702 . . . . 74.14 112.132 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -75.23 -46.34 34.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.865 0.466 . . . . 75.51 111.287 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -82.68 -46.31 13.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.804 0.668 . . . . 74.42 112.804 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.56 48.64 1.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 112.772 0.656 . . . . 64.32 112.772 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 74.6 t80 -159.68 -48.37 0.05 Allowed 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 116.082 -0.508 . . . . 75.13 110.88 171.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 m -66.02 -47.28 63.36 Favored Pre-proline 0 CA--C 1.573 1.848 0 N-CA-C 112.815 0.672 . . . . 62.13 112.815 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -90.08 11.07 2.87 Favored 'Trans proline' 0 C--N 1.395 2.993 0 C-N-CA 122.638 2.225 . . . . 75.02 113.202 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.0 141.26 38.97 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 122.988 0.515 . . . . 72.12 111.861 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.29 158.24 58.32 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.501 2.134 . . . . 75.43 111.384 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -51.54 -41.99 61.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.573 0.582 . . . . 74.52 112.573 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.9 m -54.14 -42.85 70.0 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.514 0.726 . . . . 53.12 111.536 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -74.92 -33.17 61.94 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.061 0.545 . . . . 70.32 112.019 178.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.09 -31.96 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.231 0.539 . . . . 75.52 110.921 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.58 -49.73 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.795 0.838 . . . . 64.44 111.008 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 80' ' ' LYS . 13.4 pt-20 -71.18 -35.47 71.6 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 111.588 0.218 . . . . 64.22 111.588 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.94 -44.53 26.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.314 0.645 . . . . 71.31 110.99 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.38 -49.86 58.82 Favored Glycine 0 N--CA 1.475 1.265 0 O-C-N 123.292 0.37 . . . . 75.43 113.639 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.599 HG23 HD13 ' A' ' 90' ' ' LEU . 86.7 m -55.73 -40.39 72.41 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 123.033 0.533 . . . . 73.25 110.632 171.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -71.33 -21.77 62.0 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 123.075 0.55 . . . . 74.31 111.434 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 67.2 m170 -87.29 -8.57 56.59 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.03 0.932 . . . . 71.01 112.363 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.8 -61.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.389 1.076 . . . . 74.45 108.88 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.599 HD13 HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -110.08 84.74 1.98 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.359 -1.348 . . . . 62.44 107.359 176.619 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.53 78.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 114.896 0.718 . . . . 51.51 114.896 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.632 HH12 HD11 ' A' ' 95' ' ' ILE . 27.8 mtm105 -137.94 151.43 47.96 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.375 1.07 . . . . 74.4 111.089 -174.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 132.02 85.85 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-N 115.471 -0.786 . . . . 62.21 110.748 168.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.27 135.91 46.28 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.31 2.673 . . . . 70.02 113.824 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.632 HD11 HH12 ' A' ' 92' ' ' ARG . 49.6 mm -82.69 -69.12 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.495 0.718 . . . . 75.43 112.76 -170.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -147.81 156.58 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.583 0.753 . . . . 72.12 109.073 -165.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -58.44 -40.31 82.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.954 0.724 . . . . 75.22 112.954 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.63 71.78 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.248 0.462 . . . . 43.53 112.248 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -65.7 -40.32 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.613 0.765 . . . . 75.33 110.919 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.03 -50.44 64.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.533 0.733 . . . . 73.21 110.968 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.2 mmm180 -52.05 -40.85 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.537 1.135 . . . . 72.04 112.386 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.417 ' O ' HG13 ' A' ' 106' ' ' ILE . 35.7 ttpt -56.39 -52.68 63.73 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.76 0.824 . . . . 71.53 111.194 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -72.24 -36.79 69.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.795 0.438 . . . . 74.45 112.167 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.47 -40.83 96.43 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.956 0.902 . . . . 65.34 111.296 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.6 -28.93 68.17 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.466 -0.788 . . . . 70.33 111.015 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 102' ' ' LYS . 82.2 mt -63.19 -39.14 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 122.991 0.516 . . . . 61.3 110.526 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.96 -39.92 96.11 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.836 0.454 . . . . 72.43 111.602 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.21 -37.32 53.63 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.716 0.635 . . . . 54.23 112.716 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.0 p -80.93 -60.15 2.41 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.193 0.597 . . . . 71.33 112.493 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -103.04 -36.23 8.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.0 0.92 . . . . 72.34 112.801 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.4 -162.01 12.51 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 122.847 0.261 . . . . 63.21 113.315 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.437 HG12 HD11 ' A' ' 69' ' ' LEU . 9.5 tp -79.69 -29.14 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.111 0.564 . . . . 75.44 111.476 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.434 ' H ' ' HD3' ' A' ' 113' ' ' ARG . 0.8 OUTLIER -59.64 -49.42 77.82 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.384 0.673 . . . . 74.4 110.381 -175.584 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -33.3 73.88 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.128 -0.942 . . . . 74.3 112.738 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.21 -52.29 66.3 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.234 0.613 . . . . 73.52 111.328 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.83 -45.68 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.666 0.786 . . . . 72.34 110.718 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -57.94 -35.68 71.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.166 0.986 . . . . 72.12 111.387 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -67.55 -48.37 67.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.128 0.571 . . . . 73.12 111.387 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' A' ' 90' ' ' LEU . 82.0 mt -58.31 -44.74 88.73 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.617 0.767 . . . . 62.5 112.554 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.8 t -68.17 -52.19 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.079 0.952 . . . . 71.44 111.954 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.81 24.06 4.4 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.291 0.636 . . . . 60.24 112.155 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 19.6 t -79.53 155.4 28.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.577 0.751 . . . . 72.11 112.275 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -59.98 -52.58 64.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.691 0.796 . . . . 65.51 110.952 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.94 -30.84 66.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.852 0.861 . . . . 73.14 112.595 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -71.45 -54.26 11.23 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.218 0.207 . . . . 75.45 111.098 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -69.48 -34.3 74.13 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.961 0.726 . . . . 75.22 112.961 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.57 -42.58 58.51 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 111.682 0.252 . . . . 63.1 111.682 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.81 -54.79 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.289 0.636 . . . . 75.22 111.857 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.488 ' HE2' ' H ' ' A' ' 136' ' ' TYR . 52.9 m-85 -88.41 -49.29 7.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.164 0.986 . . . . 63.34 110.832 -176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 93.25 -118.91 5.77 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.218 -0.447 . . . . 71.42 112.546 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -141.31 -23.18 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.858 0.863 . . . . 74.22 111.615 176.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -84.13 -23.54 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.558 0.577 . . . . 62.0 112.558 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.2 m -93.74 138.09 32.31 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.277 0.473 . . . . 72.11 112.277 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.18 136.34 75.92 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.851 0.86 . . . . 73.1 109.678 168.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -34.77 111.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.586 3.524 . . . . 62.34 115.5 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.488 ' H ' ' HE2' ' A' ' 129' ' ' PHE . 52.9 p90 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 123.395 0.678 . . . . 75.02 110.88 175.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.922 0.391 . . . . 73.43 110.893 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 70.15 29.14 3.83 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.193 1.397 . . . . 70.15 112.845 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.25 145.89 24.14 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.855 -0.528 . . . . 71.32 109.597 170.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -78.26 101.23 7.03 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.564 -0.532 . . . . 74.12 109.564 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.02 113.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.29 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.144 0.978 . . . . 75.13 112.608 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.58 -18.02 4.4 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 115.436 -0.802 . . . . 53.33 114.267 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.43 104.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 117.903 0.852 . . . . 71.53 111.162 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -86.54 -38.22 17.41 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 73.3 111.406 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.01 102.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.78 1.232 . . . . 71.33 113.894 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.612 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 68.5 mttt -67.77 -9.19 41.9 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.542 -0.754 . . . . 75.42 112.54 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.04 -39.6 79.1 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.561 0.744 . . . . 75.52 110.91 163.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.64 43.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.745 0.818 . . . . 63.34 110.991 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 1.7 mp -58.0 -39.81 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.079 0.951 . . . . 75.32 110.827 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -64.71 -49.88 69.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.999 0.52 . . . . 62.22 111.467 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -54.39 -42.36 70.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.166 0.802 . . . . 75.2 113.166 172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 48' ' ' LEU . 9.6 tt -58.27 -48.41 80.53 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.171 0.988 . . . . 74.14 110.893 173.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.69 -43.24 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.386 1.074 . . . . 75.11 111.379 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.3 m -63.75 -48.68 76.04 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.347 0.659 . . . . 55.43 111.012 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.82 57.77 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.327 0.862 . . . . 74.2 113.327 170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.15 72.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.259 0.837 . . . . 45.11 113.259 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -72.96 -48.1 39.63 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.588 0.755 . . . . 75.25 111.227 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.4 ttm180 -51.02 -36.88 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.223 1.009 . . . . 60.01 113.668 172.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.21 -63.68 1.27 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.8 0.44 . . . . 44.02 110.576 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.458 HD11 HG13 ' A' ' 59' ' ' ILE . 61.2 mt -65.32 -48.4 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.913 0.885 . . . . 70.32 112.452 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -84.35 9.63 12.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.258 0.623 . . . . 72.41 111.628 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 49.95 19.87 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 125.922 1.689 . . . . 70.03 115.183 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -164.12 143.51 7.75 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.416 0.626 . . . . 65.54 111.604 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.2 111.21 2.86 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.008 -0.996 . . . . 53.12 111.042 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.2 mt -78.89 134.89 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 116.105 -0.498 . . . . 72.24 109.968 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 123.8 52.98 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 124.254 0.971 . . . . 72.41 110.649 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -54.15 -37.84 87.47 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.526 2.817 . . . . 62.53 114.069 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -67.85 -24.91 65.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.663 0.785 . . . . 73.15 113.07 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.36 -44.45 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.213 0.605 . . . . 53.32 110.681 171.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.18 80.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.064 0.945 . . . . 65.45 112.195 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -72.55 -25.26 61.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.982 0.513 . . . . 65.42 111.833 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.31 -47.23 18.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.667 0.787 . . . . 62.41 110.977 -170.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.2 -32.89 59.22 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.633 -0.712 . . . . 72.41 110.764 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.37 43.08 1.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.902 0.881 . . . . 73.42 111.07 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -68.61 -43.91 75.39 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.163 0.585 . . . . 75.14 112.433 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.89 -26.89 61.52 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.844 -0.502 . . . . 42.32 111.844 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -82.21 -30.85 30.62 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.088 0.955 . . . . 75.11 110.483 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -68.79 -41.58 78.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.95 0.9 . . . . 73.41 108.862 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 t -57.09 -35.65 69.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.62 0.768 . . . . 71.4 111.92 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -42.6 99.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.9 0.48 . . . . 72.54 111.279 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 19' ' ' LEU . 49.2 tp -73.24 -36.07 66.36 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.736 0.815 . . . . 55.41 111.503 177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.7 -48.42 12.78 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 123.313 0.482 . . . . 63.1 113.153 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -78.26 3.15 16.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.744 0.646 . . . . 74.04 112.744 172.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.4 34.09 67.58 Favored Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.727 0.651 . . . . 74.22 114.727 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -68.46 -28.34 66.96 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.509 0.724 . . . . 73.44 111.58 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 pt -130.03 170.42 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.365 1.066 . . . . 72.14 110.362 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p -90.8 164.35 14.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.206 0.602 . . . . 62.14 110.258 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.73 -41.23 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.612 0.365 . . . . 74.11 110.46 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 87.0 tttt -41.78 -55.59 2.97 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.253 1.205 . . . . 73.43 114.253 162.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -66.07 -26.79 67.66 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.921 -0.581 . . . . 74.02 111.777 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -72.99 -38.36 66.68 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.166 0.986 . . . . 74.12 110.801 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.458 HG13 HD11 ' A' ' 27' ' ' ILE . 1.2 mp -73.41 -45.17 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.972 1.309 . . . . 73.21 111.829 -174.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.527 ' HB2' HG11 ' A' ' 120' ' ' VAL . 32.6 tt0 -50.28 -35.92 29.24 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.69 0.626 . . . . 74.21 112.69 165.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.45 -26.95 74.05 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-N 115.93 -0.577 . . . . 73.55 112.439 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -74.04 -48.34 30.64 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.999 0.92 . . . . 64.13 111.2 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.69 -31.65 45.82 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 116.308 1.283 . . . . 41.41 116.308 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -72.44 -17.86 61.75 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 117.472 0.636 . . . . 73.35 112.119 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -75.4 131.87 40.5 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.395 0.678 . . . . 53.24 111.368 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -61.03 -18.95 60.54 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.73 0.812 . . . . 73.42 112.808 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 32.3 tp -61.71 -41.14 97.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.608 0.763 . . . . 64.23 111.189 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.07 -37.16 86.63 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.042 0.448 . . . . 71.33 111.308 172.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.526 HD11 HG21 ' A' ' 112' ' ' ILE . 4.2 mm? -70.99 -30.11 66.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.883 0.873 . . . . 71.03 112.722 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -77.58 -25.02 49.65 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 122.133 -0.354 . . . . 61.55 110.59 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 22.4 mm-40 -75.49 -56.27 4.87 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.561 172.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -130.08 70.35 1.44 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.775 0.657 . . . . 54.33 112.775 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.41 ' H ' ' HD2' ' A' ' 75' ' ' PRO . 52.0 t80 -176.04 -61.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.493 0.717 . . . . 75.22 110.53 174.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -65.16 -38.46 28.29 Favored Pre-proline 0 CA--C 1.573 1.849 0 N-CA-C 113.961 1.097 . . . . 61.21 113.961 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 73' ' ' TYR . 43.2 Cg_endo -94.73 17.41 0.89 Allowed 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 121.987 1.791 . . . . 72.25 113.674 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -137.46 153.42 74.46 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 123.857 0.863 . . . . 71.44 111.372 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.94 153.56 63.43 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.226 1.951 . . . . 64.45 111.551 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -46.81 -54.32 10.1 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.329 1.233 . . . . 72.35 114.329 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -49.2 -32.68 10.86 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 113.956 1.095 . . . . 75.35 113.956 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -74.89 -27.63 60.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.882 0.473 . . . . 73.43 111.196 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.75 -30.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.761 0.824 . . . . 71.52 111.755 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 100' ' ' ILE . 2.0 mp -67.44 -43.78 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.004 0.521 . . . . 65.13 110.884 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.42 -26.04 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.095 -0.502 . . . . 54.14 111.846 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.6 mt -85.38 -31.17 23.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.635 0.774 . . . . 54.11 111.771 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.99 -54.75 12.61 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 116.218 -0.447 . . . . 64.11 112.435 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.644 HG23 HD12 ' A' ' 90' ' ' LEU . 47.8 m -57.64 -30.63 65.55 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.308 1.043 . . . . 54.32 111.464 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.41 -38.4 77.91 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.854 0.862 . . . . 72.44 111.819 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -94.27 -1.48 53.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.147 1.166 . . . . 73.42 114.147 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -123.36 -57.92 1.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.061 0.391 . . . . 72.33 111.69 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.644 HD12 HG23 ' A' ' 86' ' ' THR . 60.8 mt -84.12 -12.72 54.56 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.302 0.241 . . . . 72.54 111.389 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.56 11.16 56.26 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 116.2 -0.455 . . . . 72.32 113.551 -173.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -104.92 135.17 46.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.977 0.911 . . . . 53.51 111.547 -167.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.92 158.4 70.5 Favored Pre-proline 0 CA--C 1.565 1.531 0 CA-C-N 115.383 -0.826 . . . . 41.33 111.386 169.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.87 161.59 0.48 Allowed 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.043 2.495 . . . . 71.25 113.961 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.16 -75.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.771 -0.825 . . . . 73.23 108.771 -160.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -141.04 153.24 45.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.257 1.423 . . . . 73.02 107.437 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.26 -14.44 49.41 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.905 1.229 . . . . 53.32 113.618 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.37 -31.27 21.58 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.21 -1.033 . . . . 62.21 108.21 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.52 -39.53 77.48 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.289 1.436 . . . . 70.32 111.114 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.412 ' HA ' HG21 ' A' ' 82' ' ' ILE . 87.8 mt -64.02 -52.8 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.244 0.618 . . . . 62.43 110.264 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -55.26 -31.22 61.37 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.213 1.005 . . . . 75.31 113.514 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.27 -49.35 74.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.548 0.339 . . . . 74.52 110.818 173.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -68.27 -39.66 82.12 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.971 0.509 . . . . 73.52 111.29 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -58.76 -42.77 89.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.39 1.076 . . . . 73.45 112.463 172.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -62.39 -27.39 69.05 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.25 0.62 . . . . 74.02 111.958 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.04 -60.33 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 108.798 -0.816 . . . . 61.34 108.798 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 115' ' ' PHE . 22.8 tp -41.96 -31.97 0.39 Allowed 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 115.658 1.725 . . . . 64.32 115.658 160.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.19 -41.47 25.19 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 119.176 0.898 . . . . 73.42 112.317 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.2 p -97.79 -22.97 16.1 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.024 0.75 . . . . 54.23 113.024 -172.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -126.36 -38.07 2.15 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.426 0.69 . . . . 75.34 112.113 -171.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.61 174.33 14.0 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 113.986 0.354 . . . . 62.05 113.986 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -67.66 -29.6 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.051 0.94 . . . . 73.01 110.62 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -54.67 -53.0 60.57 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.629 0.772 . . . . 74.51 111.371 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.24 -29.03 70.15 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.973 0.909 . . . . 64.23 113.153 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 55.3 t80 -67.76 -49.51 62.08 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.407 0.683 . . . . 71.42 111.106 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -59.37 -46.34 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.586 0.754 . . . . 55.4 110.414 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -56.67 -40.45 75.55 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.715 0.806 . . . . 51.13 112.345 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.64 93.22 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.262 0.625 . . . . 34.5 112.119 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' ' 90' ' ' LEU . 83.6 mt -72.6 -55.74 6.42 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.303 0.641 . . . . 75.04 111.816 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 60' ' ' GLU . 88.7 t -61.66 -42.6 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.57 0.748 . . . . 71.22 112.412 -173.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -82.75 -0.47 47.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.294 0.85 . . . . 71.23 113.294 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -66.95 158.02 31.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.015 0.526 . . . . 73.02 111.913 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -65.12 -25.99 68.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.823 0.849 . . . . 61.23 110.628 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.55 ' HB2' HD22 ' A' ' 90' ' ' LEU . 42.6 mm-40 -62.89 -48.35 79.38 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.201 1.0 . . . . 71.23 111.671 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -68.46 -46.33 70.06 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.437 0.637 . . . . 73.43 110.013 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.74 -52.03 64.83 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.468 -1.242 . . . . 74.05 112.32 -165.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.49 -42.65 19.96 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.467 0.914 . . . . 71.23 113.467 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.07 -49.16 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.252 0.621 . . . . 73.2 112.5 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -96.15 -53.98 3.46 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 120.991 0.424 . . . . 74.53 111.195 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.7 144.3 13.51 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.853 -0.612 . . . . 35.24 111.581 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 16.3 pt-20 -74.84 -19.5 60.15 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.768 0.655 . . . . 73.44 112.768 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.01 -6.91 59.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.698 0.799 . . . . 73.13 111.84 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 m -116.2 149.74 38.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.433 0.693 . . . . 72.24 112.244 -167.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 141.51 97.42 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.728 0.811 . . . . 61.22 109.563 166.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.441 ' HD3' HG12 ' A' ' 59' ' ' ILE . 38.8 Cg_endo -65.3 77.36 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.587 2.192 . . . . 41.12 112.726 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.9 p90 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 108.654 -0.869 . . . . 73.1 108.654 176.92 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.565 1.531 0 CA-C-O 120.94 0.4 . . . . 64.41 111.435 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 63.8 86.13 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.038 1.335 . . . . 64.21 112.059 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -127.48 170.75 12.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.664 1.186 . . . . 72.35 110.803 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -116.27 94.29 4.58 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.877 -0.602 . . . . 74.22 110.121 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.64 141.85 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.927 -0.768 . . . . 65.52 108.927 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.54 -20.65 0.46 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.86 1.8 . . . . 64.14 115.86 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.32 -103.7 0.86 Allowed Glycine 0 C--N 1.368 2.34 0 CA-C-N 120.155 1.343 . . . . 40.01 110.519 166.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm 41.29 49.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 125.431 1.492 . . . . 70.34 111.945 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -64.63 13.38 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 114.918 1.451 . . . . 62.14 114.918 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.98 113.08 17.88 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.867 0.841 . . . . 73.43 110.551 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -28.15 64.51 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.714 -1.585 . . . . 74.35 109.368 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.26 71.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.519 1.127 . . . . 53.13 111.08 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.09 67.86 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.072 0.767 . . . . 72.1 113.072 171.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 20' ' ' ILE . 45.7 mm -54.09 -54.45 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 112.794 0.664 . . . . 71.2 112.794 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 20' ' ' ILE . 15.5 ptpt -66.04 -30.89 71.5 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.934 0.716 . . . . 72.23 112.934 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -70.33 -48.79 54.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.23 0.612 . . . . 73.21 111.431 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.77 -43.21 8.39 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.187 0.995 . . . . 63.34 112.446 167.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 16' ' ' ILE . 66.4 mt -66.13 -35.83 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.496 0.718 . . . . 72.4 111.454 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -67.05 -41.7 86.06 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.182 0.593 . . . . 73.3 112.089 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.33 91.7 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.059 0.544 . . . . 64.42 111.983 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.48 9.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.368 -1.287 . . . . 42.14 112.166 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.13 -47.06 19.03 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.92 0.488 . . . . 73.1 112.067 167.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -68.25 -15.71 63.68 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.176 0.99 . . . . 72.32 112.391 -171.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -95.57 -35.55 11.6 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.655 -0.653 . . . . 71.43 111.592 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 50.2 mm -87.67 -66.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.147 0.579 . . . . 70.35 111.014 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.48 -17.89 64.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.284 0.634 . . . . 72.44 111.274 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' ARG . 23.2 tt0 62.65 31.33 16.8 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.535 1.534 . . . . 74.13 112.276 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -152.37 156.55 39.78 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.807 -0.633 . . . . 71.24 111.776 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.93 108.44 8.81 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.81 -1.086 . . . . 65.21 109.166 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.51 135.24 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 109.352 -0.61 . . . . 73.51 109.352 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.15 118.04 21.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.73 0.812 . . . . 74.45 111.075 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -47.74 -39.92 31.11 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.847 3.031 . . . . 74.03 114.56 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -67.99 -39.37 83.29 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 112.904 0.705 . . . . 75.14 112.904 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -67.07 -44.27 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.326 0.584 . . . . 55.44 110.542 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.58 82.85 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.27 1.028 . . . . 72.14 112.698 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -82.0 -23.82 35.78 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 116.317 -0.402 . . . . 54.01 110.765 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -75.48 -35.38 60.86 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.103 0.561 . . . . 73.22 111.483 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.6 -61.96 1.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.645 0.736 . . . . 75.54 110.996 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.8 43.79 1.07 Allowed 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 115.348 -0.842 . . . . 72.44 112.814 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.15 -51.88 33.71 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.074 -0.391 . . . . 62.41 112.014 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.96 -34.54 33.52 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.136 -0.484 . . . . 62.21 111.959 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -66.88 -39.85 87.63 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.89 0.876 . . . . 74.3 112.822 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.08 -28.7 63.48 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.164 0.586 . . . . 75.02 110.583 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -53.63 -31.41 47.2 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.451 0.7 . . . . 74.14 112.026 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.94 -44.35 66.29 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.984 0.514 . . . . 71.33 111.125 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.5 tp -65.54 -57.76 7.42 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 112.738 0.644 . . . . 61.22 112.738 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.92 -49.34 35.84 Favored Glycine 0 C--N 1.362 2.0 0 N-CA-C 115.246 0.858 . . . . 71.04 115.246 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -67.79 20.07 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 115.207 1.558 . . . . 73.51 115.207 171.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.4 19.75 0.1 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 118.633 2.213 . . . . 41.23 118.633 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -62.2 -54.72 36.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 118.476 1.138 . . . . 71.32 111.079 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 pt -108.15 140.17 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.137 -1.392 . . . . 71.51 110.467 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.0 p -69.15 169.96 11.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.792 0.437 . . . . 73.45 111.604 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.69 -24.35 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.51 0 CA-C-N 116.006 -0.543 . . . . 74.15 111.323 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -68.4 -53.13 25.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.603 1.161 . . . . 54.32 110.965 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.8 -21.81 65.21 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.83 0.852 . . . . 72.1 111.57 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.19 -43.81 40.78 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.238 -1.023 . . . . 74.34 108.238 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.3 mt -66.18 -28.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 113.696 -1.593 . . . . 64.51 112.098 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -58.21 -50.9 71.93 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.832 -0.433 . . . . 65.14 109.832 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.37 65.05 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 114.743 0.657 . . . . 74.01 114.743 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -73.44 -33.3 64.84 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.136 0.575 . . . . 72.23 111.014 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.66 -12.11 78.4 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 115.669 -0.696 . . . . 63.34 112.405 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -97.7 11.74 36.08 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.575 1.15 . . . . 72.12 111.199 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.1 p -99.48 126.97 45.51 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.34 -0.615 . . . . 53.02 109.34 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -57.94 -15.6 9.36 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.458 0.703 . . . . 65.31 112.777 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.08 -59.35 3.87 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.038 0.935 . . . . 73.5 111.726 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -49.38 -48.85 46.58 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.292 1.219 . . . . 73.02 114.292 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 112' ' ' ILE . 3.2 mm? -62.32 -21.28 65.15 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.072 0.767 . . . . 52.41 113.072 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -76.14 -42.19 47.56 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.522 -0.918 . . . . 73.04 108.522 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.2 -64.11 1.21 Allowed 'General case' 0 C--N 1.371 1.519 0 CA-C-N 118.984 0.811 . . . . 75.0 111.846 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 84' ' ' LEU . 23.1 m-85 -100.76 61.59 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.276 1.213 . . . . 74.21 114.276 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.531 ' HD1' HG21 ' A' ' 81' ' ' VAL . 31.2 t80 -171.73 -57.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 122.979 0.511 . . . . 64.24 112.099 168.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.6 m -59.14 -44.13 98.13 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 113.053 0.76 . . . . 61.23 113.053 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -96.5 16.83 0.72 Allowed 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.442 2.095 . . . . 73.3 113.945 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.55 144.02 51.22 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 112.588 0.588 . . . . 72.24 112.588 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.88 145.27 31.75 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.199 1.932 . . . . 64.23 112.637 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -21.92 -60.58 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.848 1.795 . . . . 63.52 115.848 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' HD12 ' A' ' 82' ' ' ILE . 18.5 m -66.03 -20.27 66.13 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.347 0.976 . . . . 74.11 113.099 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.57 -33.1 16.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.759 -1.2 . . . . 73.42 107.759 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.531 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.4 t -69.53 -29.06 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.578 -1.192 . . . . 42.54 110.106 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 79' ' ' THR . 90.0 mt -65.56 -43.08 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.262 0.625 . . . . 75.34 110.182 170.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.79 -65.14 0.77 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 117.575 0.171 . . . . 75.32 111.005 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.461 HD13 ' CD1' ' A' ' 72' ' ' PHE . 96.6 mt -49.06 -30.94 6.96 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.529 1.678 . . . . 70.34 115.529 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.33 -56.67 3.35 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 118.247 0.476 . . . . 73.05 112.77 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.482 HG23 HD12 ' A' ' 90' ' ' LEU . 86.6 m -60.17 -39.24 85.76 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.045 0.938 . . . . 73.32 112.734 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 87' ' ' LYS . 29.7 ttmt -71.82 -6.17 39.65 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.283 1.033 . . . . 75.15 113.49 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 55.9 m170 -100.69 -32.78 10.56 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.21 -1.033 . . . . 75.34 108.21 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -96.72 -66.72 0.89 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.944 1.298 . . . . 74.11 110.358 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 86' ' ' THR . 52.6 mt -73.74 -13.78 61.02 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.538 0.335 . . . . 75.34 111.71 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.53 -19.29 4.01 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 115.874 1.11 . . . . 53.25 115.874 168.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.21 -174.25 2.51 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 117.593 0.697 . . . . 74.54 110.21 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.15 152.87 44.5 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 121.722 -0.611 . . . . 61.12 110.151 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.01 153.52 8.72 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 C-N-CA 122.966 2.444 . . . . 72.11 114.901 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.4 mt -78.62 -64.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.314 0.487 . . . . 74.21 112.314 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -114.46 -146.96 0.41 Allowed 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 104.598 -2.371 . . . . 75.11 104.598 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -97.5 -18.17 19.17 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-N 123.644 2.929 . . . . 73.51 108.655 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.565 0.746 . . . . 65.34 111.663 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.67 -42.3 70.92 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.802 0.441 . . . . 74.13 111.021 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.3 mt -59.87 -38.97 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.515 0.726 . . . . 74.24 110.494 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -72.87 -30.31 63.87 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.914 -1.039 . . . . 62.52 110.827 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -67.69 -51.39 50.08 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.8 0.84 . . . . 73.45 110.262 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -65.64 -42.52 91.37 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.115 0.566 . . . . 75.33 112.17 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -45.3 -44.58 11.62 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.054 0.942 . . . . 75.23 112.84 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -70.95 -44.42 66.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.183 0.593 . . . . 73.41 111.601 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 73.6 mt -53.04 -53.62 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.774 0.83 . . . . 74.5 111.122 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -52.82 -42.36 65.06 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.122 1.369 . . . . 72.12 113.057 172.769 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.08 -55.07 13.84 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.028 0.531 . . . . 71.31 112.065 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.2 p -62.93 -62.7 1.54 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.685 0.794 . . . . 73.44 113.125 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -98.96 -52.36 3.58 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.841 0.856 . . . . 71.12 112.595 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.51 -148.4 17.17 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 116.555 -0.293 . . . . 62.52 113.261 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 107' ' ' LEU . 10.1 mm -79.3 -35.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.246 1.018 . . . . 70.24 112.037 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -59.39 -65.96 0.59 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.769 0.319 . . . . 65.21 110.38 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -49.29 -20.91 0.71 Allowed 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.361 1.986 . . . . 62.22 116.361 165.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -73.64 -62.75 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.309 1.413 . . . . 62.12 110.078 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 120' ' ' VAL . 50.3 mm -47.1 -59.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.07 0.948 . . . . 75.13 112.93 170.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -40.68 -46.28 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.52 0.933 . . . . 72.25 113.52 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -63.74 -23.08 67.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.864 0.691 . . . . 75.5 112.864 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.36 -34.23 18.88 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.208 1.003 . . . . 71.32 111.205 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 116' ' ' ILE . 93.1 t -69.51 -60.44 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.349 1.06 . . . . 75.43 111.229 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -76.88 -5.4 48.29 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.219 0.608 . . . . 60.5 112.394 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 32.5 t -53.48 143.48 19.4 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.564 0.746 . . . . 75.1 111.25 173.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.81 -29.19 65.3 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.438 -0.578 . . . . 63.44 109.438 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.403 ' HB2' HD22 ' A' ' 90' ' ' LEU . 11.0 mm-40 -66.55 -48.82 68.48 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.089 0.956 . . . . 74.5 111.67 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.415 ' HB2' HD23 ' A' ' 90' ' ' LEU . 90.0 t80 -60.5 -48.26 82.54 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 120.838 0.351 . . . . 62.52 110.719 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.0 -27.28 68.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 115.301 -0.863 . . . . 74.25 112.197 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -91.55 -54.41 3.91 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.974 0.51 . . . . 60.12 112.355 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.19 -52.46 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.355 0.662 . . . . 64.42 111.924 -174.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.07 -41.6 9.46 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.167 0.587 . . . . 63.25 111.241 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.53 166.69 26.44 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.993 -0.549 . . . . 72.21 113.423 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.79 -33.11 60.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.418 0.687 . . . . 74.11 112.097 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -129.01 60.45 1.55 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.319 1.057 . . . . 72.24 110.458 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.3 m -153.74 145.71 23.6 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 114.128 -1.396 . . . . 73.45 108.868 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 82.9 t -68.07 134.28 91.68 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 123.567 0.747 . . . . 70.05 110.477 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.34 85.51 0.27 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.936 2.424 . . . . 44.22 111.542 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.0 p90 . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 124.595 1.158 . . . . 52.05 112.997 -175.84 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 112.189 0.44 . . . . 64.22 112.189 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -70.89 94.94 1.1 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.191 0.596 . . . . 72.1 110.109 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.6 109.34 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.06 0.544 . . . . 75.22 110.63 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.74 110.83 21.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.269 0.557 . . . . 73.03 111.355 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.43 167.15 26.99 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.314 1.046 . . . . 60.01 109.088 169.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -85.72 117.06 24.37 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.778 0.431 . . . . 64.45 110.255 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 10' ' ' ILE . 61.7 t -89.08 136.99 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.194 -1.039 . . . . 53.33 108.194 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.11 82.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.313 0.578 . . . . 44.31 110.805 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.09 -18.75 0.4 Allowed Glycine 0 CA--C 1.536 1.367 0 CA-C-N 115.474 -0.785 . . . . 45.42 113.533 -172.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 7' ' ' VAL . 55.8 mt -73.69 88.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.016 0.908 . . . . 72.11 110.982 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -94.63 2.57 55.61 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.555 0.742 . . . . 73.24 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -79.88 121.02 24.9 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.284 0.634 . . . . 54.41 111.083 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -68.98 -26.76 65.19 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.703 0.401 . . . . 73.45 111.492 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.04 -48.81 64.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.285 0.634 . . . . 64.1 111.074 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.75 84.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.973 0.509 . . . . 74.54 111.596 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.525 HG13 ' HA2' ' A' ' 49' ' ' GLY . 29.3 mm -55.96 -49.6 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.601 0.76 . . . . 72.21 111.367 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -67.73 -27.85 67.14 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.269 0.47 . . . . 53.14 112.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.4 m -69.96 -40.09 75.61 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.197 0.522 . . . . 74.23 111.259 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.71 -39.4 84.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.49 1.116 . . . . 72.41 110.418 172.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 16' ' ' ILE . 92.6 mt -70.23 -40.62 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.529 1.132 . . . . 72.31 111.911 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.1 m -64.74 -38.71 91.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.158 0.583 . . . . 71.3 111.155 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.6 96.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.496 -0.775 . . . . 61.4 111.405 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.67 -30.76 70.94 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.539 0.736 . . . . 70.03 112.177 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.62 -48.76 75.99 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.813 0.445 . . . . 73.01 111.182 170.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -70.76 -15.12 62.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.064 0.546 . . . . 61.03 111.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -85.32 -53.62 5.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.183 0.593 . . . . 74.42 111.27 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.863 HD11 HG23 ' A' ' 59' ' ' ILE . 65.0 mt -82.35 -66.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.078 0.551 . . . . 53.11 111.353 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.492 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 22.7 m-85 -66.39 -14.56 62.3 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.955 0.902 . . . . 73.1 111.813 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 70.68 -50.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.025 1.73 . . . . 73.14 112.717 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -61.28 143.46 55.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.204 1.002 . . . . 45.22 113.273 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.55 114.32 9.5 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.614 -1.176 . . . . 73.23 108.779 162.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.4 mt -90.85 129.14 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.584 -0.524 . . . . 55.32 109.584 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.27 125.47 81.69 Favored Pre-proline 0 CA--C 1.557 1.214 0 O-C-N 123.951 0.782 . . . . 74.11 111.029 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.27 -32.21 32.15 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.751 2.968 . . . . 75.21 115.34 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -71.04 -29.55 65.49 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.191 0.441 . . . . 71.35 112.191 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.86 -44.83 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 122.749 0.42 . . . . 60.45 109.908 170.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.5 72.57 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.846 0.858 . . . . 61.54 112.619 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -79.87 -18.76 49.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.354 0.501 . . . . 74.22 112.354 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -80.47 -31.04 37.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 70.22 111.653 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.28 -55.44 3.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.045 0.538 . . . . 74.54 112.242 -174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -117.55 19.69 13.83 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.72 1.378 . . . . 71.23 114.72 -169.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.7 p -66.23 -30.2 70.6 Favored 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 120.554 1.525 . . . . 61.22 112.171 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.91 41.63 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.732 -0.667 . . . . 64.24 112.364 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -81.1 -31.51 34.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.81 1.244 . . . . 75.13 111.467 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -37.37 81.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.165 1.386 . . . . 75.25 111.765 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.6 p -59.01 -38.66 79.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.312 0.645 . . . . 72.04 112.024 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -63.17 -38.29 90.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.065 0.546 . . . . 73.15 111.897 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.51 HD11 HG22 ' A' ' 55' ' ' VAL . 42.4 tp -72.96 -42.94 62.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.702 0.287 . . . . 73.11 111.267 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.525 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -69.64 -35.43 74.3 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.357 -0.383 . . . . 70.33 113.904 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -92.58 -19.18 22.19 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.293 0.637 . . . . 73.13 111.314 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.06 19.33 26.63 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 115.783 1.073 . . . . 72.21 115.783 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.14 -29.55 67.62 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 118.226 1.013 . . . . 60.11 112.212 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.425 HD11 ' HD1' ' A' ' 58' ' ' PHE . 27.1 pt -120.68 169.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.322 0.649 . . . . 63.23 111.034 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 29.8 p -91.94 172.32 8.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.828 -0.624 . . . . 75.04 110.389 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 48' ' ' LEU . 58.6 t -71.56 -39.56 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 116.399 -0.364 . . . . 72.43 110.573 175.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HE2' HG12 ' A' ' 120' ' ' VAL . 54.7 tttm -53.95 -50.49 66.37 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.36 0.664 . . . . 74.42 112.522 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -34.22 76.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.216 0.606 . . . . 65.33 111.979 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' HD1' HD11 ' A' ' 53' ' ' ILE . 63.7 t80 -63.42 -50.61 69.14 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.141 0.576 . . . . 52.31 111.024 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.863 HG23 HD11 ' A' ' 27' ' ' ILE . 49.2 mt -70.11 -39.49 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.861 1.264 . . . . 64.1 112.57 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.79 -38.77 86.43 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.366 0.666 . . . . 71.01 110.085 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.58 -32.99 85.0 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 116.137 -0.483 . . . . 54.05 114.212 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.492 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 84.2 mt -66.61 -37.92 85.89 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.185 0.517 . . . . 73.4 110.875 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.8 -23.93 67.77 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-N 115.34 -0.845 . . . . 72.52 114.116 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -82.34 -18.74 41.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.616 0.766 . . . . 75.05 112.061 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 t -60.35 119.7 8.47 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.306 0.854 . . . . 75.1 113.306 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.76 -16.41 57.67 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 123.597 0.759 . . . . 73.54 112.038 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.98 -49.51 75.8 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.025 0.53 . . . . 64.42 111.094 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.76 -47.57 84.2 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.217 0.607 . . . . 54.45 111.32 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HG ' HG12 ' A' ' 112' ' ' ILE . 2.1 mm? -71.94 -29.45 64.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.052 0.76 . . . . 62.1 113.052 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.31 -37.41 83.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.219 0.533 . . . . 75.54 110.704 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -50.09 10.86 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.216 0.821 . . . . 52.45 113.216 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.94 34.13 5.32 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.838 1.051 . . . . 71.23 113.838 -167.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -154.48 -58.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.647 0.61 . . . . 74.1 112.647 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.4 p -65.32 -35.61 12.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 113.853 1.057 . . . . 64.1 113.853 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -92.05 -4.51 3.8 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 121.875 1.717 . . . . 74.54 113.657 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -101.88 146.72 32.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 C-N-CA 123.827 0.851 . . . . 74.45 112.157 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.06 147.5 73.64 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.273 1.982 . . . . 75.01 111.537 168.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -55.88 -39.7 71.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.473 0.709 . . . . 72.2 112.677 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.48 ' HA ' HD12 ' A' ' 82' ' ' ILE . 40.8 m -61.05 -38.9 87.82 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.98 0.912 . . . . 72.13 113.316 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -69.64 -32.3 70.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.191 -0.318 . . . . 73.11 111.725 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.5 -32.45 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.307 0.643 . . . . 70.04 110.033 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.526 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 93.6 mt -64.15 -53.5 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.488 0.715 . . . . 72.12 112.422 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -68.73 -42.5 77.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.165 0.432 . . . . 75.41 112.165 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.76 -32.93 70.24 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.313 0.645 . . . . 73.05 111.922 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.0 -47.03 57.03 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 112.172 -0.371 . . . . 75.34 112.172 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.559 HG23 HD12 ' A' ' 90' ' ' LEU . 86.7 m -67.28 -36.75 82.21 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.245 1.018 . . . . 64.45 111.136 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -55.97 -41.93 75.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.703 0.801 . . . . 73.25 112.186 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 49.1 m170 -78.58 -29.52 46.22 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 113.021 0.749 . . . . 74.51 113.021 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -100.54 -63.62 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.227 0.825 . . . . 75.04 113.227 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.559 HD12 HG23 ' A' ' 86' ' ' THR . 77.0 mt -77.08 -25.75 52.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 74.3 112.354 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.94 12.75 81.14 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 123.143 0.277 . . . . 70.25 113.208 -170.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -112.61 159.51 18.79 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.044 0.937 . . . . 51.0 110.423 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.67 154.9 62.12 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.245 0.618 . . . . 75.23 109.861 164.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.7 144.92 97.48 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.067 1.845 . . . . 71.03 112.226 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.401 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 2.5 mp -71.79 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.156 0.582 . . . . 75.33 110.868 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -126.09 173.55 9.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.758 0.823 . . . . 64.32 109.46 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 60.8 tp60 -62.42 -31.66 72.39 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 122.798 0.439 . . . . 73.33 111.072 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.44 -35.75 73.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.674 0.79 . . . . 45.22 111.331 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 11.0 tp10 -60.97 -44.94 96.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 74.41 110.235 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.9 mt -58.35 -44.28 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 114.866 -1.061 . . . . 54.15 110.998 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.1 mtt-85 -62.72 -33.64 75.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.87 0.468 . . . . 74.41 111.688 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -70.6 -53.02 17.59 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.136 0.273 . . . . 73.2 111.483 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -59.78 -36.92 77.7 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.826 0.45 . . . . 74.44 111.803 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.25 -40.68 94.31 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.993 0.917 . . . . 64.1 110.757 176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.53 -43.88 72.11 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.575 0.75 . . . . 72.43 111.599 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 98.0 mt -61.99 -47.43 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.281 1.032 . . . . 74.33 110.771 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.5 tp -61.04 -40.4 93.47 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.982 -1.008 . . . . 71.51 112.087 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.52 -44.71 77.72 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.991 0.517 . . . . 70.05 112.115 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.9 p -84.86 -65.65 0.99 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.421 0.688 . . . . 75.21 111.588 -174.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.93 -57.07 4.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.96 0.504 . . . . 73.43 111.207 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.27 -174.7 20.52 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 121.301 0.389 . . . . 73.43 113.704 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.494 HG12 ' HG ' ' A' ' 69' ' ' LEU . 10.8 tp -69.97 -31.54 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 113.124 0.787 . . . . 75.22 113.124 -170.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -65.74 -34.45 78.2 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.425 0.29 . . . . 61.21 111.452 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.08 -31.26 58.67 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.036 0.534 . . . . 73.14 111.492 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.526 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 56.6 t80 -64.55 -55.45 20.42 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.626 0.771 . . . . 72.22 111.444 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.414 HD12 ' HD2' ' A' ' 115' ' ' PHE . 1.9 mp -57.85 -44.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 122.88 0.472 . . . . 53.34 110.716 173.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.21 -34.08 71.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.824 0.449 . . . . 72.23 111.583 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.63 80.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.057 0.543 . . . . 55.14 111.858 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.86 -36.34 78.01 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.385 0.674 . . . . 73.52 111.863 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.506 HG12 ' HE2' ' A' ' 56' ' ' LYS . 98.6 t -80.52 -32.48 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.972 0.909 . . . . 52.01 111.655 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.86 4.53 52.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.22 0.608 . . . . 64.11 112.047 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.7 t -62.83 129.47 40.61 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.372 -0.603 . . . . 43.1 109.372 164.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -53.9 -35.18 61.36 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.434 0.694 . . . . 53.53 112.659 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.26 -41.79 85.05 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 123.512 0.507 . . . . 65.33 111.642 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -63.52 -56.41 16.22 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.454 0.302 . . . . 71.23 110.921 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -66.14 -36.46 83.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.143 0.794 . . . . 73.3 113.143 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HG3' HG23 ' A' ' 128' ' ' VAL . 12.9 pt-20 -71.76 -32.88 68.15 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.023 0.749 . . . . 60.21 113.023 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.441 HG23 ' HG3' ' A' ' 127' ' ' GLU . 93.6 t -100.56 -64.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 118.34 0.518 . . . . 74.33 111.696 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -99.45 67.1 1.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.736 0.815 . . . . 64.42 109.887 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.03 -156.06 0.49 Allowed Glycine 0 N--CA 1.483 1.796 0 N-CA-C 115.169 0.828 . . . . 63.14 115.169 -174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -79.21 21.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.576 0.954 . . . . 74.12 113.576 -176.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.18 -36.62 0.9 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.832 1.253 . . . . 61.33 110.809 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.3 m -91.97 137.31 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.813 0.672 . . . . 53.14 112.813 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.8 t -80.34 132.26 59.68 Favored Pre-proline 0 CA--C 1.561 1.376 0 C-N-CA 123.946 0.898 . . . . 55.42 110.355 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HD2' HD13 ' A' ' 59' ' ' ILE . 55.6 Cg_endo -66.72 84.66 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.889 2.393 . . . . 73.11 113.82 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -79.97 152.09 29.7 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.808 -0.633 . . . . 74.41 110.721 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.536 ' H ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -58.86 125.32 23.06 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.641 0.377 . . . . 75.32 110.326 175.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -84.04 40.69 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.739 1.015 . . . . 73.12 113.739 -165.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 66.07 160.09 0.13 Allowed Pre-proline 0 CA--C 1.568 1.643 0 C-N-CA 124.481 1.112 . . . . 75.24 112.123 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.96 -4.12 12.84 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.099 1.866 . . . . 73.32 113.881 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.0 p -65.14 -81.62 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.867 0.867 . . . . 71.1 112.531 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.8 mt 69.33 -32.93 0.24 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 115.831 1.789 . . . . 61.53 115.831 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.72 105.45 3.19 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.847 0.832 . . . . 75.22 112.633 -169.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -137.05 162.98 31.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.981 0.912 . . . . 74.0 111.031 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 74.85 -25.13 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.172 1.545 . . . . 74.23 115.172 165.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -64.6 96.51 0.17 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 118.461 0.573 . . . . 74.43 112.494 -170.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -95.64 -179.11 4.62 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.737 0.815 . . . . 74.21 111.843 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -66.85 129.66 40.59 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.563 0.745 . . . . 74.14 110.636 170.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 N--CA 1.478 0.955 0 C-N-CA 123.223 0.609 . . . . 72.13 110.73 177.78 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.703 -0.48 . . . . 75.31 109.703 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -100.75 135.06 42.79 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.782 0.433 . . . . 72.4 110.164 171.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.3 t -96.19 101.73 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.24 0.616 . . . . 53.03 109.508 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.01 87.15 1.84 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 116.047 -0.524 . . . . 75.04 110.502 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -120.91 148.04 44.61 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.606 0.762 . . . . 51.11 110.044 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -95.87 91.87 6.24 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.332 0.586 . . . . 72.33 111.075 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.18 112.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-N 115.0 -1.0 . . . . 73.02 109.961 164.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.5 90.1 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.118 0.967 . . . . 63.15 113.111 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -46.08 -29.33 3.38 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 115.689 1.035 . . . . 53.21 115.689 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.07 130.57 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 109.363 -0.606 . . . . 50.34 109.363 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.74 -27.49 6.63 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.882 0.473 . . . . 73.23 111.088 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -32.75 114.7 0.17 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.593 1.557 . . . . 63.21 113.57 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HE3' ' HA3' ' A' ' 49' ' ' GLY . 14.4 mmmm -67.95 -12.1 60.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.915 0.486 . . . . 71.13 112.169 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.03 76.7 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.772 0.829 . . . . 73.51 110.895 171.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.54 62.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.191 0.596 . . . . 72.43 110.963 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.462 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.9 mp -60.09 -45.51 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.36 0.664 . . . . 72.34 110.714 169.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.16 -50.49 73.84 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.359 0.663 . . . . 72.51 112.168 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -62.39 -34.45 76.76 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.115 0.566 . . . . 74.34 111.286 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 48' ' ' LEU . 9.9 tp -62.39 -45.68 92.06 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.644 0.778 . . . . 64.44 111.022 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 16' ' ' ILE . 67.4 mt -72.04 -34.1 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.265 1.026 . . . . 74.2 111.519 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -68.26 -42.72 79.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.207 0.603 . . . . 74.42 110.294 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.42 90.96 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.657 0.783 . . . . 72.11 111.238 172.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.99 97.93 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.47 0.708 . . . . 44.04 111.845 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -65.93 -49.38 68.16 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.119 0.568 . . . . 70.51 111.929 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -69.83 -15.51 63.11 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.756 0.65 . . . . 71.41 112.756 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -94.54 -47.31 6.6 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 122.971 0.508 . . . . 52.41 111.54 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 83.0 mt -83.14 -58.57 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.061 0.544 . . . . 74.1 111.934 -174.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 8.7 m-85 -73.31 -16.06 61.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.816 0.446 . . . . 72.3 110.654 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 66.49 17.44 10.65 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.196 1.398 . . . . 72.23 111.968 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -153.4 143.77 22.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 74.5 110.158 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.56 141.11 48.43 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 120.913 0.387 . . . . 62.11 110.098 165.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.4 mt -106.17 141.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 108.712 -0.847 . . . . 51.33 108.712 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.37 117.08 10.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.877 0.871 . . . . 63.41 111.28 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.32 -38.22 86.1 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.375 2.716 . . . . 73.32 113.505 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -63.56 -26.93 68.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.843 0.857 . . . . 74.41 112.744 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -83.31 -47.16 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 123.06 0.544 . . . . 72.24 110.564 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.7 68.86 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.312 1.045 . . . . 51.34 113.365 -173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -75.51 -25.85 57.62 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.165 0.432 . . . . 70.21 112.165 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -81.46 -44.17 17.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.861 0.465 . . . . 71.15 111.599 173.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -58.48 -54.01 51.89 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.614 0.721 . . . . 72.51 111.175 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -99.7 45.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.872 -1.058 . . . . 72.32 110.175 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 p -61.55 -49.62 75.93 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.273 0.629 . . . . 64.15 112.286 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 -45.91 9.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.612 -0.722 . . . . 61.24 112.638 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -66.04 -37.81 86.81 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.513 1.301 . . . . 71.42 114.513 -170.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -65.04 -46.8 79.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.18 -0.674 . . . . 73.14 109.18 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 m -59.21 -35.67 74.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.7 0.8 . . . . 60.24 111.943 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -59.29 -42.09 90.5 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.818 0.847 . . . . 75.15 112.388 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 55' ' ' VAL . 42.2 tp -74.04 -45.51 49.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.809 0.444 . . . . 74.14 111.342 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' HA3' ' HE3' ' A' ' 13' ' ' LYS . . . -64.03 -31.95 82.54 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.874 0.749 . . . . 11.11 114.376 -174.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.93 -18.87 29.78 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.306 0.643 . . . . 72.5 111.275 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.75 31.73 35.3 Favored Glycine 0 C--N 1.355 1.609 0 CA-C-N 117.731 0.241 . . . . 72.41 113.538 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -88.39 -18.96 27.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.334 0.654 . . . . 73.31 111.884 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.8 pt -122.53 163.94 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.94 0.896 . . . . 74.1 110.327 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p -77.18 152.16 34.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.954 -0.387 . . . . 74.33 109.954 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 48' ' ' LEU . 40.1 t -64.01 -32.22 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.17 0.588 . . . . 71.22 110.081 175.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 1.5 tmtp? -54.08 -48.24 70.86 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.248 1.019 . . . . 73.2 111.457 171.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.92 -37.85 72.92 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.068 -0.515 . . . . 70.43 110.941 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.78 -51.84 66.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.389 0.675 . . . . 52.51 111.257 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 27' ' ' ILE . 26.5 mm -56.03 -38.58 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.848 1.259 . . . . 74.23 111.512 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -67.52 -39.49 85.1 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.064 -0.516 . . . . 74.13 110.949 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.72 -23.07 75.64 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 113.844 0.298 . . . . 71.45 113.844 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.499 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 79.0 mt -67.63 -23.11 65.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.528 0.731 . . . . 72.11 110.975 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -87.73 -14.07 63.82 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.453 -1.249 . . . . 52.11 113.032 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -92.81 -3.68 54.28 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.85 0.86 . . . . 70.23 111.012 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -73.32 112.59 9.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.349 0.659 . . . . 72.33 110.778 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.97 -18.1 63.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.731 0.412 . . . . 72.34 111.741 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.42 -51.73 68.23 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.943 0.497 . . . . 53.32 110.47 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.416 ' HB2' ' CE2' ' A' ' 28' ' ' PHE . 69.4 t80 -59.64 -45.63 91.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.972 0.909 . . . . 60.13 112.015 175.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 63' ' ' GLY . 2.5 mm? -71.21 -29.17 64.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 112.365 0.506 . . . . 74.32 112.365 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.96 -38.95 92.66 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 121.879 -0.513 . . . . 73.44 110.565 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.95 -54.62 7.53 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 113.21 0.818 . . . . 65.54 113.21 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -117.07 36.89 4.03 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 114.06 1.133 . . . . 71.25 114.06 -168.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.416 ' HD1' HG21 ' A' ' 81' ' ' VAL . 47.5 t80 -159.29 -42.92 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.831 0.453 . . . . 72.21 111.507 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -65.96 -45.62 63.89 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 112.641 0.608 . . . . 73.2 112.641 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.55 12.23 1.37 Allowed 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.556 2.171 . . . . 72.21 113.689 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HD2' ' HG2' ' A' ' 80' ' ' LYS . 80.9 m-85 -122.62 140.78 33.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 123.27 0.628 . . . . 73.43 111.965 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' O ' HG23 ' A' ' 81' ' ' VAL . 93.4 Cg_endo -73.45 159.55 46.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.946 2.43 . . . . 72.35 112.574 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -49.77 -52.5 31.44 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.922 0.889 . . . . 71.11 113.045 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.619 ' HA ' HD12 ' A' ' 82' ' ' ILE . 62.7 m -53.86 -43.01 69.18 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.942 1.09 . . . . 74.21 113.942 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 76' ' ' TYR . 58.8 tptt -65.08 -36.75 85.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.378 0.51 . . . . 55.45 112.378 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.416 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.1 t -68.24 -26.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.779 0.431 . . . . 75.21 110.203 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.4 mt -68.44 -52.84 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.604 0.761 . . . . 74.43 111.974 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 84' ' ' LEU . 5.1 pt-20 -64.64 -43.56 93.26 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.697 0.226 . . . . 65.03 110.96 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 22.7 mt -60.2 -41.1 92.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.391 0.677 . . . . 73.22 111.289 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.26 -51.09 55.73 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.74 -0.209 . . . . 74.04 112.713 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 90' ' ' LEU . 37.5 m -67.53 -38.02 83.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.633 0.773 . . . . 64.0 111.162 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -53.93 -36.32 62.65 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.69 1.196 . . . . 74.41 112.784 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 53.2 m170 -89.47 -43.03 11.13 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.452 0.701 . . . . 73.44 112.771 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -92.23 -46.68 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.009 0.524 . . . . 71.04 112.014 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 86' ' ' THR . 48.6 mt -97.73 -7.02 31.67 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.986 0.514 . . . . 74.2 111.717 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 27.21 72.41 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 115.162 0.825 . . . . 42.44 115.162 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -154.46 177.79 10.79 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 117.501 0.651 . . . . 75.33 112.285 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.72 150.76 54.17 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.674 0.79 . . . . 63.54 111.942 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.76 136.07 47.72 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.487 2.125 . . . . 74.42 110.922 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.16 -66.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.317 0.647 . . . . 71.25 111.451 -166.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HB2' ' H ' ' A' ' 99' ' ' GLU . 8.9 m-20 -93.07 165.03 13.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.295 0.638 . . . . 75.04 111.922 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 7.0 tp-100 -67.27 -33.9 76.28 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 109.457 -0.571 . . . . 71.11 109.457 163.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.71 73.37 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.452 0.701 . . . . 53.44 111.518 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.536 ' H ' ' HB2' ' A' ' 96' ' ' ASP . 12.2 tp10 -61.87 -42.02 98.55 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.851 0.861 . . . . 73.52 110.347 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.499 HG21 HG23 ' A' ' 79' ' ' THR . 72.1 mt -63.94 -46.13 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 114.914 -1.039 . . . . 73.43 110.905 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 28.5 mmm180 -63.04 -32.2 73.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.275 0.63 . . . . 72.34 111.72 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -66.71 -51.11 59.73 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.551 0.34 . . . . 71.31 111.124 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -65.02 -29.26 70.15 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.425 0.29 . . . . 73.15 111.722 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -68.66 -41.68 78.96 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.216 1.006 . . . . 74.14 110.467 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -72.08 -39.51 68.91 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.395 -0.821 . . . . 71.45 111.146 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 92.3 mt -67.12 -44.42 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.332 0.653 . . . . 70.33 110.975 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.25 -38.81 92.62 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.541 0.736 . . . . 53.13 110.819 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.59 -54.6 9.94 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 112.403 0.52 . . . . 70.13 112.403 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.8 p -83.38 -20.15 34.76 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.401 0.889 . . . . 71.11 113.401 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -114.98 -64.78 1.27 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 122.975 0.51 . . . . 70.45 111.088 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.96 -177.99 28.65 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 120.991 -0.623 . . . . 73.32 114.115 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.0 tp -72.9 -31.35 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.577 0.751 . . . . 73.24 111.441 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -64.66 -30.99 72.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.035 0.534 . . . . 73.03 111.435 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.51 67.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.737 0.815 . . . . 71.12 110.678 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 82' ' ' ILE . 54.4 t80 -60.79 -50.29 74.04 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.391 1.076 . . . . 71.23 112.392 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.95 -45.3 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.979 0.512 . . . . 63.45 111.216 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.06 -34.36 77.84 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.838 -0.619 . . . . 41.32 111.011 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.2 87.7 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.375 0.67 . . . . 63.52 112.139 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.9 mt -76.22 -51.39 12.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.264 0.625 . . . . 64.52 112.295 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.76 -20.52 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 121.125 0.488 . . . . 45.02 111.941 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -97.78 21.48 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.386 0.674 . . . . 65.42 111.963 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.0 m -83.06 153.93 24.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.951 -0.468 . . . . 71.44 111.846 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.52 -44.47 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.436 1.094 . . . . 72.31 111.632 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 30.9 tp10 -54.08 -52.86 59.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.459 -0.791 . . . . 73.04 111.902 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -64.86 -39.88 94.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 120.523 0.201 . . . . 71.51 110.582 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -60.9 -63.38 1.32 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.482 0.713 . . . . 72.15 111.742 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -76.33 -36.87 58.05 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 113.037 0.754 . . . . 73.14 113.037 -170.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.76 -27.93 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.008 0.523 . . . . 64.42 112.251 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -118.9 -78.49 0.59 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.936 -0.478 . . . . 62.02 110.498 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.1 170.46 15.83 Favored Glycine 0 N--CA 1.474 1.191 0 N-CA-C 112.399 -0.28 . . . . 74.24 112.399 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.668 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -73.22 -11.71 60.61 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.736 0.643 . . . . 74.51 112.736 -178.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.02 -10.75 19.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.034 0.934 . . . . 75.25 112.392 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.8 m -116.22 140.24 49.52 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.266 0.839 . . . . 64.45 113.266 -168.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 59' ' ' ILE . 58.6 t -83.56 150.63 60.27 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 125.966 1.706 . . . . 71.41 110.623 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.3 90.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.729 2.286 . . . . 74.3 112.6 161.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -91.65 176.69 6.45 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.694 0.798 . . . . 75.03 111.984 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -72.75 97.05 2.13 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.77 -0.65 . . . . 74.03 110.918 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -84.82 118.39 24.45 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.552 -0.536 . . . . 62.13 109.552 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 73.12 146.15 0.11 Allowed Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 125.274 1.43 . . . . 73.41 112.054 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.85 -12.72 33.28 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.81 2.34 . . . . 74.31 112.486 171.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -103.45 179.39 4.28 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.353 1.061 . . . . 70.53 110.375 172.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.1 mt 67.65 27.55 7.65 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 124.534 1.134 . . . . 65.51 112.405 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -144.36 121.04 11.16 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.475 -0.784 . . . . 50.54 109.084 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -61.19 90.83 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.488 0.715 . . . . 61.25 111.25 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -75.78 142.42 42.33 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.509 -0.768 . . . . 75.11 112.199 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -97.33 67.37 2.12 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.972 0.909 . . . . 73.45 110.707 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 49.98 68.1 0.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.909 1.284 . . . . 71.41 111.674 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 70.46 -59.85 0.51 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.329 1.452 . . . . 65.01 112.123 -172.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.994 0.902 . . . . 64.35 110.781 177.173 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 111.157 0.058 . . . . 50.05 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.13 -176.83 3.88 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.094 0.958 . . . . 72.31 110.77 173.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t -91.23 108.6 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 107.783 -1.192 . . . . 74.3 107.783 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -74.9 106.34 6.37 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.128 0.571 . . . . 71.41 110.826 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.59 154.54 42.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.487 0.715 . . . . 74.2 110.223 175.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -70.96 147.2 48.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.142 0.973 . . . . 65.13 111.929 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.9 t -120.47 119.14 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.559 -1.645 . . . . 74.22 106.559 163.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.95 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.677 0.791 . . . . 71.04 112.177 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.57 -24.15 2.78 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.401 -0.818 . . . . 65.3 112.266 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.13 59.03 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 123.344 1.545 . . . . 73.01 109.845 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -80.28 8.47 7.38 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.189 -1.823 . . . . 72.44 113.28 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.91 133.08 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.029 0.532 . . . . 72.41 110.059 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 45.5 mtpt -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.154 0.798 . . . . 73.23 113.154 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.72 -53.02 62.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.053 0.541 . . . . 73.21 111.168 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.68 54.65 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.774 -0.648 . . . . 60.15 112.16 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 39.1 mm -57.91 -40.37 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 122.959 0.504 . . . . 74.44 111.643 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 2.6 ttpm? -56.7 -48.81 76.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.735 0.814 . . . . 73.34 112.01 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 m -68.65 -33.03 73.3 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.164 0.586 . . . . 73.44 111.618 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.63 -43.85 97.77 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.812 0.845 . . . . 73.04 110.213 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -68.7 -33.72 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.372 1.069 . . . . 71.21 111.618 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 71.6 m -67.77 -41.58 83.04 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.253 0.621 . . . . 74.33 110.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.4 85.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.262 0.625 . . . . 71.44 111.478 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.52 -30.36 70.59 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.893 0.877 . . . . 65.23 112.272 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -76.31 -37.69 57.07 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.401 0.519 . . . . 75.43 112.401 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 21' ' ' SER . 89.0 mtt180 -65.95 -26.49 67.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.523 0.729 . . . . 72.4 112.627 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.57 HE22 ' HG2' ' A' ' 135' ' ' PRO . 14.4 pt20 -85.59 -36.39 20.43 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 122.696 0.398 . . . . 75.13 111.895 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.514 HG12 ' HG3' ' A' ' 26' ' ' GLN . 46.2 mm -87.75 -63.27 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.359 0.664 . . . . 53.54 110.786 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.21 -4.75 54.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.817 0.847 . . . . 72.14 111.545 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 68.92 10.09 7.74 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.411 1.485 . . . . 74.05 112.909 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.56 144.83 25.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.42 0.628 . . . . 72.13 111.624 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -68.16 134.27 50.25 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.054 -0.976 . . . . 54.12 110.405 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.31 140.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 122.955 0.502 . . . . 75.31 110.185 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.93 129.26 91.13 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-N 115.063 -0.971 . . . . 71.35 110.839 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -54.95 -38.72 92.93 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.841 3.027 . . . . 45.51 115.181 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -64.73 -27.54 68.98 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.235 0.457 . . . . 65.31 112.235 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -79.82 -49.13 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.509 0.724 . . . . 52.44 110.037 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.552 1.141 . . . . 61.44 113.232 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.08 -26.17 56.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.926 0.49 . . . . 73.13 111.642 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -75.63 -33.52 60.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.474 0.31 . . . . 74.43 110.622 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -74.11 -53.65 9.47 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 116.016 -0.538 . . . . 55.03 111.06 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 78.9 m-85 -116.65 55.7 0.81 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.791 0.836 . . . . 73.34 111.847 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 98.7 p -62.67 -48.33 79.78 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.721 -0.612 . . . . 62.44 112.579 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.9 -40.73 13.76 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.837 -0.62 . . . . 61.42 112.418 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 21.6 t-105 -62.06 -42.0 98.74 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.324 1.05 . . . . 73.01 112.036 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.12 -46.52 88.11 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.27 1.028 . . . . 75.03 111.534 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.8 t -61.01 -41.93 97.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.488 -0.778 . . . . 62.14 111.601 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' HG23 ' A' ' 53' ' ' ILE . 59.6 mtpt -65.29 -32.6 74.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 73.13 111.835 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.69 -45.05 60.79 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.725 0.298 . . . . 73.43 111.061 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.07 76.59 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.711 -0.677 . . . . 74.53 113.942 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -91.47 -20.06 22.16 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.808 0.843 . . . . 71.35 111.871 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.61 25.17 33.57 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 114.172 0.429 . . . . 74.04 114.172 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -69.58 -44.06 71.56 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.315 0.646 . . . . 62.32 110.179 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.418 HG23 ' HE2' ' A' ' 47' ' ' LYS . 32.6 pt -110.62 157.44 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.021 0.929 . . . . 72.21 110.081 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 57' ' ' GLU . 11.9 t -90.15 167.25 12.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.566 0.346 . . . . 73.03 110.33 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 59' ' ' ILE . 66.2 t -61.79 -44.21 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 122.977 0.511 . . . . 62.24 111.134 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 64.1 tttm -55.39 -42.12 73.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.223 1.009 . . . . 62.35 112.815 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' H ' HG23 ' A' ' 54' ' ' THR . 26.5 tt0 -69.42 -36.21 76.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.758 -0.655 . . . . 74.41 111.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.0 -47.08 86.38 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.733 0.813 . . . . 72.41 110.726 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 55' ' ' VAL . 47.7 mm -56.87 -45.55 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 124.431 1.093 . . . . 72.22 111.129 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.74 -44.24 93.88 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.402 -0.817 . . . . 72.55 110.871 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.02 -26.98 69.68 Favored Glycine 0 CA--C 1.543 1.782 0 N-CA-C 114.768 0.667 . . . . 72.31 114.768 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.02 -25.89 63.8 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.006 0.522 . . . . 74.52 110.933 172.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.33 -25.47 74.33 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.503 -0.771 . . . . 60.55 113.64 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.02 -7.45 59.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.637 0.775 . . . . 54.54 111.905 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.423 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.3 p -74.41 134.55 42.39 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -56.69 -28.74 61.41 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.696 0.799 . . . . 63.41 112.29 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.6 tp -65.82 -46.71 77.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.93 0.492 . . . . 65.03 111.253 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.6 -35.51 79.11 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.191 0.52 . . . . 43.21 111.069 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.636 HD11 HG12 ' A' ' 112' ' ' ILE . 4.3 mm? -60.81 -48.35 82.18 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.8 0.84 . . . . 71.35 112.106 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -75.86 -30.59 58.95 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.489 0.551 . . . . 43.22 112.489 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.32 -47.04 45.82 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.897 0.703 . . . . 53.24 112.897 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.48 -55.33 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.794 1.035 . . . . 54.3 113.794 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' HE1' HD21 ' A' ' 107' ' ' LEU . 83.3 t80 -62.89 -33.41 75.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.057 0.762 . . . . 73.54 113.057 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.512 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 33.4 m -79.14 -55.1 0.95 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 118.549 -0.739 . . . . 63.51 112.721 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 11.9 Cg_exo -74.37 -5.06 16.38 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.657 2.238 . . . . 44.35 114.541 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -124.87 146.18 52.36 Favored Pre-proline 0 N--CA 1.494 1.726 0 C-N-CA 122.98 0.512 . . . . 74.42 111.884 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 81' ' ' VAL . 72.5 Cg_endo -72.44 168.5 24.13 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.822 2.348 . . . . 71.14 112.816 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -48.93 -54.77 14.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.402 1.081 . . . . 71.5 112.432 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.55 ' HA ' HD12 ' A' ' 82' ' ' ILE . 37.1 m -54.82 -40.05 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.935 0.894 . . . . 72.21 113.281 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -69.2 -32.0 70.98 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.088 0.403 . . . . 71.32 112.088 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 77' ' ' PRO . 59.0 t -69.39 -26.18 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.029 0.532 . . . . 74.32 109.997 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 79' ' ' THR . 61.0 mt -74.36 -52.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.724 0.809 . . . . 74.41 111.003 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -56.25 24.07 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.941 0.897 . . . . 72.4 112.261 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.96 -40.2 94.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.281 0.632 . . . . 74.24 111.323 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.68 -51.45 55.86 Favored Glycine 0 N--CA 1.474 1.219 0 O-C-N 123.481 0.488 . . . . 72.25 112.93 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 94' ' ' PRO . 40.1 p -61.43 -36.46 80.41 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.522 0.729 . . . . 72.3 112.514 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -73.0 -16.46 61.51 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.94 0.719 . . . . 72.53 112.94 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -86.27 -40.64 15.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.869 0.468 . . . . 74.32 111.319 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' HG22 ' A' ' 59' ' ' ILE . 88.4 m-85 -91.05 -64.74 1.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.343 0.592 . . . . 72.43 110.7 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.46 -10.01 59.2 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.008 0.923 . . . . 63.14 112.397 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.86 21.37 67.45 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 114.209 0.443 . . . . 44.53 114.209 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -149.47 169.92 19.78 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.875 0.87 . . . . 74.45 111.051 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.6 150.69 39.22 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.427 0.691 . . . . 71.12 110.264 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HG3' HG21 ' A' ' 86' ' ' THR . 32.9 Cg_exo -58.55 159.87 18.84 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.931 2.421 . . . . 61.11 112.712 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.43 -62.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.978 0.511 . . . . 62.44 111.542 -169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -133.85 163.21 30.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.636 0.775 . . . . 64.43 110.148 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -59.13 -33.12 70.5 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.848 0.859 . . . . 73.54 112.615 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.12 77.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.514 0.326 . . . . 64.24 111.803 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.9 -36.71 70.09 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.032 0.533 . . . . 73.43 111.111 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.22 -43.61 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.876 0.47 . . . . 60.12 110.077 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 mtm105 -66.27 -30.22 70.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.331 0.652 . . . . 71.02 111.804 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -62.56 -52.47 63.29 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.987 0.515 . . . . 75.13 111.094 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.09 -37.41 84.95 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.898 0.479 . . . . 74.14 111.514 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.37 -39.55 94.84 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.405 1.082 . . . . 70.43 110.863 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.74 -44.62 77.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.475 0.71 . . . . 73.41 111.104 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.89 -43.29 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.016 0.926 . . . . 74.44 111.61 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.8 tt -65.1 -41.07 95.28 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.224 0.61 . . . . 73.54 110.966 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.01 -38.54 86.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.738 0.415 . . . . 41.34 112.032 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.9 p -81.6 -69.59 0.6 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.775 0.83 . . . . 63.21 112.125 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -83.96 -35.3 24.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.98 0.912 . . . . 72.54 111.891 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.08 -172.41 14.88 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 121.119 0.288 . . . . 44.43 113.518 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.636 HG12 HD11 ' A' ' 69' ' ' LEU . 7.4 tp -68.97 -38.21 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.558 0.743 . . . . 73.41 112.249 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -63.52 -42.89 98.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.322 0.649 . . . . 63.11 111.434 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.4 -32.67 66.57 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.713 -0.676 . . . . 63.02 110.636 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.451 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 32.8 t80 -61.78 -51.92 66.33 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 124.122 0.969 . . . . 75.11 112.269 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.9 mm -55.97 -51.77 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.85 0.86 . . . . 74.13 110.442 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -52.14 -49.05 64.5 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 115.23 -0.896 . . . . 75.43 111.86 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.77 67.88 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 61.14 112.787 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.48 -53.3 36.73 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.093 0.473 . . . . 53.4 110.585 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.484 HG12 ' NZ ' ' A' ' 56' ' ' LYS . 39.2 t -69.12 -18.54 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.792 0.837 . . . . 73.44 112.612 -171.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.16 13.65 2.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 73.31 112.766 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.7 p -77.34 136.56 38.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.326 0.651 . . . . 73.25 110.774 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.444 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 46.4 tt0 -68.71 -39.77 80.29 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.713 0.635 . . . . 72.51 112.713 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -53.89 -30.85 47.73 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.516 0.561 . . . . 74.1 112.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.28 -56.46 21.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.138 0.575 . . . . 61.44 110.527 172.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 123' ' ' GLN . 1.9 p-10 -73.87 -20.86 60.29 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 111.976 0.361 . . . . 73.33 111.976 -173.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 27.6 mm-40 -67.49 -59.15 3.61 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.149 0.499 . . . . 64.52 111.164 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -71.96 -61.0 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.598 -0.728 . . . . 61.04 111.574 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -84.43 -62.6 1.51 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.083 0.553 . . . . 61.42 110.46 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.26 173.47 27.39 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.615 -0.72 . . . . 54.23 112.657 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.31 -34.19 48.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.884 0.473 . . . . 75.33 111.606 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.25 -8.31 59.08 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.042 0.937 . . . . 61.05 112.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -113.05 143.95 43.45 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.384 0.674 . . . . 73.23 111.344 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.05 130.01 85.53 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.924 0.89 . . . . 74.32 109.248 170.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.57 ' HG2' HE22 ' A' ' 26' ' ' GLN . 89.9 Cg_exo -46.97 85.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.953 3.102 . . . . 65.12 115.71 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -79.33 85.52 5.15 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.63 0.729 . . . . 73.41 109.036 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -56.65 104.72 0.16 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.478 -0.783 . . . . 75.33 110.502 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -69.49 83.43 0.41 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.908 0.861 . . . . 73.43 111.422 -169.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -142.29 112.68 6.12 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.545 1.138 . . . . 71.02 109.645 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.77 15.57 1.07 Allowed 'Trans proline' 0 CA--C 1.562 1.904 0 C-N-CA 123.012 2.475 . . . . 62.43 113.825 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.0 t -127.96 -24.49 3.19 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.681 0.793 . . . . 64.24 112.681 -171.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.21 22.66 6.51 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.247 0.832 . . . . 72.11 113.247 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -31.33 68.27 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 122.936 0.494 . . . . 72.53 112.077 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -84.16 -16.81 42.16 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.409 0.684 . . . . 71.23 111.249 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 25.4 t60 70.3 7.65 6.31 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.425 1.09 . . . . 74.12 112.487 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 63.63 -73.54 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.181 1.392 . . . . 70.21 111.681 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -76.31 154.37 35.12 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.664 0.786 . . . . 75.54 110.687 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -64.13 -29.46 70.59 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.449 0.7 . . . . 64.35 111.4 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.8 p80 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.845 0.831 . . . . 71.43 110.631 171.918 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.911 0.386 . . . . 74.51 111.883 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -116.34 14.89 15.81 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 123.621 0.768 . . . . 73.13 110.759 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 136' ' ' TYR . 6.3 p -129.7 103.66 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 124.326 1.05 . . . . 75.42 109.145 -174.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -107.72 105.52 15.4 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.437 0.695 . . . . 73.31 112.011 -168.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -94.7 111.12 22.9 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.136 0.575 . . . . 71.25 111.417 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.403 ' HD2' ' HG ' ' A' ' 48' ' ' LEU . 6.2 ptm180 -62.23 131.18 48.55 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.226 0.536 . . . . 74.42 110.915 169.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 10' ' ' ILE . 47.4 t -98.87 131.63 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.148 -0.686 . . . . 73.42 109.148 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.03 -36.16 2.4 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.717 1.006 . . . . 72.15 113.717 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -70.96 -24.52 77.03 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.605 1.002 . . . . 64.01 115.605 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 7' ' ' VAL . 71.9 mt -71.24 89.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 118.191 0.996 . . . . 64.12 110.71 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.48 6.64 0.58 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.654 1.353 . . . . 73.14 114.654 173.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.09 98.28 9.79 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.698 -0.626 . . . . 62.33 111.155 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -59.12 -24.93 63.42 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.802 0.841 . . . . 75.33 110.973 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -48.51 68.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.862 0.865 . . . . 71.24 111.082 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.26 67.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 64.5 112.414 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mm -61.01 -48.9 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.714 0.405 . . . . 73.53 109.916 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -61.37 -35.76 78.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.351 0.5 . . . . 74.45 112.351 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.5 m -65.65 -41.34 92.68 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.876 0.47 . . . . 75.43 111.23 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.56 -46.07 87.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.384 1.074 . . . . 62.21 111.116 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.498 HD13 ' HG2' ' A' ' 45' ' ' GLU . 91.6 mt -61.79 -43.29 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.908 1.283 . . . . 61.25 111.601 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.7 m -63.84 -45.12 90.95 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.633 -0.712 . . . . 71.32 110.297 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.4 71.24 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.808 0.843 . . . . 74.34 112.498 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.83 -43.55 81.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.309 0.644 . . . . 61.3 112.552 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HE1' HD22 ' A' ' 62' ' ' LEU . 21.5 m-85 -60.94 -28.42 68.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.101 0.778 . . . . 72.03 113.101 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.81 -13.99 60.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.609 0.764 . . . . 75.13 112.007 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -118.32 -52.05 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.17 0.433 . . . . 64.21 112.17 169.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 88' ' ' HIS . 41.7 mm -55.8 -38.14 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 123.81 0.844 . . . . 75.42 112.197 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -114.72 2.83 14.55 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.643 0.777 . . . . 73.22 110.799 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 35.28 35.72 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 116.053 1.871 . . . . 63.43 116.053 -168.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.515 HH12 ' HG3' ' A' ' 71' ' ' GLU . 3.9 ptp85 -135.55 155.54 50.32 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.586 0.708 . . . . 73.44 111.635 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.97 96.26 8.79 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.909 -1.041 . . . . 54.24 109.541 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.74 134.32 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.038 -0.727 . . . . 74.12 109.038 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.35 126.78 87.16 Favored Pre-proline 0 CA--C 1.551 0.999 0 O-C-N 123.993 0.808 . . . . 72.4 110.238 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.49 -25.21 75.73 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.826 2.351 . . . . 62.12 112.857 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -79.2 -26.78 42.56 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.31 0.644 . . . . 52.14 112.21 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.7 mt -80.07 -39.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.053 0.541 . . . . 61.52 110.207 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.51 85.62 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.944 0.898 . . . . 54.02 111.709 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -72.93 -20.4 61.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.685 0.624 . . . . 72.13 112.685 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -75.87 -41.53 51.94 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.004 0.43 . . . . 60.23 110.639 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -76.57 -39.85 51.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.906 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 96.4 m-85 -116.66 26.62 9.72 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.675 0.991 . . . . 61.54 113.675 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -49.21 -49.83 41.16 Favored 'General case' 0 N--CA 1.515 2.78 0 N-CA-C 114.502 1.297 . . . . 62.52 114.502 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -75.1 -34.53 51.89 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.392 -0.367 . . . . 54.02 112.766 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -63.4 -31.64 72.85 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.201 1.001 . . . . 65.13 111.328 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HG2' HD13 ' A' ' 20' ' ' ILE . 47.7 mt-10 -70.45 -41.75 72.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.167 0.987 . . . . 71.32 110.67 172.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.9 t -61.84 -39.24 91.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 53.23 111.017 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.5 mmmm -60.16 -38.0 81.82 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.747 0.419 . . . . 74.54 110.726 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD11 HG22 ' A' ' 55' ' ' VAL . 22.7 tp -73.25 -49.05 29.9 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.522 0.729 . . . . 75.31 111.942 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.37 73.59 Favored Glycine 0 N--CA 1.484 1.841 0 C-N-CA 123.315 0.483 . . . . 54.13 114.199 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -85.74 -19.11 31.28 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.444 0.697 . . . . 75.52 110.02 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.02 24.65 47.87 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.714 -1.13 . . . . 64.33 112.739 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -66.23 -40.04 89.97 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.003 0.921 . . . . 63.12 110.29 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' HD2' ' A' ' 58' ' ' PHE . 22.2 pt -116.1 143.83 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.91 0.884 . . . . 71.5 110.123 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 57' ' ' GLU . 8.7 t -71.73 162.83 28.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.413 0.285 . . . . 73.42 111.24 163.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 48' ' ' LEU . 22.2 t -65.16 -34.54 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.231 0.212 . . . . 73.22 110.985 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.573 ' HD2' ' HG3' ' A' ' 131' ' ' GLU . 26.8 tttp -50.43 -51.04 50.22 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.695 0.798 . . . . 74.04 113.059 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 54' ' ' THR . 29.1 tt0 -69.61 -31.2 69.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.474 0.71 . . . . 60.12 110.945 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HD2' HD11 ' A' ' 53' ' ' ILE . 36.9 t80 -57.85 -46.94 84.04 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.192 0.597 . . . . 72.12 110.93 170.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 55' ' ' VAL . 51.5 mm -60.69 -40.21 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.039 0.936 . . . . 71.32 111.308 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -54.34 -50.74 66.72 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 115.58 -0.737 . . . . 75.01 111.74 172.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.72 -28.62 57.14 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 115.063 0.785 . . . . 75.34 115.063 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD22 ' HE1' ' A' ' 24' ' ' TYR . 43.9 mt -71.65 -37.7 70.79 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.018 0.527 . . . . 70.32 110.988 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.91 -26.17 73.19 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 116.413 -0.358 . . . . 53.34 113.454 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.64 -3.17 55.83 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.896 0.879 . . . . 72.5 112.052 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -81.79 130.11 34.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.012 0.525 . . . . 70.14 111.798 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.37 -17.28 28.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.152 0.981 . . . . 75.14 112.371 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.69 -57.09 14.15 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.804 0.442 . . . . 74.14 111.198 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -58.73 -37.04 75.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.97 0.729 . . . . 74.01 112.97 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.681 HD11 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -61.89 -49.68 75.23 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.34 0.496 . . . . 74.12 112.34 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.94 -31.22 71.65 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 113.043 0.757 . . . . 74.43 113.043 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.515 ' HG3' HH12 ' A' ' 30' ' ' ARG . 19.7 mm-40 -87.93 -60.77 1.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.724 1.009 . . . . 64.22 113.724 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -111.77 60.16 0.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.746 0.703 . . . . 73.41 112.429 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 81' ' ' VAL . 58.6 t80 -165.57 -58.7 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.236 0.614 . . . . 72.25 110.293 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 m -63.75 -49.18 77.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 113.021 0.749 . . . . 62.41 113.021 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -86.98 13.34 2.73 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.016 1.811 . . . . 71.22 113.505 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -124.09 150.02 62.01 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.642 0.777 . . . . 61.33 111.455 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.82 165.78 31.8 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.412 2.074 . . . . 63.31 112.406 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.1 -34.76 78.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 73.33 112.517 -170.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.501 ' HA ' HD12 ' A' ' 82' ' ' ILE . 78.4 m -70.39 -38.37 74.66 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.536 0.734 . . . . 74.42 112.353 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.3 -34.42 76.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.147 -0.346 . . . . 63.11 111.601 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 73' ' ' TYR . 87.1 t -56.56 -34.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.595 0.758 . . . . 64.33 110.848 171.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 79' ' ' THR . 77.0 mt -74.04 -48.7 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.546 0.739 . . . . 74.23 111.917 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -58.06 6.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.215 0.45 . . . . 75.15 112.215 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.3 mt -61.85 -25.21 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.35 0.66 . . . . 72.53 111.047 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 89' ' ' PHE . . . -63.7 -40.8 98.92 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 114.695 -1.138 . . . . 60.04 112.147 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -79.1 -44.52 21.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.256 0.623 . . . . 63.4 111.978 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -61.77 -49.55 75.93 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.327 0.862 . . . . 73.14 113.327 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.48 ' O ' HD13 ' A' ' 27' ' ' ILE . 11.8 m170 -61.59 -31.02 71.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.525 0.73 . . . . 72.03 112.534 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.609 ' HB3' HD12 ' A' ' 90' ' ' LEU . 1.1 t80 -98.96 -67.04 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.252 0.621 . . . . 75.03 112.088 -167.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 89' ' ' PHE . 6.5 mp -77.32 -5.42 49.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.459 0.911 . . . . 72.13 113.459 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.57 33.04 75.69 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.054 0.252 . . . . 62.14 113.081 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.672 HH22 HG21 ' A' ' 128' ' ' VAL . 19.2 ptp180 -160.02 157.25 28.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.955 0.902 . . . . 72.34 111.297 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.82 153.09 95.81 Favored Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 109.944 -0.391 . . . . 31.13 109.944 168.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.15 167.14 4.84 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.451 2.101 . . . . 65.42 113.063 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.494 HD13 ' HG2' ' A' ' 99' ' ' GLU . 2.6 mp -80.59 -53.34 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.108 0.563 . . . . 71.5 110.402 -169.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.47 165.14 10.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 74.01 109.187 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 58.2 tp60 -61.94 -30.25 70.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.854 0.462 . . . . 70.2 111.697 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.05 -45.47 88.67 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.058 0.543 . . . . 62.32 111.763 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.494 ' HG2' HD13 ' A' ' 95' ' ' ILE . 7.9 tp10 -62.55 -38.23 89.24 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.176 0.591 . . . . 75.4 111.303 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.455 HG21 HG23 ' A' ' 79' ' ' THR . 72.4 mt -60.58 -42.53 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.761 0.824 . . . . 52.33 111.209 173.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.6 mtt180 -58.13 -37.0 73.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.64 0.607 . . . . 63.43 112.64 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -62.08 -53.74 51.15 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 120.879 0.371 . . . . 62.02 110.59 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -62.38 -36.22 81.6 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.567 -0.742 . . . . 65.44 112.412 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.56 -38.95 91.04 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.529 0.732 . . . . 64.03 111.387 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.58 -38.5 90.38 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.582 -0.735 . . . . 75.13 110.506 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 81.9 mt -64.47 -48.64 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 123.589 0.756 . . . . 70.11 111.291 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.25 -37.09 66.77 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.137 0.575 . . . . 75.02 112.099 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.58 -48.53 32.08 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.191 0.596 . . . . 62.34 111.881 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -77.05 -71.91 0.38 Allowed 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.618 -0.719 . . . . 73.12 112.413 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -89.89 -53.49 4.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 70.12 112.003 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 -157.97 23.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.346 0.499 . . . . 34.43 114.346 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.681 HG12 HD11 ' A' ' 69' ' ' LEU . 8.8 tp -76.98 -37.58 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.507 0.723 . . . . 73.1 112.457 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.11 -31.22 71.96 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 75.4 111.521 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.76 57.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.99 -1.004 . . . . 73.04 110.671 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -67.19 -45.69 76.16 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 64.25 111.048 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 120' ' ' VAL . 47.9 mm -63.97 -55.53 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.901 0.48 . . . . 65.44 110.171 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.58 -38.57 55.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.115 0.566 . . . . 73.33 112.237 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.86 88.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.552 0.341 . . . . 53.21 111.813 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.63 -39.29 77.23 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.274 0.63 . . . . 72.23 111.862 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 116' ' ' ILE . 18.1 t -67.41 -41.89 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.482 0.658 . . . . 70.34 110.605 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.2 -10.0 53.72 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.907 0.883 . . . . 73.32 111.444 -177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.9 t -57.6 146.47 30.27 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.273 0.629 . . . . 75.41 111.448 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.7 pt20 -69.46 -38.01 77.57 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.926 0.49 . . . . 73.34 110.405 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -61.39 -38.71 88.02 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.101 0.961 . . . . 62.34 111.777 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.496 ' HD1' ' HA ' ' A' ' 90' ' ' LEU . 59.5 t80 -77.2 -41.89 39.64 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.581 0.753 . . . . 75.54 111.447 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 63.9 t30 -67.44 -51.59 49.84 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.183 0.808 . . . . 71.15 113.183 -165.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 12.6 pt-20 -91.16 -26.14 19.23 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.409 0.522 . . . . 72.0 112.409 -171.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 HH22 ' A' ' 92' ' ' ARG . 79.2 t -78.76 -50.72 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 122.871 0.469 . . . . 72.55 110.732 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.491 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 1.5 t80 -81.03 -45.79 16.02 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.594 0.758 . . . . 71.22 111.972 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.76 -144.02 17.04 Favored Glycine 0 N--CA 1.482 1.752 0 CA-C-O 119.749 -0.473 . . . . 71.31 112.807 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.573 ' HG3' ' HD2' ' A' ' 56' ' ' LYS . 4.7 mp0 -126.13 -58.13 1.38 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 117.831 0.815 . . . . 72.15 112.5 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.71 11.8 0.96 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.878 1.807 . . . . 63.23 115.878 -162.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.0 t -134.94 174.29 10.76 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.956 0.724 . . . . 64.23 112.956 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -84.71 136.34 39.39 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 123.896 0.879 . . . . 74.1 110.287 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -58.54 134.1 58.81 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.966 2.444 . . . . 74.32 112.214 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.519 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 17.9 p90 -108.82 150.34 27.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.947 0.899 . . . . 74.42 112.247 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -83.49 98.92 9.8 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.022 -0.99 . . . . 74.1 109.703 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -81.98 63.55 6.26 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.209 0.604 . . . . 71.12 111.497 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -138.98 139.06 22.33 Favored Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 123.041 0.537 . . . . 64.53 111.178 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.33 -47.6 9.52 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 123.0 2.466 . . . . 63.32 112.526 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.0 t -89.05 130.33 35.53 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.066 0.46 . . . . 55.1 110.135 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.86 145.32 51.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.903 0.881 . . . . 71.34 110.303 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -69.14 88.29 0.42 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.356 0.662 . . . . 71.33 111.42 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -83.51 77.77 9.77 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.576 0.703 . . . . 74.31 109.361 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -107.35 -178.16 3.56 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.416 -0.811 . . . . 71.21 111.273 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -76.49 171.95 13.77 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 115.568 -0.742 . . . . 75.33 111.485 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -150.6 90.24 1.62 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.596 0.758 . . . . 53.41 111.009 -174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -73.09 126.78 30.79 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.901 -0.59 . . . . 74.11 110.179 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.1 t60 . . . . . 0 N--CA 1.484 1.275 0 C-N-CA 123.695 0.798 . . . . 64.4 111.874 -178.731 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.6 ttm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 110.162 -0.31 . . . . 73.1 110.162 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.55 140.86 15.44 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.402 0.681 . . . . 72.24 110.669 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.36 121.0 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.695 -0.483 . . . . 65.21 109.695 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.99 93.22 1.35 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.432 0.634 . . . . 73.55 109.624 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -126.58 151.05 48.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.389 1.075 . . . . 65.51 109.002 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -84.87 122.17 28.79 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.094 -0.379 . . . . 72.43 110.373 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -83.37 122.32 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.222 0.609 . . . . 44.51 109.439 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.06 94.35 0.23 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.41 0.684 . . . . 65.31 112.069 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.73 11.41 16.98 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.636 0.615 . . . . 62.03 114.636 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.25 97.98 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.801 0 CA-C-N 117.632 0.716 . . . . 74.21 110.64 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -64.18 -32.22 73.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.835 -1.165 . . . . 52.34 113.154 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -42.68 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.772 0.829 . . . . 64.11 112.336 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -71.67 -9.03 57.65 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 114.865 -1.061 . . . . 73.11 111.359 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.35 -41.71 93.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.375 0.67 . . . . 72.24 109.991 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.1 75.47 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.822 0.849 . . . . 74.12 111.838 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.92 -44.99 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.923 0.489 . . . . 73.31 111.354 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -73.76 -35.67 65.03 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.557 0.743 . . . . 75.44 112.899 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 t -66.71 -29.97 70.09 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 120.711 0.291 . . . . 74.14 111.413 172.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.613 HD22 HD21 ' A' ' 48' ' ' LEU . 8.3 tt -68.27 -45.3 73.51 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.072 0.949 . . . . 65.24 109.661 173.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.11 -44.9 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 124.504 1.122 . . . . 73.13 111.71 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -69.17 -36.85 77.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.374 0.67 . . . . 73.11 111.722 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.06 80.09 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.628 0.771 . . . . 53.01 111.105 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.15 -42.81 65.52 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.098 0.959 . . . . 71.5 111.911 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.84 -49.86 48.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.019 0.527 . . . . 72.02 111.895 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -64.0 -14.88 57.47 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.829 1.048 . . . . 70.34 113.829 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -95.23 -61.66 1.44 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.327 0.512 . . . . 62.32 110.398 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.3 -42.82 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 123.587 0.755 . . . . 73.42 111.837 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.32 -12.16 33.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.497 0.319 . . . . 71.32 111.709 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.35 32.72 22.41 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.042 1.497 . . . . 72.14 115.042 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 166.63 29.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.092 0.775 . . . . 73.24 113.092 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.43 101.29 8.09 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 114.208 -1.36 . . . . 52.44 110.6 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -80.69 118.84 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.352 -0.61 . . . . 73.12 109.352 167.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.14 93.63 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.336 0.655 . . . . 71.51 111.45 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.13 -37.41 79.6 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.235 2.623 . . . . 64.53 114.3 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -71.5 -26.85 62.86 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.483 0.549 . . . . 74.41 112.483 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.45 -38.22 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.158 0.504 . . . . 75.44 110.199 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.16 -32.98 74.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.154 0.982 . . . . 60.4 112.797 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -76.13 -16.82 59.81 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.681 0.392 . . . . 64.24 111.728 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -80.54 -47.39 14.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.028 0.531 . . . . 75.42 110.983 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.86 -45.58 23.85 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.621 0.768 . . . . 75.13 111.695 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 75.8 m-85 -116.64 52.71 0.92 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.764 0.825 . . . . 74.34 111.657 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.74 -55.4 13.25 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.123 0.487 . . . . 64.35 112.189 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.86 -30.31 63.79 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.706 -0.679 . . . . 62.25 113.008 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 6.7 t-105 -67.5 -38.24 84.02 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.718 0.807 . . . . 64.23 112.041 -174.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -57.62 -49.84 75.11 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.253 1.021 . . . . 73.32 110.177 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -53.47 -49.78 66.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.212 1.005 . . . . 74.45 111.881 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.99 -33.88 76.35 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.721 0.637 . . . . 75.33 112.721 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.613 HD21 HD22 ' A' ' 19' ' ' LEU . 37.9 tp -71.8 -43.25 65.99 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 120.731 0.3 . . . . 72.44 110.93 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.85 -19.72 77.07 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.597 0.599 . . . . 72.5 114.597 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -94.9 -12.21 27.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.128 0.571 . . . . 74.54 112.098 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.0 71.37 Favored Glycine 0 C--N 1.35 1.308 0 C-N-CA 121.859 -0.21 . . . . 70.23 113.615 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.73 -32.42 65.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.644 0.777 . . . . 44.43 111.394 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -129.35 156.58 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.427 0.691 . . . . 63.43 109.517 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 p -85.4 178.8 7.32 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.818 0.342 . . . . 75.31 110.611 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 59' ' ' ILE . 74.4 t -64.34 -38.28 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 116.492 -0.322 . . . . 71.24 110.527 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 13.9 tttm -60.02 -44.21 94.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.894 0.478 . . . . 64.34 111.731 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -68.01 -24.73 65.15 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.344 0.658 . . . . 74.12 111.456 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -77.44 -48.11 18.0 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.283 -1.006 . . . . 75.14 108.283 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 46.7 mm -60.67 -33.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 125.062 1.345 . . . . 71.24 111.244 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.26 -51.52 69.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.283 0.633 . . . . 71.35 111.214 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.34 -29.47 66.18 Favored Glycine 0 C--N 1.357 1.729 0 N-CA-C 114.883 0.713 . . . . 72.31 114.883 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.27 -28.57 68.14 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.969 0.385 . . . . 55.34 110.989 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.73 -31.57 44.15 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.116 -0.493 . . . . 51.01 113.461 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.8 -4.44 57.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.56 0.744 . . . . 70.03 112.643 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 p -77.77 141.38 39.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.042 0.383 . . . . 61.41 111.407 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -56.93 -31.29 64.8 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.714 0.805 . . . . 71.11 111.677 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.3 tp -62.0 -46.68 88.13 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.562 0.745 . . . . 74.45 111.315 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -63.21 -36.45 83.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.924 0.393 . . . . 72.43 111.333 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 112' ' ' ILE . 4.5 mm? -68.18 -45.23 74.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.722 0.809 . . . . 60.03 112.815 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -73.17 -30.46 63.58 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.002 -0.436 . . . . 73.34 112.126 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -82.12 -53.49 6.05 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.796 1.036 . . . . 73.1 113.796 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -118.25 42.13 2.77 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.399 0.888 . . . . 73.25 113.399 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.553 ' HA ' HG22 ' A' ' 81' ' ' VAL . 65.7 t80 -155.9 -53.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.027 0.442 . . . . 62.54 111.256 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 m -68.59 -48.1 33.33 Favored Pre-proline 0 CA--C 1.573 1.854 0 N-CA-C 113.33 0.863 . . . . 72.22 113.33 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.73 3.93 7.46 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.92 1.746 . . . . 74.53 113.961 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.27 150.77 70.92 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.697 0.799 . . . . 73.5 111.654 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.24 171.01 15.8 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.351 2.034 . . . . 73.11 111.906 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.59 -49.55 74.57 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.329 0.651 . . . . 75.03 111.542 -176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 HG21 ' A' ' 100' ' ' ILE . 30.4 m -58.67 -21.99 55.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.934 1.293 . . . . 75.01 114.389 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.86 -35.53 13.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.989 -0.745 . . . . 64.23 108.989 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 73' ' ' TYR . 60.2 t -56.81 -31.88 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.538 -0.755 . . . . 73.14 110.244 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 79' ' ' THR . 92.1 mt -68.09 -53.28 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.36 -0.836 . . . . 74.32 112.119 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.24 -50.13 56.02 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.402 1.001 . . . . 70.02 112.392 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.21 -31.04 69.78 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.098 0.559 . . . . 75.41 112.053 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.81 -45.74 50.19 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.558 -0.292 . . . . 62.31 112.902 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.638 HG23 HD12 ' A' ' 90' ' ' LEU . 88.0 m -64.19 -43.81 93.94 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.499 0.72 . . . . 62.55 111.911 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -60.98 -28.29 68.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.659 0.985 . . . . 74.1 113.659 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -73.41 -34.65 65.6 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.581 0.586 . . . . 63.13 112.581 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -104.76 -65.02 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.67 0.388 . . . . 65.03 111.581 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD12 HG23 ' A' ' 86' ' ' THR . 90.5 mt -75.47 -12.03 60.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.127 0.571 . . . . 74.44 112.466 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.45 24.95 75.41 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.651 0.62 . . . . 63.22 114.651 175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -159.27 -176.19 5.67 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 117.618 0.709 . . . . 52.34 111.794 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.02 30.58 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.693 0.797 . . . . 70.25 110.603 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.89 155.31 18.55 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.43 2.753 . . . . 72.55 113.636 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.481 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 49.5 mt -65.1 -52.61 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.694 0.798 . . . . 63.12 112.568 -169.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -148.59 171.58 15.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.47 0.708 . . . . 65.31 109.297 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -60.79 -28.98 69.16 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.031 0.532 . . . . 72.21 111.524 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.44 85.94 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.712 0.805 . . . . 52.44 111.215 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 15.4 tp10 -58.85 -43.61 90.79 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.288 1.035 . . . . 73.31 111.631 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.587 HG21 HG23 ' A' ' 79' ' ' THR . 73.2 mt -62.67 -50.56 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.873 0.869 . . . . 72.53 111.251 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -64.59 -29.59 70.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.324 0.65 . . . . 74.34 111.655 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -62.09 -49.92 74.03 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.711 0.804 . . . . 72.51 110.409 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -63.25 -40.72 98.23 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.902 0.481 . . . . 72.23 111.714 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.9 -34.97 77.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.406 0.683 . . . . 40.2 110.972 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -64.28 -36.43 84.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.763 0.825 . . . . 51.31 111.325 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.96 -42.89 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.601 0.761 . . . . 70.23 110.989 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -36.17 82.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.192 0.597 . . . . 75.12 111.669 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.46 -44.85 73.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.216 0.606 . . . . 53.3 111.495 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.2 p -77.71 -69.59 0.53 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.119 0.785 . . . . 74.15 113.119 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -93.3 -46.95 7.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.964 -0.46 . . . . 73.22 111.724 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.8 -159.68 15.39 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 121.002 0.223 . . . . 62.25 113.581 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 69' ' ' LEU . 8.5 tp -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 123.908 0.883 . . . . 74.03 113.114 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -57.36 -42.35 81.85 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.316 0.646 . . . . 71.31 111.709 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.96 -28.24 43.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.269 -0.878 . . . . 75.45 110.899 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.63 -48.66 71.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.049 0.939 . . . . 72.42 110.931 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.67 -54.63 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 74.11 110.323 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -45.41 -42.08 9.91 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.13 0.972 . . . . 73.24 113.052 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.68 94.31 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.767 0.427 . . . . 61.23 111.882 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.7 -41.7 78.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.521 0.728 . . . . 61.14 112.131 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.28 -47.54 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 122.806 0.442 . . . . 63.34 111.689 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -81.46 2.27 29.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.46 0.541 . . . . 74.0 112.46 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 t -61.2 132.5 53.86 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.953 0.501 . . . . 52.3 109.986 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.03 -36.0 74.24 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.265 0.353 . . . . 72.43 111.139 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.9 -45.41 82.61 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.965 0.906 . . . . 73.22 111.786 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.468 ' HB2' HD23 ' A' ' 90' ' ' LEU . 87.8 t80 -58.23 -54.71 43.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.883 -0.414 . . . . 72.45 109.883 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -60.5 -28.3 68.26 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.611 0.764 . . . . 70.12 112.745 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.21 -40.1 14.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.448 0.699 . . . . 75.51 112.332 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 91.5 t -89.44 -61.52 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 122.932 0.493 . . . . 63.24 110.505 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 138' ' ' ARG . 65.4 m-85 -102.76 70.19 1.1 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.697 . . . . 70.51 109.395 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.06 178.65 0.79 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.623 -0.717 . . . . 64.03 114.537 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.644 ' HG2' ' HD3' ' A' ' 56' ' ' LYS . 27.9 mt-10 -63.91 -14.3 52.43 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.288 0.847 . . . . 54.41 113.288 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.22 -33.0 12.18 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.175 0.59 . . . . 73.15 111.884 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.5 m -86.0 136.59 33.19 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.125 0.57 . . . . 63.44 112.421 -173.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.77 135.73 31.78 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.398 1.079 . . . . 60.34 109.954 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.63 136.06 63.57 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.478 2.119 . . . . 72.12 112.796 167.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -143.65 178.74 7.59 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.11 0.564 . . . . 71.11 111.195 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -70.29 91.15 0.72 Allowed 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 121.296 0.569 . . . . 64.23 110.7 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.404 ' HD2' ' CZ ' ' A' ' 129' ' ' PHE . 14.3 ptm180 -92.46 -34.9 13.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.343 0.657 . . . . 72.24 111.759 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -106.0 144.24 28.53 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.333 0.653 . . . . 73.52 111.709 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.46 -10.21 25.12 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.058 2.506 . . . . 73.41 113.652 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -77.2 -31.22 55.14 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.934 0.494 . . . . 64.03 111.876 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.3 pp -105.23 42.74 1.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.126 0.965 . . . . 74.32 109.652 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -31.82 18.14 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 115.756 1.762 . . . . 64.11 115.756 -171.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 56.09 32.82 20.79 Favored 'General case' 0 CA--C 1.579 2.085 0 C-N-CA 124.353 1.061 . . . . 75.54 112.135 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -68.73 -33.19 73.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.47 -0.769 . . . . 72.33 111.238 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -70.14 131.82 44.87 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.322 0.649 . . . . 75.45 111.474 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -167.8 19.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.694 0.798 . . . . 72.41 112.202 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -65.73 88.13 0.1 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.439 0.696 . . . . 75.44 112.084 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 N--CA 1.481 1.102 0 C-N-CA 124.383 1.073 . . . . 72.21 109.749 178.469 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.721 0.296 . . . . 73.44 111.495 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -118.31 114.38 22.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.034 0.934 . . . . 63.42 109.485 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 t -109.68 98.81 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.465 -0.939 . . . . 65.11 108.465 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.62 123.73 17.28 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.307 1.043 . . . . 74.21 111.783 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.14 162.15 38.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.252 0.621 . . . . 72.32 111.035 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -74.86 89.24 2.33 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.693 -0.685 . . . . 74.45 110.787 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -70.93 112.45 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-N 115.878 -0.601 . . . . 62.42 111.008 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.78 43.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.001 1.32 . . . . 72.12 113.583 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.26 -42.09 55.41 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.688 0.635 . . . . 42.31 114.688 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.5 mm -71.58 -54.54 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.565 0.746 . . . . 74.24 110.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 46.37 17.21 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 126.123 1.769 . . . . 64.53 115.146 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.43 138.31 31.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.921 0.888 . . . . 74.11 110.824 -169.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.49 -29.07 65.51 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.174 0.805 . . . . 62.01 113.174 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.12 -30.5 49.41 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.698 0.399 . . . . 64.24 110.696 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.79 -38.68 64.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.26 0.624 . . . . 74.3 109.959 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.573 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.5 mp -63.95 -34.97 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 115.256 -0.884 . . . . 74.55 110.027 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 34' ' ' PRO . 24.4 ttmm -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.918 0.71 . . . . 72.43 112.918 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -69.7 -34.01 73.32 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 122.018 -0.426 . . . . 64.0 110.41 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.04 -34.35 77.83 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.854 1.262 . . . . 45.12 110.355 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 16' ' ' ILE . 51.5 mm -62.59 -53.17 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.05 0.94 . . . . 73.42 109.514 174.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -65.76 -29.05 69.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.202 1.001 . . . . 74.23 112.867 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -41.41 59.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.528 0.731 . . . . 71.25 110.543 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.02 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.941 0.897 . . . . 73.41 111.927 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.949 0.499 . . . . 70.2 112.209 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtp85 -67.57 -14.36 62.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.111 0.564 . . . . 75.03 112.028 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.754 ' HG2' ' HB2' ' A' ' 135' ' ' PRO . 23.9 tp60 -95.9 -50.33 4.93 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.928 0.491 . . . . 74.12 111.147 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -78.46 -59.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.257 0.623 . . . . 74.53 111.005 -175.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -81.51 -7.05 59.53 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.723 0.409 . . . . 65.33 111.634 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 65.97 -54.48 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.502 1.921 . . . . 65.44 114.479 -174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -65.64 139.12 58.38 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.53 0.732 . . . . 74.43 112.282 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -65.59 128.66 36.85 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.229 -0.896 . . . . 63.51 109.649 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -105.47 142.51 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.193 0.597 . . . . 65.34 109.973 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 36' ' ' ILE . . . -62.66 124.34 82.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.955 0.902 . . . . 74.0 111.402 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 51.0 Cg_exo -56.01 -32.31 85.62 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 123.513 2.809 . . . . 75.43 115.575 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -72.78 -35.73 67.48 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.37 0.268 . . . . 64.53 111.206 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 33' ' ' ALA . 71.3 mt -66.25 -41.57 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.919 0.888 . . . . 73.43 110.423 172.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.68 64.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.031 0.932 . . . . 72.12 111.691 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -75.9 -61.38 1.95 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.526 -0.761 . . . . 73.22 110.914 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -63.21 -25.69 68.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.235 0.828 . . . . 63.14 113.235 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.26 -54.49 5.91 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.86 0.464 . . . . 73.32 110.773 172.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 85.1 m-85 -113.92 60.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.678 0.791 . . . . 75.03 111.557 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -73.27 -50.94 19.53 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.928 -0.483 . . . . 71.25 111.988 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.68 -31.34 58.6 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.287 -0.415 . . . . 60.43 112.377 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 8.7 t-105 -69.93 -37.47 75.9 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.194 0.997 . . . . 75.0 111.157 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.9 -41.9 81.99 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.013 0.925 . . . . 72.03 111.542 169.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -53.62 -54.46 37.35 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.57 1.148 . . . . 65.24 113.193 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.691 ' HD3' HG21 ' A' ' 53' ' ' ILE . 15.1 ptpt -61.18 -35.08 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.269 0.84 . . . . 63.54 113.269 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.1 tp -71.15 -34.22 70.8 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.308 0.243 . . . . 62.43 110.707 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.573 ' HA2' HG12 ' A' ' 16' ' ' ILE . . . -67.08 -33.52 83.72 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.76 -0.2 . . . . 72.25 112.861 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -73.63 -10.38 59.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.01 0.924 . . . . 75.23 112.144 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.99 32.5 82.36 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 115.364 0.906 . . . . 51.34 115.364 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.4 -60.2 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.902 0.858 . . . . 73.22 110.201 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.691 HG21 ' HD3' ' A' ' 47' ' ' LYS . 21.9 pt -73.13 176.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.797 -1.547 . . . . 74.35 112.181 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.608 HG23 ' H ' ' A' ' 57' ' ' GLU . 1.8 t -99.51 153.37 19.08 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.078 -0.712 . . . . 62.02 109.078 170.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 59' ' ' ILE . 91.2 t -64.06 -31.13 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 110.119 -0.326 . . . . 75.21 110.119 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -44.83 -50.93 9.99 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.735 1.013 . . . . 63.53 113.735 166.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.608 ' H ' HG23 ' A' ' 54' ' ' THR . 31.6 tt0 -58.52 -42.51 87.9 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.651 0.38 . . . . 75.24 110.822 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' HZ ' HG23 ' A' ' 20' ' ' ILE . 86.7 t80 -63.75 -43.34 96.72 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.01 0.924 . . . . 72.33 110.881 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 55' ' ' VAL . 33.7 mm -68.11 -46.47 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.751 1.22 . . . . 63.24 111.911 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.72 -39.08 64.94 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.894 0.478 . . . . 62.03 111.471 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.09 -25.42 72.16 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 116.142 -0.481 . . . . 75.11 114.165 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.7 mt -75.68 -38.1 58.99 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.426 0.69 . . . . 71.4 111.134 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.44 -18.08 79.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 121.554 -0.355 . . . . 73.1 113.657 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -84.59 -28.15 26.75 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.528 0.731 . . . . 75.33 111.566 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.3 p -71.99 129.4 38.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.673 -0.491 . . . . 63.44 109.673 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -58.71 -15.87 13.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.138 1.162 . . . . 72.54 114.138 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.69 -42.62 93.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.885 0.874 . . . . 64.43 112.072 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -65.51 -43.21 90.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.542 0.687 . . . . 60.4 111.031 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.96 -28.75 63.64 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.012 -0.994 . . . . 74.51 111.327 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -60.37 -45.87 91.98 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.959 1.304 . . . . 73.14 111.072 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.81 -42.05 61.48 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.015 -0.993 . . . . 73.41 111.832 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -114.31 -67.56 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.922 1.082 . . . . 71.21 113.922 -167.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -61.19 -30.02 70.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.338 1.236 . . . . 71.11 114.338 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.557 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 45.8 m -78.65 -54.74 1.09 Allowed Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.729 -0.653 . . . . 75.31 112.054 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 14.8 Cg_exo -71.8 -16.86 29.57 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 121.989 1.792 . . . . 55.21 114.274 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 56.3 m-85 -115.24 147.71 39.13 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 123.088 0.555 . . . . 72.41 112.357 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 81' ' ' VAL . 91.7 Cg_endo -75.54 169.93 21.32 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.367 . . . . 75.42 112.549 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -49.95 -49.56 49.77 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.25 1.02 . . . . 74.42 113.002 -173.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.589 ' HA ' HD12 ' A' ' 82' ' ' ILE . 26.3 m -59.69 -35.53 74.67 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.6 0.76 . . . . 73.4 112.981 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 22.4 tptm -72.72 -36.18 67.74 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.904 0.383 . . . . 71.43 110.859 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.7 t -68.84 -28.53 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.242 0.617 . . . . 75.21 110.569 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 79' ' ' THR . 96.9 mt -66.77 -52.11 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 73.33 111.26 174.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -71.99 -37.57 69.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 111.832 0.308 . . . . 73.4 111.832 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.97 -31.26 61.41 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.299 0.639 . . . . 71.34 111.508 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.9 52.05 Favored Glycine 0 N--CA 1.476 1.312 0 N-CA-C 112.039 -0.424 . . . . 74.44 112.039 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.68 HG23 HD12 ' A' ' 90' ' ' LEU . 53.6 m -66.48 -35.78 81.11 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.098 0.959 . . . . 74.33 110.747 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.93 -42.44 90.08 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 60.24 112.627 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.8 m170 -82.84 -36.0 25.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.961 0.504 . . . . 75.54 112.353 -175.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -94.29 -68.87 0.78 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 119.179 -0.439 . . . . 71.13 111.274 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.68 HD12 HG23 ' A' ' 86' ' ' THR . 79.2 mt -66.9 -18.24 65.28 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.945 0.72 . . . . 73.01 112.945 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.23 21.3 78.16 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.321 0.388 . . . . 71.33 113.422 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 86' ' ' THR . 9.7 ptt180 -143.09 172.79 12.23 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.166 0.587 . . . . 74.0 110.951 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.06 151.28 54.21 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 123.246 0.618 . . . . 72.14 111.07 165.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.05 140.45 65.69 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.232 1.955 . . . . 34.22 111.486 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.65 -42.83 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.426 0.528 . . . . 75.11 112.426 -164.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -155.65 160.88 40.77 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.161 -0.681 . . . . 52.31 109.161 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -54.91 -36.08 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.447 0.699 . . . . 73.22 112.654 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.37 74.23 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.294 0.638 . . . . 60.53 112.323 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.42 -39.88 67.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.615 0.766 . . . . 64.42 111.624 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.57 -53.27 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.335 0.654 . . . . 71.2 111.713 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -55.81 -32.72 63.79 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.782 0.833 . . . . 71.44 111.867 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.4 tmmm? -61.01 -52.13 66.29 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.503 0.721 . . . . 74.03 110.856 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -64.99 -35.77 82.25 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.849 0.46 . . . . 75.2 112.021 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.408 ' HB2' HD11 ' A' ' 82' ' ' ILE . 47.9 t30 -67.87 -36.85 80.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.064 0.946 . . . . 70.41 111.398 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -67.78 -30.74 70.26 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.575 -0.739 . . . . 65.41 110.632 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 102' ' ' LYS . 74.3 mt -65.77 -40.75 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 122.952 0.501 . . . . 73.04 110.426 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.75 -37.97 76.62 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.241 0.617 . . . . 75.24 112.044 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.4 71.47 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.404 0.682 . . . . 62.1 112.115 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 p -75.79 -52.16 11.02 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.965 0.906 . . . . 72.13 111.642 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.09 -73.03 0.69 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.936 0.894 . . . . 73.41 111.356 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.02 -174.21 22.55 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.297 0.499 . . . . 74.34 113.543 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.8 mm -52.73 -36.64 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.966 1.306 . . . . 72.13 113.706 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -61.17 -51.35 69.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.884 0.373 . . . . 74.21 111.139 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.9 -37.45 87.69 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.524 -0.762 . . . . 73.45 112.539 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.39 -55.95 17.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.31 1.044 . . . . 64.53 112.624 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -57.51 -44.55 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.673 0.789 . . . . 63.52 110.693 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -57.58 -39.19 76.22 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.322 0.649 . . . . 74.02 112.263 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.96 98.49 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.245 0.618 . . . . 64.14 111.472 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.0 mt -62.83 -55.04 29.84 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.836 0.854 . . . . 72.11 111.399 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 56' ' ' LYS . 74.9 t -67.23 -32.6 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 123.186 0.595 . . . . 75.04 112.438 -173.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.93 22.11 15.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.63 -0.669 . . . . 74.22 111.824 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -71.5 142.03 50.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.258 0.623 . . . . 72.41 110.453 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.65 -37.39 79.62 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.724 0.41 . . . . 72.33 111.563 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.58 -32.5 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 120.776 0.322 . . . . 74.24 110.887 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -75.49 -54.13 7.53 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.455 0.702 . . . . 73.13 111.712 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -69.86 -23.35 63.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.905 0.705 . . . . 74.42 112.905 -169.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.46 -39.1 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.042 0.537 . . . . 75.23 111.984 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.29 -58.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.089 0.947 . . . . 75.44 110.394 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.527 ' HE2' ' HB2' ' A' ' 56' ' ' LYS . 45.5 t80 -59.88 -46.64 88.68 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.037 1.735 . . . . 74.2 112.786 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.94 -129.18 9.2 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-O 119.534 -0.592 . . . . 41.21 112.183 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -135.06 -64.58 0.65 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.504 0.652 . . . . 65.21 111.271 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.43 1.14 34.45 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.844 0.858 . . . . 73.44 112.693 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.9 m -92.35 151.65 20.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.843 0.857 . . . . 72.5 111.528 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.7 137.67 85.65 Favored Pre-proline 0 N--CA 1.488 1.452 0 C-N-CA 124.468 1.107 . . . . 74.4 110.284 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.754 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 2.8 Cg_exo -67.82 135.57 35.86 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.158 1.905 . . . . 74.32 111.798 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -136.21 141.35 43.99 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.493 0.717 . . . . 75.24 110.299 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.481 ' H ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -86.47 18.54 3.22 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.437 0.695 . . . . 70.43 112.523 -176.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 65.72 -104.89 0.1 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 125.031 1.332 . . . . 75.13 112.514 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.55 ' H ' ' HD3' ' A' ' 140' ' ' PRO . 38.8 p90 -160.38 27.1 0.03 OUTLIER Pre-proline 0 CA--C 1.59 2.496 0 N-CA-C 116.208 1.929 . . . . 53.43 116.208 -171.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.55 ' HD3' ' H ' ' A' ' 139' ' ' PHE . 15.9 Cg_exo -66.79 -11.89 33.8 Favored 'Trans proline' 0 C--N 1.401 3.298 0 CA-C-N 123.4 2.25 . . . . 74.2 112.878 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 t -61.7 -44.16 97.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.404 1.082 . . . . 74.45 111.466 169.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.6 mt 61.77 6.44 1.62 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.149 1.38 . . . . 71.03 113.88 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -85.89 89.15 7.69 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.562 0.696 . . . . 74.14 109.324 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -83.74 98.11 9.5 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.49 -0.777 . . . . 73.0 111.968 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.5 126.01 34.65 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.747 -0.661 . . . . 74.2 109.532 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -68.52 -6.5 25.62 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.862 1.06 . . . . 74.41 113.862 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -132.39 128.19 37.04 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.886 0.874 . . . . 63.3 110.502 167.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -155.23 81.73 1.06 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.702 0.801 . . . . 74.34 109.505 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 N--CA 1.49 1.555 0 C-N-CA 124.064 0.946 . . . . 74.43 112.417 -170.905 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.607 0.241 . . . . 63.34 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -138.28 130.4 28.61 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.871 0.868 . . . . 75.45 109.852 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 p -108.99 125.24 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.67 0.788 . . . . 54.2 110.68 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -92.23 87.22 6.0 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.63 0.729 . . . . 71.31 109.748 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.53 155.43 17.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.546 0.738 . . . . 73.13 110.881 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -92.77 113.8 26.18 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.22 -1.03 . . . . 70.53 108.22 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.56 124.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.912 -0.773 . . . . 74.2 108.912 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.87 99.86 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.707 0.803 . . . . 54.45 111.945 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.29 -31.49 2.34 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.067 -0.515 . . . . 73.31 113.929 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.3 mt -67.68 102.16 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-O 121.709 0.766 . . . . 70.14 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -113.62 24.93 11.69 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.709 -1.132 . . . . 73.34 110.176 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.42 109.31 21.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.697 0.799 . . . . 71.2 108.984 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -61.51 -23.34 65.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.64 0.607 . . . . 61.41 112.64 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.27 -38.84 68.72 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.267 0.627 . . . . 74.14 111.074 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.01 52.14 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.357 0.663 . . . . 74.53 111.289 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.41 HG21 ' HA2' ' A' ' 49' ' ' GLY . 49.0 mm -72.52 -42.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.08 0.552 . . . . 74.14 110.07 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.38 -31.75 73.02 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.866 0.867 . . . . 72.04 112.527 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -77.14 -31.0 55.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 120.902 0.382 . . . . 72.23 111.446 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.07 -43.55 98.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.741 0.816 . . . . 74.44 109.654 170.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.3 -38.04 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.481 1.112 . . . . 71.12 111.48 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.8 t -65.74 -38.37 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.519 0.728 . . . . 60.34 111.771 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.41 -37.6 63.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.146 0.578 . . . . 60.53 110.885 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.9 77.14 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.777 0.831 . . . . 74.23 111.601 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -59.07 -49.91 76.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.984 0.514 . . . . 73.04 110.923 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.78 -26.5 68.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.88 0.696 . . . . 74.0 112.88 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -67.29 -46.89 72.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.853 0.461 . . . . 74.52 111.367 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.719 HD11 HG23 ' A' ' 59' ' ' ILE . 2.4 mp -89.12 -67.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.079 0.552 . . . . 65.1 109.954 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -83.77 82.35 8.36 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.879 0.872 . . . . 72.12 109.122 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.32 69.17 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.609 1.195 . . . . 61.41 114.113 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 176.23 145.73 0.09 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.256 1.822 . . . . 61.21 108.911 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -71.03 119.64 15.44 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-O 121.006 0.432 . . . . 75.44 110.6 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 mm -84.1 125.24 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.473 -0.936 . . . . 73.13 108.473 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 35' ' ' TYR . . . -59.24 122.47 63.77 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.603 -0.713 . . . . 52.41 111.173 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.95 -38.47 86.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.611 2.874 . . . . 71.51 114.275 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.408 ' CE1' ' HB1' ' A' ' 33' ' ' ALA . 44.1 p90 -68.71 -25.38 64.74 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.205 0.602 . . . . 72.52 112.198 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.1 mt -83.32 -44.49 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.429 0.692 . . . . 65.13 111.004 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -33.84 72.6 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.478 1.111 . . . . 34.44 112.208 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -70.83 -36.52 72.94 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.519 -0.764 . . . . 74.1 112.312 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -83.34 -41.57 18.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.344 0.498 . . . . 70.44 112.344 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.39 -54.08 28.46 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.714 . . . . 70.45 112.269 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -98.31 33.0 2.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.92 0.888 . . . . 72.34 111.006 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.8 t -62.38 -50.43 71.58 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.191 0.997 . . . . 75.31 113.081 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.16 36.72 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.788 -0.642 . . . . 72.44 112.096 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -70.54 -29.94 66.54 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.497 0.719 . . . . 74.43 111.957 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -38.57 75.49 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.691 0.796 . . . . 70.14 110.834 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.0 t -52.37 -38.16 58.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.153 0.981 . . . . 73.43 113.365 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.33 -40.07 62.43 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 111.969 0.359 . . . . 63.24 111.969 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.32 -30.69 67.72 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 118.212 0.46 . . . . 73.42 112.178 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' HG21 ' A' ' 16' ' ' ILE . . . -70.36 -31.7 68.54 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.893 0.163 . . . . 71.31 112.711 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.548 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 56.1 m-20 -88.19 -18.44 28.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.534 0.734 . . . . 64.23 111.609 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.17 71.86 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.143 0.417 . . . . 72.12 114.143 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.5 mm-40 -61.07 -32.6 72.25 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.822 0.849 . . . . 71.22 111.677 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -113.41 158.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.574 0.749 . . . . 62.3 110.055 171.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.4 p -84.75 169.18 14.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.255 0.622 . . . . 63.13 110.99 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 59' ' ' ILE . 50.8 t -63.79 -47.69 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.479 -0.563 . . . . 75.4 109.479 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -43.57 -51.84 6.62 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.61 1.337 . . . . 53.33 114.61 169.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -57.75 -39.49 77.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.094 0.558 . . . . 72.04 111.301 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.435 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 45.3 t80 -71.83 -38.72 70.13 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.482 0.713 . . . . 75.54 110.792 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.719 HG23 HD11 ' A' ' 27' ' ' ILE . 30.6 mm -63.47 -50.35 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.983 1.313 . . . . 64.5 110.937 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' HG11 ' A' ' 120' ' ' VAL . 25.8 tt0 -57.34 -38.85 74.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.085 -0.961 . . . . 74.12 111.425 172.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.73 85.22 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.821 -0.627 . . . . 63.42 113.941 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 84.1 mt -69.78 -39.89 76.37 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.245 0.618 . . . . 44.14 111.326 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.75 81.95 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.529 0.572 . . . . 72.11 114.529 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -72.77 -21.69 60.96 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.518 0.727 . . . . 71.43 111.73 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -63.22 128.68 36.94 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.095 0.558 . . . . 65.14 111.919 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.14 -19.2 52.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.24 113.09 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.78 -44.01 97.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.33 0.652 . . . . 64.13 110.723 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -67.54 -31.13 71.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.832 0.453 . . . . 75.34 111.475 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 4.3 mm? -71.89 -34.46 69.16 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.276 0.63 . . . . 70.13 112.318 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -29.7 34.95 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.543 -0.723 . . . . 74.44 111.693 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.85 -56.63 4.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.664 0.616 . . . . 72.34 112.664 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -128.05 60.01 1.47 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.539 0.735 . . . . 75.43 112.306 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.607 ' HD1' HG11 ' A' ' 81' ' ' VAL . 76.9 t80 -162.66 -60.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.911 -0.586 . . . . 65.45 110.725 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.6 p -64.33 -41.26 58.76 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 114.405 1.261 . . . . 72.41 114.405 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.32 -7.58 8.9 Favored 'Trans proline' 0 C--N 1.389 2.704 0 CA-C-N 121.84 1.693 . . . . 70.35 114.039 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -109.37 149.98 40.5 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 123.805 0.842 . . . . 72.55 111.819 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.89 152.94 76.65 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.095 1.863 . . . . 62.22 111.323 168.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -50.56 -47.79 57.72 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.804 0.842 . . . . 72.43 112.708 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.529 ' HA ' HD12 ' A' ' 82' ' ' ILE . 17.8 m -55.61 -33.59 64.12 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.656 0.783 . . . . 63.23 112.354 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -76.23 -36.0 58.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.001 0.521 . . . . 72.42 111.636 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.607 HG11 ' HD1' ' A' ' 73' ' ' TYR . 59.7 t -63.09 -34.8 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.445 0.641 . . . . 74.24 110.476 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.5 mt -63.21 -51.28 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.814 -1.084 . . . . 64.44 111.92 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.4 -31.06 60.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.821 0.448 . . . . 72.4 111.442 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -76.93 -28.51 55.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.418 0.687 . . . . 72.25 111.222 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.26 -54.52 8.87 Favored Glycine 0 C--N 1.344 1.022 0 C-N-CA 122.101 -0.095 . . . . 35.04 112.935 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 t -60.59 -33.34 72.58 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.42 0.896 . . . . 72.2 113.42 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.23 -14.74 62.34 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.543 0.571 . . . . 52.31 112.543 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -89.41 -50.25 6.22 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.774 0.657 . . . . 44.3 112.774 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -85.67 -40.04 16.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.864 0.466 . . . . 55.31 111.82 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 124' ' ' GLU . 77.6 mt -95.84 -49.02 5.5 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 122.439 0.296 . . . . 74.0 110.994 175.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.29 40.39 87.45 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 122.192 -0.317 . . . . 71.12 113.707 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.686 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 2.6 ptm180 -131.2 7.97 4.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.157 0.799 . . . . 74.24 113.157 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 60.12 158.56 0.11 Allowed Pre-proline 0 N--CA 1.504 2.256 0 N-CA-C 113.87 1.063 . . . . 52.02 113.87 -163.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.02 152.96 61.21 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.318 2.012 . . . . 61.03 113.705 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -74.44 -72.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 C-N-CA 123.193 0.597 . . . . 74.24 111.08 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -123.86 171.36 9.73 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.816 0.846 . . . . 54.12 109.854 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -69.5 -29.79 67.5 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.776 -0.578 . . . . 61.41 110.172 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.52 -30.94 68.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.088 0.555 . . . . 41.43 111.96 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -71.89 -39.62 69.45 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.209 0.604 . . . . 62.33 111.21 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.41 ' O ' HD13 ' A' ' 82' ' ' ILE . 76.7 mt -63.98 -52.15 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.217 0.607 . . . . 73.11 110.567 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -54.74 -39.91 68.76 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.11 0.964 . . . . 73.13 111.91 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' O ' HG13 ' A' ' 106' ' ' ILE . 34.6 ttpt -57.15 -45.55 83.5 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.527 0.731 . . . . 64.03 111.15 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.511 ' HD1' HD12 ' A' ' 106' ' ' ILE . 17.8 m-85 -68.25 -35.39 77.83 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.755 0.422 . . . . 75.1 111.921 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -67.46 -32.71 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.892 0.477 . . . . 74.13 110.988 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -64.45 -40.75 96.33 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.865 0.866 . . . . 62.05 110.429 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.511 HD12 ' HD1' ' A' ' 103' ' ' TYR . 80.1 mt -62.48 -46.16 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 124.267 1.027 . . . . 71.31 111.52 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.3 -42.72 99.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.207 0.603 . . . . 74.23 111.69 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.2 -44.6 75.47 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.743 0.646 . . . . 74.3 112.743 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.4 p -72.41 -51.77 18.91 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.021 0.749 . . . . 73.4 113.021 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.26 -46.75 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 112.906 0.706 . . . . 74.22 112.906 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.1 -153.45 20.74 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 115.414 0.925 . . . . 70.44 115.414 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.1 tp -70.81 -35.57 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.107 0.963 . . . . 51.42 112.775 -169.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -61.2 -44.27 97.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.427 0.528 . . . . 73.52 112.427 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -29.44 66.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.029 0.531 . . . . 61.13 112.294 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -65.12 -48.07 74.88 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.269 0.628 . . . . 74.22 110.707 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 112' ' ' ILE . 46.7 mm -64.22 -45.6 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.568 0.747 . . . . 63.24 110.026 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -58.87 -36.36 74.49 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.103 0.961 . . . . 70.4 111.671 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.18 -28.72 68.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.4 0.68 . . . . 50.4 112.142 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.0 -43.56 13.05 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.838 0.855 . . . . 42.45 112.326 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 60' ' ' GLU . 61.8 t -78.15 -37.54 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.416 0.686 . . . . 74.33 111.504 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -87.53 4.37 43.8 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.918 0.487 . . . . 73.24 112.039 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.1 t -67.62 137.58 55.74 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.921 0.488 . . . . 74.42 110.489 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.545 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . 13.7 pt20 -54.74 -29.21 53.07 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.786 1.032 . . . . 75.1 113.786 -175.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.686 ' HG2' ' HD2' ' A' ' 92' ' ' ARG . 34.3 tp10 -50.85 -47.53 60.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.121 0.968 . . . . 64.33 112.225 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.9 -44.58 20.14 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.624 0.769 . . . . 73.52 111.092 168.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 123' ' ' GLN . 6.8 t30 -72.46 -67.7 0.53 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.707 1.002 . . . . 72.1 113.707 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 8.3 pt-20 -56.81 -37.21 70.86 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.296 0.85 . . . . 75.23 113.296 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.67 -61.62 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 112.502 0.556 . . . . 70.42 112.502 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.3 -53.59 2.63 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.05 0.54 . . . . 62.24 111.479 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.65 -126.91 8.78 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.878 -0.601 . . . . 51.32 113.095 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -106.42 -20.46 13.37 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.781 0.832 . . . . 74.25 111.377 -169.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.21 11.84 38.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.143 1.534 . . . . 74.42 115.143 -156.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 t -153.91 164.23 38.74 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 119.43 1.014 . . . . 73.34 112.333 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 55.3 t -67.86 135.37 92.14 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 123.871 0.868 . . . . 63.55 110.498 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 134' ' ' VAL . 7.1 Cg_exo -71.85 76.74 1.97 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.207 2.605 . . . . 74.3 113.198 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -86.17 171.23 11.46 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.32 0.648 . . . . 75.41 110.701 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -62.82 133.07 54.17 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.108 0.48 . . . . 61.52 111.832 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.526 ' HB3' HD21 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -84.94 130.34 34.65 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.034 0.445 . . . . 70.24 110.552 176.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -66.74 158.98 77.72 Favored Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 125.129 1.372 . . . . 53.41 111.695 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -52.13 -39.16 71.45 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 123.529 2.819 . . . . 60.23 113.377 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.7 t -107.24 148.54 28.8 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.48 0.712 . . . . 52.2 110.164 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 138' ' ' ARG . 94.7 mt -118.66 109.17 15.81 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.471 0.708 . . . . 53.34 110.377 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -85.26 69.21 10.72 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.823 0.821 . . . . 73.23 109.586 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -148.88 88.04 1.58 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.881 -1.155 . . . . 72.42 107.881 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -54.14 107.32 0.26 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.34 1.056 . . . . 74.41 113.784 -169.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -75.37 150.14 38.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.775 0.83 . . . . 72.55 110.889 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -65.67 140.37 58.48 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 112.596 0.591 . . . . 64.44 112.596 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -94.32 -11.14 30.65 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.99 0.916 . . . . 64.21 111.622 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 17.9 p80 . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 123.87 0.868 . . . . 73.15 110.628 174.568 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 110.309 -0.256 . . . . 54.13 110.309 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -128.41 127.93 43.51 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 121.562 0.696 . . . . 60.13 111.868 -171.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.2 t -114.69 118.71 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.712 1.205 . . . . 54.51 108.803 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -88.01 101.15 13.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.296 0.638 . . . . 73.43 111.123 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -132.06 163.2 28.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.014 0.526 . . . . 71.11 111.176 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.642 HH22 ' HG ' ' A' ' 48' ' ' LEU . 19.7 tpp85 -79.47 98.25 6.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.262 -0.881 . . . . 71.45 109.736 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.73 130.71 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.338 -0.986 . . . . 72.33 108.338 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.66 75.8 0.59 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.861 0.839 . . . . 70.21 111.928 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.75 -37.98 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.517 -1.22 . . . . 64.2 112.356 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.43 80.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.439 0 CA-C-O 122.529 1.156 . . . . 64.43 110.819 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -89.44 10.03 24.17 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.583 -1.644 . . . . 64.11 113.599 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' HG12 ' A' ' 16' ' ' ILE . 5.6 m-20 -70.69 126.15 28.8 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.007 0.523 . . . . 75.03 111.198 -172.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -60.45 -29.47 69.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.926 0.491 . . . . 73.32 112.035 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 -50.58 62.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.025 0.93 . . . . 75.14 110.937 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.4 94.51 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.603 0.761 . . . . 65.24 112.496 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.579 HG21 ' HA2' ' A' ' 49' ' ' GLY . 46.1 mm -63.2 -49.06 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.06 0.544 . . . . 61.12 111.556 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.25 -25.14 61.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.313 0.486 . . . . 65.44 112.313 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.8 m -65.73 -38.63 89.68 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.792 0.437 . . . . 74.33 111.226 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.33 -40.36 93.59 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.012 0.925 . . . . 73.0 109.983 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.27 -43.92 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.653 1.181 . . . . 63.23 111.544 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -70.47 -35.54 73.36 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.311 0.644 . . . . 74.11 111.438 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.18 90.14 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.666 0.786 . . . . 54.33 112.022 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.78 99.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.512 0.725 . . . . 63.32 111.126 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.464 ' HE2' ' HB1' ' A' ' 37' ' ' ALA . 13.3 m-30 -70.92 -41.02 71.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.567 -0.742 . . . . 72.31 111.556 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -60.88 -35.78 77.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.256 1.022 . . . . 54.02 112.367 179.217 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.0 -62.92 1.54 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.876 0.471 . . . . 71.35 110.122 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.75 -54.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.78 0.832 . . . . 73.02 112.674 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -78.98 -8.33 58.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.121 0.568 . . . . 75.35 112.029 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 146' ' ' HIS . 8.8 tp10 53.85 45.77 27.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.521 1.153 . . . . 74.02 112.577 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.428 HH21 ' HG3' ' A' ' 71' ' ' GLU . 8.0 ptp180 -153.85 -179.0 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.348 -0.842 . . . . 72.43 111.264 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -125.78 107.95 11.02 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.848 -1.167 . . . . 61.03 107.848 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 24' ' ' TYR . 20.0 mt -90.98 139.84 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.769 0.428 . . . . 73.34 110.849 -174.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.67 94.6 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.791 -0.623 . . . . 64.41 109.941 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.58 -44.13 41.7 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.656 2.904 . . . . 71.44 113.957 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.01 -44.58 79.95 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.173 -0.921 . . . . 73.21 112.523 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -57.91 -43.78 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 122.956 0.502 . . . . 75.41 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB1' ' HE2' ' A' ' 24' ' ' TYR . . . -58.72 -48.19 81.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.287 1.035 . . . . 71.42 111.795 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -80.95 -12.13 59.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.619 0.6 . . . . 72.23 112.619 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -80.3 -47.26 14.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.677 -0.64 . . . . 73.31 111.729 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.52 -42.48 67.9 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 120.949 0.404 . . . . 74.1 111.047 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.508 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 60.7 m-85 -105.66 55.07 0.69 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.785 0.834 . . . . 64.45 110.939 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.6 m -64.34 -50.2 68.68 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 122.891 0.476 . . . . 62.13 111.636 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -70.64 -39.01 67.66 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.85 -0.614 . . . . 74.53 113.389 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -70.32 -42.16 72.3 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.135 0.974 . . . . 72.11 112.889 -169.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.04 -39.72 93.3 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.883 0.473 . . . . 73.41 110.584 174.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 m -62.77 -47.56 82.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.856 0.863 . . . . 63.32 111.885 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.4 mmmm -59.12 -44.87 92.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.069 0.547 . . . . 72.24 111.983 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' HH22 ' A' ' 6' ' ' ARG . 16.3 tp -74.0 -33.28 63.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 116.317 -0.402 . . . . 71.23 111.32 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.579 ' HA2' HG21 ' A' ' 16' ' ' ILE . . . -66.0 -26.72 72.4 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 123.035 0.35 . . . . 73.21 113.883 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -92.28 -17.51 24.67 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.548 0.739 . . . . 54.33 110.985 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.79 28.51 60.82 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.887 -0.597 . . . . 72.44 113.973 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.41 -25.27 54.33 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.697 0.799 . . . . 74.14 112.647 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.17 171.0 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.727 0.811 . . . . 74.33 109.151 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 p -89.69 170.27 10.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.7 -0.852 . . . . 62.41 108.7 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -59.56 -33.53 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 119.721 -0.18 . . . . 52.01 110.562 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 131' ' ' GLU . 78.7 tttt -44.82 -56.81 4.19 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.0 1.32 . . . . 72.22 113.556 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.98 -40.58 78.74 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.288 0.635 . . . . 62.31 111.354 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 85.3 t80 -53.49 -51.9 61.26 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.908 0.755 . . . . 73.43 110.808 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 55' ' ' VAL . 37.8 mm -57.88 -43.5 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.643 1.177 . . . . 70.4 111.758 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' HG11 ' A' ' 120' ' ' VAL . 32.2 tt0 -58.97 -47.95 83.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 122.783 0.433 . . . . 65.23 111.81 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.17 -18.83 65.43 Favored Glycine 0 CA--C 1.541 1.698 0 N-CA-C 114.867 0.707 . . . . 62.1 114.867 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 54.2 mt -70.73 -30.67 67.26 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 117.566 0.683 . . . . 54.33 111.105 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.61 -10.67 79.94 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 115.315 -0.857 . . . . 72.33 114.129 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -95.54 -7.75 37.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.658 0.783 . . . . 75.24 111.014 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.439 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.7 p -84.13 137.35 33.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.986 0.514 . . . . 62.3 111.273 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 6.0 t30 -62.38 -23.58 66.89 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.01 0.524 . . . . 72.11 111.576 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.5 tp -67.56 -38.01 83.5 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.605 0.762 . . . . 75.22 111.611 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -74.27 -45.6 46.72 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 120.811 0.339 . . . . 74.42 110.716 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.527 HD11 HG12 ' A' ' 112' ' ' ILE . 4.0 mm? -55.96 -44.17 78.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.587 1.155 . . . . 64.2 112.887 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.82 -29.71 70.23 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.873 0.694 . . . . 65.13 112.873 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' HG3' HH21 ' A' ' 30' ' ' ARG . 6.3 mm-40 -93.37 -36.64 12.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.314 1.227 . . . . 74.22 114.314 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HD1' HD13 ' A' ' 84' ' ' LEU . 80.1 m-85 -128.86 32.42 4.78 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.658 0.614 . . . . 75.44 112.658 -171.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HD1' HG11 ' A' ' 81' ' ' VAL . 78.1 t80 -150.16 -54.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.95 0.5 . . . . 74.55 110.974 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -68.16 -43.7 35.6 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.582 0.956 . . . . 65.21 113.582 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.1 7.63 4.97 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.127 1.885 . . . . 74.1 113.422 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 58.3 m-85 -130.07 141.6 42.44 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.579 0.751 . . . . 75.24 111.395 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.65 167.55 16.97 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.29 1.993 . . . . 71.12 111.766 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.52 -40.72 72.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.289 0.636 . . . . 62.11 112.356 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.62 ' HA ' HD12 ' A' ' 82' ' ' ILE . 99.2 m -66.36 -42.38 88.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.073 0.949 . . . . 72.45 113.457 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 48.8 tptt -63.66 -32.95 74.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.258 0.466 . . . . 64.3 112.258 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.568 HG11 ' HD1' ' A' ' 73' ' ' TYR . 45.8 t -63.18 -30.56 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.188 0.595 . . . . 73.23 110.642 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.6 mt -69.92 -51.17 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.947 0.899 . . . . 73.02 112.251 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.64 -45.44 65.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.115 0.416 . . . . 72.53 111.697 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.518 HD23 ' HD3' ' A' ' 87' ' ' LYS . 74.8 mt -61.85 -29.04 69.91 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.361 0.665 . . . . 64.5 112.196 171.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.1 -41.67 46.7 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 115.705 -0.68 . . . . 75.12 111.903 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.438 HG23 HD12 ' A' ' 90' ' ' LEU . 78.3 m -68.9 -46.1 69.22 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.308 0.643 . . . . 65.13 112.016 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HD3' HD23 ' A' ' 84' ' ' LEU . 14.6 ptmt -70.5 -24.42 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.59 0.959 . . . . 73.34 113.59 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -85.02 -33.61 22.49 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 113.695 0.998 . . . . 62.01 113.695 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -104.18 -41.97 5.65 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.844 1.053 . . . . 65.11 113.844 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.438 HD12 HG23 ' A' ' 86' ' ' THR . 69.0 mt -94.71 -14.7 24.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.127 0.417 . . . . 71.32 112.127 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.87 14.97 2.05 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.608 0.603 . . . . 62.14 114.608 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.655 ' HA ' HH11 ' A' ' 138' ' ' ARG . 24.3 ttt180 -98.23 -84.78 0.38 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.321 0.648 . . . . 60.54 112.476 -161.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 175.98 137.11 0.19 Allowed Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 72.13 108.938 -168.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.39 122.89 10.18 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.459 1.44 . . . . 51.1 109.531 165.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.29 -63.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 122.086 -0.383 . . . . 74.3 111.504 -168.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -158.14 166.5 32.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.473 -0.936 . . . . 74.34 108.473 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -66.29 -27.76 68.18 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.232 0.469 . . . . 73.2 111.396 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.2 72.44 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.945 0.498 . . . . 71.21 111.458 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.87 -45.73 84.8 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.25 0.62 . . . . 74.3 110.667 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.545 HG21 HG23 ' A' ' 79' ' ' THR . 85.0 mt -59.33 -36.76 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.685 -0.689 . . . . 74.22 110.573 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -68.81 -31.96 71.33 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.676 0.39 . . . . 73.31 111.608 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.53 -50.1 41.16 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.528 0.331 . . . . 73.22 111.44 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -62.58 -38.44 90.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.081 0.4 . . . . 72.43 112.081 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.59 -36.16 77.85 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.935 0.894 . . . . 73.33 111.255 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -69.36 -44.02 72.43 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.67 0.788 . . . . 72.54 110.907 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -42.78 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.551 0.741 . . . . 70.35 110.831 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.429 HD11 ' HE1' ' A' ' 73' ' ' TYR . 31.5 tp -65.51 -33.29 75.58 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.364 1.065 . . . . 71.21 112.438 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.41 -46.35 17.72 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.019 0.528 . . . . 63.13 112.322 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.8 p -70.45 -45.16 66.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.99 0.916 . . . . 74.24 111.843 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -110.6 -68.79 0.9 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.228 0.611 . . . . 71.15 111.914 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.89 -170.33 28.57 Favored Glycine 0 C--N 1.356 1.688 0 C-N-CA 121.691 -0.29 . . . . 73.12 113.792 -175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 69' ' ' LEU . 8.6 tp -65.82 -39.2 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.925 0.89 . . . . 71.12 112.637 -173.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -65.69 -33.57 76.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.946 0.498 . . . . 75.52 111.861 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.87 -34.63 51.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.606 0.762 . . . . 54.25 110.425 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.78 -51.98 65.0 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.273 1.029 . . . . 54.5 111.174 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.88 -51.88 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.937 0.895 . . . . 52.42 110.867 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -48.29 -47.78 36.25 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.675 0.79 . . . . 44.23 112.288 171.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -33.54 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.569 0.747 . . . . 72.13 112.337 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.59 -57.99 4.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.955 0.502 . . . . 73.43 110.895 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 60' ' ' GLU . 94.3 t -63.77 -35.85 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 113.847 1.054 . . . . 73.54 113.847 -166.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -108.62 36.27 2.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 75.15 112.101 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.4 p -84.02 171.26 13.11 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.163 0.506 . . . . 63.12 110.789 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -69.56 -31.53 69.77 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.01 0.91 . . . . 70.25 110.339 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -69.81 -36.2 75.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.425 1.49 . . . . 63.52 111.596 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -76.22 -37.66 57.45 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.994 0.518 . . . . 70.41 110.958 173.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.15 -61.09 2.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.811 0.844 . . . . 74.42 112.577 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.56 -38.71 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.722 0.296 . . . . 72.23 111.72 -168.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.03 -44.36 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.639 0.775 . . . . 61.11 111.657 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -101.68 -45.64 5.19 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.042 0.537 . . . . 74.34 112.174 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.19 20.04 63.52 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-O 119.715 -0.492 . . . . 63.54 113.906 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 8.5 pt-20 57.08 -1.81 0.05 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.903 2.186 . . . . 71.35 116.903 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -93.04 -17.5 23.78 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.315 0.646 . . . . 73.24 111.433 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 t -108.99 162.42 14.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.439 0.696 . . . . 75.5 112.339 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.21 136.96 89.09 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.706 -1.133 . . . . 65.41 108.401 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.78 88.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.548 2.165 . . . . 61.31 112.179 173.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -70.24 107.88 3.92 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.395 -0.82 . . . . 72.53 108.896 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -45.44 112.62 0.47 Allowed 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.062 -0.972 . . . . 63.41 111.718 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.655 HH11 ' HA ' ' A' ' 92' ' ' ARG . 34.1 mtp-105 -84.17 13.53 5.11 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.957 0.903 . . . . 74.44 112.062 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 88.6 m-85 -90.94 115.67 64.79 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 124.342 1.057 . . . . 54.43 110.743 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 139' ' ' PHE . 33.4 Cg_endo -62.63 -32.97 78.99 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.999 2.466 . . . . 70.2 112.743 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.5 t -78.95 170.53 16.55 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.922 0.889 . . . . 45.42 111.614 175.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 80.7 mt 68.44 20.76 8.44 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 124.796 1.239 . . . . 73.42 112.341 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.35 -26.33 66.52 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.908 1.283 . . . . 72.41 112.181 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -51.67 -26.4 9.08 Favored 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 125.031 1.332 . . . . 73.22 114.555 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.7 p80 46.19 117.42 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.002 0 C-N-CA 126.591 1.956 . . . . 74.42 115.235 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.501 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 49.6 m-70 -75.28 132.31 40.94 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.914 1.079 . . . . 73.03 113.914 -167.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -101.42 162.9 12.56 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.782 1.233 . . . . 74.5 109.625 164.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -149.33 127.01 11.69 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.137 0.575 . . . . 74.42 110.355 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.4 t60 . . . . . 0 N--CA 1.481 1.093 0 C-N-CA 123.695 0.798 . . . . 51.15 109.984 178.155 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 112.088 0.403 . . . . 62.24 112.088 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -114.77 161.69 17.84 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.33 0.652 . . . . 63.12 112.212 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.1 t -126.71 124.91 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.175 0.99 . . . . 62.22 109.107 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -83.29 124.21 30.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.332 0.587 . . . . 72.02 111.168 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.21 173.77 16.36 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.847 1.259 . . . . 74.11 109.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.616 ' NH2' ' HA2' ' A' ' 51' ' ' GLY . 81.4 mtp180 -102.5 116.21 32.16 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.57 0.7 . . . . 71.01 111.315 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.4 2.62 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.977 0 C-N-CA 125.345 1.458 . . . . 62.4 111.004 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 78.58 -67.47 0.17 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.406 1.882 . . . . 61.41 110.369 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 49.28 4.12 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.036 0.374 . . . . 64.43 114.036 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 6' ' ' ARG . 66.6 mt -72.99 -53.4 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.256 0.622 . . . . 75.12 110.11 172.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 65.7 -65.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.348 1.459 . . . . 73.25 112.094 -171.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 16' ' ' ILE . 32.1 t70 -44.68 133.96 5.71 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.966 1.706 . . . . 73.22 115.588 -173.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.28 -25.38 39.47 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 112.93 -1.941 . . . . 73.24 112.545 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -70.84 -51.46 26.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 64.03 111.444 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.24 -50.64 58.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.73 1.011 . . . . 74.14 113.73 167.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 12' ' ' ASP . 43.8 mm -56.84 -43.05 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.852 0.686 . . . . 63.22 112.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 2.7 pptp? -67.14 -30.47 70.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 112.512 0.56 . . . . 63.21 112.512 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 m -70.57 -49.4 48.31 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.14 0.495 . . . . 70.42 111.022 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -44.54 -46.49 9.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.821 -1.081 . . . . 73.54 111.805 165.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.9 -36.19 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.341 1.056 . . . . 71.25 112.353 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -61.71 -49.01 78.17 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.261 0.624 . . . . 54.53 111.668 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.34 88.96 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.138 0.575 . . . . 63.14 111.827 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.67 -31.17 15.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.684 -1.144 . . . . 74.23 112.596 171.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.88 -48.15 17.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.888 0.475 . . . . 65.21 111.766 168.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -55.8 -28.36 55.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.355 1.613 . . . . 72.13 115.355 -167.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -86.68 -41.64 14.03 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.097 0.408 . . . . 64.12 111.274 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.588 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -75.8 -57.25 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.537 0.735 . . . . 62.42 111.221 -173.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.446 ' HB3' HH11 ' A' ' 30' ' ' ARG . 93.2 m-85 -78.91 -6.38 56.03 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.095 0.558 . . . . 75.12 111.94 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 54.87 37.67 29.02 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 125.425 1.49 . . . . 65.32 112.927 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.446 HH11 ' HB3' ' A' ' 28' ' ' PHE . 10.0 ptp85 -155.0 151.73 28.83 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.275 0.559 . . . . 55.34 112.247 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.04 100.94 2.1 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.149 -0.932 . . . . 62.22 109.427 165.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.3 mt -81.11 126.53 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 110.044 -0.354 . . . . 72.43 110.044 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.38 132.45 94.17 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.814 0.846 . . . . 45.23 111.035 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.81 -33.03 98.27 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.999 2.466 . . . . 75.23 113.368 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -69.17 -21.71 63.97 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.956 0.724 . . . . 65.41 112.956 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -81.99 -48.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.152 0.581 . . . . 74.04 109.884 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 -32.02 71.99 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.073 0.949 . . . . 55.03 113.182 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -76.6 -19.19 58.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.849 0.46 . . . . 73.22 111.747 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -80.15 -47.1 15.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.223 0.609 . . . . 63.34 111.251 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -85.5 -59.82 2.21 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.889 0.376 . . . . 65.01 111.725 -171.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -93.15 41.55 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.565 0.746 . . . . 74.54 112.535 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.9 t -66.68 -50.8 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.523 0.729 . . . . 70.15 112.058 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.2 -28.6 57.94 Favored Glycine 0 N--CA 1.477 1.374 0 CA-C-N 115.777 -0.647 . . . . 33.12 113.051 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -65.3 -25.12 67.49 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.237 1.015 . . . . 75.53 112.259 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.66 -45.27 75.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.65 0.78 . . . . 73.2 110.824 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -57.45 -30.92 65.41 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.02 0.928 . . . . 33.14 112.575 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -73.58 -35.74 65.47 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.473 0.309 . . . . 55.45 111.687 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.2 tp -73.38 -60.94 2.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.282 0.845 . . . . 74.3 113.282 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.59 -36.67 76.71 Favored Glycine 0 C--N 1.358 1.772 0 CA-C-N 118.622 0.646 . . . . 73.32 114.377 -171.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -59.98 -16.59 31.68 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.89 0.876 . . . . 63.2 113.347 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.616 ' HA2' ' NH2' ' A' ' 6' ' ' ARG . . . 103.04 5.17 47.37 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 114.635 0.614 . . . . 72.44 114.635 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.2 -63.99 1.03 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.187 0.493 . . . . 72.41 111.991 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -85.06 -142.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-N 116.025 -0.534 . . . . 73.31 111.259 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.433 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 3.3 t -170.43 152.16 3.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 73.13 108.916 -165.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.05 -31.49 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 112.603 0.594 . . . . 65.2 112.603 -171.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -76.38 -44.0 38.26 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.097 -0.377 . . . . 73.21 111.183 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.84 -22.18 66.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.49 0.716 . . . . 71.33 111.435 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -74.29 -46.21 42.64 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.427 -1.323 . . . . 73.01 107.427 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 27' ' ' ILE . 54.0 mt -70.92 -30.78 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 113.46 -1.7 . . . . 64.12 113.318 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -63.93 -46.81 83.11 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 122.819 0.448 . . . . 73.31 110.536 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.87 -35.54 47.93 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 114.617 0.607 . . . . 72.34 114.617 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -69.11 -26.18 64.78 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.165 0.586 . . . . 74.51 111.526 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.07 -23.94 58.41 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 116.078 -0.51 . . . . 53.23 113.09 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.447 ' HE1' ' HB ' ' A' ' 116' ' ' ILE . 3.6 m-30 -86.0 5.7 32.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.787 0.835 . . . . 73.02 110.955 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.1 t -85.46 129.84 34.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.484 0.713 . . . . 63.13 110.41 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.661 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 23.5 p-10 -62.77 -16.13 56.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.995 0.739 . . . . 72.32 112.995 -175.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 43.1 tp -61.5 -59.7 4.84 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.013 0.525 . . . . 74.1 110.681 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.8 -36.94 65.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.949 0.722 . . . . 73.53 112.949 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.661 ' HB2' ' HA ' ' A' ' 66' ' ' ASN . 4.2 mm? -63.95 -30.51 71.58 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.349 0.87 . . . . 63.03 113.349 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -92.02 -40.59 11.01 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.718 -0.614 . . . . 63.41 112.189 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 10.3 pt-20 -78.04 -54.69 5.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.097 1.147 . . . . 74.23 114.097 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -83.89 -59.06 2.53 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.115 0.871 . . . . 74.22 113.076 171.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.523 ' HE1' HD21 ' A' ' 107' ' ' LEU . 61.6 t80 -55.67 -46.63 77.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.213 1.19 . . . . 72.34 114.213 -166.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.8 m -71.03 -55.96 6.05 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.445 0.906 . . . . 73.52 113.445 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.02 -28.32 19.39 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.931 1.754 . . . . 64.3 112.999 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.418 ' HD1' ' HG2' ' A' ' 80' ' ' LYS . 91.0 m-85 -94.06 140.96 23.06 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 122.822 0.449 . . . . 72.22 110.77 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.525 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.4 Cg_exo -54.29 146.11 52.24 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.088 2.525 . . . . 31.31 113.515 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -30.48 -46.69 0.08 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 123.62 0.768 . . . . 43.43 112.934 156.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.498 ' HA ' HD12 ' A' ' 82' ' ' ILE . 21.4 m -70.59 -23.84 62.65 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.334 0.654 . . . . 73.22 112.601 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HG2' ' HD1' ' A' ' 76' ' ' TYR . 53.5 tptt -91.14 -28.32 17.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.19 0.519 . . . . 74.2 110.382 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 77' ' ' PRO . 84.7 t -62.86 -27.51 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.791 0.836 . . . . 71.43 110.038 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 79' ' ' THR . 81.5 mt -65.88 -47.52 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.098 0.959 . . . . 54.25 112.626 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HG3' ' H ' ' A' ' 84' ' ' LEU . 7.2 pt-20 -78.51 -57.8 3.58 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.908 0.322 . . . . 73.23 110.818 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.546 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 97.0 mt -43.85 -31.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.774 1.398 . . . . 74.42 114.774 161.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.33 -49.72 8.07 Favored Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.855 -0.498 . . . . 73.1 111.855 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.692 HG23 HD12 ' A' ' 90' ' ' LEU . 88.3 m -59.88 -31.55 69.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.673 1.189 . . . . 65.2 112.277 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -75.84 -57.16 4.04 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.598 -0.689 . . . . 55.1 111.486 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.7 m170 -50.9 -30.58 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.979 1.474 . . . . 74.41 114.979 172.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -101.52 -68.62 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.233 0.827 . . . . 72.35 113.233 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.692 HD12 HG23 ' A' ' 86' ' ' THR . 66.0 mt -71.42 -28.36 63.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.853 0.686 . . . . 73.33 112.853 -173.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.99 33.63 20.44 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 122.94 0.15 . . . . 50.33 112.788 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.82 -177.05 6.13 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.172 0.989 . . . . 73.44 110.782 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.19 165.42 13.9 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.532 0.733 . . . . 75.14 109.74 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.75 173.73 4.38 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.272 1.982 . . . . 61.11 111.973 169.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 mt -119.04 -86.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 121.127 0.489 . . . . 73.34 109.992 -167.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -88.63 172.41 9.31 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.961 -1.125 . . . . 51.44 107.961 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 2.8 tp-100 -74.9 -10.1 59.17 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 121.441 1.928 . . . . 74.14 109.59 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.75 84.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.851 0.86 . . . . 73.35 110.563 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.8 -54.11 46.4 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.903 0.881 . . . . 72.14 110.289 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.419 ' HA ' HG21 ' A' ' 82' ' ' ILE . 75.6 mt -64.71 -36.17 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-N 114.818 -1.083 . . . . 73.14 112.275 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.545 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 70.3 mtp180 -74.54 -38.84 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.851 0.46 . . . . 63.42 109.913 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.35 -56.44 18.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.233 -0.894 . . . . 73.21 110.921 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -61.49 -52.74 63.24 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.387 0.514 . . . . 73.44 112.387 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -43.73 -48.23 7.97 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 115.394 -0.821 . . . . 53.44 112.676 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -73.3 -41.03 64.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.856 0.462 . . . . 71.22 111.705 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.9 mt -59.83 -55.18 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 124.081 0.952 . . . . 75.21 111.637 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.523 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.3 tt -50.98 -53.14 35.78 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.038 0.935 . . . . 50.15 112.204 170.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.35 78.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.44 0.533 . . . . 72.53 112.44 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.0 p -68.31 -53.03 27.03 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.109 0.781 . . . . 71.0 113.109 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -101.53 -62.32 1.27 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.654 0.782 . . . . 74.0 112.262 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -172.8 31.8 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.97 0.348 . . . . 73.33 113.97 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.429 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.2 tp -68.74 -33.71 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.903 0.881 . . . . 72.11 112.209 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -65.07 -55.86 16.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.701 0.4 . . . . 73.53 110.69 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -50.1 -30.93 12.05 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 114.713 -1.131 . . . . 73.32 113.451 168.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -75.67 -42.9 49.92 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.272 0.629 . . . . 74.32 112.201 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.447 ' HB ' ' HE1' ' A' ' 64' ' ' TYR . 46.3 mm -72.52 -52.3 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.01 0.524 . . . . 72.34 109.718 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -43.63 -38.24 2.96 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.7 1.2 . . . . 72.41 113.112 166.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.85 76.61 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.021 0.528 . . . . 63.05 112.404 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.402 ' O ' HD21 ' A' ' 90' ' ' LEU . 78.1 mt -83.99 -59.9 2.27 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.603 0.761 . . . . 74.34 110.841 176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 t -44.95 -50.89 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.584 1.554 . . . . 65.02 113.216 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -100.3 17.47 21.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.402 0.519 . . . . 62.54 112.402 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.9 p -74.03 164.15 26.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.951 -0.759 . . . . 54.31 108.951 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -72.41 -22.51 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.965 -0.46 . . . . 71.43 111.669 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.46 -53.31 44.57 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.335 0.494 . . . . 64.03 112.335 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -61.6 -40.46 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.153 -0.684 . . . . 65.31 109.153 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -57.93 -42.7 85.38 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.164 0.986 . . . . 71.2 112.69 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.99 -47.38 11.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.773 -0.579 . . . . 71.11 112.013 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.4 -41.38 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.925 0.49 . . . . 72.42 111.987 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 36.9 m-85 -116.01 -68.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.822 0.449 . . . . 73.14 110.669 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.51 -127.56 9.13 Favored Glycine 0 C--N 1.347 1.139 0 C-N-CA 123.227 0.442 . . . . 73.44 112.403 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -88.86 -73.12 0.51 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.41 0.684 . . . . 73.1 111.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 36.0 m-20 -102.35 66.6 0.99 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.548 0.69 . . . . 65.24 112.835 -171.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.9 m -148.32 124.43 10.76 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.043 -0.981 . . . . 75.54 109.495 173.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.68 138.23 83.08 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.251 0.62 . . . . 72.42 109.936 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.458 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 52.4 Cg_exo -53.6 89.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 123.152 2.568 . . . . 70.21 113.319 173.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -73.19 169.26 17.43 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.17 -0.923 . . . . 62.55 111.456 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -59.87 93.29 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.211 -0.904 . . . . 74.43 112.047 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -77.75 -26.73 50.11 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.351 0.596 . . . . 55.25 109.961 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -95.61 149.49 36.16 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.235 1.014 . . . . 73.12 109.593 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.75 2.55 4.57 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.749 2.299 . . . . 72.31 113.949 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.0 p 53.86 57.98 5.51 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.449 1.5 . . . . 64.11 111.699 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.11 81.04 6.45 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.229 -0.896 . . . . 71.11 111.706 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -130.55 103.15 6.47 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.398 1.079 . . . . 62.13 108.765 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -72.52 -22.0 61.1 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.215 0.606 . . . . 74.3 112.174 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -61.08 112.83 2.25 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.999 0.519 . . . . 71.21 110.888 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -69.12 95.31 0.73 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 109.479 -0.563 . . . . 75.04 109.479 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -107.71 171.74 7.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.471 0.708 . . . . 73.32 111.27 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.98 165.79 19.35 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.026 0.931 . . . . 63.02 110.385 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 112.364 0.505 . . . . 65.24 112.364 -169.94 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.57 -0.159 . . . . 74.51 110.57 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -136.15 170.74 15.52 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.702 0.801 . . . . 72.04 110.804 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 t -78.92 -32.92 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.355 0 CA-C-N 115.574 -0.739 . . . . 64.44 109.393 165.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.67 -0.3 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 126.211 1.805 . . . . 70.04 113.196 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -47.32 113.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.284 1.433 . . . . 74.25 114.061 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.543 ' NH1' HD22 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -51.28 94.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.337 1.606 . . . . 75.32 115.337 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 8' ' ' ALA . 2.9 t -45.89 178.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.223 0 C-N-CA 126.046 1.738 . . . . 63.3 112.514 162.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.592 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -73.96 132.32 42.31 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 107.598 -1.26 . . . . 73.34 107.598 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -13.5 74.6 0.0 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 117.85 1.9 . . . . 64.45 117.85 -158.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -67.38 134.28 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.236 0.614 . . . . 63.54 110.679 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -83.33 -13.41 55.1 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.537 0.735 . . . . 71.43 112.523 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.92 112.47 18.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.924 0.489 . . . . 72.44 110.759 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.39 -10.88 37.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.438 0.695 . . . . 64.41 112.026 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.11 -51.44 13.45 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.439 0.638 . . . . 71.21 109.634 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.5 71.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.683 -1.144 . . . . 62.1 112.378 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 41.1 mm -78.25 -48.79 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.467 0.707 . . . . 74.35 110.783 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -67.4 -44.81 77.94 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.653 0.781 . . . . 51.12 113.008 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.3 m -63.37 -37.84 88.82 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.335 0.654 . . . . 70.31 111.889 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' NH1' ' A' ' 6' ' ' ARG . 11.4 tp -53.0 -51.56 61.24 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.747 -1.115 . . . . 70.44 110.103 169.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.85 -37.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.955 1.302 . . . . 70.34 113.121 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.1 p -69.19 -53.06 21.95 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.587 0.355 . . . . 71.55 111.149 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.417 ' HB1' HG11 ' A' ' 134' ' ' VAL . . . -59.86 -26.46 65.85 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 113.33 0.863 . . . . 71.42 113.33 171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.57 -33.88 74.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 123.473 0.483 . . . . 62.33 110.758 172.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -78.78 -49.21 13.39 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.691 . . . . 42.32 111.834 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.9 mtp85 -50.0 -26.07 3.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.842 1.793 . . . . 74.32 115.842 -168.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 -58.53 2.54 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 118.34 0.518 . . . . 51.15 110.239 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.47 -55.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.555 0.742 . . . . 72.52 110.5 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.89 -27.02 67.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.422 0.689 . . . . 74.22 112.594 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 67.63 32.44 5.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.615 1.198 . . . . 73.5 109.588 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.449 ' NH2' ' HG3' ' A' ' 71' ' ' GLU . 18.9 ptp180 -168.23 150.73 5.41 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.945 -1.48 . . . . 75.13 110.36 -173.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.22 108.89 5.61 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.822 -0.627 . . . . 74.2 110.286 165.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.05 133.03 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.946 -0.761 . . . . 75.23 108.946 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.25 138.1 95.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.837 -0.601 . . . . 63.43 110.6 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.61 -43.09 23.33 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.839 3.026 . . . . 75.21 114.992 -170.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -70.11 -32.9 71.16 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 112.764 0.653 . . . . 74.1 112.764 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -72.85 -42.31 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.269 0.628 . . . . 53.03 110.953 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.48 -36.35 83.48 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.247 0.619 . . . . 75.42 112.164 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 42' ' ' SER . 3.7 pt20 -79.4 -36.26 39.39 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.909 -0.587 . . . . 71.51 112.077 -176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -81.66 -43.87 17.95 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.223 0.823 . . . . 73.02 113.223 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.59 -60.33 2.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.757 0.423 . . . . 70.1 111.787 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -89.67 38.04 0.9 Allowed 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.651 0.982 . . . . 74.54 113.651 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' GLN . 90.7 p -72.08 -49.83 33.27 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.69 0.396 . . . . 71.21 111.326 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 47' ' ' LYS . . . -69.5 -27.4 73.53 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 123.259 0.457 . . . . 43.14 113.112 174.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -81.63 -39.38 24.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.221 1.009 . . . . 74.43 110.63 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.58 -29.29 67.8 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.337 0.655 . . . . 61.35 111.668 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -65.83 -36.54 83.76 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.665 0.786 . . . . 60.14 111.87 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 43' ' ' GLY . 26.9 mtpp -67.74 -37.85 82.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.912 0.885 . . . . 64.02 111.076 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.0 -37.56 75.73 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.95 0.9 . . . . 70.41 110.862 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.67 -28.68 68.77 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-N 115.988 -0.551 . . . . 23.24 113.753 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -87.84 4.47 44.42 Favored 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 124.173 0.989 . . . . 71.23 111.043 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 50.09 33.6 22.46 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 115.422 0.929 . . . . 34.01 115.422 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -71.29 -80.03 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.077 -0.712 . . . . 64.33 109.077 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -63.04 -164.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 113.962 1.097 . . . . 75.52 113.962 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.2 p -127.58 172.57 10.62 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.211 -1.403 . . . . 33.44 107.211 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.11 -32.39 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 O-C-N 121.833 -0.542 . . . . 75.31 110.039 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -64.72 -38.96 92.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.744 0.818 . . . . 74.44 111.584 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.28 -26.06 42.39 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.679 0.792 . . . . 74.03 109.654 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -62.2 -49.08 77.21 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.235 1.014 . . . . 73.33 110.306 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 ' HD3' ' A' ' 135' ' ' PRO . 96.7 mt -59.91 -28.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 125.202 1.401 . . . . 75.01 112.656 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.8 -42.02 96.78 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.472 0.709 . . . . 62.31 109.764 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.26 -23.61 58.57 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 114.501 0.56 . . . . 63.33 114.501 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.2 mt -68.91 -40.75 78.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.189 0.518 . . . . 54.51 110.147 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.33 -24.6 63.74 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-N 114.846 -1.07 . . . . 62.35 114.027 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -84.84 -12.68 53.02 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.691 0.796 . . . . 75.31 112.487 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -74.98 121.9 22.67 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.946 0.498 . . . . 65.33 111.19 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.23 -15.63 26.37 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.167 0.987 . . . . 64.12 113.503 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.5 tp -59.65 -61.35 2.69 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.209 0.458 . . . . 61.53 112.048 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -51.63 -38.78 56.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 112.771 0.656 . . . . 72.4 112.771 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 3.0 mm? -69.6 -26.59 64.52 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.245 0.831 . . . . 70.24 113.245 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.33 -49.28 72.34 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.756 -1.215 . . . . 73.41 108.994 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HG3' ' NH2' ' A' ' 30' ' ' ARG . 3.2 mm-40 -64.66 -56.89 10.9 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 114.333 -1.303 . . . . 51.24 112.73 172.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.06 69.34 0.72 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.68 0.993 . . . . 65.11 113.68 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 42.4 t80 -170.68 -56.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.013 1.325 . . . . 61.42 108.663 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.2 p -69.97 -39.7 11.46 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.469 1.285 . . . . 63.42 114.469 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.51 -42.61 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.928 0 CA-C-N 122.147 1.802 . . . . 74.24 112.632 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.46 147.67 82.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.546 1.138 . . . . 73.24 112.057 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.21 148.12 84.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.21 1.94 . . . . 62.24 111.55 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -52.38 -49.74 63.82 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.146 0.978 . . . . 71.21 112.807 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.464 ' HA ' HD12 ' A' ' 82' ' ' ILE . 59.7 m -51.71 -44.01 63.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.597 0.962 . . . . 74.24 113.597 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -65.04 -37.13 86.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.984 0.514 . . . . 70.22 111.837 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.29 -24.53 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 122.887 0.475 . . . . 63.32 111.286 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 79' ' ' THR . 90.6 mt -72.03 -54.31 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.208 0.603 . . . . 63.23 111.682 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.66 -23.54 67.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.241 0.544 . . . . 71.03 111.768 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tt -79.85 -45.75 18.11 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.777 1.231 . . . . 70.0 108.684 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.84 -54.26 29.38 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.001 -0.999 . . . . 61.4 114.358 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.58 ' HA ' HD13 ' A' ' 119' ' ' LEU . 34.6 p -54.64 -39.52 68.06 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.201 0.6 . . . . 71.12 112.145 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.05 -37.84 61.93 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 113.449 0.907 . . . . 62.35 113.449 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -88.05 13.68 10.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.617 0.969 . . . . 73.03 113.617 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.74 -69.75 0.51 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.577 0.751 . . . . 60.04 109.677 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.4 HD12 ' HB ' ' A' ' 86' ' ' THR . 78.5 mt -61.78 -19.91 63.01 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.472 1.109 . . . . 72.0 112.781 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.34 87.49 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 114.351 0.501 . . . . 52.43 114.351 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.42 174.92 14.68 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 123.299 0.64 . . . . 53.31 110.721 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.45 160.76 78.89 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 124.001 0.92 . . . . 51.24 111.321 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -55.44 -174.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.038 2.492 . . . . 65.41 114.486 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.55 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 68.5 mt -97.43 -24.34 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 75.21 110.333 -164.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 179.23 -174.86 0.22 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.222 1.409 . . . . 73.43 109.316 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -76.94 -35.06 57.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.665 0.386 . . . . 72.34 111.929 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.45 -35.03 75.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.85 0.46 . . . . 51.2 111.421 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.55 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 19.8 tp10 -57.58 -47.48 82.0 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.726 0.81 . . . . 75.02 110.558 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.11 -46.87 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 124.094 0.957 . . . . 64.34 112.022 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -67.57 -30.58 70.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.392 0.886 . . . . 73.31 113.392 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -53.75 -47.45 70.66 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.467 0.707 . . . . 74.4 110.865 166.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -78.23 -22.17 48.84 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.701 -1.136 . . . . 74.12 111.056 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -74.68 -41.96 59.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.651 1.181 . . . . 64.42 110.72 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -72.11 -49.85 32.86 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.77 0.828 . . . . 73.45 111.267 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 87.6 mt -56.86 -37.22 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 124.466 1.106 . . . . 73.44 111.679 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.06 -49.68 34.53 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.698 0.799 . . . . 74.14 110.953 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.37 95.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.722 0.809 . . . . 63.54 112.634 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.8 p -75.59 -65.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 74.34 112.459 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -87.6 -37.31 16.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.795 0.838 . . . . 75.42 112.953 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 173.51 13.2 Favored Glycine 0 C--N 1.346 1.132 0 C-N-CA 122.002 -0.142 . . . . 51.42 112.98 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 116' ' ' ILE . 9.9 tp -61.29 -30.66 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 123.158 0.583 . . . . 73.21 110.417 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -56.58 -40.48 75.3 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.533 1.133 . . . . 74.4 112.749 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.5 55.7 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.041 0.537 . . . . 71.22 111.386 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 57.9 t80 -65.12 -50.8 64.66 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.75 0.82 . . . . 73.22 110.324 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 112' ' ' ILE . 49.2 mm -59.78 -44.3 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.16 0.984 . . . . 65.42 110.943 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -56.89 -39.73 74.94 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.977 0.911 . . . . 65.33 111.889 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.2 77.72 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.324 0.65 . . . . 74.54 112.26 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 86' ' ' THR . 13.6 mt -79.76 -39.17 31.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.166 0.587 . . . . 74.52 110.937 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.45 -34.2 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.491 0.716 . . . . 62.0 111.176 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -99.7 22.89 10.31 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.368 0.667 . . . . 74.12 112.385 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.4 t -83.03 132.56 35.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.157 0.583 . . . . 65.31 110.773 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -44.34 -37.55 3.39 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.315 1.228 . . . . 71.34 114.315 170.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.33 -41.1 92.83 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-N 118.31 0.505 . . . . 72.41 111.322 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -73.79 -53.88 9.29 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.877 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -69.7 -27.59 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.045 0.757 . . . . 64.22 113.045 -172.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.51 -47.19 34.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.831 0.453 . . . . 74.43 112.169 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.9 -51.78 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.341 0.591 . . . . 62.33 111.273 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -77.1 -67.54 0.7 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.075 0.95 . . . . 72.51 111.12 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.61 -148.12 16.5 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.658 0.623 . . . . 23.31 114.658 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -114.89 -23.73 8.98 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.849 0.859 . . . . 70.32 111.841 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.76 -32.55 12.66 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.314 1.046 . . . . 64.32 113.65 -158.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -98.66 165.98 11.54 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.304 0.853 . . . . 70.33 113.304 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.518 HG23 HD12 ' A' ' 19' ' ' LEU . 6.6 t -83.51 142.27 42.92 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 124.164 0.986 . . . . 74.03 108.766 165.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HD3' HD11 ' A' ' 59' ' ' ILE . 34.6 Cg_endo -61.98 83.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.901 2.4 . . . . 54.5 113.32 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -68.55 136.06 52.51 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 114.08 -1.418 . . . . 70.23 108.711 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -71.64 120.19 16.87 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 108.392 -0.966 . . . . 73.22 108.392 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -52.59 -29.0 23.51 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 124.878 1.271 . . . . 75.33 112.61 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -119.91 143.84 36.1 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.784 1.234 . . . . 73.44 108.534 167.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.535 ' HG3' ' HA ' ' A' ' 146' ' ' HIS . 73.0 Cg_endo -79.44 38.21 0.72 Allowed 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 122.491 2.128 . . . . 72.21 113.598 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m 63.12 10.15 4.35 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 125.43 1.492 . . . . 63.31 112.319 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp 56.19 26.05 9.88 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 124.308 1.043 . . . . 72.25 111.857 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.71 -76.07 0.28 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.403 1.081 . . . . 65.52 110.336 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -145.84 165.57 28.48 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.019 1.328 . . . . 71.05 108.64 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 77.7 t60 60.2 57.7 2.87 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 121.778 0.799 . . . . 63.3 111.435 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 1.6 p-80 -67.36 107.03 2.27 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.886 -0.597 . . . . 74.31 109.774 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.98 86.19 0.71 Allowed 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 122.367 1.08 . . . . 62.31 112.575 -170.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -78.66 94.71 5.1 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.417 -1.265 . . . . 71.33 109.564 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 t60 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.172 0.511 . . . . 71.13 110.303 -174.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 120.593 0.235 . . . . 64.54 110.526 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -72.11 93.46 1.42 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.387 0.613 . . . . 63.33 110.21 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -91.34 114.14 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.593 0.757 . . . . 73.51 110.886 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -80.44 104.98 11.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.368 0.604 . . . . 73.14 110.123 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 133' ' ' THR . 19.6 ptmt -149.16 168.56 22.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.997 0.919 . . . . 71.05 110.144 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 ttp85 -119.4 106.64 12.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.729 -0.471 . . . . 70.43 109.729 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 8' ' ' ALA . 3.3 t -79.0 -149.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.959 0 C-N-CA 124.083 0.953 . . . . 61.21 109.13 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.615 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -85.43 -81.28 0.2 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 119.945 1.248 . . . . 55.4 109.767 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -32.29 -30.22 0.01 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.001 2.76 . . . . 62.51 120.001 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 7' ' ' VAL . 50.8 mt -64.99 105.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 119.855 1.828 . . . . 75.05 110.558 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -155.47 24.62 0.4 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.527 1.131 . . . . 73.43 108.756 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' O ' HG12 ' A' ' 16' ' ' ILE . 3.8 m-20 -100.01 142.72 31.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.141 1.376 . . . . 71.44 108.891 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.45 ' NZ ' ' HG2' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -67.0 -39.23 87.06 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 120.945 1.702 . . . . 74.4 112.631 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.54 66.49 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 122.367 1.08 . . . . 74.24 112.231 171.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB1' HG23 ' A' ' 10' ' ' ILE . . . -76.62 -38.92 53.91 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 112.978 -1.919 . . . . 70.54 111.071 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.62 HG13 ' HA2' ' A' ' 49' ' ' GLY . 51.0 mm -81.21 -39.62 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 N-CA-C 114.029 1.122 . . . . 62.22 114.029 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 28.1 mtpp -74.59 -50.86 16.29 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.109 -0.994 . . . . 72.22 111.347 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 m -49.12 -21.57 0.77 Allowed 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.124 -1.398 . . . . 62.32 113.168 164.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 16' ' ' ILE . 7.8 tt -81.43 -42.98 19.55 Favored 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 123.588 0.755 . . . . 74.31 110.659 169.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 16' ' ' ILE . 85.5 mt -75.18 -48.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 N-CA-C 116.494 2.035 . . . . 53.01 116.494 -171.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 24' ' ' TYR . 44.0 m -66.67 -39.24 88.09 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.702 1.239 . . . . 61.14 109.882 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.94 -28.23 22.58 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 111.58 -2.554 . . . . 71.11 111.708 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.39 24.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.719 0.808 . . . . 54.13 111.763 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CD2' ' HA ' ' A' ' 21' ' ' SER . 21.6 m-85 -68.98 -52.48 28.44 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 120.98 0.419 . . . . 74.2 110.914 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -46.98 -16.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.539 1.311 . . . . 75.05 114.539 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.518 HE22 ' HA ' ' A' ' 88' ' ' HIS . 13.0 tm0? -87.48 -61.16 1.78 Allowed 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.144 0.577 . . . . 72.11 109.627 166.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 59' ' ' ILE . 61.7 mt -78.15 -65.46 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 124.509 1.123 . . . . 73.2 113.119 -170.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 66.4 m-85 -74.87 -9.64 58.73 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.032 0.933 . . . . 62.22 112.476 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 76.33 -56.02 0.58 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.988 1.715 . . . . 70.44 112.914 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -84.07 156.33 22.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.95 0.9 . . . . 64.33 112.927 -165.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -62.84 120.01 10.48 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.569 -1.196 . . . . 75.25 109.717 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.4 mt -109.65 120.24 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.454 -1.684 . . . . 70.35 106.454 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 134.06 72.29 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 123.929 0.768 . . . . 61.32 112.06 -172.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.33 -31.02 36.02 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.811 3.007 . . . . 71.11 115.164 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -75.89 -39.05 57.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.722 0.409 . . . . 73.43 111.989 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -47.77 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 122.735 0.414 . . . . 71.2 110.205 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.06 79.19 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.111 0.964 . . . . 51.13 112.561 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -75.42 -25.03 57.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.252 0.464 . . . . 52.03 112.252 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.29 -47.56 15.65 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 117.987 0.358 . . . . 75.54 111.622 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -66.07 -51.21 60.18 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.469 0.708 . . . . 74.12 111.168 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.22 48.23 0.85 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.054 -0.976 . . . . 65.22 110.373 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -64.97 -51.88 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.246 0.462 . . . . 41.31 112.246 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -31.29 58.5 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.045 -0.525 . . . . 52.01 113.287 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -72.22 -50.96 23.36 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.254 0.622 . . . . 73.33 111.494 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HG2' ' NZ ' ' A' ' 13' ' ' LYS . 35.7 tt0 -50.36 -37.91 39.61 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.503 0.927 . . . . 74.3 113.503 165.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.6 m -65.82 -35.6 81.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.484 0.314 . . . . 74.13 111.495 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -65.08 -42.38 94.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.218 0.451 . . . . 74.3 112.218 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.77 -50.7 33.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 120.755 0.312 . . . . 73.34 111.056 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.62 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -50.58 -51.36 33.03 Favored Glycine 0 CA--C 1.545 1.909 0 N-CA-C 116.285 1.274 . . . . 54.31 116.285 174.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 2.2 m-20 -73.11 0.19 12.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.925 1.083 . . . . 73.31 113.925 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.33 26.29 67.74 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.745 0.658 . . . . 54.23 114.745 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.0 mm-40 -67.61 -29.94 69.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.941 0.896 . . . . 75.42 111.164 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.419 HD11 ' HD1' ' A' ' 58' ' ' PHE . 21.1 pt -132.77 156.67 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.518 1.127 . . . . 64.35 108.93 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 57' ' ' GLU . 10.2 t -82.04 166.86 19.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.028 -0.42 . . . . 73.43 110.738 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -61.79 -38.31 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.717 0.407 . . . . 43.4 111.172 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 57' ' ' GLU . 1.1 tmtp? -56.79 -58.79 6.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.604 1.162 . . . . 72.23 112.137 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.565 ' H ' HG23 ' A' ' 54' ' ' THR . 21.8 tt0 -50.1 -34.57 22.35 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 114.375 -1.284 . . . . 54.33 111.983 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.424 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 59.8 t80 -71.48 -38.03 71.26 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 123.399 0.68 . . . . 75.42 112.211 173.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 27' ' ' ILE . 22.4 mm -73.36 -50.24 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 124.731 1.213 . . . . 70.33 111.696 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.526 ' HB2' HG11 ' A' ' 120' ' ' VAL . 31.9 tt0 -51.02 -41.43 59.8 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.487 1.115 . . . . 72.5 110.878 163.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.21 -38.9 62.64 Favored Glycine 0 CA--C 1.55 2.219 0 CA-C-N 112.438 -2.164 . . . . 74.12 112.98 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 80.9 mt -77.15 -36.02 55.59 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.068 0.947 . . . . 54.33 112.328 176.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.68 -21.85 61.12 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 114.31 0.484 . . . . 64.52 114.31 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -77.44 -34.18 54.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.502 0.721 . . . . 71.24 111.831 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 t -48.04 140.55 6.9 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.473 1.286 . . . . 73.34 114.473 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -62.02 -30.09 70.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.696 1.199 . . . . 63.22 113.423 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 tp -69.43 -24.27 63.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.399 0.619 . . . . 73.32 111.593 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.92 -34.87 57.67 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.13 -0.941 . . . . 72.53 108.752 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 -51.31 20.05 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.882 -1.053 . . . . 71.14 113.697 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 12.7 ptpt -64.15 -55.66 20.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.995 2.18 . . . . 64.32 115.234 172.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -51.51 -22.69 3.35 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.629 1.714 . . . . 54.4 115.629 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -137.44 -19.62 1.22 Allowed 'General case' 0 N--CA 1.514 2.768 0 N-CA-C 116.939 2.2 . . . . 73.03 116.939 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.418 ' HA ' HG22 ' A' ' 81' ' ' VAL . 85.8 t80 -110.83 -37.49 5.4 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.512 1.051 . . . . 73.33 112.773 -176.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.9 m -71.52 -46.74 13.17 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 114.332 1.234 . . . . 73.34 114.332 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.4 Cg_endo -84.08 -15.02 6.97 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.784 2.323 . . . . 52.33 112.408 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.6 140.21 21.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.66 0.784 . . . . 71.54 110.91 -172.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.407 ' O ' HG23 ' A' ' 81' ' ' VAL . 46.2 Cg_endo -66.01 151.93 82.65 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.148 1.899 . . . . 73.03 111.447 171.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -45.74 -28.42 1.03 Allowed 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.859 1.264 . . . . 70.54 112.605 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 m -61.61 -52.67 63.43 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.502 -1.681 . . . . 71.12 109.87 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.419 ' HD2' ' HB3' ' A' ' 83' ' ' GLU . 55.2 tptt -73.83 -26.87 60.82 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.182 0.993 . . . . 64.11 113.232 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.515 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 62.8 t -66.13 -25.16 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 122.955 0.502 . . . . 64.32 111.271 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.517 HG22 ' HB3' ' A' ' 94' ' ' PRO . 46.3 mt -80.41 -28.53 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.164 0.985 . . . . 61.44 112.466 169.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 80' ' ' LYS . 6.0 tm-20 -76.85 -51.92 10.42 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.453 0.701 . . . . 75.31 109.43 -172.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 87' ' ' LYS . 93.9 mt -75.53 -15.09 60.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.561 1.144 . . . . 74.32 109.829 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . -82.05 -49.8 5.15 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.02 -0.991 . . . . 65.34 114.026 -158.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -73.3 -19.21 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.973 1.387 . . . . 51.03 110.577 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 91.8 mttt -62.18 -33.31 74.3 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.015 -0.993 . . . . 75.11 111.371 -167.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.518 ' HA ' HE22 ' A' ' 26' ' ' GLN . 66.5 m-70 -87.88 13.11 11.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.854 0.862 . . . . 65.42 113.031 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -138.74 -58.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.531 -1.285 . . . . 75.02 107.531 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HA ' HH12 ' A' ' 138' ' ' ARG . 0.2 OUTLIER -127.04 91.1 3.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.143 0.977 . . . . 73.2 108.978 164.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 87' ' ' LYS . . . -65.69 87.26 0.1 OUTLIER Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.656 -0.702 . . . . 75.43 113.015 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.523 ' HE ' HD12 ' A' ' 90' ' ' LEU . 4.4 ptp180 -143.31 24.46 1.77 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.925 0.49 . . . . 64.31 111.766 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.21 174.58 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.307 0.855 . . . . 72.31 113.307 -158.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 82' ' ' ILE . 61.5 Cg_endo -72.25 137.24 28.21 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.694 1.596 . . . . 62.22 110.518 161.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.92 -61.39 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.428 1.091 . . . . 70.44 112.134 -170.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -147.76 157.84 43.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.718 0.407 . . . . 71.42 111.005 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -63.25 -10.35 15.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.425 0.898 . . . . 64.42 113.425 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.96 -42.05 12.73 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.264 1.031 . . . . 71.34 108.389 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 102' ' ' LYS . 4.0 tm-20 -64.25 -32.47 74.07 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 113.759 -1.564 . . . . 74.55 111.62 170.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.88 -54.49 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 123.284 0.634 . . . . 61.24 110.024 173.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -46.55 -34.74 5.14 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 114.23 1.196 . . . . 54.41 114.23 167.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 31.6 ttpt -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.969 0.508 . . . . 74.43 112.035 175.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.15 -46.53 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.596 0.358 . . . . 74.44 110.607 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -44.86 -42.6 8.11 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.153 0.981 . . . . 74.42 112.962 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -64.88 -29.63 70.59 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.142 0.428 . . . . 72.14 111.777 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.9 mt -79.67 -57.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.086 -1.079 . . . . 70.14 108.086 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.6 tp -45.99 -35.0 4.38 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.422 1.638 . . . . 61.42 115.422 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.32 -21.57 53.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.032 0.752 . . . . 51.33 113.032 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.7 p -113.2 -14.46 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.093 0.557 . . . . 71.41 112.08 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -138.97 -51.8 0.55 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.692 0.797 . . . . 74.12 111.156 -170.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.86 169.85 13.68 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 114.258 0.463 . . . . 52.13 114.258 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' ' 115' ' ' PHE . 8.0 tp -37.74 -34.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.247 1.573 . . . . 72.53 115.247 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -53.39 -53.91 44.42 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.397 0.679 . . . . 74.41 111.508 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.34 37.65 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.543 -1.208 . . . . 63.11 112.033 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.403 ' HD2' HD12 ' A' ' 112' ' ' ILE . 31.0 t80 -50.64 -70.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.51 1.3 . . . . 75.34 114.51 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.44 -37.07 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 114.034 1.124 . . . . 63.02 114.034 170.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -67.14 -38.14 85.03 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.772 0.715 . . . . 74.31 111.218 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.19 -52.05 57.25 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 123.082 0.553 . . . . 75.44 111.806 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.2 mt -49.66 -54.55 17.92 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.445 0.906 . . . . 63.33 113.445 171.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 60' ' ' GLU . 89.9 t -69.11 -26.34 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 123.84 0.856 . . . . 72.32 112.694 -172.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -100.6 13.55 34.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.146 0.795 . . . . 71.41 113.146 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.3 m -66.92 151.01 48.4 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 122.863 0.465 . . . . 70.13 110.371 167.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.529 ' HG3' HD21 ' A' ' 126' ' ' ASN . 29.9 tt0 -72.0 -25.24 61.76 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.0 0.818 . . . . 73.41 110.524 -174.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.506 ' HB3' HH21 ' A' ' 92' ' ' ARG . 41.4 mt-10 -62.15 -36.11 80.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.877 0.871 . . . . 51.25 111.329 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -67.69 -40.3 84.38 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 109.995 -0.372 . . . . 75.52 109.995 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.529 HD21 ' HG3' ' A' ' 123' ' ' GLN . 1.5 p30 -68.6 -38.4 80.58 Favored 'General case' 0 C--N 1.366 1.311 0 CA-C-O 118.673 -0.679 . . . . 73.52 112.025 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -60.87 -56.88 15.92 Favored 'General case' 0 C--N 1.367 1.337 0 N-CA-C 115.257 1.576 . . . . 75.21 115.257 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.98 -35.84 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.348 0.594 . . . . 72.02 111.397 -162.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 44.2 m-85 -111.94 -45.35 3.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.517 -0.765 . . . . 55.53 110.688 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.62 -87.36 0.93 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.403 -1.479 . . . . 41.44 109.403 -162.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.25 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.134 0.973 . . . . 75.42 111.175 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -81.8 36.71 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.67 0.788 . . . . 70.02 112.385 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 5' ' ' LYS . 45.5 m -147.52 145.4 29.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.026 0.93 . . . . 75.22 110.051 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.05 132.83 82.2 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 108.65 -0.87 . . . . 74.42 108.65 172.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 38.1 Cg_endo -62.0 81.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.598 2.199 . . . . 44.44 113.447 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -59.81 145.85 43.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.006 0.522 . . . . 62.55 111.18 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.462 ' NH1' ' HA ' ' A' ' 141' ' ' THR . 10.6 ttp180 -70.49 118.06 12.81 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.398 0.679 . . . . 75.54 110.848 -173.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.594 HH12 ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -65.31 -18.15 65.08 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.652 1.181 . . . . 74.25 113.315 -173.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -122.79 140.16 32.64 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.412 0.685 . . . . 61.53 111.288 -175.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.17 -31.14 27.69 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.587 2.858 . . . . 75.33 113.974 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.462 ' HA ' ' NH1' ' A' ' 137' ' ' ARG . 8.8 t -145.48 141.25 28.16 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.259 0.552 . . . . 73.42 111.966 172.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.5 mt -129.49 140.63 51.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.307 1.043 . . . . 63.22 108.859 171.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -69.38 95.26 0.78 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.119 0.568 . . . . 72.53 111.735 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -153.4 127.75 9.21 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.349 -0.841 . . . . 71.34 109.912 171.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -70.16 172.75 7.56 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.312 0.645 . . . . 71.13 111.146 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -100.91 151.5 21.67 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.265 0.626 . . . . 74.21 110.762 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -86.15 -26.44 25.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.778 0.831 . . . . 64.24 111.695 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 67.07 -68.16 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.076 1.35 . . . . 72.51 111.305 -172.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 N--CA 1.48 1.06 0 C-N-CA 124.187 0.995 . . . . 71.4 111.383 176.755 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 110.546 -0.168 . . . . 71.12 110.546 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -160.64 -40.71 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.535 0.334 . . . . 63.34 111.316 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t 48.82 86.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 124.642 1.177 . . . . 52.12 112.307 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -71.4 132.75 45.26 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.994 0.518 . . . . 75.31 110.101 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -152.6 159.84 43.22 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.502 . . . . 63.54 112.017 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.7 100.03 12.03 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.548 -0.908 . . . . 71.32 108.548 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.436 ' H ' HD12 ' A' ' 10' ' ' ILE . 98.0 t -78.38 141.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.614 -0.514 . . . . 72.51 109.614 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.99 93.07 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.359 0.664 . . . . 64.01 111.845 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.15 2.01 6.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 119.457 -0.635 . . . . 72.33 114.462 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 7' ' ' VAL . 35.2 mt -79.88 82.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.673 1.236 . . . . 73.44 109.951 172.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -107.03 13.22 27.76 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.02 -0.991 . . . . 72.33 110.077 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.85 116.5 22.78 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.547 1.139 . . . . 73.14 109.076 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.34 -24.11 63.86 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.925 1.083 . . . . 75.12 113.925 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.95 -31.18 70.73 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.077 0.465 . . . . 63.35 111.06 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -50.21 13.94 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.645 -0.707 . . . . 72.3 110.698 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.2 mm -55.65 -45.45 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.406 1.082 . . . . 61.13 113.191 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.55 -39.54 91.44 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 111.988 0.366 . . . . 74.41 111.988 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 m -62.74 -41.13 99.05 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.394 0.677 . . . . 75.53 112.053 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.491 HD23 HD21 ' A' ' 48' ' ' LEU . 20.6 tp -61.78 -44.7 96.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.368 0.667 . . . . 74.4 111.086 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.16 -41.32 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.666 1.186 . . . . 72.44 111.147 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.6 m -62.94 -53.02 60.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.387 0.675 . . . . 54.25 111.287 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.62 82.16 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.714 0.806 . . . . 72.45 112.539 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.86 -42.93 72.64 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.123 0.569 . . . . 42.21 111.357 173.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.34 -43.72 85.33 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.278 0.631 . . . . 64.03 111.979 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -68.21 -13.2 62.06 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.334 0.654 . . . . 55.44 112.308 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -89.77 -63.13 1.33 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.771 0.428 . . . . 71.14 111.386 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -65.12 -57.78 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 122.662 0.385 . . . . 64.21 110.727 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -83.04 -13.05 56.58 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.291 0.636 . . . . 75.24 112.252 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 65.58 -53.44 0.36 Allowed 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.367 1.467 . . . . 72.44 114.108 -168.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -57.57 128.76 38.66 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.203 1.001 . . . . 71.32 113.022 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.0 120.31 13.42 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.117 -0.947 . . . . 75.14 109.515 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.79 126.7 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.378 -0.601 . . . . 74.44 109.378 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.34 135.23 96.15 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 123.649 0.593 . . . . 62.45 109.991 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 -35.1 86.82 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.409 2.739 . . . . 74.13 114.14 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -69.73 -38.8 77.01 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.484 0.314 . . . . 75.11 111.437 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.423 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 71.4 mt -63.05 -41.73 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.547 0.739 . . . . 71.1 110.269 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -53.22 59.77 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.084 -0.962 . . . . 41.31 111.855 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.6 -11.44 59.87 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.954 1.464 . . . . 70.21 114.954 -172.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 36' ' ' ILE . 8.4 p30 -81.66 -45.21 16.09 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.875 1.216 . . . . 64.42 110.797 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.77 -46.27 14.46 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.804 0.841 . . . . 74.14 111.609 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -105.8 44.3 1.05 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 124.657 1.183 . . . . 64.44 109.755 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -51.67 66.88 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.818 0.673 . . . . 60.42 112.818 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.05 -30.88 64.82 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.625 -0.716 . . . . 61.01 112.569 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.41 ' CZ2' ' HA3' ' A' ' 61' ' ' GLY . 13.8 t-105 -72.58 -42.05 65.02 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.305 1.042 . . . . 75.33 111.701 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.85 -50.44 73.43 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.443 1.097 . . . . 64.02 110.777 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.1 t -59.61 -43.79 93.63 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.014 -0.994 . . . . 62.03 111.786 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HG2' HG12 ' A' ' 53' ' ' ILE . 25.2 ttmm -58.83 -46.5 87.54 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.755 1.222 . . . . 54.44 112.553 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.491 HD21 HD23 ' A' ' 19' ' ' LEU . 48.4 tp -64.56 -44.71 89.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.778 0.431 . . . . 75.32 111.278 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.73 -39.97 98.16 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 116.36 -0.382 . . . . 62.32 113.863 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -79.96 6.49 11.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.109 0.964 . . . . 73.22 112.915 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.35 32.55 68.32 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 114.595 0.598 . . . . 72.23 114.595 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.14 -26.53 42.8 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.155 0.582 . . . . 74.42 109.531 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.409 HG12 ' HG2' ' A' ' 47' ' ' LYS . 40.5 pt -134.76 170.14 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 124.282 1.033 . . . . 74.22 110.764 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.6 p -95.58 -176.57 3.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.388 0.675 . . . . 71.1 109.637 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 59' ' ' ILE . 80.0 t -65.89 -45.81 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 119.27 -0.395 . . . . 73.31 110.927 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 51.0 tttm -47.43 -52.65 16.27 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.807 1.04 . . . . 72.23 113.807 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.72 -37.17 85.47 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.672 0.389 . . . . 61.43 111.707 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 50.7 t80 -61.22 -43.27 99.15 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.66 0.784 . . . . 71.42 111.124 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 55' ' ' VAL . 34.9 mm -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.829 1.252 . . . . 64.32 111.247 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -52.18 -45.48 65.14 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.597 0.759 . . . . 72.13 112.061 172.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' HA3' ' CZ2' ' A' ' 44' ' ' TRP . . . -62.84 -36.79 93.87 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.266 -0.425 . . . . 75.21 113.324 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 46.2 mt -64.69 -44.11 91.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.378 0.671 . . . . 73.54 111.551 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.39 -34.74 86.43 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 115.447 0.939 . . . . 74.34 115.447 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -74.71 -23.13 58.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.29 0.545 . . . . 75.54 112.011 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -55.85 134.44 51.88 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.502 0.926 . . . . 72.52 113.502 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -60.65 -26.2 66.88 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.269 1.028 . . . . 73.2 112.092 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.18 -39.53 93.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.964 0.506 . . . . 72.14 111.1 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -69.33 -39.25 78.28 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.19 0.519 . . . . 74.34 110.56 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD11 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -64.74 -31.19 72.3 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.655 -0.702 . . . . 74.14 112.132 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -75.23 -46.34 34.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.865 0.466 . . . . 75.51 111.287 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -82.68 -46.31 13.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.804 0.668 . . . . 74.42 112.804 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.56 48.64 1.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 112.772 0.656 . . . . 64.32 112.772 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 74.6 t80 -159.68 -48.37 0.05 Allowed 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 116.082 -0.508 . . . . 75.13 110.88 171.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 m -66.02 -47.28 63.36 Favored Pre-proline 0 CA--C 1.573 1.848 0 N-CA-C 112.815 0.672 . . . . 62.13 112.815 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -90.08 11.07 2.87 Favored 'Trans proline' 0 C--N 1.395 2.993 0 C-N-CA 122.638 2.225 . . . . 75.02 113.202 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.0 141.26 38.97 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 122.988 0.515 . . . . 72.12 111.861 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.29 158.24 58.32 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.501 2.134 . . . . 75.43 111.384 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -51.54 -41.99 61.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.573 0.582 . . . . 74.52 112.573 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.9 m -54.14 -42.85 70.0 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.514 0.726 . . . . 53.12 111.536 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -74.92 -33.17 61.94 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.061 0.545 . . . . 70.32 112.019 178.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.09 -31.96 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.231 0.539 . . . . 75.52 110.921 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.58 -49.73 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.795 0.838 . . . . 64.44 111.008 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 80' ' ' LYS . 13.4 pt-20 -71.18 -35.47 71.6 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 111.588 0.218 . . . . 64.22 111.588 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.94 -44.53 26.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.314 0.645 . . . . 71.31 110.99 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.38 -49.86 58.82 Favored Glycine 0 N--CA 1.475 1.265 0 O-C-N 123.292 0.37 . . . . 75.43 113.639 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.599 HG23 HD13 ' A' ' 90' ' ' LEU . 86.7 m -55.73 -40.39 72.41 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 123.033 0.533 . . . . 73.25 110.632 171.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -71.33 -21.77 62.0 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 123.075 0.55 . . . . 74.31 111.434 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 67.2 m170 -87.29 -8.57 56.59 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.03 0.932 . . . . 71.01 112.363 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.8 -61.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.389 1.076 . . . . 74.45 108.88 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.599 HD13 HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -110.08 84.74 1.98 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.359 -1.348 . . . . 62.44 107.359 176.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.53 78.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 114.896 0.718 . . . . 51.51 114.896 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.632 HH12 HD11 ' A' ' 95' ' ' ILE . 27.8 mtm105 -137.94 151.43 47.96 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.375 1.07 . . . . 74.4 111.089 -174.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 132.02 85.85 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-N 115.471 -0.786 . . . . 62.21 110.748 168.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.27 135.91 46.28 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.31 2.673 . . . . 70.02 113.824 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.632 HD11 HH12 ' A' ' 92' ' ' ARG . 49.6 mm -82.69 -69.12 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.495 0.718 . . . . 75.43 112.76 -170.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -147.81 156.58 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.583 0.753 . . . . 72.12 109.073 -165.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -58.44 -40.31 82.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.954 0.724 . . . . 75.22 112.954 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.63 71.78 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.248 0.462 . . . . 43.53 112.248 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -65.7 -40.32 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.613 0.765 . . . . 75.33 110.919 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.03 -50.44 64.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.533 0.733 . . . . 73.21 110.968 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.2 mmm180 -52.05 -40.85 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.537 1.135 . . . . 72.04 112.386 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.417 ' O ' HG13 ' A' ' 106' ' ' ILE . 35.7 ttpt -56.39 -52.68 63.73 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.76 0.824 . . . . 71.53 111.194 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -72.24 -36.79 69.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.795 0.438 . . . . 74.45 112.167 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -64.47 -40.83 96.43 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.956 0.902 . . . . 65.34 111.296 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.6 -28.93 68.17 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.466 -0.788 . . . . 70.33 111.015 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 102' ' ' LYS . 82.2 mt -63.19 -39.14 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 122.991 0.516 . . . . 61.3 110.526 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.96 -39.92 96.11 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.836 0.454 . . . . 72.43 111.602 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.21 -37.32 53.63 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.716 0.635 . . . . 54.23 112.716 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.0 p -80.93 -60.15 2.41 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.193 0.597 . . . . 71.33 112.493 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -103.04 -36.23 8.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.0 0.92 . . . . 72.34 112.801 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.4 -162.01 12.51 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 122.847 0.261 . . . . 63.21 113.315 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.437 HG12 HD11 ' A' ' 69' ' ' LEU . 9.5 tp -79.69 -29.14 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.111 0.564 . . . . 75.44 111.476 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.434 ' H ' ' HD3' ' A' ' 113' ' ' ARG . 0.8 OUTLIER -59.64 -49.42 77.82 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.384 0.673 . . . . 74.4 110.381 -175.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -33.3 73.88 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.128 -0.942 . . . . 74.3 112.738 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.21 -52.29 66.3 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.234 0.613 . . . . 73.52 111.328 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.83 -45.68 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.666 0.786 . . . . 72.34 110.718 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -57.94 -35.68 71.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.166 0.986 . . . . 72.12 111.387 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -67.55 -48.37 67.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.128 0.571 . . . . 73.12 111.387 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' A' ' 90' ' ' LEU . 82.0 mt -58.31 -44.74 88.73 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.617 0.767 . . . . 62.5 112.554 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.8 t -68.17 -52.19 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.079 0.952 . . . . 71.44 111.954 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.81 24.06 4.4 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.291 0.636 . . . . 60.24 112.155 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 19.6 t -79.53 155.4 28.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.577 0.751 . . . . 72.11 112.275 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -59.98 -52.58 64.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.691 0.796 . . . . 65.51 110.952 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.94 -30.84 66.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.852 0.861 . . . . 73.14 112.595 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -71.45 -54.26 11.23 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.218 0.207 . . . . 75.45 111.098 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -69.48 -34.3 74.13 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.961 0.726 . . . . 75.22 112.961 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.57 -42.58 58.51 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 111.682 0.252 . . . . 63.1 111.682 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.81 -54.79 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.289 0.636 . . . . 75.22 111.857 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.488 ' HE2' ' H ' ' A' ' 136' ' ' TYR . 52.9 m-85 -88.41 -49.29 7.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.164 0.986 . . . . 63.34 110.832 -176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 93.25 -118.91 5.77 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.218 -0.447 . . . . 71.42 112.546 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -141.31 -23.18 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.858 0.863 . . . . 74.22 111.615 176.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -84.13 -23.54 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.558 0.577 . . . . 62.0 112.558 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.2 m -93.74 138.09 32.31 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.277 0.473 . . . . 72.11 112.277 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.18 136.34 75.92 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.851 0.86 . . . . 73.1 109.678 168.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -34.77 111.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.586 3.524 . . . . 62.34 115.5 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.488 ' H ' ' HE2' ' A' ' 129' ' ' PHE . 52.9 p90 -120.23 147.06 45.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.395 0.678 . . . . 75.02 110.88 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -75.08 124.34 26.83 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.978 -0.555 . . . . 74.32 109.516 167.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -86.44 52.74 2.58 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.455 1.121 . . . . 55.12 109.861 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -144.61 140.83 16.94 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.231 1.012 . . . . 73.32 109.864 -173.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.83 18.73 1.23 Allowed 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.814 2.343 . . . . 75.25 113.995 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.0 p 55.97 24.31 7.55 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 125.466 1.506 . . . . 74.54 113.49 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.1 mt 56.54 48.84 15.86 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.97 0.908 . . . . 74.32 111.237 -173.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 56.85 15.47 2.27 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 126.099 1.76 . . . . 74.43 113.717 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -61.02 -42.97 99.48 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.95 0.5 . . . . 62.41 111.77 -172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -137.15 103.57 5.16 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.676 0.75 . . . . 75.53 110.892 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -116.91 111.74 20.06 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.275 1.03 . . . . 73.43 109.125 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 74.75 -39.73 0.42 Allowed 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.58 1.552 . . . . 71.55 112.28 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -63.53 103.62 0.55 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.207 1.003 . . . . 63.3 110.097 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 121.235 0.54 . . . . 74.42 111.532 -175.842 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.723 0.296 . . . . 71.02 110.388 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -92.19 57.19 3.0 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.305 1.05 . . . . 72.24 110.391 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.93 -21.91 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-N 114.66 -1.155 . . . . 73.43 110.893 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 70.15 29.14 3.83 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.193 1.397 . . . . 70.15 112.845 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.25 145.89 24.14 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.855 -0.528 . . . . 71.32 109.597 170.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -78.26 101.23 7.03 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.564 -0.532 . . . . 74.12 109.564 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.02 113.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.29 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.144 0.978 . . . . 75.13 112.608 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.58 -18.02 4.4 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 115.436 -0.802 . . . . 53.33 114.267 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.43 104.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 117.903 0.852 . . . . 71.53 111.162 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -86.54 -38.22 17.41 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 73.3 111.406 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.01 102.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.78 1.232 . . . . 71.33 113.894 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.612 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 68.5 mttt -67.77 -9.19 41.9 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.542 -0.754 . . . . 75.42 112.54 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.04 -39.6 79.1 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.561 0.744 . . . . 75.52 110.91 163.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.64 43.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.745 0.818 . . . . 63.34 110.991 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 1.7 mp -58.0 -39.81 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.079 0.951 . . . . 75.32 110.827 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -64.71 -49.88 69.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.999 0.52 . . . . 62.22 111.467 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -54.39 -42.36 70.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.166 0.802 . . . . 75.2 113.166 172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 48' ' ' LEU . 9.6 tt -58.27 -48.41 80.53 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.171 0.988 . . . . 74.14 110.893 173.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.69 -43.24 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.386 1.074 . . . . 75.11 111.379 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.3 m -63.75 -48.68 76.04 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.347 0.659 . . . . 55.43 111.012 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.82 57.77 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.327 0.862 . . . . 74.2 113.327 170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.15 72.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.259 0.837 . . . . 45.11 113.259 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -72.96 -48.1 39.63 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.588 0.755 . . . . 75.25 111.227 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.4 ttm180 -51.02 -36.88 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.223 1.009 . . . . 60.01 113.668 172.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.21 -63.68 1.27 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.8 0.44 . . . . 44.02 110.576 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.458 HD11 HG13 ' A' ' 59' ' ' ILE . 61.2 mt -65.32 -48.4 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.913 0.885 . . . . 70.32 112.452 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -84.35 9.63 12.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.258 0.623 . . . . 72.41 111.628 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 49.95 19.87 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 125.922 1.689 . . . . 70.03 115.183 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -164.12 143.51 7.75 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.416 0.626 . . . . 65.54 111.604 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.2 111.21 2.86 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.008 -0.996 . . . . 53.12 111.042 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.2 mt -78.89 134.89 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 116.105 -0.498 . . . . 72.24 109.968 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 123.8 52.98 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 124.254 0.971 . . . . 72.41 110.649 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -54.15 -37.84 87.47 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.526 2.817 . . . . 62.53 114.069 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -67.85 -24.91 65.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.663 0.785 . . . . 73.15 113.07 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.36 -44.45 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.213 0.605 . . . . 53.32 110.681 171.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.18 80.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.064 0.945 . . . . 65.45 112.195 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -72.55 -25.26 61.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.982 0.513 . . . . 65.42 111.833 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.31 -47.23 18.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.667 0.787 . . . . 62.41 110.977 -170.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.2 -32.89 59.22 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.633 -0.712 . . . . 72.41 110.764 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.37 43.08 1.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.902 0.881 . . . . 73.42 111.07 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -68.61 -43.91 75.39 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.163 0.585 . . . . 75.14 112.433 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.89 -26.89 61.52 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.844 -0.502 . . . . 42.32 111.844 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -82.21 -30.85 30.62 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.088 0.955 . . . . 75.11 110.483 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -68.79 -41.58 78.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.95 0.9 . . . . 73.41 108.862 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 t -57.09 -35.65 69.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.62 0.768 . . . . 71.4 111.92 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -42.6 99.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.9 0.48 . . . . 72.54 111.279 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 19' ' ' LEU . 49.2 tp -73.24 -36.07 66.36 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.736 0.815 . . . . 55.41 111.503 177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.7 -48.42 12.78 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 123.313 0.482 . . . . 63.1 113.153 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -78.26 3.15 16.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.744 0.646 . . . . 74.04 112.744 172.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.4 34.09 67.58 Favored Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.727 0.651 . . . . 74.22 114.727 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -68.46 -28.34 66.96 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.509 0.724 . . . . 73.44 111.58 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 pt -130.03 170.42 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.365 1.066 . . . . 72.14 110.362 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p -90.8 164.35 14.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.206 0.602 . . . . 62.14 110.258 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.73 -41.23 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.612 0.365 . . . . 74.11 110.46 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 87.0 tttt -41.78 -55.59 2.97 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.253 1.205 . . . . 73.43 114.253 162.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -66.07 -26.79 67.66 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.921 -0.581 . . . . 74.02 111.777 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -72.99 -38.36 66.68 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.166 0.986 . . . . 74.12 110.801 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.458 HG13 HD11 ' A' ' 27' ' ' ILE . 1.2 mp -73.41 -45.17 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.972 1.309 . . . . 73.21 111.829 -174.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.527 ' HB2' HG11 ' A' ' 120' ' ' VAL . 32.6 tt0 -50.28 -35.92 29.24 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.69 0.626 . . . . 74.21 112.69 165.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.45 -26.95 74.05 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-N 115.93 -0.577 . . . . 73.55 112.439 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -74.04 -48.34 30.64 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.999 0.92 . . . . 64.13 111.2 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.69 -31.65 45.82 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 116.308 1.283 . . . . 41.41 116.308 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -72.44 -17.86 61.75 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 117.472 0.636 . . . . 73.35 112.119 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -75.4 131.87 40.5 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.395 0.678 . . . . 53.24 111.368 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -61.03 -18.95 60.54 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.73 0.812 . . . . 73.42 112.808 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 32.3 tp -61.71 -41.14 97.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.608 0.763 . . . . 64.23 111.189 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.07 -37.16 86.63 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.042 0.448 . . . . 71.33 111.308 172.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD11 HG21 ' A' ' 112' ' ' ILE . 4.2 mm? -70.99 -30.11 66.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.883 0.873 . . . . 71.03 112.722 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -77.58 -25.02 49.65 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 122.133 -0.354 . . . . 61.55 110.59 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 22.4 mm-40 -75.49 -56.27 4.87 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.561 172.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -130.08 70.35 1.44 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.775 0.657 . . . . 54.33 112.775 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.41 ' H ' ' HD2' ' A' ' 75' ' ' PRO . 52.0 t80 -176.04 -61.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.493 0.717 . . . . 75.22 110.53 174.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -65.16 -38.46 28.29 Favored Pre-proline 0 CA--C 1.573 1.849 0 N-CA-C 113.961 1.097 . . . . 61.21 113.961 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 73' ' ' TYR . 43.2 Cg_endo -94.73 17.41 0.89 Allowed 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 121.987 1.791 . . . . 72.25 113.674 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -137.46 153.42 74.46 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 123.857 0.863 . . . . 71.44 111.372 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.94 153.56 63.43 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.226 1.951 . . . . 64.45 111.551 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -46.81 -54.32 10.1 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.329 1.233 . . . . 72.35 114.329 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -49.2 -32.68 10.86 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 113.956 1.095 . . . . 75.35 113.956 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -74.89 -27.63 60.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.882 0.473 . . . . 73.43 111.196 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.75 -30.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.761 0.824 . . . . 71.52 111.755 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 100' ' ' ILE . 2.0 mp -67.44 -43.78 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.004 0.521 . . . . 65.13 110.884 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.42 -26.04 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.095 -0.502 . . . . 54.14 111.846 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.6 mt -85.38 -31.17 23.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.635 0.774 . . . . 54.11 111.771 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.99 -54.75 12.61 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 116.218 -0.447 . . . . 64.11 112.435 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.644 HG23 HD12 ' A' ' 90' ' ' LEU . 47.8 m -57.64 -30.63 65.55 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.308 1.043 . . . . 54.32 111.464 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.41 -38.4 77.91 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.854 0.862 . . . . 72.44 111.819 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -94.27 -1.48 53.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.147 1.166 . . . . 73.42 114.147 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -123.36 -57.92 1.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.061 0.391 . . . . 72.33 111.69 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.644 HD12 HG23 ' A' ' 86' ' ' THR . 60.8 mt -84.12 -12.72 54.56 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.302 0.241 . . . . 72.54 111.389 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.56 11.16 56.26 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 116.2 -0.455 . . . . 72.32 113.551 -173.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -104.92 135.17 46.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.977 0.911 . . . . 53.51 111.547 -167.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.92 158.4 70.5 Favored Pre-proline 0 CA--C 1.565 1.531 0 CA-C-N 115.383 -0.826 . . . . 41.33 111.386 169.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.87 161.59 0.48 Allowed 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.043 2.495 . . . . 71.25 113.961 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.16 -75.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.771 -0.825 . . . . 73.23 108.771 -160.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -141.04 153.24 45.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.257 1.423 . . . . 73.02 107.437 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.26 -14.44 49.41 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.905 1.229 . . . . 53.32 113.618 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.37 -31.27 21.58 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.21 -1.033 . . . . 62.21 108.21 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.52 -39.53 77.48 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.289 1.436 . . . . 70.32 111.114 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.412 ' HA ' HG21 ' A' ' 82' ' ' ILE . 87.8 mt -64.02 -52.8 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.244 0.618 . . . . 62.43 110.264 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -55.26 -31.22 61.37 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.213 1.005 . . . . 75.31 113.514 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.27 -49.35 74.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.548 0.339 . . . . 74.52 110.818 173.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -68.27 -39.66 82.12 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.971 0.509 . . . . 73.52 111.29 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -58.76 -42.77 89.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.39 1.076 . . . . 73.45 112.463 172.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -62.39 -27.39 69.05 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.25 0.62 . . . . 74.02 111.958 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.04 -60.33 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 108.798 -0.816 . . . . 61.34 108.798 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 115' ' ' PHE . 22.8 tp -41.96 -31.97 0.39 Allowed 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 115.658 1.725 . . . . 64.32 115.658 160.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.19 -41.47 25.19 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 119.176 0.898 . . . . 73.42 112.317 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.2 p -97.79 -22.97 16.1 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.024 0.75 . . . . 54.23 113.024 -172.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -126.36 -38.07 2.15 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.426 0.69 . . . . 75.34 112.113 -171.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.61 174.33 14.0 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 113.986 0.354 . . . . 62.05 113.986 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -67.66 -29.6 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.051 0.94 . . . . 73.01 110.62 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -54.67 -53.0 60.57 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.629 0.772 . . . . 74.51 111.371 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.24 -29.03 70.15 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.973 0.909 . . . . 64.23 113.153 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 55.3 t80 -67.76 -49.51 62.08 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.407 0.683 . . . . 71.42 111.106 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -59.37 -46.34 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.586 0.754 . . . . 55.4 110.414 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -56.67 -40.45 75.55 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.715 0.806 . . . . 51.13 112.345 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.64 93.22 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.262 0.625 . . . . 34.5 112.119 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' ' 90' ' ' LEU . 83.6 mt -72.6 -55.74 6.42 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.303 0.641 . . . . 75.04 111.816 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 60' ' ' GLU . 88.7 t -61.66 -42.6 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.57 0.748 . . . . 71.22 112.412 -173.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -82.75 -0.47 47.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.294 0.85 . . . . 71.23 113.294 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -66.95 158.02 31.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.015 0.526 . . . . 73.02 111.913 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -65.12 -25.99 68.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.823 0.849 . . . . 61.23 110.628 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.55 ' HB2' HD22 ' A' ' 90' ' ' LEU . 42.6 mm-40 -62.89 -48.35 79.38 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.201 1.0 . . . . 71.23 111.671 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -68.46 -46.33 70.06 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.437 0.637 . . . . 73.43 110.013 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.74 -52.03 64.83 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.468 -1.242 . . . . 74.05 112.32 -165.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.49 -42.65 19.96 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.467 0.914 . . . . 71.23 113.467 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.07 -49.16 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.252 0.621 . . . . 73.2 112.5 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -96.15 -53.98 3.46 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 120.991 0.424 . . . . 74.53 111.195 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.7 144.3 13.51 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.853 -0.612 . . . . 35.24 111.581 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 16.3 pt-20 -74.84 -19.5 60.15 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.768 0.655 . . . . 73.44 112.768 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.01 -6.91 59.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.698 0.799 . . . . 73.13 111.84 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 m -116.2 149.74 38.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.433 0.693 . . . . 72.24 112.244 -167.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 141.51 97.42 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.728 0.811 . . . . 61.22 109.563 166.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.441 ' HD3' HG12 ' A' ' 59' ' ' ILE . 38.8 Cg_endo -65.3 77.36 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.587 2.192 . . . . 41.12 112.726 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -76.64 85.77 3.3 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.654 -0.869 . . . . 73.1 108.654 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -52.87 94.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.535 1.16 . . . . 72.33 111.542 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -83.34 1.34 41.73 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 113.382 -1.735 . . . . 65.01 112.877 -160.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.53 129.96 91.05 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 124.181 0.993 . . . . 74.11 110.713 -177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.89 -5.17 7.06 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.723 2.949 . . . . 73.11 115.488 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -62.28 -23.61 66.81 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.128 0.971 . . . . 74.1 113.032 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.77 -10.86 18.78 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.016 0.747 . . . . 61.02 113.016 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.11 86.77 1.37 Allowed 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.71 0.767 . . . . 71.45 111.193 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -106.79 12.39 29.09 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 124.419 1.088 . . . . 74.51 110.433 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -130.71 177.34 7.47 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.459 1.104 . . . . 73.1 110.965 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -67.61 104.21 1.55 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.385 0.674 . . . . 61.2 111.26 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -150.94 117.01 5.57 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.557 0.743 . . . . 51.43 109.257 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -65.95 99.34 0.48 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.216 0.606 . . . . 64.13 111.691 -173.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.5 t60 . . . . . 0 N--CA 1.486 1.325 0 C-N-CA 123.545 0.738 . . . . 65.13 110.283 -177.829 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 111.771 0.285 . . . . 62.4 111.771 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.693 ' HE3' ' HA ' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -74.39 98.62 3.31 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.149 0.5 . . . . 73.54 110.665 -179.263 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p -112.31 -12.97 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.531 0 C-N-CA 124.201 1.0 . . . . 64.41 111.435 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 63.8 86.13 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.038 1.335 . . . . 64.21 112.059 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -127.48 170.75 12.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.664 1.186 . . . . 72.35 110.803 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -116.27 94.29 4.58 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.877 -0.602 . . . . 74.22 110.121 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.64 141.85 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.927 -0.768 . . . . 65.52 108.927 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.54 -20.65 0.46 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.86 1.8 . . . . 64.14 115.86 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.32 -103.7 0.86 Allowed Glycine 0 C--N 1.368 2.34 0 CA-C-N 120.155 1.343 . . . . 40.01 110.519 166.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm 41.29 49.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 125.431 1.492 . . . . 70.34 111.945 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -64.63 13.38 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 114.918 1.451 . . . . 62.14 114.918 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.98 113.08 17.88 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.867 0.841 . . . . 73.43 110.551 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -28.15 64.51 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.714 -1.585 . . . . 74.35 109.368 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.26 71.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.519 1.127 . . . . 53.13 111.08 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.09 67.86 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.072 0.767 . . . . 72.1 113.072 171.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 20' ' ' ILE . 45.7 mm -54.09 -54.45 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 112.794 0.664 . . . . 71.2 112.794 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 20' ' ' ILE . 15.5 ptpt -66.04 -30.89 71.5 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.934 0.716 . . . . 72.23 112.934 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -70.33 -48.79 54.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.23 0.612 . . . . 73.21 111.431 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.77 -43.21 8.39 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.187 0.995 . . . . 63.34 112.446 167.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 16' ' ' ILE . 66.4 mt -66.13 -35.83 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.496 0.718 . . . . 72.4 111.454 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -67.05 -41.7 86.06 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.182 0.593 . . . . 73.3 112.089 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.33 91.7 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.059 0.544 . . . . 64.42 111.983 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.48 9.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.368 -1.287 . . . . 42.14 112.166 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.13 -47.06 19.03 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.92 0.488 . . . . 73.1 112.067 167.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -68.25 -15.71 63.68 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.176 0.99 . . . . 72.32 112.391 -171.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -95.57 -35.55 11.6 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.655 -0.653 . . . . 71.43 111.592 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 50.2 mm -87.67 -66.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.147 0.579 . . . . 70.35 111.014 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.48 -17.89 64.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.284 0.634 . . . . 72.44 111.274 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' ARG . 23.2 tt0 62.65 31.33 16.8 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.535 1.534 . . . . 74.13 112.276 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -152.37 156.55 39.78 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.807 -0.633 . . . . 71.24 111.776 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.93 108.44 8.81 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.81 -1.086 . . . . 65.21 109.166 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.51 135.24 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 109.352 -0.61 . . . . 73.51 109.352 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.15 118.04 21.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.73 0.812 . . . . 74.45 111.075 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -47.74 -39.92 31.11 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.847 3.031 . . . . 74.03 114.56 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -67.99 -39.37 83.29 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 112.904 0.705 . . . . 75.14 112.904 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -67.07 -44.27 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.326 0.584 . . . . 55.44 110.542 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.58 82.85 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.27 1.028 . . . . 72.14 112.698 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -82.0 -23.82 35.78 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 116.317 -0.402 . . . . 54.01 110.765 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -75.48 -35.38 60.86 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.103 0.561 . . . . 73.22 111.483 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.6 -61.96 1.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.645 0.736 . . . . 75.54 110.996 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.8 43.79 1.07 Allowed 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 115.348 -0.842 . . . . 72.44 112.814 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.15 -51.88 33.71 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.074 -0.391 . . . . 62.41 112.014 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.96 -34.54 33.52 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.136 -0.484 . . . . 62.21 111.959 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -66.88 -39.85 87.63 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.89 0.876 . . . . 74.3 112.822 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.08 -28.7 63.48 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.164 0.586 . . . . 75.02 110.583 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -53.63 -31.41 47.2 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.451 0.7 . . . . 74.14 112.026 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.94 -44.35 66.29 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.984 0.514 . . . . 71.33 111.125 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.5 tp -65.54 -57.76 7.42 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 112.738 0.644 . . . . 61.22 112.738 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.92 -49.34 35.84 Favored Glycine 0 C--N 1.362 2.0 0 N-CA-C 115.246 0.858 . . . . 71.04 115.246 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -67.79 20.07 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 115.207 1.558 . . . . 73.51 115.207 171.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.4 19.75 0.1 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 118.633 2.213 . . . . 41.23 118.633 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -62.2 -54.72 36.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 118.476 1.138 . . . . 71.32 111.079 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 pt -108.15 140.17 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.137 -1.392 . . . . 71.51 110.467 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.0 p -69.15 169.96 11.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.792 0.437 . . . . 73.45 111.604 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.69 -24.35 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.51 0 CA-C-N 116.006 -0.543 . . . . 74.15 111.323 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -68.4 -53.13 25.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.603 1.161 . . . . 54.32 110.965 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.8 -21.81 65.21 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.83 0.852 . . . . 72.1 111.57 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.19 -43.81 40.78 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.238 -1.023 . . . . 74.34 108.238 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.3 mt -66.18 -28.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 113.696 -1.593 . . . . 64.51 112.098 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -58.21 -50.9 71.93 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.832 -0.433 . . . . 65.14 109.832 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.37 65.05 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 114.743 0.657 . . . . 74.01 114.743 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -73.44 -33.3 64.84 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.136 0.575 . . . . 72.23 111.014 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.66 -12.11 78.4 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 115.669 -0.696 . . . . 63.34 112.405 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -97.7 11.74 36.08 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.575 1.15 . . . . 72.12 111.199 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.1 p -99.48 126.97 45.51 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.34 -0.615 . . . . 53.02 109.34 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -57.94 -15.6 9.36 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.458 0.703 . . . . 65.31 112.777 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.08 -59.35 3.87 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.038 0.935 . . . . 73.5 111.726 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -49.38 -48.85 46.58 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.292 1.219 . . . . 73.02 114.292 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 112' ' ' ILE . 3.2 mm? -62.32 -21.28 65.15 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.072 0.767 . . . . 52.41 113.072 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -76.14 -42.19 47.56 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.522 -0.918 . . . . 73.04 108.522 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.2 -64.11 1.21 Allowed 'General case' 0 C--N 1.371 1.519 0 CA-C-N 118.984 0.811 . . . . 75.0 111.846 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 84' ' ' LEU . 23.1 m-85 -100.76 61.59 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.276 1.213 . . . . 74.21 114.276 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.531 ' HD1' HG21 ' A' ' 81' ' ' VAL . 31.2 t80 -171.73 -57.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 122.979 0.511 . . . . 64.24 112.099 168.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.6 m -59.14 -44.13 98.13 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 113.053 0.76 . . . . 61.23 113.053 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -96.5 16.83 0.72 Allowed 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.442 2.095 . . . . 73.3 113.945 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.55 144.02 51.22 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 112.588 0.588 . . . . 72.24 112.588 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.88 145.27 31.75 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.199 1.932 . . . . 64.23 112.637 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -21.92 -60.58 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.848 1.795 . . . . 63.52 115.848 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' HD12 ' A' ' 82' ' ' ILE . 18.5 m -66.03 -20.27 66.13 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.347 0.976 . . . . 74.11 113.099 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.57 -33.1 16.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.759 -1.2 . . . . 73.42 107.759 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.531 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.4 t -69.53 -29.06 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.578 -1.192 . . . . 42.54 110.106 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 79' ' ' THR . 90.0 mt -65.56 -43.08 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.262 0.625 . . . . 75.34 110.182 170.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.79 -65.14 0.77 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 117.575 0.171 . . . . 75.32 111.005 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.461 HD13 ' CD1' ' A' ' 72' ' ' PHE . 96.6 mt -49.06 -30.94 6.96 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.529 1.678 . . . . 70.34 115.529 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.33 -56.67 3.35 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 118.247 0.476 . . . . 73.05 112.77 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.482 HG23 HD12 ' A' ' 90' ' ' LEU . 86.6 m -60.17 -39.24 85.76 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.045 0.938 . . . . 73.32 112.734 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 87' ' ' LYS . 29.7 ttmt -71.82 -6.17 39.65 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.283 1.033 . . . . 75.15 113.49 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 55.9 m170 -100.69 -32.78 10.56 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.21 -1.033 . . . . 75.34 108.21 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -96.72 -66.72 0.89 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.944 1.298 . . . . 74.11 110.358 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 86' ' ' THR . 52.6 mt -73.74 -13.78 61.02 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.538 0.335 . . . . 75.34 111.71 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.53 -19.29 4.01 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 115.874 1.11 . . . . 53.25 115.874 168.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.21 -174.25 2.51 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 117.593 0.697 . . . . 74.54 110.21 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.15 152.87 44.5 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 121.722 -0.611 . . . . 61.12 110.151 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.01 153.52 8.72 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 C-N-CA 122.966 2.444 . . . . 72.11 114.901 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.4 mt -78.62 -64.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.314 0.487 . . . . 74.21 112.314 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -114.46 -146.96 0.41 Allowed 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 104.598 -2.371 . . . . 75.11 104.598 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -97.5 -18.17 19.17 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-N 123.644 2.929 . . . . 73.51 108.655 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.565 0.746 . . . . 65.34 111.663 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.67 -42.3 70.92 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.802 0.441 . . . . 74.13 111.021 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.3 mt -59.87 -38.97 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.515 0.726 . . . . 74.24 110.494 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -72.87 -30.31 63.87 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.914 -1.039 . . . . 62.52 110.827 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -67.69 -51.39 50.08 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.8 0.84 . . . . 73.45 110.262 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -65.64 -42.52 91.37 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.115 0.566 . . . . 75.33 112.17 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -45.3 -44.58 11.62 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.054 0.942 . . . . 75.23 112.84 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -70.95 -44.42 66.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.183 0.593 . . . . 73.41 111.601 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 73.6 mt -53.04 -53.62 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.774 0.83 . . . . 74.5 111.122 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -52.82 -42.36 65.06 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.122 1.369 . . . . 72.12 113.057 172.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.08 -55.07 13.84 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.028 0.531 . . . . 71.31 112.065 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.2 p -62.93 -62.7 1.54 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.685 0.794 . . . . 73.44 113.125 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -98.96 -52.36 3.58 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.841 0.856 . . . . 71.12 112.595 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.51 -148.4 17.17 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 116.555 -0.293 . . . . 62.52 113.261 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 107' ' ' LEU . 10.1 mm -79.3 -35.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.246 1.018 . . . . 70.24 112.037 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -59.39 -65.96 0.59 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.769 0.319 . . . . 65.21 110.38 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -49.29 -20.91 0.71 Allowed 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.361 1.986 . . . . 62.22 116.361 165.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -73.64 -62.75 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.309 1.413 . . . . 62.12 110.078 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 120' ' ' VAL . 50.3 mm -47.1 -59.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.07 0.948 . . . . 75.13 112.93 170.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -40.68 -46.28 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.52 0.933 . . . . 72.25 113.52 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -63.74 -23.08 67.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.864 0.691 . . . . 75.5 112.864 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.36 -34.23 18.88 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.208 1.003 . . . . 71.32 111.205 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 116' ' ' ILE . 93.1 t -69.51 -60.44 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.349 1.06 . . . . 75.43 111.229 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -76.88 -5.4 48.29 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.219 0.608 . . . . 60.5 112.394 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 32.5 t -53.48 143.48 19.4 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.564 0.746 . . . . 75.1 111.25 173.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.81 -29.19 65.3 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.438 -0.578 . . . . 63.44 109.438 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.403 ' HB2' HD22 ' A' ' 90' ' ' LEU . 11.0 mm-40 -66.55 -48.82 68.48 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.089 0.956 . . . . 74.5 111.67 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.415 ' HB2' HD23 ' A' ' 90' ' ' LEU . 90.0 t80 -60.5 -48.26 82.54 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 120.838 0.351 . . . . 62.52 110.719 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.0 -27.28 68.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 115.301 -0.863 . . . . 74.25 112.197 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -91.55 -54.41 3.91 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.974 0.51 . . . . 60.12 112.355 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.19 -52.46 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.355 0.662 . . . . 64.42 111.924 -174.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.07 -41.6 9.46 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.167 0.587 . . . . 63.25 111.241 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.53 166.69 26.44 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.993 -0.549 . . . . 72.21 113.423 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.79 -33.11 60.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.418 0.687 . . . . 74.11 112.097 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -129.01 60.45 1.55 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.319 1.057 . . . . 72.24 110.458 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.3 m -153.74 145.71 23.6 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 114.128 -1.396 . . . . 73.45 108.868 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 82.9 t -68.07 134.28 91.68 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 123.567 0.747 . . . . 70.05 110.477 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.34 85.51 0.27 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.936 2.424 . . . . 44.22 111.542 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -58.13 161.61 4.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.595 1.158 . . . . 52.05 112.997 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -66.16 128.51 36.37 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.812 -1.086 . . . . 72.31 109.811 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 57.5 mmm-85 -80.4 26.92 0.36 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.767 0.827 . . . . 43.22 112.587 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -132.91 162.64 56.31 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.911 1.284 . . . . 72.14 109.69 -172.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.36 51.02 2.79 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.823 2.348 . . . . 54.15 113.924 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.9 p -116.56 -1.86 12.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.849 0.86 . . . . 74.31 111.834 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.18 -27.61 69.49 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.07 1.137 . . . . 73.4 114.07 -170.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.43 -7.72 27.49 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.158 0.983 . . . . 51.5 112.681 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -35.45 113.62 0.21 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 124.873 1.269 . . . . 74.25 114.263 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -64.62 128.77 37.18 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.935 0.894 . . . . 63.43 110.908 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -123.22 136.42 54.72 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.323 1.049 . . . . 74.42 110.998 -172.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -74.15 167.56 21.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.611 0.764 . . . . 62.14 111.84 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -88.95 133.93 34.14 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.546 -0.752 . . . . 74.12 110.779 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.8 t60 . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.711 0.804 . . . . 73.0 109.786 177.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.729 0.299 . . . . 75.22 110.63 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.74 110.83 21.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.269 0.557 . . . . 73.03 111.355 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.43 167.15 26.99 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.314 1.046 . . . . 60.01 109.088 169.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -85.72 117.06 24.37 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.778 0.431 . . . . 64.45 110.255 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 10' ' ' ILE . 61.7 t -89.08 136.99 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.194 -1.039 . . . . 53.33 108.194 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.11 82.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.313 0.578 . . . . 44.31 110.805 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.09 -18.75 0.4 Allowed Glycine 0 CA--C 1.536 1.367 0 CA-C-N 115.474 -0.785 . . . . 45.42 113.533 -172.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 7' ' ' VAL . 55.8 mt -73.69 88.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.016 0.908 . . . . 72.11 110.982 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -94.63 2.57 55.61 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.555 0.742 . . . . 73.24 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -79.88 121.02 24.9 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.284 0.634 . . . . 54.41 111.083 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -68.98 -26.76 65.19 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.703 0.401 . . . . 73.45 111.492 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.04 -48.81 64.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.285 0.634 . . . . 64.1 111.074 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.75 84.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.973 0.509 . . . . 74.54 111.596 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.525 HG13 ' HA2' ' A' ' 49' ' ' GLY . 29.3 mm -55.96 -49.6 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.601 0.76 . . . . 72.21 111.367 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -67.73 -27.85 67.14 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.269 0.47 . . . . 53.14 112.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.4 m -69.96 -40.09 75.61 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.197 0.522 . . . . 74.23 111.259 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.71 -39.4 84.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.49 1.116 . . . . 72.41 110.418 172.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 16' ' ' ILE . 92.6 mt -70.23 -40.62 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.529 1.132 . . . . 72.31 111.911 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.1 m -64.74 -38.71 91.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.158 0.583 . . . . 71.3 111.155 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.6 96.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.496 -0.775 . . . . 61.4 111.405 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.67 -30.76 70.94 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.539 0.736 . . . . 70.03 112.177 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.62 -48.76 75.99 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.813 0.445 . . . . 73.01 111.182 170.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -70.76 -15.12 62.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.064 0.546 . . . . 61.03 111.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -85.32 -53.62 5.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.183 0.593 . . . . 74.42 111.27 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.863 HD11 HG23 ' A' ' 59' ' ' ILE . 65.0 mt -82.35 -66.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.078 0.551 . . . . 53.11 111.353 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.492 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 22.7 m-85 -66.39 -14.56 62.3 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.955 0.902 . . . . 73.1 111.813 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 70.68 -50.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.025 1.73 . . . . 73.14 112.717 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -61.28 143.46 55.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.204 1.002 . . . . 45.22 113.273 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.55 114.32 9.5 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.614 -1.176 . . . . 73.23 108.779 162.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.4 mt -90.85 129.14 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.584 -0.524 . . . . 55.32 109.584 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.27 125.47 81.69 Favored Pre-proline 0 CA--C 1.557 1.214 0 O-C-N 123.951 0.782 . . . . 74.11 111.029 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.27 -32.21 32.15 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.751 2.968 . . . . 75.21 115.34 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -71.04 -29.55 65.49 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.191 0.441 . . . . 71.35 112.191 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.86 -44.83 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 122.749 0.42 . . . . 60.45 109.908 170.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.5 72.57 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.846 0.858 . . . . 61.54 112.619 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -79.87 -18.76 49.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.354 0.501 . . . . 74.22 112.354 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -80.47 -31.04 37.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 70.22 111.653 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.28 -55.44 3.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.045 0.538 . . . . 74.54 112.242 -174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -117.55 19.69 13.83 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.72 1.378 . . . . 71.23 114.72 -169.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.7 p -66.23 -30.2 70.6 Favored 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 120.554 1.525 . . . . 61.22 112.171 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.91 41.63 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.732 -0.667 . . . . 64.24 112.364 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -81.1 -31.51 34.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.81 1.244 . . . . 75.13 111.467 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -37.37 81.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.165 1.386 . . . . 75.25 111.765 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.6 p -59.01 -38.66 79.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.312 0.645 . . . . 72.04 112.024 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -63.17 -38.29 90.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.065 0.546 . . . . 73.15 111.897 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.51 HD11 HG22 ' A' ' 55' ' ' VAL . 42.4 tp -72.96 -42.94 62.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.702 0.287 . . . . 73.11 111.267 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.525 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -69.64 -35.43 74.3 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.357 -0.383 . . . . 70.33 113.904 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -92.58 -19.18 22.19 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.293 0.637 . . . . 73.13 111.314 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.06 19.33 26.63 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 115.783 1.073 . . . . 72.21 115.783 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.14 -29.55 67.62 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 118.226 1.013 . . . . 60.11 112.212 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.425 HD11 ' HD1' ' A' ' 58' ' ' PHE . 27.1 pt -120.68 169.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.322 0.649 . . . . 63.23 111.034 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 29.8 p -91.94 172.32 8.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.828 -0.624 . . . . 75.04 110.389 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 48' ' ' LEU . 58.6 t -71.56 -39.56 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 116.399 -0.364 . . . . 72.43 110.573 175.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HE2' HG12 ' A' ' 120' ' ' VAL . 54.7 tttm -53.95 -50.49 66.37 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.36 0.664 . . . . 74.42 112.522 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -34.22 76.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.216 0.606 . . . . 65.33 111.979 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' HD1' HD11 ' A' ' 53' ' ' ILE . 63.7 t80 -63.42 -50.61 69.14 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.141 0.576 . . . . 52.31 111.024 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.863 HG23 HD11 ' A' ' 27' ' ' ILE . 49.2 mt -70.11 -39.49 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.861 1.264 . . . . 64.1 112.57 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.79 -38.77 86.43 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.366 0.666 . . . . 71.01 110.085 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.58 -32.99 85.0 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 116.137 -0.483 . . . . 54.05 114.212 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.492 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 84.2 mt -66.61 -37.92 85.89 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.185 0.517 . . . . 73.4 110.875 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.8 -23.93 67.77 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-N 115.34 -0.845 . . . . 72.52 114.116 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -82.34 -18.74 41.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.616 0.766 . . . . 75.05 112.061 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 t -60.35 119.7 8.47 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.306 0.854 . . . . 75.1 113.306 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.76 -16.41 57.67 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 123.597 0.759 . . . . 73.54 112.038 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.98 -49.51 75.8 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.025 0.53 . . . . 64.42 111.094 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.76 -47.57 84.2 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.217 0.607 . . . . 54.45 111.32 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HG ' HG12 ' A' ' 112' ' ' ILE . 2.1 mm? -71.94 -29.45 64.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.052 0.76 . . . . 62.1 113.052 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.31 -37.41 83.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.219 0.533 . . . . 75.54 110.704 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -50.09 10.86 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.216 0.821 . . . . 52.45 113.216 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.94 34.13 5.32 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.838 1.051 . . . . 71.23 113.838 -167.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -154.48 -58.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.647 0.61 . . . . 74.1 112.647 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.4 p -65.32 -35.61 12.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 113.853 1.057 . . . . 64.1 113.853 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -92.05 -4.51 3.8 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 121.875 1.717 . . . . 74.54 113.657 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -101.88 146.72 32.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 C-N-CA 123.827 0.851 . . . . 74.45 112.157 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.06 147.5 73.64 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.273 1.982 . . . . 75.01 111.537 168.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -55.88 -39.7 71.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.473 0.709 . . . . 72.2 112.677 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.48 ' HA ' HD12 ' A' ' 82' ' ' ILE . 40.8 m -61.05 -38.9 87.82 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.98 0.912 . . . . 72.13 113.316 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -69.64 -32.3 70.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.191 -0.318 . . . . 73.11 111.725 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.5 -32.45 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.307 0.643 . . . . 70.04 110.033 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.526 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 93.6 mt -64.15 -53.5 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.488 0.715 . . . . 72.12 112.422 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -68.73 -42.5 77.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.165 0.432 . . . . 75.41 112.165 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.76 -32.93 70.24 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.313 0.645 . . . . 73.05 111.922 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.0 -47.03 57.03 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 112.172 -0.371 . . . . 75.34 112.172 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.559 HG23 HD12 ' A' ' 90' ' ' LEU . 86.7 m -67.28 -36.75 82.21 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.245 1.018 . . . . 64.45 111.136 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -55.97 -41.93 75.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.703 0.801 . . . . 73.25 112.186 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 49.1 m170 -78.58 -29.52 46.22 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 113.021 0.749 . . . . 74.51 113.021 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -100.54 -63.62 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.227 0.825 . . . . 75.04 113.227 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.559 HD12 HG23 ' A' ' 86' ' ' THR . 77.0 mt -77.08 -25.75 52.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 74.3 112.354 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.94 12.75 81.14 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 123.143 0.277 . . . . 70.25 113.208 -170.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -112.61 159.51 18.79 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.044 0.937 . . . . 51.0 110.423 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.67 154.9 62.12 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.245 0.618 . . . . 75.23 109.861 164.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.7 144.92 97.48 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.067 1.845 . . . . 71.03 112.226 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.401 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 2.5 mp -71.79 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.156 0.582 . . . . 75.33 110.868 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -126.09 173.55 9.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.758 0.823 . . . . 64.32 109.46 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 60.8 tp60 -62.42 -31.66 72.39 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 122.798 0.439 . . . . 73.33 111.072 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.44 -35.75 73.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.674 0.79 . . . . 45.22 111.331 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 11.0 tp10 -60.97 -44.94 96.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 74.41 110.235 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.9 mt -58.35 -44.28 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 114.866 -1.061 . . . . 54.15 110.998 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.1 mtt-85 -62.72 -33.64 75.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.87 0.468 . . . . 74.41 111.688 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -70.6 -53.02 17.59 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.136 0.273 . . . . 73.2 111.483 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -59.78 -36.92 77.7 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.826 0.45 . . . . 74.44 111.803 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.25 -40.68 94.31 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.993 0.917 . . . . 64.1 110.757 176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.436 HE21 HG23 ' A' ' 109' ' ' THR . 22.0 tp60 -69.53 -43.88 72.11 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.575 0.75 . . . . 72.43 111.599 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 98.0 mt -61.99 -47.43 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.281 1.032 . . . . 74.33 110.771 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.5 tp -61.04 -40.4 93.47 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.982 -1.008 . . . . 71.51 112.087 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.52 -44.71 77.72 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.991 0.517 . . . . 70.05 112.115 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.436 HG23 HE21 ' A' ' 105' ' ' GLN . 40.9 p -84.86 -65.65 0.99 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.421 0.688 . . . . 75.21 111.588 -174.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.93 -57.07 4.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.96 0.504 . . . . 73.43 111.207 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.27 -174.7 20.52 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 121.301 0.389 . . . . 73.43 113.704 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.494 HG12 ' HG ' ' A' ' 69' ' ' LEU . 10.8 tp -69.97 -31.54 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 113.124 0.787 . . . . 75.22 113.124 -170.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -65.74 -34.45 78.2 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.425 0.29 . . . . 61.21 111.452 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.08 -31.26 58.67 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.036 0.534 . . . . 73.14 111.492 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.526 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 56.6 t80 -64.55 -55.45 20.42 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.626 0.771 . . . . 72.22 111.444 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.414 HD12 ' HD2' ' A' ' 115' ' ' PHE . 1.9 mp -57.85 -44.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 122.88 0.472 . . . . 53.34 110.716 173.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.21 -34.08 71.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.824 0.449 . . . . 72.23 111.583 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.63 80.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.057 0.543 . . . . 55.14 111.858 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.86 -36.34 78.01 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.385 0.674 . . . . 73.52 111.863 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.506 HG12 ' HE2' ' A' ' 56' ' ' LYS . 98.6 t -80.52 -32.48 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.972 0.909 . . . . 52.01 111.655 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.86 4.53 52.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.22 0.608 . . . . 64.11 112.047 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.7 t -62.83 129.47 40.61 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.372 -0.603 . . . . 43.1 109.372 164.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.476 ' H ' ' NE2' ' A' ' 123' ' ' GLN . 1.5 mp0 -53.9 -35.18 61.36 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.434 0.694 . . . . 53.53 112.659 -171.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.26 -41.79 85.05 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 123.512 0.507 . . . . 65.33 111.642 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -63.52 -56.41 16.22 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.454 0.302 . . . . 71.23 110.921 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -66.14 -36.46 83.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.143 0.794 . . . . 73.3 113.143 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HG3' HG23 ' A' ' 128' ' ' VAL . 12.9 pt-20 -71.76 -32.88 68.15 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.023 0.749 . . . . 60.21 113.023 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.441 HG23 ' HG3' ' A' ' 127' ' ' GLU . 93.6 t -100.56 -64.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 118.34 0.518 . . . . 74.33 111.696 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -99.45 67.1 1.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.736 0.815 . . . . 64.42 109.887 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.03 -156.06 0.49 Allowed Glycine 0 N--CA 1.483 1.796 0 N-CA-C 115.169 0.828 . . . . 63.14 115.169 -174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -79.21 21.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.576 0.954 . . . . 74.12 113.576 -176.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.18 -36.62 0.9 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.832 1.253 . . . . 61.33 110.809 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.3 m -91.97 137.31 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.813 0.672 . . . . 53.14 112.813 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.8 t -80.34 132.26 59.68 Favored Pre-proline 0 CA--C 1.561 1.376 0 C-N-CA 123.946 0.898 . . . . 55.42 110.355 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HD2' HD13 ' A' ' 59' ' ' ILE . 55.6 Cg_endo -66.72 84.66 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.889 2.393 . . . . 73.11 113.82 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.6 p90 . . . . . 0 N--CA 1.478 0.97 0 CA-C-N 115.808 -0.633 . . . . 74.41 110.721 172.841 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.508 -0.553 . . . . 53.03 109.508 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.01 87.15 1.84 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 116.047 -0.524 . . . . 75.04 110.502 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -120.91 148.04 44.61 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.606 0.762 . . . . 51.11 110.044 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -95.87 91.87 6.24 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.332 0.586 . . . . 72.33 111.075 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.18 112.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-N 115.0 -1.0 . . . . 73.02 109.961 164.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.5 90.1 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.118 0.967 . . . . 63.15 113.111 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -46.08 -29.33 3.38 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 115.689 1.035 . . . . 53.21 115.689 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.07 130.57 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 109.363 -0.606 . . . . 50.34 109.363 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.74 -27.49 6.63 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.882 0.473 . . . . 73.23 111.088 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -32.75 114.7 0.17 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.593 1.557 . . . . 63.21 113.57 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HE3' ' HA3' ' A' ' 49' ' ' GLY . 14.4 mmmm -67.95 -12.1 60.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.915 0.486 . . . . 71.13 112.169 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.03 76.7 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.772 0.829 . . . . 73.51 110.895 171.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.54 62.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.191 0.596 . . . . 72.43 110.963 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.462 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.9 mp -60.09 -45.51 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.36 0.664 . . . . 72.34 110.714 169.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.16 -50.49 73.84 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.359 0.663 . . . . 72.51 112.168 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -62.39 -34.45 76.76 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.115 0.566 . . . . 74.34 111.286 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 48' ' ' LEU . 9.9 tp -62.39 -45.68 92.06 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.644 0.778 . . . . 64.44 111.022 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 16' ' ' ILE . 67.4 mt -72.04 -34.1 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.265 1.026 . . . . 74.2 111.519 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -68.26 -42.72 79.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.207 0.603 . . . . 74.42 110.294 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.42 90.96 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.657 0.783 . . . . 72.11 111.238 172.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.99 97.93 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.47 0.708 . . . . 44.04 111.845 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -65.93 -49.38 68.16 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.119 0.568 . . . . 70.51 111.929 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -69.83 -15.51 63.11 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.756 0.65 . . . . 71.41 112.756 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -94.54 -47.31 6.6 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 122.971 0.508 . . . . 52.41 111.54 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 83.0 mt -83.14 -58.57 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.061 0.544 . . . . 74.1 111.934 -174.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 8.7 m-85 -73.31 -16.06 61.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.816 0.446 . . . . 72.3 110.654 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 66.49 17.44 10.65 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.196 1.398 . . . . 72.23 111.968 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -153.4 143.77 22.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 74.5 110.158 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.56 141.11 48.43 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 120.913 0.387 . . . . 62.11 110.098 165.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.4 mt -106.17 141.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 108.712 -0.847 . . . . 51.33 108.712 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.37 117.08 10.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.877 0.871 . . . . 63.41 111.28 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.32 -38.22 86.1 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.375 2.716 . . . . 73.32 113.505 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -63.56 -26.93 68.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.843 0.857 . . . . 74.41 112.744 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -83.31 -47.16 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 123.06 0.544 . . . . 72.24 110.564 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.7 68.86 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.312 1.045 . . . . 51.34 113.365 -173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -75.51 -25.85 57.62 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.165 0.432 . . . . 70.21 112.165 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -81.46 -44.17 17.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.861 0.465 . . . . 71.15 111.599 173.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -58.48 -54.01 51.89 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.614 0.721 . . . . 72.51 111.175 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -99.7 45.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.872 -1.058 . . . . 72.32 110.175 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 p -61.55 -49.62 75.93 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.273 0.629 . . . . 64.15 112.286 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 -45.91 9.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.612 -0.722 . . . . 61.24 112.638 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -66.04 -37.81 86.81 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.513 1.301 . . . . 71.42 114.513 -170.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -65.04 -46.8 79.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.18 -0.674 . . . . 73.14 109.18 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 m -59.21 -35.67 74.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.7 0.8 . . . . 60.24 111.943 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -59.29 -42.09 90.5 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.818 0.847 . . . . 75.15 112.388 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 55' ' ' VAL . 42.2 tp -74.04 -45.51 49.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.809 0.444 . . . . 74.14 111.342 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' HA3' ' HE3' ' A' ' 13' ' ' LYS . . . -64.03 -31.95 82.54 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.874 0.749 . . . . 11.11 114.376 -174.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.93 -18.87 29.78 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.306 0.643 . . . . 72.5 111.275 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.75 31.73 35.3 Favored Glycine 0 C--N 1.355 1.609 0 CA-C-N 117.731 0.241 . . . . 72.41 113.538 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -88.39 -18.96 27.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.334 0.654 . . . . 73.31 111.884 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.8 pt -122.53 163.94 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.94 0.896 . . . . 74.1 110.327 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p -77.18 152.16 34.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.954 -0.387 . . . . 74.33 109.954 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 48' ' ' LEU . 40.1 t -64.01 -32.22 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.17 0.588 . . . . 71.22 110.081 175.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 1.5 tmtp? -54.08 -48.24 70.86 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.248 1.019 . . . . 73.2 111.457 171.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.92 -37.85 72.92 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.068 -0.515 . . . . 70.43 110.941 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.78 -51.84 66.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.389 0.675 . . . . 52.51 111.257 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 27' ' ' ILE . 26.5 mm -56.03 -38.58 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.848 1.259 . . . . 74.23 111.512 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -67.52 -39.49 85.1 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.064 -0.516 . . . . 74.13 110.949 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.72 -23.07 75.64 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 113.844 0.298 . . . . 71.45 113.844 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.499 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 79.0 mt -67.63 -23.11 65.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.528 0.731 . . . . 72.11 110.975 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.431 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -87.73 -14.07 63.82 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.453 -1.249 . . . . 52.11 113.032 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -92.81 -3.68 54.28 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.85 0.86 . . . . 70.23 111.012 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -73.32 112.59 9.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.349 0.659 . . . . 72.33 110.778 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.97 -18.1 63.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.731 0.412 . . . . 72.34 111.741 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.42 -51.73 68.23 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.943 0.497 . . . . 53.32 110.47 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.416 ' HB2' ' CE2' ' A' ' 28' ' ' PHE . 69.4 t80 -59.64 -45.63 91.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.972 0.909 . . . . 60.13 112.015 175.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 63' ' ' GLY . 2.5 mm? -71.21 -29.17 64.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 112.365 0.506 . . . . 74.32 112.365 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.96 -38.95 92.66 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 121.879 -0.513 . . . . 73.44 110.565 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.95 -54.62 7.53 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 113.21 0.818 . . . . 65.54 113.21 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -117.07 36.89 4.03 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 114.06 1.133 . . . . 71.25 114.06 -168.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.416 ' HD1' HG21 ' A' ' 81' ' ' VAL . 47.5 t80 -159.29 -42.92 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.831 0.453 . . . . 72.21 111.507 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -65.96 -45.62 63.89 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 112.641 0.608 . . . . 73.2 112.641 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.55 12.23 1.37 Allowed 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.556 2.171 . . . . 72.21 113.689 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HD2' ' HG2' ' A' ' 80' ' ' LYS . 80.9 m-85 -122.62 140.78 33.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 123.27 0.628 . . . . 73.43 111.965 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' O ' HG23 ' A' ' 81' ' ' VAL . 93.4 Cg_endo -73.45 159.55 46.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.946 2.43 . . . . 72.35 112.574 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -49.77 -52.5 31.44 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.922 0.889 . . . . 71.11 113.045 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.619 ' HA ' HD12 ' A' ' 82' ' ' ILE . 62.7 m -53.86 -43.01 69.18 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.942 1.09 . . . . 74.21 113.942 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 76' ' ' TYR . 58.8 tptt -65.08 -36.75 85.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.378 0.51 . . . . 55.45 112.378 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.416 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.1 t -68.24 -26.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.779 0.431 . . . . 75.21 110.203 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.4 mt -68.44 -52.84 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.604 0.761 . . . . 74.43 111.974 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 84' ' ' LEU . 5.1 pt-20 -64.64 -43.56 93.26 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.697 0.226 . . . . 65.03 110.96 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 22.7 mt -60.2 -41.1 92.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.391 0.677 . . . . 73.22 111.289 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.26 -51.09 55.73 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.74 -0.209 . . . . 74.04 112.713 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 90' ' ' LEU . 37.5 m -67.53 -38.02 83.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.633 0.773 . . . . 64.0 111.162 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -53.93 -36.32 62.65 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.69 1.196 . . . . 74.41 112.784 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 53.2 m170 -89.47 -43.03 11.13 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.452 0.701 . . . . 73.44 112.771 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -92.23 -46.68 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.009 0.524 . . . . 71.04 112.014 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 86' ' ' THR . 48.6 mt -97.73 -7.02 31.67 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.986 0.514 . . . . 74.2 111.717 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 27.21 72.41 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 115.162 0.825 . . . . 42.44 115.162 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -154.46 177.79 10.79 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 117.501 0.651 . . . . 75.33 112.285 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.72 150.76 54.17 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.674 0.79 . . . . 63.54 111.942 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.76 136.07 47.72 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.487 2.125 . . . . 74.42 110.922 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.16 -66.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.317 0.647 . . . . 71.25 111.451 -166.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HB2' ' H ' ' A' ' 99' ' ' GLU . 8.9 m-20 -93.07 165.03 13.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.295 0.638 . . . . 75.04 111.922 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 50.3 tp60 -67.27 -33.9 76.28 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 109.457 -0.571 . . . . 71.11 109.457 163.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.71 73.37 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.452 0.701 . . . . 53.44 111.518 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.536 ' H ' ' HB2' ' A' ' 96' ' ' ASP . 12.2 tp10 -61.87 -42.02 98.55 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.851 0.861 . . . . 73.52 110.347 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.499 HG21 HG23 ' A' ' 79' ' ' THR . 72.1 mt -63.94 -46.13 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 114.914 -1.039 . . . . 73.43 110.905 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 28.5 mmm180 -63.04 -32.2 73.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.275 0.63 . . . . 72.34 111.72 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -66.71 -51.11 59.73 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.551 0.34 . . . . 71.31 111.124 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -65.02 -29.26 70.15 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.425 0.29 . . . . 73.15 111.722 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -68.66 -41.68 78.96 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.216 1.006 . . . . 74.14 110.467 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -72.08 -39.51 68.91 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.395 -0.821 . . . . 71.45 111.146 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 92.3 mt -67.12 -44.42 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.332 0.653 . . . . 70.33 110.975 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.25 -38.81 92.62 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.541 0.736 . . . . 53.13 110.819 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.59 -54.6 9.94 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 112.403 0.52 . . . . 70.13 112.403 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.8 p -83.38 -20.15 34.76 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.401 0.889 . . . . 71.11 113.401 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -114.98 -64.78 1.27 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 122.975 0.51 . . . . 70.45 111.088 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.96 -177.99 28.65 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 120.991 -0.623 . . . . 73.32 114.115 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.0 tp -72.9 -31.35 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.577 0.751 . . . . 73.24 111.441 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -64.66 -30.99 72.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.035 0.534 . . . . 73.03 111.435 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.51 67.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.737 0.815 . . . . 71.12 110.678 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 82' ' ' ILE . 54.4 t80 -60.79 -50.29 74.04 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.391 1.076 . . . . 71.23 112.392 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.95 -45.3 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.979 0.512 . . . . 63.45 111.216 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.06 -34.36 77.84 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.838 -0.619 . . . . 41.32 111.011 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.2 87.7 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.375 0.67 . . . . 63.52 112.139 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.9 mt -76.22 -51.39 12.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.264 0.625 . . . . 64.52 112.295 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.76 -20.52 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 121.125 0.488 . . . . 45.02 111.941 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -97.78 21.48 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.386 0.674 . . . . 65.42 111.963 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.0 m -83.06 153.93 24.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.951 -0.468 . . . . 71.44 111.846 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.52 -44.47 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.436 1.094 . . . . 72.31 111.632 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 30.9 tp10 -54.08 -52.86 59.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.459 -0.791 . . . . 73.04 111.902 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -64.86 -39.88 94.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 120.523 0.201 . . . . 71.51 110.582 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -60.9 -63.38 1.32 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.482 0.713 . . . . 72.15 111.742 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -76.33 -36.87 58.05 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 113.037 0.754 . . . . 73.14 113.037 -170.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.76 -27.93 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.008 0.523 . . . . 64.42 112.251 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -118.9 -78.49 0.59 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.936 -0.478 . . . . 62.02 110.498 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.1 170.46 15.83 Favored Glycine 0 N--CA 1.474 1.191 0 N-CA-C 112.399 -0.28 . . . . 74.24 112.399 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.668 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -73.22 -11.71 60.61 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.736 0.643 . . . . 74.51 112.736 -178.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.02 -10.75 19.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.034 0.934 . . . . 75.25 112.392 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.8 m -116.22 140.24 49.52 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.266 0.839 . . . . 64.45 113.266 -168.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 59' ' ' ILE . 58.6 t -83.56 150.63 60.27 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 125.966 1.706 . . . . 71.41 110.623 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.3 90.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.729 2.286 . . . . 74.3 112.6 161.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.3 p90 . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 123.694 0.798 . . . . 75.03 111.984 -175.316 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 107.783 -1.192 . . . . 74.3 107.783 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -74.9 106.34 6.37 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.128 0.571 . . . . 71.41 110.826 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.59 154.54 42.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.487 0.715 . . . . 74.2 110.223 175.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -70.96 147.2 48.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.142 0.973 . . . . 65.13 111.929 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.9 t -120.47 119.14 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.559 -1.645 . . . . 74.22 106.559 163.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.95 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.677 0.791 . . . . 71.04 112.177 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.57 -24.15 2.78 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.401 -0.818 . . . . 65.3 112.266 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.13 59.03 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 123.344 1.545 . . . . 73.01 109.845 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -80.28 8.47 7.38 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.189 -1.823 . . . . 72.44 113.28 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.91 133.08 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.029 0.532 . . . . 72.41 110.059 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 45.5 mtpt -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.154 0.798 . . . . 73.23 113.154 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.72 -53.02 62.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.053 0.541 . . . . 73.21 111.168 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.68 54.65 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.774 -0.648 . . . . 60.15 112.16 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 39.1 mm -57.91 -40.37 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 122.959 0.504 . . . . 74.44 111.643 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 2.6 ttpm? -56.7 -48.81 76.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.735 0.814 . . . . 73.34 112.01 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 m -68.65 -33.03 73.3 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.164 0.586 . . . . 73.44 111.618 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.63 -43.85 97.77 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.812 0.845 . . . . 73.04 110.213 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -68.7 -33.72 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.372 1.069 . . . . 71.21 111.618 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 71.6 m -67.77 -41.58 83.04 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.253 0.621 . . . . 74.33 110.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.4 85.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.262 0.625 . . . . 71.44 111.478 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.52 -30.36 70.59 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.893 0.877 . . . . 65.23 112.272 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -76.31 -37.69 57.07 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.401 0.519 . . . . 75.43 112.401 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 21' ' ' SER . 89.0 mtt180 -65.95 -26.49 67.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.523 0.729 . . . . 72.4 112.627 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.57 HE22 ' HG2' ' A' ' 135' ' ' PRO . 14.4 pt20 -85.59 -36.39 20.43 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 122.696 0.398 . . . . 75.13 111.895 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.514 HG12 ' HG3' ' A' ' 26' ' ' GLN . 46.2 mm -87.75 -63.27 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.359 0.664 . . . . 53.54 110.786 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.21 -4.75 54.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.817 0.847 . . . . 72.14 111.545 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 68.92 10.09 7.74 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.411 1.485 . . . . 74.05 112.909 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.56 144.83 25.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.42 0.628 . . . . 72.13 111.624 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -68.16 134.27 50.25 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.054 -0.976 . . . . 54.12 110.405 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.31 140.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 122.955 0.502 . . . . 75.31 110.185 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.93 129.26 91.13 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-N 115.063 -0.971 . . . . 71.35 110.839 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -54.95 -38.72 92.93 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.841 3.027 . . . . 45.51 115.181 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -64.73 -27.54 68.98 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.235 0.457 . . . . 65.31 112.235 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -79.82 -49.13 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.509 0.724 . . . . 52.44 110.037 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.552 1.141 . . . . 61.44 113.232 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.08 -26.17 56.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.926 0.49 . . . . 73.13 111.642 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -75.63 -33.52 60.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.474 0.31 . . . . 74.43 110.622 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -74.11 -53.65 9.47 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 116.016 -0.538 . . . . 55.03 111.06 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 78.9 m-85 -116.65 55.7 0.81 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.791 0.836 . . . . 73.34 111.847 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 98.7 p -62.67 -48.33 79.78 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.721 -0.612 . . . . 62.44 112.579 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.9 -40.73 13.76 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.837 -0.62 . . . . 61.42 112.418 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 21.6 t-105 -62.06 -42.0 98.74 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.324 1.05 . . . . 73.01 112.036 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.12 -46.52 88.11 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.27 1.028 . . . . 75.03 111.534 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.8 t -61.01 -41.93 97.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.488 -0.778 . . . . 62.14 111.601 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' HG23 ' A' ' 53' ' ' ILE . 59.6 mtpt -65.29 -32.6 74.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 73.13 111.835 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.69 -45.05 60.79 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.725 0.298 . . . . 73.43 111.061 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.07 76.59 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.711 -0.677 . . . . 74.53 113.942 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -91.47 -20.06 22.16 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.808 0.843 . . . . 71.35 111.871 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.61 25.17 33.57 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 114.172 0.429 . . . . 74.04 114.172 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -69.58 -44.06 71.56 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.315 0.646 . . . . 62.32 110.179 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.418 HG23 ' HE2' ' A' ' 47' ' ' LYS . 32.6 pt -110.62 157.44 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.021 0.929 . . . . 72.21 110.081 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 57' ' ' GLU . 11.9 t -90.15 167.25 12.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.566 0.346 . . . . 73.03 110.33 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 59' ' ' ILE . 66.2 t -61.79 -44.21 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 122.977 0.511 . . . . 62.24 111.134 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 64.1 tttm -55.39 -42.12 73.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.223 1.009 . . . . 62.35 112.815 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' H ' HG23 ' A' ' 54' ' ' THR . 26.5 tt0 -69.42 -36.21 76.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.758 -0.655 . . . . 74.41 111.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.0 -47.08 86.38 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.733 0.813 . . . . 72.41 110.726 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 55' ' ' VAL . 47.7 mm -56.87 -45.55 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 124.431 1.093 . . . . 72.22 111.129 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.74 -44.24 93.88 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.402 -0.817 . . . . 72.55 110.871 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.02 -26.98 69.68 Favored Glycine 0 CA--C 1.543 1.782 0 N-CA-C 114.768 0.667 . . . . 72.31 114.768 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.02 -25.89 63.8 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.006 0.522 . . . . 74.52 110.933 172.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.33 -25.47 74.33 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.503 -0.771 . . . . 60.55 113.64 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.02 -7.45 59.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.637 0.775 . . . . 54.54 111.905 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.423 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.3 p -74.41 134.55 42.39 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -56.69 -28.74 61.41 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.696 0.799 . . . . 63.41 112.29 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.6 tp -65.82 -46.71 77.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.93 0.492 . . . . 65.03 111.253 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.6 -35.51 79.11 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.191 0.52 . . . . 43.21 111.069 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.636 HD11 HG12 ' A' ' 112' ' ' ILE . 4.3 mm? -60.81 -48.35 82.18 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.8 0.84 . . . . 71.35 112.106 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -75.86 -30.59 58.95 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.489 0.551 . . . . 43.22 112.489 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.32 -47.04 45.82 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.897 0.703 . . . . 53.24 112.897 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.48 -55.33 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.794 1.035 . . . . 54.3 113.794 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' HE1' HD21 ' A' ' 107' ' ' LEU . 83.3 t80 -62.89 -33.41 75.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.057 0.762 . . . . 73.54 113.057 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.512 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 33.4 m -79.14 -55.1 0.95 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 118.549 -0.739 . . . . 63.51 112.721 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 11.9 Cg_exo -74.37 -5.06 16.38 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.657 2.238 . . . . 44.35 114.541 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -124.87 146.18 52.36 Favored Pre-proline 0 N--CA 1.494 1.726 0 C-N-CA 122.98 0.512 . . . . 74.42 111.884 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 81' ' ' VAL . 72.5 Cg_endo -72.44 168.5 24.13 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.822 2.348 . . . . 71.14 112.816 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -48.93 -54.77 14.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.402 1.081 . . . . 71.5 112.432 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.55 ' HA ' HD12 ' A' ' 82' ' ' ILE . 37.1 m -54.82 -40.05 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.935 0.894 . . . . 72.21 113.281 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -69.2 -32.0 70.98 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.088 0.403 . . . . 71.32 112.088 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 77' ' ' PRO . 59.0 t -69.39 -26.18 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.029 0.532 . . . . 74.32 109.997 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 79' ' ' THR . 61.0 mt -74.36 -52.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.724 0.809 . . . . 74.41 111.003 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -56.25 24.07 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.941 0.897 . . . . 72.4 112.261 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.96 -40.2 94.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.281 0.632 . . . . 74.24 111.323 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.68 -51.45 55.86 Favored Glycine 0 N--CA 1.474 1.219 0 O-C-N 123.481 0.488 . . . . 72.25 112.93 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 94' ' ' PRO . 40.1 p -61.43 -36.46 80.41 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.522 0.729 . . . . 72.3 112.514 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -73.0 -16.46 61.51 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.94 0.719 . . . . 72.53 112.94 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -86.27 -40.64 15.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.869 0.468 . . . . 74.32 111.319 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' HG22 ' A' ' 59' ' ' ILE . 88.4 m-85 -91.05 -64.74 1.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.343 0.592 . . . . 72.43 110.7 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.46 -10.01 59.2 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.008 0.923 . . . . 63.14 112.397 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.86 21.37 67.45 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 114.209 0.443 . . . . 44.53 114.209 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -149.47 169.92 19.78 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.875 0.87 . . . . 74.45 111.051 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.6 150.69 39.22 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.427 0.691 . . . . 71.12 110.264 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HG3' HG21 ' A' ' 86' ' ' THR . 32.9 Cg_exo -58.55 159.87 18.84 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.931 2.421 . . . . 61.11 112.712 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.43 -62.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.978 0.511 . . . . 62.44 111.542 -169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -133.85 163.21 30.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.636 0.775 . . . . 64.43 110.148 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -59.13 -33.12 70.5 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.848 0.859 . . . . 73.54 112.615 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.12 77.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.514 0.326 . . . . 64.24 111.803 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.9 -36.71 70.09 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.032 0.533 . . . . 73.43 111.111 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.22 -43.61 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.876 0.47 . . . . 60.12 110.077 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 mtm105 -66.27 -30.22 70.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.331 0.652 . . . . 71.02 111.804 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -62.56 -52.47 63.29 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.987 0.515 . . . . 75.13 111.094 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.09 -37.41 84.95 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.898 0.479 . . . . 74.14 111.514 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.37 -39.55 94.84 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.405 1.082 . . . . 70.43 110.863 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.47 HE21 HG23 ' A' ' 109' ' ' THR . 24.1 tp60 -67.74 -44.62 77.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.475 0.71 . . . . 73.41 111.104 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.89 -43.29 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.016 0.926 . . . . 74.44 111.61 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.8 tt -65.1 -41.07 95.28 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.224 0.61 . . . . 73.54 110.966 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.01 -38.54 86.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.738 0.415 . . . . 41.34 112.032 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.47 HG23 HE21 ' A' ' 105' ' ' GLN . 40.9 p -81.6 -69.59 0.6 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.775 0.83 . . . . 63.21 112.125 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.96 -35.3 24.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.98 0.912 . . . . 72.54 111.891 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.08 -172.41 14.88 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 121.119 0.288 . . . . 44.43 113.518 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.636 HG12 HD11 ' A' ' 69' ' ' LEU . 7.4 tp -68.97 -38.21 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.558 0.743 . . . . 73.41 112.249 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -63.52 -42.89 98.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.322 0.649 . . . . 63.11 111.434 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.4 -32.67 66.57 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.713 -0.676 . . . . 63.02 110.636 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.451 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 32.8 t80 -61.78 -51.92 66.33 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 124.122 0.969 . . . . 75.11 112.269 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.9 mm -55.97 -51.77 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.85 0.86 . . . . 74.13 110.442 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -52.14 -49.05 64.5 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 115.23 -0.896 . . . . 75.43 111.86 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.77 67.88 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 61.14 112.787 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.48 -53.3 36.73 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.093 0.473 . . . . 53.4 110.585 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.484 HG12 ' NZ ' ' A' ' 56' ' ' LYS . 39.2 t -69.12 -18.54 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.792 0.837 . . . . 73.44 112.612 -171.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.16 13.65 2.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 73.31 112.766 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.7 p -77.34 136.56 38.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.326 0.651 . . . . 73.25 110.774 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.593 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 46.4 tt0 -68.71 -39.77 80.29 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.713 0.635 . . . . 72.51 112.713 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -53.89 -30.85 47.73 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.516 0.561 . . . . 74.1 112.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.28 -56.46 21.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.138 0.575 . . . . 61.44 110.527 172.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 123' ' ' GLN . 10.4 p30 -73.87 -20.86 60.29 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 111.976 0.361 . . . . 73.33 111.976 -173.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 27.6 mm-40 -67.49 -59.15 3.61 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.149 0.499 . . . . 64.52 111.164 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -71.96 -61.0 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.598 -0.728 . . . . 61.04 111.574 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -84.43 -62.6 1.51 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.083 0.553 . . . . 61.42 110.46 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.26 173.47 27.39 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.615 -0.72 . . . . 54.23 112.657 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.31 -34.19 48.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.884 0.473 . . . . 75.33 111.606 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.25 -8.31 59.08 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.042 0.937 . . . . 61.05 112.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -113.05 143.95 43.45 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.384 0.674 . . . . 73.23 111.344 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.05 130.01 85.53 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.924 0.89 . . . . 74.32 109.248 170.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.57 ' HG2' HE22 ' A' ' 26' ' ' GLN . 89.9 Cg_exo -46.97 85.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.953 3.102 . . . . 65.12 115.71 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.1 p90 . . . . . 0 CA--C 1.552 1.02 0 CA-C-O 121.63 0.729 . . . . 73.41 109.036 172.356 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 136' ' ' TYR . 6.3 p . . . . . 0 CA--C 1.556 1.196 0 CA-C-O 121.803 0.811 . . . . 75.42 109.145 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -107.72 105.52 15.4 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.437 0.695 . . . . 73.31 112.011 -168.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -94.7 111.12 22.9 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.136 0.575 . . . . 71.25 111.417 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.403 ' HD2' ' HG ' ' A' ' 48' ' ' LEU . 6.2 ptm180 -62.23 131.18 48.55 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.226 0.536 . . . . 74.42 110.915 169.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 10' ' ' ILE . 47.4 t -98.87 131.63 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.148 -0.686 . . . . 73.42 109.148 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.03 -36.16 2.4 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.717 1.006 . . . . 72.15 113.717 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -70.96 -24.52 77.03 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.605 1.002 . . . . 64.01 115.605 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 7' ' ' VAL . 71.9 mt -71.24 89.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 118.191 0.996 . . . . 64.12 110.71 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.48 6.64 0.58 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.654 1.353 . . . . 73.14 114.654 173.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.09 98.28 9.79 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.698 -0.626 . . . . 62.33 111.155 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -59.12 -24.93 63.42 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.802 0.841 . . . . 75.33 110.973 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -48.51 68.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.862 0.865 . . . . 71.24 111.082 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.26 67.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 64.5 112.414 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mm -61.01 -48.9 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.714 0.405 . . . . 73.53 109.916 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -61.37 -35.76 78.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.351 0.5 . . . . 74.45 112.351 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.5 m -65.65 -41.34 92.68 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.876 0.47 . . . . 75.43 111.23 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.56 -46.07 87.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.384 1.074 . . . . 62.21 111.116 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.498 HD13 ' HG2' ' A' ' 45' ' ' GLU . 91.6 mt -61.79 -43.29 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.908 1.283 . . . . 61.25 111.601 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.7 m -63.84 -45.12 90.95 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.633 -0.712 . . . . 71.32 110.297 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.4 71.24 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.808 0.843 . . . . 74.34 112.498 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.83 -43.55 81.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.309 0.644 . . . . 61.3 112.552 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HE1' HD22 ' A' ' 62' ' ' LEU . 21.5 m-85 -60.94 -28.42 68.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.101 0.778 . . . . 72.03 113.101 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.81 -13.99 60.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.609 0.764 . . . . 75.13 112.007 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -118.32 -52.05 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.17 0.433 . . . . 64.21 112.17 169.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 88' ' ' HIS . 41.7 mm -55.8 -38.14 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 123.81 0.844 . . . . 75.42 112.197 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -114.72 2.83 14.55 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.643 0.777 . . . . 73.22 110.799 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 35.28 35.72 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 116.053 1.871 . . . . 63.43 116.053 -168.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.515 HH12 ' HG3' ' A' ' 71' ' ' GLU . 3.9 ptp85 -135.55 155.54 50.32 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.586 0.708 . . . . 73.44 111.635 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.97 96.26 8.79 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.909 -1.041 . . . . 54.24 109.541 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.74 134.32 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.038 -0.727 . . . . 74.12 109.038 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.35 126.78 87.16 Favored Pre-proline 0 CA--C 1.551 0.999 0 O-C-N 123.993 0.808 . . . . 72.4 110.238 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.49 -25.21 75.73 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.826 2.351 . . . . 62.12 112.857 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -79.2 -26.78 42.56 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.31 0.644 . . . . 52.14 112.21 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.7 mt -80.07 -39.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.053 0.541 . . . . 61.52 110.207 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.51 85.62 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.944 0.898 . . . . 54.02 111.709 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -72.93 -20.4 61.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.685 0.624 . . . . 72.13 112.685 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -75.87 -41.53 51.94 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.004 0.43 . . . . 60.23 110.639 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -76.57 -39.85 51.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.906 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 96.4 m-85 -116.66 26.62 9.72 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.675 0.991 . . . . 61.54 113.675 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -49.21 -49.83 41.16 Favored 'General case' 0 N--CA 1.515 2.78 0 N-CA-C 114.502 1.297 . . . . 62.52 114.502 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -75.1 -34.53 51.89 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.392 -0.367 . . . . 54.02 112.766 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -63.4 -31.64 72.85 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.201 1.001 . . . . 65.13 111.328 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HG2' HD13 ' A' ' 20' ' ' ILE . 47.7 mt-10 -70.45 -41.75 72.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.167 0.987 . . . . 71.32 110.67 172.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.9 t -61.84 -39.24 91.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 53.23 111.017 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.5 mmmm -60.16 -38.0 81.82 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.747 0.419 . . . . 74.54 110.726 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD11 HG22 ' A' ' 55' ' ' VAL . 22.7 tp -73.25 -49.05 29.9 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.522 0.729 . . . . 75.31 111.942 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.37 73.59 Favored Glycine 0 N--CA 1.484 1.841 0 C-N-CA 123.315 0.483 . . . . 54.13 114.199 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -85.74 -19.11 31.28 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.444 0.697 . . . . 75.52 110.02 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.02 24.65 47.87 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.714 -1.13 . . . . 64.33 112.739 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -66.23 -40.04 89.97 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.003 0.921 . . . . 63.12 110.29 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' HD2' ' A' ' 58' ' ' PHE . 22.2 pt -116.1 143.83 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.91 0.884 . . . . 71.5 110.123 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 57' ' ' GLU . 8.7 t -71.73 162.83 28.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.413 0.285 . . . . 73.42 111.24 163.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 48' ' ' LEU . 22.2 t -65.16 -34.54 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.231 0.212 . . . . 73.22 110.985 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.573 ' HD2' ' HG3' ' A' ' 131' ' ' GLU . 26.8 tttp -50.43 -51.04 50.22 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.695 0.798 . . . . 74.04 113.059 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 54' ' ' THR . 29.1 tt0 -69.61 -31.2 69.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.474 0.71 . . . . 60.12 110.945 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HD2' HD11 ' A' ' 53' ' ' ILE . 36.9 t80 -57.85 -46.94 84.04 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.192 0.597 . . . . 72.12 110.93 170.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 55' ' ' VAL . 51.5 mm -60.69 -40.21 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.039 0.936 . . . . 71.32 111.308 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -54.34 -50.74 66.72 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 115.58 -0.737 . . . . 75.01 111.74 172.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.72 -28.62 57.14 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 115.063 0.785 . . . . 75.34 115.063 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.425 HD22 ' HE1' ' A' ' 24' ' ' TYR . 43.9 mt -71.65 -37.7 70.79 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.018 0.527 . . . . 70.32 110.988 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.91 -26.17 73.19 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 116.413 -0.358 . . . . 53.34 113.454 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.64 -3.17 55.83 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.896 0.879 . . . . 72.5 112.052 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -81.79 130.11 34.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.012 0.525 . . . . 70.14 111.798 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.37 -17.28 28.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.152 0.981 . . . . 75.14 112.371 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.69 -57.09 14.15 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.804 0.442 . . . . 74.14 111.198 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -58.73 -37.04 75.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.97 0.729 . . . . 74.01 112.97 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.681 HD11 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -61.89 -49.68 75.23 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.34 0.496 . . . . 74.12 112.34 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.94 -31.22 71.65 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 113.043 0.757 . . . . 74.43 113.043 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.515 ' HG3' HH12 ' A' ' 30' ' ' ARG . 19.7 mm-40 -87.93 -60.77 1.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.724 1.009 . . . . 64.22 113.724 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -111.77 60.16 0.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.746 0.703 . . . . 73.41 112.429 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 81' ' ' VAL . 58.6 t80 -165.57 -58.7 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.236 0.614 . . . . 72.25 110.293 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 m -63.75 -49.18 77.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 113.021 0.749 . . . . 62.41 113.021 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -86.98 13.34 2.73 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.016 1.811 . . . . 71.22 113.505 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -124.09 150.02 62.01 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.642 0.777 . . . . 61.33 111.455 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.82 165.78 31.8 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.412 2.074 . . . . 63.31 112.406 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.1 -34.76 78.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 73.33 112.517 -170.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.501 ' HA ' HD12 ' A' ' 82' ' ' ILE . 78.4 m -70.39 -38.37 74.66 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.536 0.734 . . . . 74.42 112.353 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.3 -34.42 76.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.147 -0.346 . . . . 63.11 111.601 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 73' ' ' TYR . 87.1 t -56.56 -34.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.595 0.758 . . . . 64.33 110.848 171.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 79' ' ' THR . 77.0 mt -74.04 -48.7 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.546 0.739 . . . . 74.23 111.917 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -58.06 6.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.215 0.45 . . . . 75.15 112.215 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.3 mt -61.85 -25.21 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.35 0.66 . . . . 72.53 111.047 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 89' ' ' PHE . . . -63.7 -40.8 98.92 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 114.695 -1.138 . . . . 60.04 112.147 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -79.1 -44.52 21.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.256 0.623 . . . . 63.4 111.978 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -61.77 -49.55 75.93 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.327 0.862 . . . . 73.14 113.327 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.48 ' O ' HD13 ' A' ' 27' ' ' ILE . 11.8 m170 -61.59 -31.02 71.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.525 0.73 . . . . 72.03 112.534 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.609 ' HB3' HD12 ' A' ' 90' ' ' LEU . 1.1 t80 -98.96 -67.04 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.252 0.621 . . . . 75.03 112.088 -167.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 89' ' ' PHE . 6.5 mp -77.32 -5.42 49.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.459 0.911 . . . . 72.13 113.459 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.57 33.04 75.69 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.054 0.252 . . . . 62.14 113.081 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.672 HH22 HG21 ' A' ' 128' ' ' VAL . 19.2 ptp180 -160.02 157.25 28.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.955 0.902 . . . . 72.34 111.297 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.82 153.09 95.81 Favored Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 109.944 -0.391 . . . . 31.13 109.944 168.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.15 167.14 4.84 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.451 2.101 . . . . 65.42 113.063 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.494 HD13 ' HG2' ' A' ' 99' ' ' GLU . 2.6 mp -80.59 -53.34 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.108 0.563 . . . . 71.5 110.402 -169.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.47 165.14 10.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 74.01 109.187 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 58.2 tp60 -61.94 -30.25 70.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.854 0.462 . . . . 70.2 111.697 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.05 -45.47 88.67 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.058 0.543 . . . . 62.32 111.763 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.494 ' HG2' HD13 ' A' ' 95' ' ' ILE . 7.9 tp10 -62.55 -38.23 89.24 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.176 0.591 . . . . 75.4 111.303 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.455 HG21 HG23 ' A' ' 79' ' ' THR . 72.4 mt -60.58 -42.53 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.761 0.824 . . . . 52.33 111.209 173.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.6 mtt180 -58.13 -37.0 73.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.64 0.607 . . . . 63.43 112.64 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -62.08 -53.74 51.15 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 120.879 0.371 . . . . 62.02 110.59 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -62.38 -36.22 81.6 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.567 -0.742 . . . . 65.44 112.412 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.56 -38.95 91.04 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.529 0.732 . . . . 64.03 111.387 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 109' ' ' THR . 23.0 tp60 -62.58 -38.5 90.38 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.582 -0.735 . . . . 75.13 110.506 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 81.9 mt -64.47 -48.64 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 123.589 0.756 . . . . 70.11 111.291 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.25 -37.09 66.77 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.137 0.575 . . . . 75.02 112.099 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.58 -48.53 32.08 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.191 0.596 . . . . 62.34 111.881 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.442 HG23 HE21 ' A' ' 105' ' ' GLN . 70.4 p -77.05 -71.91 0.38 Allowed 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.618 -0.719 . . . . 73.12 112.413 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -89.89 -53.49 4.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 70.12 112.003 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 -157.97 23.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.346 0.499 . . . . 34.43 114.346 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.681 HG12 HD11 ' A' ' 69' ' ' LEU . 8.8 tp -76.98 -37.58 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.507 0.723 . . . . 73.1 112.457 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.11 -31.22 71.96 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 75.4 111.521 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.76 57.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.99 -1.004 . . . . 73.04 110.671 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -67.19 -45.69 76.16 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 64.25 111.048 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 120' ' ' VAL . 47.9 mm -63.97 -55.53 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.901 0.48 . . . . 65.44 110.171 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.58 -38.57 55.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.115 0.566 . . . . 73.33 112.237 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.86 88.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.552 0.341 . . . . 53.21 111.813 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.63 -39.29 77.23 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.274 0.63 . . . . 72.23 111.862 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 116' ' ' ILE . 18.1 t -67.41 -41.89 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.482 0.658 . . . . 70.34 110.605 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 121' ' ' ASN . 0.7 OUTLIER -87.2 -10.0 53.72 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.907 0.883 . . . . 73.32 111.444 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.9 t -57.6 146.47 30.27 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.273 0.629 . . . . 75.41 111.448 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.7 pt20 -69.46 -38.01 77.57 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.926 0.49 . . . . 73.34 110.405 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -61.39 -38.71 88.02 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.101 0.961 . . . . 62.34 111.777 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.496 ' HD1' ' HA ' ' A' ' 90' ' ' LEU . 59.5 t80 -77.2 -41.89 39.64 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.581 0.753 . . . . 75.54 111.447 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 63.9 t30 -67.44 -51.59 49.84 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.183 0.808 . . . . 71.15 113.183 -165.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 12.6 pt-20 -91.16 -26.14 19.23 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.409 0.522 . . . . 72.0 112.409 -171.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 HH22 ' A' ' 92' ' ' ARG . 79.2 t -78.76 -50.72 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 122.871 0.469 . . . . 72.55 110.732 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.491 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 1.5 t80 -81.03 -45.79 16.02 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.594 0.758 . . . . 71.22 111.972 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.76 -144.02 17.04 Favored Glycine 0 N--CA 1.482 1.752 0 CA-C-O 119.749 -0.473 . . . . 71.31 112.807 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.573 ' HG3' ' HD2' ' A' ' 56' ' ' LYS . 4.7 mp0 -126.13 -58.13 1.38 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 117.831 0.815 . . . . 72.15 112.5 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.71 11.8 0.96 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.878 1.807 . . . . 63.23 115.878 -162.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.0 t -134.94 174.29 10.76 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.956 0.724 . . . . 64.23 112.956 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -84.71 136.34 39.39 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 123.896 0.879 . . . . 74.1 110.287 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -58.54 134.1 58.81 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.966 2.444 . . . . 74.32 112.214 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.519 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 17.9 p90 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 123.947 0.899 . . . . 74.42 112.247 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.695 -0.483 . . . . 65.21 109.695 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.99 93.22 1.35 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.432 0.634 . . . . 73.55 109.624 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -126.58 151.05 48.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.389 1.075 . . . . 65.51 109.002 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -84.87 122.17 28.79 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.094 -0.379 . . . . 72.43 110.373 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -83.37 122.32 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.222 0.609 . . . . 44.51 109.439 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.06 94.35 0.23 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.41 0.684 . . . . 65.31 112.069 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.73 11.41 16.98 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.636 0.615 . . . . 62.03 114.636 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.25 97.98 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.801 0 CA-C-N 117.632 0.716 . . . . 74.21 110.64 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -64.18 -32.22 73.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.835 -1.165 . . . . 52.34 113.154 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -42.68 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.772 0.829 . . . . 64.11 112.336 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -71.67 -9.03 57.65 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 114.865 -1.061 . . . . 73.11 111.359 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.35 -41.71 93.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.375 0.67 . . . . 72.24 109.991 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.1 75.47 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.822 0.849 . . . . 74.12 111.838 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.92 -44.99 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.923 0.489 . . . . 73.31 111.354 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -73.76 -35.67 65.03 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.557 0.743 . . . . 75.44 112.899 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 t -66.71 -29.97 70.09 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 120.711 0.291 . . . . 74.14 111.413 172.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.613 HD22 HD21 ' A' ' 48' ' ' LEU . 8.3 tt -68.27 -45.3 73.51 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.072 0.949 . . . . 65.24 109.661 173.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.11 -44.9 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 124.504 1.122 . . . . 73.13 111.71 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -69.17 -36.85 77.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.374 0.67 . . . . 73.11 111.722 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.06 80.09 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.628 0.771 . . . . 53.01 111.105 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.15 -42.81 65.52 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.098 0.959 . . . . 71.5 111.911 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.84 -49.86 48.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.019 0.527 . . . . 72.02 111.895 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -64.0 -14.88 57.47 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.829 1.048 . . . . 70.34 113.829 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -95.23 -61.66 1.44 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.327 0.512 . . . . 62.32 110.398 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.3 -42.82 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 123.587 0.755 . . . . 73.42 111.837 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.32 -12.16 33.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.497 0.319 . . . . 71.32 111.709 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.35 32.72 22.41 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.042 1.497 . . . . 72.14 115.042 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 166.63 29.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.092 0.775 . . . . 73.24 113.092 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.43 101.29 8.09 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 114.208 -1.36 . . . . 52.44 110.6 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -80.69 118.84 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.352 -0.61 . . . . 73.12 109.352 167.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.14 93.63 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.336 0.655 . . . . 71.51 111.45 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.13 -37.41 79.6 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.235 2.623 . . . . 64.53 114.3 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -71.5 -26.85 62.86 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.483 0.549 . . . . 74.41 112.483 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.45 -38.22 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.158 0.504 . . . . 75.44 110.199 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.16 -32.98 74.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.154 0.982 . . . . 60.4 112.797 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -76.13 -16.82 59.81 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.681 0.392 . . . . 64.24 111.728 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -80.54 -47.39 14.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.028 0.531 . . . . 75.42 110.983 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.86 -45.58 23.85 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.621 0.768 . . . . 75.13 111.695 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 75.8 m-85 -116.64 52.71 0.92 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.764 0.825 . . . . 74.34 111.657 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.74 -55.4 13.25 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.123 0.487 . . . . 64.35 112.189 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.86 -30.31 63.79 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.706 -0.679 . . . . 62.25 113.008 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 6.7 t-105 -67.5 -38.24 84.02 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.718 0.807 . . . . 64.23 112.041 -174.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -57.62 -49.84 75.11 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.253 1.021 . . . . 73.32 110.177 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -53.47 -49.78 66.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.212 1.005 . . . . 74.45 111.881 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.99 -33.88 76.35 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.721 0.637 . . . . 75.33 112.721 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.613 HD21 HD22 ' A' ' 19' ' ' LEU . 37.9 tp -71.8 -43.25 65.99 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 120.731 0.3 . . . . 72.44 110.93 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.85 -19.72 77.07 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.597 0.599 . . . . 72.5 114.597 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -94.9 -12.21 27.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.128 0.571 . . . . 74.54 112.098 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.0 71.37 Favored Glycine 0 C--N 1.35 1.308 0 C-N-CA 121.859 -0.21 . . . . 70.23 113.615 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.73 -32.42 65.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.644 0.777 . . . . 44.43 111.394 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -129.35 156.58 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.427 0.691 . . . . 63.43 109.517 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 p -85.4 178.8 7.32 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.818 0.342 . . . . 75.31 110.611 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 59' ' ' ILE . 74.4 t -64.34 -38.28 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 116.492 -0.322 . . . . 71.24 110.527 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 13.9 tttm -60.02 -44.21 94.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.894 0.478 . . . . 64.34 111.731 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -68.01 -24.73 65.15 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.344 0.658 . . . . 74.12 111.456 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -77.44 -48.11 18.0 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.283 -1.006 . . . . 75.14 108.283 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 46.7 mm -60.67 -33.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 125.062 1.345 . . . . 71.24 111.244 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.26 -51.52 69.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.283 0.633 . . . . 71.35 111.214 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.34 -29.47 66.18 Favored Glycine 0 C--N 1.357 1.729 0 N-CA-C 114.883 0.713 . . . . 72.31 114.883 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.27 -28.57 68.14 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.969 0.385 . . . . 55.34 110.989 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.73 -31.57 44.15 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.116 -0.493 . . . . 51.01 113.461 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.8 -4.44 57.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.56 0.744 . . . . 70.03 112.643 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 p -77.77 141.38 39.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.042 0.383 . . . . 61.41 111.407 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -56.93 -31.29 64.8 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.714 0.805 . . . . 71.11 111.677 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.3 tp -62.0 -46.68 88.13 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.562 0.745 . . . . 74.45 111.315 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -63.21 -36.45 83.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.924 0.393 . . . . 72.43 111.333 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 112' ' ' ILE . 4.5 mm? -68.18 -45.23 74.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.722 0.809 . . . . 60.03 112.815 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -73.17 -30.46 63.58 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.002 -0.436 . . . . 73.34 112.126 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -82.12 -53.49 6.05 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.796 1.036 . . . . 73.1 113.796 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -118.25 42.13 2.77 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.399 0.888 . . . . 73.25 113.399 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.553 ' HA ' HG22 ' A' ' 81' ' ' VAL . 65.7 t80 -155.9 -53.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.027 0.442 . . . . 62.54 111.256 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 m -68.59 -48.1 33.33 Favored Pre-proline 0 CA--C 1.573 1.854 0 N-CA-C 113.33 0.863 . . . . 72.22 113.33 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.73 3.93 7.46 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.92 1.746 . . . . 74.53 113.961 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.27 150.77 70.92 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.697 0.799 . . . . 73.5 111.654 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.24 171.01 15.8 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.351 2.034 . . . . 73.11 111.906 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.59 -49.55 74.57 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.329 0.651 . . . . 75.03 111.542 -176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 HG21 ' A' ' 100' ' ' ILE . 30.4 m -58.67 -21.99 55.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.934 1.293 . . . . 75.01 114.389 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.86 -35.53 13.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.989 -0.745 . . . . 64.23 108.989 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 73' ' ' TYR . 60.2 t -56.81 -31.88 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.538 -0.755 . . . . 73.14 110.244 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 79' ' ' THR . 92.1 mt -68.09 -53.28 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.36 -0.836 . . . . 74.32 112.119 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.24 -50.13 56.02 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.402 1.001 . . . . 70.02 112.392 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.21 -31.04 69.78 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.098 0.559 . . . . 75.41 112.053 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.81 -45.74 50.19 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.558 -0.292 . . . . 62.31 112.902 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.638 HG23 HD12 ' A' ' 90' ' ' LEU . 88.0 m -64.19 -43.81 93.94 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.499 0.72 . . . . 62.55 111.911 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -60.98 -28.29 68.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.659 0.985 . . . . 74.1 113.659 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -73.41 -34.65 65.6 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.581 0.586 . . . . 63.13 112.581 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -104.76 -65.02 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.67 0.388 . . . . 65.03 111.581 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD12 HG23 ' A' ' 86' ' ' THR . 90.5 mt -75.47 -12.03 60.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.127 0.571 . . . . 74.44 112.466 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.45 24.95 75.41 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.651 0.62 . . . . 63.22 114.651 175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -159.27 -176.19 5.67 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 117.618 0.709 . . . . 52.34 111.794 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.02 30.58 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.693 0.797 . . . . 70.25 110.603 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.89 155.31 18.55 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.43 2.753 . . . . 72.55 113.636 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.481 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 49.5 mt -65.1 -52.61 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.694 0.798 . . . . 63.12 112.568 -169.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -148.59 171.58 15.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.47 0.708 . . . . 65.31 109.297 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -60.79 -28.98 69.16 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.031 0.532 . . . . 72.21 111.524 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.44 85.94 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.712 0.805 . . . . 52.44 111.215 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 15.4 tp10 -58.85 -43.61 90.79 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.288 1.035 . . . . 73.31 111.631 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.587 HG21 HG23 ' A' ' 79' ' ' THR . 73.2 mt -62.67 -50.56 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.873 0.869 . . . . 72.53 111.251 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -64.59 -29.59 70.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.324 0.65 . . . . 74.34 111.655 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -62.09 -49.92 74.03 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.711 0.804 . . . . 72.51 110.409 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -63.25 -40.72 98.23 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.902 0.481 . . . . 72.23 111.714 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.9 -34.97 77.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.406 0.683 . . . . 40.2 110.972 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -64.28 -36.43 84.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.763 0.825 . . . . 51.31 111.325 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.96 -42.89 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.601 0.761 . . . . 70.23 110.989 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -36.17 82.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.192 0.597 . . . . 75.12 111.669 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.46 -44.85 73.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.216 0.606 . . . . 53.3 111.495 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.2 p -77.71 -69.59 0.53 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.119 0.785 . . . . 74.15 113.119 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -93.3 -46.95 7.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.964 -0.46 . . . . 73.22 111.724 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.8 -159.68 15.39 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 121.002 0.223 . . . . 62.25 113.581 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 69' ' ' LEU . 8.5 tp -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 123.908 0.883 . . . . 74.03 113.114 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -57.36 -42.35 81.85 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.316 0.646 . . . . 71.31 111.709 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.96 -28.24 43.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.269 -0.878 . . . . 75.45 110.899 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.63 -48.66 71.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.049 0.939 . . . . 72.42 110.931 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.67 -54.63 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 74.11 110.323 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -45.41 -42.08 9.91 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.13 0.972 . . . . 73.24 113.052 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.68 94.31 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.767 0.427 . . . . 61.23 111.882 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.7 -41.7 78.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.521 0.728 . . . . 61.14 112.131 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.28 -47.54 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 122.806 0.442 . . . . 63.34 111.689 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -81.46 2.27 29.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.46 0.541 . . . . 74.0 112.46 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 t -61.2 132.5 53.86 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.953 0.501 . . . . 52.3 109.986 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.03 -36.0 74.24 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.265 0.353 . . . . 72.43 111.139 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.9 -45.41 82.61 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.965 0.906 . . . . 73.22 111.786 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.468 ' HB2' HD23 ' A' ' 90' ' ' LEU . 87.8 t80 -58.23 -54.71 43.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.883 -0.414 . . . . 72.45 109.883 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -60.5 -28.3 68.26 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.611 0.764 . . . . 70.12 112.745 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.21 -40.1 14.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.448 0.699 . . . . 75.51 112.332 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 91.5 t -89.44 -61.52 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 122.932 0.493 . . . . 63.24 110.505 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -102.76 70.19 1.1 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.697 . . . . 70.51 109.395 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.06 178.65 0.79 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.623 -0.717 . . . . 64.03 114.537 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.644 ' HG2' ' HD3' ' A' ' 56' ' ' LYS . 27.9 mt-10 -63.91 -14.3 52.43 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.288 0.847 . . . . 54.41 113.288 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.22 -33.0 12.18 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.175 0.59 . . . . 73.15 111.884 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.5 m -86.0 136.59 33.19 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.125 0.57 . . . . 63.44 112.421 -173.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.77 135.73 31.78 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.398 1.079 . . . . 60.34 109.954 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.63 136.06 63.57 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.478 2.119 . . . . 72.12 112.796 167.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.5 p90 . . . . . 0 N--CA 1.483 1.188 0 C-N-CA 123.11 0.564 . . . . 71.11 111.195 177.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 t . . . . . 0 CA--C 1.55 0.949 0 N-CA-C 108.465 -0.939 . . . . 65.11 108.465 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.62 123.73 17.28 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.307 1.043 . . . . 74.21 111.783 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.14 162.15 38.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.252 0.621 . . . . 72.32 111.035 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -74.86 89.24 2.33 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.693 -0.685 . . . . 74.45 110.787 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -70.93 112.45 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-N 115.878 -0.601 . . . . 62.42 111.008 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.78 43.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.001 1.32 . . . . 72.12 113.583 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.26 -42.09 55.41 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.688 0.635 . . . . 42.31 114.688 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.5 mm -71.58 -54.54 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.565 0.746 . . . . 74.24 110.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 46.37 17.21 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 126.123 1.769 . . . . 64.53 115.146 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.43 138.31 31.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.921 0.888 . . . . 74.11 110.824 -169.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.49 -29.07 65.51 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.174 0.805 . . . . 62.01 113.174 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.12 -30.5 49.41 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.698 0.399 . . . . 64.24 110.696 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.79 -38.68 64.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.26 0.624 . . . . 74.3 109.959 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.573 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.5 mp -63.95 -34.97 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 115.256 -0.884 . . . . 74.55 110.027 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 34' ' ' PRO . 24.4 ttmm -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.918 0.71 . . . . 72.43 112.918 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -69.7 -34.01 73.32 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 122.018 -0.426 . . . . 64.0 110.41 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.04 -34.35 77.83 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.854 1.262 . . . . 45.12 110.355 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 16' ' ' ILE . 51.5 mm -62.59 -53.17 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.05 0.94 . . . . 73.42 109.514 174.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -65.76 -29.05 69.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.202 1.001 . . . . 74.23 112.867 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -41.41 59.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.528 0.731 . . . . 71.25 110.543 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.02 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.941 0.897 . . . . 73.41 111.927 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.949 0.499 . . . . 70.2 112.209 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtp85 -67.57 -14.36 62.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.111 0.564 . . . . 75.03 112.028 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.754 ' HG2' ' HB2' ' A' ' 135' ' ' PRO . 23.9 tp60 -95.9 -50.33 4.93 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.928 0.491 . . . . 74.12 111.147 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -78.46 -59.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.257 0.623 . . . . 74.53 111.005 -175.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -81.51 -7.05 59.53 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.723 0.409 . . . . 65.33 111.634 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 65.97 -54.48 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.502 1.921 . . . . 65.44 114.479 -174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -65.64 139.12 58.38 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.53 0.732 . . . . 74.43 112.282 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -65.59 128.66 36.85 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.229 -0.896 . . . . 63.51 109.649 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -105.47 142.51 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.193 0.597 . . . . 65.34 109.973 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 36' ' ' ILE . . . -62.66 124.34 82.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.955 0.902 . . . . 74.0 111.402 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 51.0 Cg_exo -56.01 -32.31 85.62 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 123.513 2.809 . . . . 75.43 115.575 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -72.78 -35.73 67.48 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.37 0.268 . . . . 64.53 111.206 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.474 ' HA ' HD21 ' A' ' 39' ' ' ASN . 71.3 mt -66.25 -41.57 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.919 0.888 . . . . 73.43 110.423 172.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.68 64.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.031 0.932 . . . . 72.12 111.691 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -75.9 -61.38 1.95 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.526 -0.761 . . . . 73.22 110.914 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 36' ' ' ILE . 9.3 p30 -63.21 -25.69 68.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.235 0.828 . . . . 63.14 113.235 -174.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.26 -54.49 5.91 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.86 0.464 . . . . 73.32 110.773 172.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 85.1 m-85 -113.92 60.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.678 0.791 . . . . 75.03 111.557 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -73.27 -50.94 19.53 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.928 -0.483 . . . . 71.25 111.988 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.68 -31.34 58.6 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.287 -0.415 . . . . 60.43 112.377 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 8.7 t-105 -69.93 -37.47 75.9 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.194 0.997 . . . . 75.0 111.157 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.9 -41.9 81.99 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.013 0.925 . . . . 72.03 111.542 169.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -53.62 -54.46 37.35 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.57 1.148 . . . . 65.24 113.193 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.691 ' HD3' HG21 ' A' ' 53' ' ' ILE . 15.1 ptpt -61.18 -35.08 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.269 0.84 . . . . 63.54 113.269 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.1 tp -71.15 -34.22 70.8 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.308 0.243 . . . . 62.43 110.707 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.573 ' HA2' HG12 ' A' ' 16' ' ' ILE . . . -67.08 -33.52 83.72 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.76 -0.2 . . . . 72.25 112.861 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -73.63 -10.38 59.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.01 0.924 . . . . 75.23 112.144 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.99 32.5 82.36 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 115.364 0.906 . . . . 51.34 115.364 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.4 -60.2 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.902 0.858 . . . . 73.22 110.201 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.691 HG21 ' HD3' ' A' ' 47' ' ' LYS . 21.9 pt -73.13 176.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.797 -1.547 . . . . 74.35 112.181 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.608 HG23 ' H ' ' A' ' 57' ' ' GLU . 1.8 t -99.51 153.37 19.08 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.078 -0.712 . . . . 62.02 109.078 170.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 59' ' ' ILE . 91.2 t -64.06 -31.13 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 110.119 -0.326 . . . . 75.21 110.119 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -44.83 -50.93 9.99 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.735 1.013 . . . . 63.53 113.735 166.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.608 ' H ' HG23 ' A' ' 54' ' ' THR . 31.6 tt0 -58.52 -42.51 87.9 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.651 0.38 . . . . 75.24 110.822 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' HZ ' HG23 ' A' ' 20' ' ' ILE . 86.7 t80 -63.75 -43.34 96.72 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.01 0.924 . . . . 72.33 110.881 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 55' ' ' VAL . 33.7 mm -68.11 -46.47 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.751 1.22 . . . . 63.24 111.911 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.72 -39.08 64.94 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.894 0.478 . . . . 62.03 111.471 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.09 -25.42 72.16 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 116.142 -0.481 . . . . 75.11 114.165 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.7 mt -75.68 -38.1 58.99 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.426 0.69 . . . . 71.4 111.134 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.44 -18.08 79.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 121.554 -0.355 . . . . 73.1 113.657 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -84.59 -28.15 26.75 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.528 0.731 . . . . 75.33 111.566 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.3 p -71.99 129.4 38.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.673 -0.491 . . . . 63.44 109.673 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -58.71 -15.87 13.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.138 1.162 . . . . 72.54 114.138 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.69 -42.62 93.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.885 0.874 . . . . 64.43 112.072 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -65.51 -43.21 90.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.542 0.687 . . . . 60.4 111.031 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.96 -28.75 63.64 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.012 -0.994 . . . . 74.51 111.327 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -60.37 -45.87 91.98 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.959 1.304 . . . . 73.14 111.072 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.81 -42.05 61.48 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.015 -0.993 . . . . 73.41 111.832 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -114.31 -67.56 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.922 1.082 . . . . 71.21 113.922 -167.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -61.19 -30.02 70.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.338 1.236 . . . . 71.11 114.338 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.557 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 45.8 m -78.65 -54.74 1.09 Allowed Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.729 -0.653 . . . . 75.31 112.054 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 14.8 Cg_exo -71.8 -16.86 29.57 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 121.989 1.792 . . . . 55.21 114.274 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 56.3 m-85 -115.24 147.71 39.13 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 123.088 0.555 . . . . 72.41 112.357 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 81' ' ' VAL . 91.7 Cg_endo -75.54 169.93 21.32 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.367 . . . . 75.42 112.549 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -49.95 -49.56 49.77 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.25 1.02 . . . . 74.42 113.002 -173.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.589 ' HA ' HD12 ' A' ' 82' ' ' ILE . 26.3 m -59.69 -35.53 74.67 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.6 0.76 . . . . 73.4 112.981 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 22.4 tptm -72.72 -36.18 67.74 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.904 0.383 . . . . 71.43 110.859 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.7 t -68.84 -28.53 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.242 0.617 . . . . 75.21 110.569 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 79' ' ' THR . 96.9 mt -66.77 -52.11 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 73.33 111.26 174.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -71.99 -37.57 69.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 111.832 0.308 . . . . 73.4 111.832 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.97 -31.26 61.41 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.299 0.639 . . . . 71.34 111.508 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.9 52.05 Favored Glycine 0 N--CA 1.476 1.312 0 N-CA-C 112.039 -0.424 . . . . 74.44 112.039 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.68 HG23 HD12 ' A' ' 90' ' ' LEU . 53.6 m -66.48 -35.78 81.11 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.098 0.959 . . . . 74.33 110.747 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.93 -42.44 90.08 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 60.24 112.627 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.8 m170 -82.84 -36.0 25.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.961 0.504 . . . . 75.54 112.353 -175.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -94.29 -68.87 0.78 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 119.179 -0.439 . . . . 71.13 111.274 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.68 HD12 HG23 ' A' ' 86' ' ' THR . 79.2 mt -66.9 -18.24 65.28 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.945 0.72 . . . . 73.01 112.945 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.23 21.3 78.16 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.321 0.388 . . . . 71.33 113.422 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 86' ' ' THR . 9.7 ptt180 -143.09 172.79 12.23 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.166 0.587 . . . . 74.0 110.951 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.06 151.28 54.21 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 123.246 0.618 . . . . 72.14 111.07 165.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.05 140.45 65.69 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.232 1.955 . . . . 34.22 111.486 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.65 -42.83 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.426 0.528 . . . . 75.11 112.426 -164.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -155.65 160.88 40.77 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.161 -0.681 . . . . 52.31 109.161 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -54.91 -36.08 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.447 0.699 . . . . 73.22 112.654 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.37 74.23 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.294 0.638 . . . . 60.53 112.323 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.42 -39.88 67.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.615 0.766 . . . . 64.42 111.624 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.57 -53.27 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.335 0.654 . . . . 71.2 111.713 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -55.81 -32.72 63.79 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.782 0.833 . . . . 71.44 111.867 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.4 tmmm? -61.01 -52.13 66.29 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.503 0.721 . . . . 74.03 110.856 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -64.99 -35.77 82.25 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.849 0.46 . . . . 75.2 112.021 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.408 ' HB2' HD11 ' A' ' 82' ' ' ILE . 47.9 t30 -67.87 -36.85 80.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.064 0.946 . . . . 70.41 111.398 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -67.78 -30.74 70.26 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.575 -0.739 . . . . 65.41 110.632 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 102' ' ' LYS . 74.3 mt -65.77 -40.75 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 122.952 0.501 . . . . 73.04 110.426 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.75 -37.97 76.62 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.241 0.617 . . . . 75.24 112.044 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.4 71.47 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.404 0.682 . . . . 62.1 112.115 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 p -75.79 -52.16 11.02 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.965 0.906 . . . . 72.13 111.642 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.09 -73.03 0.69 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.936 0.894 . . . . 73.41 111.356 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.02 -174.21 22.55 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.297 0.499 . . . . 74.34 113.543 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.8 mm -52.73 -36.64 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.966 1.306 . . . . 72.13 113.706 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -61.17 -51.35 69.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.884 0.373 . . . . 74.21 111.139 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.9 -37.45 87.69 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.524 -0.762 . . . . 73.45 112.539 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.39 -55.95 17.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.31 1.044 . . . . 64.53 112.624 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -57.51 -44.55 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.673 0.789 . . . . 63.52 110.693 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.58 -39.19 76.22 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.322 0.649 . . . . 74.02 112.263 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.96 98.49 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.245 0.618 . . . . 64.14 111.472 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.0 mt -62.83 -55.04 29.84 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.836 0.854 . . . . 72.11 111.399 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 56' ' ' LYS . 74.9 t -67.23 -32.6 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 123.186 0.595 . . . . 75.04 112.438 -173.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.93 22.11 15.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.63 -0.669 . . . . 74.22 111.824 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -71.5 142.03 50.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.258 0.623 . . . . 72.41 110.453 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.65 -37.39 79.62 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.724 0.41 . . . . 72.33 111.563 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.58 -32.5 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 120.776 0.322 . . . . 74.24 110.887 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -75.49 -54.13 7.53 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.455 0.702 . . . . 73.13 111.712 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -69.86 -23.35 63.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.905 0.705 . . . . 74.42 112.905 -169.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.46 -39.1 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.042 0.537 . . . . 75.23 111.984 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.29 -58.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.089 0.947 . . . . 75.44 110.394 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.527 ' HE2' ' HB2' ' A' ' 56' ' ' LYS . 45.5 t80 -59.88 -46.64 88.68 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.037 1.735 . . . . 74.2 112.786 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.94 -129.18 9.2 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-O 119.534 -0.592 . . . . 41.21 112.183 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -135.06 -64.58 0.65 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.504 0.652 . . . . 65.21 111.271 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.43 1.14 34.45 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.844 0.858 . . . . 73.44 112.693 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.9 m -92.35 151.65 20.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.843 0.857 . . . . 72.5 111.528 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.7 137.67 85.65 Favored Pre-proline 0 N--CA 1.488 1.452 0 C-N-CA 124.468 1.107 . . . . 74.4 110.284 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.754 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 2.8 Cg_exo -67.82 135.57 35.86 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.158 1.905 . . . . 74.32 111.798 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.3 p90 . . . . . 0 CA--C 1.55 0.968 0 C-N-CA 123.493 0.717 . . . . 75.24 110.299 -178.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.985 0.421 . . . . 54.2 110.68 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -92.23 87.22 6.0 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.63 0.729 . . . . 71.31 109.748 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.53 155.43 17.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.546 0.738 . . . . 73.13 110.881 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -92.77 113.8 26.18 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.22 -1.03 . . . . 70.53 108.22 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.56 124.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.912 -0.773 . . . . 74.2 108.912 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.87 99.86 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.707 0.803 . . . . 54.45 111.945 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.29 -31.49 2.34 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.067 -0.515 . . . . 73.31 113.929 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.3 mt -67.68 102.16 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-O 121.709 0.766 . . . . 70.14 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -113.62 24.93 11.69 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.709 -1.132 . . . . 73.34 110.176 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.42 109.31 21.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.697 0.799 . . . . 71.2 108.984 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -61.51 -23.34 65.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.64 0.607 . . . . 61.41 112.64 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.27 -38.84 68.72 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.267 0.627 . . . . 74.14 111.074 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.01 52.14 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.357 0.663 . . . . 74.53 111.289 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.41 HG21 ' HA2' ' A' ' 49' ' ' GLY . 49.0 mm -72.52 -42.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.08 0.552 . . . . 74.14 110.07 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.38 -31.75 73.02 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.866 0.867 . . . . 72.04 112.527 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -77.14 -31.0 55.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 120.902 0.382 . . . . 72.23 111.446 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.07 -43.55 98.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.741 0.816 . . . . 74.44 109.654 170.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.3 -38.04 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.481 1.112 . . . . 71.12 111.48 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.8 t -65.74 -38.37 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.519 0.728 . . . . 60.34 111.771 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.41 -37.6 63.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.146 0.578 . . . . 60.53 110.885 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.9 77.14 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.777 0.831 . . . . 74.23 111.601 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -59.07 -49.91 76.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.984 0.514 . . . . 73.04 110.923 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.78 -26.5 68.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.88 0.696 . . . . 74.0 112.88 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.29 -46.89 72.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.853 0.461 . . . . 74.52 111.367 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.719 HD11 HG23 ' A' ' 59' ' ' ILE . 2.4 mp -89.12 -67.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.079 0.552 . . . . 65.1 109.954 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -83.77 82.35 8.36 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.879 0.872 . . . . 72.12 109.122 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.32 69.17 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.609 1.195 . . . . 61.41 114.113 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 176.23 145.73 0.09 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.256 1.822 . . . . 61.21 108.911 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -71.03 119.64 15.44 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-O 121.006 0.432 . . . . 75.44 110.6 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 mm -84.1 125.24 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.473 -0.936 . . . . 73.13 108.473 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 35' ' ' TYR . . . -59.24 122.47 63.77 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.603 -0.713 . . . . 52.41 111.173 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.95 -38.47 86.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.611 2.874 . . . . 71.51 114.275 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.408 ' CE1' ' HB1' ' A' ' 33' ' ' ALA . 44.1 p90 -68.71 -25.38 64.74 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.205 0.602 . . . . 72.52 112.198 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.503 ' HA ' HD21 ' A' ' 39' ' ' ASN . 62.1 mt -83.32 -44.49 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.429 0.692 . . . . 65.13 111.004 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -33.84 72.6 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.478 1.111 . . . . 34.44 112.208 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -36.52 72.94 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.519 -0.764 . . . . 74.1 112.312 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.503 HD21 ' HA ' ' A' ' 36' ' ' ILE . 10.3 p30 -83.34 -41.57 18.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.344 0.498 . . . . 70.44 112.344 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.39 -54.08 28.46 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.714 . . . . 70.45 112.269 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -98.31 33.0 2.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.92 0.888 . . . . 72.34 111.006 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.8 t -62.38 -50.43 71.58 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.191 0.997 . . . . 75.31 113.081 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.16 36.72 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.788 -0.642 . . . . 72.44 112.096 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -70.54 -29.94 66.54 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.497 0.719 . . . . 74.43 111.957 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -38.57 75.49 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.691 0.796 . . . . 70.14 110.834 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.0 t -52.37 -38.16 58.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.153 0.981 . . . . 73.43 113.365 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.33 -40.07 62.43 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 111.969 0.359 . . . . 63.24 111.969 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.32 -30.69 67.72 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 118.212 0.46 . . . . 73.42 112.178 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' HG21 ' A' ' 16' ' ' ILE . . . -70.36 -31.7 68.54 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.893 0.163 . . . . 71.31 112.711 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.548 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 56.1 m-20 -88.19 -18.44 28.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.534 0.734 . . . . 64.23 111.609 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.17 71.86 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.143 0.417 . . . . 72.12 114.143 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.5 mm-40 -61.07 -32.6 72.25 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.822 0.849 . . . . 71.22 111.677 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -113.41 158.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.574 0.749 . . . . 62.3 110.055 171.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.4 p -84.75 169.18 14.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.255 0.622 . . . . 63.13 110.99 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 59' ' ' ILE . 50.8 t -63.79 -47.69 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.479 -0.563 . . . . 75.4 109.479 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -43.57 -51.84 6.62 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.61 1.337 . . . . 53.33 114.61 169.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -57.75 -39.49 77.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.094 0.558 . . . . 72.04 111.301 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.435 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 45.3 t80 -71.83 -38.72 70.13 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.482 0.713 . . . . 75.54 110.792 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.719 HG23 HD11 ' A' ' 27' ' ' ILE . 30.6 mm -63.47 -50.35 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.983 1.313 . . . . 64.5 110.937 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' HG11 ' A' ' 120' ' ' VAL . 25.8 tt0 -57.34 -38.85 74.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.085 -0.961 . . . . 74.12 111.425 172.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.73 85.22 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.821 -0.627 . . . . 63.42 113.941 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 84.1 mt -69.78 -39.89 76.37 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.245 0.618 . . . . 44.14 111.326 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.75 81.95 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.529 0.572 . . . . 72.11 114.529 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -72.77 -21.69 60.96 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.518 0.727 . . . . 71.43 111.73 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -63.22 128.68 36.94 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.095 0.558 . . . . 65.14 111.919 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.14 -19.2 52.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.24 113.09 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.78 -44.01 97.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.33 0.652 . . . . 64.13 110.723 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -67.54 -31.13 71.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.832 0.453 . . . . 75.34 111.475 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 4.3 mm? -71.89 -34.46 69.16 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.276 0.63 . . . . 70.13 112.318 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -29.7 34.95 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.543 -0.723 . . . . 74.44 111.693 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.85 -56.63 4.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.664 0.616 . . . . 72.34 112.664 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -128.05 60.01 1.47 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.539 0.735 . . . . 75.43 112.306 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.607 ' HD1' HG11 ' A' ' 81' ' ' VAL . 76.9 t80 -162.66 -60.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.911 -0.586 . . . . 65.45 110.725 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.6 p -64.33 -41.26 58.76 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 114.405 1.261 . . . . 72.41 114.405 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.32 -7.58 8.9 Favored 'Trans proline' 0 C--N 1.389 2.704 0 CA-C-N 121.84 1.693 . . . . 70.35 114.039 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -109.37 149.98 40.5 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 123.805 0.842 . . . . 72.55 111.819 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.89 152.94 76.65 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.095 1.863 . . . . 62.22 111.323 168.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -50.56 -47.79 57.72 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.804 0.842 . . . . 72.43 112.708 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.529 ' HA ' HD12 ' A' ' 82' ' ' ILE . 17.8 m -55.61 -33.59 64.12 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.656 0.783 . . . . 63.23 112.354 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -76.23 -36.0 58.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.001 0.521 . . . . 72.42 111.636 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.607 HG11 ' HD1' ' A' ' 73' ' ' TYR . 59.7 t -63.09 -34.8 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.445 0.641 . . . . 74.24 110.476 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.5 mt -63.21 -51.28 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.814 -1.084 . . . . 64.44 111.92 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.4 -31.06 60.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.821 0.448 . . . . 72.4 111.442 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -76.93 -28.51 55.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.418 0.687 . . . . 72.25 111.222 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.26 -54.52 8.87 Favored Glycine 0 C--N 1.344 1.022 0 C-N-CA 122.101 -0.095 . . . . 35.04 112.935 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 t -60.59 -33.34 72.58 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.42 0.896 . . . . 72.2 113.42 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.23 -14.74 62.34 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.543 0.571 . . . . 52.31 112.543 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -89.41 -50.25 6.22 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.774 0.657 . . . . 44.3 112.774 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -85.67 -40.04 16.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.864 0.466 . . . . 55.31 111.82 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 124' ' ' GLU . 77.6 mt -95.84 -49.02 5.5 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 122.439 0.296 . . . . 74.0 110.994 175.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.29 40.39 87.45 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 122.192 -0.317 . . . . 71.12 113.707 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.686 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 2.6 ptm180 -131.2 7.97 4.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.157 0.799 . . . . 74.24 113.157 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 60.12 158.56 0.11 Allowed Pre-proline 0 N--CA 1.504 2.256 0 N-CA-C 113.87 1.063 . . . . 52.02 113.87 -163.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.02 152.96 61.21 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.318 2.012 . . . . 61.03 113.705 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -74.44 -72.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 C-N-CA 123.193 0.597 . . . . 74.24 111.08 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -123.86 171.36 9.73 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.816 0.846 . . . . 54.12 109.854 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -69.5 -29.79 67.5 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.776 -0.578 . . . . 61.41 110.172 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.52 -30.94 68.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.088 0.555 . . . . 41.43 111.96 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -71.89 -39.62 69.45 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.209 0.604 . . . . 62.33 111.21 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.41 ' O ' HD13 ' A' ' 82' ' ' ILE . 76.7 mt -63.98 -52.15 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.217 0.607 . . . . 73.11 110.567 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -54.74 -39.91 68.76 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.11 0.964 . . . . 73.13 111.91 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' O ' HG13 ' A' ' 106' ' ' ILE . 34.6 ttpt -57.15 -45.55 83.5 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.527 0.731 . . . . 64.03 111.15 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.511 ' HD1' HD12 ' A' ' 106' ' ' ILE . 17.8 m-85 -68.25 -35.39 77.83 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.755 0.422 . . . . 75.1 111.921 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -67.46 -32.71 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.892 0.477 . . . . 74.13 110.988 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -64.45 -40.75 96.33 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.865 0.866 . . . . 62.05 110.429 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.568 HG23 HE21 ' A' ' 110' ' ' GLN . 80.1 mt -62.48 -46.16 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 124.267 1.027 . . . . 71.31 111.52 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.3 -42.72 99.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.207 0.603 . . . . 74.23 111.69 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.2 -44.6 75.47 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.743 0.646 . . . . 74.3 112.743 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.4 p -72.41 -51.77 18.91 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.021 0.749 . . . . 73.4 113.021 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.568 HE21 HG23 ' A' ' 106' ' ' ILE . 2.3 pm0 -124.26 -46.75 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 112.906 0.706 . . . . 74.22 112.906 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.1 -153.45 20.74 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 115.414 0.925 . . . . 70.44 115.414 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.1 tp -70.81 -35.57 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.107 0.963 . . . . 51.42 112.775 -169.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -61.2 -44.27 97.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.427 0.528 . . . . 73.52 112.427 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -29.44 66.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.029 0.531 . . . . 61.13 112.294 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -65.12 -48.07 74.88 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.269 0.628 . . . . 74.22 110.707 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 112' ' ' ILE . 46.7 mm -64.22 -45.6 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.568 0.747 . . . . 63.24 110.026 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -58.87 -36.36 74.49 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.103 0.961 . . . . 70.4 111.671 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.18 -28.72 68.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.4 0.68 . . . . 50.4 112.142 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.0 -43.56 13.05 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.838 0.855 . . . . 42.45 112.326 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 60' ' ' GLU . 61.8 t -78.15 -37.54 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.416 0.686 . . . . 74.33 111.504 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -87.53 4.37 43.8 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.918 0.487 . . . . 73.24 112.039 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.1 t -67.62 137.58 55.74 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.921 0.488 . . . . 74.42 110.489 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.545 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . 13.7 pt20 -54.74 -29.21 53.07 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.786 1.032 . . . . 75.1 113.786 -175.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.686 ' HG2' ' HD2' ' A' ' 92' ' ' ARG . 34.3 tp10 -50.85 -47.53 60.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.121 0.968 . . . . 64.33 112.225 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.9 -44.58 20.14 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.624 0.769 . . . . 73.52 111.092 168.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 123' ' ' GLN . 6.8 t30 -72.46 -67.7 0.53 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.707 1.002 . . . . 72.1 113.707 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 8.3 pt-20 -56.81 -37.21 70.86 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.296 0.85 . . . . 75.23 113.296 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.67 -61.62 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 112.502 0.556 . . . . 70.42 112.502 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.3 -53.59 2.63 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.05 0.54 . . . . 62.24 111.479 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.65 -126.91 8.78 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.878 -0.601 . . . . 51.32 113.095 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -106.42 -20.46 13.37 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.781 0.832 . . . . 74.25 111.377 -169.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.21 11.84 38.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.143 1.534 . . . . 74.42 115.143 -156.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 t -153.91 164.23 38.74 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 119.43 1.014 . . . . 73.34 112.333 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 55.3 t -67.86 135.37 92.14 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 123.871 0.868 . . . . 63.55 110.498 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 134' ' ' VAL . 7.1 Cg_exo -71.85 76.74 1.97 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.207 2.605 . . . . 74.3 113.198 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.0 p90 . . . . . 0 N--CA 1.485 1.321 0 C-N-CA 123.32 0.648 . . . . 75.41 110.701 176.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.803 -0.814 . . . . 54.51 108.803 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -88.01 101.15 13.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.296 0.638 . . . . 73.43 111.123 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -132.06 163.2 28.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.014 0.526 . . . . 71.11 111.176 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.642 HH22 ' HG ' ' A' ' 48' ' ' LEU . 19.7 tpp85 -79.47 98.25 6.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.262 -0.881 . . . . 71.45 109.736 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.73 130.71 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.338 -0.986 . . . . 72.33 108.338 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.66 75.8 0.59 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.861 0.839 . . . . 70.21 111.928 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.75 -37.98 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.517 -1.22 . . . . 64.2 112.356 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.43 80.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.439 0 CA-C-O 122.529 1.156 . . . . 64.43 110.819 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -89.44 10.03 24.17 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.583 -1.644 . . . . 64.11 113.599 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' HG12 ' A' ' 16' ' ' ILE . 5.6 m-20 -70.69 126.15 28.8 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.007 0.523 . . . . 75.03 111.198 -172.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -60.45 -29.47 69.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.926 0.491 . . . . 73.32 112.035 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 -50.58 62.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.025 0.93 . . . . 75.14 110.937 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.4 94.51 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.603 0.761 . . . . 65.24 112.496 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.579 HG21 ' HA2' ' A' ' 49' ' ' GLY . 46.1 mm -63.2 -49.06 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.06 0.544 . . . . 61.12 111.556 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.25 -25.14 61.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.313 0.486 . . . . 65.44 112.313 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.8 m -65.73 -38.63 89.68 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.792 0.437 . . . . 74.33 111.226 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.33 -40.36 93.59 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.012 0.925 . . . . 73.0 109.983 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.27 -43.92 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.653 1.181 . . . . 63.23 111.544 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -70.47 -35.54 73.36 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.311 0.644 . . . . 74.11 111.438 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.18 90.14 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.666 0.786 . . . . 54.33 112.022 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.78 99.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.512 0.725 . . . . 63.32 111.126 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.464 ' HE2' ' HB1' ' A' ' 37' ' ' ALA . 13.3 m-30 -70.92 -41.02 71.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.567 -0.742 . . . . 72.31 111.556 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -60.88 -35.78 77.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.256 1.022 . . . . 54.02 112.367 179.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.0 -62.92 1.54 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.876 0.471 . . . . 71.35 110.122 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.75 -54.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.78 0.832 . . . . 73.02 112.674 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -78.98 -8.33 58.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.121 0.568 . . . . 75.35 112.029 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 53.85 45.77 27.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.521 1.153 . . . . 74.02 112.577 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.428 HH21 ' HG3' ' A' ' 71' ' ' GLU . 8.0 ptp180 -153.85 -179.0 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.348 -0.842 . . . . 72.43 111.264 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -125.78 107.95 11.02 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.848 -1.167 . . . . 61.03 107.848 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 24' ' ' TYR . 20.0 mt -90.98 139.84 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.769 0.428 . . . . 73.34 110.849 -174.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.67 94.6 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.791 -0.623 . . . . 64.41 109.941 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.58 -44.13 41.7 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.656 2.904 . . . . 71.44 113.957 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.01 -44.58 79.95 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.173 -0.921 . . . . 73.21 112.523 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -57.91 -43.78 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 122.956 0.502 . . . . 75.41 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB1' ' HE2' ' A' ' 24' ' ' TYR . . . -58.72 -48.19 81.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.287 1.035 . . . . 71.42 111.795 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.95 -12.13 59.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.619 0.6 . . . . 72.23 112.619 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -80.3 -47.26 14.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.677 -0.64 . . . . 73.31 111.729 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.52 -42.48 67.9 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 120.949 0.404 . . . . 74.1 111.047 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.508 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 60.7 m-85 -105.66 55.07 0.69 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.785 0.834 . . . . 64.45 110.939 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.6 m -64.34 -50.2 68.68 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 122.891 0.476 . . . . 62.13 111.636 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -70.64 -39.01 67.66 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.85 -0.614 . . . . 74.53 113.389 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -70.32 -42.16 72.3 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.135 0.974 . . . . 72.11 112.889 -169.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.04 -39.72 93.3 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.883 0.473 . . . . 73.41 110.584 174.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 m -62.77 -47.56 82.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.856 0.863 . . . . 63.32 111.885 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.4 mmmm -59.12 -44.87 92.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.069 0.547 . . . . 72.24 111.983 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' HH22 ' A' ' 6' ' ' ARG . 16.3 tp -74.0 -33.28 63.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 116.317 -0.402 . . . . 71.23 111.32 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.579 ' HA2' HG21 ' A' ' 16' ' ' ILE . . . -66.0 -26.72 72.4 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 123.035 0.35 . . . . 73.21 113.883 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -92.28 -17.51 24.67 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.548 0.739 . . . . 54.33 110.985 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.79 28.51 60.82 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.887 -0.597 . . . . 72.44 113.973 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.41 -25.27 54.33 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.697 0.799 . . . . 74.14 112.647 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.17 171.0 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.727 0.811 . . . . 74.33 109.151 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 p -89.69 170.27 10.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.7 -0.852 . . . . 62.41 108.7 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -59.56 -33.53 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 119.721 -0.18 . . . . 52.01 110.562 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 131' ' ' GLU . 78.7 tttt -44.82 -56.81 4.19 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.0 1.32 . . . . 72.22 113.556 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.98 -40.58 78.74 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.288 0.635 . . . . 62.31 111.354 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 85.3 t80 -53.49 -51.9 61.26 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.908 0.755 . . . . 73.43 110.808 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 55' ' ' VAL . 37.8 mm -57.88 -43.5 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.643 1.177 . . . . 70.4 111.758 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' HG11 ' A' ' 120' ' ' VAL . 32.2 tt0 -58.97 -47.95 83.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 122.783 0.433 . . . . 65.23 111.81 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.17 -18.83 65.43 Favored Glycine 0 CA--C 1.541 1.698 0 N-CA-C 114.867 0.707 . . . . 62.1 114.867 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 54.2 mt -70.73 -30.67 67.26 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 117.566 0.683 . . . . 54.33 111.105 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.61 -10.67 79.94 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 115.315 -0.857 . . . . 72.33 114.129 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -95.54 -7.75 37.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.658 0.783 . . . . 75.24 111.014 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.439 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.7 p -84.13 137.35 33.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.986 0.514 . . . . 62.3 111.273 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 6.0 t30 -62.38 -23.58 66.89 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.01 0.524 . . . . 72.11 111.576 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.5 tp -67.56 -38.01 83.5 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.605 0.762 . . . . 75.22 111.611 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -74.27 -45.6 46.72 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 120.811 0.339 . . . . 74.42 110.716 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.527 HD11 HG12 ' A' ' 112' ' ' ILE . 4.0 mm? -55.96 -44.17 78.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.587 1.155 . . . . 64.2 112.887 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.82 -29.71 70.23 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.873 0.694 . . . . 65.13 112.873 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' HG3' HH21 ' A' ' 30' ' ' ARG . 6.3 mm-40 -93.37 -36.64 12.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.314 1.227 . . . . 74.22 114.314 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HD1' HD13 ' A' ' 84' ' ' LEU . 80.1 m-85 -128.86 32.42 4.78 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.658 0.614 . . . . 75.44 112.658 -171.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HD1' HG11 ' A' ' 81' ' ' VAL . 78.1 t80 -150.16 -54.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.95 0.5 . . . . 74.55 110.974 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -68.16 -43.7 35.6 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.582 0.956 . . . . 65.21 113.582 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.1 7.63 4.97 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.127 1.885 . . . . 74.1 113.422 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 58.3 m-85 -130.07 141.6 42.44 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.579 0.751 . . . . 75.24 111.395 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.65 167.55 16.97 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.29 1.993 . . . . 71.12 111.766 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.52 -40.72 72.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.289 0.636 . . . . 62.11 112.356 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.62 ' HA ' HD12 ' A' ' 82' ' ' ILE . 99.2 m -66.36 -42.38 88.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.073 0.949 . . . . 72.45 113.457 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 48.8 tptt -63.66 -32.95 74.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.258 0.466 . . . . 64.3 112.258 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.568 HG11 ' HD1' ' A' ' 73' ' ' TYR . 45.8 t -63.18 -30.56 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.188 0.595 . . . . 73.23 110.642 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.6 mt -69.92 -51.17 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.947 0.899 . . . . 73.02 112.251 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.64 -45.44 65.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.115 0.416 . . . . 72.53 111.697 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.518 HD23 ' HD3' ' A' ' 87' ' ' LYS . 74.8 mt -61.85 -29.04 69.91 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.361 0.665 . . . . 64.5 112.196 171.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.1 -41.67 46.7 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 115.705 -0.68 . . . . 75.12 111.903 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.438 HG23 HD12 ' A' ' 90' ' ' LEU . 78.3 m -68.9 -46.1 69.22 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.308 0.643 . . . . 65.13 112.016 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HD3' HD23 ' A' ' 84' ' ' LEU . 14.6 ptmt -70.5 -24.42 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.59 0.959 . . . . 73.34 113.59 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -85.02 -33.61 22.49 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 113.695 0.998 . . . . 62.01 113.695 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -104.18 -41.97 5.65 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.844 1.053 . . . . 65.11 113.844 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.438 HD12 HG23 ' A' ' 86' ' ' THR . 69.0 mt -94.71 -14.7 24.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.127 0.417 . . . . 71.32 112.127 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.87 14.97 2.05 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.608 0.603 . . . . 62.14 114.608 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -98.23 -84.78 0.38 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.321 0.648 . . . . 60.54 112.476 -161.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 175.98 137.11 0.19 Allowed Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 72.13 108.938 -168.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.39 122.89 10.18 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.459 1.44 . . . . 51.1 109.531 165.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.29 -63.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 122.086 -0.383 . . . . 74.3 111.504 -168.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -158.14 166.5 32.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.473 -0.936 . . . . 74.34 108.473 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -66.29 -27.76 68.18 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.232 0.469 . . . . 73.2 111.396 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.2 72.44 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.945 0.498 . . . . 71.21 111.458 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.87 -45.73 84.8 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.25 0.62 . . . . 74.3 110.667 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.545 HG21 HG23 ' A' ' 79' ' ' THR . 85.0 mt -59.33 -36.76 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.685 -0.689 . . . . 74.22 110.573 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -68.81 -31.96 71.33 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.676 0.39 . . . . 73.31 111.608 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.53 -50.1 41.16 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.528 0.331 . . . . 73.22 111.44 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -62.58 -38.44 90.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.081 0.4 . . . . 72.43 112.081 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.59 -36.16 77.85 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.935 0.894 . . . . 73.33 111.255 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -69.36 -44.02 72.43 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.67 0.788 . . . . 72.54 110.907 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -42.78 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.551 0.741 . . . . 70.35 110.831 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.429 HD11 ' HE1' ' A' ' 73' ' ' TYR . 31.5 tp -65.51 -33.29 75.58 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.364 1.065 . . . . 71.21 112.438 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.41 -46.35 17.72 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.019 0.528 . . . . 63.13 112.322 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.8 p -70.45 -45.16 66.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.99 0.916 . . . . 74.24 111.843 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -110.6 -68.79 0.9 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.228 0.611 . . . . 71.15 111.914 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.89 -170.33 28.57 Favored Glycine 0 C--N 1.356 1.688 0 C-N-CA 121.691 -0.29 . . . . 73.12 113.792 -175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 69' ' ' LEU . 8.6 tp -65.82 -39.2 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.925 0.89 . . . . 71.12 112.637 -173.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -65.69 -33.57 76.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.946 0.498 . . . . 75.52 111.861 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.87 -34.63 51.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.606 0.762 . . . . 54.25 110.425 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.78 -51.98 65.0 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.273 1.029 . . . . 54.5 111.174 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.88 -51.88 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.937 0.895 . . . . 52.42 110.867 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -48.29 -47.78 36.25 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.675 0.79 . . . . 44.23 112.288 171.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -33.54 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.569 0.747 . . . . 72.13 112.337 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.59 -57.99 4.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.955 0.502 . . . . 73.43 110.895 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 60' ' ' GLU . 94.3 t -63.77 -35.85 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 113.847 1.054 . . . . 73.54 113.847 -166.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.62 36.27 2.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 75.15 112.101 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.4 p -84.02 171.26 13.11 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.163 0.506 . . . . 63.12 110.789 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -69.56 -31.53 69.77 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.01 0.91 . . . . 70.25 110.339 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -69.81 -36.2 75.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.425 1.49 . . . . 63.52 111.596 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -76.22 -37.66 57.45 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.994 0.518 . . . . 70.41 110.958 173.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.15 -61.09 2.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.811 0.844 . . . . 74.42 112.577 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.56 -38.71 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.722 0.296 . . . . 72.23 111.72 -168.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.03 -44.36 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.639 0.775 . . . . 61.11 111.657 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -101.68 -45.64 5.19 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.042 0.537 . . . . 74.34 112.174 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.19 20.04 63.52 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-O 119.715 -0.492 . . . . 63.54 113.906 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 8.5 pt-20 57.08 -1.81 0.05 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.903 2.186 . . . . 71.35 116.903 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -93.04 -17.5 23.78 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.315 0.646 . . . . 73.24 111.433 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 t -108.99 162.42 14.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.439 0.696 . . . . 75.5 112.339 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.21 136.96 89.09 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.706 -1.133 . . . . 65.41 108.401 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.78 88.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.548 2.165 . . . . 61.31 112.179 173.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 p90 . . . . . 0 CA--C 1.543 0.705 0 CA-C-N 115.395 -0.82 . . . . 72.53 108.896 174.121 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.107 -0.701 . . . . 62.22 109.107 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -83.29 124.21 30.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.332 0.587 . . . . 72.02 111.168 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.21 173.77 16.36 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.847 1.259 . . . . 74.11 109.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.616 ' NH2' ' HA2' ' A' ' 51' ' ' GLY . 81.4 mtp180 -102.5 116.21 32.16 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.57 0.7 . . . . 71.01 111.315 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.4 2.62 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.977 0 C-N-CA 125.345 1.458 . . . . 62.4 111.004 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 78.58 -67.47 0.17 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.406 1.882 . . . . 61.41 110.369 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 49.28 4.12 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.036 0.374 . . . . 64.43 114.036 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 6' ' ' ARG . 66.6 mt -72.99 -53.4 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.256 0.622 . . . . 75.12 110.11 172.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 65.7 -65.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.348 1.459 . . . . 73.25 112.094 -171.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 16' ' ' ILE . 32.1 t70 -44.68 133.96 5.71 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.966 1.706 . . . . 73.22 115.588 -173.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.28 -25.38 39.47 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 112.93 -1.941 . . . . 73.24 112.545 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -70.84 -51.46 26.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 64.03 111.444 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.24 -50.64 58.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.73 1.011 . . . . 74.14 113.73 167.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 12' ' ' ASP . 43.8 mm -56.84 -43.05 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.852 0.686 . . . . 63.22 112.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 2.7 pptp? -67.14 -30.47 70.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 112.512 0.56 . . . . 63.21 112.512 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 m -70.57 -49.4 48.31 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.14 0.495 . . . . 70.42 111.022 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -44.54 -46.49 9.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.821 -1.081 . . . . 73.54 111.805 165.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.9 -36.19 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.341 1.056 . . . . 71.25 112.353 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -61.71 -49.01 78.17 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.261 0.624 . . . . 54.53 111.668 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.34 88.96 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.138 0.575 . . . . 63.14 111.827 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.67 -31.17 15.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.684 -1.144 . . . . 74.23 112.596 171.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.88 -48.15 17.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.888 0.475 . . . . 65.21 111.766 168.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -55.8 -28.36 55.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.355 1.613 . . . . 72.13 115.355 -167.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -86.68 -41.64 14.03 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.097 0.408 . . . . 64.12 111.274 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.588 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -75.8 -57.25 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.537 0.735 . . . . 62.42 111.221 -173.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.446 ' HB3' HH11 ' A' ' 30' ' ' ARG . 93.2 m-85 -78.91 -6.38 56.03 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.095 0.558 . . . . 75.12 111.94 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 54.87 37.67 29.02 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 125.425 1.49 . . . . 65.32 112.927 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.446 HH11 ' HB3' ' A' ' 28' ' ' PHE . 10.0 ptp85 -155.0 151.73 28.83 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.275 0.559 . . . . 55.34 112.247 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.04 100.94 2.1 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.149 -0.932 . . . . 62.22 109.427 165.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.3 mt -81.11 126.53 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 110.044 -0.354 . . . . 72.43 110.044 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.38 132.45 94.17 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.814 0.846 . . . . 45.23 111.035 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.81 -33.03 98.27 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.999 2.466 . . . . 75.23 113.368 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -69.17 -21.71 63.97 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.956 0.724 . . . . 65.41 112.956 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -81.99 -48.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.152 0.581 . . . . 74.04 109.884 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 -32.02 71.99 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.073 0.949 . . . . 55.03 113.182 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -76.6 -19.19 58.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.849 0.46 . . . . 73.22 111.747 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -80.15 -47.1 15.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.223 0.609 . . . . 63.34 111.251 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -85.5 -59.82 2.21 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.889 0.376 . . . . 65.01 111.725 -171.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -93.15 41.55 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.565 0.746 . . . . 74.54 112.535 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.9 t -66.68 -50.8 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.523 0.729 . . . . 70.15 112.058 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.2 -28.6 57.94 Favored Glycine 0 N--CA 1.477 1.374 0 CA-C-N 115.777 -0.647 . . . . 33.12 113.051 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -65.3 -25.12 67.49 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.237 1.015 . . . . 75.53 112.259 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.66 -45.27 75.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.65 0.78 . . . . 73.2 110.824 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -57.45 -30.92 65.41 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.02 0.928 . . . . 33.14 112.575 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -73.58 -35.74 65.47 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.473 0.309 . . . . 55.45 111.687 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.2 tp -73.38 -60.94 2.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.282 0.845 . . . . 74.3 113.282 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.59 -36.67 76.71 Favored Glycine 0 C--N 1.358 1.772 0 CA-C-N 118.622 0.646 . . . . 73.32 114.377 -171.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -59.98 -16.59 31.68 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.89 0.876 . . . . 63.2 113.347 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.616 ' HA2' ' NH2' ' A' ' 6' ' ' ARG . . . 103.04 5.17 47.37 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 114.635 0.614 . . . . 72.44 114.635 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.2 -63.99 1.03 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.187 0.493 . . . . 72.41 111.991 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -85.06 -142.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-N 116.025 -0.534 . . . . 73.31 111.259 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.433 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 3.3 t -170.43 152.16 3.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 73.13 108.916 -165.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.05 -31.49 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 112.603 0.594 . . . . 65.2 112.603 -171.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -76.38 -44.0 38.26 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.097 -0.377 . . . . 73.21 111.183 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.84 -22.18 66.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.49 0.716 . . . . 71.33 111.435 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -74.29 -46.21 42.64 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.427 -1.323 . . . . 73.01 107.427 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 27' ' ' ILE . 54.0 mt -70.92 -30.78 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 113.46 -1.7 . . . . 64.12 113.318 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -63.93 -46.81 83.11 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 122.819 0.448 . . . . 73.31 110.536 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.87 -35.54 47.93 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 114.617 0.607 . . . . 72.34 114.617 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -69.11 -26.18 64.78 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.165 0.586 . . . . 74.51 111.526 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.07 -23.94 58.41 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 116.078 -0.51 . . . . 53.23 113.09 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.447 ' HE1' ' HB ' ' A' ' 116' ' ' ILE . 3.6 m-30 -86.0 5.7 32.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.787 0.835 . . . . 73.02 110.955 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.1 t -85.46 129.84 34.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.484 0.713 . . . . 63.13 110.41 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.661 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 23.5 p-10 -62.77 -16.13 56.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.995 0.739 . . . . 72.32 112.995 -175.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 43.1 tp -61.5 -59.7 4.84 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.013 0.525 . . . . 74.1 110.681 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.8 -36.94 65.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.949 0.722 . . . . 73.53 112.949 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.661 ' HB2' ' HA ' ' A' ' 66' ' ' ASN . 4.2 mm? -63.95 -30.51 71.58 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.349 0.87 . . . . 63.03 113.349 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -92.02 -40.59 11.01 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.718 -0.614 . . . . 63.41 112.189 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 10.3 pt-20 -78.04 -54.69 5.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.097 1.147 . . . . 74.23 114.097 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -83.89 -59.06 2.53 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.115 0.871 . . . . 74.22 113.076 171.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.523 ' HE1' HD21 ' A' ' 107' ' ' LEU . 61.6 t80 -55.67 -46.63 77.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.213 1.19 . . . . 72.34 114.213 -166.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.8 m -71.03 -55.96 6.05 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.445 0.906 . . . . 73.52 113.445 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.02 -28.32 19.39 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.931 1.754 . . . . 64.3 112.999 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.418 ' HD1' ' HG2' ' A' ' 80' ' ' LYS . 91.0 m-85 -94.06 140.96 23.06 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 122.822 0.449 . . . . 72.22 110.77 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.525 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.4 Cg_exo -54.29 146.11 52.24 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.088 2.525 . . . . 31.31 113.515 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.425 ' ND2' ' HA ' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -30.48 -46.69 0.08 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 123.62 0.768 . . . . 43.43 112.934 156.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.498 ' HA ' HD12 ' A' ' 82' ' ' ILE . 21.4 m -70.59 -23.84 62.65 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.334 0.654 . . . . 73.22 112.601 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HG2' ' HD1' ' A' ' 76' ' ' TYR . 53.5 tptt -91.14 -28.32 17.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.19 0.519 . . . . 74.2 110.382 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 77' ' ' PRO . 84.7 t -62.86 -27.51 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.791 0.836 . . . . 71.43 110.038 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 79' ' ' THR . 81.5 mt -65.88 -47.52 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.098 0.959 . . . . 54.25 112.626 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HG3' ' H ' ' A' ' 84' ' ' LEU . 7.2 pt-20 -78.51 -57.8 3.58 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.908 0.322 . . . . 73.23 110.818 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.546 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 97.0 mt -43.85 -31.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.774 1.398 . . . . 74.42 114.774 161.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.33 -49.72 8.07 Favored Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.855 -0.498 . . . . 73.1 111.855 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.692 HG23 HD12 ' A' ' 90' ' ' LEU . 88.3 m -59.88 -31.55 69.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.673 1.189 . . . . 65.2 112.277 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -75.84 -57.16 4.04 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.598 -0.689 . . . . 55.1 111.486 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.7 m170 -50.9 -30.58 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.979 1.474 . . . . 74.41 114.979 172.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -101.52 -68.62 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.233 0.827 . . . . 72.35 113.233 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.692 HD12 HG23 ' A' ' 86' ' ' THR . 66.0 mt -71.42 -28.36 63.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.853 0.686 . . . . 73.33 112.853 -173.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.99 33.63 20.44 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 122.94 0.15 . . . . 50.33 112.788 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.82 -177.05 6.13 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.172 0.989 . . . . 73.44 110.782 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.19 165.42 13.9 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.532 0.733 . . . . 75.14 109.74 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.75 173.73 4.38 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.272 1.982 . . . . 61.11 111.973 169.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 mt -119.04 -86.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 121.127 0.489 . . . . 73.34 109.992 -167.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -88.63 172.41 9.31 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.961 -1.125 . . . . 51.44 107.961 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 2.8 tp-100 -74.9 -10.1 59.17 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 121.441 1.928 . . . . 74.14 109.59 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.75 84.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.851 0.86 . . . . 73.35 110.563 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.8 -54.11 46.4 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.903 0.881 . . . . 72.14 110.289 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.419 ' HA ' HG21 ' A' ' 82' ' ' ILE . 75.6 mt -64.71 -36.17 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-N 114.818 -1.083 . . . . 73.14 112.275 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.545 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 70.3 mtp180 -74.54 -38.84 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.851 0.46 . . . . 63.42 109.913 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.35 -56.44 18.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.233 -0.894 . . . . 73.21 110.921 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -61.49 -52.74 63.24 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.387 0.514 . . . . 73.44 112.387 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.425 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 14.2 t-20 -43.73 -48.23 7.97 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 115.394 -0.821 . . . . 53.44 112.676 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.427 HE21 HG23 ' A' ' 109' ' ' THR . 22.3 tp60 -73.3 -41.03 64.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.856 0.462 . . . . 71.22 111.705 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.9 mt -59.83 -55.18 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 124.081 0.952 . . . . 75.21 111.637 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.523 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.3 tt -50.98 -53.14 35.78 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.038 0.935 . . . . 50.15 112.204 170.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.35 78.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.44 0.533 . . . . 72.53 112.44 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.427 HG23 HE21 ' A' ' 105' ' ' GLN . 75.0 p -68.31 -53.03 27.03 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.109 0.781 . . . . 71.0 113.109 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -101.53 -62.32 1.27 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.654 0.782 . . . . 74.0 112.262 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -172.8 31.8 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.97 0.348 . . . . 73.33 113.97 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.429 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.2 tp -68.74 -33.71 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.903 0.881 . . . . 72.11 112.209 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -65.07 -55.86 16.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.701 0.4 . . . . 73.53 110.69 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -50.1 -30.93 12.05 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 114.713 -1.131 . . . . 73.32 113.451 168.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -75.67 -42.9 49.92 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.272 0.629 . . . . 74.32 112.201 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.447 ' HB ' ' HE1' ' A' ' 64' ' ' TYR . 46.3 mm -72.52 -52.3 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.01 0.524 . . . . 72.34 109.718 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -43.63 -38.24 2.96 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.7 1.2 . . . . 72.41 113.112 166.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.85 76.61 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.021 0.528 . . . . 63.05 112.404 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.402 ' O ' HD21 ' A' ' 90' ' ' LEU . 78.1 mt -83.99 -59.9 2.27 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.603 0.761 . . . . 74.34 110.841 176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 t -44.95 -50.89 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.584 1.554 . . . . 65.02 113.216 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -100.3 17.47 21.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.402 0.519 . . . . 62.54 112.402 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.9 p -74.03 164.15 26.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.951 -0.759 . . . . 54.31 108.951 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.41 -22.51 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.965 -0.46 . . . . 71.43 111.669 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.46 -53.31 44.57 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.335 0.494 . . . . 64.03 112.335 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -61.6 -40.46 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.153 -0.684 . . . . 65.31 109.153 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -57.93 -42.7 85.38 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.164 0.986 . . . . 71.2 112.69 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.99 -47.38 11.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.773 -0.579 . . . . 71.11 112.013 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.4 -41.38 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.925 0.49 . . . . 72.42 111.987 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 36.9 m-85 -116.01 -68.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.822 0.449 . . . . 73.14 110.669 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.51 -127.56 9.13 Favored Glycine 0 C--N 1.347 1.139 0 C-N-CA 123.227 0.442 . . . . 73.44 112.403 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -88.86 -73.12 0.51 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.41 0.684 . . . . 73.1 111.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 36.0 m-20 -102.35 66.6 0.99 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.548 0.69 . . . . 65.24 112.835 -171.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.9 m -148.32 124.43 10.76 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.043 -0.981 . . . . 75.54 109.495 173.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.68 138.23 83.08 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.251 0.62 . . . . 72.42 109.936 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.458 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 52.4 Cg_exo -53.6 89.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 123.152 2.568 . . . . 70.21 113.319 173.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.4 p90 . . . . . 0 CA--C 1.543 0.711 0 CA-C-N 115.17 -0.923 . . . . 62.55 111.456 176.711 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 CA--C 1.56 1.355 0 N-CA-C 109.393 -0.595 . . . . 64.44 109.393 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.67 -0.3 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 126.211 1.805 . . . . 70.04 113.196 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -47.32 113.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.284 1.433 . . . . 74.25 114.061 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.543 ' NH1' HD22 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -51.28 94.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.337 1.606 . . . . 75.32 115.337 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 8' ' ' ALA . 2.9 t -45.89 178.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.223 0 C-N-CA 126.046 1.738 . . . . 63.3 112.514 162.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.592 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -73.96 132.32 42.31 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 107.598 -1.26 . . . . 73.34 107.598 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -13.5 74.6 0.0 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 117.85 1.9 . . . . 64.45 117.85 -158.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -67.38 134.28 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.236 0.614 . . . . 63.54 110.679 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -83.33 -13.41 55.1 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.537 0.735 . . . . 71.43 112.523 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.92 112.47 18.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.924 0.489 . . . . 72.44 110.759 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.39 -10.88 37.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.438 0.695 . . . . 64.41 112.026 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.11 -51.44 13.45 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.439 0.638 . . . . 71.21 109.634 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.5 71.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.683 -1.144 . . . . 62.1 112.378 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 41.1 mm -78.25 -48.79 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.467 0.707 . . . . 74.35 110.783 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -67.4 -44.81 77.94 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.653 0.781 . . . . 51.12 113.008 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.3 m -63.37 -37.84 88.82 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.335 0.654 . . . . 70.31 111.889 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' NH1' ' A' ' 6' ' ' ARG . 11.4 tp -53.0 -51.56 61.24 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.747 -1.115 . . . . 70.44 110.103 169.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.85 -37.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.955 1.302 . . . . 70.34 113.121 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.1 p -69.19 -53.06 21.95 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.587 0.355 . . . . 71.55 111.149 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.417 ' HB1' HG11 ' A' ' 134' ' ' VAL . . . -59.86 -26.46 65.85 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 113.33 0.863 . . . . 71.42 113.33 171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.57 -33.88 74.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 123.473 0.483 . . . . 62.33 110.758 172.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -78.78 -49.21 13.39 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.691 . . . . 42.32 111.834 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.9 mtp85 -50.0 -26.07 3.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.842 1.793 . . . . 74.32 115.842 -168.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 -58.53 2.54 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 118.34 0.518 . . . . 51.15 110.239 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.47 -55.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.555 0.742 . . . . 72.52 110.5 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.89 -27.02 67.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.422 0.689 . . . . 74.22 112.594 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 67.63 32.44 5.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.615 1.198 . . . . 73.5 109.588 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.449 ' NH2' ' HG3' ' A' ' 71' ' ' GLU . 18.9 ptp180 -168.23 150.73 5.41 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.945 -1.48 . . . . 75.13 110.36 -173.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.22 108.89 5.61 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.822 -0.627 . . . . 74.2 110.286 165.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.05 133.03 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.946 -0.761 . . . . 75.23 108.946 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.25 138.1 95.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.837 -0.601 . . . . 63.43 110.6 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.61 -43.09 23.33 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.839 3.026 . . . . 75.21 114.992 -170.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -70.11 -32.9 71.16 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 112.764 0.653 . . . . 74.1 112.764 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -72.85 -42.31 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.269 0.628 . . . . 53.03 110.953 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.48 -36.35 83.48 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.247 0.619 . . . . 75.42 112.164 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 42' ' ' SER . 3.7 pt20 -79.4 -36.26 39.39 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.909 -0.587 . . . . 71.51 112.077 -176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -81.66 -43.87 17.95 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.223 0.823 . . . . 73.02 113.223 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.59 -60.33 2.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.757 0.423 . . . . 70.1 111.787 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -89.67 38.04 0.9 Allowed 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.651 0.982 . . . . 74.54 113.651 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' GLN . 90.7 p -72.08 -49.83 33.27 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.69 0.396 . . . . 71.21 111.326 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 47' ' ' LYS . . . -69.5 -27.4 73.53 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 123.259 0.457 . . . . 43.14 113.112 174.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -81.63 -39.38 24.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.221 1.009 . . . . 74.43 110.63 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.58 -29.29 67.8 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.337 0.655 . . . . 61.35 111.668 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -65.83 -36.54 83.76 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.665 0.786 . . . . 60.14 111.87 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 43' ' ' GLY . 26.9 mtpp -67.74 -37.85 82.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.912 0.885 . . . . 64.02 111.076 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.0 -37.56 75.73 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.95 0.9 . . . . 70.41 110.862 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.67 -28.68 68.77 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-N 115.988 -0.551 . . . . 23.24 113.753 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -87.84 4.47 44.42 Favored 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 124.173 0.989 . . . . 71.23 111.043 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 50.09 33.6 22.46 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 115.422 0.929 . . . . 34.01 115.422 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -71.29 -80.03 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.077 -0.712 . . . . 64.33 109.077 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -63.04 -164.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 113.962 1.097 . . . . 75.52 113.962 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.2 p -127.58 172.57 10.62 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.211 -1.403 . . . . 33.44 107.211 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.11 -32.39 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 O-C-N 121.833 -0.542 . . . . 75.31 110.039 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -64.72 -38.96 92.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.744 0.818 . . . . 74.44 111.584 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.28 -26.06 42.39 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.679 0.792 . . . . 74.03 109.654 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -62.2 -49.08 77.21 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.235 1.014 . . . . 73.33 110.306 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 ' HD3' ' A' ' 135' ' ' PRO . 96.7 mt -59.91 -28.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 125.202 1.401 . . . . 75.01 112.656 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.8 -42.02 96.78 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.472 0.709 . . . . 62.31 109.764 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.26 -23.61 58.57 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 114.501 0.56 . . . . 63.33 114.501 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.2 mt -68.91 -40.75 78.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.189 0.518 . . . . 54.51 110.147 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.33 -24.6 63.74 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-N 114.846 -1.07 . . . . 62.35 114.027 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -84.84 -12.68 53.02 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.691 0.796 . . . . 75.31 112.487 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -74.98 121.9 22.67 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.946 0.498 . . . . 65.33 111.19 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.23 -15.63 26.37 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.167 0.987 . . . . 64.12 113.503 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.5 tp -59.65 -61.35 2.69 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.209 0.458 . . . . 61.53 112.048 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -51.63 -38.78 56.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 112.771 0.656 . . . . 72.4 112.771 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 3.0 mm? -69.6 -26.59 64.52 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.245 0.831 . . . . 70.24 113.245 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.33 -49.28 72.34 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.756 -1.215 . . . . 73.41 108.994 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HG3' ' NH2' ' A' ' 30' ' ' ARG . 3.2 mm-40 -64.66 -56.89 10.9 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 114.333 -1.303 . . . . 51.24 112.73 172.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.06 69.34 0.72 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.68 0.993 . . . . 65.11 113.68 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 42.4 t80 -170.68 -56.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.013 1.325 . . . . 61.42 108.663 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.2 p -69.97 -39.7 11.46 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.469 1.285 . . . . 63.42 114.469 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.51 -42.61 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.928 0 CA-C-N 122.147 1.802 . . . . 74.24 112.632 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.46 147.67 82.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.546 1.138 . . . . 73.24 112.057 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.21 148.12 84.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.21 1.94 . . . . 62.24 111.55 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -52.38 -49.74 63.82 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.146 0.978 . . . . 71.21 112.807 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.464 ' HA ' HD12 ' A' ' 82' ' ' ILE . 59.7 m -51.71 -44.01 63.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.597 0.962 . . . . 74.24 113.597 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -65.04 -37.13 86.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.984 0.514 . . . . 70.22 111.837 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.29 -24.53 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 122.887 0.475 . . . . 63.32 111.286 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 79' ' ' THR . 90.6 mt -72.03 -54.31 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.208 0.603 . . . . 63.23 111.682 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.66 -23.54 67.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.241 0.544 . . . . 71.03 111.768 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tt -79.85 -45.75 18.11 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.777 1.231 . . . . 70.0 108.684 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.84 -54.26 29.38 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.001 -0.999 . . . . 61.4 114.358 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.58 ' HA ' HD13 ' A' ' 119' ' ' LEU . 34.6 p -54.64 -39.52 68.06 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.201 0.6 . . . . 71.12 112.145 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.05 -37.84 61.93 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 113.449 0.907 . . . . 62.35 113.449 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -88.05 13.68 10.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.617 0.969 . . . . 73.03 113.617 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.74 -69.75 0.51 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.577 0.751 . . . . 60.04 109.677 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.4 HD12 ' HB ' ' A' ' 86' ' ' THR . 78.5 mt -61.78 -19.91 63.01 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.472 1.109 . . . . 72.0 112.781 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.34 87.49 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 114.351 0.501 . . . . 52.43 114.351 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.42 174.92 14.68 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 123.299 0.64 . . . . 53.31 110.721 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.45 160.76 78.89 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 124.001 0.92 . . . . 51.24 111.321 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -55.44 -174.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.038 2.492 . . . . 65.41 114.486 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.55 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 68.5 mt -97.43 -24.34 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 75.21 110.333 -164.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 179.23 -174.86 0.22 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.222 1.409 . . . . 73.43 109.316 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -76.94 -35.06 57.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.665 0.386 . . . . 72.34 111.929 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.45 -35.03 75.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.85 0.46 . . . . 51.2 111.421 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.55 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 19.8 tp10 -57.58 -47.48 82.0 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.726 0.81 . . . . 75.02 110.558 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.11 -46.87 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 124.094 0.957 . . . . 64.34 112.022 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -67.57 -30.58 70.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.392 0.886 . . . . 73.31 113.392 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -53.75 -47.45 70.66 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.467 0.707 . . . . 74.4 110.865 166.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -78.23 -22.17 48.84 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.701 -1.136 . . . . 74.12 111.056 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -74.68 -41.96 59.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.651 1.181 . . . . 64.42 110.72 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -72.11 -49.85 32.86 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.77 0.828 . . . . 73.45 111.267 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 87.6 mt -56.86 -37.22 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 124.466 1.106 . . . . 73.44 111.679 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.06 -49.68 34.53 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.698 0.799 . . . . 74.14 110.953 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.37 95.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.722 0.809 . . . . 63.54 112.634 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.8 p -75.59 -65.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 74.34 112.459 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -87.6 -37.31 16.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.795 0.838 . . . . 75.42 112.953 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 173.51 13.2 Favored Glycine 0 C--N 1.346 1.132 0 C-N-CA 122.002 -0.142 . . . . 51.42 112.98 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 116' ' ' ILE . 9.9 tp -61.29 -30.66 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 123.158 0.583 . . . . 73.21 110.417 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -56.58 -40.48 75.3 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.533 1.133 . . . . 74.4 112.749 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.5 55.7 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.041 0.537 . . . . 71.22 111.386 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 57.9 t80 -65.12 -50.8 64.66 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.75 0.82 . . . . 73.22 110.324 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 112' ' ' ILE . 49.2 mm -59.78 -44.3 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.16 0.984 . . . . 65.42 110.943 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -56.89 -39.73 74.94 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.977 0.911 . . . . 65.33 111.889 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.2 77.72 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.324 0.65 . . . . 74.54 112.26 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 86' ' ' THR . 13.6 mt -79.76 -39.17 31.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.166 0.587 . . . . 74.52 110.937 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.45 -34.2 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.491 0.716 . . . . 62.0 111.176 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -99.7 22.89 10.31 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.368 0.667 . . . . 74.12 112.385 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.4 t -83.03 132.56 35.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.157 0.583 . . . . 65.31 110.773 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -44.34 -37.55 3.39 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.315 1.228 . . . . 71.34 114.315 170.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.33 -41.1 92.83 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-N 118.31 0.505 . . . . 72.41 111.322 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -73.79 -53.88 9.29 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.877 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -69.7 -27.59 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.045 0.757 . . . . 64.22 113.045 -172.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.51 -47.19 34.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.831 0.453 . . . . 74.43 112.169 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.9 -51.78 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.341 0.591 . . . . 62.33 111.273 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -77.1 -67.54 0.7 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.075 0.95 . . . . 72.51 111.12 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.61 -148.12 16.5 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.658 0.623 . . . . 23.31 114.658 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -114.89 -23.73 8.98 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.849 0.859 . . . . 70.32 111.841 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.76 -32.55 12.66 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.314 1.046 . . . . 64.32 113.65 -158.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -98.66 165.98 11.54 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.304 0.853 . . . . 70.33 113.304 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.518 HG23 HD12 ' A' ' 19' ' ' LEU . 6.6 t -83.51 142.27 42.92 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 124.164 0.986 . . . . 74.03 108.766 165.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HD3' HD11 ' A' ' 59' ' ' ILE . 34.6 Cg_endo -61.98 83.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.901 2.4 . . . . 54.5 113.32 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.3 p90 . . . . . 0 C--O 1.246 0.903 0 CA-C-N 114.08 -1.418 . . . . 70.23 108.711 170.258 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 CA--C 1.553 1.068 0 CA-C-O 121.468 0.651 . . . . 73.51 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -80.44 104.98 11.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.368 0.604 . . . . 73.14 110.123 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 133' ' ' THR . 19.6 ptmt -149.16 168.56 22.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.997 0.919 . . . . 71.05 110.144 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 ttp85 -119.4 106.64 12.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.729 -0.471 . . . . 70.43 109.729 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 8' ' ' ALA . 3.3 t -79.0 -149.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.959 0 C-N-CA 124.083 0.953 . . . . 61.21 109.13 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.615 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -85.43 -81.28 0.2 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 119.945 1.248 . . . . 55.4 109.767 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -32.29 -30.22 0.01 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.001 2.76 . . . . 62.51 120.001 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 7' ' ' VAL . 50.8 mt -64.99 105.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 119.855 1.828 . . . . 75.05 110.558 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -155.47 24.62 0.4 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.527 1.131 . . . . 73.43 108.756 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' O ' HG12 ' A' ' 16' ' ' ILE . 3.8 m-20 -100.01 142.72 31.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.141 1.376 . . . . 71.44 108.891 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.45 ' NZ ' ' HG2' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -67.0 -39.23 87.06 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 120.945 1.702 . . . . 74.4 112.631 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.54 66.49 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 122.367 1.08 . . . . 74.24 112.231 171.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB1' HG23 ' A' ' 10' ' ' ILE . . . -76.62 -38.92 53.91 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 112.978 -1.919 . . . . 70.54 111.071 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.62 HG13 ' HA2' ' A' ' 49' ' ' GLY . 51.0 mm -81.21 -39.62 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 N-CA-C 114.029 1.122 . . . . 62.22 114.029 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 28.1 mtpp -74.59 -50.86 16.29 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.109 -0.994 . . . . 72.22 111.347 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 m -49.12 -21.57 0.77 Allowed 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.124 -1.398 . . . . 62.32 113.168 164.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 16' ' ' ILE . 7.8 tt -81.43 -42.98 19.55 Favored 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 123.588 0.755 . . . . 74.31 110.659 169.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 16' ' ' ILE . 85.5 mt -75.18 -48.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 N-CA-C 116.494 2.035 . . . . 53.01 116.494 -171.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 24' ' ' TYR . 44.0 m -66.67 -39.24 88.09 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.702 1.239 . . . . 61.14 109.882 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.94 -28.23 22.58 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 111.58 -2.554 . . . . 71.11 111.708 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.39 24.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.719 0.808 . . . . 54.13 111.763 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CD2' ' HA ' ' A' ' 21' ' ' SER . 21.6 m-85 -68.98 -52.48 28.44 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 120.98 0.419 . . . . 74.2 110.914 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -46.98 -16.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.539 1.311 . . . . 75.05 114.539 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.518 HE22 ' HA ' ' A' ' 88' ' ' HIS . 13.0 tm0? -87.48 -61.16 1.78 Allowed 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.144 0.577 . . . . 72.11 109.627 166.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 59' ' ' ILE . 61.7 mt -78.15 -65.46 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 124.509 1.123 . . . . 73.2 113.119 -170.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 66.4 m-85 -74.87 -9.64 58.73 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.032 0.933 . . . . 62.22 112.476 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 76.33 -56.02 0.58 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.988 1.715 . . . . 70.44 112.914 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -84.07 156.33 22.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.95 0.9 . . . . 64.33 112.927 -165.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -62.84 120.01 10.48 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.569 -1.196 . . . . 75.25 109.717 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.4 mt -109.65 120.24 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.454 -1.684 . . . . 70.35 106.454 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 134.06 72.29 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 123.929 0.768 . . . . 61.32 112.06 -172.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.33 -31.02 36.02 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.811 3.007 . . . . 71.11 115.164 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -75.89 -39.05 57.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.722 0.409 . . . . 73.43 111.989 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -47.77 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 122.735 0.414 . . . . 71.2 110.205 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.06 79.19 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.111 0.964 . . . . 51.13 112.561 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -75.42 -25.03 57.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.252 0.464 . . . . 52.03 112.252 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.29 -47.56 15.65 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 117.987 0.358 . . . . 75.54 111.622 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -66.07 -51.21 60.18 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.469 0.708 . . . . 74.12 111.168 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.22 48.23 0.85 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.054 -0.976 . . . . 65.22 110.373 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -64.97 -51.88 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.246 0.462 . . . . 41.31 112.246 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -31.29 58.5 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.045 -0.525 . . . . 52.01 113.287 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -72.22 -50.96 23.36 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.254 0.622 . . . . 73.33 111.494 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HG2' ' NZ ' ' A' ' 13' ' ' LYS . 35.7 tt0 -50.36 -37.91 39.61 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.503 0.927 . . . . 74.3 113.503 165.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.6 m -65.82 -35.6 81.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.484 0.314 . . . . 74.13 111.495 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -65.08 -42.38 94.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.218 0.451 . . . . 74.3 112.218 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.77 -50.7 33.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 120.755 0.312 . . . . 73.34 111.056 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.62 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -50.58 -51.36 33.03 Favored Glycine 0 CA--C 1.545 1.909 0 N-CA-C 116.285 1.274 . . . . 54.31 116.285 174.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 2.2 m-20 -73.11 0.19 12.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.925 1.083 . . . . 73.31 113.925 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.33 26.29 67.74 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.745 0.658 . . . . 54.23 114.745 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.0 mm-40 -67.61 -29.94 69.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.941 0.896 . . . . 75.42 111.164 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.419 HD11 ' HD1' ' A' ' 58' ' ' PHE . 21.1 pt -132.77 156.67 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.518 1.127 . . . . 64.35 108.93 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 57' ' ' GLU . 10.2 t -82.04 166.86 19.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.028 -0.42 . . . . 73.43 110.738 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -61.79 -38.31 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.717 0.407 . . . . 43.4 111.172 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 57' ' ' GLU . 1.1 tmtp? -56.79 -58.79 6.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.604 1.162 . . . . 72.23 112.137 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.565 ' H ' HG23 ' A' ' 54' ' ' THR . 21.8 tt0 -50.1 -34.57 22.35 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 114.375 -1.284 . . . . 54.33 111.983 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.424 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 59.8 t80 -71.48 -38.03 71.26 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 123.399 0.68 . . . . 75.42 112.211 173.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 27' ' ' ILE . 22.4 mm -73.36 -50.24 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 124.731 1.213 . . . . 70.33 111.696 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.526 ' HB2' HG11 ' A' ' 120' ' ' VAL . 31.9 tt0 -51.02 -41.43 59.8 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.487 1.115 . . . . 72.5 110.878 163.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.21 -38.9 62.64 Favored Glycine 0 CA--C 1.55 2.219 0 CA-C-N 112.438 -2.164 . . . . 74.12 112.98 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 80.9 mt -77.15 -36.02 55.59 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.068 0.947 . . . . 54.33 112.328 176.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.68 -21.85 61.12 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 114.31 0.484 . . . . 64.52 114.31 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -77.44 -34.18 54.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.502 0.721 . . . . 71.24 111.831 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 t -48.04 140.55 6.9 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.473 1.286 . . . . 73.34 114.473 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -62.02 -30.09 70.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.696 1.199 . . . . 63.22 113.423 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 tp -69.43 -24.27 63.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.399 0.619 . . . . 73.32 111.593 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.92 -34.87 57.67 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.13 -0.941 . . . . 72.53 108.752 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 -51.31 20.05 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.882 -1.053 . . . . 71.14 113.697 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 12.7 ptpt -64.15 -55.66 20.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.995 2.18 . . . . 64.32 115.234 172.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -51.51 -22.69 3.35 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.629 1.714 . . . . 54.4 115.629 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -137.44 -19.62 1.22 Allowed 'General case' 0 N--CA 1.514 2.768 0 N-CA-C 116.939 2.2 . . . . 73.03 116.939 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.418 ' HA ' HG22 ' A' ' 81' ' ' VAL . 85.8 t80 -110.83 -37.49 5.4 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.512 1.051 . . . . 73.33 112.773 -176.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.9 m -71.52 -46.74 13.17 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 114.332 1.234 . . . . 73.34 114.332 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.4 Cg_endo -84.08 -15.02 6.97 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.784 2.323 . . . . 52.33 112.408 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.6 140.21 21.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.66 0.784 . . . . 71.54 110.91 -172.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.407 ' O ' HG23 ' A' ' 81' ' ' VAL . 46.2 Cg_endo -66.01 151.93 82.65 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.148 1.899 . . . . 73.03 111.447 171.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -45.74 -28.42 1.03 Allowed 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.859 1.264 . . . . 70.54 112.605 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 m -61.61 -52.67 63.43 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.502 -1.681 . . . . 71.12 109.87 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.419 ' HD2' ' HB3' ' A' ' 83' ' ' GLU . 55.2 tptt -73.83 -26.87 60.82 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.182 0.993 . . . . 64.11 113.232 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.515 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 62.8 t -66.13 -25.16 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 122.955 0.502 . . . . 64.32 111.271 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.517 HG22 ' HB3' ' A' ' 94' ' ' PRO . 46.3 mt -80.41 -28.53 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.164 0.985 . . . . 61.44 112.466 169.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 80' ' ' LYS . 6.0 tm-20 -76.85 -51.92 10.42 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.453 0.701 . . . . 75.31 109.43 -172.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 87' ' ' LYS . 93.9 mt -75.53 -15.09 60.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.561 1.144 . . . . 74.32 109.829 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . -82.05 -49.8 5.15 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.02 -0.991 . . . . 65.34 114.026 -158.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -73.3 -19.21 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.973 1.387 . . . . 51.03 110.577 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 91.8 mttt -62.18 -33.31 74.3 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.015 -0.993 . . . . 75.11 111.371 -167.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.518 ' HA ' HE22 ' A' ' 26' ' ' GLN . 66.5 m-70 -87.88 13.11 11.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.854 0.862 . . . . 65.42 113.031 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -138.74 -58.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.531 -1.285 . . . . 75.02 107.531 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.523 HD12 ' HE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -127.04 91.1 3.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.143 0.977 . . . . 73.2 108.978 164.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 87' ' ' LYS . . . -65.69 87.26 0.1 OUTLIER Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.656 -0.702 . . . . 75.43 113.015 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.523 ' HE ' HD12 ' A' ' 90' ' ' LEU . 4.4 ptp180 -143.31 24.46 1.77 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.925 0.49 . . . . 64.31 111.766 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.21 174.58 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.307 0.855 . . . . 72.31 113.307 -158.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 82' ' ' ILE . 61.5 Cg_endo -72.25 137.24 28.21 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.694 1.596 . . . . 62.22 110.518 161.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.92 -61.39 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.428 1.091 . . . . 70.44 112.134 -170.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -147.76 157.84 43.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.718 0.407 . . . . 71.42 111.005 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -63.25 -10.35 15.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.425 0.898 . . . . 64.42 113.425 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.96 -42.05 12.73 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.264 1.031 . . . . 71.34 108.389 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 102' ' ' LYS . 4.0 tm-20 -64.25 -32.47 74.07 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 113.759 -1.564 . . . . 74.55 111.62 170.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.88 -54.49 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 123.284 0.634 . . . . 61.24 110.024 173.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -46.55 -34.74 5.14 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 114.23 1.196 . . . . 54.41 114.23 167.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 31.6 ttpt -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.969 0.508 . . . . 74.43 112.035 175.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.15 -46.53 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.596 0.358 . . . . 74.44 110.607 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -44.86 -42.6 8.11 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.153 0.981 . . . . 74.42 112.962 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -64.88 -29.63 70.59 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.142 0.428 . . . . 72.14 111.777 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.9 mt -79.67 -57.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.086 -1.079 . . . . 70.14 108.086 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.6 tp -45.99 -35.0 4.38 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.422 1.638 . . . . 61.42 115.422 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.32 -21.57 53.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.032 0.752 . . . . 51.33 113.032 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.7 p -113.2 -14.46 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.093 0.557 . . . . 71.41 112.08 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -138.97 -51.8 0.55 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.692 0.797 . . . . 74.12 111.156 -170.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.86 169.85 13.68 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 114.258 0.463 . . . . 52.13 114.258 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' ' 115' ' ' PHE . 8.0 tp -37.74 -34.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.247 1.573 . . . . 72.53 115.247 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -53.39 -53.91 44.42 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.397 0.679 . . . . 74.41 111.508 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.34 37.65 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.543 -1.208 . . . . 63.11 112.033 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.403 ' HD2' HD12 ' A' ' 112' ' ' ILE . 31.0 t80 -50.64 -70.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.51 1.3 . . . . 75.34 114.51 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.44 -37.07 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 114.034 1.124 . . . . 63.02 114.034 170.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -67.14 -38.14 85.03 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.772 0.715 . . . . 74.31 111.218 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.19 -52.05 57.25 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 123.082 0.553 . . . . 75.44 111.806 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.2 mt -49.66 -54.55 17.92 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.445 0.906 . . . . 63.33 113.445 171.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 60' ' ' GLU . 89.9 t -69.11 -26.34 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 123.84 0.856 . . . . 72.32 112.694 -172.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -100.6 13.55 34.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.146 0.795 . . . . 71.41 113.146 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.3 m -66.92 151.01 48.4 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 122.863 0.465 . . . . 70.13 110.371 167.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.529 ' HG3' HD21 ' A' ' 126' ' ' ASN . 29.9 tt0 -72.0 -25.24 61.76 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.0 0.818 . . . . 73.41 110.524 -174.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.506 ' HB3' HH21 ' A' ' 92' ' ' ARG . 41.4 mt-10 -62.15 -36.11 80.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.877 0.871 . . . . 51.25 111.329 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -67.69 -40.3 84.38 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 109.995 -0.372 . . . . 75.52 109.995 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.529 HD21 ' HG3' ' A' ' 123' ' ' GLN . 1.5 p30 -68.6 -38.4 80.58 Favored 'General case' 0 C--N 1.366 1.311 0 CA-C-O 118.673 -0.679 . . . . 73.52 112.025 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -60.87 -56.88 15.92 Favored 'General case' 0 C--N 1.367 1.337 0 N-CA-C 115.257 1.576 . . . . 75.21 115.257 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.98 -35.84 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.348 0.594 . . . . 72.02 111.397 -162.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 44.2 m-85 -111.94 -45.35 3.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.517 -0.765 . . . . 55.53 110.688 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.62 -87.36 0.93 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.403 -1.479 . . . . 41.44 109.403 -162.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.25 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.134 0.973 . . . . 75.42 111.175 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -81.8 36.71 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.67 0.788 . . . . 70.02 112.385 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 5' ' ' LYS . 45.5 m -147.52 145.4 29.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.026 0.93 . . . . 75.22 110.051 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.05 132.83 82.2 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 108.65 -0.87 . . . . 74.42 108.65 172.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 38.1 Cg_endo -62.0 81.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.598 2.199 . . . . 44.44 113.447 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.9 p90 . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 123.006 0.522 . . . . 62.55 111.18 178.91 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.184 0.516 . . . . 52.12 112.307 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -71.4 132.75 45.26 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.994 0.518 . . . . 75.31 110.101 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -152.6 159.84 43.22 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.502 . . . . 63.54 112.017 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.7 100.03 12.03 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.548 -0.908 . . . . 71.32 108.548 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.436 ' H ' HD12 ' A' ' 10' ' ' ILE . 98.0 t -78.38 141.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.614 -0.514 . . . . 72.51 109.614 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.99 93.07 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.359 0.664 . . . . 64.01 111.845 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.15 2.01 6.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 119.457 -0.635 . . . . 72.33 114.462 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 7' ' ' VAL . 35.2 mt -79.88 82.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.673 1.236 . . . . 73.44 109.951 172.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -107.03 13.22 27.76 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.02 -0.991 . . . . 72.33 110.077 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.85 116.5 22.78 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.547 1.139 . . . . 73.14 109.076 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.34 -24.11 63.86 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.925 1.083 . . . . 75.12 113.925 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.95 -31.18 70.73 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.077 0.465 . . . . 63.35 111.06 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -50.21 13.94 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.645 -0.707 . . . . 72.3 110.698 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.2 mm -55.65 -45.45 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.406 1.082 . . . . 61.13 113.191 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.55 -39.54 91.44 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 111.988 0.366 . . . . 74.41 111.988 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 m -62.74 -41.13 99.05 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.394 0.677 . . . . 75.53 112.053 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.491 HD23 HD21 ' A' ' 48' ' ' LEU . 20.6 tp -61.78 -44.7 96.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.368 0.667 . . . . 74.4 111.086 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.16 -41.32 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.666 1.186 . . . . 72.44 111.147 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.6 m -62.94 -53.02 60.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.387 0.675 . . . . 54.25 111.287 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.62 82.16 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.714 0.806 . . . . 72.45 112.539 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.86 -42.93 72.64 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.123 0.569 . . . . 42.21 111.357 173.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.34 -43.72 85.33 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.278 0.631 . . . . 64.03 111.979 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -68.21 -13.2 62.06 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.334 0.654 . . . . 55.44 112.308 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -89.77 -63.13 1.33 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.771 0.428 . . . . 71.14 111.386 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -65.12 -57.78 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 122.662 0.385 . . . . 64.21 110.727 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -83.04 -13.05 56.58 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.291 0.636 . . . . 75.24 112.252 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 65.58 -53.44 0.36 Allowed 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.367 1.467 . . . . 72.44 114.108 -168.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -57.57 128.76 38.66 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.203 1.001 . . . . 71.32 113.022 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.0 120.31 13.42 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.117 -0.947 . . . . 75.14 109.515 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.79 126.7 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.378 -0.601 . . . . 74.44 109.378 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.34 135.23 96.15 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 123.649 0.593 . . . . 62.45 109.991 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 -35.1 86.82 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.409 2.739 . . . . 74.13 114.14 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -69.73 -38.8 77.01 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.484 0.314 . . . . 75.11 111.437 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.423 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 71.4 mt -63.05 -41.73 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.547 0.739 . . . . 71.1 110.269 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -53.22 59.77 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.084 -0.962 . . . . 41.31 111.855 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' ' 38' ' ' GLN . 2.5 pt20 -79.6 -11.44 59.87 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.954 1.464 . . . . 70.21 114.954 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 36' ' ' ILE . 8.4 p30 -81.66 -45.21 16.09 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.875 1.216 . . . . 64.42 110.797 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.77 -46.27 14.46 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.804 0.841 . . . . 74.14 111.609 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -105.8 44.3 1.05 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 124.657 1.183 . . . . 64.44 109.755 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -51.67 66.88 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.818 0.673 . . . . 60.42 112.818 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.05 -30.88 64.82 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.625 -0.716 . . . . 61.01 112.569 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.41 ' CZ2' ' HA3' ' A' ' 61' ' ' GLY . 13.8 t-105 -72.58 -42.05 65.02 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.305 1.042 . . . . 75.33 111.701 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.85 -50.44 73.43 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.443 1.097 . . . . 64.02 110.777 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.1 t -59.61 -43.79 93.63 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.014 -0.994 . . . . 62.03 111.786 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HG2' HG12 ' A' ' 53' ' ' ILE . 25.2 ttmm -58.83 -46.5 87.54 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.755 1.222 . . . . 54.44 112.553 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.491 HD21 HD23 ' A' ' 19' ' ' LEU . 48.4 tp -64.56 -44.71 89.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.778 0.431 . . . . 75.32 111.278 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.73 -39.97 98.16 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 116.36 -0.382 . . . . 62.32 113.863 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -79.96 6.49 11.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.109 0.964 . . . . 73.22 112.915 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.35 32.55 68.32 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 114.595 0.598 . . . . 72.23 114.595 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.14 -26.53 42.8 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.155 0.582 . . . . 74.42 109.531 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.409 HG12 ' HG2' ' A' ' 47' ' ' LYS . 40.5 pt -134.76 170.14 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 124.282 1.033 . . . . 74.22 110.764 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.6 p -95.58 -176.57 3.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.388 0.675 . . . . 71.1 109.637 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 59' ' ' ILE . 80.0 t -65.89 -45.81 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 119.27 -0.395 . . . . 73.31 110.927 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 51.0 tttm -47.43 -52.65 16.27 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.807 1.04 . . . . 72.23 113.807 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.72 -37.17 85.47 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.672 0.389 . . . . 61.43 111.707 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.431 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 50.7 t80 -61.22 -43.27 99.15 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.66 0.784 . . . . 71.42 111.124 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 55' ' ' VAL . 34.9 mm -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.829 1.252 . . . . 64.32 111.247 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -52.18 -45.48 65.14 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.597 0.759 . . . . 72.13 112.061 172.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' HA3' ' CZ2' ' A' ' 44' ' ' TRP . . . -62.84 -36.79 93.87 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.266 -0.425 . . . . 75.21 113.324 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 46.2 mt -64.69 -44.11 91.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.378 0.671 . . . . 73.54 111.551 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.39 -34.74 86.43 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 115.447 0.939 . . . . 74.34 115.447 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -74.71 -23.13 58.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.29 0.545 . . . . 75.54 112.011 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -55.85 134.44 51.88 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.502 0.926 . . . . 72.52 113.502 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -60.65 -26.2 66.88 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.269 1.028 . . . . 73.2 112.092 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.18 -39.53 93.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.964 0.506 . . . . 72.14 111.1 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -69.33 -39.25 78.28 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.19 0.519 . . . . 74.34 110.56 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD11 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -64.74 -31.19 72.3 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.655 -0.702 . . . . 74.14 112.132 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -75.23 -46.34 34.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.865 0.466 . . . . 75.51 111.287 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -82.68 -46.31 13.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.804 0.668 . . . . 74.42 112.804 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.56 48.64 1.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 112.772 0.656 . . . . 64.32 112.772 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 74.6 t80 -159.68 -48.37 0.05 Allowed 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 116.082 -0.508 . . . . 75.13 110.88 171.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 m -66.02 -47.28 63.36 Favored Pre-proline 0 CA--C 1.573 1.848 0 N-CA-C 112.815 0.672 . . . . 62.13 112.815 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -90.08 11.07 2.87 Favored 'Trans proline' 0 C--N 1.395 2.993 0 C-N-CA 122.638 2.225 . . . . 75.02 113.202 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.0 141.26 38.97 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 122.988 0.515 . . . . 72.12 111.861 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.29 158.24 58.32 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.501 2.134 . . . . 75.43 111.384 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -51.54 -41.99 61.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.573 0.582 . . . . 74.52 112.573 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.9 m -54.14 -42.85 70.0 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.514 0.726 . . . . 53.12 111.536 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -74.92 -33.17 61.94 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.061 0.545 . . . . 70.32 112.019 178.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.09 -31.96 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.231 0.539 . . . . 75.52 110.921 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.58 -49.73 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.795 0.838 . . . . 64.44 111.008 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 80' ' ' LYS . 13.4 pt-20 -71.18 -35.47 71.6 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 111.588 0.218 . . . . 64.22 111.588 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.94 -44.53 26.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.314 0.645 . . . . 71.31 110.99 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.38 -49.86 58.82 Favored Glycine 0 N--CA 1.475 1.265 0 O-C-N 123.292 0.37 . . . . 75.43 113.639 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.599 HG23 HD13 ' A' ' 90' ' ' LEU . 86.7 m -55.73 -40.39 72.41 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 123.033 0.533 . . . . 73.25 110.632 171.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -71.33 -21.77 62.0 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 123.075 0.55 . . . . 74.31 111.434 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 67.2 m170 -87.29 -8.57 56.59 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.03 0.932 . . . . 71.01 112.363 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.8 -61.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.389 1.076 . . . . 74.45 108.88 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.599 HD13 HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -110.08 84.74 1.98 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.359 -1.348 . . . . 62.44 107.359 176.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.53 78.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 114.896 0.718 . . . . 51.51 114.896 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.632 HH12 HD11 ' A' ' 95' ' ' ILE . 27.8 mtm105 -137.94 151.43 47.96 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.375 1.07 . . . . 74.4 111.089 -174.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 132.02 85.85 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-N 115.471 -0.786 . . . . 62.21 110.748 168.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.27 135.91 46.28 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.31 2.673 . . . . 70.02 113.824 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.632 HD11 HH12 ' A' ' 92' ' ' ARG . 49.6 mm -82.69 -69.12 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.495 0.718 . . . . 75.43 112.76 -170.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -147.81 156.58 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.583 0.753 . . . . 72.12 109.073 -165.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -58.44 -40.31 82.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.954 0.724 . . . . 75.22 112.954 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.63 71.78 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.248 0.462 . . . . 43.53 112.248 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -65.7 -40.32 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.613 0.765 . . . . 75.33 110.919 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.03 -50.44 64.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.533 0.733 . . . . 73.21 110.968 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.2 mmm180 -52.05 -40.85 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.537 1.135 . . . . 72.04 112.386 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.417 ' O ' HG13 ' A' ' 106' ' ' ILE . 35.7 ttpt -56.39 -52.68 63.73 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.76 0.824 . . . . 71.53 111.194 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -72.24 -36.79 69.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.795 0.438 . . . . 74.45 112.167 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.47 -40.83 96.43 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.956 0.902 . . . . 65.34 111.296 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.45 HE21 HG23 ' A' ' 109' ' ' THR . 24.3 tp60 -67.6 -28.93 68.17 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.466 -0.788 . . . . 70.33 111.015 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 102' ' ' LYS . 82.2 mt -63.19 -39.14 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 122.991 0.516 . . . . 61.3 110.526 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.96 -39.92 96.11 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.836 0.454 . . . . 72.43 111.602 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.21 -37.32 53.63 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.716 0.635 . . . . 54.23 112.716 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.45 HG23 HE21 ' A' ' 105' ' ' GLN . 67.0 p -80.93 -60.15 2.41 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.193 0.597 . . . . 71.33 112.493 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -103.04 -36.23 8.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.0 0.92 . . . . 72.34 112.801 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.4 -162.01 12.51 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 122.847 0.261 . . . . 63.21 113.315 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.437 HG12 HD11 ' A' ' 69' ' ' LEU . 9.5 tp -79.69 -29.14 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.111 0.564 . . . . 75.44 111.476 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.434 ' H ' ' HD3' ' A' ' 113' ' ' ARG . 0.8 OUTLIER -59.64 -49.42 77.82 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.384 0.673 . . . . 74.4 110.381 -175.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -33.3 73.88 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.128 -0.942 . . . . 74.3 112.738 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.21 -52.29 66.3 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.234 0.613 . . . . 73.52 111.328 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.83 -45.68 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.666 0.786 . . . . 72.34 110.718 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -57.94 -35.68 71.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.166 0.986 . . . . 72.12 111.387 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -67.55 -48.37 67.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.128 0.571 . . . . 73.12 111.387 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' A' ' 90' ' ' LEU . 82.0 mt -58.31 -44.74 88.73 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.617 0.767 . . . . 62.5 112.554 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.8 t -68.17 -52.19 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.079 0.952 . . . . 71.44 111.954 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.81 24.06 4.4 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.291 0.636 . . . . 60.24 112.155 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 19.6 t -79.53 155.4 28.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.577 0.751 . . . . 72.11 112.275 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.98 -52.58 64.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.691 0.796 . . . . 65.51 110.952 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.94 -30.84 66.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.852 0.861 . . . . 73.14 112.595 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -71.45 -54.26 11.23 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.218 0.207 . . . . 75.45 111.098 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -69.48 -34.3 74.13 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.961 0.726 . . . . 75.22 112.961 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.57 -42.58 58.51 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 111.682 0.252 . . . . 63.1 111.682 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.81 -54.79 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.289 0.636 . . . . 75.22 111.857 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.488 ' HE2' ' H ' ' A' ' 136' ' ' TYR . 52.9 m-85 -88.41 -49.29 7.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.164 0.986 . . . . 63.34 110.832 -176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 93.25 -118.91 5.77 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.218 -0.447 . . . . 71.42 112.546 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -141.31 -23.18 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.858 0.863 . . . . 74.22 111.615 176.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -84.13 -23.54 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.558 0.577 . . . . 62.0 112.558 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.2 m -93.74 138.09 32.31 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.277 0.473 . . . . 72.11 112.277 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.18 136.34 75.92 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.851 0.86 . . . . 73.1 109.678 168.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -34.77 111.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.586 3.524 . . . . 62.34 115.5 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.488 ' H ' ' HE2' ' A' ' 129' ' ' PHE . 52.9 p90 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 123.395 0.678 . . . . 75.02 110.88 175.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.922 0.391 . . . . 73.43 110.893 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 70.15 29.14 3.83 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.193 1.397 . . . . 70.15 112.845 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.25 145.89 24.14 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.855 -0.528 . . . . 71.32 109.597 170.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -78.26 101.23 7.03 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.564 -0.532 . . . . 74.12 109.564 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.02 113.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.29 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.144 0.978 . . . . 75.13 112.608 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.58 -18.02 4.4 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 115.436 -0.802 . . . . 53.33 114.267 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.43 104.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 117.903 0.852 . . . . 71.53 111.162 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -86.54 -38.22 17.41 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 73.3 111.406 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.01 102.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.78 1.232 . . . . 71.33 113.894 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.612 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 68.5 mttt -67.77 -9.19 41.9 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.542 -0.754 . . . . 75.42 112.54 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.04 -39.6 79.1 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.561 0.744 . . . . 75.52 110.91 163.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.64 43.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.745 0.818 . . . . 63.34 110.991 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 1.7 mp -58.0 -39.81 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.079 0.951 . . . . 75.32 110.827 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -64.71 -49.88 69.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.999 0.52 . . . . 62.22 111.467 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -54.39 -42.36 70.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.166 0.802 . . . . 75.2 113.166 172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 48' ' ' LEU . 9.6 tt -58.27 -48.41 80.53 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.171 0.988 . . . . 74.14 110.893 173.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.69 -43.24 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.386 1.074 . . . . 75.11 111.379 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.3 m -63.75 -48.68 76.04 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.347 0.659 . . . . 55.43 111.012 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.82 57.77 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.327 0.862 . . . . 74.2 113.327 170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.15 72.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.259 0.837 . . . . 45.11 113.259 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -72.96 -48.1 39.63 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.588 0.755 . . . . 75.25 111.227 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.4 ttm180 -51.02 -36.88 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.223 1.009 . . . . 60.01 113.668 172.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.21 -63.68 1.27 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.8 0.44 . . . . 44.02 110.576 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.458 HD11 HG13 ' A' ' 59' ' ' ILE . 61.2 mt -65.32 -48.4 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.913 0.885 . . . . 70.32 112.452 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -84.35 9.63 12.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.258 0.623 . . . . 72.41 111.628 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 49.95 19.87 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 125.922 1.689 . . . . 70.03 115.183 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -164.12 143.51 7.75 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.416 0.626 . . . . 65.54 111.604 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.2 111.21 2.86 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.008 -0.996 . . . . 53.12 111.042 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.2 mt -78.89 134.89 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 116.105 -0.498 . . . . 72.24 109.968 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 123.8 52.98 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 124.254 0.971 . . . . 72.41 110.649 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -54.15 -37.84 87.47 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.526 2.817 . . . . 62.53 114.069 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -67.85 -24.91 65.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.663 0.785 . . . . 73.15 113.07 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.36 -44.45 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.213 0.605 . . . . 53.32 110.681 171.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.18 80.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.064 0.945 . . . . 65.45 112.195 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -72.55 -25.26 61.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.982 0.513 . . . . 65.42 111.833 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.31 -47.23 18.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.667 0.787 . . . . 62.41 110.977 -170.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.2 -32.89 59.22 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.633 -0.712 . . . . 72.41 110.764 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.37 43.08 1.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.902 0.881 . . . . 73.42 111.07 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -68.61 -43.91 75.39 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.163 0.585 . . . . 75.14 112.433 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.89 -26.89 61.52 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.844 -0.502 . . . . 42.32 111.844 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -82.21 -30.85 30.62 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.088 0.955 . . . . 75.11 110.483 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -68.79 -41.58 78.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.95 0.9 . . . . 73.41 108.862 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 t -57.09 -35.65 69.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.62 0.768 . . . . 71.4 111.92 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -42.6 99.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.9 0.48 . . . . 72.54 111.279 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 19' ' ' LEU . 49.2 tp -73.24 -36.07 66.36 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.736 0.815 . . . . 55.41 111.503 177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.7 -48.42 12.78 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 123.313 0.482 . . . . 63.1 113.153 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -78.26 3.15 16.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.744 0.646 . . . . 74.04 112.744 172.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.4 34.09 67.58 Favored Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.727 0.651 . . . . 74.22 114.727 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -68.46 -28.34 66.96 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.509 0.724 . . . . 73.44 111.58 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 pt -130.03 170.42 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.365 1.066 . . . . 72.14 110.362 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p -90.8 164.35 14.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.206 0.602 . . . . 62.14 110.258 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.73 -41.23 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.612 0.365 . . . . 74.11 110.46 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 87.0 tttt -41.78 -55.59 2.97 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.253 1.205 . . . . 73.43 114.253 162.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -66.07 -26.79 67.66 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.921 -0.581 . . . . 74.02 111.777 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -72.99 -38.36 66.68 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.166 0.986 . . . . 74.12 110.801 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.458 HG13 HD11 ' A' ' 27' ' ' ILE . 1.2 mp -73.41 -45.17 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.972 1.309 . . . . 73.21 111.829 -174.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.527 ' HB2' HG11 ' A' ' 120' ' ' VAL . 32.6 tt0 -50.28 -35.92 29.24 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.69 0.626 . . . . 74.21 112.69 165.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.45 -26.95 74.05 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-N 115.93 -0.577 . . . . 73.55 112.439 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -74.04 -48.34 30.64 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.999 0.92 . . . . 64.13 111.2 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.69 -31.65 45.82 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 116.308 1.283 . . . . 41.41 116.308 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -72.44 -17.86 61.75 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 117.472 0.636 . . . . 73.35 112.119 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -75.4 131.87 40.5 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.395 0.678 . . . . 53.24 111.368 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -61.03 -18.95 60.54 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.73 0.812 . . . . 73.42 112.808 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 32.3 tp -61.71 -41.14 97.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.608 0.763 . . . . 64.23 111.189 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.07 -37.16 86.63 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.042 0.448 . . . . 71.33 111.308 172.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.526 HD11 HG21 ' A' ' 112' ' ' ILE . 4.2 mm? -70.99 -30.11 66.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.883 0.873 . . . . 71.03 112.722 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -77.58 -25.02 49.65 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 122.133 -0.354 . . . . 61.55 110.59 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 22.4 mm-40 -75.49 -56.27 4.87 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.561 172.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -130.08 70.35 1.44 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.775 0.657 . . . . 54.33 112.775 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.41 ' H ' ' HD2' ' A' ' 75' ' ' PRO . 52.0 t80 -176.04 -61.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.493 0.717 . . . . 75.22 110.53 174.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -65.16 -38.46 28.29 Favored Pre-proline 0 CA--C 1.573 1.849 0 N-CA-C 113.961 1.097 . . . . 61.21 113.961 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 73' ' ' TYR . 43.2 Cg_endo -94.73 17.41 0.89 Allowed 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 121.987 1.791 . . . . 72.25 113.674 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -137.46 153.42 74.46 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 123.857 0.863 . . . . 71.44 111.372 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.94 153.56 63.43 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.226 1.951 . . . . 64.45 111.551 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -46.81 -54.32 10.1 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.329 1.233 . . . . 72.35 114.329 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -49.2 -32.68 10.86 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 113.956 1.095 . . . . 75.35 113.956 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -74.89 -27.63 60.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.882 0.473 . . . . 73.43 111.196 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.75 -30.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.761 0.824 . . . . 71.52 111.755 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 100' ' ' ILE . 2.0 mp -67.44 -43.78 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.004 0.521 . . . . 65.13 110.884 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.42 -26.04 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.095 -0.502 . . . . 54.14 111.846 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.6 mt -85.38 -31.17 23.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.635 0.774 . . . . 54.11 111.771 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.99 -54.75 12.61 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 116.218 -0.447 . . . . 64.11 112.435 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.644 HG23 HD12 ' A' ' 90' ' ' LEU . 47.8 m -57.64 -30.63 65.55 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.308 1.043 . . . . 54.32 111.464 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.41 -38.4 77.91 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.854 0.862 . . . . 72.44 111.819 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -94.27 -1.48 53.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.147 1.166 . . . . 73.42 114.147 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -123.36 -57.92 1.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.061 0.391 . . . . 72.33 111.69 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.644 HD12 HG23 ' A' ' 86' ' ' THR . 60.8 mt -84.12 -12.72 54.56 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.302 0.241 . . . . 72.54 111.389 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.56 11.16 56.26 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 116.2 -0.455 . . . . 72.32 113.551 -173.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -104.92 135.17 46.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.977 0.911 . . . . 53.51 111.547 -167.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.92 158.4 70.5 Favored Pre-proline 0 CA--C 1.565 1.531 0 CA-C-N 115.383 -0.826 . . . . 41.33 111.386 169.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.87 161.59 0.48 Allowed 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.043 2.495 . . . . 71.25 113.961 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.16 -75.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.771 -0.825 . . . . 73.23 108.771 -160.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -141.04 153.24 45.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.257 1.423 . . . . 73.02 107.437 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -63.26 -14.44 49.41 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.905 1.229 . . . . 53.32 113.618 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.37 -31.27 21.58 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.21 -1.033 . . . . 62.21 108.21 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.52 -39.53 77.48 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.289 1.436 . . . . 70.32 111.114 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.412 ' HA ' HG21 ' A' ' 82' ' ' ILE . 87.8 mt -64.02 -52.8 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.244 0.618 . . . . 62.43 110.264 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -55.26 -31.22 61.37 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.213 1.005 . . . . 75.31 113.514 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.27 -49.35 74.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.548 0.339 . . . . 74.52 110.818 173.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -68.27 -39.66 82.12 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.971 0.509 . . . . 73.52 111.29 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -58.76 -42.77 89.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.39 1.076 . . . . 73.45 112.463 172.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -62.39 -27.39 69.05 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.25 0.62 . . . . 74.02 111.958 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.04 -60.33 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 108.798 -0.816 . . . . 61.34 108.798 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 115' ' ' PHE . 22.8 tp -41.96 -31.97 0.39 Allowed 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 115.658 1.725 . . . . 64.32 115.658 160.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.19 -41.47 25.19 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 119.176 0.898 . . . . 73.42 112.317 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.2 p -97.79 -22.97 16.1 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.024 0.75 . . . . 54.23 113.024 -172.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -126.36 -38.07 2.15 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.426 0.69 . . . . 75.34 112.113 -171.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.61 174.33 14.0 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 113.986 0.354 . . . . 62.05 113.986 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -67.66 -29.6 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.051 0.94 . . . . 73.01 110.62 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -54.67 -53.0 60.57 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.629 0.772 . . . . 74.51 111.371 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.24 -29.03 70.15 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.973 0.909 . . . . 64.23 113.153 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 55.3 t80 -67.76 -49.51 62.08 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.407 0.683 . . . . 71.42 111.106 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -59.37 -46.34 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.586 0.754 . . . . 55.4 110.414 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.67 -40.45 75.55 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.715 0.806 . . . . 51.13 112.345 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.64 93.22 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.262 0.625 . . . . 34.5 112.119 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' ' 90' ' ' LEU . 83.6 mt -72.6 -55.74 6.42 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.303 0.641 . . . . 75.04 111.816 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 60' ' ' GLU . 88.7 t -61.66 -42.6 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.57 0.748 . . . . 71.22 112.412 -173.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -82.75 -0.47 47.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.294 0.85 . . . . 71.23 113.294 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -66.95 158.02 31.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.015 0.526 . . . . 73.02 111.913 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -65.12 -25.99 68.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.823 0.849 . . . . 61.23 110.628 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.55 ' HB2' HD22 ' A' ' 90' ' ' LEU . 42.6 mm-40 -62.89 -48.35 79.38 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.201 1.0 . . . . 71.23 111.671 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -68.46 -46.33 70.06 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.437 0.637 . . . . 73.43 110.013 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.74 -52.03 64.83 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.468 -1.242 . . . . 74.05 112.32 -165.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.49 -42.65 19.96 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.467 0.914 . . . . 71.23 113.467 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.07 -49.16 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.252 0.621 . . . . 73.2 112.5 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -96.15 -53.98 3.46 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 120.991 0.424 . . . . 74.53 111.195 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.7 144.3 13.51 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.853 -0.612 . . . . 35.24 111.581 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 16.3 pt-20 -74.84 -19.5 60.15 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.768 0.655 . . . . 73.44 112.768 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.01 -6.91 59.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.698 0.799 . . . . 73.13 111.84 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 m -116.2 149.74 38.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.433 0.693 . . . . 72.24 112.244 -167.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 141.51 97.42 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.728 0.811 . . . . 61.22 109.563 166.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.441 ' HD3' HG12 ' A' ' 59' ' ' ILE . 38.8 Cg_endo -65.3 77.36 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.587 2.192 . . . . 41.12 112.726 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.9 p90 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 108.654 -0.869 . . . . 73.1 108.654 176.92 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.565 1.531 0 CA-C-O 120.94 0.4 . . . . 64.41 111.435 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 63.8 86.13 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.038 1.335 . . . . 64.21 112.059 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -127.48 170.75 12.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.664 1.186 . . . . 72.35 110.803 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -116.27 94.29 4.58 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.877 -0.602 . . . . 74.22 110.121 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.64 141.85 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.927 -0.768 . . . . 65.52 108.927 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.54 -20.65 0.46 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.86 1.8 . . . . 64.14 115.86 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.32 -103.7 0.86 Allowed Glycine 0 C--N 1.368 2.34 0 CA-C-N 120.155 1.343 . . . . 40.01 110.519 166.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm 41.29 49.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 125.431 1.492 . . . . 70.34 111.945 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -64.63 13.38 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 114.918 1.451 . . . . 62.14 114.918 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.98 113.08 17.88 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.867 0.841 . . . . 73.43 110.551 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -28.15 64.51 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.714 -1.585 . . . . 74.35 109.368 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.26 71.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.519 1.127 . . . . 53.13 111.08 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.09 67.86 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.072 0.767 . . . . 72.1 113.072 171.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 20' ' ' ILE . 45.7 mm -54.09 -54.45 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 112.794 0.664 . . . . 71.2 112.794 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 20' ' ' ILE . 15.5 ptpt -66.04 -30.89 71.5 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.934 0.716 . . . . 72.23 112.934 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -70.33 -48.79 54.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.23 0.612 . . . . 73.21 111.431 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.77 -43.21 8.39 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.187 0.995 . . . . 63.34 112.446 167.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 16' ' ' ILE . 66.4 mt -66.13 -35.83 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.496 0.718 . . . . 72.4 111.454 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -67.05 -41.7 86.06 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.182 0.593 . . . . 73.3 112.089 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.33 91.7 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.059 0.544 . . . . 64.42 111.983 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.48 9.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.368 -1.287 . . . . 42.14 112.166 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.13 -47.06 19.03 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.92 0.488 . . . . 73.1 112.067 167.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -68.25 -15.71 63.68 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.176 0.99 . . . . 72.32 112.391 -171.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -95.57 -35.55 11.6 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.655 -0.653 . . . . 71.43 111.592 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 50.2 mm -87.67 -66.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.147 0.579 . . . . 70.35 111.014 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.48 -17.89 64.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.284 0.634 . . . . 72.44 111.274 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' ARG . 23.2 tt0 62.65 31.33 16.8 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.535 1.534 . . . . 74.13 112.276 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -152.37 156.55 39.78 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.807 -0.633 . . . . 71.24 111.776 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.93 108.44 8.81 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.81 -1.086 . . . . 65.21 109.166 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.51 135.24 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 109.352 -0.61 . . . . 73.51 109.352 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.15 118.04 21.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.73 0.812 . . . . 74.45 111.075 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -47.74 -39.92 31.11 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.847 3.031 . . . . 74.03 114.56 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -67.99 -39.37 83.29 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 112.904 0.705 . . . . 75.14 112.904 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -67.07 -44.27 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.326 0.584 . . . . 55.44 110.542 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.58 82.85 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.27 1.028 . . . . 72.14 112.698 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.0 -23.82 35.78 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 116.317 -0.402 . . . . 54.01 110.765 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -75.48 -35.38 60.86 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.103 0.561 . . . . 73.22 111.483 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.6 -61.96 1.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.645 0.736 . . . . 75.54 110.996 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.8 43.79 1.07 Allowed 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 115.348 -0.842 . . . . 72.44 112.814 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.15 -51.88 33.71 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.074 -0.391 . . . . 62.41 112.014 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.96 -34.54 33.52 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.136 -0.484 . . . . 62.21 111.959 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -66.88 -39.85 87.63 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.89 0.876 . . . . 74.3 112.822 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.08 -28.7 63.48 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.164 0.586 . . . . 75.02 110.583 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -53.63 -31.41 47.2 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.451 0.7 . . . . 74.14 112.026 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.94 -44.35 66.29 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.984 0.514 . . . . 71.33 111.125 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.5 tp -65.54 -57.76 7.42 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 112.738 0.644 . . . . 61.22 112.738 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.92 -49.34 35.84 Favored Glycine 0 C--N 1.362 2.0 0 N-CA-C 115.246 0.858 . . . . 71.04 115.246 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -67.79 20.07 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 115.207 1.558 . . . . 73.51 115.207 171.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.4 19.75 0.1 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 118.633 2.213 . . . . 41.23 118.633 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -62.2 -54.72 36.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 118.476 1.138 . . . . 71.32 111.079 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 pt -108.15 140.17 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.137 -1.392 . . . . 71.51 110.467 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.0 p -69.15 169.96 11.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.792 0.437 . . . . 73.45 111.604 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.69 -24.35 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.51 0 CA-C-N 116.006 -0.543 . . . . 74.15 111.323 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -68.4 -53.13 25.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.603 1.161 . . . . 54.32 110.965 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.8 -21.81 65.21 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.83 0.852 . . . . 72.1 111.57 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.19 -43.81 40.78 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.238 -1.023 . . . . 74.34 108.238 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.3 mt -66.18 -28.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 113.696 -1.593 . . . . 64.51 112.098 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -58.21 -50.9 71.93 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.832 -0.433 . . . . 65.14 109.832 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.37 65.05 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 114.743 0.657 . . . . 74.01 114.743 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -73.44 -33.3 64.84 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.136 0.575 . . . . 72.23 111.014 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.66 -12.11 78.4 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 115.669 -0.696 . . . . 63.34 112.405 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -97.7 11.74 36.08 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.575 1.15 . . . . 72.12 111.199 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.1 p -99.48 126.97 45.51 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.34 -0.615 . . . . 53.02 109.34 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -57.94 -15.6 9.36 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.458 0.703 . . . . 65.31 112.777 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.08 -59.35 3.87 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.038 0.935 . . . . 73.5 111.726 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -49.38 -48.85 46.58 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.292 1.219 . . . . 73.02 114.292 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 112' ' ' ILE . 3.2 mm? -62.32 -21.28 65.15 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.072 0.767 . . . . 52.41 113.072 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -76.14 -42.19 47.56 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.522 -0.918 . . . . 73.04 108.522 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.2 -64.11 1.21 Allowed 'General case' 0 C--N 1.371 1.519 0 CA-C-N 118.984 0.811 . . . . 75.0 111.846 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 84' ' ' LEU . 23.1 m-85 -100.76 61.59 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.276 1.213 . . . . 74.21 114.276 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.531 ' HD1' HG21 ' A' ' 81' ' ' VAL . 31.2 t80 -171.73 -57.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 122.979 0.511 . . . . 64.24 112.099 168.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.6 m -59.14 -44.13 98.13 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 113.053 0.76 . . . . 61.23 113.053 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -96.5 16.83 0.72 Allowed 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.442 2.095 . . . . 73.3 113.945 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.55 144.02 51.22 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 112.588 0.588 . . . . 72.24 112.588 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.88 145.27 31.75 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.199 1.932 . . . . 64.23 112.637 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -21.92 -60.58 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.848 1.795 . . . . 63.52 115.848 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' HD12 ' A' ' 82' ' ' ILE . 18.5 m -66.03 -20.27 66.13 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.347 0.976 . . . . 74.11 113.099 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.57 -33.1 16.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.759 -1.2 . . . . 73.42 107.759 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.531 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.4 t -69.53 -29.06 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.578 -1.192 . . . . 42.54 110.106 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 79' ' ' THR . 90.0 mt -65.56 -43.08 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.262 0.625 . . . . 75.34 110.182 170.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.79 -65.14 0.77 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 117.575 0.171 . . . . 75.32 111.005 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.461 HD13 ' CD1' ' A' ' 72' ' ' PHE . 96.6 mt -49.06 -30.94 6.96 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.529 1.678 . . . . 70.34 115.529 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.33 -56.67 3.35 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 118.247 0.476 . . . . 73.05 112.77 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.482 HG23 HD12 ' A' ' 90' ' ' LEU . 86.6 m -60.17 -39.24 85.76 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.045 0.938 . . . . 73.32 112.734 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 87' ' ' LYS . 29.7 ttmt -71.82 -6.17 39.65 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.283 1.033 . . . . 75.15 113.49 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 55.9 m170 -100.69 -32.78 10.56 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.21 -1.033 . . . . 75.34 108.21 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -96.72 -66.72 0.89 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.944 1.298 . . . . 74.11 110.358 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 86' ' ' THR . 52.6 mt -73.74 -13.78 61.02 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.538 0.335 . . . . 75.34 111.71 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.53 -19.29 4.01 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 115.874 1.11 . . . . 53.25 115.874 168.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.21 -174.25 2.51 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 117.593 0.697 . . . . 74.54 110.21 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.15 152.87 44.5 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 121.722 -0.611 . . . . 61.12 110.151 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.01 153.52 8.72 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 C-N-CA 122.966 2.444 . . . . 72.11 114.901 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.4 mt -78.62 -64.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.314 0.487 . . . . 74.21 112.314 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -114.46 -146.96 0.41 Allowed 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 104.598 -2.371 . . . . 75.11 104.598 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -97.5 -18.17 19.17 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-N 123.644 2.929 . . . . 73.51 108.655 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.565 0.746 . . . . 65.34 111.663 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.67 -42.3 70.92 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.802 0.441 . . . . 74.13 111.021 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.3 mt -59.87 -38.97 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.515 0.726 . . . . 74.24 110.494 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -72.87 -30.31 63.87 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.914 -1.039 . . . . 62.52 110.827 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -67.69 -51.39 50.08 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.8 0.84 . . . . 73.45 110.262 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -65.64 -42.52 91.37 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.115 0.566 . . . . 75.33 112.17 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -45.3 -44.58 11.62 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.054 0.942 . . . . 75.23 112.84 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -70.95 -44.42 66.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.183 0.593 . . . . 73.41 111.601 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 73.6 mt -53.04 -53.62 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.774 0.83 . . . . 74.5 111.122 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -52.82 -42.36 65.06 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.122 1.369 . . . . 72.12 113.057 172.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.08 -55.07 13.84 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.028 0.531 . . . . 71.31 112.065 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.2 p -62.93 -62.7 1.54 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.685 0.794 . . . . 73.44 113.125 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -98.96 -52.36 3.58 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.841 0.856 . . . . 71.12 112.595 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.51 -148.4 17.17 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 116.555 -0.293 . . . . 62.52 113.261 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 107' ' ' LEU . 10.1 mm -79.3 -35.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.246 1.018 . . . . 70.24 112.037 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -59.39 -65.96 0.59 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.769 0.319 . . . . 65.21 110.38 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -49.29 -20.91 0.71 Allowed 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.361 1.986 . . . . 62.22 116.361 165.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -73.64 -62.75 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.309 1.413 . . . . 62.12 110.078 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 120' ' ' VAL . 50.3 mm -47.1 -59.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.07 0.948 . . . . 75.13 112.93 170.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -40.68 -46.28 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.52 0.933 . . . . 72.25 113.52 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -63.74 -23.08 67.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.864 0.691 . . . . 75.5 112.864 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.36 -34.23 18.88 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.208 1.003 . . . . 71.32 111.205 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 116' ' ' ILE . 93.1 t -69.51 -60.44 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.349 1.06 . . . . 75.43 111.229 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -76.88 -5.4 48.29 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.219 0.608 . . . . 60.5 112.394 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 32.5 t -53.48 143.48 19.4 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.564 0.746 . . . . 75.1 111.25 173.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.81 -29.19 65.3 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.438 -0.578 . . . . 63.44 109.438 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.403 ' HB2' HD22 ' A' ' 90' ' ' LEU . 11.0 mm-40 -66.55 -48.82 68.48 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.089 0.956 . . . . 74.5 111.67 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.415 ' HB2' HD23 ' A' ' 90' ' ' LEU . 90.0 t80 -60.5 -48.26 82.54 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 120.838 0.351 . . . . 62.52 110.719 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.0 -27.28 68.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 115.301 -0.863 . . . . 74.25 112.197 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -91.55 -54.41 3.91 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.974 0.51 . . . . 60.12 112.355 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.19 -52.46 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.355 0.662 . . . . 64.42 111.924 -174.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.07 -41.6 9.46 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.167 0.587 . . . . 63.25 111.241 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.53 166.69 26.44 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.993 -0.549 . . . . 72.21 113.423 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.79 -33.11 60.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.418 0.687 . . . . 74.11 112.097 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -129.01 60.45 1.55 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.319 1.057 . . . . 72.24 110.458 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.3 m -153.74 145.71 23.6 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 114.128 -1.396 . . . . 73.45 108.868 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 82.9 t -68.07 134.28 91.68 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 123.567 0.747 . . . . 70.05 110.477 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.34 85.51 0.27 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.936 2.424 . . . . 44.22 111.542 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.0 p90 . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 124.595 1.158 . . . . 52.05 112.997 -175.84 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 112.189 0.44 . . . . 64.22 112.189 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -70.89 94.94 1.1 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.191 0.596 . . . . 72.1 110.109 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.6 109.34 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.06 0.544 . . . . 75.22 110.63 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.74 110.83 21.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.269 0.557 . . . . 73.03 111.355 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.43 167.15 26.99 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.314 1.046 . . . . 60.01 109.088 169.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -85.72 117.06 24.37 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.778 0.431 . . . . 64.45 110.255 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 10' ' ' ILE . 61.7 t -89.08 136.99 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.194 -1.039 . . . . 53.33 108.194 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.11 82.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.313 0.578 . . . . 44.31 110.805 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.09 -18.75 0.4 Allowed Glycine 0 CA--C 1.536 1.367 0 CA-C-N 115.474 -0.785 . . . . 45.42 113.533 -172.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 7' ' ' VAL . 55.8 mt -73.69 88.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 118.016 0.908 . . . . 72.11 110.982 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -94.63 2.57 55.61 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.555 0.742 . . . . 73.24 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -79.88 121.02 24.9 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.284 0.634 . . . . 54.41 111.083 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -68.98 -26.76 65.19 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.703 0.401 . . . . 73.45 111.492 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.04 -48.81 64.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.285 0.634 . . . . 64.1 111.074 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.75 84.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.973 0.509 . . . . 74.54 111.596 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.525 HG13 ' HA2' ' A' ' 49' ' ' GLY . 29.3 mm -55.96 -49.6 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.601 0.76 . . . . 72.21 111.367 171.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -67.73 -27.85 67.14 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.269 0.47 . . . . 53.14 112.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.4 m -69.96 -40.09 75.61 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.197 0.522 . . . . 74.23 111.259 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.71 -39.4 84.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.49 1.116 . . . . 72.41 110.418 172.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 16' ' ' ILE . 92.6 mt -70.23 -40.62 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.529 1.132 . . . . 72.31 111.911 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.1 m -64.74 -38.71 91.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.158 0.583 . . . . 71.3 111.155 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.6 96.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.496 -0.775 . . . . 61.4 111.405 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.67 -30.76 70.94 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.539 0.736 . . . . 70.03 112.177 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.62 -48.76 75.99 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.813 0.445 . . . . 73.01 111.182 170.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -70.76 -15.12 62.65 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.064 0.546 . . . . 61.03 111.967 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -85.32 -53.62 5.11 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.183 0.593 . . . . 74.42 111.27 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.863 HD11 HG23 ' A' ' 59' ' ' ILE . 65.0 mt -82.35 -66.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.078 0.551 . . . . 53.11 111.353 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.492 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 22.7 m-85 -66.39 -14.56 62.3 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.955 0.902 . . . . 73.1 111.813 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 70.68 -50.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.025 1.73 . . . . 73.14 112.717 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -61.28 143.46 55.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.204 1.002 . . . . 45.22 113.273 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -71.55 114.32 9.5 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.614 -1.176 . . . . 73.23 108.779 162.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.4 mt -90.85 129.14 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 109.584 -0.524 . . . . 55.32 109.584 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.27 125.47 81.69 Favored Pre-proline 0 CA--C 1.557 1.214 0 O-C-N 123.951 0.782 . . . . 74.11 111.029 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.27 -32.21 32.15 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.751 2.968 . . . . 75.21 115.34 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -71.04 -29.55 65.49 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.191 0.441 . . . . 71.35 112.191 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -72.86 -44.83 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 122.749 0.42 . . . . 60.45 109.908 170.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.5 72.57 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.846 0.858 . . . . 61.54 112.619 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -79.87 -18.76 49.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.354 0.501 . . . . 74.22 112.354 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -80.47 -31.04 37.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 70.22 111.653 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.28 -55.44 3.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.045 0.538 . . . . 74.54 112.242 -174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -117.55 19.69 13.83 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.72 1.378 . . . . 71.23 114.72 -169.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.7 p -66.23 -30.2 70.6 Favored 'General case' 0 N--CA 1.513 2.712 0 CA-C-N 120.554 1.525 . . . . 61.22 112.171 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.83 -30.91 41.63 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.732 -0.667 . . . . 64.24 112.364 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -81.1 -31.51 34.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.81 1.244 . . . . 75.13 111.467 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -37.37 81.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.165 1.386 . . . . 75.25 111.765 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.6 p -59.01 -38.66 79.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.312 0.645 . . . . 72.04 112.024 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -63.17 -38.29 90.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.065 0.546 . . . . 73.15 111.897 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.51 HD11 HG22 ' A' ' 55' ' ' VAL . 42.4 tp -72.96 -42.94 62.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.702 0.287 . . . . 73.11 111.267 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.525 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -69.64 -35.43 74.3 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.357 -0.383 . . . . 70.33 113.904 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -92.58 -19.18 22.19 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.293 0.637 . . . . 73.13 111.314 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.06 19.33 26.63 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 115.783 1.073 . . . . 72.21 115.783 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.14 -29.55 67.62 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 118.226 1.013 . . . . 60.11 112.212 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.425 HD11 ' HD1' ' A' ' 58' ' ' PHE . 27.1 pt -120.68 169.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.322 0.649 . . . . 63.23 111.034 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 29.8 p -91.94 172.32 8.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.828 -0.624 . . . . 75.04 110.389 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 48' ' ' LEU . 58.6 t -71.56 -39.56 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 116.399 -0.364 . . . . 72.43 110.573 175.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HE2' HG12 ' A' ' 120' ' ' VAL . 54.7 tttm -53.95 -50.49 66.37 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.36 0.664 . . . . 74.42 112.522 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -34.22 76.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.216 0.606 . . . . 65.33 111.979 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' HD1' HD11 ' A' ' 53' ' ' ILE . 63.7 t80 -63.42 -50.61 69.14 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.141 0.576 . . . . 52.31 111.024 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.863 HG23 HD11 ' A' ' 27' ' ' ILE . 49.2 mt -70.11 -39.49 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.861 1.264 . . . . 64.1 112.57 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.79 -38.77 86.43 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.366 0.666 . . . . 71.01 110.085 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.58 -32.99 85.0 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 116.137 -0.483 . . . . 54.05 114.212 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.492 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 84.2 mt -66.61 -37.92 85.89 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.185 0.517 . . . . 73.4 110.875 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.8 -23.93 67.77 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-N 115.34 -0.845 . . . . 72.52 114.116 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -82.34 -18.74 41.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.616 0.766 . . . . 75.05 112.061 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 t -60.35 119.7 8.47 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.306 0.854 . . . . 75.1 113.306 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.76 -16.41 57.67 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 123.597 0.759 . . . . 73.54 112.038 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.98 -49.51 75.8 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.025 0.53 . . . . 64.42 111.094 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.76 -47.57 84.2 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.217 0.607 . . . . 54.45 111.32 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HG ' HG12 ' A' ' 112' ' ' ILE . 2.1 mm? -71.94 -29.45 64.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.052 0.76 . . . . 62.1 113.052 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -61.31 -37.41 83.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.219 0.533 . . . . 75.54 110.704 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -50.09 10.86 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.216 0.821 . . . . 52.45 113.216 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.94 34.13 5.32 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.838 1.051 . . . . 71.23 113.838 -167.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -154.48 -58.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.647 0.61 . . . . 74.1 112.647 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.4 p -65.32 -35.61 12.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 113.853 1.057 . . . . 64.1 113.853 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -92.05 -4.51 3.8 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 121.875 1.717 . . . . 74.54 113.657 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -101.88 146.72 32.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 C-N-CA 123.827 0.851 . . . . 74.45 112.157 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.06 147.5 73.64 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.273 1.982 . . . . 75.01 111.537 168.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -55.88 -39.7 71.9 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.473 0.709 . . . . 72.2 112.677 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.48 ' HA ' HD12 ' A' ' 82' ' ' ILE . 40.8 m -61.05 -38.9 87.82 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.98 0.912 . . . . 72.13 113.316 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -69.64 -32.3 70.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.191 -0.318 . . . . 73.11 111.725 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.5 -32.45 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.307 0.643 . . . . 70.04 110.033 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.526 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 93.6 mt -64.15 -53.5 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.488 0.715 . . . . 72.12 112.422 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -68.73 -42.5 77.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.165 0.432 . . . . 75.41 112.165 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.76 -32.93 70.24 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.313 0.645 . . . . 73.05 111.922 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.0 -47.03 57.03 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 112.172 -0.371 . . . . 75.34 112.172 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.559 HG23 HD12 ' A' ' 90' ' ' LEU . 86.7 m -67.28 -36.75 82.21 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.245 1.018 . . . . 64.45 111.136 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -55.97 -41.93 75.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.703 0.801 . . . . 73.25 112.186 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 49.1 m170 -78.58 -29.52 46.22 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 113.021 0.749 . . . . 74.51 113.021 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -100.54 -63.62 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 113.227 0.825 . . . . 75.04 113.227 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.559 HD12 HG23 ' A' ' 86' ' ' THR . 77.0 mt -77.08 -25.75 52.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -0.835 . . . . 74.3 112.354 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.94 12.75 81.14 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 123.143 0.277 . . . . 70.25 113.208 -170.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -112.61 159.51 18.79 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.044 0.937 . . . . 51.0 110.423 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.67 154.9 62.12 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.245 0.618 . . . . 75.23 109.861 164.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -58.7 144.92 97.48 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.067 1.845 . . . . 71.03 112.226 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.401 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 2.5 mp -71.79 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.156 0.582 . . . . 75.33 110.868 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -126.09 173.55 9.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.758 0.823 . . . . 64.32 109.46 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 60.8 tp60 -62.42 -31.66 72.39 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 122.798 0.439 . . . . 73.33 111.072 172.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.44 -35.75 73.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.674 0.79 . . . . 45.22 111.331 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 11.0 tp10 -60.97 -44.94 96.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 74.41 110.235 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.9 mt -58.35 -44.28 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 114.866 -1.061 . . . . 54.15 110.998 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.1 mtt-85 -62.72 -33.64 75.52 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.87 0.468 . . . . 74.41 111.688 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -70.6 -53.02 17.59 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.136 0.273 . . . . 73.2 111.483 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -59.78 -36.92 77.7 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.826 0.45 . . . . 74.44 111.803 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -65.25 -40.68 94.31 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.993 0.917 . . . . 64.1 110.757 176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.436 HE21 HG23 ' A' ' 109' ' ' THR . 22.0 tp60 -69.53 -43.88 72.11 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.575 0.75 . . . . 72.43 111.599 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 98.0 mt -61.99 -47.43 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.281 1.032 . . . . 74.33 110.771 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.5 tp -61.04 -40.4 93.47 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.982 -1.008 . . . . 71.51 112.087 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.52 -44.71 77.72 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.991 0.517 . . . . 70.05 112.115 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.436 HG23 HE21 ' A' ' 105' ' ' GLN . 40.9 p -84.86 -65.65 0.99 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.421 0.688 . . . . 75.21 111.588 -174.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.93 -57.07 4.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.96 0.504 . . . . 73.43 111.207 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.27 -174.7 20.52 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 121.301 0.389 . . . . 73.43 113.704 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.494 HG12 ' HG ' ' A' ' 69' ' ' LEU . 10.8 tp -69.97 -31.54 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 113.124 0.787 . . . . 75.22 113.124 -170.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -65.74 -34.45 78.2 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.425 0.29 . . . . 61.21 111.452 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.08 -31.26 58.67 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.036 0.534 . . . . 73.14 111.492 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.526 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 56.6 t80 -64.55 -55.45 20.42 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.626 0.771 . . . . 72.22 111.444 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.414 HD12 ' HD2' ' A' ' 115' ' ' PHE . 1.9 mp -57.85 -44.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 122.88 0.472 . . . . 53.34 110.716 173.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.21 -34.08 71.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.824 0.449 . . . . 72.23 111.583 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.63 80.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.057 0.543 . . . . 55.14 111.858 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.86 -36.34 78.01 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.385 0.674 . . . . 73.52 111.863 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.506 HG12 ' HE2' ' A' ' 56' ' ' LYS . 98.6 t -80.52 -32.48 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.972 0.909 . . . . 52.01 111.655 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.86 4.53 52.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.22 0.608 . . . . 64.11 112.047 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.7 t -62.83 129.47 40.61 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.372 -0.603 . . . . 43.1 109.372 164.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.476 ' H ' ' NE2' ' A' ' 123' ' ' GLN . 1.5 mp0 -53.9 -35.18 61.36 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.434 0.694 . . . . 53.53 112.659 -171.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.26 -41.79 85.05 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 123.512 0.507 . . . . 65.33 111.642 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -63.52 -56.41 16.22 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.454 0.302 . . . . 71.23 110.921 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -66.14 -36.46 83.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.143 0.794 . . . . 73.3 113.143 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HG3' HG23 ' A' ' 128' ' ' VAL . 12.9 pt-20 -71.76 -32.88 68.15 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.023 0.749 . . . . 60.21 113.023 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.441 HG23 ' HG3' ' A' ' 127' ' ' GLU . 93.6 t -100.56 -64.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 118.34 0.518 . . . . 74.33 111.696 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -99.45 67.1 1.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.736 0.815 . . . . 64.42 109.887 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.03 -156.06 0.49 Allowed Glycine 0 N--CA 1.483 1.796 0 N-CA-C 115.169 0.828 . . . . 63.14 115.169 -174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 0.9 OUTLIER -79.21 21.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.576 0.954 . . . . 74.12 113.576 -176.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.18 -36.62 0.9 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.832 1.253 . . . . 61.33 110.809 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.3 m -91.97 137.31 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.813 0.672 . . . . 53.14 112.813 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.8 t -80.34 132.26 59.68 Favored Pre-proline 0 CA--C 1.561 1.376 0 C-N-CA 123.946 0.898 . . . . 55.42 110.355 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HD2' HD13 ' A' ' 59' ' ' ILE . 55.6 Cg_endo -66.72 84.66 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.889 2.393 . . . . 73.11 113.82 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -79.97 152.09 29.7 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.808 -0.633 . . . . 74.41 110.721 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.536 ' H ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -58.86 125.32 23.06 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.641 0.377 . . . . 75.32 110.326 175.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -84.04 40.69 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.739 1.015 . . . . 73.12 113.739 -165.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 66.07 160.09 0.13 Allowed Pre-proline 0 CA--C 1.568 1.643 0 C-N-CA 124.481 1.112 . . . . 75.24 112.123 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.96 -4.12 12.84 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.099 1.866 . . . . 73.32 113.881 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.0 p -65.14 -81.62 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.867 0.867 . . . . 71.1 112.531 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.8 mt 69.33 -32.93 0.24 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 115.831 1.789 . . . . 61.53 115.831 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.72 105.45 3.19 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.847 0.832 . . . . 75.22 112.633 -169.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -137.05 162.98 31.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.981 0.912 . . . . 74.0 111.031 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 74.85 -25.13 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.172 1.545 . . . . 74.23 115.172 165.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -64.6 96.51 0.17 Allowed 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 118.461 0.573 . . . . 74.43 112.494 -170.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -95.64 -179.11 4.62 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.737 0.815 . . . . 74.21 111.843 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -66.85 129.66 40.59 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.563 0.745 . . . . 74.14 110.636 170.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 N--CA 1.478 0.955 0 C-N-CA 123.223 0.609 . . . . 72.13 110.73 177.78 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.703 -0.48 . . . . 75.31 109.703 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -100.75 135.06 42.79 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.782 0.433 . . . . 72.4 110.164 171.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.3 t -96.19 101.73 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.24 0.616 . . . . 53.03 109.508 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.01 87.15 1.84 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 116.047 -0.524 . . . . 75.04 110.502 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -120.91 148.04 44.61 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.606 0.762 . . . . 51.11 110.044 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -95.87 91.87 6.24 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.332 0.586 . . . . 72.33 111.075 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.18 112.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-N 115.0 -1.0 . . . . 73.02 109.961 164.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.5 90.1 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.118 0.967 . . . . 63.15 113.111 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -46.08 -29.33 3.38 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 115.689 1.035 . . . . 53.21 115.689 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.07 130.57 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 109.363 -0.606 . . . . 50.34 109.363 171.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.74 -27.49 6.63 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.882 0.473 . . . . 73.23 111.088 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -32.75 114.7 0.17 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.593 1.557 . . . . 63.21 113.57 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HE3' ' HA3' ' A' ' 49' ' ' GLY . 14.4 mmmm -67.95 -12.1 60.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.915 0.486 . . . . 71.13 112.169 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.03 76.7 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.772 0.829 . . . . 73.51 110.895 171.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.54 62.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.191 0.596 . . . . 72.43 110.963 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.462 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.9 mp -60.09 -45.51 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.36 0.664 . . . . 72.34 110.714 169.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.16 -50.49 73.84 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.359 0.663 . . . . 72.51 112.168 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -62.39 -34.45 76.76 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.115 0.566 . . . . 74.34 111.286 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 48' ' ' LEU . 9.9 tp -62.39 -45.68 92.06 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.644 0.778 . . . . 64.44 111.022 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 16' ' ' ILE . 67.4 mt -72.04 -34.1 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.265 1.026 . . . . 74.2 111.519 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.2 m -68.26 -42.72 79.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.207 0.603 . . . . 74.42 110.294 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.42 90.96 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.657 0.783 . . . . 72.11 111.238 172.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.99 97.93 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.47 0.708 . . . . 44.04 111.845 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -65.93 -49.38 68.16 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.119 0.568 . . . . 70.51 111.929 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -69.83 -15.51 63.11 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.756 0.65 . . . . 71.41 112.756 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -94.54 -47.31 6.6 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 122.971 0.508 . . . . 52.41 111.54 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 83.0 mt -83.14 -58.57 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.061 0.544 . . . . 74.1 111.934 -174.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 8.7 m-85 -73.31 -16.06 61.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.816 0.446 . . . . 72.3 110.654 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 66.49 17.44 10.65 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.196 1.398 . . . . 72.23 111.968 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -153.4 143.77 22.41 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.42 1.088 . . . . 74.5 110.158 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.56 141.11 48.43 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 120.913 0.387 . . . . 62.11 110.098 165.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.4 mt -106.17 141.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 108.712 -0.847 . . . . 51.33 108.712 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.37 117.08 10.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.877 0.871 . . . . 63.41 111.28 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.32 -38.22 86.1 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.375 2.716 . . . . 73.32 113.505 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -63.56 -26.93 68.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.843 0.857 . . . . 74.41 112.744 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -83.31 -47.16 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 123.06 0.544 . . . . 72.24 110.564 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.7 68.86 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.312 1.045 . . . . 51.34 113.365 -173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -75.51 -25.85 57.62 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.165 0.432 . . . . 70.21 112.165 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -81.46 -44.17 17.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.861 0.465 . . . . 71.15 111.599 173.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -58.48 -54.01 51.89 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.614 0.721 . . . . 72.51 111.175 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -99.7 45.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.872 -1.058 . . . . 72.32 110.175 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 p -61.55 -49.62 75.93 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.273 0.629 . . . . 64.15 112.286 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 -45.91 9.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.612 -0.722 . . . . 61.24 112.638 172.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -66.04 -37.81 86.81 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.513 1.301 . . . . 71.42 114.513 -170.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -65.04 -46.8 79.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.18 -0.674 . . . . 73.14 109.18 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 m -59.21 -35.67 74.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.7 0.8 . . . . 60.24 111.943 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -59.29 -42.09 90.5 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.818 0.847 . . . . 75.15 112.388 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 HG22 ' A' ' 55' ' ' VAL . 42.2 tp -74.04 -45.51 49.11 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.809 0.444 . . . . 74.14 111.342 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' HA3' ' HE3' ' A' ' 13' ' ' LYS . . . -64.03 -31.95 82.54 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.874 0.749 . . . . 11.11 114.376 -174.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.93 -18.87 29.78 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.306 0.643 . . . . 72.5 111.275 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.75 31.73 35.3 Favored Glycine 0 C--N 1.355 1.609 0 CA-C-N 117.731 0.241 . . . . 72.41 113.538 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -88.39 -18.96 27.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.334 0.654 . . . . 73.31 111.884 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.8 pt -122.53 163.94 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.94 0.896 . . . . 74.1 110.327 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.6 p -77.18 152.16 34.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.954 -0.387 . . . . 74.33 109.954 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 48' ' ' LEU . 40.1 t -64.01 -32.22 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.17 0.588 . . . . 71.22 110.081 175.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 1.5 tmtp? -54.08 -48.24 70.86 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.248 1.019 . . . . 73.2 111.457 171.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.92 -37.85 72.92 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.068 -0.515 . . . . 70.43 110.941 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.78 -51.84 66.03 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.389 0.675 . . . . 52.51 111.257 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 27' ' ' ILE . 26.5 mm -56.03 -38.58 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.848 1.259 . . . . 74.23 111.512 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -67.52 -39.49 85.1 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.064 -0.516 . . . . 74.13 110.949 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.72 -23.07 75.64 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 113.844 0.298 . . . . 71.45 113.844 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.499 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 79.0 mt -67.63 -23.11 65.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.528 0.731 . . . . 72.11 110.975 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -87.73 -14.07 63.82 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.453 -1.249 . . . . 52.11 113.032 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -92.81 -3.68 54.28 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.85 0.86 . . . . 70.23 111.012 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -73.32 112.59 9.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.349 0.659 . . . . 72.33 110.778 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.97 -18.1 63.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.731 0.412 . . . . 72.34 111.741 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.42 -51.73 68.23 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.943 0.497 . . . . 53.32 110.47 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.416 ' HB2' ' CE2' ' A' ' 28' ' ' PHE . 69.4 t80 -59.64 -45.63 91.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.972 0.909 . . . . 60.13 112.015 175.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 63' ' ' GLY . 2.5 mm? -71.21 -29.17 64.82 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 112.365 0.506 . . . . 74.32 112.365 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.96 -38.95 92.66 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 121.879 -0.513 . . . . 73.44 110.565 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -73.95 -54.62 7.53 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 113.21 0.818 . . . . 65.54 113.21 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -117.07 36.89 4.03 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 114.06 1.133 . . . . 71.25 114.06 -168.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.416 ' HD1' HG21 ' A' ' 81' ' ' VAL . 47.5 t80 -159.29 -42.92 0.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.831 0.453 . . . . 72.21 111.507 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -65.96 -45.62 63.89 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 112.641 0.608 . . . . 73.2 112.641 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.55 12.23 1.37 Allowed 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.556 2.171 . . . . 72.21 113.689 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HD2' ' HG2' ' A' ' 80' ' ' LYS . 80.9 m-85 -122.62 140.78 33.64 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 123.27 0.628 . . . . 73.43 111.965 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' O ' HG23 ' A' ' 81' ' ' VAL . 93.4 Cg_endo -73.45 159.55 46.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.946 2.43 . . . . 72.35 112.574 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -49.77 -52.5 31.44 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.922 0.889 . . . . 71.11 113.045 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.619 ' HA ' HD12 ' A' ' 82' ' ' ILE . 62.7 m -53.86 -43.01 69.18 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.942 1.09 . . . . 74.21 113.942 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 76' ' ' TYR . 58.8 tptt -65.08 -36.75 85.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.378 0.51 . . . . 55.45 112.378 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.416 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.1 t -68.24 -26.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.779 0.431 . . . . 75.21 110.203 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.619 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.4 mt -68.44 -52.84 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.604 0.761 . . . . 74.43 111.974 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 84' ' ' LEU . 5.1 pt-20 -64.64 -43.56 93.26 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 117.697 0.226 . . . . 65.03 110.96 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 22.7 mt -60.2 -41.1 92.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.391 0.677 . . . . 73.22 111.289 176.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.26 -51.09 55.73 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.74 -0.209 . . . . 74.04 112.713 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 90' ' ' LEU . 37.5 m -67.53 -38.02 83.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.633 0.773 . . . . 64.0 111.162 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -53.93 -36.32 62.65 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.69 1.196 . . . . 74.41 112.784 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 53.2 m170 -89.47 -43.03 11.13 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.452 0.701 . . . . 73.44 112.771 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -92.23 -46.68 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.009 0.524 . . . . 71.04 112.014 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 86' ' ' THR . 48.6 mt -97.73 -7.02 31.67 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.986 0.514 . . . . 74.2 111.717 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 27.21 72.41 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 115.162 0.825 . . . . 42.44 115.162 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -154.46 177.79 10.79 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 117.501 0.651 . . . . 75.33 112.285 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.72 150.76 54.17 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.674 0.79 . . . . 63.54 111.942 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.76 136.07 47.72 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.487 2.125 . . . . 74.42 110.922 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.16 -66.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.317 0.647 . . . . 71.25 111.451 -166.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HB2' ' H ' ' A' ' 99' ' ' GLU . 8.9 m-20 -93.07 165.03 13.04 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.295 0.638 . . . . 75.04 111.922 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 50.3 tp60 -67.27 -33.9 76.28 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 109.457 -0.571 . . . . 71.11 109.457 163.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.71 73.37 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.452 0.701 . . . . 53.44 111.518 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.536 ' H ' ' HB2' ' A' ' 96' ' ' ASP . 12.2 tp10 -61.87 -42.02 98.55 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.851 0.861 . . . . 73.52 110.347 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.499 HG21 HG23 ' A' ' 79' ' ' THR . 72.1 mt -63.94 -46.13 94.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 114.914 -1.039 . . . . 73.43 110.905 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 28.5 mmm180 -63.04 -32.2 73.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.275 0.63 . . . . 72.34 111.72 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -66.71 -51.11 59.73 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.551 0.34 . . . . 71.31 111.124 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -65.02 -29.26 70.15 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.425 0.29 . . . . 73.15 111.722 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -68.66 -41.68 78.96 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.216 1.006 . . . . 74.14 110.467 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -72.08 -39.51 68.91 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.395 -0.821 . . . . 71.45 111.146 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 92.3 mt -67.12 -44.42 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.332 0.653 . . . . 70.33 110.975 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.25 -38.81 92.62 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.541 0.736 . . . . 53.13 110.819 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.59 -54.6 9.94 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 112.403 0.52 . . . . 70.13 112.403 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.8 p -83.38 -20.15 34.76 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.401 0.889 . . . . 71.11 113.401 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -114.98 -64.78 1.27 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 122.975 0.51 . . . . 70.45 111.088 174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.96 -177.99 28.65 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 120.991 -0.623 . . . . 73.32 114.115 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.0 tp -72.9 -31.35 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.577 0.751 . . . . 73.24 111.441 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -64.66 -30.99 72.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.035 0.534 . . . . 73.03 111.435 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.51 67.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.737 0.815 . . . . 71.12 110.678 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 82' ' ' ILE . 54.4 t80 -60.79 -50.29 74.04 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.391 1.076 . . . . 71.23 112.392 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.95 -45.3 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.979 0.512 . . . . 63.45 111.216 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.06 -34.36 77.84 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.838 -0.619 . . . . 41.32 111.011 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.2 87.7 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.375 0.67 . . . . 63.52 112.139 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 90.9 mt -76.22 -51.39 12.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.264 0.625 . . . . 64.52 112.295 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.76 -20.52 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 121.125 0.488 . . . . 45.02 111.941 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -97.78 21.48 10.43 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.386 0.674 . . . . 65.42 111.963 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.0 m -83.06 153.93 24.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.951 -0.468 . . . . 71.44 111.846 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.52 -44.47 25.69 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.436 1.094 . . . . 72.31 111.632 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 90' ' ' LEU . 30.9 tp10 -54.08 -52.86 59.61 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.459 -0.791 . . . . 73.04 111.902 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -64.86 -39.88 94.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 120.523 0.201 . . . . 71.51 110.582 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -60.9 -63.38 1.32 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.482 0.713 . . . . 72.15 111.742 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -76.33 -36.87 58.05 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 113.037 0.754 . . . . 73.14 113.037 -170.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.76 -27.93 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.008 0.523 . . . . 64.42 112.251 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -118.9 -78.49 0.59 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.936 -0.478 . . . . 62.02 110.498 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.1 170.46 15.83 Favored Glycine 0 N--CA 1.474 1.191 0 N-CA-C 112.399 -0.28 . . . . 74.24 112.399 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.668 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -73.22 -11.71 60.61 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.736 0.643 . . . . 74.51 112.736 -178.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -102.02 -10.75 19.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.034 0.934 . . . . 75.25 112.392 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.8 m -116.22 140.24 49.52 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.266 0.839 . . . . 64.45 113.266 -168.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 59' ' ' ILE . 58.6 t -83.56 150.63 60.27 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 125.966 1.706 . . . . 71.41 110.623 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.3 90.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.729 2.286 . . . . 74.3 112.6 161.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -91.65 176.69 6.45 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.694 0.798 . . . . 75.03 111.984 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -72.75 97.05 2.13 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.77 -0.65 . . . . 74.03 110.918 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -84.82 118.39 24.45 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.552 -0.536 . . . . 62.13 109.552 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 73.12 146.15 0.11 Allowed Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 125.274 1.43 . . . . 73.41 112.054 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.85 -12.72 33.28 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.81 2.34 . . . . 74.31 112.486 171.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -103.45 179.39 4.28 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.353 1.061 . . . . 70.53 110.375 172.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.1 mt 67.65 27.55 7.65 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 124.534 1.134 . . . . 65.51 112.405 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -144.36 121.04 11.16 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.475 -0.784 . . . . 50.54 109.084 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -61.19 90.83 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.488 0.715 . . . . 61.25 111.25 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -75.78 142.42 42.33 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.509 -0.768 . . . . 75.11 112.199 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -97.33 67.37 2.12 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.972 0.909 . . . . 73.45 110.707 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 49.98 68.1 0.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.909 1.284 . . . . 71.41 111.674 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 70.46 -59.85 0.51 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.329 1.452 . . . . 65.01 112.123 -172.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.994 0.902 . . . . 64.35 110.781 177.173 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 111.157 0.058 . . . . 50.05 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.13 -176.83 3.88 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.094 0.958 . . . . 72.31 110.77 173.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t -91.23 108.6 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 107.783 -1.192 . . . . 74.3 107.783 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -74.9 106.34 6.37 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.128 0.571 . . . . 71.41 110.826 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.59 154.54 42.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.487 0.715 . . . . 74.2 110.223 175.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -70.96 147.2 48.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.142 0.973 . . . . 65.13 111.929 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.9 t -120.47 119.14 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.559 -1.645 . . . . 74.22 106.559 163.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.95 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.677 0.791 . . . . 71.04 112.177 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.57 -24.15 2.78 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.401 -0.818 . . . . 65.3 112.266 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.5 mm -86.13 59.03 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 123.344 1.545 . . . . 73.01 109.845 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -80.28 8.47 7.38 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.189 -1.823 . . . . 72.44 113.28 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.91 133.08 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.029 0.532 . . . . 72.41 110.059 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 45.5 mtpt -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.154 0.798 . . . . 73.23 113.154 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.72 -53.02 62.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.053 0.541 . . . . 73.21 111.168 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.8 -40.68 54.65 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.774 -0.648 . . . . 60.15 112.16 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 39.1 mm -57.91 -40.37 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 122.959 0.504 . . . . 74.44 111.643 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 2.6 ttpm? -56.7 -48.81 76.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.735 0.814 . . . . 73.34 112.01 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 m -68.65 -33.03 73.3 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.164 0.586 . . . . 73.44 111.618 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.63 -43.85 97.77 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.812 0.845 . . . . 73.04 110.213 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -68.7 -33.72 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.372 1.069 . . . . 71.21 111.618 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 71.6 m -67.77 -41.58 83.04 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.253 0.621 . . . . 74.33 110.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.4 85.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.262 0.625 . . . . 71.44 111.478 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.52 -30.36 70.59 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.893 0.877 . . . . 65.23 112.272 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -76.31 -37.69 57.07 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.401 0.519 . . . . 75.43 112.401 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 21' ' ' SER . 89.0 mtt180 -65.95 -26.49 67.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.523 0.729 . . . . 72.4 112.627 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.57 HE22 ' HG2' ' A' ' 135' ' ' PRO . 14.4 pt20 -85.59 -36.39 20.43 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 122.696 0.398 . . . . 75.13 111.895 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.514 HG12 ' HG3' ' A' ' 26' ' ' GLN . 46.2 mm -87.75 -63.27 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.359 0.664 . . . . 53.54 110.786 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.21 -4.75 54.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.817 0.847 . . . . 72.14 111.545 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 68.92 10.09 7.74 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.411 1.485 . . . . 74.05 112.909 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -150.56 144.83 25.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.42 0.628 . . . . 72.13 111.624 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -68.16 134.27 50.25 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.054 -0.976 . . . . 54.12 110.405 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.31 140.08 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 122.955 0.502 . . . . 75.31 110.185 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.93 129.26 91.13 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-N 115.063 -0.971 . . . . 71.35 110.839 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -54.95 -38.72 92.93 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.841 3.027 . . . . 45.51 115.181 -171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -64.73 -27.54 68.98 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.235 0.457 . . . . 65.31 112.235 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.2 mt -79.82 -49.13 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.509 0.724 . . . . 52.44 110.037 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.17 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.552 1.141 . . . . 61.44 113.232 -175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -76.08 -26.17 56.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.926 0.49 . . . . 73.13 111.642 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -75.63 -33.52 60.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.474 0.31 . . . . 74.43 110.622 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -74.11 -53.65 9.47 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 116.016 -0.538 . . . . 55.03 111.06 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 78.9 m-85 -116.65 55.7 0.81 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.791 0.836 . . . . 73.34 111.847 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 98.7 p -62.67 -48.33 79.78 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.721 -0.612 . . . . 62.44 112.579 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.9 -40.73 13.76 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.837 -0.62 . . . . 61.42 112.418 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 21.6 t-105 -62.06 -42.0 98.74 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.324 1.05 . . . . 73.01 112.036 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.12 -46.52 88.11 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.27 1.028 . . . . 75.03 111.534 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.8 t -61.01 -41.93 97.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.488 -0.778 . . . . 62.14 111.601 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' HG23 ' A' ' 53' ' ' ILE . 59.6 mtpt -65.29 -32.6 74.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.508 0.723 . . . . 73.13 111.835 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.69 -45.05 60.79 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 120.725 0.298 . . . . 73.43 111.061 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.07 76.59 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.711 -0.677 . . . . 74.53 113.942 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -91.47 -20.06 22.16 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.808 0.843 . . . . 71.35 111.871 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.61 25.17 33.57 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 114.172 0.429 . . . . 74.04 114.172 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -69.58 -44.06 71.56 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.315 0.646 . . . . 62.32 110.179 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.418 HG23 ' HE2' ' A' ' 47' ' ' LYS . 32.6 pt -110.62 157.44 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.021 0.929 . . . . 72.21 110.081 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 57' ' ' GLU . 11.9 t -90.15 167.25 12.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.566 0.346 . . . . 73.03 110.33 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 59' ' ' ILE . 66.2 t -61.79 -44.21 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 122.977 0.511 . . . . 62.24 111.134 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 64.1 tttm -55.39 -42.12 73.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.223 1.009 . . . . 62.35 112.815 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' H ' HG23 ' A' ' 54' ' ' THR . 26.5 tt0 -69.42 -36.21 76.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.758 -0.655 . . . . 74.41 111.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.0 -47.08 86.38 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.733 0.813 . . . . 72.41 110.726 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 55' ' ' VAL . 47.7 mm -56.87 -45.55 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 124.431 1.093 . . . . 72.22 111.129 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.74 -44.24 93.88 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.402 -0.817 . . . . 72.55 110.871 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.02 -26.98 69.68 Favored Glycine 0 CA--C 1.543 1.782 0 N-CA-C 114.768 0.667 . . . . 72.31 114.768 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.02 -25.89 63.8 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.006 0.522 . . . . 74.52 110.933 172.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.33 -25.47 74.33 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.503 -0.771 . . . . 60.55 113.64 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.02 -7.45 59.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.637 0.775 . . . . 54.54 111.905 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.423 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.3 p -74.41 134.55 42.39 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -56.69 -28.74 61.41 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.696 0.799 . . . . 63.41 112.29 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.6 tp -65.82 -46.71 77.58 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.93 0.492 . . . . 65.03 111.253 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.6 -35.51 79.11 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.191 0.52 . . . . 43.21 111.069 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.636 HD11 HG12 ' A' ' 112' ' ' ILE . 4.3 mm? -60.81 -48.35 82.18 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.8 0.84 . . . . 71.35 112.106 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -75.86 -30.59 58.95 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.489 0.551 . . . . 43.22 112.489 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.32 -47.04 45.82 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.897 0.703 . . . . 53.24 112.897 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.48 -55.33 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.794 1.035 . . . . 54.3 113.794 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' HE1' HD21 ' A' ' 107' ' ' LEU . 83.3 t80 -62.89 -33.41 75.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.057 0.762 . . . . 73.54 113.057 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.512 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 33.4 m -79.14 -55.1 0.95 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 118.549 -0.739 . . . . 63.51 112.721 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 11.9 Cg_exo -74.37 -5.06 16.38 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.657 2.238 . . . . 44.35 114.541 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -124.87 146.18 52.36 Favored Pre-proline 0 N--CA 1.494 1.726 0 C-N-CA 122.98 0.512 . . . . 74.42 111.884 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 81' ' ' VAL . 72.5 Cg_endo -72.44 168.5 24.13 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.822 2.348 . . . . 71.14 112.816 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -48.93 -54.77 14.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.402 1.081 . . . . 71.5 112.432 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.55 ' HA ' HD12 ' A' ' 82' ' ' ILE . 37.1 m -54.82 -40.05 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.935 0.894 . . . . 72.21 113.281 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -69.2 -32.0 70.98 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.088 0.403 . . . . 71.32 112.088 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 77' ' ' PRO . 59.0 t -69.39 -26.18 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.029 0.532 . . . . 74.32 109.997 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 79' ' ' THR . 61.0 mt -74.36 -52.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.724 0.809 . . . . 74.41 111.003 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -56.25 24.07 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.941 0.897 . . . . 72.4 112.261 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.96 -40.2 94.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.281 0.632 . . . . 74.24 111.323 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.68 -51.45 55.86 Favored Glycine 0 N--CA 1.474 1.219 0 O-C-N 123.481 0.488 . . . . 72.25 112.93 -174.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 94' ' ' PRO . 40.1 p -61.43 -36.46 80.41 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.522 0.729 . . . . 72.3 112.514 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -73.0 -16.46 61.51 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.94 0.719 . . . . 72.53 112.94 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -86.27 -40.64 15.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.869 0.468 . . . . 74.32 111.319 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' HG22 ' A' ' 59' ' ' ILE . 88.4 m-85 -91.05 -64.74 1.09 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.343 0.592 . . . . 72.43 110.7 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.46 -10.01 59.2 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.008 0.923 . . . . 63.14 112.397 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.86 21.37 67.45 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 114.209 0.443 . . . . 44.53 114.209 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -149.47 169.92 19.78 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.875 0.87 . . . . 74.45 111.051 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.6 150.69 39.22 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.427 0.691 . . . . 71.12 110.264 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HG3' HG21 ' A' ' 86' ' ' THR . 32.9 Cg_exo -58.55 159.87 18.84 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.931 2.421 . . . . 61.11 112.712 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.43 -62.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.978 0.511 . . . . 62.44 111.542 -169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -133.85 163.21 30.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.636 0.775 . . . . 64.43 110.148 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -59.13 -33.12 70.5 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.848 0.859 . . . . 73.54 112.615 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.12 77.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.514 0.326 . . . . 64.24 111.803 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.9 -36.71 70.09 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.032 0.533 . . . . 73.43 111.111 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.22 -43.61 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.876 0.47 . . . . 60.12 110.077 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 mtm105 -66.27 -30.22 70.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.331 0.652 . . . . 71.02 111.804 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -62.56 -52.47 63.29 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.987 0.515 . . . . 75.13 111.094 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.09 -37.41 84.95 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.898 0.479 . . . . 74.14 111.514 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -63.37 -39.55 94.84 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.405 1.082 . . . . 70.43 110.863 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.47 HE21 HG23 ' A' ' 109' ' ' THR . 24.1 tp60 -67.74 -44.62 77.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.475 0.71 . . . . 73.41 111.104 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.8 mt -61.89 -43.29 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.016 0.926 . . . . 74.44 111.61 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.8 tt -65.1 -41.07 95.28 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.224 0.61 . . . . 73.54 110.966 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.01 -38.54 86.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.738 0.415 . . . . 41.34 112.032 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.47 HG23 HE21 ' A' ' 105' ' ' GLN . 40.9 p -81.6 -69.59 0.6 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.775 0.83 . . . . 63.21 112.125 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.96 -35.3 24.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.98 0.912 . . . . 72.54 111.891 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.08 -172.41 14.88 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 121.119 0.288 . . . . 44.43 113.518 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.636 HG12 HD11 ' A' ' 69' ' ' LEU . 7.4 tp -68.97 -38.21 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.558 0.743 . . . . 73.41 112.249 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -63.52 -42.89 98.43 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.322 0.649 . . . . 63.11 111.434 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.4 -32.67 66.57 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.713 -0.676 . . . . 63.02 110.636 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.451 ' HZ ' ' HA ' ' A' ' 82' ' ' ILE . 32.8 t80 -61.78 -51.92 66.33 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 124.122 0.969 . . . . 75.11 112.269 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.9 mm -55.97 -51.77 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.85 0.86 . . . . 74.13 110.442 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -52.14 -49.05 64.5 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 115.23 -0.896 . . . . 75.43 111.86 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.77 67.88 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 61.14 112.787 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.48 -53.3 36.73 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.093 0.473 . . . . 53.4 110.585 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.484 HG12 ' NZ ' ' A' ' 56' ' ' LYS . 39.2 t -69.12 -18.54 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.792 0.837 . . . . 73.44 112.612 -171.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -80.16 13.65 2.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.56 -0.712 . . . . 73.31 112.766 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 99.7 p -77.34 136.56 38.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.326 0.651 . . . . 73.25 110.774 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.593 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 46.4 tt0 -68.71 -39.77 80.29 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.713 0.635 . . . . 72.51 112.713 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -53.89 -30.85 47.73 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.516 0.561 . . . . 74.1 112.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.28 -56.46 21.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.138 0.575 . . . . 61.44 110.527 172.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 123' ' ' GLN . 10.4 p30 -73.87 -20.86 60.29 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 111.976 0.361 . . . . 73.33 111.976 -173.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 27.6 mm-40 -67.49 -59.15 3.61 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.149 0.499 . . . . 64.52 111.164 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -71.96 -61.0 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.598 -0.728 . . . . 61.04 111.574 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -84.43 -62.6 1.51 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.083 0.553 . . . . 61.42 110.46 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.26 173.47 27.39 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.615 -0.72 . . . . 54.23 112.657 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.31 -34.19 48.88 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.884 0.473 . . . . 75.33 111.606 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.25 -8.31 59.08 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.042 0.937 . . . . 61.05 112.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -113.05 143.95 43.45 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.384 0.674 . . . . 73.23 111.344 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.05 130.01 85.53 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.924 0.89 . . . . 74.32 109.248 170.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.57 ' HG2' HE22 ' A' ' 26' ' ' GLN . 89.9 Cg_exo -46.97 85.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.953 3.102 . . . . 65.12 115.71 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -79.33 85.52 5.15 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.63 0.729 . . . . 73.41 109.036 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -56.65 104.72 0.16 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.478 -0.783 . . . . 75.33 110.502 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -69.49 83.43 0.41 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.908 0.861 . . . . 73.43 111.422 -169.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -142.29 112.68 6.12 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.545 1.138 . . . . 71.02 109.645 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.77 15.57 1.07 Allowed 'Trans proline' 0 CA--C 1.562 1.904 0 C-N-CA 123.012 2.475 . . . . 62.43 113.825 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.0 t -127.96 -24.49 3.19 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.681 0.793 . . . . 64.24 112.681 -171.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.21 22.66 6.51 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.247 0.832 . . . . 72.11 113.247 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -31.33 68.27 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 122.936 0.494 . . . . 72.53 112.077 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -84.16 -16.81 42.16 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.409 0.684 . . . . 71.23 111.249 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 25.4 t60 70.3 7.65 6.31 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.425 1.09 . . . . 74.12 112.487 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 63.63 -73.54 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.181 1.392 . . . . 70.21 111.681 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -76.31 154.37 35.12 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.664 0.786 . . . . 75.54 110.687 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -64.13 -29.46 70.59 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.449 0.7 . . . . 64.35 111.4 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.8 p80 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.845 0.831 . . . . 71.43 110.631 171.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.911 0.386 . . . . 74.51 111.883 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -116.34 14.89 15.81 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 123.621 0.768 . . . . 73.13 110.759 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 136' ' ' TYR . 6.3 p -129.7 103.66 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 124.326 1.05 . . . . 75.42 109.145 -174.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -107.72 105.52 15.4 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.437 0.695 . . . . 73.31 112.011 -168.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -94.7 111.12 22.9 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.136 0.575 . . . . 71.25 111.417 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.403 ' HD2' ' HG ' ' A' ' 48' ' ' LEU . 6.2 ptm180 -62.23 131.18 48.55 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.226 0.536 . . . . 74.42 110.915 169.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 10' ' ' ILE . 47.4 t -98.87 131.63 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.148 -0.686 . . . . 73.42 109.148 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.03 -36.16 2.4 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.717 1.006 . . . . 72.15 113.717 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -70.96 -24.52 77.03 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.605 1.002 . . . . 64.01 115.605 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 7' ' ' VAL . 71.9 mt -71.24 89.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 118.191 0.996 . . . . 64.12 110.71 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.48 6.64 0.58 Allowed 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.654 1.353 . . . . 73.14 114.654 173.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.09 98.28 9.79 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.698 -0.626 . . . . 62.33 111.155 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -59.12 -24.93 63.42 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.802 0.841 . . . . 75.33 110.973 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -48.51 68.11 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.862 0.865 . . . . 71.24 111.082 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.26 67.79 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 64.5 112.414 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mm -61.01 -48.9 86.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.714 0.405 . . . . 73.53 109.916 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -61.37 -35.76 78.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.351 0.5 . . . . 74.45 112.351 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.5 m -65.65 -41.34 92.68 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.876 0.47 . . . . 75.43 111.23 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.56 -46.07 87.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.384 1.074 . . . . 62.21 111.116 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.498 HD13 ' HG2' ' A' ' 45' ' ' GLU . 91.6 mt -61.79 -43.29 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.908 1.283 . . . . 61.25 111.601 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.7 m -63.84 -45.12 90.95 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.633 -0.712 . . . . 71.32 110.297 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.4 71.24 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.808 0.843 . . . . 74.34 112.498 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.83 -43.55 81.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.309 0.644 . . . . 61.3 112.552 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HE1' HD22 ' A' ' 62' ' ' LEU . 21.5 m-85 -60.94 -28.42 68.95 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.101 0.778 . . . . 72.03 113.101 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.81 -13.99 60.54 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.609 0.764 . . . . 75.13 112.007 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -118.32 -52.05 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.17 0.433 . . . . 64.21 112.17 169.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 88' ' ' HIS . 41.7 mm -55.8 -38.14 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 123.81 0.844 . . . . 75.42 112.197 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -114.72 2.83 14.55 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.643 0.777 . . . . 73.22 110.799 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 35.28 35.72 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 116.053 1.871 . . . . 63.43 116.053 -168.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.515 HH12 ' HG3' ' A' ' 71' ' ' GLU . 3.9 ptp85 -135.55 155.54 50.32 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.586 0.708 . . . . 73.44 111.635 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.97 96.26 8.79 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.909 -1.041 . . . . 54.24 109.541 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.74 134.32 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.038 -0.727 . . . . 74.12 109.038 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.35 126.78 87.16 Favored Pre-proline 0 CA--C 1.551 0.999 0 O-C-N 123.993 0.808 . . . . 72.4 110.238 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.49 -25.21 75.73 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.826 2.351 . . . . 62.12 112.857 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -79.2 -26.78 42.56 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.31 0.644 . . . . 52.14 112.21 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.7 mt -80.07 -39.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.053 0.541 . . . . 61.52 110.207 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.51 85.62 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.944 0.898 . . . . 54.02 111.709 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -72.93 -20.4 61.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.685 0.624 . . . . 72.13 112.685 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -75.87 -41.53 51.94 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.004 0.43 . . . . 60.23 110.639 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -76.57 -39.85 51.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.906 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 96.4 m-85 -116.66 26.62 9.72 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.675 0.991 . . . . 61.54 113.675 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -49.21 -49.83 41.16 Favored 'General case' 0 N--CA 1.515 2.78 0 N-CA-C 114.502 1.297 . . . . 62.52 114.502 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -75.1 -34.53 51.89 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.392 -0.367 . . . . 54.02 112.766 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -63.4 -31.64 72.85 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.201 1.001 . . . . 65.13 111.328 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HG2' HD13 ' A' ' 20' ' ' ILE . 47.7 mt-10 -70.45 -41.75 72.39 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.167 0.987 . . . . 71.32 110.67 172.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.9 t -61.84 -39.24 91.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.37 0.668 . . . . 53.23 111.017 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.5 mmmm -60.16 -38.0 81.82 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.747 0.419 . . . . 74.54 110.726 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD11 HG22 ' A' ' 55' ' ' VAL . 22.7 tp -73.25 -49.05 29.9 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.522 0.729 . . . . 75.31 111.942 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.37 73.59 Favored Glycine 0 N--CA 1.484 1.841 0 C-N-CA 123.315 0.483 . . . . 54.13 114.199 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -85.74 -19.11 31.28 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.444 0.697 . . . . 75.52 110.02 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.02 24.65 47.87 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.714 -1.13 . . . . 64.33 112.739 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -66.23 -40.04 89.97 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.003 0.921 . . . . 63.12 110.29 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' HD2' ' A' ' 58' ' ' PHE . 22.2 pt -116.1 143.83 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.91 0.884 . . . . 71.5 110.123 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 57' ' ' GLU . 8.7 t -71.73 162.83 28.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.413 0.285 . . . . 73.42 111.24 163.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 48' ' ' LEU . 22.2 t -65.16 -34.54 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.231 0.212 . . . . 73.22 110.985 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.573 ' HD2' ' HG3' ' A' ' 131' ' ' GLU . 26.8 tttp -50.43 -51.04 50.22 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.695 0.798 . . . . 74.04 113.059 171.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 54' ' ' THR . 29.1 tt0 -69.61 -31.2 69.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.474 0.71 . . . . 60.12 110.945 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HD2' HD11 ' A' ' 53' ' ' ILE . 36.9 t80 -57.85 -46.94 84.04 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.192 0.597 . . . . 72.12 110.93 170.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 55' ' ' VAL . 51.5 mm -60.69 -40.21 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.039 0.936 . . . . 71.32 111.308 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -54.34 -50.74 66.72 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 115.58 -0.737 . . . . 75.01 111.74 172.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.72 -28.62 57.14 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 115.063 0.785 . . . . 75.34 115.063 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD22 ' HE1' ' A' ' 24' ' ' TYR . 43.9 mt -71.65 -37.7 70.79 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.018 0.527 . . . . 70.32 110.988 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.91 -26.17 73.19 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 116.413 -0.358 . . . . 53.34 113.454 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.64 -3.17 55.83 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.896 0.879 . . . . 72.5 112.052 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 t -81.79 130.11 34.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.012 0.525 . . . . 70.14 111.798 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.37 -17.28 28.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.152 0.981 . . . . 75.14 112.371 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.69 -57.09 14.15 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.804 0.442 . . . . 74.14 111.198 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -58.73 -37.04 75.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.97 0.729 . . . . 74.01 112.97 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.681 HD11 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -61.89 -49.68 75.23 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.34 0.496 . . . . 74.12 112.34 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.94 -31.22 71.65 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 113.043 0.757 . . . . 74.43 113.043 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.515 ' HG3' HH12 ' A' ' 30' ' ' ARG . 19.7 mm-40 -87.93 -60.77 1.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.724 1.009 . . . . 64.22 113.724 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -111.77 60.16 0.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.746 0.703 . . . . 73.41 112.429 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 81' ' ' VAL . 58.6 t80 -165.57 -58.7 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.236 0.614 . . . . 72.25 110.293 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 m -63.75 -49.18 77.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 113.021 0.749 . . . . 62.41 113.021 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -86.98 13.34 2.73 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.016 1.811 . . . . 71.22 113.505 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -124.09 150.02 62.01 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.642 0.777 . . . . 61.33 111.455 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.82 165.78 31.8 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.412 2.074 . . . . 63.31 112.406 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.1 -34.76 78.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 73.33 112.517 -170.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.501 ' HA ' HD12 ' A' ' 82' ' ' ILE . 78.4 m -70.39 -38.37 74.66 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.536 0.734 . . . . 74.42 112.353 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.3 -34.42 76.11 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.147 -0.346 . . . . 63.11 111.601 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 73' ' ' TYR . 87.1 t -56.56 -34.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.595 0.758 . . . . 64.33 110.848 171.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 79' ' ' THR . 77.0 mt -74.04 -48.7 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.546 0.739 . . . . 74.23 111.917 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.26 -58.06 6.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.215 0.45 . . . . 75.15 112.215 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.3 mt -61.85 -25.21 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.35 0.66 . . . . 72.53 111.047 172.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 89' ' ' PHE . . . -63.7 -40.8 98.92 Favored Glycine 0 N--CA 1.468 0.783 0 CA-C-N 114.695 -1.138 . . . . 60.04 112.147 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.5 m -79.1 -44.52 21.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.256 0.623 . . . . 63.4 111.978 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -61.77 -49.55 75.93 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.327 0.862 . . . . 73.14 113.327 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.48 ' O ' HD13 ' A' ' 27' ' ' ILE . 11.8 m170 -61.59 -31.02 71.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.525 0.73 . . . . 72.03 112.534 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.609 ' HB3' HD12 ' A' ' 90' ' ' LEU . 1.1 t80 -98.96 -67.04 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.252 0.621 . . . . 75.03 112.088 -167.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.609 HD12 ' HB3' ' A' ' 89' ' ' PHE . 6.5 mp -77.32 -5.42 49.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.459 0.911 . . . . 72.13 113.459 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.57 33.04 75.69 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.054 0.252 . . . . 62.14 113.081 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.672 HH22 HG21 ' A' ' 128' ' ' VAL . 19.2 ptp180 -160.02 157.25 28.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.955 0.902 . . . . 72.34 111.297 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.82 153.09 95.81 Favored Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 109.944 -0.391 . . . . 31.13 109.944 168.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.15 167.14 4.84 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.451 2.101 . . . . 65.42 113.063 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.494 HD13 ' HG2' ' A' ' 99' ' ' GLU . 2.6 mp -80.59 -53.34 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.108 0.563 . . . . 71.5 110.402 -169.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -169.47 165.14 10.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.745 0.818 . . . . 74.01 109.187 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 58.2 tp60 -61.94 -30.25 70.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.854 0.462 . . . . 70.2 111.697 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.05 -45.47 88.67 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.058 0.543 . . . . 62.32 111.763 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.494 ' HG2' HD13 ' A' ' 95' ' ' ILE . 7.9 tp10 -62.55 -38.23 89.24 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.176 0.591 . . . . 75.4 111.303 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.455 HG21 HG23 ' A' ' 79' ' ' THR . 72.4 mt -60.58 -42.53 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.761 0.824 . . . . 52.33 111.209 173.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 90.6 mtt180 -58.13 -37.0 73.77 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.64 0.607 . . . . 63.43 112.64 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -62.08 -53.74 51.15 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 120.879 0.371 . . . . 62.02 110.59 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -62.38 -36.22 81.6 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.567 -0.742 . . . . 65.44 112.412 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -65.56 -38.95 91.04 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.529 0.732 . . . . 64.03 111.387 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 109' ' ' THR . 23.0 tp60 -62.58 -38.5 90.38 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.582 -0.735 . . . . 75.13 110.506 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 81.9 mt -64.47 -48.64 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 123.589 0.756 . . . . 70.11 111.291 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.25 -37.09 66.77 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.137 0.575 . . . . 75.02 112.099 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.58 -48.53 32.08 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.191 0.596 . . . . 62.34 111.881 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.442 HG23 HE21 ' A' ' 105' ' ' GLN . 70.4 p -77.05 -71.91 0.38 Allowed 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.618 -0.719 . . . . 73.12 112.413 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -89.89 -53.49 4.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 70.12 112.003 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 -157.97 23.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 114.346 0.499 . . . . 34.43 114.346 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.681 HG12 HD11 ' A' ' 69' ' ' LEU . 8.8 tp -76.98 -37.58 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.507 0.723 . . . . 73.1 112.457 -173.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.11 -31.22 71.96 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 75.4 111.521 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.53 -31.76 57.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.99 -1.004 . . . . 73.04 110.671 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -67.19 -45.69 76.16 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 64.25 111.048 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 120' ' ' VAL . 47.9 mm -63.97 -55.53 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.901 0.48 . . . . 65.44 110.171 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.58 -38.57 55.03 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.115 0.566 . . . . 73.33 112.237 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.86 88.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.552 0.341 . . . . 53.21 111.813 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.63 -39.29 77.23 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.274 0.63 . . . . 72.23 111.862 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 116' ' ' ILE . 18.1 t -67.41 -41.89 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.482 0.658 . . . . 70.34 110.605 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 121' ' ' ASN . 0.7 OUTLIER -87.2 -10.0 53.72 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.907 0.883 . . . . 73.32 111.444 -177.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.9 t -57.6 146.47 30.27 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.273 0.629 . . . . 75.41 111.448 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 11.7 pt20 -69.46 -38.01 77.57 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.926 0.49 . . . . 73.34 110.405 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -61.39 -38.71 88.02 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.101 0.961 . . . . 62.34 111.777 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.496 ' HD1' ' HA ' ' A' ' 90' ' ' LEU . 59.5 t80 -77.2 -41.89 39.64 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.581 0.753 . . . . 75.54 111.447 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 56' ' ' LYS . 63.9 t30 -67.44 -51.59 49.84 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.183 0.808 . . . . 71.15 113.183 -165.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 12.6 pt-20 -91.16 -26.14 19.23 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.409 0.522 . . . . 72.0 112.409 -171.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 HH22 ' A' ' 92' ' ' ARG . 79.2 t -78.76 -50.72 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 122.871 0.469 . . . . 72.55 110.732 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.491 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 1.5 t80 -81.03 -45.79 16.02 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.594 0.758 . . . . 71.22 111.972 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.76 -144.02 17.04 Favored Glycine 0 N--CA 1.482 1.752 0 CA-C-O 119.749 -0.473 . . . . 71.31 112.807 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.573 ' HG3' ' HD2' ' A' ' 56' ' ' LYS . 4.7 mp0 -126.13 -58.13 1.38 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 117.831 0.815 . . . . 72.15 112.5 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.71 11.8 0.96 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.878 1.807 . . . . 63.23 115.878 -162.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.0 t -134.94 174.29 10.76 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.956 0.724 . . . . 64.23 112.956 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 54.2 t -84.71 136.34 39.39 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 123.896 0.879 . . . . 74.1 110.287 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -58.54 134.1 58.81 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.966 2.444 . . . . 74.32 112.214 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.519 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 17.9 p90 -108.82 150.34 27.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.947 0.899 . . . . 74.42 112.247 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -83.49 98.92 9.8 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.022 -0.99 . . . . 74.1 109.703 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -81.98 63.55 6.26 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.209 0.604 . . . . 71.12 111.497 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -138.98 139.06 22.33 Favored Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 123.041 0.537 . . . . 64.53 111.178 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.33 -47.6 9.52 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 123.0 2.466 . . . . 63.32 112.526 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.0 t -89.05 130.33 35.53 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.066 0.46 . . . . 55.1 110.135 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.86 145.32 51.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.903 0.881 . . . . 71.34 110.303 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -69.14 88.29 0.42 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.356 0.662 . . . . 71.33 111.42 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -83.51 77.77 9.77 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.576 0.703 . . . . 74.31 109.361 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -107.35 -178.16 3.56 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.416 -0.811 . . . . 71.21 111.273 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -76.49 171.95 13.77 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 115.568 -0.742 . . . . 75.33 111.485 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -150.6 90.24 1.62 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.596 0.758 . . . . 53.41 111.009 -174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -73.09 126.78 30.79 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.901 -0.59 . . . . 74.11 110.179 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.1 t60 . . . . . 0 N--CA 1.484 1.275 0 C-N-CA 123.695 0.798 . . . . 64.4 111.874 -178.731 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.6 ttm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 110.162 -0.31 . . . . 73.1 110.162 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.55 140.86 15.44 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.402 0.681 . . . . 72.24 110.669 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.36 121.0 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 109.695 -0.483 . . . . 65.21 109.695 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.99 93.22 1.35 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.432 0.634 . . . . 73.55 109.624 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -126.58 151.05 48.47 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.389 1.075 . . . . 65.51 109.002 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -84.87 122.17 28.79 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 122.094 -0.379 . . . . 72.43 110.373 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -83.37 122.32 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.222 0.609 . . . . 44.51 109.439 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.06 94.35 0.23 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.41 0.684 . . . . 65.31 112.069 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.73 11.41 16.98 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.636 0.615 . . . . 62.03 114.636 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.25 97.98 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.801 0 CA-C-N 117.632 0.716 . . . . 74.21 110.64 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -64.18 -32.22 73.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.835 -1.165 . . . . 52.34 113.154 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -42.68 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.772 0.829 . . . . 64.11 112.336 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -71.67 -9.03 57.65 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 114.865 -1.061 . . . . 73.11 111.359 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.35 -41.71 93.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.375 0.67 . . . . 72.24 109.991 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.1 75.47 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.822 0.849 . . . . 74.12 111.838 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.92 -44.99 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.923 0.489 . . . . 73.31 111.354 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -73.76 -35.67 65.03 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.557 0.743 . . . . 75.44 112.899 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 t -66.71 -29.97 70.09 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 120.711 0.291 . . . . 74.14 111.413 172.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.613 HD22 HD21 ' A' ' 48' ' ' LEU . 8.3 tt -68.27 -45.3 73.51 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.072 0.949 . . . . 65.24 109.661 173.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.11 -44.9 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 124.504 1.122 . . . . 73.13 111.71 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 t -69.17 -36.85 77.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.374 0.67 . . . . 73.11 111.722 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.84 -36.06 80.09 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.628 0.771 . . . . 53.01 111.105 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.15 -42.81 65.52 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.098 0.959 . . . . 71.5 111.911 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.84 -49.86 48.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.019 0.527 . . . . 72.02 111.895 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -64.0 -14.88 57.47 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.829 1.048 . . . . 70.34 113.829 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -95.23 -61.66 1.44 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.327 0.512 . . . . 62.32 110.398 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.3 -42.82 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 123.587 0.755 . . . . 73.42 111.837 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.32 -12.16 33.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.497 0.319 . . . . 71.32 111.709 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.35 32.72 22.41 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.042 1.497 . . . . 72.14 115.042 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 166.63 29.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.092 0.775 . . . . 73.24 113.092 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.43 101.29 8.09 Favored 'General case' 0 CA--C 1.558 1.281 0 CA-C-N 114.208 -1.36 . . . . 52.44 110.6 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -80.69 118.84 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.352 -0.61 . . . . 73.12 109.352 167.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.07 132.14 93.63 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.336 0.655 . . . . 71.51 111.45 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.13 -37.41 79.6 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.235 2.623 . . . . 64.53 114.3 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -71.5 -26.85 62.86 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.483 0.549 . . . . 74.41 112.483 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -80.45 -38.22 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.158 0.504 . . . . 75.44 110.199 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.16 -32.98 74.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.154 0.982 . . . . 60.4 112.797 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -76.13 -16.82 59.81 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.681 0.392 . . . . 64.24 111.728 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -80.54 -47.39 14.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.028 0.531 . . . . 75.42 110.983 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.86 -45.58 23.85 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.621 0.768 . . . . 75.13 111.695 -175.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 75.8 m-85 -116.64 52.71 0.92 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.764 0.825 . . . . 74.34 111.657 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.74 -55.4 13.25 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.123 0.487 . . . . 64.35 112.189 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.86 -30.31 63.79 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.706 -0.679 . . . . 62.25 113.008 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 6.7 t-105 -67.5 -38.24 84.02 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.718 0.807 . . . . 64.23 112.041 -174.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -57.62 -49.84 75.11 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.253 1.021 . . . . 73.32 110.177 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -53.47 -49.78 66.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.212 1.005 . . . . 74.45 111.881 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.99 -33.88 76.35 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.721 0.637 . . . . 75.33 112.721 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.613 HD21 HD22 ' A' ' 19' ' ' LEU . 37.9 tp -71.8 -43.25 65.99 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 120.731 0.3 . . . . 72.44 110.93 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.85 -19.72 77.07 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 114.597 0.599 . . . . 72.5 114.597 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -94.9 -12.21 27.27 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.128 0.571 . . . . 74.54 112.098 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.0 71.37 Favored Glycine 0 C--N 1.35 1.308 0 C-N-CA 121.859 -0.21 . . . . 70.23 113.615 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.73 -32.42 65.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.644 0.777 . . . . 44.43 111.394 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -129.35 156.58 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.427 0.691 . . . . 63.43 109.517 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 p -85.4 178.8 7.32 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.818 0.342 . . . . 75.31 110.611 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 59' ' ' ILE . 74.4 t -64.34 -38.28 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 116.492 -0.322 . . . . 71.24 110.527 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 13.9 tttm -60.02 -44.21 94.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.894 0.478 . . . . 64.34 111.731 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -68.01 -24.73 65.15 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.344 0.658 . . . . 74.12 111.456 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -77.44 -48.11 18.0 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.283 -1.006 . . . . 75.14 108.283 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 46.7 mm -60.67 -33.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 125.062 1.345 . . . . 71.24 111.244 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.26 -51.52 69.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.283 0.633 . . . . 71.35 111.214 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.34 -29.47 66.18 Favored Glycine 0 C--N 1.357 1.729 0 N-CA-C 114.883 0.713 . . . . 72.31 114.883 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.27 -28.57 68.14 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.969 0.385 . . . . 55.34 110.989 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.73 -31.57 44.15 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 116.116 -0.493 . . . . 51.01 113.461 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.8 -4.44 57.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.56 0.744 . . . . 70.03 112.643 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.9 p -77.77 141.38 39.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.042 0.383 . . . . 61.41 111.407 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -56.93 -31.29 64.8 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.714 0.805 . . . . 71.11 111.677 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.3 tp -62.0 -46.68 88.13 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.562 0.745 . . . . 74.45 111.315 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -63.21 -36.45 83.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.924 0.393 . . . . 72.43 111.333 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 112' ' ' ILE . 4.5 mm? -68.18 -45.23 74.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.722 0.809 . . . . 60.03 112.815 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -73.17 -30.46 63.58 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.002 -0.436 . . . . 73.34 112.126 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -82.12 -53.49 6.05 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.796 1.036 . . . . 73.1 113.796 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -118.25 42.13 2.77 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.399 0.888 . . . . 73.25 113.399 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.553 ' HA ' HG22 ' A' ' 81' ' ' VAL . 65.7 t80 -155.9 -53.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.027 0.442 . . . . 62.54 111.256 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 m -68.59 -48.1 33.33 Favored Pre-proline 0 CA--C 1.573 1.854 0 N-CA-C 113.33 0.863 . . . . 72.22 113.33 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -82.73 3.93 7.46 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.92 1.746 . . . . 74.53 113.961 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -126.27 150.77 70.92 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.697 0.799 . . . . 73.5 111.654 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.24 171.01 15.8 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.351 2.034 . . . . 73.11 111.906 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.59 -49.55 74.57 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.329 0.651 . . . . 75.03 111.542 -176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 HG21 ' A' ' 100' ' ' ILE . 30.4 m -58.67 -21.99 55.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.934 1.293 . . . . 75.01 114.389 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.86 -35.53 13.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.989 -0.745 . . . . 64.23 108.989 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 73' ' ' TYR . 60.2 t -56.81 -31.88 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.538 -0.755 . . . . 73.14 110.244 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 79' ' ' THR . 92.1 mt -68.09 -53.28 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.36 -0.836 . . . . 74.32 112.119 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.24 -50.13 56.02 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.402 1.001 . . . . 70.02 112.392 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.21 -31.04 69.78 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.098 0.559 . . . . 75.41 112.053 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.81 -45.74 50.19 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.558 -0.292 . . . . 62.31 112.902 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.638 HG23 HD12 ' A' ' 90' ' ' LEU . 88.0 m -64.19 -43.81 93.94 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.499 0.72 . . . . 62.55 111.911 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -60.98 -28.29 68.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 113.659 0.985 . . . . 74.1 113.659 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -73.41 -34.65 65.6 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.581 0.586 . . . . 63.13 112.581 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -104.76 -65.02 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.67 0.388 . . . . 65.03 111.581 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD12 HG23 ' A' ' 86' ' ' THR . 90.5 mt -75.47 -12.03 60.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.127 0.571 . . . . 74.44 112.466 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.45 24.95 75.41 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.651 0.62 . . . . 63.22 114.651 175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -159.27 -176.19 5.67 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 117.618 0.709 . . . . 52.34 111.794 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.02 30.58 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.693 0.797 . . . . 70.25 110.603 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.89 155.31 18.55 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.43 2.753 . . . . 72.55 113.636 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.481 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 49.5 mt -65.1 -52.61 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.694 0.798 . . . . 63.12 112.568 -169.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -148.59 171.58 15.92 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.47 0.708 . . . . 65.31 109.297 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -60.79 -28.98 69.16 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.031 0.532 . . . . 72.21 111.524 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.44 85.94 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.712 0.805 . . . . 52.44 111.215 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 15.4 tp10 -58.85 -43.61 90.79 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.288 1.035 . . . . 73.31 111.631 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.587 HG21 HG23 ' A' ' 79' ' ' THR . 73.2 mt -62.67 -50.56 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.873 0.869 . . . . 72.53 111.251 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -64.59 -29.59 70.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.324 0.65 . . . . 74.34 111.655 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -62.09 -49.92 74.03 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.711 0.804 . . . . 72.51 110.409 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -63.25 -40.72 98.23 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.902 0.481 . . . . 72.23 111.714 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.9 -34.97 77.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.406 0.683 . . . . 40.2 110.972 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -64.28 -36.43 84.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.763 0.825 . . . . 51.31 111.325 173.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.96 -42.89 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.601 0.761 . . . . 70.23 110.989 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -36.17 82.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.192 0.597 . . . . 75.12 111.669 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.46 -44.85 73.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.216 0.606 . . . . 53.3 111.495 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.2 p -77.71 -69.59 0.53 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.119 0.785 . . . . 74.15 113.119 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -93.3 -46.95 7.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.964 -0.46 . . . . 73.22 111.724 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.8 -159.68 15.39 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-O 121.002 0.223 . . . . 62.25 113.581 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 69' ' ' LEU . 8.5 tp -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 123.908 0.883 . . . . 74.03 113.114 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -57.36 -42.35 81.85 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.316 0.646 . . . . 71.31 111.709 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.96 -28.24 43.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.269 -0.878 . . . . 75.45 110.899 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.63 -48.66 71.48 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.049 0.939 . . . . 72.42 110.931 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.67 -54.63 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 74.11 110.323 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -45.41 -42.08 9.91 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.13 0.972 . . . . 73.24 113.052 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.68 94.31 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.767 0.427 . . . . 61.23 111.882 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.7 -41.7 78.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.521 0.728 . . . . 61.14 112.131 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.28 -47.54 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 122.806 0.442 . . . . 63.34 111.689 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -81.46 2.27 29.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.46 0.541 . . . . 74.0 112.46 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 t -61.2 132.5 53.86 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.953 0.501 . . . . 52.3 109.986 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.03 -36.0 74.24 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.265 0.353 . . . . 72.43 111.139 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.9 -45.41 82.61 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.965 0.906 . . . . 73.22 111.786 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.468 ' HB2' HD23 ' A' ' 90' ' ' LEU . 87.8 t80 -58.23 -54.71 43.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.883 -0.414 . . . . 72.45 109.883 173.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -60.5 -28.3 68.26 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.611 0.764 . . . . 70.12 112.745 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.21 -40.1 14.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.448 0.699 . . . . 75.51 112.332 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 91.5 t -89.44 -61.52 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 122.932 0.493 . . . . 63.24 110.505 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 138' ' ' ARG . 65.4 m-85 -102.76 70.19 1.1 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.697 . . . . 70.51 109.395 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.06 178.65 0.79 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.623 -0.717 . . . . 64.03 114.537 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.644 ' HG2' ' HD3' ' A' ' 56' ' ' LYS . 27.9 mt-10 -63.91 -14.3 52.43 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.288 0.847 . . . . 54.41 113.288 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.22 -33.0 12.18 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.175 0.59 . . . . 73.15 111.884 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.5 m -86.0 136.59 33.19 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.125 0.57 . . . . 63.44 112.421 -173.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.77 135.73 31.78 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.398 1.079 . . . . 60.34 109.954 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.63 136.06 63.57 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.478 2.119 . . . . 72.12 112.796 167.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -143.65 178.74 7.59 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.11 0.564 . . . . 71.11 111.195 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -70.29 91.15 0.72 Allowed 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 121.296 0.569 . . . . 64.23 110.7 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.404 ' HD2' ' CZ ' ' A' ' 129' ' ' PHE . 14.3 ptm180 -92.46 -34.9 13.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.343 0.657 . . . . 72.24 111.759 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -106.0 144.24 28.53 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.333 0.653 . . . . 73.52 111.709 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.46 -10.21 25.12 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.058 2.506 . . . . 73.41 113.652 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -77.2 -31.22 55.14 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.934 0.494 . . . . 64.03 111.876 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.3 pp -105.23 42.74 1.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.126 0.965 . . . . 74.32 109.652 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -31.82 18.14 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 115.756 1.762 . . . . 64.11 115.756 -171.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 56.09 32.82 20.79 Favored 'General case' 0 CA--C 1.579 2.085 0 C-N-CA 124.353 1.061 . . . . 75.54 112.135 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -68.73 -33.19 73.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.47 -0.769 . . . . 72.33 111.238 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -70.14 131.82 44.87 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.322 0.649 . . . . 75.45 111.474 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -167.8 19.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.694 0.798 . . . . 72.41 112.202 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -65.73 88.13 0.1 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.439 0.696 . . . . 75.44 112.084 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 N--CA 1.481 1.102 0 C-N-CA 124.383 1.073 . . . . 72.21 109.749 178.469 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.721 0.296 . . . . 73.44 111.495 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -118.31 114.38 22.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.034 0.934 . . . . 63.42 109.485 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 t -109.68 98.81 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.465 -0.939 . . . . 65.11 108.465 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.62 123.73 17.28 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.307 1.043 . . . . 74.21 111.783 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.14 162.15 38.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.252 0.621 . . . . 72.32 111.035 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -74.86 89.24 2.33 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.693 -0.685 . . . . 74.45 110.787 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -70.93 112.45 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-N 115.878 -0.601 . . . . 62.42 111.008 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.78 43.26 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.001 1.32 . . . . 72.12 113.583 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.26 -42.09 55.41 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.688 0.635 . . . . 42.31 114.688 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.5 mm -71.58 -54.54 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 123.565 0.746 . . . . 74.24 110.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? 46.37 17.21 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 126.123 1.769 . . . . 64.53 115.146 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.43 138.31 31.68 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.921 0.888 . . . . 74.11 110.824 -169.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -70.49 -29.07 65.51 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.174 0.805 . . . . 62.01 113.174 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.12 -30.5 49.41 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.698 0.399 . . . . 64.24 110.696 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.79 -38.68 64.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.26 0.624 . . . . 74.3 109.959 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.573 HG12 ' HA2' ' A' ' 49' ' ' GLY . 1.5 mp -63.95 -34.97 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 115.256 -0.884 . . . . 74.55 110.027 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 34' ' ' PRO . 24.4 ttmm -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.918 0.71 . . . . 72.43 112.918 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -69.7 -34.01 73.32 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 122.018 -0.426 . . . . 64.0 110.41 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.04 -34.35 77.83 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.854 1.262 . . . . 45.12 110.355 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 16' ' ' ILE . 51.5 mm -62.59 -53.17 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.05 0.94 . . . . 73.42 109.514 174.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -65.76 -29.05 69.51 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.202 1.001 . . . . 74.23 112.867 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.01 -41.41 59.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.528 0.731 . . . . 71.25 110.543 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.02 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.941 0.897 . . . . 73.41 111.927 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.949 0.499 . . . . 70.2 112.209 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtp85 -67.57 -14.36 62.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.111 0.564 . . . . 75.03 112.028 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.754 ' HG2' ' HB2' ' A' ' 135' ' ' PRO . 23.9 tp60 -95.9 -50.33 4.93 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.928 0.491 . . . . 74.12 111.147 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -78.46 -59.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 123.257 0.623 . . . . 74.53 111.005 -175.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -81.51 -7.05 59.53 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.723 0.409 . . . . 65.33 111.634 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 65.97 -54.48 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.502 1.921 . . . . 65.44 114.479 -174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -65.64 139.12 58.38 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.53 0.732 . . . . 74.43 112.282 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -65.59 128.66 36.85 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.229 -0.896 . . . . 63.51 109.649 168.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -105.47 142.51 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.193 0.597 . . . . 65.34 109.973 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 36' ' ' ILE . . . -62.66 124.34 82.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.955 0.902 . . . . 74.0 111.402 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' A' ' 17' ' ' LYS . 51.0 Cg_exo -56.01 -32.31 85.62 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 123.513 2.809 . . . . 75.43 115.575 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -72.78 -35.73 67.48 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.37 0.268 . . . . 64.53 111.206 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.474 ' HA ' HD21 ' A' ' 39' ' ' ASN . 71.3 mt -66.25 -41.57 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.919 0.888 . . . . 73.43 110.423 172.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.68 64.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.031 0.932 . . . . 72.12 111.691 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -75.9 -61.38 1.95 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.526 -0.761 . . . . 73.22 110.914 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 36' ' ' ILE . 9.3 p30 -63.21 -25.69 68.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.235 0.828 . . . . 63.14 113.235 -174.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.26 -54.49 5.91 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.86 0.464 . . . . 73.32 110.773 172.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 85.1 m-85 -113.92 60.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.678 0.791 . . . . 75.03 111.557 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 89.8 p -73.27 -50.94 19.53 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.928 -0.483 . . . . 71.25 111.988 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.68 -31.34 58.6 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.287 -0.415 . . . . 60.43 112.377 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 8.7 t-105 -69.93 -37.47 75.9 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.194 0.997 . . . . 75.0 111.157 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.9 -41.9 81.99 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.013 0.925 . . . . 72.03 111.542 169.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -53.62 -54.46 37.35 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.57 1.148 . . . . 65.24 113.193 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.691 ' HD3' HG21 ' A' ' 53' ' ' ILE . 15.1 ptpt -61.18 -35.08 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.269 0.84 . . . . 63.54 113.269 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.1 tp -71.15 -34.22 70.8 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.308 0.243 . . . . 62.43 110.707 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.573 ' HA2' HG12 ' A' ' 16' ' ' ILE . . . -67.08 -33.52 83.72 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.76 -0.2 . . . . 72.25 112.861 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -73.63 -10.38 59.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.01 0.924 . . . . 75.23 112.144 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.99 32.5 82.36 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 115.364 0.906 . . . . 51.34 115.364 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.4 -60.2 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.902 0.858 . . . . 73.22 110.201 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.691 HG21 ' HD3' ' A' ' 47' ' ' LYS . 21.9 pt -73.13 176.1 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.797 -1.547 . . . . 74.35 112.181 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.608 HG23 ' H ' ' A' ' 57' ' ' GLU . 1.8 t -99.51 153.37 19.08 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.078 -0.712 . . . . 62.02 109.078 170.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 59' ' ' ILE . 91.2 t -64.06 -31.13 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 110.119 -0.326 . . . . 75.21 110.119 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -44.83 -50.93 9.99 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.735 1.013 . . . . 63.53 113.735 166.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.608 ' H ' HG23 ' A' ' 54' ' ' THR . 31.6 tt0 -58.52 -42.51 87.9 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.651 0.38 . . . . 75.24 110.822 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' HZ ' HG23 ' A' ' 20' ' ' ILE . 86.7 t80 -63.75 -43.34 96.72 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.01 0.924 . . . . 72.33 110.881 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 55' ' ' VAL . 33.7 mm -68.11 -46.47 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.751 1.22 . . . . 63.24 111.911 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.72 -39.08 64.94 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.894 0.478 . . . . 62.03 111.471 170.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.09 -25.42 72.16 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 116.142 -0.481 . . . . 75.11 114.165 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.7 mt -75.68 -38.1 58.99 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.426 0.69 . . . . 71.4 111.134 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.44 -18.08 79.22 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 121.554 -0.355 . . . . 73.1 113.657 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -84.59 -28.15 26.75 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.528 0.731 . . . . 75.33 111.566 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.3 p -71.99 129.4 38.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.673 -0.491 . . . . 63.44 109.673 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -58.71 -15.87 13.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.138 1.162 . . . . 72.54 114.138 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.69 -42.62 93.35 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.885 0.874 . . . . 64.43 112.072 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -65.51 -43.21 90.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.542 0.687 . . . . 60.4 111.031 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.96 -28.75 63.64 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.012 -0.994 . . . . 74.51 111.327 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -60.37 -45.87 91.98 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.959 1.304 . . . . 73.14 111.072 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.81 -42.05 61.48 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.015 -0.993 . . . . 73.41 111.832 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -114.31 -67.56 0.99 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.922 1.082 . . . . 71.21 113.922 -167.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -61.19 -30.02 70.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 114.338 1.236 . . . . 71.11 114.338 -169.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.557 ' HB ' ' HD3' ' A' ' 75' ' ' PRO . 45.8 m -78.65 -54.74 1.09 Allowed Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.729 -0.653 . . . . 75.31 112.054 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 74' ' ' THR . 14.8 Cg_exo -71.8 -16.86 29.57 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 121.989 1.792 . . . . 55.21 114.274 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 56.3 m-85 -115.24 147.71 39.13 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 123.088 0.555 . . . . 72.41 112.357 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 81' ' ' VAL . 91.7 Cg_endo -75.54 169.93 21.32 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.367 . . . . 75.42 112.549 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -49.95 -49.56 49.77 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.25 1.02 . . . . 74.42 113.002 -173.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.589 ' HA ' HD12 ' A' ' 82' ' ' ILE . 26.3 m -59.69 -35.53 74.67 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.6 0.76 . . . . 73.4 112.981 -177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 22.4 tptm -72.72 -36.18 67.74 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 120.904 0.383 . . . . 71.43 110.859 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 77' ' ' PRO . 41.7 t -68.84 -28.53 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.242 0.617 . . . . 75.21 110.569 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 79' ' ' THR . 96.9 mt -66.77 -52.11 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 73.33 111.26 174.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -71.99 -37.57 69.84 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 111.832 0.308 . . . . 73.4 111.832 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.97 -31.26 61.41 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.299 0.639 . . . . 71.34 111.508 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.83 -42.9 52.05 Favored Glycine 0 N--CA 1.476 1.312 0 N-CA-C 112.039 -0.424 . . . . 74.44 112.039 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.68 HG23 HD12 ' A' ' 90' ' ' LEU . 53.6 m -66.48 -35.78 81.11 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.098 0.959 . . . . 74.33 110.747 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.93 -42.44 90.08 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.362 0.665 . . . . 60.24 112.627 175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.8 m170 -82.84 -36.0 25.86 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.961 0.504 . . . . 75.54 112.353 -175.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -94.29 -68.87 0.78 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 119.179 -0.439 . . . . 71.13 111.274 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.68 HD12 HG23 ' A' ' 86' ' ' THR . 79.2 mt -66.9 -18.24 65.28 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.945 0.72 . . . . 73.01 112.945 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.23 21.3 78.16 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.321 0.388 . . . . 71.33 113.422 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 86' ' ' THR . 9.7 ptt180 -143.09 172.79 12.23 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.166 0.587 . . . . 74.0 110.951 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.06 151.28 54.21 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 123.246 0.618 . . . . 72.14 111.07 165.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.05 140.45 65.69 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.232 1.955 . . . . 34.22 111.486 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.65 -42.83 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.426 0.528 . . . . 75.11 112.426 -164.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -155.65 160.88 40.77 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.161 -0.681 . . . . 52.31 109.161 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -54.91 -36.08 64.84 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.447 0.699 . . . . 73.22 112.654 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.37 74.23 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.294 0.638 . . . . 60.53 112.323 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.42 -39.88 67.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.615 0.766 . . . . 64.42 111.624 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.57 -53.27 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.335 0.654 . . . . 71.2 111.713 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -55.81 -32.72 63.79 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.782 0.833 . . . . 71.44 111.867 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.4 tmmm? -61.01 -52.13 66.29 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.503 0.721 . . . . 74.03 110.856 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -64.99 -35.77 82.25 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.849 0.46 . . . . 75.2 112.021 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.408 ' HB2' HD11 ' A' ' 82' ' ' ILE . 47.9 t30 -67.87 -36.85 80.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.064 0.946 . . . . 70.41 111.398 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -67.78 -30.74 70.26 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.575 -0.739 . . . . 65.41 110.632 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 102' ' ' LYS . 74.3 mt -65.77 -40.75 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 122.952 0.501 . . . . 73.04 110.426 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.75 -37.97 76.62 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.241 0.617 . . . . 75.24 112.044 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.4 71.47 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.404 0.682 . . . . 62.1 112.115 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 p -75.79 -52.16 11.02 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.965 0.906 . . . . 72.13 111.642 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.09 -73.03 0.69 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.936 0.894 . . . . 73.41 111.356 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.02 -174.21 22.55 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.297 0.499 . . . . 74.34 113.543 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.8 mm -52.73 -36.64 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.966 1.306 . . . . 72.13 113.706 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -61.17 -51.35 69.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.884 0.373 . . . . 74.21 111.139 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.9 -37.45 87.69 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.524 -0.762 . . . . 73.45 112.539 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.39 -55.95 17.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.31 1.044 . . . . 64.53 112.624 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -57.51 -44.55 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.673 0.789 . . . . 63.52 110.693 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.58 -39.19 76.22 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.322 0.649 . . . . 74.02 112.263 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.96 98.49 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.245 0.618 . . . . 64.14 111.472 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 63.0 mt -62.83 -55.04 29.84 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.836 0.854 . . . . 72.11 111.399 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 56' ' ' LYS . 74.9 t -67.23 -32.6 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 123.186 0.595 . . . . 75.04 112.438 -173.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.93 22.11 15.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.63 -0.669 . . . . 74.22 111.824 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.2 t -71.5 142.03 50.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.258 0.623 . . . . 72.41 110.453 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.65 -37.39 79.62 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.724 0.41 . . . . 72.33 111.563 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.58 -32.5 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 120.776 0.322 . . . . 74.24 110.887 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -75.49 -54.13 7.53 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.455 0.702 . . . . 73.13 111.712 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -69.86 -23.35 63.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 112.905 0.705 . . . . 74.42 112.905 -169.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.46 -39.1 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.042 0.537 . . . . 75.23 111.984 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.29 -58.92 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.089 0.947 . . . . 75.44 110.394 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.527 ' HE2' ' HB2' ' A' ' 56' ' ' LYS . 45.5 t80 -59.88 -46.64 88.68 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.037 1.735 . . . . 74.2 112.786 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.94 -129.18 9.2 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-O 119.534 -0.592 . . . . 41.21 112.183 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -135.06 -64.58 0.65 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.504 0.652 . . . . 65.21 111.271 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.43 1.14 34.45 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.844 0.858 . . . . 73.44 112.693 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.9 m -92.35 151.65 20.16 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.843 0.857 . . . . 72.5 111.528 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.7 137.67 85.65 Favored Pre-proline 0 N--CA 1.488 1.452 0 C-N-CA 124.468 1.107 . . . . 74.4 110.284 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.754 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 2.8 Cg_exo -67.82 135.57 35.86 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.158 1.905 . . . . 74.32 111.798 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -136.21 141.35 43.99 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.493 0.717 . . . . 75.24 110.299 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.481 ' H ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -86.47 18.54 3.22 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.437 0.695 . . . . 70.43 112.523 -176.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 65.72 -104.89 0.1 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 125.031 1.332 . . . . 75.13 112.514 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.55 ' H ' ' HD3' ' A' ' 140' ' ' PRO . 38.8 p90 -160.38 27.1 0.03 OUTLIER Pre-proline 0 CA--C 1.59 2.496 0 N-CA-C 116.208 1.929 . . . . 53.43 116.208 -171.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.55 ' HD3' ' H ' ' A' ' 139' ' ' PHE . 15.9 Cg_exo -66.79 -11.89 33.8 Favored 'Trans proline' 0 C--N 1.401 3.298 0 CA-C-N 123.4 2.25 . . . . 74.2 112.878 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 t -61.7 -44.16 97.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.404 1.082 . . . . 74.45 111.466 169.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.6 mt 61.77 6.44 1.62 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.149 1.38 . . . . 71.03 113.88 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -85.89 89.15 7.69 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.562 0.696 . . . . 74.14 109.324 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -83.74 98.11 9.5 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.49 -0.777 . . . . 73.0 111.968 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.5 126.01 34.65 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.747 -0.661 . . . . 74.2 109.532 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -68.52 -6.5 25.62 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.862 1.06 . . . . 74.41 113.862 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -132.39 128.19 37.04 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.886 0.874 . . . . 63.3 110.502 167.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -155.23 81.73 1.06 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.702 0.801 . . . . 74.34 109.505 173.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 N--CA 1.49 1.555 0 C-N-CA 124.064 0.946 . . . . 74.43 112.417 -170.905 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.607 0.241 . . . . 63.34 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -138.28 130.4 28.61 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.871 0.868 . . . . 75.45 109.852 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 p -108.99 125.24 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.67 0.788 . . . . 54.2 110.68 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -92.23 87.22 6.0 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.63 0.729 . . . . 71.31 109.748 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.53 155.43 17.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.546 0.738 . . . . 73.13 110.881 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -92.77 113.8 26.18 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.22 -1.03 . . . . 70.53 108.22 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.56 124.44 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.912 -0.773 . . . . 74.2 108.912 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.87 99.86 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.707 0.803 . . . . 54.45 111.945 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.29 -31.49 2.34 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.067 -0.515 . . . . 73.31 113.929 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.3 mt -67.68 102.16 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-O 121.709 0.766 . . . . 70.14 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -113.62 24.93 11.69 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.709 -1.132 . . . . 73.34 110.176 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.42 109.31 21.18 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.697 0.799 . . . . 71.2 108.984 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -61.51 -23.34 65.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.64 0.607 . . . . 61.41 112.64 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.27 -38.84 68.72 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.267 0.627 . . . . 74.14 111.074 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.01 52.14 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.357 0.663 . . . . 74.53 111.289 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.41 HG21 ' HA2' ' A' ' 49' ' ' GLY . 49.0 mm -72.52 -42.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.08 0.552 . . . . 74.14 110.07 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.38 -31.75 73.02 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.866 0.867 . . . . 72.04 112.527 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -77.14 -31.0 55.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 120.902 0.382 . . . . 72.23 111.446 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.07 -43.55 98.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.741 0.816 . . . . 74.44 109.654 170.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.3 -38.04 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.481 1.112 . . . . 71.12 111.48 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.8 t -65.74 -38.37 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.519 0.728 . . . . 60.34 111.771 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.41 -37.6 63.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.146 0.578 . . . . 60.53 110.885 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.9 77.14 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.777 0.831 . . . . 74.23 111.601 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -59.07 -49.91 76.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.984 0.514 . . . . 73.04 110.923 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.78 -26.5 68.66 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.88 0.696 . . . . 74.0 112.88 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.29 -46.89 72.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.853 0.461 . . . . 74.52 111.367 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.719 HD11 HG23 ' A' ' 59' ' ' ILE . 2.4 mp -89.12 -67.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.079 0.552 . . . . 65.1 109.954 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -83.77 82.35 8.36 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.879 0.872 . . . . 72.12 109.122 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.32 69.17 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 122.609 1.195 . . . . 61.41 114.113 167.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 176.23 145.73 0.09 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.256 1.822 . . . . 61.21 108.911 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -71.03 119.64 15.44 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-O 121.006 0.432 . . . . 75.44 110.6 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 mm -84.1 125.24 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.473 -0.936 . . . . 73.13 108.473 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 35' ' ' TYR . . . -59.24 122.47 63.77 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.603 -0.713 . . . . 52.41 111.173 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.95 -38.47 86.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.611 2.874 . . . . 71.51 114.275 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.408 ' CE1' ' HB1' ' A' ' 33' ' ' ALA . 44.1 p90 -68.71 -25.38 64.74 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.205 0.602 . . . . 72.52 112.198 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.503 ' HA ' HD21 ' A' ' 39' ' ' ASN . 62.1 mt -83.32 -44.49 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.429 0.692 . . . . 65.13 111.004 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -33.84 72.6 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.478 1.111 . . . . 34.44 112.208 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -36.52 72.94 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.519 -0.764 . . . . 74.1 112.312 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.503 HD21 ' HA ' ' A' ' 36' ' ' ILE . 10.3 p30 -83.34 -41.57 18.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.344 0.498 . . . . 70.44 112.344 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.39 -54.08 28.46 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.714 . . . . 70.45 112.269 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -98.31 33.0 2.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.92 0.888 . . . . 72.34 111.006 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.8 t -62.38 -50.43 71.58 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.191 0.997 . . . . 75.31 113.081 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.16 36.72 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.788 -0.642 . . . . 72.44 112.096 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -70.54 -29.94 66.54 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.497 0.719 . . . . 74.43 111.957 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -38.57 75.49 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.691 0.796 . . . . 70.14 110.834 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.0 t -52.37 -38.16 58.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.153 0.981 . . . . 73.43 113.365 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -74.33 -40.07 62.43 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 111.969 0.359 . . . . 63.24 111.969 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.32 -30.69 67.72 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 118.212 0.46 . . . . 73.42 112.178 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' HG21 ' A' ' 16' ' ' ILE . . . -70.36 -31.7 68.54 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 120.893 0.163 . . . . 71.31 112.711 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.548 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 56.1 m-20 -88.19 -18.44 28.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.534 0.734 . . . . 64.23 111.609 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.2 13.17 71.86 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 114.143 0.417 . . . . 72.12 114.143 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.5 mm-40 -61.07 -32.6 72.25 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.822 0.849 . . . . 71.22 111.677 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -113.41 158.3 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.574 0.749 . . . . 62.3 110.055 171.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.4 p -84.75 169.18 14.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.255 0.622 . . . . 63.13 110.99 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 59' ' ' ILE . 50.8 t -63.79 -47.69 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 109.479 -0.563 . . . . 75.4 109.479 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -43.57 -51.84 6.62 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.61 1.337 . . . . 53.33 114.61 169.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -57.75 -39.49 77.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.094 0.558 . . . . 72.04 111.301 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.435 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 45.3 t80 -71.83 -38.72 70.13 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.482 0.713 . . . . 75.54 110.792 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.719 HG23 HD11 ' A' ' 27' ' ' ILE . 30.6 mm -63.47 -50.35 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.983 1.313 . . . . 64.5 110.937 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' HG11 ' A' ' 120' ' ' VAL . 25.8 tt0 -57.34 -38.85 74.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.085 -0.961 . . . . 74.12 111.425 172.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.73 85.22 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 115.821 -0.627 . . . . 63.42 113.941 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 84.1 mt -69.78 -39.89 76.37 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.245 0.618 . . . . 44.14 111.326 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.89 -31.75 81.95 Favored Glycine 0 CA--C 1.539 1.548 0 N-CA-C 114.529 0.572 . . . . 72.11 114.529 170.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -72.77 -21.69 60.96 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.518 0.727 . . . . 71.43 111.73 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -63.22 128.68 36.94 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.095 0.558 . . . . 65.14 111.919 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.14 -19.2 52.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.24 113.09 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.78 -44.01 97.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.33 0.652 . . . . 64.13 110.723 174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -67.54 -31.13 71.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.832 0.453 . . . . 75.34 111.475 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 4.3 mm? -71.89 -34.46 69.16 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.276 0.63 . . . . 70.13 112.318 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -29.7 34.95 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.543 -0.723 . . . . 74.44 111.693 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.85 -56.63 4.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.664 0.616 . . . . 72.34 112.664 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -128.05 60.01 1.47 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.539 0.735 . . . . 75.43 112.306 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.607 ' HD1' HG11 ' A' ' 81' ' ' VAL . 76.9 t80 -162.66 -60.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.911 -0.586 . . . . 65.45 110.725 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.6 p -64.33 -41.26 58.76 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 114.405 1.261 . . . . 72.41 114.405 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.32 -7.58 8.9 Favored 'Trans proline' 0 C--N 1.389 2.704 0 CA-C-N 121.84 1.693 . . . . 70.35 114.039 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -109.37 149.98 40.5 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 123.805 0.842 . . . . 72.55 111.819 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.89 152.94 76.65 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.095 1.863 . . . . 62.22 111.323 168.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -50.56 -47.79 57.72 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.804 0.842 . . . . 72.43 112.708 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.529 ' HA ' HD12 ' A' ' 82' ' ' ILE . 17.8 m -55.61 -33.59 64.12 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.656 0.783 . . . . 63.23 112.354 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -76.23 -36.0 58.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.001 0.521 . . . . 72.42 111.636 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.607 HG11 ' HD1' ' A' ' 73' ' ' TYR . 59.7 t -63.09 -34.8 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.445 0.641 . . . . 74.24 110.476 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.5 mt -63.21 -51.28 73.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.814 -1.084 . . . . 64.44 111.92 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.4 -31.06 60.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.821 0.448 . . . . 72.4 111.442 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -76.93 -28.51 55.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.418 0.687 . . . . 72.25 111.222 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.26 -54.52 8.87 Favored Glycine 0 C--N 1.344 1.022 0 C-N-CA 122.101 -0.095 . . . . 35.04 112.935 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 t -60.59 -33.34 72.58 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.42 0.896 . . . . 72.2 113.42 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.23 -14.74 62.34 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.543 0.571 . . . . 52.31 112.543 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -89.41 -50.25 6.22 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.774 0.657 . . . . 44.3 112.774 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -85.67 -40.04 16.59 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.864 0.466 . . . . 55.31 111.82 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 124' ' ' GLU . 77.6 mt -95.84 -49.02 5.5 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 122.439 0.296 . . . . 74.0 110.994 175.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.29 40.39 87.45 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 122.192 -0.317 . . . . 71.12 113.707 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.686 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 2.6 ptm180 -131.2 7.97 4.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.157 0.799 . . . . 74.24 113.157 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 60.12 158.56 0.11 Allowed Pre-proline 0 N--CA 1.504 2.256 0 N-CA-C 113.87 1.063 . . . . 52.02 113.87 -163.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.02 152.96 61.21 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.318 2.012 . . . . 61.03 113.705 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -74.44 -72.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 C-N-CA 123.193 0.597 . . . . 74.24 111.08 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -123.86 171.36 9.73 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.816 0.846 . . . . 54.12 109.854 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -69.5 -29.79 67.5 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.776 -0.578 . . . . 61.41 110.172 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.52 -30.94 68.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.088 0.555 . . . . 41.43 111.96 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -71.89 -39.62 69.45 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.209 0.604 . . . . 62.33 111.21 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.41 ' O ' HD13 ' A' ' 82' ' ' ILE . 76.7 mt -63.98 -52.15 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.217 0.607 . . . . 73.11 110.567 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -54.74 -39.91 68.76 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.11 0.964 . . . . 73.13 111.91 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' O ' HG13 ' A' ' 106' ' ' ILE . 34.6 ttpt -57.15 -45.55 83.5 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.527 0.731 . . . . 64.03 111.15 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.511 ' HD1' HD12 ' A' ' 106' ' ' ILE . 17.8 m-85 -68.25 -35.39 77.83 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.755 0.422 . . . . 75.1 111.921 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -67.46 -32.71 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.892 0.477 . . . . 74.13 110.988 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -64.45 -40.75 96.33 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.865 0.866 . . . . 62.05 110.429 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.568 HG23 HE21 ' A' ' 110' ' ' GLN . 80.1 mt -62.48 -46.16 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 124.267 1.027 . . . . 71.31 111.52 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.3 -42.72 99.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.207 0.603 . . . . 74.23 111.69 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.2 -44.6 75.47 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.743 0.646 . . . . 74.3 112.743 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.4 p -72.41 -51.77 18.91 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.021 0.749 . . . . 73.4 113.021 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.568 HE21 HG23 ' A' ' 106' ' ' ILE . 2.3 pm0 -124.26 -46.75 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 112.906 0.706 . . . . 74.22 112.906 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.1 -153.45 20.74 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 115.414 0.925 . . . . 70.44 115.414 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.1 tp -70.81 -35.57 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.107 0.963 . . . . 51.42 112.775 -169.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -61.2 -44.27 97.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.427 0.528 . . . . 73.52 112.427 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -29.44 66.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.029 0.531 . . . . 61.13 112.294 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -65.12 -48.07 74.88 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.269 0.628 . . . . 74.22 110.707 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 112' ' ' ILE . 46.7 mm -64.22 -45.6 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.568 0.747 . . . . 63.24 110.026 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -58.87 -36.36 74.49 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.103 0.961 . . . . 70.4 111.671 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.18 -28.72 68.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.4 0.68 . . . . 50.4 112.142 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.0 -43.56 13.05 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.838 0.855 . . . . 42.45 112.326 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 60' ' ' GLU . 61.8 t -78.15 -37.54 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.416 0.686 . . . . 74.33 111.504 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -87.53 4.37 43.8 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.918 0.487 . . . . 73.24 112.039 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.1 t -67.62 137.58 55.74 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.921 0.488 . . . . 74.42 110.489 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.545 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . 13.7 pt20 -54.74 -29.21 53.07 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.786 1.032 . . . . 75.1 113.786 -175.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.686 ' HG2' ' HD2' ' A' ' 92' ' ' ARG . 34.3 tp10 -50.85 -47.53 60.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.121 0.968 . . . . 64.33 112.225 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.9 -44.58 20.14 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.624 0.769 . . . . 73.52 111.092 168.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 123' ' ' GLN . 6.8 t30 -72.46 -67.7 0.53 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.707 1.002 . . . . 72.1 113.707 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 123' ' ' GLN . 8.3 pt-20 -56.81 -37.21 70.86 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.296 0.85 . . . . 75.23 113.296 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.67 -61.62 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 112.502 0.556 . . . . 70.42 112.502 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.3 -53.59 2.63 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.05 0.54 . . . . 62.24 111.479 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.65 -126.91 8.78 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 115.878 -0.601 . . . . 51.32 113.095 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -106.42 -20.46 13.37 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.781 0.832 . . . . 74.25 111.377 -169.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.21 11.84 38.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.143 1.534 . . . . 74.42 115.143 -156.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.6 t -153.91 164.23 38.74 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 119.43 1.014 . . . . 73.34 112.333 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 55.3 t -67.86 135.37 92.14 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 123.871 0.868 . . . . 63.55 110.498 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 134' ' ' VAL . 7.1 Cg_exo -71.85 76.74 1.97 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.207 2.605 . . . . 74.3 113.198 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -86.17 171.23 11.46 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.32 0.648 . . . . 75.41 110.701 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -62.82 133.07 54.17 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.108 0.48 . . . . 61.52 111.832 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.526 ' HB3' HD21 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -84.94 130.34 34.65 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.034 0.445 . . . . 70.24 110.552 176.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -66.74 158.98 77.72 Favored Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 125.129 1.372 . . . . 53.41 111.695 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -52.13 -39.16 71.45 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 123.529 2.819 . . . . 60.23 113.377 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.7 t -107.24 148.54 28.8 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.48 0.712 . . . . 52.2 110.164 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 138' ' ' ARG . 94.7 mt -118.66 109.17 15.81 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.471 0.708 . . . . 53.34 110.377 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -85.26 69.21 10.72 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.823 0.821 . . . . 73.23 109.586 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -148.88 88.04 1.58 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.881 -1.155 . . . . 72.42 107.881 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -54.14 107.32 0.26 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.34 1.056 . . . . 74.41 113.784 -169.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -75.37 150.14 38.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.775 0.83 . . . . 72.55 110.889 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -65.67 140.37 58.48 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 112.596 0.591 . . . . 64.44 112.596 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -94.32 -11.14 30.65 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.99 0.916 . . . . 64.21 111.622 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 17.9 p80 . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 123.87 0.868 . . . . 73.15 110.628 174.568 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 110.309 -0.256 . . . . 54.13 110.309 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -128.41 127.93 43.51 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 121.562 0.696 . . . . 60.13 111.868 -171.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.2 t -114.69 118.71 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.712 1.205 . . . . 54.51 108.803 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -88.01 101.15 13.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.296 0.638 . . . . 73.43 111.123 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -132.06 163.2 28.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.014 0.526 . . . . 71.11 111.176 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.642 HH22 ' HG ' ' A' ' 48' ' ' LEU . 19.7 tpp85 -79.47 98.25 6.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.262 -0.881 . . . . 71.45 109.736 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.73 130.71 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.338 -0.986 . . . . 72.33 108.338 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.66 75.8 0.59 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.861 0.839 . . . . 70.21 111.928 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.75 -37.98 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.517 -1.22 . . . . 64.2 112.356 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.43 80.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.439 0 CA-C-O 122.529 1.156 . . . . 64.43 110.819 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -89.44 10.03 24.17 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.583 -1.644 . . . . 64.11 113.599 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' O ' HG12 ' A' ' 16' ' ' ILE . 5.6 m-20 -70.69 126.15 28.8 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.007 0.523 . . . . 75.03 111.198 -172.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -60.45 -29.47 69.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.926 0.491 . . . . 73.32 112.035 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.42 -50.58 62.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.025 0.93 . . . . 75.14 110.937 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.4 94.51 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.603 0.761 . . . . 65.24 112.496 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.579 HG21 ' HA2' ' A' ' 49' ' ' GLY . 46.1 mm -63.2 -49.06 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 123.06 0.544 . . . . 61.12 111.556 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.25 -25.14 61.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.313 0.486 . . . . 65.44 112.313 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.8 m -65.73 -38.63 89.68 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.792 0.437 . . . . 74.33 111.226 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.33 -40.36 93.59 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.012 0.925 . . . . 73.0 109.983 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.27 -43.92 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.653 1.181 . . . . 63.23 111.544 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -70.47 -35.54 73.36 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.311 0.644 . . . . 74.11 111.438 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.18 90.14 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.666 0.786 . . . . 54.33 112.022 173.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.78 99.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.512 0.725 . . . . 63.32 111.126 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.464 ' HE2' ' HB1' ' A' ' 37' ' ' ALA . 13.3 m-30 -70.92 -41.02 71.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.567 -0.742 . . . . 72.31 111.556 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -60.88 -35.78 77.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.256 1.022 . . . . 54.02 112.367 179.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.0 -62.92 1.54 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.876 0.471 . . . . 71.35 110.122 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.75 -54.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.78 0.832 . . . . 73.02 112.674 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -78.98 -8.33 58.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.121 0.568 . . . . 75.35 112.029 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 146' ' ' HIS . 8.8 tp10 53.85 45.77 27.1 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.521 1.153 . . . . 74.02 112.577 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.428 HH21 ' HG3' ' A' ' 71' ' ' GLU . 8.0 ptp180 -153.85 -179.0 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.348 -0.842 . . . . 72.43 111.264 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -125.78 107.95 11.02 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.848 -1.167 . . . . 61.03 107.848 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 24' ' ' TYR . 20.0 mt -90.98 139.84 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.769 0.428 . . . . 73.34 110.849 -174.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.67 94.6 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.791 -0.623 . . . . 64.41 109.941 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.58 -44.13 41.7 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.656 2.904 . . . . 71.44 113.957 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.01 -44.58 79.95 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.173 -0.921 . . . . 73.21 112.523 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -57.91 -43.78 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 122.956 0.502 . . . . 75.41 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB1' ' HE2' ' A' ' 24' ' ' TYR . . . -58.72 -48.19 81.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.287 1.035 . . . . 71.42 111.795 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.95 -12.13 59.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.619 0.6 . . . . 72.23 112.619 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -80.3 -47.26 14.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.677 -0.64 . . . . 73.31 111.729 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.52 -42.48 67.9 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 120.949 0.404 . . . . 74.1 111.047 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.508 ' HB3' ' HB3' ' A' ' 44' ' ' TRP . 60.7 m-85 -105.66 55.07 0.69 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.785 0.834 . . . . 64.45 110.939 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.6 m -64.34 -50.2 68.68 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 122.891 0.476 . . . . 62.13 111.636 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 47' ' ' LYS . . . -70.64 -39.01 67.66 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.85 -0.614 . . . . 74.53 113.389 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -70.32 -42.16 72.3 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.135 0.974 . . . . 72.11 112.889 -169.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.04 -39.72 93.3 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.883 0.473 . . . . 73.41 110.584 174.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 m -62.77 -47.56 82.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.856 0.863 . . . . 63.32 111.885 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 14.4 mmmm -59.12 -44.87 92.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.069 0.547 . . . . 72.24 111.983 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' HH22 ' A' ' 6' ' ' ARG . 16.3 tp -74.0 -33.28 63.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 116.317 -0.402 . . . . 71.23 111.32 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.579 ' HA2' HG21 ' A' ' 16' ' ' ILE . . . -66.0 -26.72 72.4 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 123.035 0.35 . . . . 73.21 113.883 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -92.28 -17.51 24.67 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.548 0.739 . . . . 54.33 110.985 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.79 28.51 60.82 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.887 -0.597 . . . . 72.44 113.973 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.41 -25.27 54.33 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.697 0.799 . . . . 74.14 112.647 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.17 171.0 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.727 0.811 . . . . 74.33 109.151 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 p -89.69 170.27 10.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.7 -0.852 . . . . 62.41 108.7 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -59.56 -33.53 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 119.721 -0.18 . . . . 52.01 110.562 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 131' ' ' GLU . 78.7 tttt -44.82 -56.81 4.19 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.0 1.32 . . . . 72.22 113.556 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.98 -40.58 78.74 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.288 0.635 . . . . 62.31 111.354 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 85.3 t80 -53.49 -51.9 61.26 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 123.908 0.755 . . . . 73.43 110.808 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 55' ' ' VAL . 37.8 mm -57.88 -43.5 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.643 1.177 . . . . 70.4 111.758 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' HG11 ' A' ' 120' ' ' VAL . 32.2 tt0 -58.97 -47.95 83.3 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 122.783 0.433 . . . . 65.23 111.81 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.17 -18.83 65.43 Favored Glycine 0 CA--C 1.541 1.698 0 N-CA-C 114.867 0.707 . . . . 62.1 114.867 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 54.2 mt -70.73 -30.67 67.26 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 117.566 0.683 . . . . 54.33 111.105 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.61 -10.67 79.94 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 115.315 -0.857 . . . . 72.33 114.129 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -95.54 -7.75 37.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.658 0.783 . . . . 75.24 111.014 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.439 ' O ' HD23 ' A' ' 69' ' ' LEU . 57.7 p -84.13 137.35 33.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.986 0.514 . . . . 62.3 111.273 -172.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 6.0 t30 -62.38 -23.58 66.89 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.01 0.524 . . . . 72.11 111.576 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.5 tp -67.56 -38.01 83.5 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.605 0.762 . . . . 75.22 111.611 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -74.27 -45.6 46.72 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 120.811 0.339 . . . . 74.42 110.716 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.527 HD11 HG12 ' A' ' 112' ' ' ILE . 4.0 mm? -55.96 -44.17 78.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.587 1.155 . . . . 64.2 112.887 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.82 -29.71 70.23 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.873 0.694 . . . . 65.13 112.873 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' HG3' HH21 ' A' ' 30' ' ' ARG . 6.3 mm-40 -93.37 -36.64 12.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.314 1.227 . . . . 74.22 114.314 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HD1' HD13 ' A' ' 84' ' ' LEU . 80.1 m-85 -128.86 32.42 4.78 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.658 0.614 . . . . 75.44 112.658 -171.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HD1' HG11 ' A' ' 81' ' ' VAL . 78.1 t80 -150.16 -54.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.95 0.5 . . . . 74.55 110.974 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -68.16 -43.7 35.6 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 113.582 0.956 . . . . 65.21 113.582 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.1 7.63 4.97 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.127 1.885 . . . . 74.1 113.422 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' HB3' ' HB3' ' A' ' 80' ' ' LYS . 58.3 m-85 -130.07 141.6 42.44 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 123.579 0.751 . . . . 75.24 111.395 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.65 167.55 16.97 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.29 1.993 . . . . 71.12 111.766 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.52 -40.72 72.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.289 0.636 . . . . 62.11 112.356 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.62 ' HA ' HD12 ' A' ' 82' ' ' ILE . 99.2 m -66.36 -42.38 88.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.073 0.949 . . . . 72.45 113.457 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 48.8 tptt -63.66 -32.95 74.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.258 0.466 . . . . 64.3 112.258 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.568 HG11 ' HD1' ' A' ' 73' ' ' TYR . 45.8 t -63.18 -30.56 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.188 0.595 . . . . 73.23 110.642 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 79' ' ' THR . 95.6 mt -69.92 -51.17 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.947 0.899 . . . . 73.02 112.251 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.64 -45.44 65.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.115 0.416 . . . . 72.53 111.697 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.518 HD23 ' HD3' ' A' ' 87' ' ' LYS . 74.8 mt -61.85 -29.04 69.91 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.361 0.665 . . . . 64.5 112.196 171.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.1 -41.67 46.7 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 115.705 -0.68 . . . . 75.12 111.903 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.438 HG23 HD12 ' A' ' 90' ' ' LEU . 78.3 m -68.9 -46.1 69.22 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.308 0.643 . . . . 65.13 112.016 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HD3' HD23 ' A' ' 84' ' ' LEU . 14.6 ptmt -70.5 -24.42 62.84 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.59 0.959 . . . . 73.34 113.59 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -85.02 -33.61 22.49 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 113.695 0.998 . . . . 62.01 113.695 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -104.18 -41.97 5.65 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 113.844 1.053 . . . . 65.11 113.844 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.438 HD12 HG23 ' A' ' 86' ' ' THR . 69.0 mt -94.71 -14.7 24.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.127 0.417 . . . . 71.32 112.127 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.87 14.97 2.05 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.608 0.603 . . . . 62.14 114.608 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.655 ' HA ' HH11 ' A' ' 138' ' ' ARG . 24.3 ttt180 -98.23 -84.78 0.38 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.321 0.648 . . . . 60.54 112.476 -161.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 175.98 137.11 0.19 Allowed Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.616 0.766 . . . . 72.13 108.938 -168.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.39 122.89 10.18 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.459 1.44 . . . . 51.1 109.531 165.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.29 -63.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 O-C-N 122.086 -0.383 . . . . 74.3 111.504 -168.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -158.14 166.5 32.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.473 -0.936 . . . . 74.34 108.473 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -66.29 -27.76 68.18 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.232 0.469 . . . . 73.2 111.396 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.2 72.44 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.945 0.498 . . . . 71.21 111.458 175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.87 -45.73 84.8 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.25 0.62 . . . . 74.3 110.667 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.545 HG21 HG23 ' A' ' 79' ' ' THR . 85.0 mt -59.33 -36.76 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.685 -0.689 . . . . 74.22 110.573 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -68.81 -31.96 71.33 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.676 0.39 . . . . 73.31 111.608 176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.53 -50.1 41.16 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.528 0.331 . . . . 73.22 111.44 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -62.58 -38.44 90.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.081 0.4 . . . . 72.43 112.081 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -60.59 -36.16 77.85 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.935 0.894 . . . . 73.33 111.255 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -69.36 -44.02 72.43 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.67 0.788 . . . . 72.54 110.907 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -42.78 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.551 0.741 . . . . 70.35 110.831 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.429 HD11 ' HE1' ' A' ' 73' ' ' TYR . 31.5 tp -65.51 -33.29 75.58 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.364 1.065 . . . . 71.21 112.438 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.41 -46.35 17.72 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.019 0.528 . . . . 63.13 112.322 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.8 p -70.45 -45.16 66.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.99 0.916 . . . . 74.24 111.843 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -110.6 -68.79 0.9 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.228 0.611 . . . . 71.15 111.914 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.89 -170.33 28.57 Favored Glycine 0 C--N 1.356 1.688 0 C-N-CA 121.691 -0.29 . . . . 73.12 113.792 -175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 69' ' ' LEU . 8.6 tp -65.82 -39.2 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.925 0.89 . . . . 71.12 112.637 -173.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -65.69 -33.57 76.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.946 0.498 . . . . 75.52 111.861 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.87 -34.63 51.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.606 0.762 . . . . 54.25 110.425 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.78 -51.98 65.0 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.273 1.029 . . . . 54.5 111.174 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.88 -51.88 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.937 0.895 . . . . 52.42 110.867 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -48.29 -47.78 36.25 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.675 0.79 . . . . 44.23 112.288 171.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.38 -33.54 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.569 0.747 . . . . 72.13 112.337 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.59 -57.99 4.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.955 0.502 . . . . 73.43 110.895 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 60' ' ' GLU . 94.3 t -63.77 -35.85 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 113.847 1.054 . . . . 73.54 113.847 -166.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -108.62 36.27 2.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 75.15 112.101 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.4 p -84.02 171.26 13.11 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.163 0.506 . . . . 63.12 110.789 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -69.56 -31.53 69.77 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 122.01 0.91 . . . . 70.25 110.339 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -69.81 -36.2 75.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.425 1.49 . . . . 63.52 111.596 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -76.22 -37.66 57.45 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.994 0.518 . . . . 70.41 110.958 173.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.15 -61.09 2.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.811 0.844 . . . . 74.42 112.577 -171.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.56 -38.71 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.722 0.296 . . . . 72.23 111.72 -168.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.03 -44.36 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 C-N-CA 123.639 0.775 . . . . 61.11 111.657 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -101.68 -45.64 5.19 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.042 0.537 . . . . 74.34 112.174 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.19 20.04 63.52 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-O 119.715 -0.492 . . . . 63.54 113.906 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 8.5 pt-20 57.08 -1.81 0.05 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.903 2.186 . . . . 71.35 116.903 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -93.04 -17.5 23.78 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.315 0.646 . . . . 73.24 111.433 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 t -108.99 162.42 14.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.439 0.696 . . . . 75.5 112.339 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.21 136.96 89.09 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.706 -1.133 . . . . 65.41 108.401 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.78 88.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.548 2.165 . . . . 61.31 112.179 173.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -70.24 107.88 3.92 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.395 -0.82 . . . . 72.53 108.896 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -45.44 112.62 0.47 Allowed 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.062 -0.972 . . . . 63.41 111.718 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.655 HH11 ' HA ' ' A' ' 92' ' ' ARG . 34.1 mtp-105 -84.17 13.53 5.11 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.957 0.903 . . . . 74.44 112.062 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 140' ' ' PRO . 88.6 m-85 -90.94 115.67 64.79 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 124.342 1.057 . . . . 54.43 110.743 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 139' ' ' PHE . 33.4 Cg_endo -62.63 -32.97 78.99 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.999 2.466 . . . . 70.2 112.743 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.5 t -78.95 170.53 16.55 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.922 0.889 . . . . 45.42 111.614 175.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 80.7 mt 68.44 20.76 8.44 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 124.796 1.239 . . . . 73.42 112.341 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.35 -26.33 66.52 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.908 1.283 . . . . 72.41 112.181 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -51.67 -26.4 9.08 Favored 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 125.031 1.332 . . . . 73.22 114.555 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.7 p80 46.19 117.42 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.002 0 C-N-CA 126.591 1.956 . . . . 74.42 115.235 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.501 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 49.6 m-70 -75.28 132.31 40.94 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.914 1.079 . . . . 73.03 113.914 -167.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -101.42 162.9 12.56 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.782 1.233 . . . . 74.5 109.625 164.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -149.33 127.01 11.69 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.137 0.575 . . . . 74.42 110.355 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.4 t60 . . . . . 0 N--CA 1.481 1.093 0 C-N-CA 123.695 0.798 . . . . 51.15 109.984 178.155 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 112.088 0.403 . . . . 62.24 112.088 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -114.77 161.69 17.84 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.33 0.652 . . . . 63.12 112.212 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.1 t -126.71 124.91 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.175 0.99 . . . . 62.22 109.107 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -83.29 124.21 30.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.332 0.587 . . . . 72.02 111.168 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.21 173.77 16.36 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.847 1.259 . . . . 74.11 109.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.616 ' NH2' ' HA2' ' A' ' 51' ' ' GLY . 81.4 mtp180 -102.5 116.21 32.16 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.57 0.7 . . . . 71.01 111.315 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.4 2.62 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.977 0 C-N-CA 125.345 1.458 . . . . 62.4 111.004 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 78.58 -67.47 0.17 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.406 1.882 . . . . 61.41 110.369 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.77 49.28 4.12 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.036 0.374 . . . . 64.43 114.036 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 6' ' ' ARG . 66.6 mt -72.99 -53.4 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.256 0.622 . . . . 75.12 110.11 172.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 65.7 -65.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.348 1.459 . . . . 73.25 112.094 -171.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 16' ' ' ILE . 32.1 t70 -44.68 133.96 5.71 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.966 1.706 . . . . 73.22 115.588 -173.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.28 -25.38 39.47 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 112.93 -1.941 . . . . 73.24 112.545 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -70.84 -51.46 26.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 64.03 111.444 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.24 -50.64 58.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.73 1.011 . . . . 74.14 113.73 167.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 12' ' ' ASP . 43.8 mm -56.84 -43.05 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 112.852 0.686 . . . . 63.22 112.852 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 2.7 pptp? -67.14 -30.47 70.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 112.512 0.56 . . . . 63.21 112.512 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 m -70.57 -49.4 48.31 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.14 0.495 . . . . 70.42 111.022 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -44.54 -46.49 9.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.821 -1.081 . . . . 73.54 111.805 165.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.9 -36.19 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.341 1.056 . . . . 71.25 112.353 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -61.71 -49.01 78.17 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.261 0.624 . . . . 54.53 111.668 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.34 88.96 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.138 0.575 . . . . 63.14 111.827 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.67 -31.17 15.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.684 -1.144 . . . . 74.23 112.596 171.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.88 -48.15 17.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.888 0.475 . . . . 65.21 111.766 168.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.6 mtt-85 -55.8 -28.36 55.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.355 1.613 . . . . 72.13 115.355 -167.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -86.68 -41.64 14.03 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.097 0.408 . . . . 64.12 111.274 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.588 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -75.8 -57.25 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.537 0.735 . . . . 62.42 111.221 -173.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.446 ' HB3' HH11 ' A' ' 30' ' ' ARG . 93.2 m-85 -78.91 -6.38 56.03 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.095 0.558 . . . . 75.12 111.94 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 54.87 37.67 29.02 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 125.425 1.49 . . . . 65.32 112.927 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.446 HH11 ' HB3' ' A' ' 28' ' ' PHE . 10.0 ptp85 -155.0 151.73 28.83 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.275 0.559 . . . . 55.34 112.247 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.04 100.94 2.1 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.149 -0.932 . . . . 62.22 109.427 165.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.3 mt -81.11 126.53 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 110.044 -0.354 . . . . 72.43 110.044 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.38 132.45 94.17 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.814 0.846 . . . . 45.23 111.035 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.81 -33.03 98.27 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.999 2.466 . . . . 75.23 113.368 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -69.17 -21.71 63.97 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.956 0.724 . . . . 65.41 112.956 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -81.99 -48.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.152 0.581 . . . . 74.04 109.884 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 -32.02 71.99 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.073 0.949 . . . . 55.03 113.182 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -76.6 -19.19 58.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.849 0.46 . . . . 73.22 111.747 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -80.15 -47.1 15.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.223 0.609 . . . . 63.34 111.251 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -85.5 -59.82 2.21 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 120.889 0.376 . . . . 65.01 111.725 -171.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -93.15 41.55 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.565 0.746 . . . . 74.54 112.535 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.9 t -66.68 -50.8 61.71 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.523 0.729 . . . . 70.15 112.058 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.2 -28.6 57.94 Favored Glycine 0 N--CA 1.477 1.374 0 CA-C-N 115.777 -0.647 . . . . 33.12 113.051 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -65.3 -25.12 67.49 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.237 1.015 . . . . 75.53 112.259 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.66 -45.27 75.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.65 0.78 . . . . 73.2 110.824 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.3 t -57.45 -30.92 65.41 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.02 0.928 . . . . 33.14 112.575 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -73.58 -35.74 65.47 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.473 0.309 . . . . 55.45 111.687 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.2 tp -73.38 -60.94 2.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.282 0.845 . . . . 74.3 113.282 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.59 -36.67 76.71 Favored Glycine 0 C--N 1.358 1.772 0 CA-C-N 118.622 0.646 . . . . 73.32 114.377 -171.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -59.98 -16.59 31.68 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.89 0.876 . . . . 63.2 113.347 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.616 ' HA2' ' NH2' ' A' ' 6' ' ' ARG . . . 103.04 5.17 47.37 Favored Glycine 0 N--CA 1.475 1.287 0 N-CA-C 114.635 0.614 . . . . 72.44 114.635 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.2 -63.99 1.03 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.187 0.493 . . . . 72.41 111.991 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -85.06 -142.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-N 116.025 -0.534 . . . . 73.31 111.259 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.433 ' HA ' ' NH1' ' A' ' 6' ' ' ARG . 3.3 t -170.43 152.16 3.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 73.13 108.916 -165.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.05 -31.49 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 112.603 0.594 . . . . 65.2 112.603 -171.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -76.38 -44.0 38.26 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.097 -0.377 . . . . 73.21 111.183 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.84 -22.18 66.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.49 0.716 . . . . 71.33 111.435 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -74.29 -46.21 42.64 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.427 -1.323 . . . . 73.01 107.427 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 27' ' ' ILE . 54.0 mt -70.92 -30.78 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 113.46 -1.7 . . . . 64.12 113.318 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -63.93 -46.81 83.11 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 122.819 0.448 . . . . 73.31 110.536 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.87 -35.54 47.93 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 114.617 0.607 . . . . 72.34 114.617 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -69.11 -26.18 64.78 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.165 0.586 . . . . 74.51 111.526 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.07 -23.94 58.41 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 116.078 -0.51 . . . . 53.23 113.09 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.447 ' HE1' ' HB ' ' A' ' 116' ' ' ILE . 3.6 m-30 -86.0 5.7 32.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.787 0.835 . . . . 73.02 110.955 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.1 t -85.46 129.84 34.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.484 0.713 . . . . 63.13 110.41 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.661 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 23.5 p-10 -62.77 -16.13 56.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.995 0.739 . . . . 72.32 112.995 -175.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 43.1 tp -61.5 -59.7 4.84 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.013 0.525 . . . . 74.1 110.681 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.8 -36.94 65.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.949 0.722 . . . . 73.53 112.949 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.661 ' HB2' ' HA ' ' A' ' 66' ' ' ASN . 4.2 mm? -63.95 -30.51 71.58 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.349 0.87 . . . . 63.03 113.349 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -92.02 -40.59 11.01 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.718 -0.614 . . . . 63.41 112.189 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 10.3 pt-20 -78.04 -54.69 5.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.097 1.147 . . . . 74.23 114.097 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -83.89 -59.06 2.53 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 119.115 0.871 . . . . 74.22 113.076 171.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.523 ' HE1' HD21 ' A' ' 107' ' ' LEU . 61.6 t80 -55.67 -46.63 77.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.213 1.19 . . . . 72.34 114.213 -166.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.8 m -71.03 -55.96 6.05 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 113.445 0.906 . . . . 73.52 113.445 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.02 -28.32 19.39 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.931 1.754 . . . . 64.3 112.999 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.418 ' HD1' ' HG2' ' A' ' 80' ' ' LYS . 91.0 m-85 -94.06 140.96 23.06 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 122.822 0.449 . . . . 72.22 110.77 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.525 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.4 Cg_exo -54.29 146.11 52.24 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.088 2.525 . . . . 31.31 113.515 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.425 ' ND2' ' HA ' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -30.48 -46.69 0.08 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 123.62 0.768 . . . . 43.43 112.934 156.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.498 ' HA ' HD12 ' A' ' 82' ' ' ILE . 21.4 m -70.59 -23.84 62.65 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.334 0.654 . . . . 73.22 112.601 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HG2' ' HD1' ' A' ' 76' ' ' TYR . 53.5 tptt -91.14 -28.32 17.96 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.19 0.519 . . . . 74.2 110.382 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 77' ' ' PRO . 84.7 t -62.86 -27.51 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.791 0.836 . . . . 71.43 110.038 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 79' ' ' THR . 81.5 mt -65.88 -47.52 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.098 0.959 . . . . 54.25 112.626 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HG3' ' H ' ' A' ' 84' ' ' LEU . 7.2 pt-20 -78.51 -57.8 3.58 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.908 0.322 . . . . 73.23 110.818 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.546 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 97.0 mt -43.85 -31.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.774 1.398 . . . . 74.42 114.774 161.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.33 -49.72 8.07 Favored Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.855 -0.498 . . . . 73.1 111.855 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.692 HG23 HD12 ' A' ' 90' ' ' LEU . 88.3 m -59.88 -31.55 69.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.673 1.189 . . . . 65.2 112.277 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -75.84 -57.16 4.04 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.598 -0.689 . . . . 55.1 111.486 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 30.7 m170 -50.9 -30.58 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.979 1.474 . . . . 74.41 114.979 172.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -101.52 -68.62 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.233 0.827 . . . . 72.35 113.233 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.692 HD12 HG23 ' A' ' 86' ' ' THR . 66.0 mt -71.42 -28.36 63.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.853 0.686 . . . . 73.33 112.853 -173.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.99 33.63 20.44 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 122.94 0.15 . . . . 50.33 112.788 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.82 -177.05 6.13 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.172 0.989 . . . . 73.44 110.782 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.19 165.42 13.9 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.532 0.733 . . . . 75.14 109.74 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.75 173.73 4.38 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.272 1.982 . . . . 61.11 111.973 169.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 mt -119.04 -86.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 121.127 0.489 . . . . 73.34 109.992 -167.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -88.63 172.41 9.31 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.961 -1.125 . . . . 51.44 107.961 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 2.8 tp-100 -74.9 -10.1 59.17 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 121.441 1.928 . . . . 74.14 109.59 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.75 84.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.851 0.86 . . . . 73.35 110.563 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.8 -54.11 46.4 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.903 0.881 . . . . 72.14 110.289 167.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.419 ' HA ' HG21 ' A' ' 82' ' ' ILE . 75.6 mt -64.71 -36.17 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-N 114.818 -1.083 . . . . 73.14 112.275 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.545 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 70.3 mtp180 -74.54 -38.84 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.851 0.46 . . . . 63.42 109.913 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.35 -56.44 18.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.233 -0.894 . . . . 73.21 110.921 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -61.49 -52.74 63.24 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.387 0.514 . . . . 73.44 112.387 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.425 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 14.2 t-20 -43.73 -48.23 7.97 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 115.394 -0.821 . . . . 53.44 112.676 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.427 HE21 HG23 ' A' ' 109' ' ' THR . 22.3 tp60 -73.3 -41.03 64.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.856 0.462 . . . . 71.22 111.705 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 58.9 mt -59.83 -55.18 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 124.081 0.952 . . . . 75.21 111.637 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.523 HD21 ' HE1' ' A' ' 73' ' ' TYR . 6.3 tt -50.98 -53.14 35.78 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.038 0.935 . . . . 50.15 112.204 170.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.97 -49.35 78.19 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.44 0.533 . . . . 72.53 112.44 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.427 HG23 HE21 ' A' ' 105' ' ' GLN . 75.0 p -68.31 -53.03 27.03 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.109 0.781 . . . . 71.0 113.109 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -101.53 -62.32 1.27 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.654 0.782 . . . . 74.0 112.262 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -172.8 31.8 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.97 0.348 . . . . 73.33 113.97 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.429 ' O ' HG12 ' A' ' 116' ' ' ILE . 10.2 tp -68.74 -33.71 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.903 0.881 . . . . 72.11 112.209 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -65.07 -55.86 16.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.701 0.4 . . . . 73.53 110.69 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -50.1 -30.93 12.05 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 114.713 -1.131 . . . . 73.32 113.451 168.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -75.67 -42.9 49.92 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.272 0.629 . . . . 74.32 112.201 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.447 ' HB ' ' HE1' ' A' ' 64' ' ' TYR . 46.3 mm -72.52 -52.3 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.01 0.524 . . . . 72.34 109.718 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -43.63 -38.24 2.96 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.7 1.2 . . . . 72.41 113.112 166.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.85 76.61 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.021 0.528 . . . . 63.05 112.404 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.402 ' O ' HD21 ' A' ' 90' ' ' LEU . 78.1 mt -83.99 -59.9 2.27 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.603 0.761 . . . . 74.34 110.841 176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.9 t -44.95 -50.89 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.584 1.554 . . . . 65.02 113.216 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -100.3 17.47 21.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.402 0.519 . . . . 62.54 112.402 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.9 p -74.03 164.15 26.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.951 -0.759 . . . . 54.31 108.951 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -72.41 -22.51 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.965 -0.46 . . . . 71.43 111.669 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.46 -53.31 44.57 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.335 0.494 . . . . 64.03 112.335 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -61.6 -40.46 94.9 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.153 -0.684 . . . . 65.31 109.153 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -57.93 -42.7 85.38 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.164 0.986 . . . . 71.2 112.69 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.99 -47.38 11.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.773 -0.579 . . . . 71.11 112.013 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.4 -41.38 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 122.925 0.49 . . . . 72.42 111.987 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 36.9 m-85 -116.01 -68.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.822 0.449 . . . . 73.14 110.669 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.51 -127.56 9.13 Favored Glycine 0 C--N 1.347 1.139 0 C-N-CA 123.227 0.442 . . . . 73.44 112.403 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -88.86 -73.12 0.51 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.41 0.684 . . . . 73.1 111.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 6' ' ' ARG . 36.0 m-20 -102.35 66.6 0.99 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.548 0.69 . . . . 65.24 112.835 -171.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.9 m -148.32 124.43 10.76 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.043 -0.981 . . . . 75.54 109.495 173.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.68 138.23 83.08 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.251 0.62 . . . . 72.42 109.936 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.458 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 52.4 Cg_exo -53.6 89.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 123.152 2.568 . . . . 70.21 113.319 173.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -73.19 169.26 17.43 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.17 -0.923 . . . . 62.55 111.456 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -59.87 93.29 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.211 -0.904 . . . . 74.43 112.047 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -77.75 -26.73 50.11 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.351 0.596 . . . . 55.25 109.961 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -95.61 149.49 36.16 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.235 1.014 . . . . 73.12 109.593 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.75 2.55 4.57 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.749 2.299 . . . . 72.31 113.949 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.0 p 53.86 57.98 5.51 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.449 1.5 . . . . 64.11 111.699 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.11 81.04 6.45 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.229 -0.896 . . . . 71.11 111.706 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -130.55 103.15 6.47 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.398 1.079 . . . . 62.13 108.765 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -72.52 -22.0 61.1 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.215 0.606 . . . . 74.3 112.174 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -61.08 112.83 2.25 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.999 0.519 . . . . 71.21 110.888 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -69.12 95.31 0.73 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 109.479 -0.563 . . . . 75.04 109.479 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -107.71 171.74 7.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.471 0.708 . . . . 73.32 111.27 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.98 165.79 19.35 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.026 0.931 . . . . 63.02 110.385 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 112.364 0.505 . . . . 65.24 112.364 -169.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.57 -0.159 . . . . 74.51 110.57 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -136.15 170.74 15.52 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.702 0.801 . . . . 72.04 110.804 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 t -78.92 -32.92 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.355 0 CA-C-N 115.574 -0.739 . . . . 64.44 109.393 165.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.67 -0.3 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 126.211 1.805 . . . . 70.04 113.196 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -47.32 113.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.284 1.433 . . . . 74.25 114.061 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.543 ' NH1' HD22 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -51.28 94.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.337 1.606 . . . . 75.32 115.337 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 8' ' ' ALA . 2.9 t -45.89 178.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.223 0 C-N-CA 126.046 1.738 . . . . 63.3 112.514 162.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.592 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -73.96 132.32 42.31 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 107.598 -1.26 . . . . 73.34 107.598 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -13.5 74.6 0.0 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 117.85 1.9 . . . . 64.45 117.85 -158.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -67.38 134.28 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.236 0.614 . . . . 63.54 110.679 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -83.33 -13.41 55.1 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.537 0.735 . . . . 71.43 112.523 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.92 112.47 18.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.924 0.489 . . . . 72.44 110.759 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.39 -10.88 37.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.438 0.695 . . . . 64.41 112.026 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.11 -51.44 13.45 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.439 0.638 . . . . 71.21 109.634 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.5 71.95 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.683 -1.144 . . . . 62.1 112.378 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 41.1 mm -78.25 -48.79 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.467 0.707 . . . . 74.35 110.783 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -67.4 -44.81 77.94 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.653 0.781 . . . . 51.12 113.008 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.3 m -63.37 -37.84 88.82 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.335 0.654 . . . . 70.31 111.889 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' NH1' ' A' ' 6' ' ' ARG . 11.4 tp -53.0 -51.56 61.24 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.747 -1.115 . . . . 70.44 110.103 169.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.85 -37.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.955 1.302 . . . . 70.34 113.121 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.1 p -69.19 -53.06 21.95 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.587 0.355 . . . . 71.55 111.149 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.417 ' HB1' HG11 ' A' ' 134' ' ' VAL . . . -59.86 -26.46 65.85 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 113.33 0.863 . . . . 71.42 113.33 171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.57 -33.88 74.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 123.473 0.483 . . . . 62.33 110.758 172.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -78.78 -49.21 13.39 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.691 . . . . 42.32 111.834 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.9 mtp85 -50.0 -26.07 3.93 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.842 1.793 . . . . 74.32 115.842 -168.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 -58.53 2.54 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 118.34 0.518 . . . . 51.15 110.239 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.47 -55.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.555 0.742 . . . . 72.52 110.5 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.89 -27.02 67.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.422 0.689 . . . . 74.22 112.594 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 67.63 32.44 5.53 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.615 1.198 . . . . 73.5 109.588 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.449 ' NH2' ' HG3' ' A' ' 71' ' ' GLU . 18.9 ptp180 -168.23 150.73 5.41 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.945 -1.48 . . . . 75.13 110.36 -173.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.22 108.89 5.61 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 115.822 -0.627 . . . . 74.2 110.286 165.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.05 133.03 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.946 -0.761 . . . . 75.23 108.946 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.25 138.1 95.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.837 -0.601 . . . . 63.43 110.6 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.61 -43.09 23.33 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.839 3.026 . . . . 75.21 114.992 -170.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -70.11 -32.9 71.16 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 112.764 0.653 . . . . 74.1 112.764 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.6 mt -72.85 -42.31 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.269 0.628 . . . . 53.03 110.953 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.48 -36.35 83.48 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.247 0.619 . . . . 75.42 112.164 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 42' ' ' SER . 3.7 pt20 -79.4 -36.26 39.39 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 115.909 -0.587 . . . . 71.51 112.077 -176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -81.66 -43.87 17.95 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.223 0.823 . . . . 73.02 113.223 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -73.59 -60.33 2.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.757 0.423 . . . . 70.1 111.787 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -89.67 38.04 0.9 Allowed 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.651 0.982 . . . . 74.54 113.651 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' GLN . 90.7 p -72.08 -49.83 33.27 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.69 0.396 . . . . 71.21 111.326 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 47' ' ' LYS . . . -69.5 -27.4 73.53 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 123.259 0.457 . . . . 43.14 113.112 174.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -81.63 -39.38 24.53 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.221 1.009 . . . . 74.43 110.63 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.58 -29.29 67.8 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.337 0.655 . . . . 61.35 111.668 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -65.83 -36.54 83.76 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.665 0.786 . . . . 60.14 111.87 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 43' ' ' GLY . 26.9 mtpp -67.74 -37.85 82.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.912 0.885 . . . . 64.02 111.076 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.0 -37.56 75.73 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.95 0.9 . . . . 70.41 110.862 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.67 -28.68 68.77 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-N 115.988 -0.551 . . . . 23.24 113.753 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -87.84 4.47 44.42 Favored 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 124.173 0.989 . . . . 71.23 111.043 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 50.09 33.6 22.46 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 115.422 0.929 . . . . 34.01 115.422 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -71.29 -80.03 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.077 -0.712 . . . . 64.33 109.077 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -63.04 -164.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 113.962 1.097 . . . . 75.52 113.962 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.2 p -127.58 172.57 10.62 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 107.211 -1.403 . . . . 33.44 107.211 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.11 -32.39 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 O-C-N 121.833 -0.542 . . . . 75.31 110.039 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -64.72 -38.96 92.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.744 0.818 . . . . 74.44 111.584 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.28 -26.06 42.39 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.679 0.792 . . . . 74.03 109.654 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -62.2 -49.08 77.21 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.235 1.014 . . . . 73.33 110.306 167.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 ' HD3' ' A' ' 135' ' ' PRO . 96.7 mt -59.91 -28.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 125.202 1.401 . . . . 75.01 112.656 175.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.8 -42.02 96.78 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.472 0.709 . . . . 62.31 109.764 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.26 -23.61 58.57 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 114.501 0.56 . . . . 63.33 114.501 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.2 mt -68.91 -40.75 78.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.189 0.518 . . . . 54.51 110.147 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.33 -24.6 63.74 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-N 114.846 -1.07 . . . . 62.35 114.027 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -84.84 -12.68 53.02 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.691 0.796 . . . . 75.31 112.487 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -74.98 121.9 22.67 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.946 0.498 . . . . 65.33 111.19 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -60.23 -15.63 26.37 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.167 0.987 . . . . 64.12 113.503 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.5 tp -59.65 -61.35 2.69 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.209 0.458 . . . . 61.53 112.048 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -51.63 -38.78 56.27 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 112.771 0.656 . . . . 72.4 112.771 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' TYR . 3.0 mm? -69.6 -26.59 64.52 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.245 0.831 . . . . 70.24 113.245 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -64.33 -49.28 72.34 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.756 -1.215 . . . . 73.41 108.994 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HG3' ' NH2' ' A' ' 30' ' ' ARG . 3.2 mm-40 -64.66 -56.89 10.9 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 114.333 -1.303 . . . . 51.24 112.73 172.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.06 69.34 0.72 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.68 0.993 . . . . 65.11 113.68 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 42.4 t80 -170.68 -56.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.013 1.325 . . . . 61.42 108.663 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.2 p -69.97 -39.7 11.46 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.469 1.285 . . . . 63.42 114.469 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.51 -42.61 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.928 0 CA-C-N 122.147 1.802 . . . . 74.24 112.632 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.46 147.67 82.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.546 1.138 . . . . 73.24 112.057 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.21 148.12 84.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.21 1.94 . . . . 62.24 111.55 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -52.38 -49.74 63.82 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.146 0.978 . . . . 71.21 112.807 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.464 ' HA ' HD12 ' A' ' 82' ' ' ILE . 59.7 m -51.71 -44.01 63.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.597 0.962 . . . . 74.24 113.597 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -65.04 -37.13 86.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.984 0.514 . . . . 70.22 111.837 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.29 -24.53 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 122.887 0.475 . . . . 63.32 111.286 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 79' ' ' THR . 90.6 mt -72.03 -54.31 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.208 0.603 . . . . 63.23 111.682 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.66 -23.54 67.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.241 0.544 . . . . 71.03 111.768 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 tt -79.85 -45.75 18.11 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.777 1.231 . . . . 70.0 108.684 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.84 -54.26 29.38 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.001 -0.999 . . . . 61.4 114.358 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.58 ' HA ' HD13 ' A' ' 119' ' ' LEU . 34.6 p -54.64 -39.52 68.06 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.201 0.6 . . . . 71.12 112.145 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.05 -37.84 61.93 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 113.449 0.907 . . . . 62.35 113.449 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -88.05 13.68 10.62 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.617 0.969 . . . . 73.03 113.617 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.74 -69.75 0.51 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.577 0.751 . . . . 60.04 109.677 169.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.4 HD12 ' HB ' ' A' ' 86' ' ' THR . 78.5 mt -61.78 -19.91 63.01 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.472 1.109 . . . . 72.0 112.781 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.9 0.34 87.49 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 114.351 0.501 . . . . 52.43 114.351 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.42 174.92 14.68 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 123.299 0.64 . . . . 53.31 110.721 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.45 160.76 78.89 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 124.001 0.92 . . . . 51.24 111.321 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -55.44 -174.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.038 2.492 . . . . 65.41 114.486 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.55 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 68.5 mt -97.43 -24.34 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 75.21 110.333 -164.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 179.23 -174.86 0.22 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.222 1.409 . . . . 73.43 109.316 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -76.94 -35.06 57.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.665 0.386 . . . . 72.34 111.929 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.45 -35.03 75.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.85 0.46 . . . . 51.2 111.421 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.55 ' HG2' ' H ' ' A' ' 95' ' ' ILE . 19.8 tp10 -57.58 -47.48 82.0 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.726 0.81 . . . . 75.02 110.558 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.11 -46.87 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 124.094 0.957 . . . . 64.34 112.022 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -67.57 -30.58 70.23 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.392 0.886 . . . . 73.31 113.392 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -53.75 -47.45 70.66 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.467 0.707 . . . . 74.4 110.865 166.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -78.23 -22.17 48.84 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.701 -1.136 . . . . 74.12 111.056 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -74.68 -41.96 59.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.651 1.181 . . . . 64.42 110.72 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -72.11 -49.85 32.86 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.77 0.828 . . . . 73.45 111.267 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 87.6 mt -56.86 -37.22 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 124.466 1.106 . . . . 73.44 111.679 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.06 -49.68 34.53 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.698 0.799 . . . . 74.14 110.953 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.37 95.39 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.722 0.809 . . . . 63.54 112.634 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.8 p -75.59 -65.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 74.34 112.459 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -87.6 -37.31 16.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.795 0.838 . . . . 75.42 112.953 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.06 173.51 13.2 Favored Glycine 0 C--N 1.346 1.132 0 C-N-CA 122.002 -0.142 . . . . 51.42 112.98 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 116' ' ' ILE . 9.9 tp -61.29 -30.66 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 123.158 0.583 . . . . 73.21 110.417 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -56.58 -40.48 75.3 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.533 1.133 . . . . 74.4 112.749 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.5 55.7 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.041 0.537 . . . . 71.22 111.386 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 57.9 t80 -65.12 -50.8 64.66 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.75 0.82 . . . . 73.22 110.324 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 112' ' ' ILE . 49.2 mm -59.78 -44.3 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.16 0.984 . . . . 65.42 110.943 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -56.89 -39.73 74.94 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.977 0.911 . . . . 65.33 111.889 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.2 77.72 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.324 0.65 . . . . 74.54 112.26 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.58 HD13 ' HA ' ' A' ' 86' ' ' THR . 13.6 mt -79.76 -39.17 31.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.166 0.587 . . . . 74.52 110.937 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.45 -34.2 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.491 0.716 . . . . 62.0 111.176 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -99.7 22.89 10.31 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.368 0.667 . . . . 74.12 112.385 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.4 t -83.03 132.56 35.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.157 0.583 . . . . 65.31 110.773 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -44.34 -37.55 3.39 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.315 1.228 . . . . 71.34 114.315 170.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.33 -41.1 92.83 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-N 118.31 0.505 . . . . 72.41 111.322 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -73.79 -53.88 9.29 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.877 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -69.7 -27.59 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.045 0.757 . . . . 64.22 113.045 -172.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -74.51 -47.19 34.52 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.831 0.453 . . . . 74.43 112.169 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.9 -51.78 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.341 0.591 . . . . 62.33 111.273 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -77.1 -67.54 0.7 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.075 0.95 . . . . 72.51 111.12 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.61 -148.12 16.5 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 114.658 0.623 . . . . 23.31 114.658 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -114.89 -23.73 8.98 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.849 0.859 . . . . 70.32 111.841 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.76 -32.55 12.66 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.314 1.046 . . . . 64.32 113.65 -158.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -98.66 165.98 11.54 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.304 0.853 . . . . 70.33 113.304 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.518 HG23 HD12 ' A' ' 19' ' ' LEU . 6.6 t -83.51 142.27 42.92 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 124.164 0.986 . . . . 74.03 108.766 165.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HD3' HD11 ' A' ' 59' ' ' ILE . 34.6 Cg_endo -61.98 83.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.901 2.4 . . . . 54.5 113.32 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -68.55 136.06 52.51 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 114.08 -1.418 . . . . 70.23 108.711 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -71.64 120.19 16.87 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 108.392 -0.966 . . . . 73.22 108.392 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -52.59 -29.0 23.51 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 124.878 1.271 . . . . 75.33 112.61 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -119.91 143.84 36.1 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.784 1.234 . . . . 73.44 108.534 167.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.535 ' HG3' ' HA ' ' A' ' 146' ' ' HIS . 73.0 Cg_endo -79.44 38.21 0.72 Allowed 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 122.491 2.128 . . . . 72.21 113.598 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m 63.12 10.15 4.35 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 125.43 1.492 . . . . 63.31 112.319 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp 56.19 26.05 9.88 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 124.308 1.043 . . . . 72.25 111.857 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.71 -76.07 0.28 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.403 1.081 . . . . 65.52 110.336 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -145.84 165.57 28.48 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.019 1.328 . . . . 71.05 108.64 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 77.7 t60 60.2 57.7 2.87 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 121.778 0.799 . . . . 63.3 111.435 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 1.6 p-80 -67.36 107.03 2.27 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.886 -0.597 . . . . 74.31 109.774 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.98 86.19 0.71 Allowed 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 122.367 1.08 . . . . 62.31 112.575 -170.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -78.66 94.71 5.1 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.417 -1.265 . . . . 71.33 109.564 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 t60 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.172 0.511 . . . . 71.13 110.303 -174.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 120.593 0.235 . . . . 64.54 110.526 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -72.11 93.46 1.42 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.387 0.613 . . . . 63.33 110.21 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -91.34 114.14 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.593 0.757 . . . . 73.51 110.886 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -80.44 104.98 11.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.368 0.604 . . . . 73.14 110.123 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 133' ' ' THR . 19.6 ptmt -149.16 168.56 22.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.997 0.919 . . . . 71.05 110.144 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 ttp85 -119.4 106.64 12.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.729 -0.471 . . . . 70.43 109.729 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 8' ' ' ALA . 3.3 t -79.0 -149.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.959 0 C-N-CA 124.083 0.953 . . . . 61.21 109.13 176.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.615 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -85.43 -81.28 0.2 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 119.945 1.248 . . . . 55.4 109.767 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -32.29 -30.22 0.01 OUTLIER Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.001 2.76 . . . . 62.51 120.001 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 7' ' ' VAL . 50.8 mt -64.99 105.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 119.855 1.828 . . . . 75.05 110.558 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -155.47 24.62 0.4 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.527 1.131 . . . . 73.43 108.756 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' O ' HG12 ' A' ' 16' ' ' ILE . 3.8 m-20 -100.01 142.72 31.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.141 1.376 . . . . 71.44 108.891 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.45 ' NZ ' ' HG2' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -67.0 -39.23 87.06 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 120.945 1.702 . . . . 74.4 112.631 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.54 66.49 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 122.367 1.08 . . . . 74.24 112.231 171.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB1' HG23 ' A' ' 10' ' ' ILE . . . -76.62 -38.92 53.91 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 112.978 -1.919 . . . . 70.54 111.071 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.62 HG13 ' HA2' ' A' ' 49' ' ' GLY . 51.0 mm -81.21 -39.62 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 N-CA-C 114.029 1.122 . . . . 62.22 114.029 -175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 28.1 mtpp -74.59 -50.86 16.29 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.109 -0.994 . . . . 72.22 111.347 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 m -49.12 -21.57 0.77 Allowed 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.124 -1.398 . . . . 62.32 113.168 164.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 16' ' ' ILE . 7.8 tt -81.43 -42.98 19.55 Favored 'General case' 0 CA--C 1.586 2.338 0 C-N-CA 123.588 0.755 . . . . 74.31 110.659 169.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 16' ' ' ILE . 85.5 mt -75.18 -48.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 N-CA-C 116.494 2.035 . . . . 53.01 116.494 -171.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 24' ' ' TYR . 44.0 m -66.67 -39.24 88.09 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.702 1.239 . . . . 61.14 109.882 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.94 -28.23 22.58 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 111.58 -2.554 . . . . 71.11 111.708 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.73 -34.39 24.89 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.719 0.808 . . . . 54.13 111.763 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CD2' ' HA ' ' A' ' 21' ' ' SER . 21.6 m-85 -68.98 -52.48 28.44 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 120.98 0.419 . . . . 74.2 110.914 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -46.98 -16.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.539 1.311 . . . . 75.05 114.539 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.518 HE22 ' HA ' ' A' ' 88' ' ' HIS . 13.0 tm0? -87.48 -61.16 1.78 Allowed 'General case' 0 CA--C 1.568 1.649 0 C-N-CA 123.144 0.577 . . . . 72.11 109.627 166.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 59' ' ' ILE . 61.7 mt -78.15 -65.46 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 124.509 1.123 . . . . 73.2 113.119 -170.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 66.4 m-85 -74.87 -9.64 58.73 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.032 0.933 . . . . 62.22 112.476 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 76.33 -56.02 0.58 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.988 1.715 . . . . 70.44 112.914 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -84.07 156.33 22.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.95 0.9 . . . . 64.33 112.927 -165.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -62.84 120.01 10.48 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.569 -1.196 . . . . 75.25 109.717 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.4 mt -109.65 120.24 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.454 -1.684 . . . . 70.35 106.454 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 134.06 72.29 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 123.929 0.768 . . . . 61.32 112.06 -172.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.33 -31.02 36.02 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.811 3.007 . . . . 71.11 115.164 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -75.89 -39.05 57.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.722 0.409 . . . . 73.43 111.989 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -47.77 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 122.735 0.414 . . . . 71.2 110.205 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.06 79.19 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.111 0.964 . . . . 51.13 112.561 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -75.42 -25.03 57.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.252 0.464 . . . . 52.03 112.252 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -79.29 -47.56 15.65 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 117.987 0.358 . . . . 75.54 111.622 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -66.07 -51.21 60.18 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.469 0.708 . . . . 74.12 111.168 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.22 48.23 0.85 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.054 -0.976 . . . . 65.22 110.373 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -64.97 -51.88 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 112.246 0.462 . . . . 41.31 112.246 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -31.29 58.5 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.045 -0.525 . . . . 52.01 113.287 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -72.22 -50.96 23.36 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.254 0.622 . . . . 73.33 111.494 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HG2' ' NZ ' ' A' ' 13' ' ' LYS . 35.7 tt0 -50.36 -37.91 39.61 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.503 0.927 . . . . 74.3 113.503 165.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.6 m -65.82 -35.6 81.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.484 0.314 . . . . 74.13 111.495 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -65.08 -42.38 94.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.218 0.451 . . . . 74.3 112.218 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.77 -50.7 33.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 120.755 0.312 . . . . 73.34 111.056 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.62 ' HA2' HG13 ' A' ' 16' ' ' ILE . . . -50.58 -51.36 33.03 Favored Glycine 0 CA--C 1.545 1.909 0 N-CA-C 116.285 1.274 . . . . 54.31 116.285 174.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' HG2' ' A' ' 52' ' ' GLU . 2.2 m-20 -73.11 0.19 12.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.925 1.083 . . . . 73.31 113.925 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.33 26.29 67.74 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 114.745 0.658 . . . . 54.23 114.745 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 50' ' ' ASN . 10.0 mm-40 -67.61 -29.94 69.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.941 0.896 . . . . 75.42 111.164 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.419 HD11 ' HD1' ' A' ' 58' ' ' PHE . 21.1 pt -132.77 156.67 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.518 1.127 . . . . 64.35 108.93 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 57' ' ' GLU . 10.2 t -82.04 166.86 19.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.028 -0.42 . . . . 73.43 110.738 170.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 59' ' ' ILE . 61.7 t -61.79 -38.31 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.717 0.407 . . . . 43.4 111.172 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 57' ' ' GLU . 1.1 tmtp? -56.79 -58.79 6.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.604 1.162 . . . . 72.23 112.137 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.565 ' H ' HG23 ' A' ' 54' ' ' THR . 21.8 tt0 -50.1 -34.57 22.35 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 114.375 -1.284 . . . . 54.33 111.983 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.424 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 59.8 t80 -71.48 -38.03 71.26 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 123.399 0.68 . . . . 75.42 112.211 173.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 27' ' ' ILE . 22.4 mm -73.36 -50.24 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 124.731 1.213 . . . . 70.33 111.696 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.526 ' HB2' HG11 ' A' ' 120' ' ' VAL . 31.9 tt0 -51.02 -41.43 59.8 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.487 1.115 . . . . 72.5 110.878 163.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.21 -38.9 62.64 Favored Glycine 0 CA--C 1.55 2.219 0 CA-C-N 112.438 -2.164 . . . . 74.12 112.98 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HB3' ' HE1' ' A' ' 28' ' ' PHE . 80.9 mt -77.15 -36.02 55.59 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.068 0.947 . . . . 54.33 112.328 176.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.68 -21.85 61.12 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 114.31 0.484 . . . . 64.52 114.31 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -77.44 -34.18 54.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.502 0.721 . . . . 71.24 111.831 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 t -48.04 140.55 6.9 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.473 1.286 . . . . 73.34 114.473 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -62.02 -30.09 70.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.696 1.199 . . . . 63.22 113.423 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 tp -69.43 -24.27 63.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.399 0.619 . . . . 73.32 111.593 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.92 -34.87 57.67 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.13 -0.941 . . . . 72.53 108.752 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.65 -51.31 20.05 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.882 -1.053 . . . . 71.14 113.697 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 12.7 ptpt -64.15 -55.66 20.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.995 2.18 . . . . 64.32 115.234 172.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -51.51 -22.69 3.35 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.629 1.714 . . . . 54.4 115.629 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -137.44 -19.62 1.22 Allowed 'General case' 0 N--CA 1.514 2.768 0 N-CA-C 116.939 2.2 . . . . 73.03 116.939 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.418 ' HA ' HG22 ' A' ' 81' ' ' VAL . 85.8 t80 -110.83 -37.49 5.4 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.512 1.051 . . . . 73.33 112.773 -176.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.9 m -71.52 -46.74 13.17 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 114.332 1.234 . . . . 73.34 114.332 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.4 Cg_endo -84.08 -15.02 6.97 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.784 2.323 . . . . 52.33 112.408 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.6 140.21 21.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.66 0.784 . . . . 71.54 110.91 -172.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.407 ' O ' HG23 ' A' ' 81' ' ' VAL . 46.2 Cg_endo -66.01 151.93 82.65 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.148 1.899 . . . . 73.03 111.447 171.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -45.74 -28.42 1.03 Allowed 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.859 1.264 . . . . 70.54 112.605 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.7 m -61.61 -52.67 63.43 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.502 -1.681 . . . . 71.12 109.87 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.419 ' HD2' ' HB3' ' A' ' 83' ' ' GLU . 55.2 tptt -73.83 -26.87 60.82 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.182 0.993 . . . . 64.11 113.232 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.515 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 62.8 t -66.13 -25.16 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 122.955 0.502 . . . . 64.32 111.271 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.517 HG22 ' HB3' ' A' ' 94' ' ' PRO . 46.3 mt -80.41 -28.53 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.164 0.985 . . . . 61.44 112.466 169.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 80' ' ' LYS . 6.0 tm-20 -76.85 -51.92 10.42 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.453 0.701 . . . . 75.31 109.43 -172.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 87' ' ' LYS . 93.9 mt -75.53 -15.09 60.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.561 1.144 . . . . 74.32 109.829 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . -82.05 -49.8 5.15 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.02 -0.991 . . . . 65.34 114.026 -158.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -73.3 -19.21 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 118.973 1.387 . . . . 51.03 110.577 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 91.8 mttt -62.18 -33.31 74.3 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.015 -0.993 . . . . 75.11 111.371 -167.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.518 ' HA ' HE22 ' A' ' 26' ' ' GLN . 66.5 m-70 -87.88 13.11 11.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.854 0.862 . . . . 65.42 113.031 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -138.74 -58.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.531 -1.285 . . . . 75.02 107.531 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HA ' HH12 ' A' ' 138' ' ' ARG . 0.2 OUTLIER -127.04 91.1 3.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.143 0.977 . . . . 73.2 108.978 164.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 87' ' ' LYS . . . -65.69 87.26 0.1 OUTLIER Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.656 -0.702 . . . . 75.43 113.015 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.523 ' HE ' HD12 ' A' ' 90' ' ' LEU . 4.4 ptp180 -143.31 24.46 1.77 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.925 0.49 . . . . 64.31 111.766 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 51.21 174.58 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.084 0 N-CA-C 113.307 0.855 . . . . 72.31 113.307 -158.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 82' ' ' ILE . 61.5 Cg_endo -72.25 137.24 28.21 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.694 1.596 . . . . 62.22 110.518 161.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.92 -61.39 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.428 1.091 . . . . 70.44 112.134 -170.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -147.76 157.84 43.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.718 0.407 . . . . 71.42 111.005 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -63.25 -10.35 15.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.425 0.898 . . . . 64.42 113.425 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.96 -42.05 12.73 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.264 1.031 . . . . 71.34 108.389 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 102' ' ' LYS . 4.0 tm-20 -64.25 -32.47 74.07 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 113.759 -1.564 . . . . 74.55 111.62 170.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.88 -54.49 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 123.284 0.634 . . . . 61.24 110.024 173.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -46.55 -34.74 5.14 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 114.23 1.196 . . . . 54.41 114.23 167.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 31.6 ttpt -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.969 0.508 . . . . 74.43 112.035 175.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -83.15 -46.53 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.596 0.358 . . . . 74.44 110.607 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -44.86 -42.6 8.11 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.153 0.981 . . . . 74.42 112.962 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -64.88 -29.63 70.59 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.142 0.428 . . . . 72.14 111.777 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 85.9 mt -79.67 -57.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 108.086 -1.079 . . . . 70.14 108.086 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.6 tp -45.99 -35.0 4.38 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.422 1.638 . . . . 61.42 115.422 165.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.32 -21.57 53.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.032 0.752 . . . . 51.33 113.032 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.7 p -113.2 -14.46 12.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.093 0.557 . . . . 71.41 112.08 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -138.97 -51.8 0.55 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.692 0.797 . . . . 74.12 111.156 -170.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.86 169.85 13.68 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 114.258 0.463 . . . . 52.13 114.258 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' ' 115' ' ' PHE . 8.0 tp -37.74 -34.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.247 1.573 . . . . 72.53 115.247 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -53.39 -53.91 44.42 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.397 0.679 . . . . 74.41 111.508 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.34 37.65 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.543 -1.208 . . . . 63.11 112.033 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.403 ' HD2' HD12 ' A' ' 112' ' ' ILE . 31.0 t80 -50.64 -70.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.51 1.3 . . . . 75.34 114.51 172.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.44 -37.07 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 114.034 1.124 . . . . 63.02 114.034 170.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -67.14 -38.14 85.03 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.772 0.715 . . . . 74.31 111.218 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.19 -52.05 57.25 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 123.082 0.553 . . . . 75.44 111.806 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 61.2 mt -49.66 -54.55 17.92 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.445 0.906 . . . . 63.33 113.445 171.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 60' ' ' GLU . 89.9 t -69.11 -26.34 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 C-N-CA 123.84 0.856 . . . . 72.32 112.694 -172.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -100.6 13.55 34.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.146 0.795 . . . . 71.41 113.146 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.3 m -66.92 151.01 48.4 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 122.863 0.465 . . . . 70.13 110.371 167.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.529 ' HG3' HD21 ' A' ' 126' ' ' ASN . 29.9 tt0 -72.0 -25.24 61.76 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.0 0.818 . . . . 73.41 110.524 -174.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.506 ' HB3' HH21 ' A' ' 92' ' ' ARG . 41.4 mt-10 -62.15 -36.11 80.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.877 0.871 . . . . 51.25 111.329 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -67.69 -40.3 84.38 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 109.995 -0.372 . . . . 75.52 109.995 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.529 HD21 ' HG3' ' A' ' 123' ' ' GLN . 1.5 p30 -68.6 -38.4 80.58 Favored 'General case' 0 C--N 1.366 1.311 0 CA-C-O 118.673 -0.679 . . . . 73.52 112.025 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -60.87 -56.88 15.92 Favored 'General case' 0 C--N 1.367 1.337 0 N-CA-C 115.257 1.576 . . . . 75.21 115.257 171.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.98 -35.84 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.348 0.594 . . . . 72.02 111.397 -162.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 135' ' ' PRO . 44.2 m-85 -111.94 -45.35 3.33 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.517 -0.765 . . . . 55.53 110.688 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.62 -87.36 0.93 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.403 -1.479 . . . . 41.44 109.403 -162.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.25 -31.74 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.134 0.973 . . . . 75.42 111.175 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -81.8 36.71 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.67 0.788 . . . . 70.02 112.385 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 5' ' ' LYS . 45.5 m -147.52 145.4 29.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.026 0.93 . . . . 75.22 110.051 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.05 132.83 82.2 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 108.65 -0.87 . . . . 74.42 108.65 172.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 38.1 Cg_endo -62.0 81.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.598 2.199 . . . . 44.44 113.447 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -59.81 145.85 43.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.006 0.522 . . . . 62.55 111.18 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.462 ' NH1' ' HA ' ' A' ' 141' ' ' THR . 10.6 ttp180 -70.49 118.06 12.81 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.398 0.679 . . . . 75.54 110.848 -173.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.594 HH12 ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -65.31 -18.15 65.08 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.652 1.181 . . . . 74.25 113.315 -173.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -122.79 140.16 32.64 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.412 0.685 . . . . 61.53 111.288 -175.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.17 -31.14 27.69 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.587 2.858 . . . . 75.33 113.974 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.462 ' HA ' ' NH1' ' A' ' 137' ' ' ARG . 8.8 t -145.48 141.25 28.16 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.259 0.552 . . . . 73.42 111.966 172.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.5 mt -129.49 140.63 51.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.307 1.043 . . . . 63.22 108.859 171.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -69.38 95.26 0.78 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.119 0.568 . . . . 72.53 111.735 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -153.4 127.75 9.21 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.349 -0.841 . . . . 71.34 109.912 171.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -70.16 172.75 7.56 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.312 0.645 . . . . 71.13 111.146 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -100.91 151.5 21.67 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.265 0.626 . . . . 74.21 110.762 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -86.15 -26.44 25.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.778 0.831 . . . . 64.24 111.695 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 67.07 -68.16 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.076 1.35 . . . . 72.51 111.305 -172.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 N--CA 1.48 1.06 0 C-N-CA 124.187 0.995 . . . . 71.4 111.383 176.755 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 110.546 -0.168 . . . . 71.12 110.546 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -160.64 -40.71 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.535 0.334 . . . . 63.34 111.316 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t 48.82 86.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 124.642 1.177 . . . . 52.12 112.307 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -71.4 132.75 45.26 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.994 0.518 . . . . 75.31 110.101 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -152.6 159.84 43.22 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.502 . . . . 63.54 112.017 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.7 100.03 12.03 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.548 -0.908 . . . . 71.32 108.548 172.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.436 ' H ' HD12 ' A' ' 10' ' ' ILE . 98.0 t -78.38 141.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.614 -0.514 . . . . 72.51 109.614 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.99 93.07 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.359 0.664 . . . . 64.01 111.845 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.15 2.01 6.61 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-O 119.457 -0.635 . . . . 72.33 114.462 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 7' ' ' VAL . 35.2 mt -79.88 82.21 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 118.673 1.236 . . . . 73.44 109.951 172.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -107.03 13.22 27.76 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.02 -0.991 . . . . 72.33 110.077 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -83.85 116.5 22.78 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.547 1.139 . . . . 73.14 109.076 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.34 -24.11 63.86 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.925 1.083 . . . . 75.12 113.925 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.95 -31.18 70.73 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.077 0.465 . . . . 63.35 111.06 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -50.21 13.94 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.645 -0.707 . . . . 72.3 110.698 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.2 mm -55.65 -45.45 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 124.406 1.082 . . . . 61.13 113.191 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.55 -39.54 91.44 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 111.988 0.366 . . . . 74.41 111.988 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 m -62.74 -41.13 99.05 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.394 0.677 . . . . 75.53 112.053 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.491 HD23 HD21 ' A' ' 48' ' ' LEU . 20.6 tp -61.78 -44.7 96.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.368 0.667 . . . . 74.4 111.086 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.16 -41.32 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.666 1.186 . . . . 72.44 111.147 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.6 m -62.94 -53.02 60.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.387 0.675 . . . . 54.25 111.287 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.62 82.16 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.714 0.806 . . . . 72.45 112.539 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.86 -42.93 72.64 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.123 0.569 . . . . 42.21 111.357 173.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.34 -43.72 85.33 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.278 0.631 . . . . 64.03 111.979 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -68.21 -13.2 62.06 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.334 0.654 . . . . 55.44 112.308 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -89.77 -63.13 1.33 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.771 0.428 . . . . 71.14 111.386 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 1.8 mp -65.12 -57.78 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 122.662 0.385 . . . . 64.21 110.727 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -83.04 -13.05 56.58 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.291 0.636 . . . . 75.24 112.252 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 65.58 -53.44 0.36 Allowed 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 125.367 1.467 . . . . 72.44 114.108 -168.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -57.57 128.76 38.66 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.203 1.001 . . . . 71.32 113.022 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.0 120.31 13.42 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.117 -0.947 . . . . 75.14 109.515 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.79 126.7 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.378 -0.601 . . . . 74.44 109.378 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.34 135.23 96.15 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 123.649 0.593 . . . . 62.45 109.991 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 -35.1 86.82 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.409 2.739 . . . . 74.13 114.14 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -69.73 -38.8 77.01 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.484 0.314 . . . . 75.11 111.437 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.423 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 71.4 mt -63.05 -41.73 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 123.547 0.739 . . . . 71.1 110.269 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -53.22 59.77 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.084 -0.962 . . . . 41.31 111.855 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' ' 38' ' ' GLN . 2.5 pt20 -79.6 -11.44 59.87 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.954 1.464 . . . . 70.21 114.954 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 36' ' ' ILE . 8.4 p30 -81.66 -45.21 16.09 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 119.875 1.216 . . . . 64.42 110.797 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.77 -46.27 14.46 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.804 0.841 . . . . 74.14 111.609 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -105.8 44.3 1.05 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 124.657 1.183 . . . . 64.44 109.755 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -51.67 66.88 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 112.818 0.673 . . . . 60.42 112.818 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.05 -30.88 64.82 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.625 -0.716 . . . . 61.01 112.569 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.41 ' CZ2' ' HA3' ' A' ' 61' ' ' GLY . 13.8 t-105 -72.58 -42.05 65.02 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.305 1.042 . . . . 75.33 111.701 -176.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.85 -50.44 73.43 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.443 1.097 . . . . 64.02 110.777 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.1 t -59.61 -43.79 93.63 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.014 -0.994 . . . . 62.03 111.786 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HG2' HG12 ' A' ' 53' ' ' ILE . 25.2 ttmm -58.83 -46.5 87.54 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.755 1.222 . . . . 54.44 112.553 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.491 HD21 HD23 ' A' ' 19' ' ' LEU . 48.4 tp -64.56 -44.71 89.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.778 0.431 . . . . 75.32 111.278 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.73 -39.97 98.16 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 116.36 -0.382 . . . . 62.32 113.863 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -79.96 6.49 11.15 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.109 0.964 . . . . 73.22 112.915 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.35 32.55 68.32 Favored Glycine 0 CA--C 1.538 1.51 0 N-CA-C 114.595 0.598 . . . . 72.23 114.595 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.14 -26.53 42.8 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.155 0.582 . . . . 74.42 109.531 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.409 HG12 ' HG2' ' A' ' 47' ' ' LYS . 40.5 pt -134.76 170.14 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 124.282 1.033 . . . . 74.22 110.764 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.6 p -95.58 -176.57 3.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.388 0.675 . . . . 71.1 109.637 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 59' ' ' ILE . 80.0 t -65.89 -45.81 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 119.27 -0.395 . . . . 73.31 110.927 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 51.0 tttm -47.43 -52.65 16.27 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.807 1.04 . . . . 72.23 113.807 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.72 -37.17 85.47 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.672 0.389 . . . . 61.43 111.707 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 50.7 t80 -61.22 -43.27 99.15 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.66 0.784 . . . . 71.42 111.124 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 55' ' ' VAL . 34.9 mm -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.829 1.252 . . . . 64.32 111.247 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -52.18 -45.48 65.14 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.597 0.759 . . . . 72.13 112.061 172.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' HA3' ' CZ2' ' A' ' 44' ' ' TRP . . . -62.84 -36.79 93.87 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.266 -0.425 . . . . 75.21 113.324 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 58' ' ' PHE . 46.2 mt -64.69 -44.11 91.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.378 0.671 . . . . 73.54 111.551 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.39 -34.74 86.43 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 115.447 0.939 . . . . 74.34 115.447 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -74.71 -23.13 58.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.29 0.545 . . . . 75.54 112.011 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -55.85 134.44 51.88 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.502 0.926 . . . . 72.52 113.502 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -60.65 -26.2 66.88 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.269 1.028 . . . . 73.2 112.092 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.18 -39.53 93.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.964 0.506 . . . . 72.14 111.1 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -69.33 -39.25 78.28 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.19 0.519 . . . . 74.34 110.56 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD11 HG12 ' A' ' 112' ' ' ILE . 4.6 mm? -64.74 -31.19 72.3 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.655 -0.702 . . . . 74.14 112.132 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -75.23 -46.34 34.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.865 0.466 . . . . 75.51 111.287 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -82.68 -46.31 13.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.804 0.668 . . . . 74.42 112.804 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.56 48.64 1.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 112.772 0.656 . . . . 64.32 112.772 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 69' ' ' LEU . 74.6 t80 -159.68 -48.37 0.05 Allowed 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 116.082 -0.508 . . . . 75.13 110.88 171.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 m -66.02 -47.28 63.36 Favored Pre-proline 0 CA--C 1.573 1.848 0 N-CA-C 112.815 0.672 . . . . 62.13 112.815 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -90.08 11.07 2.87 Favored 'Trans proline' 0 C--N 1.395 2.993 0 C-N-CA 122.638 2.225 . . . . 75.02 113.202 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.0 141.26 38.97 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 122.988 0.515 . . . . 72.12 111.861 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.29 158.24 58.32 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.501 2.134 . . . . 75.43 111.384 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -51.54 -41.99 61.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.573 0.582 . . . . 74.52 112.573 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.9 m -54.14 -42.85 70.0 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.514 0.726 . . . . 53.12 111.536 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -74.92 -33.17 61.94 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.061 0.545 . . . . 70.32 112.019 178.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.8 t -65.09 -31.96 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.231 0.539 . . . . 75.52 110.921 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.0 mt -73.58 -49.73 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.795 0.838 . . . . 64.44 111.008 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 80' ' ' LYS . 13.4 pt-20 -71.18 -35.47 71.6 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 111.588 0.218 . . . . 64.22 111.588 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.94 -44.53 26.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.314 0.645 . . . . 71.31 110.99 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.38 -49.86 58.82 Favored Glycine 0 N--CA 1.475 1.265 0 O-C-N 123.292 0.37 . . . . 75.43 113.639 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.599 HG23 HD13 ' A' ' 90' ' ' LEU . 86.7 m -55.73 -40.39 72.41 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 123.033 0.533 . . . . 73.25 110.632 171.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -71.33 -21.77 62.0 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 123.075 0.55 . . . . 74.31 111.434 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 67.2 m170 -87.29 -8.57 56.59 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.03 0.932 . . . . 71.01 112.363 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.8 -61.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.389 1.076 . . . . 74.45 108.88 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.599 HD13 HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -110.08 84.74 1.98 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.359 -1.348 . . . . 62.44 107.359 176.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.53 78.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 114.896 0.718 . . . . 51.51 114.896 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.632 HH12 HD11 ' A' ' 95' ' ' ILE . 27.8 mtm105 -137.94 151.43 47.96 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.375 1.07 . . . . 74.4 111.089 -174.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 132.02 85.85 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-N 115.471 -0.786 . . . . 62.21 110.748 168.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.27 135.91 46.28 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.31 2.673 . . . . 70.02 113.824 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.632 HD11 HH12 ' A' ' 92' ' ' ARG . 49.6 mm -82.69 -69.12 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.495 0.718 . . . . 75.43 112.76 -170.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -147.81 156.58 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.583 0.753 . . . . 72.12 109.073 -165.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -58.44 -40.31 82.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.954 0.724 . . . . 75.22 112.954 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.63 71.78 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.248 0.462 . . . . 43.53 112.248 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -65.7 -40.32 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.613 0.765 . . . . 75.33 110.919 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.03 -50.44 64.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.533 0.733 . . . . 73.21 110.968 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.2 mmm180 -52.05 -40.85 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.537 1.135 . . . . 72.04 112.386 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.417 ' O ' HG13 ' A' ' 106' ' ' ILE . 35.7 ttpt -56.39 -52.68 63.73 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.76 0.824 . . . . 71.53 111.194 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -72.24 -36.79 69.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.795 0.438 . . . . 74.45 112.167 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.47 -40.83 96.43 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.956 0.902 . . . . 65.34 111.296 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.45 HE21 HG23 ' A' ' 109' ' ' THR . 24.3 tp60 -67.6 -28.93 68.17 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.466 -0.788 . . . . 70.33 111.015 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 102' ' ' LYS . 82.2 mt -63.19 -39.14 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 122.991 0.516 . . . . 61.3 110.526 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.96 -39.92 96.11 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.836 0.454 . . . . 72.43 111.602 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.21 -37.32 53.63 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.716 0.635 . . . . 54.23 112.716 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.45 HG23 HE21 ' A' ' 105' ' ' GLN . 67.0 p -80.93 -60.15 2.41 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.193 0.597 . . . . 71.33 112.493 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -103.04 -36.23 8.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.0 0.92 . . . . 72.34 112.801 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.4 -162.01 12.51 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 122.847 0.261 . . . . 63.21 113.315 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.437 HG12 HD11 ' A' ' 69' ' ' LEU . 9.5 tp -79.69 -29.14 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.111 0.564 . . . . 75.44 111.476 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.434 ' H ' ' HD3' ' A' ' 113' ' ' ARG . 0.8 OUTLIER -59.64 -49.42 77.82 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.384 0.673 . . . . 74.4 110.381 -175.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -33.3 73.88 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.128 -0.942 . . . . 74.3 112.738 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.21 -52.29 66.3 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.234 0.613 . . . . 73.52 111.328 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.83 -45.68 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.666 0.786 . . . . 72.34 110.718 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -57.94 -35.68 71.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.166 0.986 . . . . 72.12 111.387 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -67.55 -48.37 67.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.128 0.571 . . . . 73.12 111.387 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' A' ' 90' ' ' LEU . 82.0 mt -58.31 -44.74 88.73 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.617 0.767 . . . . 62.5 112.554 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.8 t -68.17 -52.19 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.079 0.952 . . . . 71.44 111.954 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.81 24.06 4.4 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.291 0.636 . . . . 60.24 112.155 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 19.6 t -79.53 155.4 28.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.577 0.751 . . . . 72.11 112.275 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.98 -52.58 64.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.691 0.796 . . . . 65.51 110.952 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.94 -30.84 66.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.852 0.861 . . . . 73.14 112.595 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -71.45 -54.26 11.23 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.218 0.207 . . . . 75.45 111.098 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -69.48 -34.3 74.13 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.961 0.726 . . . . 75.22 112.961 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -74.57 -42.58 58.51 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 111.682 0.252 . . . . 63.1 111.682 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.81 -54.79 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.289 0.636 . . . . 75.22 111.857 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.488 ' HE2' ' H ' ' A' ' 136' ' ' TYR . 52.9 m-85 -88.41 -49.29 7.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.164 0.986 . . . . 63.34 110.832 -176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 93.25 -118.91 5.77 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.218 -0.447 . . . . 71.42 112.546 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -141.31 -23.18 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.858 0.863 . . . . 74.22 111.615 176.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -84.13 -23.54 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.558 0.577 . . . . 62.0 112.558 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.2 m -93.74 138.09 32.31 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.277 0.473 . . . . 72.11 112.277 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.18 136.34 75.92 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.851 0.86 . . . . 73.1 109.678 168.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -34.77 111.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.586 3.524 . . . . 62.34 115.5 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.488 ' H ' ' HE2' ' A' ' 129' ' ' PHE . 52.9 p90 -120.23 147.06 45.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.395 0.678 . . . . 75.02 110.88 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -75.08 124.34 26.83 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.978 -0.555 . . . . 74.32 109.516 167.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -86.44 52.74 2.58 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.455 1.121 . . . . 55.12 109.861 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -144.61 140.83 16.94 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.231 1.012 . . . . 73.32 109.864 -173.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.83 18.73 1.23 Allowed 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.814 2.343 . . . . 75.25 113.995 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.0 p 55.97 24.31 7.55 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 125.466 1.506 . . . . 74.54 113.49 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.1 mt 56.54 48.84 15.86 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.97 0.908 . . . . 74.32 111.237 -173.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 56.85 15.47 2.27 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 126.099 1.76 . . . . 74.43 113.717 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -61.02 -42.97 99.48 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.95 0.5 . . . . 62.41 111.77 -172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -137.15 103.57 5.16 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.676 0.75 . . . . 75.53 110.892 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -116.91 111.74 20.06 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.275 1.03 . . . . 73.43 109.125 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 74.75 -39.73 0.42 Allowed 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.58 1.552 . . . . 71.55 112.28 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -63.53 103.62 0.55 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.207 1.003 . . . . 63.3 110.097 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 121.235 0.54 . . . . 74.42 111.532 -175.842 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.723 0.296 . . . . 71.02 110.388 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -92.19 57.19 3.0 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 122.305 1.05 . . . . 72.24 110.391 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.93 -21.91 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-N 114.66 -1.155 . . . . 73.43 110.893 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 70.15 29.14 3.83 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.193 1.397 . . . . 70.15 112.845 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.25 145.89 24.14 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.855 -0.528 . . . . 71.32 109.597 170.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -78.26 101.23 7.03 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.564 -0.532 . . . . 74.12 109.564 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.02 113.33 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.29 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.144 0.978 . . . . 75.13 112.608 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.58 -18.02 4.4 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 115.436 -0.802 . . . . 53.33 114.267 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.43 104.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 117.903 0.852 . . . . 71.53 111.162 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -86.54 -38.22 17.41 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.826 0.85 . . . . 73.3 111.406 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.01 102.18 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.78 1.232 . . . . 71.33 113.894 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.612 ' HA ' ' HB ' ' A' ' 16' ' ' ILE . 68.5 mttt -67.77 -9.19 41.9 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.542 -0.754 . . . . 75.42 112.54 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.04 -39.6 79.1 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.561 0.744 . . . . 75.52 110.91 163.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.64 43.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.745 0.818 . . . . 63.34 110.991 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' A' ' 13' ' ' LYS . 1.7 mp -58.0 -39.81 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.079 0.951 . . . . 75.32 110.827 169.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -64.71 -49.88 69.14 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.999 0.52 . . . . 62.22 111.467 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -54.39 -42.36 70.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.166 0.802 . . . . 75.2 113.166 172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 48' ' ' LEU . 9.6 tt -58.27 -48.41 80.53 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.171 0.988 . . . . 74.14 110.893 173.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.69 -43.24 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.386 1.074 . . . . 75.11 111.379 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.3 m -63.75 -48.68 76.04 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.347 0.659 . . . . 55.43 111.012 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.82 57.77 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.327 0.862 . . . . 74.2 113.327 170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.15 72.88 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.259 0.837 . . . . 45.11 113.259 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -72.96 -48.1 39.63 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.588 0.755 . . . . 75.25 111.227 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.4 ttm180 -51.02 -36.88 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.223 1.009 . . . . 60.01 113.668 172.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.21 -63.68 1.27 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.8 0.44 . . . . 44.02 110.576 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.458 HD11 HG13 ' A' ' 59' ' ' ILE . 61.2 mt -65.32 -48.4 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.913 0.885 . . . . 70.32 112.452 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -84.35 9.63 12.66 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.258 0.623 . . . . 72.41 111.628 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 49.95 19.87 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 125.922 1.689 . . . . 70.03 115.183 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -164.12 143.51 7.75 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.416 0.626 . . . . 65.54 111.604 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.2 111.21 2.86 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.008 -0.996 . . . . 53.12 111.042 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.2 mt -78.89 134.89 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 116.105 -0.498 . . . . 72.24 109.968 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 123.8 52.98 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 124.254 0.971 . . . . 72.41 110.649 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -54.15 -37.84 87.47 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.526 2.817 . . . . 62.53 114.069 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -67.85 -24.91 65.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.663 0.785 . . . . 73.15 113.07 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.1 mt -83.36 -44.45 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.213 0.605 . . . . 53.32 110.681 171.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.18 80.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.064 0.945 . . . . 65.45 112.195 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -72.55 -25.26 61.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.982 0.513 . . . . 65.42 111.833 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.31 -47.23 18.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.667 0.787 . . . . 62.41 110.977 -170.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.2 -32.89 59.22 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.633 -0.712 . . . . 72.41 110.764 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.37 43.08 1.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.902 0.881 . . . . 73.42 111.07 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -68.61 -43.91 75.39 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 123.163 0.585 . . . . 75.14 112.433 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.89 -26.89 61.52 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 111.844 -0.502 . . . . 42.32 111.844 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -82.21 -30.85 30.62 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.088 0.955 . . . . 75.11 110.483 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -68.79 -41.58 78.52 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.95 0.9 . . . . 73.41 108.862 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 t -57.09 -35.65 69.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.62 0.768 . . . . 71.4 111.92 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -42.6 99.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.9 0.48 . . . . 72.54 111.279 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 19' ' ' LEU . 49.2 tp -73.24 -36.07 66.36 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.736 0.815 . . . . 55.41 111.503 177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.7 -48.42 12.78 Favored Glycine 0 C--N 1.353 1.522 0 C-N-CA 123.313 0.482 . . . . 63.1 113.153 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -78.26 3.15 16.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.744 0.646 . . . . 74.04 112.744 172.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.4 34.09 67.58 Favored Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.727 0.651 . . . . 74.22 114.727 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -68.46 -28.34 66.96 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.509 0.724 . . . . 73.44 111.58 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 pt -130.03 170.42 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.365 1.066 . . . . 72.14 110.362 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.0 p -90.8 164.35 14.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.206 0.602 . . . . 62.14 110.258 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.73 -41.23 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.612 0.365 . . . . 74.11 110.46 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 131' ' ' GLU . 87.0 tttt -41.78 -55.59 2.97 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.253 1.205 . . . . 73.43 114.253 162.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -66.07 -26.79 67.66 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.921 -0.581 . . . . 74.02 111.777 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -72.99 -38.36 66.68 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.166 0.986 . . . . 74.12 110.801 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.458 HG13 HD11 ' A' ' 27' ' ' ILE . 1.2 mp -73.41 -45.17 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.972 1.309 . . . . 73.21 111.829 -174.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.527 ' HB2' HG11 ' A' ' 120' ' ' VAL . 32.6 tt0 -50.28 -35.92 29.24 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 112.69 0.626 . . . . 74.21 112.69 165.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.45 -26.95 74.05 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-N 115.93 -0.577 . . . . 73.55 112.439 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -74.04 -48.34 30.64 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.999 0.92 . . . . 64.13 111.2 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.69 -31.65 45.82 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 116.308 1.283 . . . . 41.41 116.308 169.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -72.44 -17.86 61.75 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 117.472 0.636 . . . . 73.35 112.119 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -75.4 131.87 40.5 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.395 0.678 . . . . 53.24 111.368 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -61.03 -18.95 60.54 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.73 0.812 . . . . 73.42 112.808 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 32.3 tp -61.71 -41.14 97.22 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.608 0.763 . . . . 64.23 111.189 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.07 -37.16 86.63 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.042 0.448 . . . . 71.33 111.308 172.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD11 HG21 ' A' ' 112' ' ' ILE . 4.2 mm? -70.99 -30.11 66.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.883 0.873 . . . . 71.03 112.722 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -77.58 -25.02 49.65 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 122.133 -0.354 . . . . 61.55 110.59 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 67' ' ' LEU . 22.4 mm-40 -75.49 -56.27 4.87 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.561 172.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -130.08 70.35 1.44 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.775 0.657 . . . . 54.33 112.775 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.41 ' H ' ' HD2' ' A' ' 75' ' ' PRO . 52.0 t80 -176.04 -61.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.493 0.717 . . . . 75.22 110.53 174.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -65.16 -38.46 28.29 Favored Pre-proline 0 CA--C 1.573 1.849 0 N-CA-C 113.961 1.097 . . . . 61.21 113.961 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 73' ' ' TYR . 43.2 Cg_endo -94.73 17.41 0.89 Allowed 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 121.987 1.791 . . . . 72.25 113.674 174.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -137.46 153.42 74.46 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 123.857 0.863 . . . . 71.44 111.372 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.94 153.56 63.43 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.226 1.951 . . . . 64.45 111.551 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -46.81 -54.32 10.1 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.329 1.233 . . . . 72.35 114.329 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -49.2 -32.68 10.86 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 113.956 1.095 . . . . 75.35 113.956 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -74.89 -27.63 60.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.882 0.473 . . . . 73.43 111.196 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.75 -30.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.761 0.824 . . . . 71.52 111.755 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 100' ' ' ILE . 2.0 mp -67.44 -43.78 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.004 0.521 . . . . 65.13 110.884 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.42 -26.04 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.095 -0.502 . . . . 54.14 111.846 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.6 mt -85.38 -31.17 23.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.635 0.774 . . . . 54.11 111.771 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.99 -54.75 12.61 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 116.218 -0.447 . . . . 64.11 112.435 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.644 HG23 HD12 ' A' ' 90' ' ' LEU . 47.8 m -57.64 -30.63 65.55 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.308 1.043 . . . . 54.32 111.464 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.41 -38.4 77.91 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.854 0.862 . . . . 72.44 111.819 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -94.27 -1.48 53.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.147 1.166 . . . . 73.42 114.147 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -123.36 -57.92 1.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.061 0.391 . . . . 72.33 111.69 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.644 HD12 HG23 ' A' ' 86' ' ' THR . 60.8 mt -84.12 -12.72 54.56 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.302 0.241 . . . . 72.54 111.389 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.56 11.16 56.26 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 116.2 -0.455 . . . . 72.32 113.551 -173.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -104.92 135.17 46.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.977 0.911 . . . . 53.51 111.547 -167.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.92 158.4 70.5 Favored Pre-proline 0 CA--C 1.565 1.531 0 CA-C-N 115.383 -0.826 . . . . 41.33 111.386 169.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.87 161.59 0.48 Allowed 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.043 2.495 . . . . 71.25 113.961 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.16 -75.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.771 -0.825 . . . . 73.23 108.771 -160.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -141.04 153.24 45.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.257 1.423 . . . . 73.02 107.437 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -63.26 -14.44 49.41 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 119.905 1.229 . . . . 53.32 113.618 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.37 -31.27 21.58 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.21 -1.033 . . . . 62.21 108.21 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.52 -39.53 77.48 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.289 1.436 . . . . 70.32 111.114 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.412 ' HA ' HG21 ' A' ' 82' ' ' ILE . 87.8 mt -64.02 -52.8 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.244 0.618 . . . . 62.43 110.264 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -55.26 -31.22 61.37 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.213 1.005 . . . . 75.31 113.514 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -63.27 -49.35 74.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.548 0.339 . . . . 74.52 110.818 173.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -68.27 -39.66 82.12 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.971 0.509 . . . . 73.52 111.29 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -58.76 -42.77 89.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.39 1.076 . . . . 73.45 112.463 172.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -62.39 -27.39 69.05 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.25 0.62 . . . . 74.02 111.958 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.04 -60.33 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 108.798 -0.816 . . . . 61.34 108.798 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 115' ' ' PHE . 22.8 tp -41.96 -31.97 0.39 Allowed 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 115.658 1.725 . . . . 64.32 115.658 160.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.19 -41.47 25.19 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 119.176 0.898 . . . . 73.42 112.317 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 69.2 p -97.79 -22.97 16.1 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.024 0.75 . . . . 54.23 113.024 -172.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -126.36 -38.07 2.15 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.426 0.69 . . . . 75.34 112.113 -171.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.61 174.33 14.0 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 113.986 0.354 . . . . 62.05 113.986 175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -67.66 -29.6 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.051 0.94 . . . . 73.01 110.62 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -54.67 -53.0 60.57 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.629 0.772 . . . . 74.51 111.371 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.24 -29.03 70.15 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.973 0.909 . . . . 64.23 113.153 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 55.3 t80 -67.76 -49.51 62.08 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.407 0.683 . . . . 71.42 111.106 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -59.37 -46.34 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.586 0.754 . . . . 55.4 110.414 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.67 -40.45 75.55 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.715 0.806 . . . . 51.13 112.345 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.64 93.22 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.262 0.625 . . . . 34.5 112.119 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' ' 90' ' ' LEU . 83.6 mt -72.6 -55.74 6.42 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.303 0.641 . . . . 75.04 111.816 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 60' ' ' GLU . 88.7 t -61.66 -42.6 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.57 0.748 . . . . 71.22 112.412 -173.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -82.75 -0.47 47.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.294 0.85 . . . . 71.23 113.294 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -66.95 158.02 31.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.015 0.526 . . . . 73.02 111.913 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -65.12 -25.99 68.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.823 0.849 . . . . 61.23 110.628 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.55 ' HB2' HD22 ' A' ' 90' ' ' LEU . 42.6 mm-40 -62.89 -48.35 79.38 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.201 1.0 . . . . 71.23 111.671 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -68.46 -46.33 70.06 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.437 0.637 . . . . 73.43 110.013 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -62.74 -52.03 64.83 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.468 -1.242 . . . . 74.05 112.32 -165.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.49 -42.65 19.96 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.467 0.914 . . . . 71.23 113.467 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.07 -49.16 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.252 0.621 . . . . 73.2 112.5 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -96.15 -53.98 3.46 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 120.991 0.424 . . . . 74.53 111.195 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.7 144.3 13.51 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.853 -0.612 . . . . 35.24 111.581 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 56' ' ' LYS . 16.3 pt-20 -74.84 -19.5 60.15 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.768 0.655 . . . . 73.44 112.768 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.01 -6.91 59.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.698 0.799 . . . . 73.13 111.84 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 m -116.2 149.74 38.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.433 0.693 . . . . 72.24 112.244 -167.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 141.51 97.42 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.728 0.811 . . . . 61.22 109.563 166.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.441 ' HD3' HG12 ' A' ' 59' ' ' ILE . 38.8 Cg_endo -65.3 77.36 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.587 2.192 . . . . 41.12 112.726 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -76.64 85.77 3.3 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.654 -0.869 . . . . 73.1 108.654 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -52.87 94.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.535 1.16 . . . . 72.33 111.542 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -83.34 1.34 41.73 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 113.382 -1.735 . . . . 65.01 112.877 -160.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.53 129.96 91.05 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 124.181 0.993 . . . . 74.11 110.713 -177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -62.89 -5.17 7.06 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.723 2.949 . . . . 73.11 115.488 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -62.28 -23.61 66.81 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.128 0.971 . . . . 74.1 113.032 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.77 -10.86 18.78 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.016 0.747 . . . . 61.02 113.016 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.11 86.77 1.37 Allowed 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.71 0.767 . . . . 71.45 111.193 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -106.79 12.39 29.09 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 124.419 1.088 . . . . 74.51 110.433 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -130.71 177.34 7.47 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.459 1.104 . . . . 73.1 110.965 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -67.61 104.21 1.55 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.385 0.674 . . . . 61.2 111.26 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -150.94 117.01 5.57 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.557 0.743 . . . . 51.43 109.257 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -65.95 99.34 0.48 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.216 0.606 . . . . 64.13 111.691 -173.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.5 t60 . . . . . 0 N--CA 1.486 1.325 0 C-N-CA 123.545 0.738 . . . . 65.13 110.283 -177.829 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 111.771 0.285 . . . . 62.4 111.771 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.693 ' HE3' ' HA ' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -74.39 98.62 3.31 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.149 0.5 . . . . 73.54 110.665 -179.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p -112.31 -12.97 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.531 0 C-N-CA 124.201 1.0 . . . . 64.41 111.435 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 63.8 86.13 0.13 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.038 1.335 . . . . 64.21 112.059 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -127.48 170.75 12.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.664 1.186 . . . . 72.35 110.803 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -116.27 94.29 4.58 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.877 -0.602 . . . . 74.22 110.121 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 t -74.64 141.85 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.927 -0.768 . . . . 65.52 108.927 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.54 -20.65 0.46 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.86 1.8 . . . . 64.14 115.86 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.32 -103.7 0.86 Allowed Glycine 0 C--N 1.368 2.34 0 CA-C-N 120.155 1.343 . . . . 40.01 110.519 166.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm 41.29 49.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 C-N-CA 125.431 1.492 . . . . 70.34 111.945 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -64.63 13.38 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 114.918 1.451 . . . . 62.14 114.918 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.98 113.08 17.88 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.867 0.841 . . . . 73.43 110.551 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.72 -28.15 64.51 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.714 -1.585 . . . . 74.35 109.368 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.26 71.07 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.519 1.127 . . . . 53.13 111.08 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.09 67.86 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.072 0.767 . . . . 72.1 113.072 171.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 20' ' ' ILE . 45.7 mm -54.09 -54.45 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 112.794 0.664 . . . . 71.2 112.794 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 20' ' ' ILE . 15.5 ptpt -66.04 -30.89 71.5 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.934 0.716 . . . . 72.23 112.934 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -70.33 -48.79 54.86 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.23 0.612 . . . . 73.21 111.431 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.77 -43.21 8.39 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.187 0.995 . . . . 63.34 112.446 167.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 16' ' ' ILE . 66.4 mt -66.13 -35.83 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.496 0.718 . . . . 72.4 111.454 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -67.05 -41.7 86.06 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.182 0.593 . . . . 73.3 112.089 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.33 91.7 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.059 0.544 . . . . 64.42 111.983 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.48 9.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.368 -1.287 . . . . 42.14 112.166 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -78.13 -47.06 19.03 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.92 0.488 . . . . 73.1 112.067 167.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -68.25 -15.71 63.68 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.176 0.99 . . . . 72.32 112.391 -171.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -95.57 -35.55 11.6 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.655 -0.653 . . . . 71.43 111.592 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 88' ' ' HIS . 50.2 mm -87.67 -66.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.147 0.579 . . . . 70.35 111.014 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.48 -17.89 64.86 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.284 0.634 . . . . 72.44 111.274 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' ARG . 23.2 tt0 62.65 31.33 16.8 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.535 1.534 . . . . 74.13 112.276 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -152.37 156.55 39.78 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.807 -0.633 . . . . 71.24 111.776 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.93 108.44 8.81 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.81 -1.086 . . . . 65.21 109.166 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.3 mt -90.51 135.24 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 109.352 -0.61 . . . . 73.51 109.352 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.15 118.04 21.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.73 0.812 . . . . 74.45 111.075 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -47.74 -39.92 31.11 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.847 3.031 . . . . 74.03 114.56 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -67.99 -39.37 83.29 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 112.904 0.705 . . . . 75.14 112.904 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -67.07 -44.27 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.326 0.584 . . . . 55.44 110.542 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.58 82.85 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.27 1.028 . . . . 72.14 112.698 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.0 -23.82 35.78 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 116.317 -0.402 . . . . 54.01 110.765 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -75.48 -35.38 60.86 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.103 0.561 . . . . 73.22 111.483 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.6 -61.96 1.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.645 0.736 . . . . 75.54 110.996 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.8 43.79 1.07 Allowed 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 115.348 -0.842 . . . . 72.44 112.814 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.15 -51.88 33.71 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 122.074 -0.391 . . . . 62.41 112.014 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.96 -34.54 33.52 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.136 -0.484 . . . . 62.21 111.959 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -66.88 -39.85 87.63 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.89 0.876 . . . . 74.3 112.822 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.08 -28.7 63.48 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.164 0.586 . . . . 75.02 110.583 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -53.63 -31.41 47.2 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.451 0.7 . . . . 74.14 112.026 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.94 -44.35 66.29 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.984 0.514 . . . . 71.33 111.125 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.5 tp -65.54 -57.76 7.42 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 112.738 0.644 . . . . 61.22 112.738 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.92 -49.34 35.84 Favored Glycine 0 C--N 1.362 2.0 0 N-CA-C 115.246 0.858 . . . . 71.04 115.246 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -67.79 20.07 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 115.207 1.558 . . . . 73.51 115.207 171.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.4 19.75 0.1 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 118.633 2.213 . . . . 41.23 118.633 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -62.2 -54.72 36.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 118.476 1.138 . . . . 71.32 111.079 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 pt -108.15 140.17 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.137 -1.392 . . . . 71.51 110.467 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.0 p -69.15 169.96 11.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.792 0.437 . . . . 73.45 111.604 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.69 -24.35 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.51 0 CA-C-N 116.006 -0.543 . . . . 74.15 111.323 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -68.4 -53.13 25.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.603 1.161 . . . . 54.32 110.965 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.8 -21.81 65.21 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.83 0.852 . . . . 72.1 111.57 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.19 -43.81 40.78 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.238 -1.023 . . . . 74.34 108.238 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.3 mt -66.18 -28.64 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 113.696 -1.593 . . . . 64.51 112.098 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -58.21 -50.9 71.93 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.832 -0.433 . . . . 65.14 109.832 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.37 65.05 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 114.743 0.657 . . . . 74.01 114.743 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -73.44 -33.3 64.84 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.136 0.575 . . . . 72.23 111.014 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.66 -12.11 78.4 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 115.669 -0.696 . . . . 63.34 112.405 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -97.7 11.74 36.08 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.575 1.15 . . . . 72.12 111.199 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.1 p -99.48 126.97 45.51 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.34 -0.615 . . . . 53.02 109.34 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -57.94 -15.6 9.36 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.458 0.703 . . . . 65.31 112.777 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.08 -59.35 3.87 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.038 0.935 . . . . 73.5 111.726 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -49.38 -48.85 46.58 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.292 1.219 . . . . 73.02 114.292 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 112' ' ' ILE . 3.2 mm? -62.32 -21.28 65.15 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.072 0.767 . . . . 52.41 113.072 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -76.14 -42.19 47.56 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.522 -0.918 . . . . 73.04 108.522 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.2 -64.11 1.21 Allowed 'General case' 0 C--N 1.371 1.519 0 CA-C-N 118.984 0.811 . . . . 75.0 111.846 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.461 ' CD1' HD13 ' A' ' 84' ' ' LEU . 23.1 m-85 -100.76 61.59 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.276 1.213 . . . . 74.21 114.276 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.531 ' HD1' HG21 ' A' ' 81' ' ' VAL . 31.2 t80 -171.73 -57.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 122.979 0.511 . . . . 64.24 112.099 168.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.6 m -59.14 -44.13 98.13 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 113.053 0.76 . . . . 61.23 113.053 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -96.5 16.83 0.72 Allowed 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.442 2.095 . . . . 73.3 113.945 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.55 144.02 51.22 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 112.588 0.588 . . . . 72.24 112.588 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.88 145.27 31.75 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.199 1.932 . . . . 64.23 112.637 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -21.92 -60.58 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.848 1.795 . . . . 63.52 115.848 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' HD12 ' A' ' 82' ' ' ILE . 18.5 m -66.03 -20.27 66.13 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.347 0.976 . . . . 74.11 113.099 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.57 -33.1 16.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.759 -1.2 . . . . 73.42 107.759 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.531 HG21 ' HD1' ' A' ' 73' ' ' TYR . 47.4 t -69.53 -29.06 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.578 -1.192 . . . . 42.54 110.106 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 79' ' ' THR . 90.0 mt -65.56 -43.08 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.262 0.625 . . . . 75.34 110.182 170.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.79 -65.14 0.77 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 117.575 0.171 . . . . 75.32 111.005 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.461 HD13 ' CD1' ' A' ' 72' ' ' PHE . 96.6 mt -49.06 -30.94 6.96 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.529 1.678 . . . . 70.34 115.529 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.33 -56.67 3.35 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 118.247 0.476 . . . . 73.05 112.77 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.482 HG23 HD12 ' A' ' 90' ' ' LEU . 86.6 m -60.17 -39.24 85.76 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.045 0.938 . . . . 73.32 112.734 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 87' ' ' LYS . 29.7 ttmt -71.82 -6.17 39.65 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.283 1.033 . . . . 75.15 113.49 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 27' ' ' ILE . 55.9 m170 -100.69 -32.78 10.56 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.21 -1.033 . . . . 75.34 108.21 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -96.72 -66.72 0.89 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.944 1.298 . . . . 74.11 110.358 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 86' ' ' THR . 52.6 mt -73.74 -13.78 61.02 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.538 0.335 . . . . 75.34 111.71 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.53 -19.29 4.01 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 115.874 1.11 . . . . 53.25 115.874 168.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.21 -174.25 2.51 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 117.593 0.697 . . . . 74.54 110.21 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.15 152.87 44.5 Favored Pre-proline 0 CA--C 1.557 1.224 0 O-C-N 121.722 -0.611 . . . . 61.12 110.151 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.01 153.52 8.72 Favored 'Trans proline' 0 CA--C 1.567 2.144 0 C-N-CA 122.966 2.444 . . . . 72.11 114.901 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.4 mt -78.62 -64.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.314 0.487 . . . . 74.21 112.314 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -114.46 -146.96 0.41 Allowed 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 104.598 -2.371 . . . . 75.11 104.598 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -97.5 -18.17 19.17 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-N 123.644 2.929 . . . . 73.51 108.655 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.26 -28.15 69.14 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.565 0.746 . . . . 65.34 111.663 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -70.67 -42.3 70.92 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 122.802 0.441 . . . . 74.13 111.021 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.3 mt -59.87 -38.97 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.515 0.726 . . . . 74.24 110.494 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -72.87 -30.31 63.87 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.914 -1.039 . . . . 62.52 110.827 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -67.69 -51.39 50.08 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.8 0.84 . . . . 73.45 110.262 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -65.64 -42.52 91.37 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.115 0.566 . . . . 75.33 112.17 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -45.3 -44.58 11.62 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.054 0.942 . . . . 75.23 112.84 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -70.95 -44.42 66.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.183 0.593 . . . . 73.41 111.601 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 73.6 mt -53.04 -53.62 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.774 0.83 . . . . 74.5 111.122 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -52.82 -42.36 65.06 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.122 1.369 . . . . 72.12 113.057 172.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.08 -55.07 13.84 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.028 0.531 . . . . 71.31 112.065 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.2 p -62.93 -62.7 1.54 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.685 0.794 . . . . 73.44 113.125 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -98.96 -52.36 3.58 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.841 0.856 . . . . 71.12 112.595 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.51 -148.4 17.17 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 116.555 -0.293 . . . . 62.52 113.261 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 107' ' ' LEU . 10.1 mm -79.3 -35.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.246 1.018 . . . . 70.24 112.037 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -59.39 -65.96 0.59 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.769 0.319 . . . . 65.21 110.38 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -49.29 -20.91 0.71 Allowed 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.361 1.986 . . . . 62.22 116.361 165.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -73.64 -62.75 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.309 1.413 . . . . 62.12 110.078 172.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 120' ' ' VAL . 50.3 mm -47.1 -59.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.07 0.948 . . . . 75.13 112.93 170.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -40.68 -46.28 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.52 0.933 . . . . 72.25 113.52 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 122' ' ' SER . . . -63.74 -23.08 67.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.864 0.691 . . . . 75.5 112.864 177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.36 -34.23 18.88 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.208 1.003 . . . . 71.32 111.205 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 116' ' ' ILE . 93.1 t -69.51 -60.44 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.349 1.06 . . . . 75.43 111.229 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -76.88 -5.4 48.29 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.219 0.608 . . . . 60.5 112.394 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 32.5 t -53.48 143.48 19.4 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.564 0.746 . . . . 75.1 111.25 173.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -70.81 -29.19 65.3 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.438 -0.578 . . . . 63.44 109.438 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.403 ' HB2' HD22 ' A' ' 90' ' ' LEU . 11.0 mm-40 -66.55 -48.82 68.48 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.089 0.956 . . . . 74.5 111.67 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.415 ' HB2' HD23 ' A' ' 90' ' ' LEU . 90.0 t80 -60.5 -48.26 82.54 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 120.838 0.351 . . . . 62.52 110.719 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.0 -27.28 68.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 115.301 -0.863 . . . . 74.25 112.197 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -91.55 -54.41 3.91 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.974 0.51 . . . . 60.12 112.355 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.19 -52.46 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.355 0.662 . . . . 64.42 111.924 -174.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.07 -41.6 9.46 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.167 0.587 . . . . 63.25 111.241 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.53 166.69 26.44 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.993 -0.549 . . . . 72.21 113.423 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.79 -33.11 60.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.418 0.687 . . . . 74.11 112.097 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -129.01 60.45 1.55 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.319 1.057 . . . . 72.24 110.458 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.3 m -153.74 145.71 23.6 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 114.128 -1.396 . . . . 73.45 108.868 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 82.9 t -68.07 134.28 91.68 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 123.567 0.747 . . . . 70.05 110.477 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.34 85.51 0.27 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.936 2.424 . . . . 44.22 111.542 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -58.13 161.61 4.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.595 1.158 . . . . 52.05 112.997 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -66.16 128.51 36.37 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.812 -1.086 . . . . 72.31 109.811 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 57.5 mmm-85 -80.4 26.92 0.36 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.767 0.827 . . . . 43.22 112.587 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -132.91 162.64 56.31 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.911 1.284 . . . . 72.14 109.69 -172.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.36 51.02 2.79 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.823 2.348 . . . . 54.15 113.924 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.9 p -116.56 -1.86 12.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.849 0.86 . . . . 74.31 111.834 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.18 -27.61 69.49 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.07 1.137 . . . . 73.4 114.07 -170.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.43 -7.72 27.49 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.158 0.983 . . . . 51.5 112.681 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -35.45 113.62 0.21 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 124.873 1.269 . . . . 74.25 114.263 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -64.62 128.77 37.18 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.935 0.894 . . . . 63.43 110.908 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -123.22 136.42 54.72 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.323 1.049 . . . . 74.42 110.998 -172.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -74.15 167.56 21.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.611 0.764 . . . . 62.14 111.84 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -88.95 133.93 34.14 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.546 -0.752 . . . . 74.12 110.779 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.8 t60 . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.711 0.804 . . . . 73.0 109.786 177.848 . . . . . . . . 0 0 . 1 stop_ save_